data_2m5y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m5y _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 110.15 -0.315 . . . . 74.099999999999994 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -93.53 178.07 5.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.42 0.688 . . . . 75.010000000000005 110.108 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.31 156.5 42.97 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.749 0.82 . . . . 74.209999999999994 109.666 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -128.52 170.56 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.464 0.706 . . . . 75.439999999999998 110.41 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 t -164.63 171.15 14.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.211 1.004 . . . . 73.140000000000001 109.438 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -135.78 163.54 29.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.026 0.93 . . . . 63.409999999999997 109.18 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.7 mtt -127.54 131.62 50.03 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.019 0.928 . . . . 64.349999999999994 108.698 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.5 p -111.9 141.49 45.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.411 0.684 . . . . 74.239999999999995 110.142 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.9 p -127.29 158.74 36.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.806 0.843 . . . . 71.340000000000003 110.108 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 t -143.4 162.27 36.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.628 0.771 . . . . 71.230000000000004 109.311 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.9 m -149.09 137.72 21.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.306 0.643 . . . . 74.109999999999999 109.942 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.51 165.87 12.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.55 0.74 . . . . 55.0 109.861 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.64 136.63 12.48 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.179 0.592 . . . . 73.549999999999997 109.884 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.53 139.26 37.17 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.075 2.516 . . . . 73.340000000000003 112.867 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 p -102.18 128.14 48.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.994 0.918 . . . . 74.409999999999997 109.899 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 m -87.88 121.98 30.96 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.569 0.748 . . . . 70.030000000000001 109.582 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 m -136.23 124.43 23.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.081 0.952 . . . . 65.120000000000005 109.066 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.2 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.044 0.938 . . . . 75.109999999999999 109.755 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.42 140.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.693 0.797 . . . . 70.439999999999998 109.525 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.98 136.88 19.65 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.096 0.959 . . . . 74.510000000000005 109.448 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo . . . . . 0 C--N 1.382 2.315 0 C-N-CA 123.22 2.613 . . . . 62.049999999999997 113.841 178.76 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.88 -0.415 . . . . 71.319999999999993 109.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.18 149.34 26.01 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.32 0.581 . . . . 75.319999999999993 110.799 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 64' ' ' THR . 48.1 t -114.9 146.57 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.312 1.045 . . . . 71.230000000000004 108.84 172.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.555 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.0 ptp180 -145.18 117.02 8.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.225 0.536 . . . . 73.129999999999995 111.571 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.52 111.9 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.311 0.644 . . . . 75.099999999999994 109.774 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 33.7 m-85 -101.08 118.76 37.63 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.187 0.595 . . . . 73.540000000000006 109.856 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.518 ' ND2' ' HB ' ' A' ' 120' ' ' VAL . 4.6 t-20 -95.9 125.36 40.4 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.345 -1.354 . . . . 75.420000000000002 107.345 169.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.764 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.6 tt -80.39 -34.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 111.931 0.345 . . . . 73.239999999999995 111.931 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -111.43 -20.52 12.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.689 0.396 . . . . 75.230000000000004 111.511 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.9 114.92 0.62 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.808 -0.517 . . . . 74.209999999999994 111.808 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.419 HG21 HD22 ' A' ' 41' ' ' ASN . 13.2 t -145.15 -155.67 0.63 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.059 -0.719 . . . . 65.340000000000003 109.059 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.98 154.78 25.52 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.587 1.155 . . . . 74.150000000000006 112.477 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.33 -1.8 16.56 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 115.455 -0.793 . . . . 74.25 114.691 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.69 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.028 0.931 . . . . 74.129999999999995 111.58 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 120' ' ' VAL . . . -66.4 -49.26 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.354 -0.839 . . . . 65.209999999999994 110.863 173.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB1' HG22 ' A' ' 66' ' ' VAL . . . -71.3 -20.47 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.465 0.706 . . . . 75.030000000000001 111.753 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -28.97 69.07 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.603 0.761 . . . . 74.299999999999997 111.354 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.519 ' HB ' HG11 ' A' ' 94' ' ' VAL . 68.5 p -62.87 -40.99 99.19 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.486 0.492 . . . . 74.530000000000001 110.346 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 64' ' ' THR . . . -66.27 -37.41 85.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.055 0.942 . . . . 74.239999999999995 111.809 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -65.44 -51.73 58.12 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.584 -0.735 . . . . 74.409999999999997 110.946 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -67.76 -26.22 66.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.572 -1.194 . . . . 74.340000000000003 110.836 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 37' ' ' VAL . 18.3 tp -76.3 -49.85 15.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.949 -1.023 . . . . 62.210000000000001 111.198 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 34.9 ttpt -63.19 -35.82 81.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.915 0.486 . . . . 74.310000000000002 110.685 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -22.49 62.14 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 54.219999999999999 111.341 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.67 57.83 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.413 0.685 . . . . 75.439999999999998 111.36 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.37 41.17 0.98 Allowed Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.445 -0.343 . . . . 75.530000000000001 113.069 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -106.25 156.9 18.0 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.304 0.642 . . . . 74.209999999999994 109.927 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.4 m -66.95 -69.48 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.275 0.984 . . . . 71.430000000000007 111.361 -161.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.29 136.76 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.188 -1.042 . . . . 72.209999999999994 108.188 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 53' ' ' ALA . 73.7 p -129.55 94.9 3.87 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.937 -0.764 . . . . 71.109999999999999 108.937 172.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -103.63 131.56 50.67 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.644 0.778 . . . . 72.150000000000006 109.663 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.475 HG22 ' HB1' ' A' ' 50' ' ' ALA . 6.4 p -116.3 131.11 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 121.712 -0.617 . . . . 75.409999999999997 110.638 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -150.27 159.76 28.25 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.648 -0.705 . . . . 54.240000000000002 111.618 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -95.04 119.8 34.17 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.744 -0.836 . . . . 54.310000000000002 108.744 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.5 tt -150.64 133.93 16.25 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.004 -1.11 . . . . 74.319999999999993 108.004 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.764 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.9 m -80.85 100.07 8.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.361 0.665 . . . . 73.329999999999998 109.882 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.61 106.21 8.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.166 -0.679 . . . . 61.329999999999998 109.166 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.71 0.47 9.99 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.695 2.263 . . . . 74.409999999999997 112.465 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -95.83 -23.4 16.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.249 1.019 . . . . 74.310000000000002 110.647 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.739 HG23 HG13 ' A' ' 119' ' ' VAL . 14.3 m -97.27 155.49 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.291 0.636 . . . . 74.340000000000003 109.865 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.29 9.28 2.28 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.702 0.801 . . . . 73.109999999999999 110.586 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.46 156.51 33.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.74 1.216 . . . . 74.530000000000001 108.611 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -59.2 111.89 1.51 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.053 -0.721 . . . . 74.140000000000001 109.053 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.8 m -138.45 127.95 24.72 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.313 -0.858 . . . . 74.409999999999997 110.611 -168.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.592 HG23 HG13 ' A' ' 118' ' ' VAL . 50.3 t -102.4 113.19 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.784 -1.191 . . . . 72.129999999999995 107.784 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 117' ' ' ILE . 1.4 t80 -98.87 142.47 30.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.969 1.308 . . . . 75.239999999999995 109.926 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 22.5 p90 -133.06 164.56 26.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.459 -0.792 . . . . 72.319999999999993 111.2 168.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.1 m -107.48 172.41 6.84 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 106.895 -1.521 . . . . 74.099999999999994 106.895 163.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.53 28.41 8.76 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.91 0.484 . . . . 74.200000000000003 111.176 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 84.6 t -77.17 126.25 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.416 -0.957 . . . . 74.319999999999993 108.416 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.92 -80.48 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.267 1.027 . . . . 73.340000000000003 110.912 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.56 35.6 0.23 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.9 -0.48 . . . . 74.439999999999998 111.9 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 48.9 mt-10 -61.8 -19.64 62.74 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.172 0.589 . . . . 73.219999999999999 112.269 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.429 ' HA ' ' CG ' ' A' ' 81' ' ' TYR . 41.0 ptt85 -63.08 -28.8 70.33 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.287 0.477 . . . . 74.409999999999997 112.287 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.37 82.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.723 0.809 . . . . 64.120000000000005 111.798 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.7 t -67.67 -46.52 72.13 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.422 -0.354 . . . . 74.219999999999999 111.151 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 79' ' ' VAL . . . -71.98 -27.72 62.94 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.744 0.417 . . . . 63.340000000000003 111.934 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.04 -33.8 76.91 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.529 0.732 . . . . 73.299999999999997 110.496 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.42 -47.64 19.26 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.662 -0.699 . . . . 72.209999999999994 110.509 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.519 HG11 ' HB ' ' A' ' 52' ' ' THR . 98.8 t -68.95 -33.66 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.468 0.707 . . . . 72.430000000000007 111.757 -175.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.583 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -58.54 -29.08 63.3 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.347 -0.388 . . . . 72.430000000000007 112.561 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -86.96 -30.89 20.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.282 0.633 . . . . 74.25 111.018 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.2 m -64.34 -43.24 95.23 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.644 0.735 . . . . 74.310000000000002 110.546 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.43 HD21 HG21 ' A' ' 120' ' ' VAL . 57.3 tp -85.29 -32.15 22.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.59 -1.186 . . . . 72.420000000000002 110.204 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 66.8 1.96 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.432 -1.067 . . . . 63.520000000000003 110.432 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.97 166.44 24.47 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.553 1.141 . . . . 65.109999999999999 110.359 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.32 110.99 7.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.429 0.691 . . . . 64.25 109.325 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.583 HG22 ' HA3' ' A' ' 95' ' ' GLY . 5.4 t -86.63 134.03 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.26 -1.015 . . . . 73.239999999999995 108.26 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -140.39 153.12 46.23 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-O 121.402 0.62 . . . . 73.430000000000007 111.013 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HA ' ' CE1' ' A' ' 81' ' ' TYR . 6.2 mp -76.78 -163.62 0.36 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 114.342 -1.299 . . . . 72.209999999999994 110.331 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -70.63 28.61 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 72.450000000000003 112.823 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 33.8 tp -70.88 -48.72 14.49 Favored Pre-proline 0 CA--C 1.568 1.641 0 O-C-N 121.601 -0.687 . . . . 74.209999999999994 111.265 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 106' ' ' LEU . 51.0 Cg_exo -58.39 -12.91 14.87 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 122.819 2.346 . . . . 74.439999999999998 114.006 170.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -66.37 -35.08 79.42 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.25 0.62 . . . . 72.510000000000005 109.651 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.1 tp -82.7 -34.15 27.4 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.911 0.386 . . . . 75.310000000000002 110.098 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -68.62 -48.78 63.21 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.454 -0.793 . . . . 74.140000000000001 111.335 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -126.86 -33.99 2.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.635 0.774 . . . . 64.349999999999994 111.554 -172.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.91 72.96 0.33 Allowed Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.766 1.226 . . . . 75.219999999999999 109.503 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.508 ' HB3' HD12 ' A' ' 117' ' ' ILE . 5.9 Cg_exo -81.92 148.38 15.43 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 123.407 2.738 . . . . 71.340000000000003 112.148 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.72 119.2 5.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.284 2.656 . . . . 71.329999999999998 112.938 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.17 -113.33 5.75 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.927 0.767 . . . . 63.530000000000001 112.867 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.1 t -116.45 136.87 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.964 1.306 . . . . 71.310000000000002 108.098 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.555 HG22 ' HG3' ' A' ' 38' ' ' ARG . 11.8 pt -128.68 149.95 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.304 -0.628 . . . . 74.120000000000005 109.304 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.592 HG13 HG23 ' A' ' 79' ' ' VAL . 59.2 t -117.54 102.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.114 -1.439 . . . . 72.430000000000007 107.114 175.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.739 HG13 HG23 ' A' ' 74' ' ' VAL . 23.8 t -94.18 126.04 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.108 -0.701 . . . . 74.340000000000003 109.108 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.518 ' HB ' ' ND2' ' A' ' 41' ' ' ASN . 21.5 t -115.82 128.09 73.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.558 -0.904 . . . . 72.239999999999995 108.558 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.433 HG23 HG21 ' A' ' 42' ' ' ILE . 19.7 p -95.17 137.48 34.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.214 0.605 . . . . 75.5 109.492 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 119.022 -0.877 . . . . 73.439999999999998 111.96 -177.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.623 -0.51 . . . . 71.439999999999998 109.623 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 p -130.42 111.02 11.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.225 1.01 . . . . 63.240000000000002 109.066 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.15 113.35 1.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.075 0.55 . . . . 74.420000000000002 109.756 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -150.8 114.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.726 0.81 . . . . 72.439999999999998 109.708 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -133.59 120.37 20.64 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.081 0.952 . . . . 65.040000000000006 108.636 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -151.79 109.22 3.6 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.743 0.817 . . . . 74.329999999999998 109.395 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.42 145.38 11.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.295 1.038 . . . . 74.230000000000004 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 142.85 24.79 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.098 0.475 . . . . 75.349999999999994 111.001 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -139.95 131.01 26.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 74.329999999999998 109.107 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -157.41 137.4 12.51 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.048 0.939 . . . . 74.299999999999997 109.311 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.7 m -147.56 102.95 3.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.426 0.69 . . . . 74.239999999999995 109.593 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 107.97 19.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.464 0.706 . . . . 65.299999999999997 109.261 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.26 111.7 44.92 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.589 0.756 . . . . 73.349999999999994 109.747 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.59 169.46 15.3 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.967 2.444 . . . . 75.310000000000002 112.304 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -152.86 119.99 5.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.583 0.753 . . . . 72.25 109.545 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 m -90.41 172.3 8.83 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.994 0.517 . . . . 62.200000000000003 109.836 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 m -132.04 144.22 50.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.119 0.568 . . . . 72.329999999999998 110.655 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 161.93 27.19 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.484 1.114 . . . . 75.120000000000005 110.145 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.89 140.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.103 0.561 . . . . 73.200000000000003 109.803 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.44 113.18 64.7 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.416 -0.957 . . . . 73.439999999999998 108.416 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.37 1.7 0 C-N-CA 122.494 2.129 . . . . 74.409999999999997 111.511 176.262 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.99 -0.374 . . . . 61.329999999999998 109.99 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HG3' ' HB ' ' A' ' 63' ' ' VAL . 28.9 tt0 -98.77 107.74 20.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.038 0.535 . . . . 71.319999999999993 110.044 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.458 HG22 HD22 ' A' ' 56' ' ' LEU . 22.1 t -95.64 135.89 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.194 0.598 . . . . 74.349999999999994 109.742 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.531 ' HD3' ' HE2' ' A' ' 40' ' ' TYR . 7.9 ptp180 -150.74 134.85 16.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.854 0.861 . . . . 74.25 110.573 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HA ' HG11 ' A' ' 118' ' ' VAL . 41.0 t -100.5 133.28 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 65.120000000000005 109.545 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.531 ' HE2' ' HD3' ' A' ' 38' ' ' ARG . 69.6 m-85 -130.12 107.77 9.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.683 0.793 . . . . 73.299999999999997 109.735 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -84.39 118.03 23.99 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.988 -0.745 . . . . 72.030000000000001 108.988 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.709 HG13 ' HA ' ' A' ' 70' ' ' SER . 17.0 tt -78.86 -33.21 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.113 -0.329 . . . . 74.420000000000002 110.113 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -99.1 -162.48 0.96 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.18 0.992 . . . . 74.129999999999995 109.619 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.71 116.12 8.5 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 123.575 0.547 . . . . 71.239999999999995 112.312 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -69.96 101.63 1.82 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.738 0.78 . . . . 73.049999999999997 110.692 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.77 145.53 27.2 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.999 -0.546 . . . . 71.239999999999995 109.862 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -58.02 -38.41 89.12 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 124.42 1.075 . . . . 55.039999999999999 114.377 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.61 68.43 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.775 0.83 . . . . 64.129999999999995 112.398 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.71 71.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.715 0.806 . . . . 72.299999999999997 111.731 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.41 -23.62 37.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.318 0.647 . . . . 74.129999999999995 111.441 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 41.9 mmm-85 -64.75 -21.71 66.82 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.141 0.577 . . . . 74.120000000000005 112.004 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.5 p -61.54 -45.97 91.91 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.905 0.482 . . . . 74.409999999999997 110.052 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.9 84.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.66 0.784 . . . . 55.030000000000001 111.363 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -42.49 95.91 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.181 0.926 . . . . 74.530000000000001 111.968 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -63.2 -46.21 88.1 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.852 -0.613 . . . . 74.319999999999993 110.636 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.458 HD22 HG22 ' A' ' 37' ' ' VAL . 10.5 mp -72.68 -26.85 61.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.506 -0.77 . . . . 72.430000000000007 111.634 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.16 -51.17 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.076 -1.083 . . . . 75.409999999999997 108.076 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.99 59.38 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.708 -1.133 . . . . 72.129999999999995 112.128 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.76 -22.45 37.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.054 0.542 . . . . 74.349999999999994 110.571 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 44.03 5.54 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.054 -0.521 . . . . 70.030000000000001 113.782 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.65 158.64 30.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 74.230000000000004 109.448 169.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 m -58.02 -52.29 66.11 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.165 0.916 . . . . 74.530000000000001 111.302 -159.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 73.9 t -135.72 139.55 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.328 -0.99 . . . . 73.299999999999997 108.328 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 p -134.68 113.77 12.03 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.351 1.061 . . . . 74.010000000000005 108.485 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 22.8 t70 -128.38 154.91 45.5 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.817 0.847 . . . . 63.43 109.373 -171.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.62 153.66 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.392 0.615 . . . . 73.120000000000005 110.503 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.42 169.96 42.32 Favored Glycine 0 C--O 1.245 0.806 0 CA-C-N 114.783 -1.099 . . . . 72.340000000000003 110.51 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -146.32 116.61 7.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.262 -1.014 . . . . 55.119999999999997 108.262 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 mt -148.89 136.35 20.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.693 0.797 . . . . 75.510000000000005 109.411 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.709 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 m -76.52 97.94 4.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.404 -0.961 . . . . 54.240000000000002 108.404 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.8 119.8 70.0 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.861 -0.792 . . . . 72.230000000000004 108.861 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.76 -2.92 12.86 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.267 1.978 . . . . 70.409999999999997 112.712 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.09 -26.16 17.58 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.003 0.921 . . . . 73.209999999999994 111.829 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.08 140.21 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.308 0.643 . . . . 73.140000000000001 110.189 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.3 33.21 3.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.336 0.654 . . . . 74.349999999999994 110.073 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.14 149.87 50.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.527 0.731 . . . . 70.349999999999994 109.848 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.545 ' HB ' ' H ' ' A' ' 121' ' ' THR . 5.6 t -78.89 102.49 8.26 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 121.972 0.891 . . . . 74.299999999999997 108.73 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.5 m -149.8 143.35 25.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.169 -0.923 . . . . 70.120000000000005 108.971 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 23.2 t -93.92 114.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.527 -1.286 . . . . 74.349999999999994 107.527 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' HB2' HG12 ' A' ' 117' ' ' ILE . 96.8 m-85 -101.08 142.52 32.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.629 -1.249 . . . . 73.430000000000007 107.629 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -130.73 151.95 50.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.629 -0.508 . . . . 75.25 109.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.415 HG22 HG21 ' A' ' 84' ' ' VAL . 28.0 m -92.37 147.1 23.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.526 -1.287 . . . . 74.430000000000007 107.526 168.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.34 22.74 1.2 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.396 0.678 . . . . 74.439999999999998 112.661 -173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 82' ' ' THR . 84.3 t -62.31 99.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.067 -0.716 . . . . 71.310000000000002 109.067 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.25 12.6 2.64 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.445 1.098 . . . . 71.030000000000001 112.182 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.32 62.65 2.05 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 120.243 -0.198 . . . . 72.239999999999995 113.401 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.71 -16.74 51.75 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.38 0.672 . . . . 73.310000000000002 111.524 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -26.1 6.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.047 0.939 . . . . 74.329999999999998 112.758 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.51 -53.21 60.73 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.774 0.671 . . . . 71.430000000000007 111.148 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -74.34 -32.61 62.87 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 116.293 -0.412 . . . . 62.119999999999997 110.694 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.56 75.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.393 0.677 . . . . 74.439999999999998 112.241 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HA ' HG11 ' A' ' 102' ' ' VAL . 29.2 t70 -64.96 -43.13 93.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.219 1.008 . . . . 71.310000000000002 110.01 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.38 80.15 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.366 1.041 . . . . 70.319999999999993 111.846 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.58 -56.4 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 123.649 0.593 . . . . 74.340000000000003 110.389 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.72 67.55 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.89 0.744 . . . . 72.230000000000004 113.842 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -69.63 -47.16 64.35 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.256 1.022 . . . . 75.409999999999997 109.666 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.6 m -75.81 -35.92 59.89 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.972 -1.013 . . . . 72.439999999999998 111.03 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.01 -30.49 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.569 -0.741 . . . . 75.310000000000002 110.193 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.01 55.53 4.38 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.447 -0.661 . . . . 62.340000000000003 111.447 -175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.1 160.76 39.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.64 0.776 . . . . 74.439999999999998 110.266 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 142.18 52.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.065 0.946 . . . . 72.420000000000002 110.442 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 92' ' ' ASP . 35.9 m -103.11 131.45 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.48 -0.933 . . . . 72.049999999999997 108.48 171.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 49.5 mt-10 -140.83 159.73 41.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.478 1.111 . . . . 74.310000000000002 109.528 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.48 158.61 35.76 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.225 -0.657 . . . . 74.010000000000005 109.225 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 14.0 ptt180 -50.06 -41.74 48.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.044 1.338 . . . . 74.540000000000006 112.585 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.9 mt 67.34 158.76 0.14 Allowed Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 123.533 0.733 . . . . 72.019999999999996 110.222 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.36 -24.14 41.46 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.41 2.073 . . . . 72.430000000000007 113.701 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.2 -54.97 6.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.277 1.031 . . . . 61.530000000000001 111.54 -174.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 2.7 mm? -76.47 -20.14 57.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 116.508 -0.314 . . . . 74.099999999999994 110.258 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -69.02 -11.54 60.88 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.041 0.536 . . . . 74.530000000000001 111.856 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.34 -32.2 19.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.388 0.675 . . . . 75.129999999999995 110.713 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.5 pp0? -89.57 168.04 16.01 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 117.639 -1.172 . . . . 53.140000000000001 109.0 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 30.3 Cg_exo -29.34 122.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.406 3.568 1 C-N-CA 125.309 4.006 . . . . 63.130000000000003 116.685 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.11 161.12 47.03 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.15 2.567 . . . . 75.25 113.07 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 -158.95 14.04 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.253 -0.885 . . . . 65.420000000000002 111.207 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.7 t -83.54 108.35 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.891 0.877 . . . . 64.299999999999997 109.626 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.55 HD11 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.31 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.592 -0.892 . . . . 75.400000000000006 108.592 173.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' A' ' 39' ' ' VAL . 1.4 p -95.53 105.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.447 -0.946 . . . . 61.219999999999999 108.447 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 4.0 p -94.07 123.48 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.619 -0.882 . . . . 75.25 108.619 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.65 132.51 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.397 0.679 . . . . 73.519999999999996 109.946 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.545 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.0 t -119.89 151.61 38.63 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.058 -1.09 . . . . 62.420000000000002 108.058 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.297 0 CA-C-O 118.978 -0.901 . . . . 71.129999999999995 112.147 178.563 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 109.76 -0.459 . . . . 65.120000000000005 109.76 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -71.43 104.75 3.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.379 -0.828 . . . . 72.310000000000002 108.941 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.63 118.36 4.99 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.372 0.669 . . . . 72.230000000000004 110.134 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.95 155.99 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.292 1.037 . . . . 74.340000000000003 109.138 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.4 m -150.89 144.15 24.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.919 0.887 . . . . 73.420000000000002 109.386 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -160.88 160.85 31.49 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.878 0.871 . . . . 72.209999999999994 110.272 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 53.2 ttp -171.76 113.28 0.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.78 -1.193 . . . . 74.109999999999999 107.78 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -61.45 114.11 3.04 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.253 0.621 . . . . 73.340000000000003 110.563 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -70.22 -41.75 73.2 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.401 0.68 . . . . 75.420000000000002 111.393 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.2 m 68.55 152.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.981 1.313 . . . . 74.420000000000002 110.946 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.3 t -158.67 174.69 14.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.093 0.557 . . . . 73.409999999999997 110.329 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.18 148.87 28.77 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.113 0.965 . . . . 72.329999999999998 109.415 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.69 107.2 34.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 108.896 -0.779 . . . . 64.25 108.896 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.99 132.22 3.26 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.761 2.307 . . . . 73.219999999999999 112.472 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.3 p -123.21 124.34 42.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.877 0.471 . . . . 72.120000000000005 110.643 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m -149.02 118.23 6.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.495 1.118 . . . . 72.349999999999994 108.027 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 p -132.82 145.69 51.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.045 0.938 . . . . 74.530000000000001 109.216 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.3 p -144.91 120.15 10.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.182 0.593 . . . . 73.329999999999998 110.102 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 139.67 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.54 -0.911 . . . . 63.310000000000002 108.54 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.55 157.55 41.13 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 123.344 0.658 . . . . 74.25 110.322 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.383 2.379 0 C-N-CA 123.062 2.508 . . . . 75.129999999999995 113.042 177.138 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.62 ' HB1' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 108.358 -0.979 . . . . 52.240000000000002 108.358 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.656 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -95.86 87.8 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.581 . . . . 72.140000000000001 109.616 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 94' ' ' VAL . 47.1 t -117.59 142.12 33.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.184 -0.462 . . . . 71.099999999999994 110.782 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.6 158.52 43.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.293 -0.412 . . . . 72.519999999999996 111.383 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.08 129.11 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.37 0.668 . . . . 72.540000000000006 110.244 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 19.0 m-85 -109.86 107.83 17.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.316 1.046 . . . . 73.340000000000003 108.323 163.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -93.31 112.73 24.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.169 -1.789 . . . . 75.340000000000003 106.169 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.673 HG13 ' HA ' ' A' ' 70' ' ' SER . 13.5 tt -73.11 -45.21 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.037 -0.414 . . . . 64.400000000000006 111.33 -172.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -29.41 28.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 72.019999999999996 110.591 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.33 54.28 13.95 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 123.734 0.646 . . . . 72.420000000000002 113.016 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.91 0.484 . . . . 72.230000000000004 110.584 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 49' ' ' ALA . 10.1 tp10 -63.77 121.81 14.9 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.403 0.52 . . . . 75.030000000000001 112.403 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.75 -23.8 51.8 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.861 -0.608 . . . . 73.430000000000007 112.291 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 52' ' ' THR . . . -65.09 -27.07 68.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.157 0.583 . . . . 65.150000000000006 110.852 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' H ' ' HG3' ' A' ' 46' ' ' GLU . . . -57.17 -47.34 81.46 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 124.032 0.833 . . . . 74.540000000000006 110.931 173.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.22 77.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.73 -0.668 . . . . 73.25 111.368 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -69.99 -22.68 63.11 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.326 1.051 . . . . 74.120000000000005 111.139 -172.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 98' ' ' LEU . 75.5 p -67.98 -49.82 59.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.262 0.225 . . . . 73.140000000000001 111.488 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -22.03 61.63 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.233 0.539 . . . . 63.329999999999998 111.209 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.94 -47.83 60.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.247 . . . . 65.400000000000006 110.512 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -70.71 -30.86 67.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.654 -0.498 . . . . 73.319999999999993 109.654 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.468 HD23 HG22 ' A' ' 64' ' ' THR . 53.4 tp -66.16 -33.29 75.45 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.337 -0.847 . . . . 73.450000000000003 111.295 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -58.4 -43.13 88.46 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.725 -0.843 . . . . 75.329999999999998 108.725 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.3 -18.88 54.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.211 1.004 . . . . 71.340000000000003 112.319 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.34 42.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 75.019999999999996 112.038 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.12 46.72 0.69 Allowed Glycine 0 C--N 1.348 1.232 0 O-C-N 123.106 0.254 . . . . 60.229999999999997 112.503 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -60.4 158.04 12.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.518 1.127 . . . . 71.140000000000001 112.145 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 m -109.69 -43.52 4.03 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.714 -0.847 . . . . 64.099999999999994 108.714 164.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 83.3 t -135.63 128.37 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.194 0.998 . . . . 73.549999999999997 108.597 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.468 HG22 HD23 ' A' ' 56' ' ' LEU . 3.2 p -130.31 116.79 18.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 53.210000000000001 108.534 173.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -121.19 158.76 27.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.419 -0.956 . . . . 71.120000000000005 108.419 172.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.24 140.1 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.452 0.701 . . . . 73.129999999999995 109.986 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.87 146.5 11.36 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.725 -0.55 . . . . 65.030000000000001 111.725 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.11 113.1 26.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.532 0.733 . . . . 71.239999999999995 109.481 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.4 mp -145.22 136.05 24.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.97 -0.456 . . . . 71.010000000000005 110.303 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.673 ' HA ' HG13 ' A' ' 42' ' ' ILE . 26.9 p -73.64 99.96 3.23 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 123.853 0.721 . . . . 73.230000000000004 109.722 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 74' ' ' VAL . 62.2 mt -93.17 123.75 59.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.926 -0.398 . . . . 75.310000000000002 109.926 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.71 -6.6 16.21 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.067 2.511 . . . . 75.340000000000003 113.853 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -90.06 -23.61 21.39 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.0 0.52 . . . . 73.319999999999993 110.676 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.678 HG21 HG13 ' A' ' 119' ' ' VAL . 28.9 m -104.0 148.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.641 0.734 . . . . 73.400000000000006 110.901 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.09 13.29 1.63 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.452 -1.249 . . . . 75.409999999999997 109.024 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.02 154.74 26.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.984 1.314 . . . . 75.439999999999998 108.366 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -71.93 111.73 7.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.05 0.54 . . . . 75.219999999999999 109.993 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -144.28 134.21 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.683 0.793 . . . . 74.120000000000005 111.166 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.663 HG23 HG21 ' A' ' 118' ' ' VAL . 21.0 t -99.28 117.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.304 1.042 . . . . 71.400000000000006 109.173 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.423 ' HE1' HD12 ' A' ' 106' ' ' LEU . 92.0 m-85 -94.89 120.06 34.48 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 109.155 -0.684 . . . . 74.439999999999998 109.155 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.642 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 11.4 p90 -134.53 175.54 9.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.899 0.857 . . . . 71.439999999999998 111.623 175.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 m -139.13 161.3 37.73 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.138 -1.43 . . . . 75.519999999999996 107.138 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -92.27 30.46 1.46 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.051 0.54 . . . . 62.520000000000003 111.369 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.64 100.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 123.655 0.782 . . . . 60.109999999999999 109.489 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.03 -75.33 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.808 1.243 . . . . 74.420000000000002 111.417 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.61 22.95 1.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.384 -0.371 . . . . 74.340000000000003 112.718 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.73 -28.6 65.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.998 0.519 . . . . 73.209999999999994 111.847 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -66.41 -48.24 70.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.051 -0.722 . . . . 73.430000000000007 109.051 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.87 -38.16 85.81 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.715 0.806 . . . . 72.129999999999995 111.535 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.62 HG21 ' HB1' ' A' ' 35' ' ' ALA . 28.4 m -66.64 -49.0 67.64 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 64.340000000000003 109.721 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.5 -32.3 73.56 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.744 -1.116 . . . . 63.539999999999999 112.763 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.82 -43.72 97.85 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.171 0.919 . . . . 73.420000000000002 110.031 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.58 98.65 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.146 0.904 . . . . 75.319999999999993 111.325 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 37' ' ' VAL . 86.3 t -64.35 -53.57 41.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 C-N-CA 124.202 1.001 . . . . 75.519999999999996 111.45 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.492 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -71.96 -21.79 78.96 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.29 -0.868 . . . . 60.32 113.463 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -73.81 -41.92 61.67 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.38 -0.6 . . . . 74.120000000000005 109.38 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -61.46 -39.82 92.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.409 -0.814 . . . . 75.109999999999999 110.942 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.744 HD12 ' HB1' ' A' ' 100' ' ' ALA . 2.6 tm? -74.91 -35.77 62.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.822 0.449 . . . . 73.230000000000004 110.812 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.55 51.84 7.9 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.275 -0.73 . . . . 75.030000000000001 111.275 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.744 ' HB1' HD12 ' A' ' 98' ' ' LEU . . . -109.37 168.0 9.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.425 1.09 . . . . 71.340000000000003 109.996 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.39 104.02 5.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.954 -0.758 . . . . 75.400000000000006 108.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.642 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.3 m -83.35 130.97 34.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.281 -1.007 . . . . 74.439999999999998 108.281 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -153.46 159.79 42.41 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.372 0.606 . . . . 63.210000000000001 110.875 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.29 -178.01 0.16 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.981 1.313 . . . . 74.420000000000002 111.731 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 106' ' ' LEU . 8.4 ptm180 -53.92 -43.52 69.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.84 0.856 . . . . 73.109999999999999 112.91 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.435 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 77.3 mt 62.4 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.566 1.578 0 C-N-CA 124.501 1.12 . . . . 74.319999999999993 111.591 -172.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.08 -17.61 39.19 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.302 2.001 . . . . 74.340000000000003 113.0 167.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -26.11 63.76 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.876 0.87 . . . . 74.420000000000002 111.606 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.95 -23.54 66.63 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 111.78 0.289 . . . . 74.400000000000006 111.78 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 m -60.03 -36.62 77.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.181 0.592 . . . . 64.409999999999997 110.893 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.05 -32.31 22.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.838 0.855 . . . . 74.310000000000002 111.261 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -80.0 157.46 73.69 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.587 0.755 . . . . 72.230000000000004 109.176 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.14 125.53 15.39 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.12 1.88 . . . . 74.329999999999998 111.389 170.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.62 120.27 7.56 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.357 2.705 . . . . 74.530000000000001 113.706 -174.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.74 -178.39 22.62 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.284 -1.126 . . . . 73.430000000000007 110.284 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.5 123.82 34.81 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.178 0.513 . . . . 73.140000000000001 110.849 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.53 135.52 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.105 -1.072 . . . . 74.120000000000005 108.105 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.663 HG21 HG23 ' A' ' 79' ' ' VAL . 2.4 p -105.24 106.0 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.388 -1.338 . . . . 73.340000000000003 107.388 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.678 HG13 HG21 ' A' ' 74' ' ' VAL . 15.8 t -93.35 121.97 44.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.954 -0.758 . . . . 73.239999999999995 108.954 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.99 129.47 73.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.164 0.986 . . . . 72.209999999999994 109.583 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -91.56 162.29 14.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.909 0.756 . . . . 73.219999999999999 110.273 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.592 0 CA-C-N 115.485 -0.78 . . . . 70.200000000000003 113.435 -179.271 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.774 0.321 . . . . 74.349999999999994 111.032 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -119.45 133.52 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.776 0.83 . . . . 74.349999999999994 109.546 172.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 148.62 24.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.87 0.868 . . . . 64.420000000000002 109.944 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -156.61 134.67 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.241 0.616 . . . . 73.340000000000003 109.952 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.5 p -146.05 166.4 26.2 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.308 0.643 . . . . 72.010000000000005 110.469 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -156.55 162.55 39.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.103 0.961 . . . . 75.209999999999994 109.769 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 146.07 32.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.35 0.66 . . . . 75.400000000000006 110.704 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.0 m -147.21 135.38 21.54 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 71.030000000000001 110.393 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 m -97.27 148.26 23.29 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.451 1.1 . . . . 73.25 110.824 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -126.17 100.64 6.41 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.266 1.027 . . . . 73.299999999999997 108.353 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 t -77.3 149.0 35.39 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.975 0.51 . . . . 74.109999999999999 110.905 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.71 167.85 16.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.551 0.74 . . . . 75.209999999999994 110.847 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.14 146.08 32.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.659 0.783 . . . . 60.439999999999998 110.845 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.46 166.34 29.64 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.986 2.457 . . . . 75.25 112.646 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 t -157.66 154.76 28.88 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.968 0.507 . . . . 73.340000000000003 111.04 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.8 m -146.64 130.36 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.983 0.913 . . . . 74.299999999999997 109.61 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 p -120.44 151.1 39.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.941 0.896 . . . . 63.109999999999999 110.314 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 p -158.69 146.48 18.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.666 0.786 . . . . 71.430000000000007 109.871 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.54 155.55 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.642 0.777 . . . . 75.430000000000007 109.783 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -107.64 140.75 21.87 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.652 0.781 . . . . 75.25 110.213 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo . . . . . 0 C--N 1.378 2.113 0 C-N-CA 123.16 2.573 . . . . 73.209999999999994 113.054 178.937 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.989 -0.745 . . . . 74.040000000000006 108.989 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -118.53 132.8 56.21 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.716 0.806 . . . . 73.200000000000003 109.568 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.487 ' HA ' HG11 ' A' ' 116' ' ' VAL . 12.1 t -95.78 142.36 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.961 0.904 . . . . 75.310000000000002 110.225 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HG3' HG22 ' A' ' 117' ' ' ILE . 7.9 ptm180 -151.23 126.4 9.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.096 0.406 . . . . 74.299999999999997 112.096 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.528 ' HA ' HG11 ' A' ' 118' ' ' VAL . 16.6 t -101.0 111.2 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.086 0.954 . . . . 54.140000000000001 110.5 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -99.41 107.3 19.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.182 0.515 . . . . 72.040000000000006 110.236 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -98.0 110.91 23.4 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.388 -1.338 . . . . 75.519999999999996 107.388 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.619 ' HB ' HG11 ' A' ' 74' ' ' VAL . 4.8 tt -78.34 -50.7 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.953 0.406 . . . . 73.400000000000006 111.121 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -83.85 -2.68 56.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.274 -0.875 . . . . 64.209999999999994 111.504 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.32 59.6 8.69 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 111.623 -0.591 . . . . 62.009999999999998 111.623 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -78.59 -172.71 3.05 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.909 0.884 . . . . 74.319999999999993 111.063 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 43.2 tt0 -53.71 139.79 31.42 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.371 1.068 . . . . 62.299999999999997 111.384 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.92 -9.66 53.76 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.722 0.649 . . . . 71.010000000000005 114.722 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.516 ' H ' ' HG2' ' A' ' 46' ' ' GLU . . . -67.23 -22.48 65.69 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.354 0.577 . . . . 73.010000000000005 111.25 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.562 ' HB2' HG21 ' A' ' 120' ' ' VAL . . . -68.58 -39.68 80.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.291 0.636 . . . . 74.530000000000001 110.405 171.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.58 52.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.327 0.651 . . . . 72.030000000000001 111.355 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 24.0 tpp180 -70.82 -15.77 62.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.226 1.01 . . . . 74.510000000000005 111.205 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.468 ' O ' HD13 ' A' ' 56' ' ' LEU . 78.4 p -61.63 -47.01 87.35 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.874 -0.417 . . . . 74.519999999999996 109.874 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.49 61.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.204 0.601 . . . . 64.200000000000003 111.2 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 25.5 t70 -60.04 -35.37 74.96 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.206 0.602 . . . . 72.230000000000004 111.465 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.481 HH21 HD12 ' A' ' 56' ' ' LEU . 52.6 ttp180 -64.41 -40.83 96.55 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.598 0.759 . . . . 71.420000000000002 110.232 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.481 HD12 HH21 ' A' ' 55' ' ' ARG . 9.8 mp -65.23 -34.44 78.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.451 -0.795 . . . . 65.25 110.645 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.62 -41.0 93.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.861 0.464 . . . . 73.120000000000005 110.722 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.42 65.85 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.599 -0.728 . . . . 73.209999999999994 111.233 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.41 -21.28 42.4 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.421 0.688 . . . . 71.209999999999994 111.011 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.55 44.46 2.5 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.463 -0.335 . . . . 60.240000000000002 113.544 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -87.67 158.44 18.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.643 0.777 . . . . 73.340000000000003 108.963 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -58.79 -69.5 0.19 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.191 0.932 . . . . 64.129999999999995 112.3 -160.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.97 137.48 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.039 -1.097 . . . . 73.219999999999999 108.039 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 p -128.51 108.59 10.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.769 0.828 . . . . 74.019999999999996 109.14 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 8.3 t70 -104.27 159.03 16.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.584 1.154 . . . . 64.239999999999995 109.397 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.79 115.54 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.838 0.855 . . . . 73.319999999999993 109.128 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.24 93.45 0.69 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.626 -0.716 . . . . 73.010000000000005 111.927 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -77.46 82.88 3.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.374 0.607 . . . . 74.230000000000004 109.495 173.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -160.15 143.97 14.15 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.199 -0.455 . . . . 75.329999999999998 111.006 -171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -82.66 100.74 10.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.009 0.924 . . . . 73.150000000000006 110.268 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -101.09 153.8 37.54 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.284 0.634 . . . . 63.439999999999998 109.535 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.76 -15.92 23.17 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.037 2.491 . . . . 74.530000000000001 114.566 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.37 -23.33 13.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.3 0.64 . . . . 71.319999999999993 110.914 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.686 HG13 HG12 ' A' ' 119' ' ' VAL . 79.5 t -93.52 123.06 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.133 1.373 . . . . 73.540000000000006 110.043 -177.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HA ' HD11 ' A' ' 42' ' ' ILE . . . -159.04 -74.15 0.08 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.012 0.525 . . . . 74.439999999999998 111.543 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.57 147.89 25.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.469 0.708 . . . . 71.409999999999997 110.284 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.2 t -66.15 100.24 0.59 Allowed 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.033 0.92 . . . . 75.409999999999997 109.997 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 m -152.23 135.64 15.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 74.239999999999995 109.096 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 20.3 t -96.06 111.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.407 -0.96 . . . . 72.450000000000003 108.407 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -96.7 124.33 40.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.604 -0.887 . . . . 73.140000000000001 108.604 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -121.82 151.22 40.85 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.144 0.577 . . . . 74.140000000000001 112.156 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.689 HG22 ' HD3' ' A' ' 105' ' ' ARG . 3.3 m -103.21 166.82 10.21 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.084 -1.08 . . . . 64.219999999999999 108.084 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 14.63 18.25 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.974 -0.454 . . . . 75.5 111.887 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.15 110.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.779 0.832 . . . . 75.420000000000002 110.61 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 67.23 -76.48 0.05 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.831 1.252 . . . . 70.0 112.076 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.36 35.16 0.48 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.491 -1.044 . . . . 71.530000000000001 110.491 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HG2' ' HB ' ' A' ' 116' ' ' VAL . 29.7 tt0 -75.9 -18.93 59.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 65.430000000000007 111.736 -170.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.57 -35.54 79.21 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 110.245 -0.28 . . . . 74.439999999999998 110.245 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.95 56.82 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.557 0.743 . . . . 71.439999999999998 112.192 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 116' ' ' VAL . 12.6 t -85.0 -25.62 27.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.484 -0.562 . . . . 71.420000000000002 109.484 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.89 -38.71 64.3 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.916 0.886 . . . . 52.439999999999998 111.299 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.48 -56.33 17.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.746 -1.57 . . . . 64.040000000000006 110.52 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.6 -47.39 79.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.177 0.923 . . . . 72.099999999999994 111.914 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.25 -51.51 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.697 0.799 . . . . 72.120000000000005 111.963 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.93 -27.43 73.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 116.035 -0.53 . . . . 74.349999999999994 113.271 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -79.28 -26.44 42.32 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.407 0.683 . . . . 74.219999999999999 110.463 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.7 m -83.33 -32.69 26.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.143 0.977 . . . . 73.420000000000002 110.987 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 tp -85.89 -31.99 21.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.219 0.608 . . . . 71.439999999999998 110.611 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.86 27.12 35.48 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.508 -0.769 . . . . 71.209999999999994 112.464 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.36 144.2 37.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.741 0.816 . . . . 74.450000000000003 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.63 127.14 31.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.031 0.933 . . . . 71.420000000000002 111.09 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.41 HG12 ' HB ' ' A' ' 79' ' ' VAL . 18.8 m -92.43 106.68 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.136 0.974 . . . . 74.299999999999997 110.632 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.74 166.43 11.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.951 1.3 . . . . 63.149999999999999 109.414 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mp -67.22 175.92 2.44 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.198 0.523 . . . . 74.239999999999995 111.057 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.689 ' HD3' HG22 ' A' ' 82' ' ' THR . 32.0 ptt-85 -55.95 -44.82 78.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.406 1.082 . . . . 74.219999999999999 112.412 -173.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.9 mt 60.63 170.13 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.521 1.128 . . . . 75.140000000000001 111.202 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.52 -18.13 14.39 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.079 1.853 . . . . 70.25 113.659 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.19 -55.69 26.08 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.181 1.392 . . . . 64.040000000000006 112.076 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 8.1 tt -68.04 -25.78 65.54 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 122.57 0.348 . . . . 74.040000000000006 110.381 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 t -76.35 -19.57 58.06 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.551 0.741 . . . . 72.120000000000005 111.912 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.08 -33.24 33.52 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.957 0.503 . . . . 65.209999999999994 111.247 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.405 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pp0? -104.89 167.31 10.04 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.227 1.011 . . . . 71.310000000000002 109.362 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 19.1 Cg_endo -57.16 132.48 51.53 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.037 2.491 . . . . 74.420000000000002 114.48 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.79 160.5 1.78 Allowed 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 124.175 3.25 . . . . 61.240000000000002 116.072 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.35 147.55 8.32 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 110.255 -1.138 . . . . 74.409999999999997 110.255 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 37' ' ' VAL . 2.4 p -60.58 118.82 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.466 0.706 . . . . 63.450000000000003 110.848 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.495 HG22 ' HG3' ' A' ' 38' ' ' ARG . 39.5 pt -103.8 107.43 22.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 122.033 0.92 . . . . 64.349999999999994 109.861 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 39' ' ' VAL . 1.2 p -90.14 105.12 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.501 -1.296 . . . . 74.230000000000004 107.501 169.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.686 HG12 HG13 ' A' ' 74' ' ' VAL . 52.9 t -92.26 131.3 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.612 -1.176 . . . . 65.0 108.241 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' A' ' 49' ' ' ALA . 3.5 t -130.38 130.13 65.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.214 0.605 . . . . 72.439999999999998 109.939 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -91.37 167.37 12.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.463 0.705 . . . . 72.540000000000006 110.145 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.337 0 CA-C-O 119.515 -0.603 . . . . 72.239999999999995 112.963 178.161 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.6 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.885 -0.413 . . . . 75.400000000000006 109.885 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 t -139.95 143.42 36.55 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.44 0.696 . . . . 52.299999999999997 109.184 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.9 153.59 31.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.562 0.745 . . . . 61.200000000000003 110.693 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.13 118.94 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.963 0.905 . . . . 73.439999999999998 110.031 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 m -144.76 109.73 5.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.974 0.91 . . . . 71.230000000000004 109.091 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 m -120.85 141.8 50.25 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.724 0.81 . . . . 74.010000000000005 109.678 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -125.03 146.11 49.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.126 0.97 . . . . 74.510000000000005 109.662 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.9 m -146.45 127.04 14.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.218 0.607 . . . . 73.340000000000003 110.002 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 p -111.81 137.46 49.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.796 0.838 . . . . 64.439999999999998 109.77 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 p -81.19 132.18 35.34 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.093 0.957 . . . . 72.439999999999998 111.492 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.5 p -113.19 160.52 18.17 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.573 1.149 . . . . 71.030000000000001 109.076 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.66 144.47 22.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.823 0.449 . . . . 63.130000000000003 111.149 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.63 124.14 43.46 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.752 0.821 . . . . 75.200000000000003 109.891 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.21 162.76 38.89 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.681 2.254 . . . . 62.210000000000001 112.819 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -83.01 146.62 28.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.211 1.005 . . . . 75.200000000000003 110.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 m -143.9 103.8 4.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.945 0.898 . . . . 74.319999999999993 109.292 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 p -108.81 141.12 41.3 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 64.140000000000001 109.605 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -159.01 94.32 1.21 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.034 0.933 . . . . 74.319999999999993 108.592 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.17 123.96 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 70.329999999999998 109.611 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.71 161.38 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.935 0.894 . . . . 75.200000000000003 110.633 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo . . . . . 0 C--N 1.382 2.331 0 C-N-CA 122.91 2.406 . . . . 73.129999999999995 114.264 176.04 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 109.005 -0.739 . . . . 71.150000000000006 109.005 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.87 135.96 53.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.925 0.89 . . . . 71.109999999999999 109.234 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 64' ' ' THR . 90.7 t -132.83 123.54 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.277 -1.009 . . . . 73.450000000000003 108.277 171.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . 4.1 ptp85 -141.34 110.93 6.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.511 -0.743 . . . . 75.430000000000007 112.024 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.43 HG21 ' HB ' ' A' ' 118' ' ' VAL . 35.8 t -92.71 120.52 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.023 . . . . 73.219999999999999 109.951 -175.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 66.3 m-85 -130.09 132.96 46.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.354 0.662 . . . . 74.319999999999993 109.794 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -88.84 141.08 28.8 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.887 -1.153 . . . . 72.140000000000001 107.887 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' A' ' 121' ' ' THR . 6.3 tp -59.3 -46.32 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.459 0.704 . . . . 65.319999999999993 111.289 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.9 m -106.73 -9.94 16.28 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 71.439999999999998 111.858 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.91 63.29 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.223 0.327 . . . . 64.349999999999994 113.45 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.8 m -91.45 -52.73 4.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.275 0.63 . . . . 73.030000000000001 111.215 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.01 120.15 19.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.059 0.392 . . . . 74.510000000000005 112.059 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.96 50.97 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.303 -0.862 . . . . 72.230000000000004 112.746 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.24 73.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.248 0.619 . . . . 74.310000000000002 110.925 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.44 -52.07 64.81 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.18 0.925 . . . . 74.540000000000006 110.424 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.77 -37.67 88.4 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.772 -1.104 . . . . 72.409999999999997 111.631 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -64.87 -38.78 92.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.603 1.161 . . . . 74.200000000000003 111.617 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.403 HG21 HG21 ' A' ' 97' ' ' THR . 68.9 p -75.76 -23.35 55.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 111.128 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.53 -33.7 54.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.077 0.951 . . . . 72.109999999999999 111.551 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -52.66 -32.41 42.02 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.977 0.911 . . . . 73.200000000000003 112.031 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.73 -52.26 66.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.3 1.04 . . . . 71.129999999999995 110.356 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.45 -37.63 71.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.277 0.631 . . . . 74.450000000000003 111.295 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -71.9 -36.44 70.01 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.485 0.49 . . . . 73.219999999999999 110.708 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.45 72.78 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.357 0.41 . . . . 75.239999999999995 110.902 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.19 -21.72 58.51 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.358 -0.837 . . . . 75.209999999999994 110.862 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.44 10.53 86.13 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-N 115.639 -0.71 . . . . 53.210000000000001 113.835 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -95.41 135.62 36.81 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.856 -0.794 . . . . 74.549999999999997 108.856 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.466 HG22 HG21 ' A' ' 90' ' ' THR . 70.9 p 59.24 155.29 0.02 OUTLIER 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.871 2.068 . . . . 74.400000000000006 113.653 -173.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.64 87.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 N-CA-C 108.165 -1.05 . . . . 74.140000000000001 108.165 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 26.3 m -89.0 102.45 15.09 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.367 0.667 . . . . 74.25 110.679 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 38.9 m-20 -102.48 142.63 33.35 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.76 -0.83 . . . . 65.319999999999993 108.76 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.4 t -132.61 143.16 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.326 0.651 . . . . 72.109999999999999 110.168 -171.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.63 -126.78 2.07 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 112.541 -0.223 . . . . 64.439999999999998 112.541 165.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -144.77 145.05 31.48 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.944 0.898 . . . . 74.25 109.912 -177.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 tp -156.26 146.45 21.42 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.746 -0.835 . . . . 73.540000000000006 108.746 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.4 p -81.11 98.73 8.15 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.107 0.563 . . . . 73.109999999999999 110.453 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.47 88.21 7.28 Favored Pre-proline 0 N--CA 1.483 1.195 0 N-CA-C 108.801 -0.814 . . . . 74.209999999999994 108.801 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.71 -6.93 14.54 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.438 2.092 . . . . 64.030000000000001 112.992 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.5 -23.44 56.75 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.742 0.417 . . . . 70.439999999999998 111.145 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.44 HG13 HG12 ' A' ' 119' ' ' VAL . 2.6 p -121.32 119.45 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.693 0.797 . . . . 74.310000000000002 109.902 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.57 20.45 17.15 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.175 0.99 . . . . 73.430000000000007 111.403 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.31 139.85 45.97 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.689 0.796 . . . . 72.239999999999995 110.098 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 t -69.18 101.88 1.56 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.548 0.69 . . . . 73.129999999999995 110.283 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -138.35 145.43 41.12 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.414 0.686 . . . . 72.040000000000006 110.905 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.69 HG11 HG22 ' A' ' 118' ' ' VAL . 48.8 t -95.97 118.44 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.599 1.16 . . . . 63.310000000000002 108.085 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -110.02 129.05 55.73 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.894 0.478 . . . . 74.049999999999997 110.166 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.417 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -126.4 154.47 43.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.151 0.981 . . . . 73.420000000000002 110.091 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.524 HG23 ' HG2' ' A' ' 83' ' ' GLU . 11.8 m -102.0 -112.06 0.21 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.514 -0.921 . . . . 74.239999999999995 108.514 168.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 82' ' ' THR . 14.7 pt-20 -143.21 -19.91 0.63 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.784 1.174 . . . . 74.409999999999997 113.738 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.54 116.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.725 0.81 . . . . 71.400000000000006 112.072 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 64.49 -77.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.054 0 C-N-CA 125.149 1.38 . . . . 74.219999999999999 111.198 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.6 52.63 0.33 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.066 -1.214 . . . . 62.5 110.066 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.18 -40.67 64.54 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.074 0.55 . . . . 65.25 112.04 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -73.57 -25.76 60.52 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.447 0.536 . . . . 75.140000000000001 112.447 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.21 -39.56 63.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.087 0.555 . . . . 73.519999999999996 111.437 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.466 HG21 HG22 ' A' ' 62' ' ' THR . 6.6 t -82.89 -31.95 27.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.128 0.571 . . . . 62.329999999999998 111.404 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.23 73.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.448 0.699 . . . . 74.319999999999993 110.927 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.02 -38.51 76.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.549 1.14 . . . . 71.420000000000002 111.58 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.65 98.08 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 123.741 0.65 . . . . 71.430000000000007 111.556 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 118' ' ' VAL . 20.7 t -73.64 -48.47 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.939 -0.393 . . . . 74.209999999999994 109.939 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.57 -21.34 49.38 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.869 0.73 . . . . 71.310000000000002 113.549 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -80.53 -58.55 3.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 74.239999999999995 109.818 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.403 HG21 HG21 ' A' ' 52' ' ' THR . 24.2 m -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 124.41 1.069 . . . . 74.329999999999998 111.354 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.1 tp -96.18 -29.68 13.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.072 0.949 . . . . 72.540000000000006 110.461 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.57 47.43 10.22 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.32 -0.4 . . . . 72.010000000000005 112.565 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.05 152.63 38.39 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 64.230000000000004 110.234 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.07 34.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.754 0.822 . . . . 64.200000000000003 111.017 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.417 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 14.4 m -94.01 98.92 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.982 0.896 . . . . 74.230000000000004 109.434 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -111.72 163.42 14.16 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.455 1.102 . . . . 73.329999999999998 110.606 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 tp -71.98 169.94 14.85 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.165 -0.925 . . . . 75.349999999999994 109.967 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.506 ' HD3' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -55.39 -38.06 68.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.327 1.051 . . . . 73.329999999999998 113.106 -176.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.506 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 97.3 mt 59.71 176.43 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 124.322 1.014 . . . . 63.240000000000002 112.957 172.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -53.27 -16.45 7.0 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.216 1.944 . . . . 74.439999999999998 114.193 164.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -54.71 -30.39 55.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.725 1.21 . . . . 75.310000000000002 111.403 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.783 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 10.3 tt -62.45 -28.97 70.18 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 71.099999999999994 111.192 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -62.39 -23.17 66.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.14 0.576 . . . . 74.409999999999997 111.707 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -111.29 -33.02 6.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.463 0.705 . . . . 70.230000000000004 111.862 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.783 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 9.0 pt20 -84.07 161.32 55.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.086 0.554 . . . . 73.430000000000007 110.841 -171.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.444 ' HD2' HG22 ' A' ' 117' ' ' ILE . 40.8 Cg_exo -61.1 152.11 73.84 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.491 2.128 . . . . 73.200000000000003 113.402 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.73 161.54 38.51 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.171 2.581 . . . . 74.409999999999997 112.894 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.76 -166.88 52.43 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.879 -0.6 . . . . 51.119999999999997 111.712 -173.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.25 130.0 35.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 109.145 -0.687 . . . . 72.030000000000001 109.145 172.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 112' ' ' GLN . 17.1 pt -114.31 150.85 16.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.612 -1.255 . . . . 74.430000000000007 107.612 164.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.69 HG22 HG11 ' A' ' 79' ' ' VAL . 61.4 t -119.64 100.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 106.127 -1.805 . . . . 74.430000000000007 106.127 163.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 74' ' ' VAL . 6.7 p -95.95 125.09 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.91 -0.774 . . . . 72.140000000000001 108.91 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.56 128.07 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 109.439 -0.578 . . . . 74.230000000000004 109.439 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.415 ' HA ' HG23 ' A' ' 42' ' ' ILE . 72.6 p -107.95 101.47 10.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.185 -1.042 . . . . 70.219999999999999 108.185 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.63 -0.713 . . . . 70.450000000000003 111.704 -174.298 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 121.356 0.598 . . . . 64.439999999999998 110.636 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.4 m -142.84 103.11 4.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.129 . . . . 54.310000000000002 108.618 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.33 144.35 33.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.066 0.546 . . . . 70.109999999999999 110.126 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 tt -164.9 138.94 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.397 1.079 . . . . 72.040000000000006 108.309 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -143.2 135.63 27.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.324 -0.621 . . . . 73.239999999999995 109.324 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -146.72 135.78 22.51 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.703 0.801 . . . . 73.310000000000002 109.374 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -161.95 141.15 9.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.749 0.82 . . . . 74.5 109.037 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.9 t -165.86 148.4 7.39 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.588 0.755 . . . . 63.409999999999997 109.715 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 t -166.62 147.04 5.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.688 1.195 . . . . 64.010000000000005 107.95 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.0 t -159.13 148.1 18.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.192 0.197 . . . . 73.230000000000004 110.724 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 t -159.75 141.82 13.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.685 0.794 . . . . 73.129999999999995 109.482 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.78 133.91 4.24 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.48 0.712 . . . . 72.030000000000001 110.058 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.19 106.06 4.14 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.513 0.725 . . . . 53.439999999999998 109.283 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -90.76 159.99 4.16 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.679 2.253 . . . . 71.019999999999996 111.825 171.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.8 t -156.25 153.95 29.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.016 0.526 . . . . 73.530000000000001 110.474 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.5 p -153.79 166.75 31.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.703 0.801 . . . . 71.209999999999994 109.625 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -142.22 143.89 33.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.568 0.747 . . . . 70.439999999999998 109.055 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 p -148.48 82.96 1.47 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.837 0.855 . . . . 71.239999999999995 108.886 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.5 139.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.602 0.761 . . . . 70.209999999999994 110.915 -174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -118.21 102.94 50.21 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.047 0.939 . . . . 75.150000000000006 109.002 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 C--N 1.376 1.994 0 C-N-CA 122.985 2.457 . . . . 75.219999999999999 112.69 176.054 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.791 -0.818 . . . . 73.530000000000001 108.791 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 41.9 mt-10 -115.27 94.44 4.73 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.475 -0.784 . . . . 73.409999999999997 110.682 -169.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.716 HG13 HG23 ' A' ' 94' ' ' VAL . 22.5 t -112.86 147.16 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 123.798 0.839 . . . . 75.040000000000006 111.416 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 31.2 ttp-105 -150.78 110.04 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.486 0.714 . . . . 74.109999999999999 109.719 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.462 HG23 ' HB ' ' A' ' 118' ' ' VAL . 60.6 t -87.52 126.42 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.455 0.702 . . . . 73.420000000000002 111.129 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 10.9 m-85 -119.95 107.93 13.71 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.727 0.811 . . . . 75.439999999999998 110.561 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 47.7 t30 -97.91 138.5 35.15 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.278 -0.638 . . . . 74.010000000000005 109.278 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -97.0 -11.79 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.1 0.476 . . . . 74.409999999999997 111.414 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -156.49 119.44 4.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.259 -1.015 . . . . 73.209999999999994 108.259 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.83 -88.81 0.01 OUTLIER Glycine 0 C--N 1.362 2.002 0 O-C-N 125.154 1.534 . . . . 53.350000000000001 114.52 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 m 51.7 -79.3 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.327 1.451 . . . . 71.230000000000004 113.525 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -86.53 117.6 25.41 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.131 0.972 . . . . 72.420000000000002 110.357 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.99 -18.37 68.74 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.531 0.519 . . . . 55.530000000000001 111.938 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 52' ' ' THR . . . -46.97 -32.37 3.83 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.748 1.619 . . . . 71.129999999999995 113.37 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.28 8.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.533 0.733 . . . . 62.439999999999998 111.911 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.4 60.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.486 0.315 . . . . 73.349999999999994 111.078 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.69 -31.32 69.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.378 1.071 . . . . 64.549999999999997 111.253 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.574 ' HB ' HG11 ' A' ' 94' ' ' VAL . 29.1 p -66.35 -56.88 8.97 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 121.988 0.115 . . . . 75.430000000000007 110.817 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.39 66.1 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.905 0.383 . . . . 52.399999999999999 111.651 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.45 -45.93 87.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.402 1.081 . . . . 74.439999999999998 111.597 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -67.42 -43.74 80.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 110.431 -0.211 . . . . 73.340000000000003 110.431 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.9 -32.24 69.35 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.753 0.658 . . . . 72.510000000000005 111.821 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.426 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -60.38 -45.21 94.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.275 0.63 . . . . 64.109999999999999 110.7 176.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -19.44 45.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.427 0.691 . . . . 73.239999999999995 111.345 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.47 59.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.688 0.795 . . . . 73.430000000000007 111.321 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.87 42.77 5.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.594 -0.275 . . . . 72.239999999999995 113.465 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -90.7 157.0 17.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.794 0.837 . . . . 72.409999999999997 109.821 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 m -72.09 -50.97 23.86 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.643 0.735 . . . . 73.530000000000001 110.71 -164.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 54.9 t -129.21 126.72 64.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 114.138 -1.392 . . . . 63.32 107.446 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.0 p -141.02 84.54 1.94 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.285 -1.005 . . . . 75.420000000000002 108.285 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -103.42 158.12 16.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 74.200000000000003 110.494 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.19 146.85 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.34 1.056 . . . . 75.430000000000007 109.246 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -165.28 137.51 4.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.086 -0.806 . . . . 54.5 111.086 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 4.3 p-10 -105.64 108.39 19.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.554 -0.536 . . . . 64.200000000000003 109.554 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pp -156.26 161.37 40.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.123 0.569 . . . . 74.540000000000006 110.785 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.453 ' HA ' HG13 ' A' ' 42' ' ' ILE . 41.3 m -96.43 127.37 42.36 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.783 0.833 . . . . 74.0 109.636 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 74' ' ' VAL . 86.4 mt -120.71 149.08 49.71 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.922 0.889 . . . . 74.540000000000006 108.679 171.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.01 -4.29 15.19 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.957 2.438 . . . . 74.230000000000004 113.184 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.47 -6.17 24.31 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.067 0.947 . . . . 74.519999999999996 112.273 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.627 HG23 ' HB2' ' A' ' 71' ' ' LEU . 90.0 t -74.86 112.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 122.906 0.482 . . . . 74.530000000000001 109.814 177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.86 -41.47 3.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.928 0.891 . . . . 64.209999999999994 110.281 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.7 158.94 41.78 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.952 0.901 . . . . 63.340000000000003 109.212 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.563 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.0 t -61.09 100.49 0.12 Allowed 'General case' 0 C--O 1.243 0.755 0 CA-C-O 122.71 1.243 . . . . 72.120000000000005 109.574 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.0 m -151.3 145.49 25.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.293 -1.322 . . . . 75.129999999999995 109.123 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.685 HG23 HG13 ' A' ' 118' ' ' VAL . 58.2 t -93.74 113.78 29.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.017 -1.105 . . . . 74.019999999999996 108.017 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -94.3 111.12 22.84 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.05 -1.463 . . . . 75.120000000000005 107.05 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.599 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 8.2 p90 -120.57 140.6 51.26 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.664 0.745 . . . . 75.109999999999999 112.933 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 m -84.97 152.93 23.11 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.738 -1.208 . . . . 75.019999999999996 107.738 162.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -109.18 19.27 19.65 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.139 0.422 . . . . 73.0 112.139 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.1 t -69.31 129.0 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.841 -0.8 . . . . 72.329999999999998 108.841 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 61.04 -81.42 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.119 1.368 . . . . 74.420000000000002 111.401 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.87 33.12 0.3 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.094 -0.503 . . . . 71.519999999999996 111.875 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -69.1 -31.76 70.69 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 122.719 0.408 . . . . 75.140000000000001 111.247 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -73.4 -29.26 62.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.45 0.3 . . . . 71.549999999999997 110.717 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.6 -43.48 55.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.084 0.554 . . . . 74.140000000000001 110.611 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 t -74.24 -22.39 59.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.048 0.539 . . . . 74.219999999999999 109.904 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -70.85 -44.09 67.13 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.387 1.075 . . . . 75.409999999999997 111.513 172.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.74 -35.31 72.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.289 -1.323 . . . . 72.319999999999993 111.721 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.53 83.69 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.71 0.631 . . . . 71.040000000000006 110.987 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.716 HG23 HG13 ' A' ' 37' ' ' VAL . 24.7 t -78.05 -45.9 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.068 -0.969 . . . . 74.340000000000003 111.514 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.4 -26.73 68.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.656 0.597 . . . . 73.230000000000004 112.999 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -75.59 -45.67 36.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.463 0.705 . . . . 75.230000000000004 110.123 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.2 m -61.01 -41.51 96.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.707 0.803 . . . . 74.329999999999998 111.122 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 120' ' ' VAL . 47.9 tp -75.82 -31.76 59.52 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.946 -1.025 . . . . 73.510000000000005 110.714 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 45.73 31.31 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.494 -0.642 . . . . 75.0 111.494 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.21 175.35 7.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.937 0.895 . . . . 73.219999999999999 110.282 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.24 164.62 25.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.762 0.425 . . . . 74.099999999999994 110.322 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.599 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.9 m -138.04 140.0 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.216 1.006 . . . . 72.349999999999994 108.333 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -155.63 174.25 15.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.789 0.836 . . . . 75.129999999999995 110.028 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.5 179.82 1.23 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.649 -0.705 . . . . 63.030000000000001 111.94 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -83.11 18.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.66 0.985 . . . . 74.0 113.66 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.13 -47.72 89.73 Favored Pre-proline 0 CA--C 1.558 1.26 0 CA-C-O 118.619 -0.705 . . . . 63.350000000000001 111.761 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.75 -37.79 11.43 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 121.577 1.518 . . . . 61.219999999999999 111.517 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.33 -29.82 64.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 74.209999999999994 111.572 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -17.15 64.4 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.305 1.042 . . . . 74.540000000000006 112.404 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -65.91 -45.09 83.21 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.27 0.557 . . . . 75.239999999999995 110.983 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.21 -33.06 29.53 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.477 -0.783 . . . . 75.120000000000005 109.436 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 48.39 71.49 1.58 Allowed Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.054 1.742 . . . . 61.420000000000002 111.311 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HB2' ' NH2' ' A' ' 38' ' ' ARG . 44.0 Cg_endo -94.84 162.26 1.76 Allowed 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 123.805 3.003 . . . . 71.219999999999999 113.194 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.26 120.23 0.81 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.759 2.306 . . . . 74.099999999999994 111.265 168.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.19 162.86 20.98 Favored Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.563 -1.015 . . . . 74.239999999999995 110.563 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 91' ' ' ALA . 1.9 p -84.28 137.04 21.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 117.32 0.56 . . . . 74.329999999999998 110.529 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 38' ' ' ARG . 35.5 pt -106.43 123.1 61.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 CA-C-O 121.577 0.703 . . . . 72.129999999999995 109.809 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.685 HG13 HG23 ' A' ' 79' ' ' VAL . 98.9 t -95.94 103.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.463 -1.31 . . . . 64.129999999999995 107.463 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 69.2 t -94.06 128.77 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 109.866 -0.42 . . . . 72.099999999999994 109.866 -174.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 98' ' ' LEU . 22.5 t -113.93 139.39 39.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 107.975 -1.12 . . . . 75.019999999999996 107.975 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.563 ' H ' ' HB ' ' A' ' 77' ' ' THR . 40.3 p -120.06 104.14 9.87 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.927 -0.768 . . . . 73.219999999999999 108.927 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.451 0 CA-C-O 119.352 -0.694 . . . . 71.200000000000003 112.445 175.137 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.637 -0.135 . . . . 74.400000000000006 110.637 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -159.35 120.75 3.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.625 0.77 . . . . 73.349999999999994 109.461 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.19 97.13 1.01 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.834 0.854 . . . . 73.420000000000002 109.679 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -148.6 129.1 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.727 0.811 . . . . 73.430000000000007 109.809 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.4 p -168.67 127.09 1.09 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.391 1.076 . . . . 73.310000000000002 109.226 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -149.06 161.88 41.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.109 0.564 . . . . 71.030000000000001 109.963 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.24 149.01 52.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 70.430000000000007 110.191 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -152.69 159.62 43.16 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.261 0.625 . . . . 71.25 109.815 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.7 t -149.68 159.66 44.16 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.347 0.659 . . . . 73.439999999999998 109.757 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -162.57 168.32 21.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.046 0.939 . . . . 75.109999999999999 108.841 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.0 t -162.76 142.3 9.11 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.351 0.661 . . . . 73.340000000000003 109.832 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.52 133.49 21.36 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.81 -0.811 . . . . 72.209999999999994 108.81 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.47 123.33 6.36 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 123.53 0.732 . . . . 72.450000000000003 109.676 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.95 -170.67 1.05 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.725 2.283 . . . . 75.409999999999997 111.415 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -137.08 161.15 36.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.104 0.562 . . . . 63.399999999999999 109.781 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 t -147.53 157.43 43.56 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.773 0.829 . . . . 72.230000000000004 109.228 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.9 t -145.4 163.39 34.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.112 0.565 . . . . 72.319999999999993 110.516 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -141.76 165.39 27.59 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.985 0.914 . . . . 74.209999999999994 109.864 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.14 152.3 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.809 0.844 . . . . 71.109999999999999 109.698 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.92 114.06 39.47 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.738 0.815 . . . . 75.400000000000006 109.238 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 C--N 1.377 2.069 0 C-N-CA 123.272 2.648 . . . . 71.310000000000002 113.371 173.916 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.73 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . . . . . . . . 0 CA--C 1.545 0.771 0 CA-C-O 120.592 0.234 . . . . 62.109999999999999 110.646 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.0 mt-10 -84.84 90.61 7.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.528 0.731 . . . . 71.439999999999998 109.934 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.8 t -97.67 122.01 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.08 0.467 . . . . 75.439999999999998 109.873 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.459 ' HG3' HG21 ' A' ' 117' ' ' ILE . 8.9 ptm180 -142.79 131.46 22.6 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.155 -0.341 . . . . 74.219999999999999 110.99 -167.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -93.27 131.43 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.588 0.755 . . . . 74.519999999999996 109.875 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -126.02 104.21 8.15 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.939 -0.764 . . . . 72.040000000000006 108.939 168.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.429 HD22 HG23 ' A' ' 45' ' ' THR . 44.0 t30 -97.21 130.14 44.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.623 -0.88 . . . . 64.540000000000006 108.623 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.666 HG13 ' HA ' ' A' ' 70' ' ' SER . 20.3 tt -102.35 -35.41 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.513 0.197 . . . . 72.319999999999993 111.491 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 m -100.07 151.29 21.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.066 0.546 . . . . 74.439999999999998 110.152 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.56 87.08 0.26 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.533 -0.627 . . . . 75.510000000000005 111.533 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.429 HG23 HD22 ' A' ' 41' ' ' ASN . 11.4 t -126.03 -173.05 2.75 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.783 0.833 . . . . 73.519999999999996 109.543 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -72.65 170.37 14.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.37 1.068 . . . . 73.099999999999994 111.622 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -1.13 50.85 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 118.976 -0.902 . . . . 73.150000000000006 113.979 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.17 28.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 60.119999999999997 112.82 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.94 48.46 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.296 -0.866 . . . . 65.430000000000007 111.157 174.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.21 -21.98 60.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.19 0.596 . . . . 65.030000000000001 111.672 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -63.1 -28.8 70.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.699 1.199 . . . . 73.109999999999999 111.444 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.56 ' HB ' HG11 ' A' ' 94' ' ' VAL . 63.0 p -63.39 -42.35 98.8 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 123.419 0.45 . . . . 72.239999999999995 110.583 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.99 78.42 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.307 0.643 . . . . 74.230000000000004 111.015 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.433 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 49.0 m-20 -57.49 -38.58 74.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.075 0.859 . . . . 64.430000000000007 111.932 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.15 -52.89 56.91 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.748 0.655 . . . . 65.140000000000001 110.591 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.4 -28.39 65.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.636 -0.711 . . . . 73.200000000000003 111.351 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 38.4 ttpt -62.36 -43.76 98.06 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.581 0.752 . . . . 74.430000000000007 109.867 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.05 64.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.454 -0.794 . . . . 74.219999999999999 111.157 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -21.06 56.64 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.961 0.726 . . . . 75.239999999999995 112.961 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.79 49.15 0.29 Allowed Glycine 0 C--N 1.358 1.763 0 CA-C-N 118.007 0.367 . . . . 63.130000000000003 113.085 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -57.16 158.04 5.58 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.352 1.061 . . . . 74.540000000000006 112.173 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.3 m -91.46 -60.36 1.91 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.37 -0.974 . . . . 74.030000000000001 108.37 168.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 65.3 t -135.55 136.82 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.188 -1.412 . . . . 73.430000000000007 107.188 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.3 p -130.56 146.37 52.07 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.321 0.649 . . . . 75.109999999999999 110.175 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 10.8 t70 -143.51 146.58 33.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.968 -1.015 . . . . 75.450000000000003 108.396 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.02 138.48 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.064 -0.717 . . . . 70.239999999999995 109.064 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.93 143.78 9.27 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.459 -0.337 . . . . 65.150000000000006 112.427 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -109.07 110.91 22.29 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.121 -1.066 . . . . 75.329999999999998 108.121 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.5 tp -151.02 148.91 28.93 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.255 -0.646 . . . . 74.219999999999999 109.255 -169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.666 ' HA ' HG13 ' A' ' 42' ' ' ILE . 12.0 p -77.05 98.65 5.06 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.889 -0.596 . . . . 72.340000000000003 109.997 172.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.2 110.21 31.56 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.22 -1.03 . . . . 75.129999999999995 108.22 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.38 -6.4 17.08 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.456 2.104 . . . . 73.340000000000003 112.532 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 6.2 p-10 -92.55 -23.84 18.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.84 0.856 . . . . 75.109999999999999 111.269 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.98 149.06 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 109.954 -0.387 . . . . 75.430000000000007 109.954 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.99 -5.22 1.69 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.631 0.772 . . . . 71.219999999999999 111.643 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.94 147.42 8.21 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.255 1.022 . . . . 74.230000000000004 109.839 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.625 ' HB ' ' H ' ' A' ' 121' ' ' THR . 7.8 t -64.42 111.21 2.56 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.416 0.686 . . . . 74.219999999999999 111.296 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -150.2 151.88 33.75 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.835 -0.62 . . . . 63.140000000000001 109.581 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.465 ' HB ' HG13 ' A' ' 102' ' ' VAL . 28.9 t -102.22 116.49 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.591 -0.892 . . . . 71.519999999999996 108.591 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.552 ' HD2' HD12 ' A' ' 117' ' ' ILE . 16.2 m-85 -102.41 148.22 25.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.937 -0.764 . . . . 75.230000000000004 108.937 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.59 169.33 17.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.863 0.84 . . . . 74.120000000000005 112.534 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.1 m -118.74 166.04 13.27 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 113.751 -1.568 . . . . 72.530000000000001 107.048 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.19 23.13 9.52 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.928 0.714 . . . . 74.420000000000002 112.928 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.61 98.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.202 0.525 . . . . 72.239999999999995 110.038 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.27 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.414 1.485 . . . . 74.109999999999999 111.9 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.03 25.87 2.36 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.075 -0.847 . . . . 71.120000000000005 112.963 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.73 ' HG2' ' HA ' ' A' ' 35' ' ' ALA . 31.3 mt-10 -62.98 -36.81 84.77 Favored 'General case' 0 C--N 1.362 1.127 0 CA-C-N 117.618 0.709 . . . . 75.340000000000003 111.025 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -70.8 -32.36 69.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.214 0.321 . . . . 75.310000000000002 111.754 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.33 -31.83 66.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.231 0.612 . . . . 73.109999999999999 110.515 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.4 m -76.6 -33.27 58.42 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.032 0.933 . . . . 74.439999999999998 109.982 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.47 -34.22 70.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.126 0.971 . . . . 71.209999999999994 111.376 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -50.91 -47.04 60.9 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.604 1.19 . . . . 75.430000000000007 110.765 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.1 83.87 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 124.534 1.146 . . . . 73.099999999999994 111.69 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' A' ' 52' ' ' THR . 89.4 t -66.74 -52.27 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.12 0.968 . . . . 64.239999999999995 112.11 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -27.08 70.43 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.575 0.547 . . . . 75.219999999999999 111.754 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -78.34 -23.57 46.92 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.396 0.678 . . . . 74.400000000000006 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -78.64 -51.3 10.07 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 122.615 0.366 . . . . 73.420000000000002 110.627 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.1 tp -74.15 -26.61 60.41 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.346 0.658 . . . . 75.219999999999999 111.295 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.29 62.46 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.746 -0.661 . . . . 74.219999999999999 112.064 -172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.4 163.0 13.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.74 0.816 . . . . 71.519999999999996 110.666 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.37 134.49 38.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.128 0.571 . . . . 74.310000000000002 110.19 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 79' ' ' VAL . 34.7 m -99.22 138.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.978 -0.749 . . . . 73.310000000000002 108.978 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -154.56 168.74 25.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.7 -0.852 . . . . 71.049999999999997 108.7 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 22.5 tp -65.66 173.03 3.0 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.13 0.572 . . . . 74.120000000000005 109.851 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.464 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.4 ppt_? -49.33 -39.18 30.6 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.167 1.173 . . . . 74.230000000000004 114.167 -167.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 80' ' ' TYR . 41.0 mt 64.56 154.23 0.12 Allowed Pre-proline 0 CA--C 1.565 1.557 0 C-N-CA 124.307 1.043 . . . . 71.299999999999997 112.113 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.18 -29.03 35.78 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.647 2.898 . . . . 52.109999999999999 115.212 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 5.1 pm0 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.608 0.763 . . . . 75.25 112.861 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 0.5 OUTLIER -72.97 8.46 1.55 Allowed 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.188 0.518 . . . . 74.400000000000006 111.614 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 t -82.09 -10.56 59.16 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 72.030000000000001 111.382 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.23 -17.05 18.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 113.419 0.896 . . . . 63.350000000000001 113.419 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.475 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 2.0 pp0? -145.98 159.57 46.07 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.465 -0.779 . . . . 73.5 110.267 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 12.6 Cg_endo -52.7 125.4 17.88 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 123.795 2.997 . . . . 74.319999999999993 115.284 -167.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 109' ' ' LEU . 55.0 Cg_exo -57.44 153.67 39.9 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.925 3.083 . . . . 71.310000000000002 115.023 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.68 -149.41 21.55 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 109.861 -1.295 . . . . 63.509999999999998 109.861 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.1 t -94.48 105.56 17.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.377 -0.972 . . . . 74.109999999999999 108.377 167.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.552 HD12 ' HD2' ' A' ' 80' ' ' TYR . 32.0 pt -108.21 122.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.12 -1.067 . . . . 63.109999999999999 108.12 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.15 101.21 12.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.702 -1.592 . . . . 74.219999999999999 106.702 164.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.12 120.03 49.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.561 -0.745 . . . . 72.420000000000002 109.458 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.49 128.51 65.45 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 123.729 0.812 . . . . 74.010000000000005 110.269 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.625 ' H ' ' HB ' ' A' ' 77' ' ' THR . 77.7 p -112.05 153.28 27.12 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.891 1.276 . . . . 74.140000000000001 108.002 172.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.432 0 CA-C-O 119.141 -0.81 . . . . 53.539999999999999 112.836 178.71 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.094 -0.706 . . . . 71.129999999999995 109.094 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -157.24 112.08 2.75 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.279 -1.008 . . . . 74.5 108.279 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.9 140.19 20.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.924 0.489 . . . . 75.150000000000006 110.857 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 tp -149.93 129.3 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.552 0.741 . . . . 63.210000000000001 109.143 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 102.6 4.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.329 0.652 . . . . 74.129999999999995 109.623 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 p -127.04 140.94 51.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.077 0.951 . . . . 73.349999999999994 109.383 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -136.68 165.33 26.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.343 0.657 . . . . 72.409999999999997 109.738 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.4 p -121.43 147.0 46.32 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.141 0.977 . . . . 71.140000000000001 109.423 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -125.02 139.22 54.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.73 0.812 . . . . 75.049999999999997 110.377 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.4 p -123.22 175.29 6.75 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.345 1.058 . . . . 73.519999999999996 110.117 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 t -158.67 173.55 16.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.38 0.672 . . . . 74.230000000000004 110.402 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.72 138.4 32.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.699 0.8 . . . . 72.129999999999995 110.539 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.48 157.82 35.58 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.208 1.003 . . . . 74.409999999999997 110.632 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.57 172.98 11.48 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.757 2.304 . . . . 73.010000000000005 112.704 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.3 p -137.47 148.36 46.01 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.604 0.762 . . . . 75.209999999999994 109.595 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -112.12 116.23 30.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.057 0.943 . . . . 74.439999999999998 110.271 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 p -91.51 128.74 37.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.523 0.729 . . . . 75.219999999999999 109.217 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.9 p -72.86 154.53 40.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.177 0.591 . . . . 75.319999999999993 111.145 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.94 141.44 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.892 -0.781 . . . . 74.430000000000007 108.892 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -82.31 149.24 61.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.947 0.499 . . . . 74.310000000000002 110.424 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 C--N 1.376 1.998 0 C-N-CA 122.625 2.217 . . . . 74.439999999999998 112.288 177.42 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.598 ' HB1' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.245 0.86 0 CA-C-O 121.639 0.733 . . . . 74.400000000000006 111.468 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.66 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.0 mp0 -76.69 106.45 8.36 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.545 -1.207 . . . . 75.049999999999997 108.929 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.18 136.13 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.564 -0.902 . . . . 71.030000000000001 108.564 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.537 ' HG3' HG21 ' A' ' 117' ' ' ILE . 10.6 ptm180 -146.93 115.15 6.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.498 0.666 . . . . 73.5 111.035 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.575 HG22 ' HB1' ' A' ' 53' ' ' ALA . 58.2 t -98.71 116.17 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.101 0.96 . . . . 72.340000000000003 110.215 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 62.9 m-85 -115.69 115.06 25.71 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.705 0.802 . . . . 70.140000000000001 110.606 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.659 ' HB3' ' H ' ' A' ' 45' ' ' THR . 21.7 m-80 -90.16 114.21 26.13 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.087 0.955 . . . . 54.119999999999997 110.054 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -81.52 -53.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 122.267 -0.271 . . . . 74.340000000000003 110.295 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -130.15 7.8 5.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.702 0.401 . . . . 71.450000000000003 111.707 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.17 -61.5 1.91 Allowed Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.895 -0.882 . . . . 70.519999999999996 110.895 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.659 ' H ' ' HB3' ' A' ' 41' ' ' ASN . 6.9 t 43.55 31.8 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 127.231 2.212 . . . . 72.239999999999995 114.195 173.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.84 153.93 51.39 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.587 0.755 . . . . 74.540000000000006 109.448 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.26 -22.66 56.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 124.203 0.939 . . . . 52.520000000000003 114.874 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.54 75.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.131 0.572 . . . . 72.140000000000001 111.233 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -82.96 -42.94 17.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.672 0.789 . . . . 65.140000000000001 111.184 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.56 65.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.586 0.754 . . . . 72.120000000000005 112.1 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -59.42 -28.27 66.79 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.759 1.224 . . . . 65.420000000000002 112.708 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -69.71 -28.44 65.84 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 119.902 -0.094 . . . . 73.310000000000002 110.97 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB1' HG22 ' A' ' 39' ' ' VAL . . . -82.55 -32.0 28.81 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.848 0.859 . . . . 73.319999999999993 111.736 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.83 -56.79 17.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.467 1.107 . . . . 64.150000000000006 110.894 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -23.26 53.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.786 -0.643 . . . . 74.430000000000007 110.894 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 64' ' ' THR . 15.5 tp -63.89 -40.03 95.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.912 0.885 . . . . 72.010000000000005 110.636 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -44.79 96.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.071 -0.968 . . . . 74.420000000000002 109.178 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.5 -11.52 60.04 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.74 -1.118 . . . . 64.200000000000003 112.252 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.99 -13.26 53.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.287 0.635 . . . . 71.010000000000005 110.905 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.36 15.24 18.06 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.793 -0.448 . . . . 63.420000000000002 114.059 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -75.49 158.1 33.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.15 0.58 . . . . 73.140000000000001 110.684 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 m -84.63 -60.62 2.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.655 0.382 . . . . 73.349999999999994 111.171 -162.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 46.5 t -116.75 129.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.937 -0.764 . . . . 72.219999999999999 108.937 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.412 HG22 HD22 ' A' ' 56' ' ' LEU . 25.3 p -138.31 83.73 1.99 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.535 1.134 . . . . 74.299999999999997 108.087 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -100.1 125.09 46.16 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.69 -0.855 . . . . 53.32 108.69 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.435 HG12 ' HB ' ' A' ' 39' ' ' VAL . 29.6 m -117.3 150.31 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.002 0.429 . . . . 75.299999999999997 110.504 -174.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.78 162.23 35.63 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-N 115.456 -0.793 . . . . 75.239999999999995 111.373 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.11 110.67 20.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.81 . . . . 71.510000000000005 109.158 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -145.28 136.84 25.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.608 0.763 . . . . 75.129999999999995 109.998 -170.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -79.7 99.64 7.51 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.937 -0.764 . . . . 52.219999999999999 108.937 171.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HB2' HG13 ' A' ' 74' ' ' VAL . 47.8 mt -93.36 140.82 23.33 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 115.893 -0.594 . . . . 75.140000000000001 109.603 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.57 -10.1 14.6 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.575 2.183 . . . . 75.120000000000005 113.175 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.39 -24.36 25.78 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.621 0.768 . . . . 73.340000000000003 111.325 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 71' ' ' LEU . 7.1 p -91.07 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.226 0.61 . . . . 72.120000000000005 110.66 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.79 -0.83 1.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.895 -1.048 . . . . 71.430000000000007 110.325 167.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.3 155.74 18.26 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 125.292 1.437 . . . . 75.340000000000003 108.44 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -62.4 109.74 1.45 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.494 0.664 . . . . 75.540000000000006 110.623 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.9 m -143.92 143.39 31.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.464 0.705 . . . . 73.519999999999996 110.265 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.727 HG23 HG13 ' A' ' 118' ' ' VAL . 92.7 t -105.94 112.81 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.137 -1.06 . . . . 74.530000000000001 108.137 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -98.92 125.03 44.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.828 -0.804 . . . . 72.5 108.828 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.432 ' HA ' HG13 ' A' ' 116' ' ' VAL . 25.9 p90 -109.34 139.75 43.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.642 0.588 . . . . 72.230000000000004 110.67 175.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 83' ' ' GLU . 2.1 m -82.96 -163.36 0.71 Allowed 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 108.663 -0.866 . . . . 73.109999999999999 108.663 171.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.463 ' H ' HG22 ' A' ' 82' ' ' THR . 10.5 pt-20 -136.55 13.27 3.21 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.676 -1.265 . . . . 74.230000000000004 113.408 -160.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.75 108.24 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 N-CA-C 109.337 -0.616 . . . . 75.129999999999995 109.337 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.18 -77.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.761 1.624 . . . . 75.430000000000007 111.448 -172.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.69 57.11 0.31 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.254 -0.739 . . . . 74.310000000000002 111.254 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.59 -17.29 59.85 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.044 0.538 . . . . 74.030000000000001 112.277 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -55.16 -40.56 70.76 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.774 0.43 . . . . 73.219999999999999 110.792 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.23 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.701 0.801 . . . . 61.530000000000001 112.87 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.598 HG21 ' HB1' ' A' ' 35' ' ' ALA . 14.0 t -71.53 -33.2 68.98 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.644 0.378 . . . . 72.319999999999993 111.005 -175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 81' ' ' TYR . . . -80.85 -30.08 35.75 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 74.549999999999997 111.872 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.617 1.167 . . . . 64.25 110.15 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.96 -27.03 68.56 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.453 -0.794 . . . . 72.349999999999994 112.056 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.673 HG13 HG22 ' A' ' 118' ' ' VAL . 24.0 t -81.4 -58.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 C-N-CA 123.129 0.571 . . . . 73.239999999999995 111.046 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -61.82 -29.23 71.69 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.714 -0.676 . . . . 73.129999999999995 113.865 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -79.27 -24.97 42.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.064 0.546 . . . . 74.209999999999994 110.897 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -77.68 -47.99 17.84 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.088 0.471 . . . . 71.239999999999995 110.015 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 120' ' ' VAL . 51.4 tp -68.56 -32.06 71.71 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.137 0.975 . . . . 74.140000000000001 111.44 -177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.93 34.44 24.3 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-N 116.186 -0.461 . . . . 62.149999999999999 112.352 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.81 140.37 49.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.09 0.956 . . . . 73.219999999999999 108.796 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 130.38 41.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.406 0.682 . . . . 74.430000000000007 110.941 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -86.33 120.79 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 123.884 0.874 . . . . 74.120000000000005 110.296 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -126.8 159.21 34.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.466 1.106 . . . . 73.409999999999997 109.874 176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.78 168.68 12.86 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.030000000000001 111.632 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -27.59 65.66 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.929 1.291 . . . . 72.430000000000007 113.781 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt 65.03 173.13 0.08 OUTLIER Pre-proline 0 CA--C 1.568 1.654 0 N-CA-C 113.276 0.843 . . . . 72.329999999999998 113.276 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.76 -17.1 34.34 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.438 2.092 . . . . 74.510000000000005 112.67 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 3.2 mp0 -65.05 -15.67 62.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.524 1.129 . . . . 75.230000000000004 112.967 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -61.89 -23.81 66.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 118.473 0.579 . . . . 74.040000000000006 109.505 -178.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.3 p -51.43 -32.5 26.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.943 0.897 . . . . 75.219999999999999 111.826 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.52 -32.29 7.77 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.737 0.815 . . . . 72.400000000000006 111.138 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 26.0 mt-30 -64.35 133.88 95.8 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.174 0.59 . . . . 63.310000000000002 110.909 -173.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.575 ' HD2' HG22 ' A' ' 117' ' ' ILE . 52.7 Cg_exo -58.17 147.44 83.7 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.357 2.705 . . . . 74.400000000000006 113.331 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.55 131.24 43.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.583 2.855 . . . . 74.329999999999998 113.441 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.47 -178.39 31.4 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.937 -0.865 . . . . 64.049999999999997 110.937 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.432 HG13 ' HA ' ' A' ' 81' ' ' TYR . 4.5 m -76.4 123.9 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 109.733 -0.469 . . . . 72.540000000000006 109.733 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.575 HG22 ' HD2' ' A' ' 113' ' ' PRO . 22.7 pt -107.49 114.17 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.876 0.846 . . . . 71.420000000000002 109.843 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.727 HG13 HG23 ' A' ' 79' ' ' VAL . 58.6 t -92.62 100.83 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.455 -1.313 . . . . 64.329999999999998 107.455 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 10.9 p -107.41 125.57 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.552 0.691 . . . . 73.430000000000007 110.819 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 98' ' ' LEU . 11.3 t -119.67 138.41 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.506 0.723 . . . . 74.540000000000006 111.231 -169.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 t -128.01 132.06 49.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.702 -0.851 . . . . 74.310000000000002 108.702 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 118.723 -1.043 . . . . 74.530000000000001 112.757 -177.603 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.84 0.352 . . . . 65.510000000000005 110.548 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.1 t -112.63 163.38 14.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.617 0.767 . . . . 71.109999999999999 110.144 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 131.96 20.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 109.841 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.7 pt -136.63 121.42 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.657 0.783 . . . . 73.409999999999997 109.737 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -157.17 129.75 7.5 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.259 1.024 . . . . 73.430000000000007 109.36 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -149.03 115.59 5.89 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.725 -0.842 . . . . 72.239999999999995 108.725 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -141.73 109.77 5.84 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.891 -1.151 . . . . 70.150000000000006 107.891 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -139.56 119.37 13.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.476 0.655 . . . . 65.230000000000004 110.292 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 p -142.15 150.24 40.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.844 1.258 . . . . 65.310000000000002 108.689 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.4 p -142.48 152.92 43.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.447 1.099 . . . . 55.130000000000003 108.963 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -159.85 155.34 25.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.065 0.546 . . . . 74.430000000000007 110.664 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.15 157.52 23.34 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.409 1.083 . . . . 73.430000000000007 109.051 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.92 107.15 11.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.43 0.692 . . . . 64.299999999999997 109.568 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.98 -172.82 1.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.98 2.453 . . . . 74.430000000000007 112.167 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -170.21 146.13 2.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.598 0.759 . . . . 54.409999999999997 110.174 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.3 p -92.64 166.8 12.3 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.289 -0.634 . . . . 73.430000000000007 109.289 171.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.4 t -133.72 137.28 45.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.253 0.621 . . . . 74.439999999999998 110.509 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.4 p -167.46 153.01 7.4 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.634 0.774 . . . . 62.409999999999997 110.235 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -167.33 109.81 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 C-N-CA 123.713 0.805 . . . . 73.530000000000001 110.403 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -126.33 120.42 23.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 123.347 0.659 . . . . 73.120000000000005 110.361 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 C--N 1.369 1.644 0 C-N-CA 122.464 2.11 . . . . 74.219999999999999 111.32 172.219 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.826 0 N-CA-C 109.524 -0.547 . . . . 61.240000000000002 109.524 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . 8.6 pt-20 -66.54 121.56 15.63 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.424 -0.807 . . . . 73.140000000000001 110.224 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 t -92.76 144.3 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.126 -0.943 . . . . 72.409999999999997 109.073 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 5.9 ptp85 -151.25 161.19 43.16 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.92 0.488 . . . . 74.519999999999996 110.885 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 50' ' ' ALA . 58.8 t -126.27 123.89 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.955 . . . . 75.319999999999993 109.081 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -112.31 108.06 17.12 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 124.286 1.035 . . . . 74.420000000000002 109.326 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.422 HD21 ' HB ' ' A' ' 120' ' ' VAL . 16.7 m120 -78.5 112.99 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.772 -1.195 . . . . 55.509999999999998 107.772 170.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 70' ' ' SER . 3.0 tp -75.85 -43.25 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.362 -0.607 . . . . 75.439999999999998 109.362 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -144.17 156.02 44.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.888 0.875 . . . . 74.310000000000002 108.843 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.89 6.94 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.146 -0.808 . . . . 74.109999999999999 113.325 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.2 t 40.79 78.46 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.949 1.7 . . . . 70.209999999999994 113.106 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -121.68 114.49 21.21 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.914 0.485 . . . . 72.120000000000005 110.468 -174.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.01 -11.9 84.92 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.42 -0.809 . . . . 74.040000000000006 113.605 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.62 91.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.237 0.615 . . . . 75.530000000000001 110.9 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 120' ' ' VAL . . . -70.7 -33.39 70.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.689 -0.687 . . . . 53.549999999999997 110.727 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' A' ' 39' ' ' VAL . . . -77.49 -21.87 52.13 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.366 0.666 . . . . 74.109999999999999 112.135 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -66.08 -28.67 69.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.843 1.257 . . . . 73.230000000000004 111.049 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.565 HG21 ' HB3' ' A' ' 98' ' ' LEU . 78.2 p -63.02 -46.47 87.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.136 0.574 . . . . 63.539999999999999 110.713 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.58 65.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.535 0.734 . . . . 75.019999999999996 111.169 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.09 -28.62 69.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.176 0.59 . . . . 71.510000000000005 111.415 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -69.04 -36.98 78.32 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.603 0.361 . . . . 74.329999999999998 110.659 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.6 mp -62.54 -24.29 67.43 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.17 0.588 . . . . 74.230000000000004 111.586 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HZ1' ' HB2' ' A' ' 57' ' ' LYS . 4.6 ttmp? -56.42 -49.02 75.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.262 0.625 . . . . 72.209999999999994 110.314 173.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.02 -24.12 41.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.515 -0.766 . . . . 75.329999999999998 111.613 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -74.5 -17.31 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.374 0.67 . . . . 74.239999999999995 111.928 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 33.73 2.53 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.055 0.382 . . . . 73.219999999999999 114.055 170.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -100.37 157.62 16.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.512 0.725 . . . . 74.400000000000006 109.815 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -62.31 -73.82 0.1 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.881 . . . . 73.230000000000004 112.291 -161.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 75.6 t -123.02 144.29 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.319 -1.363 . . . . 72.129999999999995 107.319 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 p -138.6 101.36 4.32 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.987 -1.486 . . . . 75.510000000000005 106.987 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 9.3 t70 -107.21 149.62 27.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 64.140000000000001 109.967 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 50' ' ' ALA . 88.7 t -127.32 137.14 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.942 0.897 . . . . 63.439999999999998 108.995 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.43 159.6 32.54 Favored Glycine 0 C--N 1.344 1.018 0 O-C-N 123.539 0.524 . . . . 64.439999999999998 111.862 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -123.97 104.74 9.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.461 1.105 . . . . 74.540000000000006 108.314 174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 mp -133.36 134.09 43.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.049 0.54 . . . . 74.209999999999994 110.13 -171.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.48 ' HA ' HD13 ' A' ' 42' ' ' ILE . 24.6 p -85.4 98.68 10.71 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.543 -0.753 . . . . 62.030000000000001 108.975 172.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.632 ' HB2' HG23 ' A' ' 74' ' ' VAL . 82.6 mt -107.35 141.6 23.32 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.434 -0.951 . . . . 75.25 108.434 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.86 -17.87 17.38 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.575 2.183 . . . . 72.129999999999995 113.403 -169.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -94.78 -24.61 17.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.208 1.003 . . . . 73.239999999999995 111.844 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 71' ' ' LEU . 13.1 m -91.88 147.03 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.844 0.457 . . . . 74.099999999999994 109.975 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -164.79 -41.79 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.817 0.847 . . . . 74.519999999999996 109.772 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.58 134.45 33.63 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.007 -0.997 . . . . 72.200000000000003 110.325 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.61 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.8 t -74.83 98.24 3.47 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 122.272 1.034 . . . . 73.239999999999995 109.114 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 80' ' ' TYR . 63.2 m -153.83 155.03 35.03 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.377 -1.283 . . . . 73.010000000000005 108.808 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.672 HG11 HG23 ' A' ' 118' ' ' VAL . 23.5 t -94.57 116.22 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.516 -0.92 . . . . 74.140000000000001 108.516 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 78' ' ' THR . 75.4 m-85 -108.53 132.75 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.4 0.68 . . . . 73.409999999999997 111.904 -171.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 38.9 p90 -144.59 -177.18 5.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.919 0.888 . . . . 74.200000000000003 110.662 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -141.09 -91.72 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 118.891 -0.576 . . . . 74.010000000000005 110.095 165.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.47 -22.18 0.82 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.266 1.21 . . . . 62.219999999999999 114.266 -170.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 95.9 t -58.88 117.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 124.161 0.984 . . . . 72.329999999999998 112.046 -169.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 52.52 25.86 3.88 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.533 1.133 . . . . 72.230000000000004 113.635 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.11 57.59 5.63 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.774 -0.53 . . . . 64.239999999999995 111.774 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 37.1 mt-10 -52.69 -44.95 66.61 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.768 . . . . 73.120000000000005 111.989 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -65.34 -25.38 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.819 0.847 . . . . 74.510000000000005 112.566 -176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.96 0.504 . . . . 62.43 110.615 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.435 HG22 HG13 ' A' ' 116' ' ' VAL . 10.0 t -82.33 -26.99 32.52 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.469 -0.787 . . . . 74.510000000000005 111.177 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB1' HG22 ' A' ' 116' ' ' VAL . . . -69.03 -36.69 78.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.832 0.853 . . . . 74.319999999999993 111.012 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.23 -49.29 78.19 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 124.746 1.279 . . . . 73.109999999999999 109.766 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.86 78.54 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.352 1.032 . . . . 53.5 112.025 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.664 HG13 HG21 ' A' ' 118' ' ' VAL . 64.8 t -63.65 -53.89 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 122.974 0.51 . . . . 61.409999999999997 110.548 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.74 -23.46 69.06 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 124.164 0.915 . . . . 61.43 113.87 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -76.1 -39.35 55.46 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.955 -0.757 . . . . 71.230000000000004 108.955 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.7 m -74.6 -34.45 62.85 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.308 -0.86 . . . . 74.519999999999996 112.119 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 52' ' ' THR . 3.4 pp -93.74 -17.57 23.03 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.127 0.421 . . . . 73.120000000000005 111.932 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.48 52.75 4.08 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 113.966 0.346 . . . . 62.240000000000002 113.966 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.73 168.41 16.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.756 0.822 . . . . 74.310000000000002 109.718 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.46 165.5 25.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.599 0.759 . . . . 72.099999999999994 110.604 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.57 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 31.2 m -123.8 114.81 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 123.55 0.74 . . . . 65.329999999999998 109.586 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 35.5 mm-40 -124.39 174.78 7.53 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.538 1.135 . . . . 74.239999999999995 110.156 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.16 149.48 27.93 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.676 -0.693 . . . . 74.409999999999997 109.874 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.409 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 24.4 ptt180 -88.09 28.38 1.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.757 1.223 . . . . 72.450000000000003 111.641 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.574 ' HG ' ' HD3' ' A' ' 107' ' ' PRO . 4.3 pp -68.12 -32.31 3.93 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 117.597 -1.192 . . . . 64.340000000000003 112.728 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.574 ' HD3' ' HG ' ' A' ' 106' ' ' LEU . 13.1 Cg_exo -75.16 -34.48 3.66 Favored 'Trans proline' 0 C--N 1.405 3.506 0 CA-C-N 122.518 1.935 . . . . 73.219999999999999 111.914 167.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.618 ' HG3' HG11 ' A' ' 74' ' ' VAL . 8.3 mp0 -72.43 -10.5 59.87 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.542 1.137 . . . . 74.030000000000001 111.077 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.456 HD11 ' HG2' ' A' ' 112' ' ' GLN . 13.1 tp -68.78 -12.41 61.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.31 1.044 . . . . 73.310000000000002 111.12 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -61.9 -46.78 87.9 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.619 0.768 . . . . 65.420000000000002 110.909 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.01 -33.82 26.45 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.795 0.838 . . . . 55.049999999999997 109.677 172.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.456 ' HG2' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER 57.57 74.22 0.68 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.983 1.313 . . . . 73.299999999999997 111.028 -179.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.41 132.69 6.0 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 122.712 2.275 . . . . 75.299999999999997 111.656 172.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.32 152.65 52.12 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.705 2.937 . . . . 74.409999999999997 114.409 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.26 -167.5 27.38 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.222 -0.899 . . . . 75.230000000000004 113.616 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.709 HG22 ' HB1' ' A' ' 91' ' ' ALA . 3.2 p -87.06 131.95 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.311 -0.625 . . . . 73.230000000000004 109.311 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.46 149.81 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.859 0.864 . . . . 74.25 109.829 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.672 HG23 HG11 ' A' ' 79' ' ' VAL . 47.7 t -121.55 103.58 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.036 -1.468 . . . . 72.299999999999997 107.036 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.608 HG13 ' HB ' ' A' ' 74' ' ' VAL . 95.5 t -93.51 123.82 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.518 -0.919 . . . . 73.340000000000003 108.518 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.443 HG21 ' HB2' ' A' ' 49' ' ' ALA . 58.0 t -128.74 129.86 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.342 0.657 . . . . 64.340000000000003 109.84 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.61 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.5 t -105.8 155.86 18.88 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.332 0.653 . . . . 74.129999999999995 109.83 168.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.027 0 CA-C-O 119.174 -0.792 . . . . 51.240000000000002 111.764 179.569 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 108.727 -0.842 . . . . 74.450000000000003 108.727 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.9 m -134.47 123.49 24.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.68 0.792 . . . . 72.239999999999995 110.334 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.63 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.696 0.798 . . . . 64.209999999999994 110.23 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.69 143.16 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.072 -1.084 . . . . 74.430000000000007 108.072 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -164.24 111.92 1.11 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 74.219999999999999 110.225 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.1 t -161.71 125.81 3.3 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.305 1.042 . . . . 71.200000000000003 109.333 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.3 ptp -171.57 146.44 2.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.906 0.882 . . . . 75.329999999999998 110.241 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -173.58 141.19 0.84 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.042 0.937 . . . . 64.209999999999994 109.66 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.6 t -167.13 106.23 0.58 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.468 0.707 . . . . 74.120000000000005 110.64 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -161.1 102.92 1.27 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.251 1.421 . . . . 74.299999999999997 109.082 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.1 p -135.58 125.7 26.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.757 0.823 . . . . 74.340000000000003 109.947 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.34 132.05 7.72 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.173 0.989 . . . . 61.420000000000002 109.942 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.48 107.35 10.08 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.617 0.767 . . . . 74.519999999999996 109.983 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.41 144.75 20.57 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.953 2.435 . . . . 74.120000000000005 111.863 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.3 p -122.41 148.41 45.14 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.694 0.398 . . . . 72.040000000000006 110.685 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m -146.28 111.88 5.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.716 0.806 . . . . 74.120000000000005 109.925 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.5 p -124.74 129.45 50.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.92 0.888 . . . . 71.230000000000004 109.473 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 m -150.49 111.45 4.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.739 0.816 . . . . 75.430000000000007 108.873 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.75 131.36 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.484 0.714 . . . . 72.230000000000004 109.992 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -123.79 112.73 28.84 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.146 0.979 . . . . 73.310000000000002 108.747 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 C--N 1.376 1.978 0 C-N-CA 122.391 2.061 . . . . 74.450000000000003 111.633 177.208 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.245 0.853 0 CA-C-O 121.018 0.437 . . . . 73.409999999999997 110.17 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.81 108.13 19.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.008 0.923 . . . . 72.140000000000001 110.441 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.507 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 41.3 t -106.88 138.7 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.192 0.997 . . . . 75.299999999999997 109.613 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.53 128.95 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.433 -0.58 . . . . 73.120000000000005 109.433 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.3 t -103.72 128.11 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.34 0.656 . . . . 75.319999999999993 109.389 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.634 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 38.3 m-85 -124.03 131.45 53.56 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.423 0.689 . . . . 74.519999999999996 110.286 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -85.7 112.08 20.7 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.988 -1.115 . . . . 72.519999999999996 107.988 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 71' ' ' LEU . 9.2 tp -75.31 -47.19 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.042 0.449 . . . . 74.450000000000003 111.355 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 m -107.51 3.18 24.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.988 0.915 . . . . 72.219999999999999 110.383 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 136.83 1.48 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.52 -0.632 . . . . 51.100000000000001 111.52 -170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 t -157.28 -178.95 7.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.359 0.664 . . . . 71.519999999999996 110.032 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.72 154.11 42.22 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.222 1.009 . . . . 71.209999999999994 111.071 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.79 -2.49 16.99 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 115.022 0.769 . . . . 53.32 115.022 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.51 -28.12 69.73 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.612 0.765 . . . . 74.329999999999998 111.518 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.2 -42.75 75.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.277 0.631 . . . . 72.430000000000007 110.576 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.36 -28.46 67.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.61 -0.723 . . . . 75.219999999999999 111.667 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -65.28 -24.95 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.601 1.16 . . . . 74.329999999999998 111.752 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 98' ' ' LEU . 68.9 p -71.89 -47.59 51.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.367 0.267 . . . . 75.329999999999998 110.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.1 93.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.308 0.575 . . . . 73.140000000000001 110.639 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.29 -32.96 74.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.532 -1.213 . . . . 63.399999999999999 111.422 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -72.04 -41.07 67.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.054 0.542 . . . . 75.049999999999997 109.66 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -70.91 -26.03 63.03 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.394 -0.821 . . . . 73.519999999999996 111.336 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -61.71 -51.22 69.29 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.077 -0.712 . . . . 71.439999999999998 109.077 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.3 71.36 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.152 -0.931 . . . . 74.209999999999994 111.143 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.43 1.25 16.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.536 0.734 . . . . 73.010000000000005 112.309 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.6 40.19 11.27 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 113.96 0.344 . . . . 61.350000000000001 113.96 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -89.09 155.27 19.56 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.246 0.523 . . . . 73.209999999999994 109.76 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -66.03 -60.33 2.94 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.041 0.756 . . . . 75.200000000000003 113.041 -159.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.27 103.21 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.326 -0.99 . . . . 73.430000000000007 108.326 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 16.8 p -107.96 105.51 15.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 73.430000000000007 109.86 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -115.16 156.64 24.9 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.649 1.18 . . . . 73.400000000000006 109.679 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.77 144.54 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.768 0.427 . . . . 75.120000000000005 111.023 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.57 -158.54 13.61 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.498 -0.641 . . . . 60.409999999999997 111.498 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -107.49 173.42 6.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.23 -0.656 . . . . 74.310000000000002 109.23 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 27.7 tp -144.51 138.99 27.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 111.258 0.096 . . . . 72.129999999999995 111.258 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.7 p -87.57 133.58 33.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.67 -0.863 . . . . 72.230000000000004 108.67 170.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.805 ' HA ' HD12 ' A' ' 42' ' ' ILE . 32.4 tp -44.17 101.45 0.25 Allowed Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 125.177 1.391 . . . . 72.129999999999995 113.949 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.85 -100.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.109 2.539 . . . . 75.219999999999999 109.96 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.07 -22.13 12.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.054 0.942 . . . . 73.129999999999995 111.621 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.97 128.07 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.647 -0.501 . . . . 74.400000000000006 109.647 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.57 16.43 9.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.937 0.895 . . . . 74.409999999999997 111.536 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 156.97 46.17 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.559 0.744 . . . . 72.230000000000004 109.916 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 t -62.34 100.47 0.18 Allowed 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.057 0.932 . . . . 74.310000000000002 110.316 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.2 m -148.12 143.07 26.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 74.450000000000003 109.321 -172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.703 HG11 HG22 ' A' ' 118' ' ' VAL . 42.6 t -95.94 115.86 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.603 -1.258 . . . . 75.439999999999998 107.603 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.539 ' HB3' HG13 ' A' ' 117' ' ' ILE . 32.3 t80 -107.86 113.76 27.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.908 -1.145 . . . . 74.340000000000003 107.908 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.539 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 41.9 p90 -141.32 147.43 38.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.135 0.791 . . . . 74.129999999999995 113.135 -170.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -85.94 -157.82 0.36 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.96 -1.126 . . . . 70.329999999999998 107.96 167.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -124.99 7.18 7.97 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.108 -0.995 . . . . 64.310000000000002 110.907 173.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 98.7 t -66.61 128.41 29.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 123.82 0.848 . . . . 74.310000000000002 109.603 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HG3' HG12 ' A' ' 84' ' ' VAL . 35.4 mt-10 62.1 20.9 12.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.523 0.729 . . . . 74.040000000000006 111.125 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.35 35.5 52.31 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.683 -0.51 . . . . 74.430000000000007 113.387 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 29.4 mt-10 -52.57 -33.47 45.98 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.933 0.716 . . . . 74.239999999999995 112.933 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -64.57 -31.34 72.52 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.839 0.455 . . . . 74.209999999999994 112.182 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.99 -37.41 29.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.505 0.722 . . . . 75.040000000000006 111.554 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.411 HG21 ' HB1' ' A' ' 35' ' ' ALA . 69.5 p -74.41 -36.83 63.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.466 -0.788 . . . . 72.219999999999999 110.894 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -30.72 69.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.498 -1.228 . . . . 63.409999999999997 111.89 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.29 -44.33 92.52 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.333 1.021 . . . . 72.120000000000005 110.136 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.01 75.26 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.516 -0.765 . . . . 61.310000000000002 112.272 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.634 HG13 HG23 ' A' ' 118' ' ' VAL . 64.3 t -74.32 -59.3 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.498 -0.319 . . . . 74.219999999999999 110.519 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.84 -23.05 55.67 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.811 0.694 . . . . 72.109999999999999 114.011 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -67.87 -60.03 2.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.485 1.114 . . . . 73.409999999999997 109.758 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.6 m -71.63 -32.76 68.3 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 114.902 -1.045 . . . . 74.200000000000003 111.141 -172.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.564 ' HB2' HG22 ' A' ' 52' ' ' THR . 48.7 tp -81.11 -27.28 35.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.941 0.896 . . . . 74.219999999999999 110.497 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.74 43.65 83.68 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.564 0.54 . . . . 75.310000000000002 112.667 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.53 25.04 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.774 0.83 . . . . 75.109999999999999 110.173 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.77 139.98 58.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.32 0.648 . . . . 75.409999999999997 110.355 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.539 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.2 m -112.15 131.83 62.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.425 0.69 . . . . 74.439999999999998 109.24 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.53 144.2 46.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.565 0.746 . . . . 74.439999999999998 111.309 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 16.2 tp -66.36 -177.2 0.51 Allowed 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 114.198 -1.364 . . . . 74.349999999999994 110.815 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.583 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 6.7 ppt_? -56.51 -28.6 60.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.863 1.265 . . . . 65.040000000000006 113.733 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 104' ' ' LEU . 74.6 mt 62.1 168.04 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.538 1.135 . . . . 75.420000000000002 113.039 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -73.25 -12.34 25.35 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.285 1.99 . . . . 74.109999999999999 112.605 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' HH ' ' A' ' 80' ' ' TYR . 16.1 mm-40 -69.49 -18.85 63.73 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.227 1.011 . . . . 74.150000000000006 112.624 -169.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.8 -4.26 19.27 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.666 0.617 . . . . 71.319999999999993 112.666 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -60.25 -21.72 62.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.266 0.626 . . . . 61.340000000000003 111.763 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -115.51 -32.99 5.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.84 0.856 . . . . 74.209999999999994 110.83 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -96.41 127.03 41.51 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.065 0.946 . . . . 74.219999999999999 110.846 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.96 134.11 57.94 Favored 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 122.18 1.92 . . . . 75.219999999999999 112.7 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.91 163.12 32.16 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.278 2.652 . . . . 74.310000000000002 113.415 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 130.58 146.36 5.9 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 108.647 -1.781 . . . . 73.099999999999994 108.647 -171.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 53.7 t -65.0 99.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 118.718 1.259 . . . . 72.400000000000006 108.767 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 80' ' ' TYR . 29.4 pt -107.57 106.93 21.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.467 -1.308 . . . . 74.219999999999999 107.467 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.703 HG22 HG11 ' A' ' 79' ' ' VAL . 42.1 t -89.83 101.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.34 -1.356 . . . . 74.420000000000002 107.34 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.0 t -93.67 113.14 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.33 -1.359 . . . . 73.329999999999998 107.33 -174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.53 127.36 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 110.223 -0.288 . . . . 74.329999999999998 110.223 -171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -89.98 160.54 16.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.938 0.895 . . . . 74.430000000000007 109.743 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.958 -0.912 . . . . 61.009999999999998 111.373 178.509 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.393 -0.225 . . . . 71.230000000000004 110.393 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -160.76 145.12 13.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.03 0.532 . . . . 63.130000000000003 109.974 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.73 139.47 20.75 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.463 0.705 . . . . 71.230000000000004 109.941 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -108.87 167.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.008 0.923 . . . . 75.420000000000002 111.057 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 t -83.84 -167.29 1.67 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.324 1.049 . . . . 74.329999999999998 110.419 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.9 m -141.04 137.28 32.82 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.034 0.934 . . . . 73.319999999999993 109.246 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.495 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.5 OUTLIER -95.09 127.67 41.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.84 0.856 . . . . 74.340000000000003 110.134 -175.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 m -145.9 144.33 30.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.76 0.824 . . . . 73.109999999999999 109.776 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -145.01 166.06 26.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.88 0.872 . . . . 75.040000000000006 110.638 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -136.95 143.31 42.79 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.662 0.785 . . . . 71.219999999999999 109.83 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 t -103.11 176.45 5.14 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.321 1.048 . . . . 72.209999999999994 110.107 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.8 170.53 15.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.461 0.704 . . . . 74.319999999999993 110.482 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.36 120.06 15.7 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.344 1.057 . . . . 64.409999999999997 109.968 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.04 159.97 37.12 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.626 2.217 . . . . 63.340000000000003 112.422 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -149.42 140.02 22.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 71.400000000000006 109.322 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -145.45 139.68 27.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.227 0.611 . . . . 74.409999999999997 110.038 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -121.41 176.01 5.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.136 0.974 . . . . 72.230000000000004 109.947 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.2 p -146.65 136.76 23.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.814 0.846 . . . . 73.430000000000007 109.646 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.83 147.91 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.402 0.681 . . . . 73.120000000000005 110.251 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -103.86 157.02 34.8 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 123.81 0.844 . . . . 71.049999999999997 109.844 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo . . . . . 0 C--N 1.377 2.032 0 C-N-CA 122.477 2.118 . . . . 72.219999999999999 111.708 170.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HB3' ' HG2' ' A' ' 87' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 110.554 -0.165 . . . . 73.140000000000001 110.554 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -142.25 102.21 4.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.755 0.822 . . . . 72.439999999999998 109.96 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 64' ' ' THR . 11.4 t -114.67 151.35 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-O 121.839 0.828 . . . . 74.299999999999997 111.584 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HB3' HG23 ' A' ' 117' ' ' ILE . 33.2 ttm105 -153.64 141.29 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.121 1.369 . . . . 73.129999999999995 108.872 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 49' ' ' ALA . 39.0 t -131.48 119.83 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.7 0.8 . . . . 73.329999999999998 108.904 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HH ' HD13 ' A' ' 117' ' ' ILE . 45.4 p90 -141.6 149.13 40.31 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.09 0.471 . . . . 73.450000000000003 111.125 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -78.81 141.28 37.88 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.09 -0.959 . . . . 74.239999999999995 109.051 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.515 HD11 HG11 ' A' ' 74' ' ' VAL . 9.2 tp -79.61 -36.97 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 122.783 0.433 . . . . 75.109999999999999 110.123 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -96.39 -39.14 9.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.647 0.779 . . . . 70.319999999999993 109.96 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.08 60.82 2.2 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.953 -0.567 . . . . 70.109999999999999 112.004 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m -119.17 -42.64 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.596 0.759 . . . . 72.319999999999993 110.812 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -122.22 148.13 45.35 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.025 0.53 . . . . 75.510000000000005 110.926 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.03 1.57 63.13 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.124 -0.82 . . . . 74.129999999999995 114.274 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.18 -35.03 10.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.742 1.217 . . . . 74.400000000000006 113.368 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HB3' HG11 ' A' ' 39' ' ' VAL . . . -63.07 -52.2 63.68 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.226 0.611 . . . . 61.009999999999998 111.033 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.87 -27.48 68.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.412 -0.813 . . . . 71.400000000000006 111.402 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -70.46 -52.4 22.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.522 0.729 . . . . 74.450000000000003 110.644 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -72.97 -23.96 60.72 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.075 -0.511 . . . . 74.049999999999997 110.954 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.42 -20.67 54.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.974 0.909 . . . . 71.239999999999995 111.816 173.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.45 -41.1 66.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.276 1.03 . . . . 54.130000000000003 109.11 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.51 -38.0 89.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.593 -1.185 . . . . 75.439999999999998 109.556 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.512 HD21 HG11 ' A' ' 37' ' ' VAL . 62.6 tp -63.12 -50.65 69.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.116 0.966 . . . . 72.150000000000006 112.331 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -27.17 66.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.846 0.355 . . . . 73.299999999999997 110.811 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.82 -20.85 34.87 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.679 0.791 . . . . 74.200000000000003 111.202 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.6 -23.48 27.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.541 0.736 . . . . 72.140000000000001 111.623 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.74 48.89 0.32 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.718 -0.49 . . . . 64.540000000000006 112.988 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -57.32 157.46 6.44 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.403 0.681 . . . . 73.099999999999994 111.099 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 35' ' ' ALA . 28.3 m -89.97 -66.34 0.93 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.133 -1.062 . . . . 62.299999999999997 108.133 173.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -144.28 134.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.135 -1.802 . . . . 63.539999999999999 106.135 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 91.4 m -143.25 123.59 13.85 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 122.836 0.454 . . . . 74.109999999999999 109.891 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -102.08 126.01 48.92 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.721 -0.844 . . . . 72.230000000000004 108.721 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 27.1 m -114.76 146.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.873 0.469 . . . . 71.519999999999996 110.25 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.25 -136.04 3.94 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 123.476 0.485 . . . . 75.310000000000002 113.314 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -159.39 117.53 2.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.115 0.966 . . . . 75.25 109.677 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.2 tp -150.65 140.7 22.05 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.257 0.623 . . . . 73.25 109.767 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.474 ' HA ' HD12 ' A' ' 42' ' ' ILE . 39.0 m -88.61 99.35 12.26 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.302 0.641 . . . . 73.439999999999998 110.236 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 40' ' ' TYR . 4.5 mm? -85.05 125.16 71.16 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.351 -0.981 . . . . 75.040000000000006 108.351 168.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 -11.85 32.33 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.67 2.246 . . . . 74.329999999999998 113.321 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.73 -22.79 23.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.84 0.856 . . . . 71.409999999999997 112.334 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.515 HG11 HD11 ' A' ' 42' ' ' ILE . 11.0 p -123.89 154.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.336 0.654 . . . . 65.340000000000003 110.131 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.36 40.61 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.209 1.004 . . . . 73.319999999999993 109.481 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.6 38.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.663 0.785 . . . . 55.109999999999999 110.57 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.598 ' HB ' HG21 ' A' ' 121' ' ' THR . 10.0 t -75.11 99.95 4.1 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.421 1.105 . . . . 62.219999999999999 108.688 172.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.7 m -149.13 131.01 15.17 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.02 -0.991 . . . . 73.109999999999999 109.492 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.743 HG23 HG11 ' A' ' 118' ' ' VAL . 86.9 t -95.62 114.13 31.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.526 -0.916 . . . . 75.430000000000007 108.526 174.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -101.51 137.43 39.84 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.084 -1.08 . . . . 74.409999999999997 108.084 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.472 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 43.9 p90 -134.46 143.08 47.31 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 74.209999999999994 112.689 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.2 m -95.28 169.63 9.95 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 113.845 -1.525 . . . . 73.439999999999998 107.376 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -116.03 13.61 15.91 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.317 0.858 . . . . 74.099999999999994 113.317 -165.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 86.0 t -64.21 115.0 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.9 0.48 . . . . 63.229999999999997 110.552 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 64.31 -77.17 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.937 1.295 . . . . 73.530000000000001 111.231 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.87 45.23 0.24 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.246 -0.342 . . . . 42.439999999999998 112.246 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . 42.4 mt-10 -61.22 -32.7 72.48 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.511 0.724 . . . . 75.409999999999997 112.31 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -56.73 -24.91 52.94 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.624 -0.716 . . . . 73.510000000000005 112.559 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.61 -43.64 75.97 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.616 0.766 . . . . 52.130000000000003 111.915 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.0 p -69.35 -39.64 77.99 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.423 -0.584 . . . . 74.420000000000002 109.423 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.97 96.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.367 1.067 . . . . 73.420000000000002 112.082 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.48 -38.38 87.15 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.377 1.048 . . . . 75.230000000000004 110.305 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.49 69.88 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.81 0.694 . . . . 73.340000000000003 110.655 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.431 HG12 HG23 ' A' ' 118' ' ' VAL . 62.1 t -67.41 -35.42 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.334 0.654 . . . . 74.120000000000005 110.856 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -68.72 -34.89 79.02 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 116.029 -0.532 . . . . 73.329999999999998 112.959 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -72.21 -44.26 63.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.608 0.763 . . . . 73.430000000000007 109.877 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.5 m -67.02 -37.85 84.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.225 1.01 . . . . 74.430000000000007 111.337 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 43.9 tp -81.73 -32.13 31.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.697 0.799 . . . . 74.230000000000004 110.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.91 40.84 15.92 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.934 -0.576 . . . . 72.510000000000005 112.081 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.56 156.27 24.96 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.519 0.728 . . . . 75.450000000000003 111.16 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.37 23.34 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.009 0.923 . . . . 74.530000000000001 110.949 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.472 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 27.4 m -89.86 112.3 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-O 121.737 0.779 . . . . 74.209999999999994 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -113.54 158.3 20.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.506 1.122 . . . . 74.519999999999996 110.256 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.0 mt -66.84 -175.9 0.45 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.748 0.819 . . . . 74.450000000000003 110.743 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 5.4 ppt_? -59.19 -37.55 77.67 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 116.355 -0.384 . . . . 64.239999999999995 111.513 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.533 ' N ' ' HD2' ' A' ' 105' ' ' ARG . 83.8 mt 58.08 172.53 0.05 OUTLIER Pre-proline 0 CA--C 1.573 1.829 0 C-N-CA 123.64 0.776 . . . . 74.109999999999999 112.491 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.72 -12.31 17.55 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.55 2.166 . . . . 72.140000000000001 114.077 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.31 -46.78 82.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.712 1.205 . . . . 64.140000000000001 112.0 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 114' ' ' PRO . 4.1 mm? -69.85 4.83 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.36 1.064 . . . . 75.200000000000003 113.429 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.9 t -72.1 -49.01 39.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.735 0.414 . . . . 74.409999999999997 110.368 171.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.87 -36.14 20.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.606 0.362 . . . . 52.210000000000001 111.36 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.48 ' HG3' HD11 ' A' ' 109' ' ' LEU . 4.8 pt20 -90.42 160.67 38.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 118.624 -0.703 . . . . 71.150000000000006 109.523 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.57 119.7 5.48 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.255 1.97 . . . . 74.219999999999999 112.66 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.604 ' HA ' HD12 ' A' ' 109' ' ' LEU . 56.4 Cg_endo -71.14 117.02 4.94 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.355 2.037 . . . . 65.239999999999995 113.2 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.433 ' H ' HD12 ' A' ' 109' ' ' LEU . . . 164.3 -161.08 34.16 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 110.858 -0.897 . . . . 63.420000000000002 110.858 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 70.6 t -77.07 106.24 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.231 -1.026 . . . . 75.25 108.231 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.615 HG23 ' HB3' ' A' ' 38' ' ' ARG . 2.8 pp -123.89 124.48 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.439 -0.949 . . . . 74.340000000000003 108.439 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.743 HG11 HG23 ' A' ' 79' ' ' VAL . 93.5 t -104.41 106.65 20.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.759 -1.2 . . . . 74.129999999999995 107.759 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.17 123.19 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.212 -0.662 . . . . 72.219999999999999 109.212 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.8 t -103.37 128.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.794 -0.817 . . . . 73.25 108.794 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.598 HG21 ' HB ' ' A' ' 77' ' ' THR . 10.1 t -72.94 132.32 43.31 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.467 -0.938 . . . . 72.530000000000001 108.467 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.082 0 N-CA-C 110.528 -1.029 . . . . 72.540000000000006 110.528 -166.352 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.241 0.609 0 N-CA-C 109.134 -0.691 . . . . 73.540000000000006 109.134 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.7 p -153.15 166.45 32.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.37 0.668 . . . . 64.120000000000005 109.964 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.98 154.55 51.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.509 0.724 . . . . 54.310000000000002 110.382 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 tt -144.48 138.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.786 0.834 . . . . 73.209999999999994 109.467 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 t -164.42 156.53 16.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.904 0.882 . . . . 72.109999999999999 109.743 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 t -162.95 154.77 17.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.201 0.6 . . . . 74.0 110.637 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.9 mtp -111.32 145.23 39.2 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.259 1.024 . . . . 74.099999999999994 109.932 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.7 p -141.7 138.2 32.25 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 73.209999999999994 109.875 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -115.12 171.93 7.37 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.425 0.69 . . . . 65.340000000000003 109.877 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -150.83 134.91 16.79 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.737 0.815 . . . . 74.329999999999998 109.24 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.2 m -99.26 124.73 44.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.054 0.542 . . . . 73.420000000000002 110.151 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.28 18.37 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.832 0.853 . . . . 74.329999999999998 109.109 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.71 109.9 60.59 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.092 0.557 . . . . 75.310000000000002 109.754 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.77 -171.22 1.19 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.514 2.143 . . . . 63.43 112.089 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -167.05 -179.39 4.61 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.086 0.955 . . . . 75.420000000000002 109.432 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -132.45 167.49 19.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.407 0.683 . . . . 73.140000000000001 110.607 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -113.3 136.49 52.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.406 1.082 . . . . 74.430000000000007 109.949 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -87.95 134.09 33.79 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.038 0.535 . . . . 73.109999999999999 109.972 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.61 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.71 0.804 . . . . 75.099999999999994 109.493 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.43 147.48 33.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 123.482 0.713 . . . . 74.019999999999996 110.081 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 C--N 1.379 2.15 0 C-N-CA 122.744 2.296 . . . . 72.400000000000006 111.526 173.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 112.955 0.724 . . . . 53.240000000000002 112.955 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HG3' ' HB ' ' A' ' 63' ' ' VAL . 36.1 tt0 -87.43 124.36 33.34 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 113.969 -1.469 . . . . 72.430000000000007 110.426 176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.1 t -110.65 140.06 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.333 1.053 . . . . 72.349999999999994 108.937 167.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -138.4 109.17 6.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.215 0.531 . . . . 75.140000000000001 109.873 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.575 ' HA ' ' HB ' ' A' ' 118' ' ' VAL . 41.1 t -95.46 134.05 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.384 1.074 . . . . 75.340000000000003 110.014 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.467 ' HE2' HD12 ' A' ' 42' ' ' ILE . 37.5 p90 -156.24 143.89 19.39 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.648 0.379 . . . . 75.129999999999995 110.53 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -97.19 142.99 28.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.503 -0.555 . . . . 75.310000000000002 109.503 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.467 HD12 ' HE2' ' A' ' 40' ' ' TYR . 7.2 mt -120.42 20.34 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 122.306 1.051 . . . . 75.319999999999993 109.891 -177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.2 m -150.18 -137.9 0.08 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.355 1.062 . . . . 73.230000000000004 108.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.07 92.25 0.05 OUTLIER Glycine 0 C--N 1.36 1.874 0 CA-C-N 118.416 0.553 . . . . 65.219999999999999 112.344 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 t -85.0 109.04 17.9 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.802 0.841 . . . . 73.340000000000003 112.122 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -103.59 171.15 7.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.141 -0.936 . . . . 73.140000000000001 109.196 166.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 -2.01 79.65 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.432 -0.349 . . . . 53.32 113.457 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.03 -30.18 71.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.939 0.896 . . . . 72.329999999999998 112.443 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.52 97.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.27 0.628 . . . . 71.129999999999995 110.891 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.62 -25.61 67.46 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.706 0.632 . . . . 74.409999999999997 112.706 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -27.68 66.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.589 1.155 . . . . 74.420000000000002 111.673 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -69.42 -59.31 3.07 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 110.38 -0.23 . . . . 75.129999999999995 110.38 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.56 65.09 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.263 0.625 . . . . 74.530000000000001 112.022 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.37 -44.33 54.66 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.742 1.217 . . . . 74.200000000000003 111.324 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -76.63 -32.7 58.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.831 -0.622 . . . . 74.510000000000005 111.451 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.78 -33.23 75.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.513 0.325 . . . . 74.299999999999997 111.799 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -66.84 -38.58 86.69 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.898 0.38 . . . . 74.219999999999999 110.096 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.61 68.31 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.566 -0.743 . . . . 72.129999999999995 111.212 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -14.59 61.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.806 0.843 . . . . 73.0 111.255 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.09 21.58 32.53 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 119.402 -0.666 . . . . 34.100000000000001 113.226 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -74.53 157.78 34.91 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.294 0.547 . . . . 63.229999999999997 109.735 170.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -69.14 -65.03 0.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.043 -0.526 . . . . 75.129999999999995 111.378 -156.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 93.0 t -127.71 135.69 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.134 -1.062 . . . . 64.030000000000001 108.134 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 p -134.1 102.42 5.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.648 0.779 . . . . 64.209999999999994 109.054 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.8 150.65 22.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.186 0.594 . . . . 62.140000000000001 109.833 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 15.1 m -143.83 139.23 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.75 0.82 . . . . 75.420000000000002 110.198 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.26 -143.18 6.34 Favored Glycine 0 C--N 1.35 1.352 0 C-N-CA 121.228 -0.511 . . . . 55.119999999999997 113.829 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -158.25 128.13 5.96 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.634 0.773 . . . . 75.239999999999995 110.595 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.1 163.56 16.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.766 0.826 . . . . 63.240000000000002 110.865 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -76.85 149.38 36.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.746 1.218 . . . . 74.409999999999997 110.213 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.97 107.36 0.84 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 123.859 0.864 . . . . 73.109999999999999 111.701 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -93.67 -87.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.132 2.554 . . . . 65.439999999999998 111.173 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.82 -15.8 13.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.094 0.958 . . . . 63.509999999999998 110.935 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.14 143.09 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.744 0.818 . . . . 74.129999999999995 111.068 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.42 23.13 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.832 0.853 . . . . 71.329999999999998 111.125 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.03 143.94 37.69 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.375 0.67 . . . . 73.340000000000003 109.317 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -73.71 96.52 2.52 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.378 1.085 . . . . 75.310000000000002 108.703 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 101' ' ' ALA . 5.2 p -151.91 137.79 18.07 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.723 -1.126 . . . . 73.430000000000007 109.844 -170.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 118' ' ' VAL . 60.9 t -96.82 116.85 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.982 -0.748 . . . . 75.340000000000003 108.982 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.27 139.33 41.9 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.928 -0.767 . . . . 74.329999999999998 108.928 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.471 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 39.6 p90 -143.03 147.43 35.08 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.703 0.763 . . . . 72.329999999999998 112.436 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -78.3 166.42 22.71 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 107.396 -1.335 . . . . 73.519999999999996 107.396 160.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.49 22.56 9.92 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.357 -0.839 . . . . 73.409999999999997 112.066 -168.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.17 111.26 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 109.662 -0.496 . . . . 74.319999999999993 109.662 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 63.48 -82.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.331 1.452 . . . . 75.310000000000002 111.492 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.99 35.07 1.19 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 116.206 -0.452 . . . . 70.019999999999996 112.989 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 35' ' ' ALA . 50.3 mt-10 -71.27 -34.29 70.56 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.429 -0.952 . . . . 74.450000000000003 108.429 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -54.56 -36.61 64.53 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.839 -1.073 . . . . 74.030000000000001 112.061 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.59 55.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.654 0.782 . . . . 71.129999999999995 111.187 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.3 p -67.97 -30.0 69.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.067 0.547 . . . . 74.230000000000004 110.831 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.86 -38.16 64.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.067 -0.969 . . . . 75.420000000000002 111.397 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.03 -38.95 90.65 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.785 0.834 . . . . 74.140000000000001 110.808 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -51.96 67.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.907 0.883 . . . . 72.219999999999999 111.275 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.1 t -73.03 -46.1 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.053 0.541 . . . . 74.409999999999997 111.848 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.74 -24.81 57.91 Favored Glycine 0 N--CA 1.468 0.811 0 O-C-N 123.561 0.538 . . . . 71.239999999999995 112.799 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -81.48 -42.21 20.62 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.62 0.768 . . . . 74.109999999999999 109.874 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.5 m -73.76 -28.96 61.95 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.311 0.577 . . . . 74.25 111.344 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.0 tp -92.31 -29.29 16.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.785 1.234 . . . . 71.030000000000001 109.423 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 46.35 18.32 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.738 0.648 . . . . 63.210000000000001 111.958 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.31 148.49 42.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.827 0.851 . . . . 75.340000000000003 109.764 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.498 ' HB3' HG22 ' A' ' 78' ' ' THR . . . -66.38 116.08 7.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.309 0.644 . . . . 62.219999999999999 110.459 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.471 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.9 m -85.25 140.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.256 0.622 . . . . 74.540000000000006 109.329 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -155.2 153.83 31.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.48 0.712 . . . . 63.229999999999997 109.651 -174.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.04 173.01 3.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.82 0.848 . . . . 70.129999999999995 110.811 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -83.58 26.66 0.66 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.998 1.11 . . . . 74.010000000000005 113.998 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.1 mm? -64.17 -53.65 45.81 Favored Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 118.146 -0.93 . . . . 74.230000000000004 111.41 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 22.8 Cg_exo -67.1 -38.25 16.5 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 121.663 1.575 . . . . 73.209999999999994 113.129 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.01 -21.38 61.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.253 0.345 . . . . 74.219999999999999 110.875 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.43 -14.36 56.37 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.328 1.051 . . . . 73.340000000000003 111.372 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 t -57.94 -48.02 81.16 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.268 0.627 . . . . 73.150000000000006 110.483 171.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.97 -31.87 21.84 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.851 0.86 . . . . 75.239999999999995 110.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.32 73.46 0.63 Allowed Pre-proline 0 CA--C 1.561 1.404 0 C-N-CA 125.786 1.634 . . . . 72.0 110.805 -173.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -88.4 148.48 6.4 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.338 2.692 . . . . 72.420000000000002 110.976 165.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -87.41 133.67 3.29 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.362 2.041 . . . . 73.450000000000003 112.787 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.97 -139.7 14.68 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.432 -0.803 . . . . 61.340000000000003 114.033 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.2 t -105.82 113.14 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.328 1.051 . . . . 72.409999999999997 110.258 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.1 pt -101.04 114.38 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 122.049 0.928 . . . . 75.219999999999999 109.075 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.698 HG12 HG23 ' A' ' 79' ' ' VAL . 89.5 t -90.69 108.49 19.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.264 -1.013 . . . . 71.129999999999995 108.264 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.4 117.56 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.333 -0.988 . . . . 74.400000000000006 108.333 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.23 142.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.045 -1.465 . . . . 73.230000000000004 107.045 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.3 p -134.98 110.68 9.25 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.889 -0.782 . . . . 63.229999999999997 108.889 168.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.212 0 CA-C-O 118.904 -0.942 . . . . 72.319999999999993 112.97 178.596 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 p . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.982 -0.377 . . . . 71.299999999999997 109.982 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.9 p -129.76 152.36 49.34 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.64 0.776 . . . . 73.510000000000005 109.748 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.45 176.4 5.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.769 0.828 . . . . 64.409999999999997 110.825 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.77 -175.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.318 1.047 . . . . 74.430000000000007 109.887 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -150.13 161.5 42.26 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.824 0.85 . . . . 64.129999999999995 110.024 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 p -98.38 153.75 18.34 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.743 0.817 . . . . 74.420000000000002 111.655 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 92.7 mmm -113.31 152.62 29.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.543 1.137 . . . . 72.409999999999997 109.257 171.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -115.65 125.77 53.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.802 0.841 . . . . 71.129999999999995 109.014 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -118.57 142.14 47.9 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.209 0.603 . . . . 73.129999999999995 109.933 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -154.84 164.64 38.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.241 1.017 . . . . 73.099999999999994 109.447 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -149.45 168.06 24.48 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 120.909 0.385 . . . . 74.310000000000002 110.967 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.14 166.25 13.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.164 0.985 . . . . 51.25 109.846 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.34 125.19 22.47 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.262 0.625 . . . . 75.230000000000004 110.909 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.42 -170.57 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.156 2.57 . . . . 75.519999999999996 112.271 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 m -133.34 146.75 51.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.715 0.806 . . . . 74.430000000000007 109.549 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 p -77.4 167.62 21.38 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.648 0.779 . . . . 55.229999999999997 111.44 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 m -110.41 131.44 55.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.514 0.725 . . . . 74.340000000000003 109.532 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.4 t -122.23 130.86 53.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.684 0.793 . . . . 55.030000000000001 109.971 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.33 149.42 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.378 0.671 . . . . 71.409999999999997 111.195 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -82.37 139.24 44.8 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 108.574 -0.898 . . . . 74.040000000000006 108.574 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo . . . . . 0 C--N 1.377 2.042 0 C-N-CA 122.501 2.134 . . . . 75.200000000000003 112.216 173.742 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 N-CA-C 109.959 -0.385 . . . . 75.519999999999996 109.959 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.2 mt-10 -80.73 117.89 21.8 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.817 -0.629 . . . . 64.150000000000006 110.065 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.412 HG23 HD22 ' A' ' 56' ' ' LEU . 24.2 t -127.3 143.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.56 0.744 . . . . 75.409999999999997 109.422 174.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.85 132.45 15.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.769 0.428 . . . . 75.430000000000007 110.075 173.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 118' ' ' VAL . 4.8 t -103.95 108.7 25.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 123.636 0.774 . . . . 74.329999999999998 109.148 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 23.7 m-85 -107.04 135.94 47.74 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.403 0.681 . . . . 71.430000000000007 109.781 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -101.06 127.3 47.64 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.261 -0.644 . . . . 53.329999999999998 109.261 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.753 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -71.89 -24.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.577 -0.527 . . . . 71.230000000000004 109.577 171.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 p -97.58 -67.03 0.87 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.698 1.199 . . . . 73.140000000000001 111.112 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.27 11.64 35.8 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.362 0.506 . . . . 72.120000000000005 113.096 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -80.23 -61.53 1.95 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.058 0.543 . . . . 75.010000000000005 111.186 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -78.35 123.9 27.51 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.609 -0.723 . . . . 72.349999999999994 111.12 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.9 -0.8 89.84 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 124.295 0.95 . . . . 52.43 114.303 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . . . -64.51 -21.74 66.77 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.781 0.791 . . . . 61.109999999999999 111.524 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.69 68.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.038 1.335 . . . . 71.349999999999994 111.958 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' HB2' HH11 ' A' ' 51' ' ' ARG . . . -62.12 -36.59 82.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.588 0.755 . . . . 63.140000000000001 111.361 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.459 HH11 ' HB2' ' A' ' 50' ' ' ALA . 9.9 mpt_? -73.0 -38.57 66.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.686 0.795 . . . . 75.239999999999995 111.167 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 p -64.71 -29.02 69.99 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.047 0.539 . . . . 62.310000000000002 111.683 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.62 7.21 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.441 0.697 . . . . 74.340000000000003 110.946 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -56.46 -43.8 79.93 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.473 1.509 . . . . 64.019999999999996 112.04 -171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.54 -0.755 . . . . 74.530000000000001 111.786 -176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD22 HG23 ' A' ' 37' ' ' VAL . 9.2 mp -73.2 -27.97 61.93 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.476 0.311 . . . . 72.519999999999996 111.406 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.77 -40.15 91.73 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.641 0.588 . . . . 75.319999999999993 109.842 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.87 -23.03 59.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.211 0.604 . . . . 62.299999999999997 111.528 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.73 -3.3 46.91 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.623 0.769 . . . . 34.340000000000003 112.557 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.44 49.26 2.22 Favored Glycine 0 C--N 1.347 1.159 0 C-N-CA 121.431 -0.414 . . . . 74.010000000000005 112.082 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.21 158.02 4.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.58 1.152 . . . . 72.25 112.654 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -91.79 -57.1 2.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 106.91 -1.515 . . . . 72.129999999999995 106.91 160.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 74.0 t -129.45 136.3 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 73.519999999999996 108.153 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 60.6 m -141.28 114.21 8.49 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.33 -0.989 . . . . 75.5 108.33 169.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -120.25 152.79 37.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.677 0.791 . . . . 73.530000000000001 110.059 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.0 139.62 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.574 -0.899 . . . . 74.25 108.574 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.45 -179.31 36.07 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.399 0.437 . . . . 71.150000000000006 112.235 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -143.96 124.21 13.78 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.405 -0.961 . . . . 71.239999999999995 108.405 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 134.46 11.33 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.746 -0.835 . . . . 74.519999999999996 108.746 -170.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.753 ' HA ' HG13 ' A' ' 42' ' ' ILE . 19.6 t -77.68 99.55 5.86 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.449 -0.945 . . . . 74.430000000000007 108.449 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.3 tp -103.83 120.62 50.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.464 0.706 . . . . 75.519999999999996 109.311 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.86 -28.41 87.14 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.732 2.955 . . . . 74.430000000000007 114.984 -171.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.72 9.05 25.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.476 0.711 . . . . 73.329999999999998 112.063 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.503 HG21 HG13 ' A' ' 119' ' ' VAL . 63.9 t -105.92 111.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.306 0.642 . . . . 75.409999999999997 109.54 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.43 10.37 11.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.694 0.798 . . . . 70.239999999999995 111.092 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -170.04 156.89 6.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.836 0.854 . . . . 61.420000000000002 110.791 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 121' ' ' THR . 2.1 t -69.71 102.37 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.57 0.748 . . . . 71.519999999999996 109.537 173.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.534 HG21 ' HG2' ' A' ' 103' ' ' GLU . 87.8 m -150.21 149.13 29.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.835 -0.62 . . . . 74.150000000000006 110.985 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' A' ' 118' ' ' VAL . 40.4 t -94.59 113.68 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.282 -1.007 . . . . 74.340000000000003 108.282 175.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.543 ' HD1' ' HB2' ' A' ' 103' ' ' GLU . 28.8 m-85 -99.27 135.44 40.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.527 -0.916 . . . . 71.310000000000002 108.527 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.93 138.16 53.24 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.144 0.497 . . . . 75.409999999999997 111.123 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -73.03 153.5 40.86 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 114.935 -1.03 . . . . 74.430000000000007 109.159 170.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.66 ' HB3' HD12 ' A' ' 104' ' ' LEU . 11.6 pt-20 -102.06 26.26 7.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.28 0.474 . . . . 74.219999999999999 112.28 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.2 t -70.8 93.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 108.499 -0.926 . . . . 73.120000000000005 108.499 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 70.52 -77.74 0.05 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.444 1.498 . . . . 71.129999999999995 111.162 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.43 50.06 0.31 Allowed Glycine 0 C--N 1.352 1.453 0 N-CA-C 112.523 -0.231 . . . . 65.150000000000006 112.523 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.24 -18.64 63.9 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 120.843 0.354 . . . . 63.420000000000002 110.675 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.64 -28.25 68.33 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.847 0.859 . . . . 72.340000000000003 111.386 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.77 -36.03 81.76 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.622 0.769 . . . . 74.200000000000003 110.754 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 m -74.7 -38.26 62.4 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.771 -1.104 . . . . 71.219999999999999 110.498 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -20.04 56.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.751 0.82 . . . . 44.329999999999998 112.351 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -58.57 -49.7 76.49 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.898 -0.778 . . . . 74.329999999999998 108.898 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.85 70.74 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 124.442 1.088 . . . . 72.430000000000007 111.45 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.82 -46.85 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.212 0.605 . . . . 74.540000000000006 111.686 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.41 -26.99 62.62 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.681 0.613 . . . . 74.510000000000005 111.913 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -85.4 -31.34 22.96 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.132 0.973 . . . . 74.540000000000006 110.777 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.0 m -76.57 -29.91 56.83 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.914 0.388 . . . . 75.340000000000003 110.435 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 tp -95.79 -32.71 12.56 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.604 0.762 . . . . 71.230000000000004 110.141 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.72 44.62 47.9 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.187 -0.461 . . . . 73.409999999999997 111.985 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.95 177.57 6.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.955 0.902 . . . . 73.420000000000002 110.116 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.81 158.55 35.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.743 -0.662 . . . . 74.530000000000001 109.918 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.557 HG12 ' HB ' ' A' ' 79' ' ' VAL . 27.3 m -127.1 144.15 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.768 0.827 . . . . 74.230000000000004 109.669 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.543 ' HB2' ' HD1' ' A' ' 80' ' ' TYR . 59.9 mm-40 -129.84 149.39 51.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.227 1.011 . . . . 73.129999999999995 109.872 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.66 HD12 ' HB3' ' A' ' 83' ' ' GLU . 51.7 tp -69.24 175.98 3.57 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.803 -1.09 . . . . 72.319999999999993 108.837 165.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.503 ' HB3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -67.62 20.31 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.37 1.619 . . . . 64.120000000000005 115.37 -175.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.84 -46.1 81.57 Favored Pre-proline 0 CA--C 1.564 1.486 0 CA-C-O 117.947 -1.025 . . . . 75.549999999999997 111.871 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.0 -42.12 32.26 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 122.188 1.925 . . . . 64.409999999999997 111.233 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 88.0 mt-10 -60.17 -26.48 66.35 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 115.998 -0.546 . . . . 73.319999999999993 111.134 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.61 -10.18 17.35 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.101 0.96 . . . . 74.230000000000004 112.319 -171.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -56.74 -49.95 73.7 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.843 0.857 . . . . 72.409999999999997 111.625 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.11 -33.44 2.19 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.579 0.752 . . . . 62.049999999999997 111.16 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 73.67 80.08 0.17 Allowed Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 126.029 1.731 . . . . 75.349999999999994 111.746 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 69.1 Cg_endo -81.26 124.34 4.78 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.574 2.183 . . . . 73.530000000000001 110.371 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.91 116.66 4.79 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.033 1.822 . . . . 73.420000000000002 111.21 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.81 156.82 12.69 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.243 0.449 . . . . 74.140000000000001 112.222 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.25 119.75 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.174 1.39 . . . . 73.540000000000006 112.774 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 80' ' ' TYR . 44.4 pt -110.76 106.86 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.763 -0.828 . . . . 73.209999999999994 108.763 172.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.56 ' HB ' HG11 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -96.39 111.81 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.394 -0.965 . . . . 71.420000000000002 108.394 175.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.5 t -114.91 118.69 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.593 -0.276 . . . . 72.120000000000005 110.975 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -99.23 144.17 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.525 0.73 . . . . 73.329999999999998 110.019 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.603 ' H ' ' HB ' ' A' ' 77' ' ' THR . 12.0 t -118.27 165.45 13.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.788 0.835 . . . . 73.010000000000005 109.596 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 N-CA-C 110.53 -1.028 . . . . 63.219999999999999 110.53 179.253 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 110.322 -0.251 . . . . 71.049999999999997 110.322 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 p -152.12 133.66 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 72.239999999999995 110.257 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.88 119.25 3.57 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.386 -0.968 . . . . 73.439999999999998 108.386 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -116.75 133.43 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.102 0.561 . . . . 74.209999999999994 110.581 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -147.46 127.02 13.26 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.948 0.899 . . . . 73.200000000000003 108.865 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -145.72 103.12 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.706 0.803 . . . . 62.350000000000001 109.068 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -145.1 149.58 35.3 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.111 0.964 . . . . 75.129999999999995 109.725 -178.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -148.2 160.87 42.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.167 0.587 . . . . 73.239999999999995 109.812 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -147.56 150.48 34.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.58 0.752 . . . . 75.099999999999994 109.477 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -155.89 161.66 40.54 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.592 0.757 . . . . 71.420000000000002 109.957 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.7 t -153.67 178.64 9.64 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.241 1.016 . . . . 62.219999999999999 109.387 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.18 173.44 11.58 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.608 1.163 . . . . 73.329999999999998 109.262 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 121.48 6.38 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.471 0.709 . . . . 73.0 110.146 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.32 141.11 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.78 2.32 . . . . 75.200000000000003 112.325 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.6 p -136.3 142.09 43.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.664 0.786 . . . . 74.329999999999998 110.168 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.7 p -173.83 134.85 0.48 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.277 1.031 . . . . 71.319999999999993 109.913 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.0 p -102.35 -177.26 3.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.864 0.866 . . . . 72.040000000000006 111.065 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -149.12 126.83 11.73 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.487 -0.931 . . . . 72.430000000000007 108.487 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.68 157.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.692 0.797 . . . . 73.549999999999997 110.069 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -113.36 131.44 22.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 73.439999999999998 110.044 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 C--N 1.378 2.086 0 C-N-CA 122.954 2.436 . . . . 75.439999999999998 112.558 178.546 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.11 -0.33 . . . . 72.040000000000006 110.11 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.24 104.18 13.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.231 0.613 . . . . 74.5 109.387 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.9 t -96.47 127.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.538 -0.912 . . . . 75.319999999999993 108.538 174.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 65' ' ' ASP . 43.5 ttm105 -147.77 111.81 5.15 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.169 -0.332 . . . . 75.310000000000002 110.436 -171.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 130.99 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.169 0.588 . . . . 75.040000000000006 109.586 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 17.1 m-85 -124.95 132.46 53.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.952 0.901 . . . . 73.420000000000002 109.02 167.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.404 ' H ' ' HA ' ' A' ' 68' ' ' ASN . 41.0 m-80 -94.31 121.81 36.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 73.540000000000006 109.707 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.7 tp -78.99 -27.79 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.401 0.68 . . . . 75.129999999999995 109.332 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.467 ' HB3' ' H ' ' A' ' 122' ' ' GLY . 34.6 t -125.21 -162.04 1.07 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.596 1.158 . . . . 71.230000000000004 108.384 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.01 136.37 51.3 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 118.364 0.529 . . . . 53.549999999999997 112.791 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.3 t -78.56 122.67 26.2 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.994 0.518 . . . . 64.219999999999999 110.601 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.93 160.32 18.73 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.12 -0.696 . . . . 74.25 109.12 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.35 -41.57 87.73 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.3 0.375 . . . . 71.310000000000002 112.361 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 52' ' ' THR . . . -63.33 -31.46 72.62 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.208 1.003 . . . . 72.230000000000004 112.307 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.43 -49.72 76.28 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.839 0.712 . . . . 72.150000000000006 111.305 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.93 -32.0 57.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.464 -0.789 . . . . 43.439999999999998 110.669 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.65 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 31.6 tpt180 -71.4 -20.19 62.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.888 0.875 . . . . 72.219999999999999 111.987 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 48' ' ' ALA . 42.1 p -58.95 -52.79 64.22 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.561 0.619 . . . . 64.010000000000005 110.208 174.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.59 -25.67 45.31 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.98 -1.009 . . . . 74.140000000000001 111.515 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.65 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 31.8 t70 -79.06 -22.71 44.95 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.116 0.966 . . . . 63.420000000000002 110.819 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -86.76 -37.96 17.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.603 0.761 . . . . 71.109999999999999 109.126 168.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 tp -71.21 -19.36 62.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.489 0.715 . . . . 72.340000000000003 112.16 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.99 -27.34 69.34 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 110.491 -0.188 . . . . 73.329999999999998 110.491 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.95 60.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.696 0.798 . . . . 74.230000000000004 111.495 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.33 12.51 6.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.739 0.816 . . . . 62.240000000000002 112.723 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.29 46.39 6.98 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 120.313 -0.159 . . . . 75.420000000000002 113.091 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -58.97 152.12 20.42 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.255 1.022 . . . . 74.519999999999996 111.316 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 35' ' ' ALA . 58.7 m -86.4 -55.03 4.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.718 -0.845 . . . . 74.150000000000006 108.718 171.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.61 147.37 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.591 -0.892 . . . . 73.200000000000003 108.591 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 54.0 m -142.84 144.9 32.7 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.523 1.129 . . . . 71.140000000000001 109.801 -172.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 29.6 t70 -143.67 143.9 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.483 1.113 . . . . 63.43 108.34 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.85 133.13 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.363 -0.977 . . . . 71.239999999999995 108.363 173.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.85 -160.8 11.23 Favored Glycine 0 C--O 1.246 0.86 0 N-CA-C 111.609 -0.597 . . . . 75.329999999999998 111.609 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.404 ' HA ' ' H ' ' A' ' 41' ' ' ASN . 26.2 p30 -130.34 140.15 50.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.366 1.066 . . . . 73.530000000000001 108.466 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -157.48 134.43 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.51 -0.552 . . . . 75.200000000000003 109.51 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.5 t -73.39 98.23 2.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.972 -1.122 . . . . 73.239999999999995 107.972 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.74 98.55 9.89 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.832 -1.173 . . . . 74.049999999999997 107.832 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.64 -1.01 10.12 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.725 2.283 . . . . 75.209999999999994 113.156 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.99 -23.55 41.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.784 0.833 . . . . 65.219999999999999 110.551 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.49 HG13 HG21 ' A' ' 119' ' ' VAL . 2.7 p -134.05 140.03 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.428 1.091 . . . . 71.329999999999998 110.84 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.46 62.07 1.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.544 -0.91 . . . . 64.420000000000002 108.544 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.04 155.75 16.5 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.195 -0.911 . . . . 51.32 110.361 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t -82.43 98.62 8.98 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.604 -1.258 . . . . 75.150000000000006 107.604 167.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 m -149.25 139.65 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.999 -1.001 . . . . 74.25 109.173 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 118' ' ' VAL . 97.9 t -95.74 116.27 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.205 -1.035 . . . . 74.409999999999997 108.205 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.607 ' HB2' HG13 ' A' ' 117' ' ' ILE . 90.4 m-85 -109.53 154.76 22.25 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.27 -0.641 . . . . 75.109999999999999 109.27 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -139.46 170.43 15.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.738 -0.665 . . . . 74.340000000000003 111.19 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.0 p -110.75 -159.29 0.67 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.627 -0.879 . . . . 75.010000000000005 108.627 164.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.21 21.05 12.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.192 0.997 . . . . 70.549999999999997 110.092 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.38 100.9 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.866 0.866 . . . . 75.299999999999997 110.015 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 70.06 -75.86 0.07 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.588 1.555 . . . . 71.040000000000006 111.62 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.47 40.81 0.81 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.644 -1.383 . . . . 63.140000000000001 109.644 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.54 -39.18 85.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.961 -0.619 . . . . 65.25 110.142 -172.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -67.01 -31.4 71.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.589 -0.732 . . . . 75.099999999999994 110.947 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.2 -43.11 64.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.607 0.763 . . . . 74.109999999999999 111.427 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 94' ' ' VAL . 9.8 t -76.69 -34.55 58.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.65 -0.5 . . . . 64.450000000000003 109.65 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HB1' HG22 ' A' ' 116' ' ' VAL . . . -64.06 -38.74 92.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.362 0.665 . . . . 73.439999999999998 111.963 176.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.581 ' HA ' HG12 ' A' ' 102' ' ' VAL . 25.7 t70 -58.1 -36.04 72.3 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.322 1.014 . . . . 72.549999999999997 110.318 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.9 78.47 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.474 -0.785 . . . . 63.520000000000003 111.226 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 118' ' ' VAL . 22.0 t -71.26 -34.62 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.28 0.632 . . . . 74.430000000000007 112.284 -174.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 79' ' ' VAL . . . -59.48 -34.86 83.03 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 121.954 0.752 . . . . 61.210000000000001 112.006 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -80.63 -30.58 36.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.836 -1.182 . . . . 72.329999999999998 110.658 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 m -74.36 -21.02 59.87 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.04 0.536 . . . . 75.329999999999998 110.942 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 38.7 tp -97.16 -32.18 12.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.178 0.591 . . . . 75.5 110.609 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.6 53.8 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.869 -0.605 . . . . 35.520000000000003 112.027 -170.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.23 -177.69 3.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.375 1.07 . . . . 72.239999999999995 111.082 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.65 154.8 17.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.522 0.729 . . . . 75.209999999999994 110.318 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 92' ' ' ASP . 19.9 m -108.35 129.95 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.452 -0.573 . . . . 75.040000000000006 109.452 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.34 164.03 28.34 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.863 0.865 . . . . 75.519999999999996 111.185 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.28 -175.32 0.11 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.969 -1.014 . . . . 72.140000000000001 112.134 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.32 -27.48 62.46 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.757 -0.64 . . . . 75.430000000000007 112.048 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.64 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 124.549 1.14 . . . . 71.329999999999998 111.714 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.12 -27.16 84.23 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.487 2.124 . . . . 73.129999999999995 112.281 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -79.2 -53.57 6.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.885 1.274 . . . . 74.239999999999995 110.97 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.444 HD11 ' HB ' ' A' ' 74' ' ' VAL . 52.1 mt -82.53 16.05 2.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.84 0.856 . . . . 75.230000000000004 111.611 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.3 m -84.94 -11.13 56.21 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.82 0.448 . . . . 62.450000000000003 110.55 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.37 8.08 29.39 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.481 0.712 . . . . 73.510000000000005 110.994 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -76.66 164.98 56.12 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.925 0.89 . . . . 75.219999999999999 110.708 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.2 122.29 11.32 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.948 1.766 . . . . 74.540000000000006 111.098 163.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.29 136.77 55.49 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.926 3.084 . . . . 70.140000000000001 115.277 -164.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.75 -162.5 15.49 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.583 -0.735 . . . . 72.230000000000004 113.22 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.468 HG22 ' HB1' ' A' ' 91' ' ' ALA . 57.9 t -66.69 115.65 4.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 124.092 0.957 . . . . 64.040000000000006 108.972 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.607 HG13 ' HB2' ' A' ' 80' ' ' TYR . 7.6 pt -106.23 106.67 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.524 -0.917 . . . . 74.450000000000003 108.524 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 79' ' ' VAL . 44.5 t -88.52 100.95 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.547 -1.649 . . . . 74.329999999999998 106.547 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 74' ' ' VAL . 49.8 t -93.5 118.46 39.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 N-CA-C 107.109 -1.441 . . . . 73.120000000000005 107.109 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.24 136.6 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 122.972 0.509 . . . . 75.209999999999994 109.762 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -117.54 137.29 52.67 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.565 0.746 . . . . 72.420000000000002 109.386 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.467 ' H ' ' HB3' ' A' ' 43' ' ' SER . . . . . . . . 0 CA--C 1.534 1.265 0 N-CA-C 110.721 -0.951 . . . . 44.409999999999997 110.721 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 110.179 -0.304 . . . . 71.5 110.179 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.9 p -158.77 129.82 6.25 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.028 0.931 . . . . 64.219999999999999 109.101 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.38 133.3 8.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.515 0.726 . . . . 72.310000000000002 109.37 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.77 137.34 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.314 0.646 . . . . 74.540000000000006 109.816 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 p -156.87 129.51 7.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.512 0.725 . . . . 73.200000000000003 109.263 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -151.35 136.96 17.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.254 -0.647 . . . . 73.120000000000005 109.254 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.2 mmm -127.59 116.98 21.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.568 0.747 . . . . 74.019999999999996 109.339 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -145.05 99.92 3.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.614 0.765 . . . . 74.109999999999999 110.017 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -155.99 137.71 14.25 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.092 0.957 . . . . 74.319999999999993 109.106 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -155.84 149.49 25.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.92 . . . . 74.519999999999996 109.261 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -140.88 119.66 12.54 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.42 1.088 . . . . 75.439999999999998 109.033 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.78 147.06 25.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.597 0.759 . . . . 74.510000000000005 111.122 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.8 116.8 62.87 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.765 -0.828 . . . . 65.129999999999995 108.765 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 137.65 40.42 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.547 2.165 . . . . 74.450000000000003 112.751 -172.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -77.48 135.95 38.3 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.493 0.717 . . . . 73.209999999999994 109.572 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 p -146.26 148.76 32.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.949 0.5 . . . . 74.129999999999995 110.455 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -152.26 179.86 8.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.94 0.896 . . . . 64.510000000000005 109.31 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.7 p -158.62 156.75 30.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.817 0.847 . . . . 72.209999999999994 109.794 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.45 147.09 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.161 0.585 . . . . 62.219999999999999 109.86 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -111.91 143.95 29.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 108.729 -0.841 . . . . 71.409999999999997 108.729 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 C--N 1.371 1.751 0 C-N-CA 122.217 1.945 . . . . 74.209999999999994 111.889 171.182 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.245 0.863 0 N-CA-C 109.49 -0.559 . . . . 71.219999999999999 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.46 148.13 24.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.143 0.577 . . . . 63.140000000000001 111.565 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 64' ' ' THR . 87.3 t -137.8 125.8 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.608 1.163 . . . . 72.510000000000005 108.09 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 116' ' ' VAL . 9.6 ptp180 -127.84 111.12 13.27 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.27 -0.894 . . . . 75.340000000000003 109.706 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.68 110.36 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.477 0.711 . . . . 74.349999999999994 110.655 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HB2' HG12 ' A' ' 119' ' ' VAL . 51.1 m-85 -100.91 106.04 17.35 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 109.179 -0.674 . . . . 70.409999999999997 109.179 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 4.5 m-20 -87.28 113.73 23.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.636 -1.246 . . . . 70.349999999999994 107.636 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.612 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.2 tt -70.13 -28.22 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.605 0.717 . . . . 72.439999999999998 110.165 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 41' ' ' ASN . 22.8 t -130.27 159.35 37.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.704 -1.134 . . . . 75.230000000000004 108.44 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.22 -45.04 44.0 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.888 0.743 . . . . 51.310000000000002 113.422 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t 47.86 -164.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.236 1.815 . . . . 62.509999999999998 112.798 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -71.42 136.42 47.69 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 121.716 -0.615 . . . . 74.239999999999995 109.677 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.09 -26.57 65.96 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.884 0.74 . . . . 55.140000000000001 114.443 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . . . -58.27 -26.62 63.17 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.123 0.969 . . . . 75.109999999999999 112.693 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 120' ' ' VAL . . . -59.62 -47.58 85.05 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.661 0.784 . . . . 75.349999999999994 111.579 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HB3' HG11 ' A' ' 66' ' ' VAL . . . -80.97 -29.4 35.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.269 -0.878 . . . . 61.420000000000002 111.077 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . 4.0 tmt_? -74.13 -19.25 60.63 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.577 -1.192 . . . . 74.109999999999999 111.016 -173.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 34.3 p -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 109.65 -0.5 . . . . 64.099999999999994 109.65 172.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.71 -41.52 79.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.514 0.726 . . . . 72.200000000000003 111.628 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.15 -37.69 86.16 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.44 0.696 . . . . 72.510000000000005 111.063 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -77.97 -33.01 51.65 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.113 0.565 . . . . 74.530000000000001 110.589 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 52' ' ' THR . 13.3 tp -63.31 -43.66 97.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.621 0.768 . . . . 71.420000000000002 112.019 -169.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -19.34 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.267 0.84 . . . . 72.200000000000003 113.267 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.21 -27.89 68.75 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.87 0.468 . . . . 71.439999999999998 112.048 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.91 -9.9 59.08 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.129 0.571 . . . . 73.209999999999994 112.266 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.48 47.11 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 113.802 0.281 . . . . 73.430000000000007 113.802 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.482 ' HE2' HG23 ' A' ' 90' ' ' THR . 6.5 m-85 -91.9 157.96 16.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.652 0.781 . . . . 75.230000000000004 109.632 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.458 HG21 HG22 ' A' ' 63' ' ' VAL . 20.2 m -71.59 -77.47 0.09 Allowed 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.445 0.466 . . . . 75.129999999999995 111.903 -162.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 62' ' ' THR . 69.5 t -127.44 103.49 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 108.787 -0.82 . . . . 75.040000000000006 108.787 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 41.2 p -95.46 91.14 6.05 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.599 -0.889 . . . . 71.450000000000003 108.599 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 12.2 t70 -102.17 131.84 48.44 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.973 -1.012 . . . . 72.040000000000006 108.655 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 50' ' ' ALA . 65.7 t -125.98 133.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.93 -0.396 . . . . 74.349999999999994 109.93 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.36 146.62 17.29 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.245 -0.742 . . . . 54.210000000000001 111.245 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 24.9 p-10 -111.89 117.34 32.5 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.609 -0.515 . . . . 73.209999999999994 109.609 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.7 tp -159.15 138.54 11.46 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 122.493 -0.129 . . . . 71.230000000000004 110.831 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.612 ' HA ' HG13 ' A' ' 42' ' ' ILE . 49.3 m -68.69 103.4 1.73 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.491 -0.559 . . . . 73.030000000000001 109.491 171.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.52 ' HB2' HG12 ' A' ' 74' ' ' VAL . 64.1 mt -112.23 132.4 22.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 123.928 0.891 . . . . 75.120000000000005 108.619 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.37 -20.57 54.89 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.608 2.205 . . . . 71.140000000000001 113.935 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.55 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 5.3 p-10 -82.04 -26.96 33.29 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.035 0.383 . . . . 72.420000000000002 112.035 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.601 HG11 HD11 ' A' ' 42' ' ' ILE . 2.4 p -97.8 117.31 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.676 0.75 . . . . 73.310000000000002 109.408 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.76 6.9 4.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.584 1.154 . . . . 75.120000000000005 108.926 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.3 151.58 15.65 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.456 1.102 . . . . 72.319999999999993 109.184 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -74.73 114.38 13.1 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.255 0.55 . . . . 74.340000000000003 110.375 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.2 m -145.73 143.62 29.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.505 1.122 . . . . 72.319999999999993 109.305 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.68 HG23 HG11 ' A' ' 118' ' ' VAL . 92.8 t -110.57 115.53 50.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 109.131 -0.692 . . . . 75.349999999999994 109.131 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.91 154.42 17.31 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.721 0.808 . . . . 74.129999999999995 109.575 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.76 152.9 42.77 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.266 -0.642 . . . . 74.219999999999999 109.266 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -106.71 135.58 48.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.163 -1.051 . . . . 74.030000000000001 108.163 172.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.5 0.31 4.19 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.378 1.251 . . . . 75.239999999999995 114.378 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.35 111.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 123.485 0.714 . . . . 71.019999999999996 110.753 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 70.74 -69.34 0.18 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.41 1.484 . . . . 63.009999999999998 112.037 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.95 51.52 0.06 OUTLIER Glycine 0 C--O 1.241 0.54 0 CA-C-O 119.976 -0.347 . . . . 54.439999999999998 112.767 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HB3' HG21 ' A' ' 116' ' ' VAL . 39.9 mm-40 -66.79 -27.12 67.32 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 111.786 0.291 . . . . 73.530000000000001 111.786 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -56.21 -34.29 66.14 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.56 0.207 . . . . 73.450000000000003 111.56 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.96 -39.19 71.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.288 0.635 . . . . 74.400000000000006 112.24 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.482 HG23 ' HE2' ' A' ' 61' ' ' PHE . 60.7 p -85.22 -44.41 12.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.862 -0.608 . . . . 74.25 110.753 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -58.87 -39.33 81.05 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.209 0.604 . . . . 75.109999999999999 112.466 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.582 ' HA ' HG12 ' A' ' 102' ' ' VAL . 23.5 t70 -72.07 -27.39 62.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.013 -0.994 . . . . 75.540000000000006 110.401 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.67 -52.08 8.42 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.206 0.602 . . . . 72.299999999999997 110.813 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.51 HG13 HG21 ' A' ' 118' ' ' VAL . 69.4 t -60.44 -49.96 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.292 1.037 . . . . 65.329999999999998 111.11 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -63.88 -33.4 87.15 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.302 -0.863 . . . . 71.430000000000007 112.975 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -70.72 -37.47 73.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.151 -0.525 . . . . 62.530000000000001 110.449 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 m -68.29 -34.52 76.32 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.212 0.605 . . . . 72.25 110.927 175.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD11 ' HA ' ' A' ' 49' ' ' ALA . 63.1 tp -77.53 -33.31 54.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.704 0.802 . . . . 75.510000000000005 111.523 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.81 31.45 29.43 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.701 -0.681 . . . . 72.310000000000002 112.522 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.55 146.8 44.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.848 0.859 . . . . 64.310000000000002 109.155 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.39 149.63 33.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.131 0.572 . . . . 74.510000000000005 111.621 -172.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 92' ' ' ASP . 30.6 m -96.37 134.9 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.712 0.768 . . . . 75.030000000000001 111.319 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -134.11 165.67 24.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.438 1.495 . . . . 74.099999999999994 109.181 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.19 -174.19 0.78 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.838 0.855 . . . . 73.200000000000003 111.241 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.557 ' HB2' HD12 ' A' ' 109' ' ' LEU . 15.4 ptt180 -56.58 -40.86 75.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.804 0.842 . . . . 74.209999999999994 111.025 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.9 mt 61.2 164.39 0.1 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 125.15 1.38 . . . . 74.400000000000006 113.307 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.14 -23.56 9.77 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.329 2.686 . . . . 64.109999999999999 114.411 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 mp0 -60.67 -27.38 67.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.986 0.914 . . . . 70.409999999999997 112.825 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.557 HD12 ' HB2' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -66.08 -6.29 12.58 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.945 0.72 . . . . 73.040000000000006 112.945 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.0 p -66.2 -28.21 68.58 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.114 0.566 . . . . 72.519999999999996 112.066 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.61 -33.06 6.47 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.819 0.448 . . . . 54.340000000000003 111.743 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -90.79 136.68 27.51 Favored Pre-proline 0 N--CA 1.484 1.251 0 N-CA-C 109.29 -0.633 . . . . 73.439999999999998 109.29 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.4 95.05 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.633 2.222 . . . . 61.240000000000002 112.616 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.5 161.33 35.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.898 2.399 . . . . 74.140000000000001 114.017 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 119.95 -149.0 17.89 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.661 -0.976 . . . . 74.239999999999995 110.661 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 78.7 t -84.66 121.37 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.107 0.453 . . . . 64.400000000000006 109.783 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.434 HG23 HG11 ' A' ' 119' ' ' VAL . 4.1 mp -118.97 104.95 16.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 108.27 -1.011 . . . . 74.439999999999998 108.27 174.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.68 HG11 HG23 ' A' ' 79' ' ' VAL . 58.2 t -92.48 101.37 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.369 -0.974 . . . . 64.010000000000005 108.369 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 40' ' ' TYR . 27.1 m -98.48 128.06 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.504 -0.554 . . . . 74.120000000000005 109.504 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.716 HG22 ' HB2' ' A' ' 49' ' ' ALA . 15.3 t -127.48 132.18 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.957 0.503 . . . . 71.230000000000004 110.309 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.0 t -105.08 165.9 10.76 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.562 0.745 . . . . 72.349999999999994 109.16 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 119.106 -0.83 . . . . 62.409999999999997 113.065 174.821 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 120.767 0.318 . . . . 74.299999999999997 110.411 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.2 m -88.59 -179.37 6.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.111 0.964 . . . . 74.209999999999994 111.512 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.92 141.13 30.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.406 -0.816 . . . . 73.439999999999998 109.787 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -121.73 155.65 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.712 0.805 . . . . 73.030000000000001 110.305 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.0 t -160.17 123.07 3.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.925 0.89 . . . . 72.319999999999993 108.797 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.1 m -118.65 133.11 56.1 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.934 0.494 . . . . 74.540000000000006 110.046 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtt -100.47 126.09 46.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.13 0.972 . . . . 74.530000000000001 109.52 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -134.34 109.11 8.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.789 0.836 . . . . 74.150000000000006 109.949 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -105.38 152.64 22.7 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.141 0.976 . . . . 74.129999999999995 109.968 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -153.05 116.07 4.58 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.374 0.67 . . . . 74.519999999999996 110.295 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.6 p -133.87 143.41 48.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.047 0.939 . . . . 71.450000000000003 110.497 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.23 167.48 20.61 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.806 0.842 . . . . 74.549999999999997 110.174 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.6 143.6 36.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 73.420000000000002 110.664 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.225 2.617 . . . . 73.519999999999996 113.48 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -112.99 159.38 19.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.101 0.961 . . . . 71.409999999999997 110.545 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -108.56 144.93 35.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 74.019999999999996 110.257 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -129.59 113.62 15.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.25 0.62 . . . . 70.439999999999998 110.503 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.3 m -102.89 133.94 47.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.969 0.508 . . . . 74.349999999999994 110.268 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.96 126.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 122.998 0.519 . . . . 75.120000000000005 110.331 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -114.95 106.81 51.13 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 108.354 -0.98 . . . . 72.109999999999999 108.354 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.37 1.697 0 C-N-CA 123.119 2.546 . . . . 73.209999999999994 113.294 175.844 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.925 -0.768 . . . . 53.32 108.925 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.49 140.35 29.66 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.145 0.498 . . . . 64.209999999999994 110.446 -177.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 64' ' ' THR . 48.5 t -118.04 160.53 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.254 1.022 . . . . 75.109999999999999 109.128 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.09 127.78 11.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.725 0.41 . . . . 73.219999999999999 110.199 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.574 HG23 ' HB ' ' A' ' 118' ' ' VAL . 94.1 t -106.36 121.3 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.639 0.776 . . . . 72.209999999999994 109.463 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -115.81 133.47 56.0 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.622 0.769 . . . . 74.299999999999997 110.793 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -82.62 116.29 21.96 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.688 -0.856 . . . . 74.040000000000006 108.688 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 74' ' ' VAL . 10.5 tp -80.12 -24.03 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.354 -0.61 . . . . 74.549999999999997 109.354 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' H ' ' A' ' 122' ' ' GLY . 40.4 m -139.18 169.38 17.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.272 1.029 . . . . 73.340000000000003 109.129 170.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 84.49 0.15 Allowed Glycine 0 C--N 1.347 1.183 0 O-C-N 123.551 0.532 . . . . 52.109999999999999 112.231 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 t -97.01 178.8 5.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.631 0.772 . . . . 74.230000000000004 109.89 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.77 151.19 43.72 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.133 0.573 . . . . 74.099999999999994 111.02 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.72 -4.44 46.8 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.059 -0.856 . . . . 71.200000000000003 114.823 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.5 -28.25 69.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.196 0.998 . . . . 64.049999999999997 112.271 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.49 -45.21 91.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.378 0.671 . . . . 71.120000000000005 110.842 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.29 -31.72 62.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.231 -0.895 . . . . 72.150000000000006 111.302 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -68.92 -36.32 77.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.537 1.135 . . . . 73.340000000000003 110.447 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.7 t -73.86 -35.09 64.73 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.411 -0.358 . . . . 75.120000000000005 110.109 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.88 63.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.432 0.693 . . . . 63.420000000000002 110.89 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.81 -48.18 70.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.05 0.94 . . . . 74.230000000000004 110.884 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -78.43 -29.24 46.94 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.478 -0.783 . . . . 75.519999999999996 111.274 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.75 -45.56 74.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.234 1.014 . . . . 75.420000000000002 111.359 -174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -51.63 -46.19 63.57 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.521 1.128 . . . . 73.420000000000002 111.625 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.6 -10.68 60.14 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.801 0.841 . . . . 75.450000000000003 112.556 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.83 7.3 42.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.603 0.761 . . . . 71.319999999999993 112.394 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.43 26.18 5.76 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 120.853 0.14 . . . . 51.119999999999997 113.205 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.528 ' HE2' ' HA ' ' A' ' 90' ' ' THR . 16.4 m-85 -108.09 154.04 22.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.238 1.015 . . . . 74.340000000000003 108.412 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.507 0.323 . . . . 74.439999999999998 111.681 -167.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.62 153.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.067 -1.086 . . . . 74.299999999999997 108.067 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 22.2 p -127.23 114.44 17.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.92 -0.77 . . . . 72.030000000000001 108.92 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -101.25 127.76 47.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.556 0.742 . . . . 44.149999999999999 109.256 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.65 129.68 67.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.088 -0.708 . . . . 74.120000000000005 109.088 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.91 -179.46 30.12 Favored Glycine 0 C--N 1.341 0.808 0 O-C-N 123.601 0.563 . . . . 74.049999999999997 111.91 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.65 125.92 35.26 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.143 -1.058 . . . . 74.25 108.143 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 57.1 mt -140.18 151.46 45.25 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.746 0.818 . . . . 73.450000000000003 110.15 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.2 m -126.85 98.21 5.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.782 0.833 . . . . 75.349999999999994 109.632 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HG22 ' A' ' 74' ' ' VAL . 7.4 mp -121.09 153.46 57.79 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 124.647 1.179 . . . . 72.420000000000002 109.438 -176.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.33 -27.69 6.3 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.512 2.141 . . . . 71.209999999999994 112.745 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.6 -23.05 53.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.75 0.82 . . . . 64.299999999999997 111.19 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 71' ' ' LEU . 33.0 m -120.41 117.98 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 109.088 -0.708 . . . . 73.409999999999997 109.088 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.46 9.46 1.4 Allowed 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.869 -0.519 . . . . 71.349999999999994 111.045 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.79 158.22 44.63 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.356 1.063 . . . . 75.400000000000006 109.345 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.538 ' HB ' HG21 ' A' ' 121' ' ' THR . 7.2 t -69.34 98.22 1.05 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.285 1.04 . . . . 73.019999999999996 108.913 174.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.8 m -150.74 137.09 18.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.49 1.116 . . . . 72.340000000000003 110.217 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.621 HG22 HG11 ' A' ' 118' ' ' VAL . 40.3 t -101.67 119.7 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.314 1.046 . . . . 75.409999999999997 108.861 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -103.75 125.42 50.21 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.252 -0.647 . . . . 72.219999999999999 109.252 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -145.45 160.38 41.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.52 0.728 . . . . 74.319999999999993 110.37 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -109.36 -120.32 0.27 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 108.103 -1.073 . . . . 61.530000000000001 108.103 172.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -137.89 -9.34 1.58 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.251 0.932 . . . . 70.5 112.194 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.43 107.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.33 0.652 . . . . 75.040000000000006 111.735 -167.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 59.77 31.43 20.81 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 70.230000000000004 112.067 173.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.55 38.44 5.58 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.03 -0.986 . . . . 61.25 113.374 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.3 -44.44 71.99 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.189 0.495 . . . . 72.540000000000006 112.303 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -66.31 -24.62 66.57 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 111.888 0.329 . . . . 74.040000000000006 111.888 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.51 -37.2 57.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.386 0.674 . . . . 72.400000000000006 111.252 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HE2' ' A' ' 61' ' ' PHE . 81.8 p -82.01 -28.49 32.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.325 0.584 . . . . 71.140000000000001 110.277 -174.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.39 -31.47 54.21 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.636 1.174 . . . . 74.099999999999994 111.786 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.38 -55.54 32.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.832 1.253 . . . . 74.439999999999998 110.6 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.34 -32.24 71.08 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.676 -1.147 . . . . 75.299999999999997 112.727 -173.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 118' ' ' VAL . 47.4 t -87.87 -53.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.059 0.544 . . . . 74.430000000000007 111.588 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -29.88 75.97 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.814 -0.63 . . . . 70.109999999999999 113.75 -168.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -72.97 -36.14 67.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.095 0.558 . . . . 72.340000000000003 110.552 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.7 m -62.04 -40.23 95.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.716 0.806 . . . . 73.329999999999998 111.257 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.86 -15.31 37.09 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.31 0.485 . . . . 71.200000000000003 112.31 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.12 25.04 75.74 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.891 -0.483 . . . . 75.530000000000001 111.891 -172.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.87 136.85 33.95 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.342 1.057 . . . . 74.409999999999997 109.486 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 113.32 2.6 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.953 0.783 . . . . 71.209999999999994 111.09 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -83.87 101.58 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 122.457 1.123 . . . . 72.239999999999995 109.047 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -112.9 158.36 20.29 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.519 -1.219 . . . . 74.019999999999996 111.343 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.61 177.75 1.49 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.347 -1.297 . . . . 73.109999999999999 110.397 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -59.29 -44.76 92.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.981 -0.554 . . . . 72.109999999999999 110.695 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt 60.77 173.63 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.106 0.962 . . . . 73.349999999999994 111.777 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.61 -27.33 25.35 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.419 2.079 . . . . 72.519999999999996 113.674 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.97 -47.33 83.63 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.077 0.951 . . . . 74.439999999999998 112.325 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.544 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 23.0 tp -71.67 -12.18 61.2 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 120.896 0.379 . . . . 73.430000000000007 111.215 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 t -79.06 -14.09 59.37 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.201 0.601 . . . . 72.549999999999997 110.818 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.13 -25.82 23.93 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.548 0.739 . . . . 70.120000000000005 112.362 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 1.3 pp0? -142.54 155.85 63.65 Favored Pre-proline 0 N--CA 1.495 1.802 0 CA-C-O 118.282 -0.866 . . . . 74.140000000000001 111.132 -173.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -37.47 125.75 0.61 Allowed 'Trans proline' 0 C--N 1.397 3.1 0 C-N-CA 124.736 3.624 . . . . 70.150000000000006 115.867 -169.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -64.61 133.3 36.28 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.089 2.526 . . . . 61.130000000000003 112.175 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.467 ' H ' HD23 ' A' ' 109' ' ' LEU . . . 157.09 177.81 30.56 Favored Glycine 0 C--O 1.245 0.812 0 N-CA-C 110.667 -0.973 . . . . 61.329999999999998 110.667 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.406 HG13 HG11 ' A' ' 37' ' ' VAL . 91.8 t -80.66 100.04 4.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.817 -0.438 . . . . 75.140000000000001 109.817 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 117' ' ' ILE . 41.8 pt -102.89 108.58 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.76 -0.83 . . . . 74.540000000000006 108.76 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.621 HG11 HG22 ' A' ' 79' ' ' VAL . 51.7 t -90.6 100.99 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.373 -1.343 . . . . 72.120000000000005 107.373 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.509 HG13 ' HB ' ' A' ' 74' ' ' VAL . 61.3 t -95.93 118.17 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.827 -0.805 . . . . 50.409999999999997 108.827 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.28 133.72 63.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.107 0.563 . . . . 71.219999999999999 109.619 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.538 HG21 ' HB ' ' A' ' 77' ' ' THR . 11.8 t -98.72 156.17 16.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.505 0.722 . . . . 64.129999999999995 110.577 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.616 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.686 -1.063 . . . . 72.040000000000006 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 p . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 120.718 0.294 . . . . 75.109999999999999 110.762 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -90.7 132.78 35.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.132 0.573 . . . . 74.230000000000004 109.979 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 98.54 3.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.101 0.56 . . . . 75.219999999999999 111.128 -172.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -131.41 129.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.755 0.822 . . . . 75.109999999999999 110.335 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 p -175.47 103.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.307 1.043 . . . . 60.409999999999997 110.629 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -166.89 130.92 1.95 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.203 1.001 . . . . 74.109999999999999 109.925 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -132.35 77.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.082 -0.71 . . . . 75.349999999999994 109.082 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -85.42 104.58 15.35 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.087 -0.506 . . . . 74.150000000000006 110.14 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -146.29 145.21 30.28 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 74.030000000000001 109.562 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -149.97 168.82 22.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.769 0.428 . . . . 75.030000000000001 111.085 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.9 t -148.21 169.97 18.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.345 1.058 . . . . 64.439999999999998 109.775 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.08 167.09 22.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.314 1.045 . . . . 74.25 109.995 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.8 124.29 24.03 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.162 0.985 . . . . 64.340000000000003 109.996 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.39 123.65 11.44 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.486 2.791 . . . . 72.409999999999997 113.248 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.6 p -117.4 125.97 51.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.503 0.721 . . . . 73.140000000000001 110.98 -174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -136.98 123.19 20.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.849 0.86 . . . . 73.400000000000006 109.104 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t -155.31 127.91 7.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.47 0.708 . . . . 75.430000000000007 110.063 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.2 m -155.85 127.3 7.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.992 0.917 . . . . 71.519999999999996 109.569 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 m -90.19 156.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.503 0.721 . . . . 72.0 111.148 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.14 158.74 71.81 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 124.64 1.176 . . . . 75.010000000000005 110.201 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--N 1.382 2.308 0 C-N-CA 123.086 2.524 . . . . 73.219999999999999 112.875 172.426 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB3' ' HD2' ' A' ' 61' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 109.497 -0.557 . . . . 73.129999999999995 109.497 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -96.94 91.51 5.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.676 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.452 HG22 HD22 ' A' ' 56' ' ' LEU . 21.1 t -95.65 139.66 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.271 1.028 . . . . 72.319999999999993 109.283 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.538 ' HG3' ' HB2' ' A' ' 65' ' ' ASP . 43.7 ttm105 -148.3 131.97 16.89 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 66' ' ' VAL . 47.8 t -114.83 135.11 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.721 0.808 . . . . 75.340000000000003 109.819 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -137.32 107.23 6.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.923 0.889 . . . . 75.400000000000006 109.772 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.42 123.16 32.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.106 -1.072 . . . . 74.519999999999996 108.106 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.607 HG21 HG13 ' A' ' 74' ' ' VAL . 18.5 tt -85.86 -38.44 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 118.227 0.467 . . . . 74.099999999999994 110.682 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.0 m -149.63 155.89 40.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.818 0.847 . . . . 71.400000000000006 109.744 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 122' ' ' GLY . . . 93.57 -39.02 3.01 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.515 0.509 . . . . 73.230000000000004 112.718 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t 37.13 80.49 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.449 1.9 . . . . 73.310000000000002 113.131 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.67 173.11 9.23 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.963 -1.017 . . . . 75.400000000000006 111.372 -170.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.59 -45.67 94.09 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.31 -1.314 . . . . 62.420000000000002 114.036 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 -28.01 67.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.352 0.871 . . . . 74.200000000000003 113.352 -169.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -60.33 2.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.669 0.388 . . . . 72.150000000000006 111.029 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.4 69.12 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.735 -0.666 . . . . 74.120000000000005 111.849 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -34.4 77.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.258 1.423 . . . . 74.349999999999994 110.477 -174.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -62.25 -57.26 12.08 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 123.468 0.48 . . . . 73.310000000000002 110.317 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.491 ' HB2' ' HB ' ' A' ' 64' ' ' THR . . . -71.92 -28.37 63.44 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.08 0.152 . . . . 74.420000000000002 111.337 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.7 -31.52 71.53 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.433 0.693 . . . . 74.540000000000006 111.153 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -80.73 -45.38 17.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.32 -0.4 . . . . 71.349999999999994 110.451 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 37' ' ' VAL . 10.9 mp -66.4 -31.58 72.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.635 -0.711 . . . . 74.230000000000004 112.189 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.57 -39.65 91.89 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.885 0.374 . . . . 75.219999999999999 111.05 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.71 -29.75 61.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.456 -0.793 . . . . 70.219999999999999 110.308 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -13.08 61.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.539 0.736 . . . . 62.229999999999997 111.396 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.79 31.36 7.82 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.532 0.52 . . . . 70.120000000000005 113.687 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' HD2' ' HB3' ' A' ' 35' ' ' ALA . 7.8 m-85 -79.72 155.7 27.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.601 -0.889 . . . . 75.409999999999997 108.601 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.0 m -73.26 -59.92 2.48 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.724 0.41 . . . . 72.120000000000005 111.468 -163.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 99.5 t -114.41 141.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.692 -0.855 . . . . 74.030000000000001 108.692 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 53' ' ' ALA . 14.6 p -145.61 109.87 4.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.96 0.904 . . . . 73.209999999999994 108.807 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.538 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.4 m-20 -103.86 144.47 31.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.786 -0.82 . . . . 75.049999999999997 108.786 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.496 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 61.9 t -133.59 114.83 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.361 -0.977 . . . . 72.140000000000001 108.361 173.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.25 159.38 27.69 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 121.521 -0.371 . . . . 61.210000000000001 113.033 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -113.27 113.97 26.05 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.029 -1.1 . . . . 73.150000000000006 108.029 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.59 144.51 20.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.887 -0.783 . . . . 75.420000000000002 108.887 -167.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.433 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 t -83.62 108.7 16.88 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 65.530000000000001 109.251 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.59 149.31 35.58 Favored Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.631 . . . . 62.020000000000003 110.281 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.18 -20.8 18.54 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.958 2.439 . . . . 75.019999999999996 113.253 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -80.82 -19.16 45.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.252 1.021 . . . . 73.329999999999998 112.12 -174.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.607 HG13 HG21 ' A' ' 42' ' ' ILE . 90.6 t -56.5 133.18 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.114 0.884 . . . . 75.430000000000007 112.375 -167.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.39 -45.13 0.08 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.954 -1.476 . . . . 61.450000000000003 108.268 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.36 158.1 43.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.379 1.072 . . . . 60.009999999999998 109.339 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.489 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.7 t -62.66 111.95 2.3 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.358 0.599 . . . . 74.340000000000003 110.201 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.0 m -149.32 138.57 21.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.561 0.745 . . . . 71.230000000000004 110.485 -172.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 18.3 t -94.66 114.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.687 1.195 . . . . 75.510000000000005 108.444 173.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' HB3' HD22 ' A' ' 109' ' ' LEU . 28.7 m-85 -95.53 154.52 17.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.318 -0.993 . . . . 74.319999999999993 108.318 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -153.44 -179.88 8.17 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.546 0.688 . . . . 74.209999999999994 111.784 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 24.0 m -126.83 139.48 53.07 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 105.999 -1.852 . . . . 74.230000000000004 105.999 161.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.05 -10.21 59.24 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.962 0.727 . . . . 74.329999999999998 112.962 -170.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.31 130.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 63.210000000000001 112.843 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.24 21.05 11.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.72 1.208 . . . . 74.049999999999997 112.723 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.57 62.99 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 116.308 -0.405 . . . . 63.130000000000003 112.861 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 82' ' ' THR . 11.3 tp10 -69.53 -21.92 63.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 64.349999999999994 109.95 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -57.69 -29.28 64.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.405 1.082 . . . . 72.430000000000007 112.936 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -45.11 83.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.704 0.801 . . . . 72.109999999999999 112.023 -174.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.52 HG22 HG23 ' A' ' 116' ' ' VAL . 9.9 t -74.58 -30.99 61.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.23 -0.441 . . . . 71.439999999999998 110.759 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.9 75.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.885 0.474 . . . . 73.299999999999997 111.407 174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.79 -40.58 83.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.524 1.129 . . . . 72.129999999999995 109.57 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.09 60.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.757 -1.11 . . . . 73.420000000000002 110.681 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.01 -32.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.16 0.984 . . . . 73.540000000000006 111.827 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.43 93.53 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.957 -0.457 . . . . 74.540000000000006 111.957 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 -80.31 -25.99 39.05 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.0 0.52 . . . . 73.140000000000001 111.881 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -70.81 -43.12 69.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.951 0.5 . . . . 72.450000000000003 110.231 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 tp -86.22 -30.84 22.07 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.592 -0.731 . . . . 71.129999999999995 110.598 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.03 24.95 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.771 -0.649 . . . . 62.530000000000001 112.165 -174.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.94 167.65 9.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.994 0.917 . . . . 71.019999999999996 111.279 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.34 41.92 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.923 0.889 . . . . 75.099999999999994 111.071 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.05 119.58 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.013 0.435 . . . . 65.549999999999997 110.569 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -113.46 148.26 36.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.343 0.657 . . . . 74.540000000000006 110.997 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.64 -166.89 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.905 1.282 . . . . 64.439999999999998 111.911 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -77.04 28.55 0.14 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 124.508 1.123 . . . . 75.450000000000003 113.037 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pp -47.97 157.77 0.6 Allowed Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 125.458 1.503 . . . . 74.409999999999997 113.19 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.35 -24.29 0.97 Allowed 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 124.44 3.427 . . . . 74.209999999999994 117.847 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.68 -22.29 64.38 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.361 0.664 . . . . 74.230000000000004 112.413 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 80' ' ' TYR . 4.4 mm? -64.6 -8.91 15.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.6 0.76 . . . . 74.540000000000006 111.738 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 t -63.98 -42.01 97.36 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.281 1.032 . . . . 75.340000000000003 112.003 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.471 ' HB2' ' OE1' ' A' ' 112' ' ' GLN . 4.5 m-20 -80.77 -33.57 34.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.898 0.479 . . . . 55.329999999999998 111.562 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.471 ' OE1' ' HB2' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -90.71 157.49 43.84 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.704 0.802 . . . . 73.420000000000002 108.998 178.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.7 125.07 16.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.062 1.842 . . . . 73.420000000000002 110.783 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.22 118.96 5.9 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.146 2.564 . . . . 74.450000000000003 112.719 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.51 -158.7 31.76 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.859 -0.896 . . . . 75.129999999999995 110.859 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.52 HG23 HG22 ' A' ' 90' ' ' THR . 74.1 t -79.25 105.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.196 -0.668 . . . . 73.409999999999997 109.196 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.1 pt -116.68 107.75 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 2.1 p -87.28 105.02 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.54 -0.911 . . . . 64.040000000000006 108.54 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 74' ' ' VAL . 94.7 t -91.51 117.48 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.75 -1.204 . . . . 71.299999999999997 107.75 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.24 127.44 65.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.285 -0.635 . . . . 71.409999999999997 109.285 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.489 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.2 p -104.89 102.9 12.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.778 -1.564 . . . . 63.100000000000001 106.778 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 119.308 -0.718 . . . . 70.519999999999996 112.639 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.241 0.655 0 N-CA-C 110.03 -0.359 . . . . 72.439999999999998 110.03 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -170.37 106.2 0.3 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.36 1.064 . . . . 75.400000000000006 108.209 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.12 131.54 5.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.358 0.663 . . . . 63.240000000000002 110.042 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -169.07 130.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.528 1.131 . . . . 70.150000000000006 109.339 175.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 p -172.2 128.11 0.57 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.296 1.038 . . . . 75.430000000000007 108.617 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.7 t -148.29 110.48 4.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 109.52 -0.548 . . . . 71.409999999999997 109.52 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -136.46 104.72 5.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.684 0.794 . . . . 70.109999999999999 109.406 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -135.1 114.99 12.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.493 1.117 . . . . 75.439999999999998 109.816 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 p -148.06 143.05 26.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.842 1.257 . . . . 73.030000000000001 109.001 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -152.77 137.87 17.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.605 1.162 . . . . 65.030000000000001 108.851 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.7 p -143.92 106.41 4.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.954 0.902 . . . . 72.310000000000002 110.307 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.49 144.4 18.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.099 0.959 . . . . 71.140000000000001 110.08 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.73 105.78 4.27 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 123.724 0.81 . . . . 73.409999999999997 109.563 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.06 113.69 2.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.081 2.521 . . . . 75.030000000000001 112.341 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -152.03 119.12 5.86 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.233 0.539 . . . . 73.340000000000003 110.283 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -153.84 139.91 18.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.722 1.209 . . . . 73.439999999999998 109.251 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -148.44 128.35 13.5 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.028 0.531 . . . . 75.030000000000001 110.412 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.3 m -150.31 89.18 1.56 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.212 1.005 . . . . 73.310000000000002 108.992 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.34 140.74 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.814 0.846 . . . . 75.409999999999997 110.26 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.31 115.68 64.62 Favored Pre-proline 0 N--CA 1.479 1.001 0 N-CA-C 108.753 -0.832 . . . . 73.239999999999995 108.753 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.375 1.945 0 C-N-CA 122.678 2.252 . . . . 72.349999999999994 111.279 174.137 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.773 0.321 . . . . 73.420000000000002 110.424 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.3 mp0 -82.35 101.1 10.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.044 0.937 . . . . 73.329999999999998 109.086 176.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.13 140.1 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.883 -0.784 . . . . 73.439999999999998 108.883 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -152.08 129.0 10.98 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.623 0.769 . . . . 75.140000000000001 109.473 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG23 ' HB ' ' A' ' 118' ' ' VAL . 43.7 t -114.79 126.55 72.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.131 -1.063 . . . . 70.349999999999994 108.131 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 119' ' ' VAL . 7.9 p90 -127.56 139.72 52.58 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.475 0.655 . . . . 73.439999999999998 110.005 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.49 HD22 ' HB3' ' A' ' 46' ' ' GLU . 16.4 m120 -84.24 146.78 27.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.708 -1.133 . . . . 75.239999999999995 108.303 166.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.94 -23.23 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.005 0.431 . . . . 74.400000000000006 109.993 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.9 m -118.84 -57.37 2.04 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.737 0.815 . . . . 71.129999999999995 109.758 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 76.94 1.05 Allowed Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.802 -0.519 . . . . 63.210000000000001 111.802 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.2 m -145.13 -37.6 0.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.841 0.856 . . . . 65.530000000000001 110.074 178.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' ASN . 10.9 tp10 -73.96 109.9 7.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.997 0.519 . . . . 75.319999999999993 110.346 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.53 -24.07 59.34 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.395 -0.82 . . . . 55.109999999999999 112.522 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.31 67.6 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.07 0.548 . . . . 73.540000000000006 110.855 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.65 55.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.803 0.841 . . . . 63.25 110.598 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -27.38 66.14 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.616 -0.72 . . . . 65.040000000000006 111.609 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.7 -35.93 79.71 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.441 1.097 . . . . 73.129999999999995 110.825 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -62.35 -53.2 58.5 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 122.426 0.29 . . . . 73.0 111.229 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HB1' HG22 ' A' ' 39' ' ' VAL . . . -68.9 -30.13 68.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.379 0.272 . . . . 70.310000000000002 111.255 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.8 -39.41 94.16 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 70.540000000000006 109.95 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -74.78 -33.52 62.27 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 110.355 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.377 0.671 . . . . 75.239999999999995 111.048 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -63.04 -46.54 87.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 107.948 -1.13 . . . . 75.019999999999996 107.948 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.99 -29.23 69.02 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.263 -0.88 . . . . 75.25 111.122 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.52 -17.02 58.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.484 0.714 . . . . 73.420000000000002 111.601 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.9 37.23 7.98 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 116.492 -0.322 . . . . 74.25 113.878 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.26 159.47 28.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.063 0.545 . . . . 75.150000000000006 110.164 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.4 m -60.9 -68.91 0.26 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.811 0.694 . . . . 62.140000000000001 111.176 -167.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 89.2 t -116.48 138.16 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.806 -1.183 . . . . 75.219999999999999 107.806 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.6 p -136.4 96.28 3.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.277 -1.379 . . . . 71.120000000000005 107.277 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -102.25 145.95 28.71 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.625 -0.88 . . . . 74.349999999999994 108.625 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.09 135.1 55.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.061 0.944 . . . . 72.239999999999995 108.836 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.11 -164.27 27.37 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 121.249 -0.501 . . . . 74.040000000000006 112.3 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -146.28 118.5 8.35 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.268 -1.012 . . . . 74.439999999999998 108.268 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.53 143.03 47.19 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 108.656 -0.868 . . . . 72.209999999999994 108.656 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -86.57 97.16 10.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.117 -0.697 . . . . 75.129999999999995 109.117 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HB2' ' HH ' ' A' ' 40' ' ' TYR . 4.4 mm? -107.87 110.87 62.5 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.518 1.127 . . . . 75.349999999999994 108.454 174.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.1 -12.96 33.23 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.247 1.965 . . . . 71.140000000000001 113.236 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -77.19 -21.43 53.97 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.661 0.385 . . . . 74.200000000000003 111.671 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.22 142.12 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.557 -0.535 . . . . 71.010000000000005 109.557 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.93 22.44 1.58 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.343 1.057 . . . . 61.229999999999997 109.983 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.25 149.25 33.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.581 0.753 . . . . 73.230000000000004 109.582 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.469 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.3 t -76.88 103.55 6.89 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.873 0.844 . . . . 73.439999999999998 109.834 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.2 m -151.47 140.11 20.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.338 -0.847 . . . . 74.209999999999994 110.113 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.66 HG21 HG13 ' A' ' 118' ' ' VAL . 41.7 t -96.46 114.25 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.848 0.859 . . . . 74.430000000000007 109.154 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.83 132.71 45.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.295 1.038 . . . . 74.010000000000005 108.493 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.605 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -137.31 165.82 25.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.991 0.516 . . . . 72.040000000000006 111.904 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.0 t -106.99 148.86 28.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.607 -1.257 . . . . 75.510000000000005 107.607 161.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.538 ' HG2' ' HD2' ' A' ' 88' ' ' ARG . 46.0 mt-10 -97.16 9.04 43.26 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.915 0.486 . . . . 65.120000000000005 111.787 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.31 143.12 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.301 -0.629 . . . . 74.109999999999999 109.301 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 62.11 -83.09 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.721 1.208 . . . . 72.030000000000001 111.969 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.31 37.72 0.21 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.991 -0.443 . . . . 63.140000000000001 111.991 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.48 -35.9 24.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.542 0.337 . . . . 71.109999999999999 111.462 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 83' ' ' GLU . 61.4 ttt180 -61.25 -26.93 68.08 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.948 -0.47 . . . . 75.5 111.294 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.47 99.85 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.628 0.771 . . . . 72.010000000000005 111.956 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -81.49 -24.26 36.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.114 0.483 . . . . 72.409999999999997 110.55 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.7 59.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.929 0.892 . . . . 71.099999999999994 111.612 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.55 -45.52 75.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.417 -1.265 . . . . 75.200000000000003 109.663 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.29 -56.9 14.73 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.648 -1.16 . . . . 72.430000000000007 111.114 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 HG22 ' A' ' 118' ' ' VAL . 86.6 t -71.27 -37.32 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.726 -0.67 . . . . 61.409999999999997 111.823 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 79' ' ' VAL . . . -53.81 -35.44 52.96 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.566 0.541 . . . . 62.340000000000003 112.459 177.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -86.17 -32.8 21.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.673 -0.763 . . . . 70.420000000000002 110.308 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.9 m -65.84 -40.98 92.28 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.353 0.597 . . . . 73.430000000000007 110.399 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.53 -28.44 28.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.656 -1.156 . . . . 73.430000000000007 109.934 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.82 75.69 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.764 -0.653 . . . . 63.43 112.606 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.91 -172.59 3.75 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.83 0.852 . . . . 72.25 110.617 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 161.34 26.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.863 0.465 . . . . 42.240000000000002 109.965 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.605 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 10.0 m -129.96 124.63 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.853 0.861 . . . . 75.409999999999997 109.016 175.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -129.08 158.57 38.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.008 0.923 . . . . 74.530000000000001 110.905 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.8 -163.64 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.027 -1.442 . . . . 75.349999999999994 111.023 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.514 ' HA ' HD13 ' A' ' 109' ' ' LEU . 14.4 ttp180 -75.4 30.77 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.136 1.374 . . . . 74.349999999999994 112.955 -172.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.2 mt -46.0 152.41 0.78 Allowed Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 125.549 1.539 . . . . 73.540000000000006 113.654 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.2 -12.72 0.5 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 124.759 3.639 . . . . 71.25 116.796 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -60.31 -33.69 72.73 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.265 0.555 . . . . 71.230000000000004 110.287 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 105' ' ' ARG . 31.5 mt -76.71 5.6 7.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.298 1.039 . . . . 73.299999999999997 113.299 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.4 p -82.13 -41.36 20.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.735 -0.839 . . . . 75.140000000000001 108.735 170.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.7 -34.86 30.39 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.743 -1.117 . . . . 74.120000000000005 110.243 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -86.16 146.99 43.94 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.355 -0.839 . . . . 73.540000000000006 109.236 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.32 124.04 12.76 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.338 2.025 . . . . 74.409999999999997 111.165 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.26 133.79 51.72 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.726 2.951 . . . . 73.319999999999993 113.76 -171.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.11 -129.14 2.17 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.204 -1.158 . . . . 74.129999999999995 110.204 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.48 105.12 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.325 -0.991 . . . . 72.450000000000003 108.325 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.5 HD12 HD22 ' A' ' 109' ' ' LEU . 2.3 mp -105.59 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 N-CA-C 108.028 -1.101 . . . . 73.340000000000003 108.028 -176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.66 HG13 HG21 ' A' ' 79' ' ' VAL . 58.8 t -88.15 106.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.59 -1.263 . . . . 74.230000000000004 107.59 174.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 40' ' ' TYR . 19.2 t -93.13 130.56 42.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.74 -0.837 . . . . 71.140000000000001 108.74 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.58 129.21 74.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.65 0.78 . . . . 74.109999999999999 109.043 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.469 ' H ' ' HB ' ' A' ' 77' ' ' THR . 13.2 t -77.29 144.04 38.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.074 -1.084 . . . . 75.319999999999993 108.074 171.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 N-CA-C 110.488 -1.045 . . . . 65.219999999999999 110.488 -167.087 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.03 -0.73 . . . . 65.450000000000003 109.03 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 t -76.8 173.8 11.26 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.599 0.76 . . . . 71.319999999999993 111.489 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.69 157.31 44.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.704 0.802 . . . . 73.430000000000007 110.28 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 pt -102.84 -176.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.518 0.727 . . . . 74.340000000000003 110.785 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -148.68 173.67 12.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.29 0.636 . . . . 54.399999999999999 110.223 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -143.35 146.67 33.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.991 0.516 . . . . 73.109999999999999 111.373 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -121.4 135.22 55.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.841 0.856 . . . . 65.299999999999997 109.499 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.0 m -145.8 128.65 16.36 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.296 1.038 . . . . 74.219999999999999 108.789 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 p -110.24 162.89 14.17 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.65 0.78 . . . . 73.030000000000001 111.586 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -118.79 136.47 53.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.91 0.884 . . . . 72.049999999999997 109.688 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.6 m -78.29 157.68 29.12 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.778 0.831 . . . . 72.239999999999995 110.359 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.81 169.76 16.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 70.319999999999993 109.472 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.61 42.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.399 0.68 . . . . 74.310000000000002 111.095 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.32 176.87 9.43 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.402 2.068 . . . . 63.039999999999999 111.794 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 p -112.92 -175.89 2.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.331 0.652 . . . . 74.219999999999999 110.474 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.9 t -150.2 136.1 18.5 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.519 -0.919 . . . . 73.299999999999997 108.519 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -114.44 138.43 50.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.003 0.521 . . . . 72.140000000000001 109.621 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.7 m -148.15 121.7 9.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.435 0.694 . . . . 73.319999999999993 109.506 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.06 144.58 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.488 0.715 . . . . 74.239999999999995 110.149 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -105.98 157.24 35.21 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 124.084 0.954 . . . . 75.430000000000007 110.102 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo . . . . . 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 72.010000000000005 113.304 171.415 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 112.196 0.443 . . . . 74.019999999999996 112.196 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 27.3 mm-40 -77.07 114.49 15.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.104 0.962 . . . . 74.109999999999999 109.451 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.604 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 43.1 t -125.76 137.32 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 122.853 0.461 . . . . 75.409999999999997 110.542 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -151.27 148.99 28.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.005 0.922 . . . . 74.140000000000001 110.676 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.51 113.57 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.263 1.025 . . . . 75.209999999999994 109.505 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -103.33 107.85 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.78 0.432 . . . . 75.340000000000003 110.228 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 3.4 t-20 -94.42 119.44 33.16 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.734 -0.839 . . . . 74.230000000000004 108.734 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -102.43 -42.9 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 122.073 -0.392 . . . . 75.540000000000006 110.365 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 p -136.88 158.55 44.21 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.84 -0.8 . . . . 73.450000000000003 108.84 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.75 59.05 4.21 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.591 -1.003 . . . . 74.209999999999994 110.591 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 t -66.22 100.81 0.65 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.602 0.761 . . . . 62.119999999999997 111.491 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -147.83 155.44 41.65 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.249 0.62 . . . . 53.219999999999999 110.133 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.62 -2.53 36.36 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 118.905 -0.942 . . . . 65.129999999999995 114.001 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.98 69.46 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.095 0.958 . . . . 70.310000000000002 111.412 171.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -42.56 97.28 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 124.154 0.909 . . . . 71.420000000000002 110.988 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.22 -35.53 71.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.67 -0.696 . . . . 72.439999999999998 111.089 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.76 -31.24 71.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.901 1.28 . . . . 65.299999999999997 111.63 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 98' ' ' LEU . 48.0 p -76.97 -22.18 53.59 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.7 0.4 . . . . 72.329999999999998 111.59 176.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.19 -54.73 5.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.462 0.705 . . . . 74.450000000000003 111.205 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -54.96 -31.16 60.33 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.16 0.984 . . . . 74.549999999999997 113.147 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -59.88 -39.47 85.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.321 0.648 . . . . 74.430000000000007 111.789 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.0 -38.42 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 118.917 -0.563 . . . . 75.510000000000005 111.893 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -30.93 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.825 0.738 . . . . 74.5 110.596 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.19 -27.97 66.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.479 0.712 . . . . 73.439999999999998 110.808 173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.71 -21.8 37.78 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.63 0.772 . . . . 74.140000000000001 111.989 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.06 25.99 4.85 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 113.968 0.347 . . . . 65.400000000000006 113.968 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.43 158.73 27.27 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.34 0.656 . . . . 64.430000000000007 110.443 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -65.43 -70.1 0.26 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.969 0.793 . . . . 74.329999999999998 110.854 -165.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.02 145.15 35.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.69 -0.856 . . . . 64.420000000000002 108.69 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.486 HG22 ' HB ' ' A' ' 37' ' ' VAL . 41.4 p -137.14 100.61 4.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.527 -1.286 . . . . 73.120000000000005 107.527 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 19.0 t70 -104.9 162.5 13.27 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.897 0.879 . . . . 73.319999999999993 110.183 -172.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 141.44 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.841 0.856 . . . . 73.030000000000001 109.049 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.44 129.02 2.41 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.947 -0.461 . . . . 71.310000000000002 111.947 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 16.8 p-10 -88.66 97.39 11.09 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.447 0.699 . . . . 75.310000000000002 109.823 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.4 135.55 13.03 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.166 -0.333 . . . . 75.409999999999997 110.155 -169.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -81.16 99.41 8.53 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.433 -0.58 . . . . 70.129999999999995 109.433 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.31 151.75 89.98 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.407 -0.59 . . . . 73.329999999999998 109.407 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.04 -7.61 18.32 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.113 1.875 . . . . 61.439999999999998 112.371 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -108.93 -23.05 11.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.342 0.657 . . . . 73.400000000000006 112.43 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.06 130.13 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.36 0.6 . . . . 73.109999999999999 111.252 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.27 -7.67 4.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.431 1.092 . . . . 75.439999999999998 111.215 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.12 159.0 5.77 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.463 1.105 . . . . 72.349999999999994 109.345 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.535 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.4 t -66.75 107.24 2.09 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.694 0.759 . . . . 64.030000000000001 109.996 177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 m -144.91 153.42 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.531 -0.759 . . . . 73.5 109.293 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.635 HG23 ' HA3' ' A' ' 95' ' ' GLY . 4.3 t -112.6 114.28 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.916 -1.142 . . . . 70.329999999999998 107.916 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.567 ' HB2' HG13 ' A' ' 117' ' ' ILE . 52.4 m-85 -105.1 119.38 38.89 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.285 0.493 . . . . 73.120000000000005 110.585 -174.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.469 ' HD2' ' HB1' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -112.01 140.99 46.22 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.85 0.719 . . . . 74.310000000000002 110.462 175.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.1 t -113.78 -40.05 3.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.946 0.898 . . . . 62.030000000000001 111.654 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -89.81 37.38 0.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.858 0.863 . . . . 73.209999999999994 111.856 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -45.87 163.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.518 1.927 . . . . 74.129999999999995 114.746 -174.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 86.69 -55.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.727 2.011 . . . . 75.329999999999998 108.359 -163.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.31 -50.73 1.99 Allowed Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.205 -0.452 . . . . 75.019999999999996 112.574 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.04 -19.94 50.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.653 0.263 . . . . 74.430000000000007 111.299 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -56.81 -27.97 60.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.75 -0.659 . . . . 65.530000000000001 110.972 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.8 -46.64 57.57 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.716 0.806 . . . . 72.430000000000007 112.214 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -79.9 -33.24 40.03 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 122.672 0.389 . . . . 75.140000000000001 110.736 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.59 -48.22 75.76 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 123.799 0.687 . . . . 64.310000000000002 110.353 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.516 ' HA ' HG13 ' A' ' 102' ' ' VAL . 30.5 t70 -57.52 -40.24 78.34 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.272 0.983 . . . . 73.099999999999994 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.54 -46.1 87.51 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.961 0.788 . . . . 73.450000000000003 112.149 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.446 HG13 HG11 ' A' ' 118' ' ' VAL . 61.4 t -65.44 -52.82 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.328 0.651 . . . . 74.310000000000002 110.605 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.635 ' HA3' HG23 ' A' ' 79' ' ' VAL . . . -64.6 -26.84 71.18 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.344 -0.844 . . . . 71.540000000000006 113.281 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 2.6 tmt_? -65.07 -39.29 93.02 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.507 0.723 . . . . 75.450000000000003 109.553 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -66.46 -52.65 43.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.922 -1.035 . . . . 73.310000000000002 111.181 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 52' ' ' THR . 4.0 pp -82.45 -13.71 56.29 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.792 -0.64 . . . . 73.340000000000003 112.402 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.66 72.81 1.2 Allowed Glycine 0 C--N 1.349 1.255 0 O-C-N 123.574 0.546 . . . . 45.25 113.136 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.06 155.11 44.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.703 0.801 . . . . 75.340000000000003 110.001 172.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.97 142.53 33.36 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.492 -0.776 . . . . 74.299999999999997 110.289 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.516 HG13 ' HA ' ' A' ' 92' ' ' ASP . 34.0 m -95.19 148.25 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.417 0.687 . . . . 70.140000000000001 110.748 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -157.5 156.69 32.49 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 123.811 0.844 . . . . 75.019999999999996 110.81 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.63 161.51 23.12 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.402 1.081 . . . . 75.0 110.746 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.66 29.73 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.404 2.001 . . . . 71.239999999999995 116.404 -172.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.0 mm? -54.61 -53.62 58.12 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-N 119.562 1.074 . . . . 74.430000000000007 112.521 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 6.0 Cg_exo -80.26 -13.93 12.2 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 122.378 2.052 . . . . 75.340000000000003 112.953 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.553 ' HG2' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -58.62 -41.61 86.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.498 0.719 . . . . 72.319999999999993 110.153 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.4 tp -64.29 -12.75 44.72 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.56 0.744 . . . . 70.109999999999999 112.566 -172.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -63.64 -47.16 82.47 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.871 0.869 . . . . 74.319999999999993 111.161 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.2 -32.49 7.48 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.353 1.061 . . . . 75.129999999999995 110.944 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.1 71.92 1.04 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 126.782 2.033 . . . . 72.299999999999997 112.708 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.553 ' HD2' ' HG2' ' A' ' 108' ' ' GLU . 1.4 Cg_endo -88.71 140.74 4.34 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.1 2.533 . . . . 75.310000000000002 111.106 162.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.0 129.04 13.72 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.66 2.24 . . . . 74.310000000000002 114.468 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.23 -156.15 32.02 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.022 -0.536 . . . . 41.25 113.988 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 76.8 t -58.1 111.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 124.278 1.031 . . . . 74.200000000000003 110.138 177.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.567 HG13 ' HB2' ' A' ' 80' ' ' TYR . 39.7 pt -117.85 104.3 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.47 -1.307 . . . . 70.540000000000006 107.47 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.581 ' HB ' HG12 ' A' ' 79' ' ' VAL . 2.3 p -101.84 111.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.886 -0.783 . . . . 75.519999999999996 108.886 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -93.17 123.53 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.941 -1.027 . . . . 75.219999999999999 109.473 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.05 127.52 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.593 0.757 . . . . 73.219999999999999 110.108 -172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.535 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.8 p -123.4 119.61 30.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.512 -1.292 . . . . 74.349999999999994 107.512 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.594 0 CA-C-O 119.207 -0.774 . . . . 63.32 112.628 -174.613 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 109.931 -0.396 . . . . 75.450000000000003 109.931 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.3 p -153.49 124.65 7.45 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.939 0.896 . . . . 73.239999999999995 108.684 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.41 123.93 7.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.812 0.845 . . . . 64.530000000000001 109.517 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 tp -157.9 136.26 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.817 0.847 . . . . 73.400000000000006 109.345 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 p -150.77 88.78 1.5 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.86 0.864 . . . . 73.140000000000001 109.318 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.5 p -99.17 131.0 45.51 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.176 -0.675 . . . . 60.329999999999998 109.176 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -131.34 155.37 47.35 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.2 0.524 . . . . 74.010000000000005 111.251 -174.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -153.98 159.35 41.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.135 1.374 . . . . 75.530000000000001 108.352 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -139.59 42.23 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 122.043 0.925 . . . . 62.100000000000001 109.911 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 m -78.66 100.48 7.04 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.1 -0.955 . . . . 74.340000000000003 109.0 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 t -132.79 31.3 3.95 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.829 0.823 . . . . 75.439999999999998 110.128 -174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.23 134.65 37.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.212 -0.904 . . . . 73.530000000000001 110.898 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.84 111.9 4.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.509 0.724 . . . . 62.439999999999998 109.556 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.16 158.18 52.55 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.645 2.23 . . . . 74.340000000000003 111.275 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -159.5 167.26 29.06 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.16 0.584 . . . . 63.520000000000003 110.65 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -143.84 159.5 42.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.689 0.795 . . . . 74.439999999999998 110.291 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 t -127.63 140.21 52.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.555 0.742 . . . . 72.030000000000001 109.781 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 p -169.29 137.0 1.83 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.824 0.849 . . . . 72.209999999999994 109.877 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.11 125.9 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.353 0.661 . . . . 65.109999999999999 110.52 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.37 110.48 58.06 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.376 -0.972 . . . . 74.209999999999994 108.376 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 C--N 1.377 2.061 0 C-N-CA 123.256 2.637 . . . . 61.219999999999999 113.292 -174.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.845 0.355 . . . . 74.310000000000002 110.838 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.04 112.71 24.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.906 0.882 . . . . 75.109999999999999 108.944 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 64' ' ' THR . 99.4 t -116.42 138.95 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.68 0.792 . . . . 75.319999999999993 109.461 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -132.15 118.12 19.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.614 -0.513 . . . . 72.310000000000002 109.614 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.12 107.19 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.342 -0.614 . . . . 75.219999999999999 109.342 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -118.1 152.26 35.93 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 109.102 -0.703 . . . . 74.430000000000007 109.102 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.72 134.44 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.033 -0.728 . . . . 64.310000000000002 109.033 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.14 -39.71 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.812 -0.44 . . . . 74.310000000000002 109.812 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 p -141.73 -61.32 0.46 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.821 0.448 . . . . 64.409999999999997 111.208 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.65 100.69 1.72 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.703 -0.498 . . . . 63.340000000000003 112.064 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -88.17 41.45 1.0 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.155 0.982 . . . . 73.099999999999994 112.858 -168.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.16 137.34 56.2 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.961 0.505 . . . . 72.340000000000003 110.521 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -7.69 58.04 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.529 0.518 . . . . 70.510000000000005 113.643 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.32 64.68 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.267 1.027 . . . . 71.239999999999995 110.954 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.08 -56.96 14.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.922 -1.035 . . . . 74.420000000000002 110.59 171.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.99 67.65 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.518 -0.765 . . . . 74.400000000000006 112.568 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -29.92 68.08 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.039 0.935 . . . . 75.129999999999995 110.96 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.549 HG23 ' HB2' ' A' ' 98' ' ' LEU . 64.4 p -70.13 -36.86 75.1 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 110.085 -0.339 . . . . 72.120000000000005 110.085 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB2' ' OG1' ' A' ' 64' ' ' THR . . . -67.3 -28.5 68.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.602 0.761 . . . . 72.230000000000004 111.562 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.41 -24.47 62.93 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.015 0.926 . . . . 72.200000000000003 110.711 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -70.51 -42.0 71.88 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.906 -0.405 . . . . 72.239999999999995 109.906 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.39 -29.6 67.4 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.806 0.669 . . . . 73.150000000000006 112.806 -174.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HB2' ' HZ1' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.38 -27.47 67.13 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.897 0.38 . . . . 65.25 110.793 175.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.03 27.77 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.028 0.931 . . . . 62.439999999999998 111.746 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.39 -22.8 22.39 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.304 0.642 . . . . 72.019999999999996 112.484 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.47 46.83 0.39 Allowed Glycine 0 C--N 1.352 1.439 0 CA-C-N 117.873 0.306 . . . . 54.509999999999998 113.308 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -62.41 158.22 18.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.103 0.961 . . . . 73.5 111.818 176.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.7 m -92.54 -60.72 1.76 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.214 -1.032 . . . . 73.230000000000004 108.214 161.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -134.56 140.66 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.611 -1.255 . . . . 71.200000000000003 107.611 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t -130.56 127.12 38.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.372 -0.973 . . . . 71.030000000000001 108.372 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -122.54 144.55 49.01 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.014 -1.106 . . . . 71.409999999999997 108.014 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 m -139.85 143.61 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 122.848 0.459 . . . . 74.319999999999993 110.41 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.1 -138.13 4.63 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.016 -0.538 . . . . 63.25 112.16 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -157.96 123.05 4.39 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.265 0.626 . . . . 72.310000000000002 110.546 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 mp -129.12 156.39 43.96 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.188 0.995 . . . . 75.25 108.882 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 p -106.13 100.88 10.4 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.708 0.803 . . . . 50.130000000000003 110.055 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -119.16 119.54 31.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 123.818 0.847 . . . . 70.099999999999994 109.134 167.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.16 0.33 9.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.757 2.305 . . . . 72.519999999999996 112.713 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.0 -26.77 54.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.047 0.939 . . . . 73.510000000000005 111.104 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 t -125.56 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.755 -0.832 . . . . 75.239999999999995 108.755 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.74 -54.33 2.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.962 0.905 . . . . 45.039999999999999 110.488 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.64 160.33 25.08 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.024 0.93 . . . . 63.340000000000003 110.436 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 t -64.05 104.67 0.75 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.979 0.895 . . . . 61.32 108.887 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 101' ' ' ALA . 25.0 m -136.1 129.84 32.46 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.385 -0.825 . . . . 71.120000000000005 110.564 -171.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.726 HG23 HG13 ' A' ' 118' ' ' VAL . 73.5 t -95.18 113.65 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.049 -1.093 . . . . 60.399999999999999 108.049 175.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.475 ' HE1' ' HA ' ' A' ' 105' ' ' ARG . 10.2 t80 -96.98 136.38 37.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.057 -0.72 . . . . 73.439999999999998 109.057 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.482 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 25.1 p90 -151.73 -179.49 7.48 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.71 1.256 . . . . 73.120000000000005 108.972 172.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 4.3 m -131.7 169.22 16.49 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 106.043 -1.836 . . . . 63.43 106.043 164.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.69 21.25 2.25 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.134 -0.979 . . . . 73.120000000000005 111.826 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.45 99.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.259 1.024 . . . . 73.030000000000001 109.788 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 64.11 -75.99 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 125.56 1.544 . . . . 74.340000000000003 111.88 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.57 39.07 0.51 Allowed Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.013 0.365 . . . . 51.32 114.013 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 82' ' ' THR . 55.4 mt-10 -69.97 -36.45 75.24 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.0 0.429 . . . . 74.120000000000005 110.566 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -62.02 -37.75 86.08 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.781 -1.1 . . . . 74.530000000000001 112.54 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.77 -25.49 49.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.986 0.514 . . . . 74.540000000000006 111.492 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.5 m -78.75 -36.69 42.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.911 0.885 . . . . 74.310000000000002 109.677 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -24.38 40.45 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.928 -1.033 . . . . 65.150000000000006 111.554 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.09 -39.71 90.96 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.11 0.964 . . . . 71.129999999999995 109.977 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -23.98 66.94 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.139 -0.937 . . . . 74.129999999999995 111.996 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 118' ' ' VAL . 58.1 t -84.34 -61.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 122.872 0.469 . . . . 74.310000000000002 111.355 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.73 -27.73 73.42 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.581 0.55 . . . . 54.420000000000002 114.293 -168.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -76.11 -23.46 54.9 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.002 0.521 . . . . 74.319999999999993 110.265 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 85.3 m -84.49 -38.69 19.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.621 0.769 . . . . 73.310000000000002 111.084 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 HG23 ' A' ' 120' ' ' VAL . 46.0 tp -81.37 -31.88 33.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.782 0.833 . . . . 70.329999999999998 111.553 -172.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.67 50.57 5.57 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 111.002 -0.839 . . . . 73.230000000000004 111.002 -170.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.59 143.74 51.12 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.53 0.732 . . . . 74.310000000000002 110.606 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 78' ' ' THR . . . -63.48 114.48 3.92 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.962 0.788 . . . . 73.129999999999995 110.018 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.482 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 16.1 m -88.13 101.75 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.356 0.598 . . . . 74.329999999999998 110.114 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.59 157.24 20.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.518 1.151 . . . . 73.299999999999997 111.957 -175.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.486 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 8.0 tp -93.2 -166.59 1.55 Allowed 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 112.934 -1.939 . . . . 73.019999999999996 108.367 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.486 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 48.7 ttp180 -81.43 27.69 0.42 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.588 0.755 . . . . 74.540000000000006 112.542 -175.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.8 mm? -70.87 -66.69 0.73 Allowed Pre-proline 0 CA--C 1.558 1.27 0 CA-C-O 118.045 -0.979 . . . . 74.420000000000002 111.053 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 4.5 Cg_exo -83.85 -23.57 3.12 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 121.878 1.719 . . . . 74.549999999999997 112.988 -173.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.35 -9.96 59.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.949 -0.548 . . . . 71.409999999999997 111.587 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -20.92 66.55 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.849 0.46 . . . . 71.140000000000001 110.526 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -55.66 -45.56 77.66 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.442 0.697 . . . . 72.140000000000001 110.831 171.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -86.13 -32.44 21.31 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.401 0.68 . . . . 62.140000000000001 111.221 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.62 79.15 0.36 Allowed Pre-proline 0 CA--C 1.563 1.446 0 C-N-CA 125.734 1.614 . . . . 71.349999999999994 111.033 -169.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -84.56 125.64 3.38 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.061 2.508 . . . . 72.109999999999999 111.743 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.12 118.69 4.08 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.35 2.033 . . . . 75.439999999999998 110.906 173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.07 166.19 39.43 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 112.014 -0.434 . . . . 41.520000000000003 112.014 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.414 HG11 ' O ' ' A' ' 80' ' ' TYR . 75.9 t -66.94 126.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.023 0.929 . . . . 75.239999999999995 111.481 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.455 HG12 ' CD2' ' A' ' 80' ' ' TYR . 9.4 pt -121.85 111.95 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.162 -1.051 . . . . 75.310000000000002 108.162 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.726 HG13 HG23 ' A' ' 79' ' ' VAL . 61.3 t -94.01 108.49 20.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.845 -0.798 . . . . 75.230000000000004 108.845 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.47 120.95 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.409 -0.814 . . . . 72.239999999999995 109.789 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.593 HG23 HD23 ' A' ' 98' ' ' LEU . 44.7 t -110.28 129.59 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 122.681 0.392 . . . . 73.530000000000001 110.763 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 t -99.87 164.56 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.048 0.451 . . . . 73.400000000000006 110.745 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.806 0 CA-C-O 118.708 -1.051 . . . . 74.219999999999999 111.126 170.267 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 CA-C-O 119.508 -0.607 . . . . 74.549999999999997 112.018 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -64.4 126.35 27.54 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.998 0.919 . . . . 73.430000000000007 111.456 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -120.33 135.94 24.84 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.667 0.787 . . . . 75.140000000000001 109.188 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.25 127.18 20.36 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.007 2.471 . . . . 71.299999999999997 111.808 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -91.75 154.77 18.73 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.958 0.903 . . . . 75.049999999999997 109.49 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.9 m -56.08 132.38 50.06 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.187 0.995 . . . . 73.230000000000004 111.117 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -54.02 -79.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 O-C-N 124.194 0.934 . . . . 73.230000000000004 112.009 -170.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -134.69 -74.69 0.47 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.214 -0.662 . . . . 62.509999999999998 109.214 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -177.23 132.21 0.17 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.215 1.406 . . . . 74.340000000000003 108.196 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.0 m -87.66 134.87 33.57 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.086 0.555 . . . . 74.099999999999994 110.15 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -93.53 178.07 5.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.42 0.688 . . . . 75.010000000000005 110.108 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.31 156.5 42.97 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.749 0.82 . . . . 74.209999999999994 109.666 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -128.52 170.56 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.464 0.706 . . . . 75.439999999999998 110.41 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 t -164.63 171.15 14.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.211 1.004 . . . . 73.140000000000001 109.438 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -135.78 163.54 29.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.026 0.93 . . . . 63.409999999999997 109.18 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.7 mtt -127.54 131.62 50.03 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.019 0.928 . . . . 64.349999999999994 108.698 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.5 p -111.9 141.49 45.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.411 0.684 . . . . 74.239999999999995 110.142 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.9 p -127.29 158.74 36.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.806 0.843 . . . . 71.340000000000003 110.108 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 t -143.4 162.27 36.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.628 0.771 . . . . 71.230000000000004 109.311 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.9 m -149.09 137.72 21.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.306 0.643 . . . . 74.109999999999999 109.942 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.51 165.87 12.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.55 0.74 . . . . 55.0 109.861 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.64 136.63 12.48 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.179 0.592 . . . . 73.549999999999997 109.884 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.53 139.26 37.17 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.075 2.516 . . . . 73.340000000000003 112.867 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 p -102.18 128.14 48.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.994 0.918 . . . . 74.409999999999997 109.899 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 m -87.88 121.98 30.96 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.569 0.748 . . . . 70.030000000000001 109.582 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 m -136.23 124.43 23.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.081 0.952 . . . . 65.120000000000005 109.066 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.2 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.044 0.938 . . . . 75.109999999999999 109.755 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.42 140.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.693 0.797 . . . . 70.439999999999998 109.525 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.98 136.88 19.65 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.096 0.959 . . . . 74.510000000000005 109.448 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.26 149.33 45.98 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.22 2.613 . . . . 62.049999999999997 113.841 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.93 161.55 18.98 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.995 0.918 . . . . 71.319999999999993 111.112 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.05 121.64 33.53 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 123.629 0.772 . . . . 72.439999999999998 110.312 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.14 136.14 46.55 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.209 2.606 . . . . 74.239999999999995 111.554 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -82.5 -86.19 0.1 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.103 0.561 . . . . 75.140000000000001 111.143 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.23 132.21 27.77 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.069 0.548 . . . . 71.319999999999993 109.88 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.18 149.34 26.01 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.32 0.581 . . . . 75.319999999999993 110.799 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 64' ' ' THR . 48.1 t -114.9 146.57 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.312 1.045 . . . . 71.230000000000004 108.84 172.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.555 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.0 ptp180 -145.18 117.02 8.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.225 0.536 . . . . 73.129999999999995 111.571 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.52 111.9 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.311 0.644 . . . . 75.099999999999994 109.774 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 33.7 m-85 -101.08 118.76 37.63 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.187 0.595 . . . . 73.540000000000006 109.856 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.518 ' ND2' ' HB ' ' A' ' 120' ' ' VAL . 4.6 t-20 -95.9 125.36 40.4 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.345 -1.354 . . . . 75.420000000000002 107.345 169.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.764 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.6 tt -80.39 -34.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 111.931 0.345 . . . . 73.239999999999995 111.931 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -111.43 -20.52 12.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.689 0.396 . . . . 75.230000000000004 111.511 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.9 114.92 0.62 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.808 -0.517 . . . . 74.209999999999994 111.808 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.419 HG21 HD22 ' A' ' 41' ' ' ASN . 13.2 t -145.15 -155.67 0.63 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.059 -0.719 . . . . 65.340000000000003 109.059 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.98 154.78 25.52 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.587 1.155 . . . . 74.150000000000006 112.477 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.33 -1.8 16.56 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 115.455 -0.793 . . . . 74.25 114.691 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.69 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.028 0.931 . . . . 74.129999999999995 111.58 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 120' ' ' VAL . . . -66.4 -49.26 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.354 -0.839 . . . . 65.209999999999994 110.863 173.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB1' HG22 ' A' ' 66' ' ' VAL . . . -71.3 -20.47 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.465 0.706 . . . . 75.030000000000001 111.753 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -28.97 69.07 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.603 0.761 . . . . 74.299999999999997 111.354 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.519 ' HB ' HG11 ' A' ' 94' ' ' VAL . 68.5 p -62.87 -40.99 99.19 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.486 0.492 . . . . 74.530000000000001 110.346 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 64' ' ' THR . . . -66.27 -37.41 85.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.055 0.942 . . . . 74.239999999999995 111.809 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -65.44 -51.73 58.12 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.584 -0.735 . . . . 74.409999999999997 110.946 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -67.76 -26.22 66.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.572 -1.194 . . . . 74.340000000000003 110.836 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 37' ' ' VAL . 18.3 tp -76.3 -49.85 15.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.949 -1.023 . . . . 62.210000000000001 111.198 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 34.9 ttpt -63.19 -35.82 81.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.915 0.486 . . . . 74.310000000000002 110.685 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -22.49 62.14 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 54.219999999999999 111.341 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.67 57.83 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.413 0.685 . . . . 75.439999999999998 111.36 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.37 41.17 0.98 Allowed Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.445 -0.343 . . . . 75.530000000000001 113.069 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -106.25 156.9 18.0 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.304 0.642 . . . . 74.209999999999994 109.927 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.4 m -66.95 -69.48 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.275 0.984 . . . . 71.430000000000007 111.361 -161.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.29 136.76 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.188 -1.042 . . . . 72.209999999999994 108.188 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 53' ' ' ALA . 73.7 p -129.55 94.9 3.87 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.937 -0.764 . . . . 71.109999999999999 108.937 172.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -103.63 131.56 50.67 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.644 0.778 . . . . 72.150000000000006 109.663 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.475 HG22 ' HB1' ' A' ' 50' ' ' ALA . 6.4 p -116.3 131.11 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 121.712 -0.617 . . . . 75.409999999999997 110.638 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -150.27 159.76 28.25 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.648 -0.705 . . . . 54.240000000000002 111.618 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -95.04 119.8 34.17 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.744 -0.836 . . . . 54.310000000000002 108.744 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.5 tt -150.64 133.93 16.25 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.004 -1.11 . . . . 74.319999999999993 108.004 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.764 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.9 m -80.85 100.07 8.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.361 0.665 . . . . 73.329999999999998 109.882 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.61 106.21 8.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.166 -0.679 . . . . 61.329999999999998 109.166 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.71 0.47 9.99 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.695 2.263 . . . . 74.409999999999997 112.465 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -95.83 -23.4 16.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.249 1.019 . . . . 74.310000000000002 110.647 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.739 HG23 HG13 ' A' ' 119' ' ' VAL . 14.3 m -97.27 155.49 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.291 0.636 . . . . 74.340000000000003 109.865 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.29 9.28 2.28 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.702 0.801 . . . . 73.109999999999999 110.586 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.46 156.51 33.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.74 1.216 . . . . 74.530000000000001 108.611 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -59.2 111.89 1.51 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.053 -0.721 . . . . 74.140000000000001 109.053 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.8 m -138.45 127.95 24.72 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.313 -0.858 . . . . 74.409999999999997 110.611 -168.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.592 HG23 HG13 ' A' ' 118' ' ' VAL . 50.3 t -102.4 113.19 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.784 -1.191 . . . . 72.129999999999995 107.784 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 117' ' ' ILE . 1.4 t80 -98.87 142.47 30.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.969 1.308 . . . . 75.239999999999995 109.926 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 22.5 p90 -133.06 164.56 26.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.459 -0.792 . . . . 72.319999999999993 111.2 168.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.1 m -107.48 172.41 6.84 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 106.895 -1.521 . . . . 74.099999999999994 106.895 163.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.53 28.41 8.76 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.91 0.484 . . . . 74.200000000000003 111.176 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 84.6 t -77.17 126.25 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.416 -0.957 . . . . 74.319999999999993 108.416 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.92 -80.48 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.267 1.027 . . . . 73.340000000000003 110.912 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.56 35.6 0.23 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.9 -0.48 . . . . 74.439999999999998 111.9 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 48.9 mt-10 -61.8 -19.64 62.74 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.172 0.589 . . . . 73.219999999999999 112.269 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' HA ' ' CG ' ' A' ' 81' ' ' TYR . 41.0 ptt85 -63.08 -28.8 70.33 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.287 0.477 . . . . 74.409999999999997 112.287 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.37 82.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.723 0.809 . . . . 64.120000000000005 111.798 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.7 t -67.67 -46.52 72.13 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.422 -0.354 . . . . 74.219999999999999 111.151 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HB2' HG13 ' A' ' 79' ' ' VAL . . . -71.98 -27.72 62.94 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.744 0.417 . . . . 63.340000000000003 111.934 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.04 -33.8 76.91 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.529 0.732 . . . . 73.299999999999997 110.496 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.42 -47.64 19.26 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.662 -0.699 . . . . 72.209999999999994 110.509 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.519 HG11 ' HB ' ' A' ' 52' ' ' THR . 98.8 t -68.95 -33.66 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.468 0.707 . . . . 72.430000000000007 111.757 -175.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.583 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -58.54 -29.08 63.3 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.347 -0.388 . . . . 72.430000000000007 112.561 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -86.96 -30.89 20.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.282 0.633 . . . . 74.25 111.018 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.2 m -64.34 -43.24 95.23 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.644 0.735 . . . . 74.310000000000002 110.546 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.43 HD21 HG21 ' A' ' 120' ' ' VAL . 57.3 tp -85.29 -32.15 22.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.59 -1.186 . . . . 72.420000000000002 110.204 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 66.8 1.96 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.432 -1.067 . . . . 63.520000000000003 110.432 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.97 166.44 24.47 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.553 1.141 . . . . 65.109999999999999 110.359 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.32 110.99 7.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.429 0.691 . . . . 64.25 109.325 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.583 HG22 ' HA3' ' A' ' 95' ' ' GLY . 5.4 t -86.63 134.03 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.26 -1.015 . . . . 73.239999999999995 108.26 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -140.39 153.12 46.23 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-O 121.402 0.62 . . . . 73.430000000000007 111.013 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HA ' ' CE1' ' A' ' 81' ' ' TYR . 6.2 mp -76.78 -163.62 0.36 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 114.342 -1.299 . . . . 72.209999999999994 110.331 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -70.63 28.61 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 72.450000000000003 112.823 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 33.8 tp -70.88 -48.72 14.49 Favored Pre-proline 0 CA--C 1.568 1.641 0 O-C-N 121.601 -0.687 . . . . 74.209999999999994 111.265 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 106' ' ' LEU . 51.0 Cg_exo -58.39 -12.91 14.87 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 122.819 2.346 . . . . 74.439999999999998 114.006 170.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -66.37 -35.08 79.42 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.25 0.62 . . . . 72.510000000000005 109.651 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.1 tp -82.7 -34.15 27.4 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.911 0.386 . . . . 75.310000000000002 110.098 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -68.62 -48.78 63.21 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.454 -0.793 . . . . 74.140000000000001 111.335 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -126.86 -33.99 2.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.635 0.774 . . . . 64.349999999999994 111.554 -172.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.91 72.96 0.33 Allowed Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.766 1.226 . . . . 75.219999999999999 109.503 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.508 ' HB3' HD12 ' A' ' 117' ' ' ILE . 5.9 Cg_exo -81.92 148.38 15.43 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 123.407 2.738 . . . . 71.340000000000003 112.148 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.72 119.2 5.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.284 2.656 . . . . 71.329999999999998 112.938 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.17 -113.33 5.75 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.927 0.767 . . . . 63.530000000000001 112.867 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.1 t -116.45 136.87 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.964 1.306 . . . . 71.310000000000002 108.098 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.555 HG22 ' HG3' ' A' ' 38' ' ' ARG . 11.8 pt -128.68 149.95 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.304 -0.628 . . . . 74.120000000000005 109.304 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.592 HG13 HG23 ' A' ' 79' ' ' VAL . 59.2 t -117.54 102.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.114 -1.439 . . . . 72.430000000000007 107.114 175.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.739 HG13 HG23 ' A' ' 74' ' ' VAL . 23.8 t -94.18 126.04 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.108 -0.701 . . . . 74.340000000000003 109.108 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.518 ' HB ' ' ND2' ' A' ' 41' ' ' ASN . 21.5 t -115.82 128.09 73.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.558 -0.904 . . . . 72.239999999999995 108.558 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.433 HG23 HG21 ' A' ' 42' ' ' ILE . 19.7 p -95.17 137.48 34.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.214 0.605 . . . . 75.5 109.492 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 119.022 -0.877 . . . . 73.439999999999998 111.96 -177.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.585 -0.206 . . . . 73.349999999999994 112.585 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 p -87.92 14.77 8.21 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.856 0.862 . . . . 74.439999999999998 112.659 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -110.14 97.07 28.56 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.481 0.712 . . . . 71.319999999999993 109.729 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -94.1 -161.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.506 2.804 . . . . 70.430000000000007 112.062 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -148.03 144.45 27.93 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.466 0.706 . . . . 73.420000000000002 109.692 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.9 m 52.57 77.71 0.15 Allowed 'General case' 0 C--N 1.358 0.958 0 C-N-CA 125.075 1.35 . . . . 74.510000000000005 111.764 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.64 -44.57 85.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.316 1.047 . . . . 73.219999999999999 111.002 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -123.82 -69.83 0.79 Allowed 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.137 -0.938 . . . . 73.109999999999999 108.77 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.6 t70 56.38 90.5 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.593 1.157 . . . . 63.119999999999997 111.985 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 m -143.13 122.16 12.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.217 0.607 . . . . 71.439999999999998 109.623 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 p -130.42 111.02 11.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.225 1.01 . . . . 63.240000000000002 109.066 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.15 113.35 1.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.075 0.55 . . . . 74.420000000000002 109.756 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -150.8 114.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.726 0.81 . . . . 72.439999999999998 109.708 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -133.59 120.37 20.64 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.081 0.952 . . . . 65.040000000000006 108.636 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -151.79 109.22 3.6 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.743 0.817 . . . . 74.329999999999998 109.395 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.42 145.38 11.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.295 1.038 . . . . 74.230000000000004 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 142.85 24.79 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.098 0.475 . . . . 75.349999999999994 111.001 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -139.95 131.01 26.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 74.329999999999998 109.107 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -157.41 137.4 12.51 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.048 0.939 . . . . 74.299999999999997 109.311 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.7 m -147.56 102.95 3.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.426 0.69 . . . . 74.239999999999995 109.593 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 107.97 19.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.464 0.706 . . . . 65.299999999999997 109.261 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.26 111.7 44.92 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.589 0.756 . . . . 73.349999999999994 109.747 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.59 169.46 15.3 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.967 2.444 . . . . 75.310000000000002 112.304 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -152.86 119.99 5.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.583 0.753 . . . . 72.25 109.545 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 m -90.41 172.3 8.83 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.994 0.517 . . . . 62.200000000000003 109.836 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 m -132.04 144.22 50.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.119 0.568 . . . . 72.329999999999998 110.655 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 161.93 27.19 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.484 1.114 . . . . 75.120000000000005 110.145 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.89 140.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.103 0.561 . . . . 73.200000000000003 109.803 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.44 113.18 64.7 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.416 -0.957 . . . . 73.439999999999998 108.416 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.67 134.57 22.34 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.494 2.129 . . . . 74.409999999999997 111.511 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.49 114.39 21.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.487 0.715 . . . . 55.340000000000003 110.011 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.48 116.15 44.53 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.158 0.583 . . . . 73.340000000000003 110.406 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.08 150.29 33.46 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.573 2.182 . . . . 71.340000000000003 111.483 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' N ' HG22 ' A' ' 62' ' ' THR . 67.8 ttt180 -158.92 -75.49 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.149 0.28 . . . . 75.329999999999998 110.833 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.2 98.32 7.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.569 0.748 . . . . 61.329999999999998 109.99 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HG3' ' HB ' ' A' ' 63' ' ' VAL . 28.9 tt0 -98.77 107.74 20.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.038 0.535 . . . . 71.319999999999993 110.044 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG22 HD22 ' A' ' 56' ' ' LEU . 22.1 t -95.64 135.89 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.194 0.598 . . . . 74.349999999999994 109.742 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.531 ' HD3' ' HE2' ' A' ' 40' ' ' TYR . 7.9 ptp180 -150.74 134.85 16.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.854 0.861 . . . . 74.25 110.573 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HA ' HG11 ' A' ' 118' ' ' VAL . 41.0 t -100.5 133.28 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 65.120000000000005 109.545 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.531 ' HE2' ' HD3' ' A' ' 38' ' ' ARG . 69.6 m-85 -130.12 107.77 9.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.683 0.793 . . . . 73.299999999999997 109.735 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -84.39 118.03 23.99 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.988 -0.745 . . . . 72.030000000000001 108.988 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.709 HG13 ' HA ' ' A' ' 70' ' ' SER . 17.0 tt -78.86 -33.21 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.113 -0.329 . . . . 74.420000000000002 110.113 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -99.1 -162.48 0.96 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.18 0.992 . . . . 74.129999999999995 109.619 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.71 116.12 8.5 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 123.575 0.547 . . . . 71.239999999999995 112.312 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -69.96 101.63 1.82 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.738 0.78 . . . . 73.049999999999997 110.692 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.77 145.53 27.2 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.999 -0.546 . . . . 71.239999999999995 109.862 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -58.02 -38.41 89.12 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 124.42 1.075 . . . . 55.039999999999999 114.377 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.61 68.43 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.775 0.83 . . . . 64.129999999999995 112.398 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.71 71.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.715 0.806 . . . . 72.299999999999997 111.731 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.41 -23.62 37.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.318 0.647 . . . . 74.129999999999995 111.441 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 41.9 mmm-85 -64.75 -21.71 66.82 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.141 0.577 . . . . 74.120000000000005 112.004 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.5 p -61.54 -45.97 91.91 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.905 0.482 . . . . 74.409999999999997 110.052 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.9 84.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.66 0.784 . . . . 55.030000000000001 111.363 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -42.49 95.91 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.181 0.926 . . . . 74.530000000000001 111.968 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -63.2 -46.21 88.1 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.852 -0.613 . . . . 74.319999999999993 110.636 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.458 HD22 HG22 ' A' ' 37' ' ' VAL . 10.5 mp -72.68 -26.85 61.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.506 -0.77 . . . . 72.430000000000007 111.634 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.16 -51.17 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.076 -1.083 . . . . 75.409999999999997 108.076 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.99 59.38 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.708 -1.133 . . . . 72.129999999999995 112.128 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.76 -22.45 37.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.054 0.542 . . . . 74.349999999999994 110.571 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 44.03 5.54 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.054 -0.521 . . . . 70.030000000000001 113.782 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.65 158.64 30.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 74.230000000000004 109.448 169.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 34' ' ' ARG . 24.3 m -58.02 -52.29 66.11 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.165 0.916 . . . . 74.530000000000001 111.302 -159.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 73.9 t -135.72 139.55 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.328 -0.99 . . . . 73.299999999999997 108.328 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 p -134.68 113.77 12.03 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.351 1.061 . . . . 74.010000000000005 108.485 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 22.8 t70 -128.38 154.91 45.5 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.817 0.847 . . . . 63.43 109.373 -171.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.62 153.66 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.392 0.615 . . . . 73.120000000000005 110.503 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.42 169.96 42.32 Favored Glycine 0 C--O 1.245 0.806 0 CA-C-N 114.783 -1.099 . . . . 72.340000000000003 110.51 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -146.32 116.61 7.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.262 -1.014 . . . . 55.119999999999997 108.262 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 mt -148.89 136.35 20.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.693 0.797 . . . . 75.510000000000005 109.411 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.709 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 m -76.52 97.94 4.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.404 -0.961 . . . . 54.240000000000002 108.404 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.8 119.8 70.0 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.861 -0.792 . . . . 72.230000000000004 108.861 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.76 -2.92 12.86 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.267 1.978 . . . . 70.409999999999997 112.712 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.09 -26.16 17.58 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.003 0.921 . . . . 73.209999999999994 111.829 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.08 140.21 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.308 0.643 . . . . 73.140000000000001 110.189 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.3 33.21 3.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.336 0.654 . . . . 74.349999999999994 110.073 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.14 149.87 50.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.527 0.731 . . . . 70.349999999999994 109.848 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.545 ' HB ' ' H ' ' A' ' 121' ' ' THR . 5.6 t -78.89 102.49 8.26 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 121.972 0.891 . . . . 74.299999999999997 108.73 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.5 m -149.8 143.35 25.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.169 -0.923 . . . . 70.120000000000005 108.971 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 23.2 t -93.92 114.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.527 -1.286 . . . . 74.349999999999994 107.527 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' HB2' HG12 ' A' ' 117' ' ' ILE . 96.8 m-85 -101.08 142.52 32.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.629 -1.249 . . . . 73.430000000000007 107.629 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -130.73 151.95 50.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.629 -0.508 . . . . 75.25 109.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.415 HG22 HG21 ' A' ' 84' ' ' VAL . 28.0 m -92.37 147.1 23.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.526 -1.287 . . . . 74.430000000000007 107.526 168.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.34 22.74 1.2 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.396 0.678 . . . . 74.439999999999998 112.661 -173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 82' ' ' THR . 84.3 t -62.31 99.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.067 -0.716 . . . . 71.310000000000002 109.067 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.25 12.6 2.64 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.445 1.098 . . . . 71.030000000000001 112.182 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.32 62.65 2.05 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 120.243 -0.198 . . . . 72.239999999999995 113.401 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.71 -16.74 51.75 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.38 0.672 . . . . 73.310000000000002 111.524 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -26.1 6.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.047 0.939 . . . . 74.329999999999998 112.758 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.51 -53.21 60.73 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.774 0.671 . . . . 71.430000000000007 111.148 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -74.34 -32.61 62.87 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 116.293 -0.412 . . . . 62.119999999999997 110.694 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.56 75.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.393 0.677 . . . . 74.439999999999998 112.241 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HA ' HG11 ' A' ' 102' ' ' VAL . 29.2 t70 -64.96 -43.13 93.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.219 1.008 . . . . 71.310000000000002 110.01 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.38 80.15 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.366 1.041 . . . . 70.319999999999993 111.846 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.58 -56.4 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 123.649 0.593 . . . . 74.340000000000003 110.389 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.72 67.55 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.89 0.744 . . . . 72.230000000000004 113.842 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -69.63 -47.16 64.35 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.256 1.022 . . . . 75.409999999999997 109.666 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.6 m -75.81 -35.92 59.89 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.972 -1.013 . . . . 72.439999999999998 111.03 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.01 -30.49 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.569 -0.741 . . . . 75.310000000000002 110.193 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.01 55.53 4.38 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.447 -0.661 . . . . 62.340000000000003 111.447 -175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.1 160.76 39.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.64 0.776 . . . . 74.439999999999998 110.266 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 142.18 52.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.065 0.946 . . . . 72.420000000000002 110.442 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 92' ' ' ASP . 35.9 m -103.11 131.45 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.48 -0.933 . . . . 72.049999999999997 108.48 171.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 49.5 mt-10 -140.83 159.73 41.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.478 1.111 . . . . 74.310000000000002 109.528 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.48 158.61 35.76 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.225 -0.657 . . . . 74.010000000000005 109.225 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.581 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 14.0 ptt180 -50.06 -41.74 48.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.044 1.338 . . . . 74.540000000000006 112.585 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.9 mt 67.34 158.76 0.14 Allowed Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 123.533 0.733 . . . . 72.019999999999996 110.222 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.36 -24.14 41.46 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.41 2.073 . . . . 72.430000000000007 113.701 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.2 -54.97 6.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.277 1.031 . . . . 61.530000000000001 111.54 -174.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 2.7 mm? -76.47 -20.14 57.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 116.508 -0.314 . . . . 74.099999999999994 110.258 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -69.02 -11.54 60.88 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.041 0.536 . . . . 74.530000000000001 111.856 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.34 -32.2 19.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.388 0.675 . . . . 75.129999999999995 110.713 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.5 pp0? -89.57 168.04 16.01 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 117.639 -1.172 . . . . 53.140000000000001 109.0 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 30.3 Cg_exo -29.34 122.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.406 3.568 1 C-N-CA 125.309 4.006 . . . . 63.130000000000003 116.685 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.11 161.12 47.03 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.15 2.567 . . . . 75.25 113.07 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 -158.95 14.04 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.253 -0.885 . . . . 65.420000000000002 111.207 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.7 t -83.54 108.35 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.891 0.877 . . . . 64.299999999999997 109.626 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.55 HD11 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.31 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.592 -0.892 . . . . 75.400000000000006 108.592 173.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' A' ' 39' ' ' VAL . 1.4 p -95.53 105.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.447 -0.946 . . . . 61.219999999999999 108.447 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 4.0 p -94.07 123.48 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.619 -0.882 . . . . 75.25 108.619 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.65 132.51 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.397 0.679 . . . . 73.519999999999996 109.946 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.545 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.0 t -119.89 151.61 38.63 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.058 -1.09 . . . . 62.420000000000002 108.058 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.297 0 CA-C-O 118.978 -0.901 . . . . 71.129999999999995 112.147 178.563 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.992 0 N-CA-C 112.008 -0.437 . . . . 43.210000000000001 112.008 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -86.38 80.06 8.81 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.445 0.698 . . . . 73.140000000000001 109.231 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 m -100.24 110.19 59.04 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 115.432 -0.804 . . . . 73.230000000000004 110.192 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.39 82.82 1.99 Allowed 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.179 1.919 . . . . 71.439999999999998 111.493 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -118.55 121.61 40.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.751 -0.659 . . . . 75.239999999999995 109.424 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.7 m -76.3 146.25 39.02 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.197 0.599 . . . . 61.310000000000002 110.497 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.17 -38.29 82.75 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.04 0.936 . . . . 75.510000000000005 111.055 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.29 -73.33 0.16 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.493 -0.776 . . . . 71.329999999999998 109.307 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.6 t70 61.49 151.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.08 1.352 . . . . 73.239999999999995 112.553 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.3 m -113.49 102.66 10.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.84 0.856 . . . . 65.120000000000005 109.76 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -71.43 104.75 3.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.379 -0.828 . . . . 72.310000000000002 108.941 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.63 118.36 4.99 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.372 0.669 . . . . 72.230000000000004 110.134 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.95 155.99 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.292 1.037 . . . . 74.340000000000003 109.138 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.4 m -150.89 144.15 24.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.919 0.887 . . . . 73.420000000000002 109.386 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -160.88 160.85 31.49 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.878 0.871 . . . . 72.209999999999994 110.272 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 53.2 ttp -171.76 113.28 0.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.78 -1.193 . . . . 74.109999999999999 107.78 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -61.45 114.11 3.04 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.253 0.621 . . . . 73.340000000000003 110.563 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -70.22 -41.75 73.2 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.401 0.68 . . . . 75.420000000000002 111.393 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.2 m 68.55 152.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.981 1.313 . . . . 74.420000000000002 110.946 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.3 t -158.67 174.69 14.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.093 0.557 . . . . 73.409999999999997 110.329 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.18 148.87 28.77 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.113 0.965 . . . . 72.329999999999998 109.415 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.69 107.2 34.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 108.896 -0.779 . . . . 64.25 108.896 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.99 132.22 3.26 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.761 2.307 . . . . 73.219999999999999 112.472 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.3 p -123.21 124.34 42.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.877 0.471 . . . . 72.120000000000005 110.643 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m -149.02 118.23 6.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.495 1.118 . . . . 72.349999999999994 108.027 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 p -132.82 145.69 51.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.045 0.938 . . . . 74.530000000000001 109.216 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.3 p -144.91 120.15 10.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.182 0.593 . . . . 73.329999999999998 110.102 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 139.67 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.54 -0.911 . . . . 63.310000000000002 108.54 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.55 157.55 41.13 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 123.344 0.658 . . . . 74.25 110.322 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.71 170.07 13.32 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.062 2.508 . . . . 75.129999999999995 113.042 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.61 168.63 19.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.924 0.89 . . . . 75.230000000000004 111.129 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.21 146.25 37.73 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.921 -0.582 . . . . 72.239999999999995 109.899 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.53 172.2 16.77 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.617 2.211 . . . . 63.229999999999997 112.363 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -97.03 158.12 15.58 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.272 1.029 . . . . 75.120000000000005 112.269 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.62 ' HB1' HG21 ' A' ' 90' ' ' THR . . . -174.15 82.55 0.04 OUTLIER 'General case' 0 C--N 1.35 0.597 0 C-N-CA 125.12 1.368 . . . . 52.240000000000002 108.358 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.656 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -95.86 87.8 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.581 . . . . 72.140000000000001 109.616 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 94' ' ' VAL . 47.1 t -117.59 142.12 33.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.184 -0.462 . . . . 71.099999999999994 110.782 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.6 158.52 43.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.293 -0.412 . . . . 72.519999999999996 111.383 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.08 129.11 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.37 0.668 . . . . 72.540000000000006 110.244 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 19.0 m-85 -109.86 107.83 17.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.316 1.046 . . . . 73.340000000000003 108.323 163.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -93.31 112.73 24.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.169 -1.789 . . . . 75.340000000000003 106.169 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.673 HG13 ' HA ' ' A' ' 70' ' ' SER . 13.5 tt -73.11 -45.21 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.037 -0.414 . . . . 64.400000000000006 111.33 -172.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -29.41 28.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 72.019999999999996 110.591 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.33 54.28 13.95 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 123.734 0.646 . . . . 72.420000000000002 113.016 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.91 0.484 . . . . 72.230000000000004 110.584 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 49' ' ' ALA . 10.1 tp10 -63.77 121.81 14.9 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.403 0.52 . . . . 75.030000000000001 112.403 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.75 -23.8 51.8 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.861 -0.608 . . . . 73.430000000000007 112.291 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 52' ' ' THR . . . -65.09 -27.07 68.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.157 0.583 . . . . 65.150000000000006 110.852 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' H ' ' HG3' ' A' ' 46' ' ' GLU . . . -57.17 -47.34 81.46 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 124.032 0.833 . . . . 74.540000000000006 110.931 173.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.22 77.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.73 -0.668 . . . . 73.25 111.368 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -69.99 -22.68 63.11 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.326 1.051 . . . . 74.120000000000005 111.139 -172.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 98' ' ' LEU . 75.5 p -67.98 -49.82 59.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.262 0.225 . . . . 73.140000000000001 111.488 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -22.03 61.63 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.233 0.539 . . . . 63.329999999999998 111.209 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.94 -47.83 60.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.247 . . . . 65.400000000000006 110.512 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -70.71 -30.86 67.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.654 -0.498 . . . . 73.319999999999993 109.654 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.468 HD23 HG22 ' A' ' 64' ' ' THR . 53.4 tp -66.16 -33.29 75.45 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.337 -0.847 . . . . 73.450000000000003 111.295 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -58.4 -43.13 88.46 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.725 -0.843 . . . . 75.329999999999998 108.725 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.3 -18.88 54.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.211 1.004 . . . . 71.340000000000003 112.319 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.34 42.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 75.019999999999996 112.038 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.12 46.72 0.69 Allowed Glycine 0 C--N 1.348 1.232 0 O-C-N 123.106 0.254 . . . . 60.229999999999997 112.503 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -60.4 158.04 12.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.518 1.127 . . . . 71.140000000000001 112.145 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 m -109.69 -43.52 4.03 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.714 -0.847 . . . . 64.099999999999994 108.714 164.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 83.3 t -135.63 128.37 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.194 0.998 . . . . 73.549999999999997 108.597 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.468 HG22 HD23 ' A' ' 56' ' ' LEU . 3.2 p -130.31 116.79 18.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 53.210000000000001 108.534 173.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -121.19 158.76 27.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.419 -0.956 . . . . 71.120000000000005 108.419 172.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.24 140.1 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.452 0.701 . . . . 73.129999999999995 109.986 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.87 146.5 11.36 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.725 -0.55 . . . . 65.030000000000001 111.725 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.11 113.1 26.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.532 0.733 . . . . 71.239999999999995 109.481 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.4 mp -145.22 136.05 24.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.97 -0.456 . . . . 71.010000000000005 110.303 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.673 ' HA ' HG13 ' A' ' 42' ' ' ILE . 26.9 p -73.64 99.96 3.23 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 123.853 0.721 . . . . 73.230000000000004 109.722 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 74' ' ' VAL . 62.2 mt -93.17 123.75 59.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.926 -0.398 . . . . 75.310000000000002 109.926 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.71 -6.6 16.21 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.067 2.511 . . . . 75.340000000000003 113.853 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -90.06 -23.61 21.39 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.0 0.52 . . . . 73.319999999999993 110.676 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.678 HG21 HG13 ' A' ' 119' ' ' VAL . 28.9 m -104.0 148.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.641 0.734 . . . . 73.400000000000006 110.901 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.09 13.29 1.63 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.452 -1.249 . . . . 75.409999999999997 109.024 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.02 154.74 26.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.984 1.314 . . . . 75.439999999999998 108.366 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -71.93 111.73 7.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.05 0.54 . . . . 75.219999999999999 109.993 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -144.28 134.21 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.683 0.793 . . . . 74.120000000000005 111.166 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.663 HG23 HG21 ' A' ' 118' ' ' VAL . 21.0 t -99.28 117.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.304 1.042 . . . . 71.400000000000006 109.173 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.423 ' HE1' HD12 ' A' ' 106' ' ' LEU . 92.0 m-85 -94.89 120.06 34.48 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 109.155 -0.684 . . . . 74.439999999999998 109.155 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.642 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 11.4 p90 -134.53 175.54 9.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.899 0.857 . . . . 71.439999999999998 111.623 175.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 m -139.13 161.3 37.73 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.138 -1.43 . . . . 75.519999999999996 107.138 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -92.27 30.46 1.46 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.051 0.54 . . . . 62.520000000000003 111.369 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.64 100.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 123.655 0.782 . . . . 60.109999999999999 109.489 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.03 -75.33 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.808 1.243 . . . . 74.420000000000002 111.417 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.61 22.95 1.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.384 -0.371 . . . . 74.340000000000003 112.718 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.73 -28.6 65.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.998 0.519 . . . . 73.209999999999994 111.847 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -66.41 -48.24 70.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.051 -0.722 . . . . 73.430000000000007 109.051 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.87 -38.16 85.81 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.715 0.806 . . . . 72.129999999999995 111.535 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.62 HG21 ' HB1' ' A' ' 35' ' ' ALA . 28.4 m -66.64 -49.0 67.64 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 64.340000000000003 109.721 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.5 -32.3 73.56 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.744 -1.116 . . . . 63.539999999999999 112.763 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.82 -43.72 97.85 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.171 0.919 . . . . 73.420000000000002 110.031 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.58 98.65 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.146 0.904 . . . . 75.319999999999993 111.325 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 37' ' ' VAL . 86.3 t -64.35 -53.57 41.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 C-N-CA 124.202 1.001 . . . . 75.519999999999996 111.45 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.492 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -71.96 -21.79 78.96 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.29 -0.868 . . . . 60.32 113.463 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -73.81 -41.92 61.67 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.38 -0.6 . . . . 74.120000000000005 109.38 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -61.46 -39.82 92.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.409 -0.814 . . . . 75.109999999999999 110.942 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.744 HD12 ' HB1' ' A' ' 100' ' ' ALA . 2.6 tm? -74.91 -35.77 62.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.822 0.449 . . . . 73.230000000000004 110.812 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.55 51.84 7.9 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.275 -0.73 . . . . 75.030000000000001 111.275 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.744 ' HB1' HD12 ' A' ' 98' ' ' LEU . . . -109.37 168.0 9.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.425 1.09 . . . . 71.340000000000003 109.996 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.39 104.02 5.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.954 -0.758 . . . . 75.400000000000006 108.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.642 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.3 m -83.35 130.97 34.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.281 -1.007 . . . . 74.439999999999998 108.281 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -153.46 159.79 42.41 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.372 0.606 . . . . 63.210000000000001 110.875 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.29 -178.01 0.16 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.981 1.313 . . . . 74.420000000000002 111.731 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 106' ' ' LEU . 8.4 ptm180 -53.92 -43.52 69.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.84 0.856 . . . . 73.109999999999999 112.91 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.435 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 77.3 mt 62.4 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.566 1.578 0 C-N-CA 124.501 1.12 . . . . 74.319999999999993 111.591 -172.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.08 -17.61 39.19 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.302 2.001 . . . . 74.340000000000003 113.0 167.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -26.11 63.76 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.876 0.87 . . . . 74.420000000000002 111.606 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.95 -23.54 66.63 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 111.78 0.289 . . . . 74.400000000000006 111.78 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 m -60.03 -36.62 77.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.181 0.592 . . . . 64.409999999999997 110.893 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.05 -32.31 22.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.838 0.855 . . . . 74.310000000000002 111.261 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -80.0 157.46 73.69 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.587 0.755 . . . . 72.230000000000004 109.176 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.14 125.53 15.39 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.12 1.88 . . . . 74.329999999999998 111.389 170.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.62 120.27 7.56 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.357 2.705 . . . . 74.530000000000001 113.706 -174.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.74 -178.39 22.62 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.284 -1.126 . . . . 73.430000000000007 110.284 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.5 123.82 34.81 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.178 0.513 . . . . 73.140000000000001 110.849 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.53 135.52 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.105 -1.072 . . . . 74.120000000000005 108.105 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.663 HG21 HG23 ' A' ' 79' ' ' VAL . 2.4 p -105.24 106.0 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.388 -1.338 . . . . 73.340000000000003 107.388 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.678 HG13 HG21 ' A' ' 74' ' ' VAL . 15.8 t -93.35 121.97 44.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.954 -0.758 . . . . 73.239999999999995 108.954 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.99 129.47 73.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.164 0.986 . . . . 72.209999999999994 109.583 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -91.56 162.29 14.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.909 0.756 . . . . 73.219999999999999 110.273 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.592 0 CA-C-N 115.485 -0.78 . . . . 70.200000000000003 113.435 -179.271 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.973 0 N-CA-C 112.553 -0.219 . . . . 64.140000000000001 112.553 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 p -152.79 65.94 0.8 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.07 0.948 . . . . 71.140000000000001 109.892 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -63.84 133.4 95.55 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.896 0.878 . . . . 72.140000000000001 110.978 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.25 156.47 55.1 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.689 2.259 . . . . 74.140000000000001 111.962 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 147.42 28.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.054 0.542 . . . . 72.340000000000003 110.404 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.1 t -168.82 41.93 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.532 1.133 . . . . 74.519999999999996 109.004 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.64 -9.43 56.99 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.892 0.877 . . . . 60.43 111.6 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -44.25 -57.59 3.38 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.342 1.457 . . . . 72.219999999999999 112.855 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 57.72 99.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.608 1.163 . . . . 72.519999999999996 111.864 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.9 m -84.65 89.36 7.46 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.035 -0.415 . . . . 74.349999999999994 111.032 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -119.45 133.52 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.776 0.83 . . . . 74.349999999999994 109.546 172.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 148.62 24.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.87 0.868 . . . . 64.420000000000002 109.944 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -156.61 134.67 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.241 0.616 . . . . 73.340000000000003 109.952 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.5 p -146.05 166.4 26.2 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.308 0.643 . . . . 72.010000000000005 110.469 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -156.55 162.55 39.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.103 0.961 . . . . 75.209999999999994 109.769 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 146.07 32.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.35 0.66 . . . . 75.400000000000006 110.704 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.0 m -147.21 135.38 21.54 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 71.030000000000001 110.393 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 m -97.27 148.26 23.29 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.451 1.1 . . . . 73.25 110.824 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -126.17 100.64 6.41 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.266 1.027 . . . . 73.299999999999997 108.353 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 t -77.3 149.0 35.39 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.975 0.51 . . . . 74.109999999999999 110.905 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.71 167.85 16.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.551 0.74 . . . . 75.209999999999994 110.847 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.14 146.08 32.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.659 0.783 . . . . 60.439999999999998 110.845 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.46 166.34 29.64 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.986 2.457 . . . . 75.25 112.646 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 t -157.66 154.76 28.88 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.968 0.507 . . . . 73.340000000000003 111.04 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.8 m -146.64 130.36 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.983 0.913 . . . . 74.299999999999997 109.61 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 p -120.44 151.1 39.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.941 0.896 . . . . 63.109999999999999 110.314 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 p -158.69 146.48 18.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.666 0.786 . . . . 71.430000000000007 109.871 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.54 155.55 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.642 0.777 . . . . 75.430000000000007 109.783 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -107.64 140.75 21.87 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.652 0.781 . . . . 75.25 110.213 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -83.7 145.99 11.75 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.16 2.573 . . . . 73.209999999999994 113.054 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.49 168.67 12.41 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.71 0.804 . . . . 72.519999999999996 111.723 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.12 142.23 42.46 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 124.185 0.994 . . . . 73.540000000000006 109.969 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.42 128.93 19.14 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.504 2.136 . . . . 64.329999999999998 112.298 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HB3' ' HG2' ' A' ' 85' ' ' GLU . 69.3 mtt85 -77.59 -71.35 0.42 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.664 0.786 . . . . 64.420000000000002 110.851 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.57 127.98 5.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.989 -0.745 . . . . 74.040000000000006 108.989 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -118.53 132.8 56.21 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.716 0.806 . . . . 73.200000000000003 109.568 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.487 ' HA ' HG11 ' A' ' 116' ' ' VAL . 12.1 t -95.78 142.36 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.961 0.904 . . . . 75.310000000000002 110.225 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HG3' HG22 ' A' ' 117' ' ' ILE . 7.9 ptm180 -151.23 126.4 9.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.096 0.406 . . . . 74.299999999999997 112.096 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.528 ' HA ' HG11 ' A' ' 118' ' ' VAL . 16.6 t -101.0 111.2 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.086 0.954 . . . . 54.140000000000001 110.5 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -99.41 107.3 19.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.182 0.515 . . . . 72.040000000000006 110.236 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -98.0 110.91 23.4 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.388 -1.338 . . . . 75.519999999999996 107.388 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.619 ' HB ' HG11 ' A' ' 74' ' ' VAL . 4.8 tt -78.34 -50.7 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.953 0.406 . . . . 73.400000000000006 111.121 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -83.85 -2.68 56.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.274 -0.875 . . . . 64.209999999999994 111.504 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.32 59.6 8.69 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 111.623 -0.591 . . . . 62.009999999999998 111.623 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -78.59 -172.71 3.05 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.909 0.884 . . . . 74.319999999999993 111.063 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 43.2 tt0 -53.71 139.79 31.42 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.371 1.068 . . . . 62.299999999999997 111.384 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.92 -9.66 53.76 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.722 0.649 . . . . 71.010000000000005 114.722 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.516 ' H ' ' HG2' ' A' ' 46' ' ' GLU . . . -67.23 -22.48 65.69 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.354 0.577 . . . . 73.010000000000005 111.25 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.562 ' HB2' HG21 ' A' ' 120' ' ' VAL . . . -68.58 -39.68 80.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.291 0.636 . . . . 74.530000000000001 110.405 171.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.58 52.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.327 0.651 . . . . 72.030000000000001 111.355 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 24.0 tpp180 -70.82 -15.77 62.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.226 1.01 . . . . 74.510000000000005 111.205 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.468 ' O ' HD13 ' A' ' 56' ' ' LEU . 78.4 p -61.63 -47.01 87.35 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.874 -0.417 . . . . 74.519999999999996 109.874 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.49 61.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.204 0.601 . . . . 64.200000000000003 111.2 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 25.5 t70 -60.04 -35.37 74.96 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.206 0.602 . . . . 72.230000000000004 111.465 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.481 HH21 HD12 ' A' ' 56' ' ' LEU . 52.6 ttp180 -64.41 -40.83 96.55 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.598 0.759 . . . . 71.420000000000002 110.232 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.481 HD12 HH21 ' A' ' 55' ' ' ARG . 9.8 mp -65.23 -34.44 78.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.451 -0.795 . . . . 65.25 110.645 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.62 -41.0 93.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.861 0.464 . . . . 73.120000000000005 110.722 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.42 65.85 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.599 -0.728 . . . . 73.209999999999994 111.233 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.41 -21.28 42.4 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.421 0.688 . . . . 71.209999999999994 111.011 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.55 44.46 2.5 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.463 -0.335 . . . . 60.240000000000002 113.544 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -87.67 158.44 18.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.643 0.777 . . . . 73.340000000000003 108.963 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -58.79 -69.5 0.19 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.191 0.932 . . . . 64.129999999999995 112.3 -160.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.97 137.48 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.039 -1.097 . . . . 73.219999999999999 108.039 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 p -128.51 108.59 10.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.769 0.828 . . . . 74.019999999999996 109.14 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 8.3 t70 -104.27 159.03 16.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.584 1.154 . . . . 64.239999999999995 109.397 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.79 115.54 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.838 0.855 . . . . 73.319999999999993 109.128 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.24 93.45 0.69 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.626 -0.716 . . . . 73.010000000000005 111.927 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -77.46 82.88 3.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.374 0.607 . . . . 74.230000000000004 109.495 173.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -160.15 143.97 14.15 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.199 -0.455 . . . . 75.329999999999998 111.006 -171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -82.66 100.74 10.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.009 0.924 . . . . 73.150000000000006 110.268 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -101.09 153.8 37.54 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.284 0.634 . . . . 63.439999999999998 109.535 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.76 -15.92 23.17 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.037 2.491 . . . . 74.530000000000001 114.566 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.37 -23.33 13.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.3 0.64 . . . . 71.319999999999993 110.914 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.686 HG13 HG12 ' A' ' 119' ' ' VAL . 79.5 t -93.52 123.06 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.133 1.373 . . . . 73.540000000000006 110.043 -177.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HA ' HD11 ' A' ' 42' ' ' ILE . . . -159.04 -74.15 0.08 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.012 0.525 . . . . 74.439999999999998 111.543 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.57 147.89 25.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.469 0.708 . . . . 71.409999999999997 110.284 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.2 t -66.15 100.24 0.59 Allowed 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.033 0.92 . . . . 75.409999999999997 109.997 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 m -152.23 135.64 15.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 74.239999999999995 109.096 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 20.3 t -96.06 111.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.407 -0.96 . . . . 72.450000000000003 108.407 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -96.7 124.33 40.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.604 -0.887 . . . . 73.140000000000001 108.604 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -121.82 151.22 40.85 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.144 0.577 . . . . 74.140000000000001 112.156 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.689 HG22 ' HD3' ' A' ' 105' ' ' ARG . 3.3 m -103.21 166.82 10.21 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.084 -1.08 . . . . 64.219999999999999 108.084 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 14.63 18.25 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.974 -0.454 . . . . 75.5 111.887 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.15 110.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.779 0.832 . . . . 75.420000000000002 110.61 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.515 ' HG2' ' HB3' ' A' ' 34' ' ' ARG . 14.4 tp10 67.23 -76.48 0.05 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.831 1.252 . . . . 70.0 112.076 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.36 35.16 0.48 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.491 -1.044 . . . . 71.530000000000001 110.491 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HG2' ' HB ' ' A' ' 116' ' ' VAL . 29.7 tt0 -75.9 -18.93 59.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 65.430000000000007 111.736 -170.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.57 -35.54 79.21 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 110.245 -0.28 . . . . 74.439999999999998 110.245 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.95 56.82 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.557 0.743 . . . . 71.439999999999998 112.192 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 116' ' ' VAL . 12.6 t -85.0 -25.62 27.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.484 -0.562 . . . . 71.420000000000002 109.484 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.89 -38.71 64.3 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.916 0.886 . . . . 52.439999999999998 111.299 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.48 -56.33 17.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.746 -1.57 . . . . 64.040000000000006 110.52 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.6 -47.39 79.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.177 0.923 . . . . 72.099999999999994 111.914 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.25 -51.51 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.697 0.799 . . . . 72.120000000000005 111.963 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.93 -27.43 73.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 116.035 -0.53 . . . . 74.349999999999994 113.271 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -79.28 -26.44 42.32 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.407 0.683 . . . . 74.219999999999999 110.463 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.7 m -83.33 -32.69 26.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.143 0.977 . . . . 73.420000000000002 110.987 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 tp -85.89 -31.99 21.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.219 0.608 . . . . 71.439999999999998 110.611 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.86 27.12 35.48 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.508 -0.769 . . . . 71.209999999999994 112.464 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.36 144.2 37.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.741 0.816 . . . . 74.450000000000003 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.63 127.14 31.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.031 0.933 . . . . 71.420000000000002 111.09 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.41 HG12 ' HB ' ' A' ' 79' ' ' VAL . 18.8 m -92.43 106.68 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.136 0.974 . . . . 74.299999999999997 110.632 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.74 166.43 11.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.951 1.3 . . . . 63.149999999999999 109.414 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mp -67.22 175.92 2.44 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.198 0.523 . . . . 74.239999999999995 111.057 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.689 ' HD3' HG22 ' A' ' 82' ' ' THR . 32.0 ptt-85 -55.95 -44.82 78.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.406 1.082 . . . . 74.219999999999999 112.412 -173.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.9 mt 60.63 170.13 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.521 1.128 . . . . 75.140000000000001 111.202 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.52 -18.13 14.39 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.079 1.853 . . . . 70.25 113.659 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.19 -55.69 26.08 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.181 1.392 . . . . 64.040000000000006 112.076 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 8.1 tt -68.04 -25.78 65.54 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 122.57 0.348 . . . . 74.040000000000006 110.381 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 t -76.35 -19.57 58.06 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.551 0.741 . . . . 72.120000000000005 111.912 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.08 -33.24 33.52 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.957 0.503 . . . . 65.209999999999994 111.247 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.405 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pp0? -104.89 167.31 10.04 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.227 1.011 . . . . 71.310000000000002 109.362 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 19.1 Cg_endo -57.16 132.48 51.53 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.037 2.491 . . . . 74.420000000000002 114.48 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.79 160.5 1.78 Allowed 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 124.175 3.25 . . . . 61.240000000000002 116.072 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.35 147.55 8.32 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 110.255 -1.138 . . . . 74.409999999999997 110.255 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 37' ' ' VAL . 2.4 p -60.58 118.82 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.466 0.706 . . . . 63.450000000000003 110.848 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.495 HG22 ' HG3' ' A' ' 38' ' ' ARG . 39.5 pt -103.8 107.43 22.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 122.033 0.92 . . . . 64.349999999999994 109.861 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 39' ' ' VAL . 1.2 p -90.14 105.12 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.501 -1.296 . . . . 74.230000000000004 107.501 169.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.686 HG12 HG13 ' A' ' 74' ' ' VAL . 52.9 t -92.26 131.3 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.612 -1.176 . . . . 65.0 108.241 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' A' ' 49' ' ' ALA . 3.5 t -130.38 130.13 65.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.214 0.605 . . . . 72.439999999999998 109.939 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -91.37 167.37 12.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.463 0.705 . . . . 72.540000000000006 110.145 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.337 0 CA-C-O 119.515 -0.603 . . . . 72.239999999999995 112.963 178.161 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.981 0 CA-C-O 119.873 -0.404 . . . . 61.130000000000003 112.124 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 p -82.05 107.19 14.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.82 0.848 . . . . 71.219999999999999 110.546 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.2 t -147.86 126.28 6.07 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.725 0.81 . . . . 64.340000000000003 109.912 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.64 157.79 48.05 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.757 2.305 . . . . 75.25 113.551 -174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -118.89 94.17 4.35 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.248 -1.019 . . . . 74.519999999999996 108.248 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.5 p -102.55 23.26 12.2 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.702 0.801 . . . . 74.299999999999997 111.488 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.26 -30.81 71.71 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.802 0.841 . . . . 73.439999999999998 111.377 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -96.21 19.71 11.43 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.168 0.987 . . . . 74.109999999999999 111.057 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.55 90.39 2.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.884 -0.784 . . . . 73.099999999999994 108.884 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.6 p -115.22 116.05 27.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.689 0.795 . . . . 75.400000000000006 109.885 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 t -139.95 143.42 36.55 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.44 0.696 . . . . 52.299999999999997 109.184 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.9 153.59 31.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.562 0.745 . . . . 61.200000000000003 110.693 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.13 118.94 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.963 0.905 . . . . 73.439999999999998 110.031 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 m -144.76 109.73 5.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.974 0.91 . . . . 71.230000000000004 109.091 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 m -120.85 141.8 50.25 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.724 0.81 . . . . 74.010000000000005 109.678 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -125.03 146.11 49.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.126 0.97 . . . . 74.510000000000005 109.662 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.9 m -146.45 127.04 14.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.218 0.607 . . . . 73.340000000000003 110.002 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 p -111.81 137.46 49.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.796 0.838 . . . . 64.439999999999998 109.77 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 p -81.19 132.18 35.34 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.093 0.957 . . . . 72.439999999999998 111.492 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.5 p -113.19 160.52 18.17 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.573 1.149 . . . . 71.030000000000001 109.076 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.66 144.47 22.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.823 0.449 . . . . 63.130000000000003 111.149 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.63 124.14 43.46 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.752 0.821 . . . . 75.200000000000003 109.891 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.21 162.76 38.89 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.681 2.254 . . . . 62.210000000000001 112.819 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -83.01 146.62 28.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.211 1.005 . . . . 75.200000000000003 110.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 m -143.9 103.8 4.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.945 0.898 . . . . 74.319999999999993 109.292 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 p -108.81 141.12 41.3 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 64.140000000000001 109.605 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -159.01 94.32 1.21 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.034 0.933 . . . . 74.319999999999993 108.592 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.17 123.96 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 70.329999999999998 109.611 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.71 161.38 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.935 0.894 . . . . 75.200000000000003 110.633 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -56.05 164.88 4.45 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.91 2.406 . . . . 73.129999999999995 114.264 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.42 159.38 34.63 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.75 -1.114 . . . . 74.299999999999997 111.797 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.2 80.42 7.86 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.478 0.711 . . . . 71.400000000000006 109.888 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.43 128.99 8.27 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.193 1.929 . . . . 65.349999999999994 111.049 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.652 ' HB3' ' HG3' ' A' ' 85' ' ' GLU . 21.2 mmm180 -129.39 -20.53 3.31 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.476 0.71 . . . . 74.140000000000001 110.567 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.47 -172.67 3.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.869 0.867 . . . . 71.150000000000006 109.005 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.87 135.96 53.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.925 0.89 . . . . 71.109999999999999 109.234 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 64' ' ' THR . 90.7 t -132.83 123.54 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.277 -1.009 . . . . 73.450000000000003 108.277 171.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . 4.1 ptp85 -141.34 110.93 6.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.511 -0.743 . . . . 75.430000000000007 112.024 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 HG21 ' HB ' ' A' ' 118' ' ' VAL . 35.8 t -92.71 120.52 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.023 . . . . 73.219999999999999 109.951 -175.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 66.3 m-85 -130.09 132.96 46.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.354 0.662 . . . . 74.319999999999993 109.794 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -88.84 141.08 28.8 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.887 -1.153 . . . . 72.140000000000001 107.887 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' A' ' 121' ' ' THR . 6.3 tp -59.3 -46.32 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.459 0.704 . . . . 65.319999999999993 111.289 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.9 m -106.73 -9.94 16.28 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 71.439999999999998 111.858 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.91 63.29 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.223 0.327 . . . . 64.349999999999994 113.45 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.8 m -91.45 -52.73 4.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.275 0.63 . . . . 73.030000000000001 111.215 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.01 120.15 19.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.059 0.392 . . . . 74.510000000000005 112.059 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.96 50.97 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.303 -0.862 . . . . 72.230000000000004 112.746 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.24 73.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.248 0.619 . . . . 74.310000000000002 110.925 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.44 -52.07 64.81 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.18 0.925 . . . . 74.540000000000006 110.424 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.77 -37.67 88.4 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.772 -1.104 . . . . 72.409999999999997 111.631 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -64.87 -38.78 92.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.603 1.161 . . . . 74.200000000000003 111.617 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.403 HG21 HG21 ' A' ' 97' ' ' THR . 68.9 p -75.76 -23.35 55.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 111.128 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.53 -33.7 54.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.077 0.951 . . . . 72.109999999999999 111.551 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -52.66 -32.41 42.02 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.977 0.911 . . . . 73.200000000000003 112.031 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.73 -52.26 66.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.3 1.04 . . . . 71.129999999999995 110.356 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.45 -37.63 71.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.277 0.631 . . . . 74.450000000000003 111.295 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -71.9 -36.44 70.01 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.485 0.49 . . . . 73.219999999999999 110.708 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.45 72.78 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.357 0.41 . . . . 75.239999999999995 110.902 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.19 -21.72 58.51 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.358 -0.837 . . . . 75.209999999999994 110.862 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.44 10.53 86.13 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-N 115.639 -0.71 . . . . 53.210000000000001 113.835 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -95.41 135.62 36.81 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.856 -0.794 . . . . 74.549999999999997 108.856 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.466 HG22 HG21 ' A' ' 90' ' ' THR . 70.9 p 59.24 155.29 0.02 OUTLIER 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.871 2.068 . . . . 74.400000000000006 113.653 -173.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.64 87.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 N-CA-C 108.165 -1.05 . . . . 74.140000000000001 108.165 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 26.3 m -89.0 102.45 15.09 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.367 0.667 . . . . 74.25 110.679 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 38.9 m-20 -102.48 142.63 33.35 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.76 -0.83 . . . . 65.319999999999993 108.76 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.4 t -132.61 143.16 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.326 0.651 . . . . 72.109999999999999 110.168 -171.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.63 -126.78 2.07 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 112.541 -0.223 . . . . 64.439999999999998 112.541 165.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -144.77 145.05 31.48 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.944 0.898 . . . . 74.25 109.912 -177.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 tp -156.26 146.45 21.42 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.746 -0.835 . . . . 73.540000000000006 108.746 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.4 p -81.11 98.73 8.15 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.107 0.563 . . . . 73.109999999999999 110.453 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.47 88.21 7.28 Favored Pre-proline 0 N--CA 1.483 1.195 0 N-CA-C 108.801 -0.814 . . . . 74.209999999999994 108.801 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.71 -6.93 14.54 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.438 2.092 . . . . 64.030000000000001 112.992 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.5 -23.44 56.75 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.742 0.417 . . . . 70.439999999999998 111.145 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.44 HG13 HG12 ' A' ' 119' ' ' VAL . 2.6 p -121.32 119.45 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.693 0.797 . . . . 74.310000000000002 109.902 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.57 20.45 17.15 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.175 0.99 . . . . 73.430000000000007 111.403 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.31 139.85 45.97 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.689 0.796 . . . . 72.239999999999995 110.098 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 t -69.18 101.88 1.56 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.548 0.69 . . . . 73.129999999999995 110.283 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -138.35 145.43 41.12 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.414 0.686 . . . . 72.040000000000006 110.905 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.69 HG11 HG22 ' A' ' 118' ' ' VAL . 48.8 t -95.97 118.44 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.599 1.16 . . . . 63.310000000000002 108.085 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -110.02 129.05 55.73 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.894 0.478 . . . . 74.049999999999997 110.166 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.417 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -126.4 154.47 43.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.151 0.981 . . . . 73.420000000000002 110.091 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.524 HG23 ' HG2' ' A' ' 83' ' ' GLU . 11.8 m -102.0 -112.06 0.21 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.514 -0.921 . . . . 74.239999999999995 108.514 168.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 82' ' ' THR . 14.7 pt-20 -143.21 -19.91 0.63 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.784 1.174 . . . . 74.409999999999997 113.738 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.54 116.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.725 0.81 . . . . 71.400000000000006 112.072 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.652 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 57.3 mm-40 64.49 -77.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.054 0 C-N-CA 125.149 1.38 . . . . 74.219999999999999 111.198 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.6 52.63 0.33 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.066 -1.214 . . . . 62.5 110.066 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.18 -40.67 64.54 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.074 0.55 . . . . 65.25 112.04 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -73.57 -25.76 60.52 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.447 0.536 . . . . 75.140000000000001 112.447 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.21 -39.56 63.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.087 0.555 . . . . 73.519999999999996 111.437 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.466 HG21 HG22 ' A' ' 62' ' ' THR . 6.6 t -82.89 -31.95 27.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.128 0.571 . . . . 62.329999999999998 111.404 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.23 73.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.448 0.699 . . . . 74.319999999999993 110.927 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.02 -38.51 76.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.549 1.14 . . . . 71.420000000000002 111.58 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.65 98.08 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 123.741 0.65 . . . . 71.430000000000007 111.556 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 118' ' ' VAL . 20.7 t -73.64 -48.47 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.939 -0.393 . . . . 74.209999999999994 109.939 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.57 -21.34 49.38 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.869 0.73 . . . . 71.310000000000002 113.549 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -80.53 -58.55 3.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 74.239999999999995 109.818 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.403 HG21 HG21 ' A' ' 52' ' ' THR . 24.2 m -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 124.41 1.069 . . . . 74.329999999999998 111.354 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.1 tp -96.18 -29.68 13.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.072 0.949 . . . . 72.540000000000006 110.461 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.57 47.43 10.22 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.32 -0.4 . . . . 72.010000000000005 112.565 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.05 152.63 38.39 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 64.230000000000004 110.234 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.07 34.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.754 0.822 . . . . 64.200000000000003 111.017 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.417 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 14.4 m -94.01 98.92 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.982 0.896 . . . . 74.230000000000004 109.434 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -111.72 163.42 14.16 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.455 1.102 . . . . 73.329999999999998 110.606 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 tp -71.98 169.94 14.85 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.165 -0.925 . . . . 75.349999999999994 109.967 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.506 ' HD3' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -55.39 -38.06 68.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.327 1.051 . . . . 73.329999999999998 113.106 -176.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.506 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 97.3 mt 59.71 176.43 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 124.322 1.014 . . . . 63.240000000000002 112.957 172.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -53.27 -16.45 7.0 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.216 1.944 . . . . 74.439999999999998 114.193 164.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -54.71 -30.39 55.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.725 1.21 . . . . 75.310000000000002 111.403 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.783 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 10.3 tt -62.45 -28.97 70.18 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 71.099999999999994 111.192 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -62.39 -23.17 66.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.14 0.576 . . . . 74.409999999999997 111.707 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -111.29 -33.02 6.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.463 0.705 . . . . 70.230000000000004 111.862 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.783 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 9.0 pt20 -84.07 161.32 55.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.086 0.554 . . . . 73.430000000000007 110.841 -171.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.444 ' HD2' HG22 ' A' ' 117' ' ' ILE . 40.8 Cg_exo -61.1 152.11 73.84 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.491 2.128 . . . . 73.200000000000003 113.402 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.73 161.54 38.51 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.171 2.581 . . . . 74.409999999999997 112.894 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.76 -166.88 52.43 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.879 -0.6 . . . . 51.119999999999997 111.712 -173.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.25 130.0 35.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 109.145 -0.687 . . . . 72.030000000000001 109.145 172.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 112' ' ' GLN . 17.1 pt -114.31 150.85 16.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.612 -1.255 . . . . 74.430000000000007 107.612 164.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.69 HG22 HG11 ' A' ' 79' ' ' VAL . 61.4 t -119.64 100.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 106.127 -1.805 . . . . 74.430000000000007 106.127 163.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 74' ' ' VAL . 6.7 p -95.95 125.09 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.91 -0.774 . . . . 72.140000000000001 108.91 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.56 128.07 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 109.439 -0.578 . . . . 74.230000000000004 109.439 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.415 ' HA ' HG23 ' A' ' 42' ' ' ILE . 72.6 p -107.95 101.47 10.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.185 -1.042 . . . . 70.219999999999999 108.185 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.63 -0.713 . . . . 70.450000000000003 111.704 -174.298 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.049 0 CA-C-O 119.764 -0.464 . . . . 54.32 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 p -79.11 131.24 36.17 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.716 0.806 . . . . 74.409999999999997 111.224 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -142.27 87.26 9.62 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.557 -0.905 . . . . 75.310000000000002 108.557 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.17 157.14 46.52 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.488 2.125 . . . . 71.409999999999997 111.69 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -152.51 143.47 23.01 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.659 0.784 . . . . 74.400000000000006 110.047 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.9 p -167.26 80.5 0.2 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.373 1.069 . . . . 75.219999999999999 108.875 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.15 14.98 12.67 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.513 0.725 . . . . 73.040000000000006 110.586 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.69 -72.85 0.09 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.723 1.209 . . . . 51.049999999999997 110.649 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t70 52.36 95.21 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.049 1.34 . . . . 72.319999999999993 112.776 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -118.93 100.75 7.57 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.356 0.598 . . . . 64.439999999999998 110.636 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.4 m -142.84 103.11 4.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.129 . . . . 54.310000000000002 108.618 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.33 144.35 33.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.066 0.546 . . . . 70.109999999999999 110.126 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 tt -164.9 138.94 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.397 1.079 . . . . 72.040000000000006 108.309 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -143.2 135.63 27.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.324 -0.621 . . . . 73.239999999999995 109.324 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -146.72 135.78 22.51 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.703 0.801 . . . . 73.310000000000002 109.374 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -161.95 141.15 9.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.749 0.82 . . . . 74.5 109.037 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.9 t -165.86 148.4 7.39 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.588 0.755 . . . . 63.409999999999997 109.715 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 t -166.62 147.04 5.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.688 1.195 . . . . 64.010000000000005 107.95 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.0 t -159.13 148.1 18.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.192 0.197 . . . . 73.230000000000004 110.724 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 t -159.75 141.82 13.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.685 0.794 . . . . 73.129999999999995 109.482 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.78 133.91 4.24 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.48 0.712 . . . . 72.030000000000001 110.058 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.19 106.06 4.14 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.513 0.725 . . . . 53.439999999999998 109.283 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -90.76 159.99 4.16 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.679 2.253 . . . . 71.019999999999996 111.825 171.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.8 t -156.25 153.95 29.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.016 0.526 . . . . 73.530000000000001 110.474 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.5 p -153.79 166.75 31.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.703 0.801 . . . . 71.209999999999994 109.625 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -142.22 143.89 33.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.568 0.747 . . . . 70.439999999999998 109.055 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 p -148.48 82.96 1.47 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.837 0.855 . . . . 71.239999999999995 108.886 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.5 139.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.602 0.761 . . . . 70.209999999999994 110.915 -174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -118.21 102.94 50.21 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.047 0.939 . . . . 75.150000000000006 109.002 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.42 165.48 32.34 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.985 2.457 . . . . 75.219999999999999 112.69 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.29 153.63 23.43 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.859 0.864 . . . . 63.009999999999998 111.014 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.51 120.06 69.6 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.678 0.791 . . . . 64.140000000000001 110.434 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.95 152.23 36.24 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.747 2.298 . . . . 74.150000000000006 112.51 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.409 ' HB3' ' HG2' ' A' ' 85' ' ' GLU . 42.0 ttt180 -166.46 97.04 0.58 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.732 0.813 . . . . 72.219999999999999 109.985 -175.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.16 82.34 2.05 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.791 -0.818 . . . . 73.530000000000001 108.791 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 41.9 mt-10 -115.27 94.44 4.73 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.475 -0.784 . . . . 73.409999999999997 110.682 -169.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.716 HG13 HG23 ' A' ' 94' ' ' VAL . 22.5 t -112.86 147.16 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 123.798 0.839 . . . . 75.040000000000006 111.416 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 31.2 ttp-105 -150.78 110.04 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.486 0.714 . . . . 74.109999999999999 109.719 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.462 HG23 ' HB ' ' A' ' 118' ' ' VAL . 60.6 t -87.52 126.42 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.455 0.702 . . . . 73.420000000000002 111.129 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 10.9 m-85 -119.95 107.93 13.71 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.727 0.811 . . . . 75.439999999999998 110.561 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 47.7 t30 -97.91 138.5 35.15 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.278 -0.638 . . . . 74.010000000000005 109.278 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -97.0 -11.79 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.1 0.476 . . . . 74.409999999999997 111.414 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -156.49 119.44 4.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.259 -1.015 . . . . 73.209999999999994 108.259 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.83 -88.81 0.01 OUTLIER Glycine 0 C--N 1.362 2.002 0 O-C-N 125.154 1.534 . . . . 53.350000000000001 114.52 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 m 51.7 -79.3 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.327 1.451 . . . . 71.230000000000004 113.525 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -86.53 117.6 25.41 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.131 0.972 . . . . 72.420000000000002 110.357 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.99 -18.37 68.74 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.531 0.519 . . . . 55.530000000000001 111.938 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 52' ' ' THR . . . -46.97 -32.37 3.83 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.748 1.619 . . . . 71.129999999999995 113.37 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.28 8.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.533 0.733 . . . . 62.439999999999998 111.911 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.4 60.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.486 0.315 . . . . 73.349999999999994 111.078 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.69 -31.32 69.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.378 1.071 . . . . 64.549999999999997 111.253 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.574 ' HB ' HG11 ' A' ' 94' ' ' VAL . 29.1 p -66.35 -56.88 8.97 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 121.988 0.115 . . . . 75.430000000000007 110.817 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.39 66.1 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.905 0.383 . . . . 52.399999999999999 111.651 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.45 -45.93 87.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.402 1.081 . . . . 74.439999999999998 111.597 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -67.42 -43.74 80.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 110.431 -0.211 . . . . 73.340000000000003 110.431 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.9 -32.24 69.35 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.753 0.658 . . . . 72.510000000000005 111.821 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.426 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -60.38 -45.21 94.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.275 0.63 . . . . 64.109999999999999 110.7 176.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -19.44 45.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.427 0.691 . . . . 73.239999999999995 111.345 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.47 59.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.688 0.795 . . . . 73.430000000000007 111.321 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.87 42.77 5.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.594 -0.275 . . . . 72.239999999999995 113.465 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -90.7 157.0 17.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.794 0.837 . . . . 72.409999999999997 109.821 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 m -72.09 -50.97 23.86 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.643 0.735 . . . . 73.530000000000001 110.71 -164.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 54.9 t -129.21 126.72 64.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 114.138 -1.392 . . . . 63.32 107.446 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.0 p -141.02 84.54 1.94 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.285 -1.005 . . . . 75.420000000000002 108.285 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -103.42 158.12 16.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 74.200000000000003 110.494 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.19 146.85 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.34 1.056 . . . . 75.430000000000007 109.246 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -165.28 137.51 4.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.086 -0.806 . . . . 54.5 111.086 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 4.3 p-10 -105.64 108.39 19.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.554 -0.536 . . . . 64.200000000000003 109.554 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pp -156.26 161.37 40.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.123 0.569 . . . . 74.540000000000006 110.785 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.453 ' HA ' HG13 ' A' ' 42' ' ' ILE . 41.3 m -96.43 127.37 42.36 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.783 0.833 . . . . 74.0 109.636 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 74' ' ' VAL . 86.4 mt -120.71 149.08 49.71 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.922 0.889 . . . . 74.540000000000006 108.679 171.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.01 -4.29 15.19 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.957 2.438 . . . . 74.230000000000004 113.184 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.47 -6.17 24.31 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.067 0.947 . . . . 74.519999999999996 112.273 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.627 HG23 ' HB2' ' A' ' 71' ' ' LEU . 90.0 t -74.86 112.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 122.906 0.482 . . . . 74.530000000000001 109.814 177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.86 -41.47 3.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.928 0.891 . . . . 64.209999999999994 110.281 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.7 158.94 41.78 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.952 0.901 . . . . 63.340000000000003 109.212 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.563 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.0 t -61.09 100.49 0.12 Allowed 'General case' 0 C--O 1.243 0.755 0 CA-C-O 122.71 1.243 . . . . 72.120000000000005 109.574 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.0 m -151.3 145.49 25.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.293 -1.322 . . . . 75.129999999999995 109.123 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.685 HG23 HG13 ' A' ' 118' ' ' VAL . 58.2 t -93.74 113.78 29.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.017 -1.105 . . . . 74.019999999999996 108.017 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -94.3 111.12 22.84 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.05 -1.463 . . . . 75.120000000000005 107.05 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.599 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 8.2 p90 -120.57 140.6 51.26 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.664 0.745 . . . . 75.109999999999999 112.933 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 m -84.97 152.93 23.11 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.738 -1.208 . . . . 75.019999999999996 107.738 162.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -109.18 19.27 19.65 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.139 0.422 . . . . 73.0 112.139 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.1 t -69.31 129.0 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.841 -0.8 . . . . 72.329999999999998 108.841 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 34' ' ' ARG . 13.7 tp10 61.04 -81.42 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.119 1.368 . . . . 74.420000000000002 111.401 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.87 33.12 0.3 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.094 -0.503 . . . . 71.519999999999996 111.875 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -69.1 -31.76 70.69 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 122.719 0.408 . . . . 75.140000000000001 111.247 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -73.4 -29.26 62.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.45 0.3 . . . . 71.549999999999997 110.717 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.6 -43.48 55.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.084 0.554 . . . . 74.140000000000001 110.611 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 t -74.24 -22.39 59.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.048 0.539 . . . . 74.219999999999999 109.904 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -70.85 -44.09 67.13 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.387 1.075 . . . . 75.409999999999997 111.513 172.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.74 -35.31 72.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.289 -1.323 . . . . 72.319999999999993 111.721 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.53 83.69 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.71 0.631 . . . . 71.040000000000006 110.987 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.716 HG23 HG13 ' A' ' 37' ' ' VAL . 24.7 t -78.05 -45.9 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.068 -0.969 . . . . 74.340000000000003 111.514 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.4 -26.73 68.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.656 0.597 . . . . 73.230000000000004 112.999 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -75.59 -45.67 36.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.463 0.705 . . . . 75.230000000000004 110.123 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.2 m -61.01 -41.51 96.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.707 0.803 . . . . 74.329999999999998 111.122 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 120' ' ' VAL . 47.9 tp -75.82 -31.76 59.52 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.946 -1.025 . . . . 73.510000000000005 110.714 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 45.73 31.31 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.494 -0.642 . . . . 75.0 111.494 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.21 175.35 7.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.937 0.895 . . . . 73.219999999999999 110.282 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.24 164.62 25.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.762 0.425 . . . . 74.099999999999994 110.322 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.599 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.9 m -138.04 140.0 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.216 1.006 . . . . 72.349999999999994 108.333 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -155.63 174.25 15.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.789 0.836 . . . . 75.129999999999995 110.028 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.5 179.82 1.23 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.649 -0.705 . . . . 63.030000000000001 111.94 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -83.11 18.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.66 0.985 . . . . 74.0 113.66 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.13 -47.72 89.73 Favored Pre-proline 0 CA--C 1.558 1.26 0 CA-C-O 118.619 -0.705 . . . . 63.350000000000001 111.761 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.75 -37.79 11.43 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 121.577 1.518 . . . . 61.219999999999999 111.517 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.33 -29.82 64.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 74.209999999999994 111.572 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -17.15 64.4 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.305 1.042 . . . . 74.540000000000006 112.404 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -65.91 -45.09 83.21 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.27 0.557 . . . . 75.239999999999995 110.983 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.21 -33.06 29.53 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.477 -0.783 . . . . 75.120000000000005 109.436 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 48.39 71.49 1.58 Allowed Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.054 1.742 . . . . 61.420000000000002 111.311 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HB2' ' NH2' ' A' ' 38' ' ' ARG . 44.0 Cg_endo -94.84 162.26 1.76 Allowed 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 123.805 3.003 . . . . 71.219999999999999 113.194 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.26 120.23 0.81 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.759 2.306 . . . . 74.099999999999994 111.265 168.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.19 162.86 20.98 Favored Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.563 -1.015 . . . . 74.239999999999995 110.563 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 91' ' ' ALA . 1.9 p -84.28 137.04 21.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 117.32 0.56 . . . . 74.329999999999998 110.529 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 38' ' ' ARG . 35.5 pt -106.43 123.1 61.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 CA-C-O 121.577 0.703 . . . . 72.129999999999995 109.809 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.685 HG13 HG23 ' A' ' 79' ' ' VAL . 98.9 t -95.94 103.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.463 -1.31 . . . . 64.129999999999995 107.463 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 69.2 t -94.06 128.77 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 109.866 -0.42 . . . . 72.099999999999994 109.866 -174.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 98' ' ' LEU . 22.5 t -113.93 139.39 39.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 107.975 -1.12 . . . . 75.019999999999996 107.975 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.563 ' H ' ' HB ' ' A' ' 77' ' ' THR . 40.3 p -120.06 104.14 9.87 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.927 -0.768 . . . . 73.219999999999999 108.927 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.451 0 CA-C-O 119.352 -0.694 . . . . 71.200000000000003 112.445 175.137 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.907 -0.477 . . . . 72.239999999999995 111.907 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -67.37 111.25 3.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.363 0.665 . . . . 73.219999999999999 110.573 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m -128.62 139.08 34.53 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.446 0.698 . . . . 50.109999999999999 110.285 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.27 -170.39 0.96 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.834 2.356 . . . . 73.420000000000002 112.512 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -146.13 112.36 5.8 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.442 -0.577 . . . . 75.109999999999999 109.442 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.4 p -101.59 74.36 1.51 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.622 -0.881 . . . . 73.019999999999996 108.622 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -92.94 12.68 23.02 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 114.958 -1.019 . . . . 75.409999999999997 111.284 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.63 -70.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.641 0.776 . . . . 74.420000000000002 111.949 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.4 t70 62.71 113.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.804 1.242 . . . . 73.25 111.901 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.7 m -144.73 101.7 3.69 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.13 0.572 . . . . 74.400000000000006 110.637 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -159.35 120.75 3.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.625 0.77 . . . . 73.349999999999994 109.461 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.19 97.13 1.01 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.834 0.854 . . . . 73.420000000000002 109.679 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -148.6 129.1 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.727 0.811 . . . . 73.430000000000007 109.809 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.4 p -168.67 127.09 1.09 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.391 1.076 . . . . 73.310000000000002 109.226 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -149.06 161.88 41.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.109 0.564 . . . . 71.030000000000001 109.963 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.24 149.01 52.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 70.430000000000007 110.191 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -152.69 159.62 43.16 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.261 0.625 . . . . 71.25 109.815 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.7 t -149.68 159.66 44.16 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.347 0.659 . . . . 73.439999999999998 109.757 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -162.57 168.32 21.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.046 0.939 . . . . 75.109999999999999 108.841 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.0 t -162.76 142.3 9.11 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.351 0.661 . . . . 73.340000000000003 109.832 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.52 133.49 21.36 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.81 -0.811 . . . . 72.209999999999994 108.81 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.47 123.33 6.36 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 123.53 0.732 . . . . 72.450000000000003 109.676 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.95 -170.67 1.05 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.725 2.283 . . . . 75.409999999999997 111.415 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -137.08 161.15 36.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.104 0.562 . . . . 63.399999999999999 109.781 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 t -147.53 157.43 43.56 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.773 0.829 . . . . 72.230000000000004 109.228 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.9 t -145.4 163.39 34.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.112 0.565 . . . . 72.319999999999993 110.516 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -141.76 165.39 27.59 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.985 0.914 . . . . 74.209999999999994 109.864 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.14 152.3 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.809 0.844 . . . . 71.109999999999999 109.698 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.92 114.06 39.47 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.738 0.815 . . . . 75.400000000000006 109.238 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.45 170.54 6.62 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.272 2.648 . . . . 71.310000000000002 113.371 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.16 148.41 50.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.342 0.657 . . . . 75.319999999999993 110.565 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.65 132.05 26.98 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 123.609 0.763 . . . . 72.329999999999998 110.459 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.52 171.12 18.11 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.935 2.423 . . . . 72.239999999999995 112.122 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.614 ' HA ' HG23 ' A' ' 62' ' ' THR . 10.1 mpt_? -85.66 137.1 33.07 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.587 0.755 . . . . 75.5 110.636 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.73 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . . . -163.43 92.18 0.71 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.079 0.862 . . . . 62.109999999999999 110.646 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.0 mt-10 -84.84 90.61 7.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.528 0.731 . . . . 71.439999999999998 109.934 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.8 t -97.67 122.01 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.08 0.467 . . . . 75.439999999999998 109.873 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.459 ' HG3' HG21 ' A' ' 117' ' ' ILE . 8.9 ptm180 -142.79 131.46 22.6 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.155 -0.341 . . . . 74.219999999999999 110.99 -167.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -93.27 131.43 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.588 0.755 . . . . 74.519999999999996 109.875 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -126.02 104.21 8.15 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.939 -0.764 . . . . 72.040000000000006 108.939 168.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.429 HD22 HG23 ' A' ' 45' ' ' THR . 44.0 t30 -97.21 130.14 44.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.623 -0.88 . . . . 64.540000000000006 108.623 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.666 HG13 ' HA ' ' A' ' 70' ' ' SER . 20.3 tt -102.35 -35.41 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.513 0.197 . . . . 72.319999999999993 111.491 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 m -100.07 151.29 21.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.066 0.546 . . . . 74.439999999999998 110.152 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.56 87.08 0.26 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.533 -0.627 . . . . 75.510000000000005 111.533 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.429 HG23 HD22 ' A' ' 41' ' ' ASN . 11.4 t -126.03 -173.05 2.75 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.783 0.833 . . . . 73.519999999999996 109.543 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -72.65 170.37 14.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.37 1.068 . . . . 73.099999999999994 111.622 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -1.13 50.85 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 118.976 -0.902 . . . . 73.150000000000006 113.979 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.17 28.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 60.119999999999997 112.82 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.94 48.46 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.296 -0.866 . . . . 65.430000000000007 111.157 174.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.21 -21.98 60.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.19 0.596 . . . . 65.030000000000001 111.672 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -63.1 -28.8 70.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.699 1.199 . . . . 73.109999999999999 111.444 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.56 ' HB ' HG11 ' A' ' 94' ' ' VAL . 63.0 p -63.39 -42.35 98.8 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 123.419 0.45 . . . . 72.239999999999995 110.583 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.99 78.42 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.307 0.643 . . . . 74.230000000000004 111.015 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.433 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 49.0 m-20 -57.49 -38.58 74.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.075 0.859 . . . . 64.430000000000007 111.932 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.15 -52.89 56.91 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.748 0.655 . . . . 65.140000000000001 110.591 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.4 -28.39 65.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.636 -0.711 . . . . 73.200000000000003 111.351 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 38.4 ttpt -62.36 -43.76 98.06 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.581 0.752 . . . . 74.430000000000007 109.867 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.05 64.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.454 -0.794 . . . . 74.219999999999999 111.157 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -21.06 56.64 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.961 0.726 . . . . 75.239999999999995 112.961 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.79 49.15 0.29 Allowed Glycine 0 C--N 1.358 1.763 0 CA-C-N 118.007 0.367 . . . . 63.130000000000003 113.085 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -57.16 158.04 5.58 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.352 1.061 . . . . 74.540000000000006 112.173 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.614 HG23 ' HA ' ' A' ' 34' ' ' ARG . 17.3 m -91.46 -60.36 1.91 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.37 -0.974 . . . . 74.030000000000001 108.37 168.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 65.3 t -135.55 136.82 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.188 -1.412 . . . . 73.430000000000007 107.188 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.3 p -130.56 146.37 52.07 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.321 0.649 . . . . 75.109999999999999 110.175 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 10.8 t70 -143.51 146.58 33.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.968 -1.015 . . . . 75.450000000000003 108.396 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.02 138.48 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.064 -0.717 . . . . 70.239999999999995 109.064 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.93 143.78 9.27 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.459 -0.337 . . . . 65.150000000000006 112.427 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -109.07 110.91 22.29 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.121 -1.066 . . . . 75.329999999999998 108.121 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.5 tp -151.02 148.91 28.93 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.255 -0.646 . . . . 74.219999999999999 109.255 -169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.666 ' HA ' HG13 ' A' ' 42' ' ' ILE . 12.0 p -77.05 98.65 5.06 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.889 -0.596 . . . . 72.340000000000003 109.997 172.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.2 110.21 31.56 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.22 -1.03 . . . . 75.129999999999995 108.22 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.38 -6.4 17.08 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.456 2.104 . . . . 73.340000000000003 112.532 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 6.2 p-10 -92.55 -23.84 18.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.84 0.856 . . . . 75.109999999999999 111.269 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.98 149.06 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 109.954 -0.387 . . . . 75.430000000000007 109.954 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.99 -5.22 1.69 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.631 0.772 . . . . 71.219999999999999 111.643 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.94 147.42 8.21 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.255 1.022 . . . . 74.230000000000004 109.839 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.625 ' HB ' ' H ' ' A' ' 121' ' ' THR . 7.8 t -64.42 111.21 2.56 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.416 0.686 . . . . 74.219999999999999 111.296 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -150.2 151.88 33.75 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.835 -0.62 . . . . 63.140000000000001 109.581 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.465 ' HB ' HG13 ' A' ' 102' ' ' VAL . 28.9 t -102.22 116.49 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.591 -0.892 . . . . 71.519999999999996 108.591 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.552 ' HD2' HD12 ' A' ' 117' ' ' ILE . 16.2 m-85 -102.41 148.22 25.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.937 -0.764 . . . . 75.230000000000004 108.937 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.59 169.33 17.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.863 0.84 . . . . 74.120000000000005 112.534 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.1 m -118.74 166.04 13.27 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 113.751 -1.568 . . . . 72.530000000000001 107.048 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.19 23.13 9.52 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.928 0.714 . . . . 74.420000000000002 112.928 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.61 98.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.202 0.525 . . . . 72.239999999999995 110.038 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.27 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.414 1.485 . . . . 74.109999999999999 111.9 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.03 25.87 2.36 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.075 -0.847 . . . . 71.120000000000005 112.963 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.73 ' HG2' ' HA ' ' A' ' 35' ' ' ALA . 31.3 mt-10 -62.98 -36.81 84.77 Favored 'General case' 0 C--N 1.362 1.127 0 CA-C-N 117.618 0.709 . . . . 75.340000000000003 111.025 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -70.8 -32.36 69.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.214 0.321 . . . . 75.310000000000002 111.754 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.33 -31.83 66.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.231 0.612 . . . . 73.109999999999999 110.515 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.4 m -76.6 -33.27 58.42 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.032 0.933 . . . . 74.439999999999998 109.982 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.47 -34.22 70.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.126 0.971 . . . . 71.209999999999994 111.376 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -50.91 -47.04 60.9 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.604 1.19 . . . . 75.430000000000007 110.765 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.1 83.87 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 124.534 1.146 . . . . 73.099999999999994 111.69 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' A' ' 52' ' ' THR . 89.4 t -66.74 -52.27 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.12 0.968 . . . . 64.239999999999995 112.11 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -27.08 70.43 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.575 0.547 . . . . 75.219999999999999 111.754 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -78.34 -23.57 46.92 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.396 0.678 . . . . 74.400000000000006 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -78.64 -51.3 10.07 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 122.615 0.366 . . . . 73.420000000000002 110.627 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.1 tp -74.15 -26.61 60.41 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.346 0.658 . . . . 75.219999999999999 111.295 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.29 62.46 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.746 -0.661 . . . . 74.219999999999999 112.064 -172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.4 163.0 13.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.74 0.816 . . . . 71.519999999999996 110.666 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.37 134.49 38.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.128 0.571 . . . . 74.310000000000002 110.19 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 79' ' ' VAL . 34.7 m -99.22 138.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.978 -0.749 . . . . 73.310000000000002 108.978 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -154.56 168.74 25.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.7 -0.852 . . . . 71.049999999999997 108.7 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 22.5 tp -65.66 173.03 3.0 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.13 0.572 . . . . 74.120000000000005 109.851 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.464 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.4 ppt_? -49.33 -39.18 30.6 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.167 1.173 . . . . 74.230000000000004 114.167 -167.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.434 HD12 ' CE1' ' A' ' 80' ' ' TYR . 41.0 mt 64.56 154.23 0.12 Allowed Pre-proline 0 CA--C 1.565 1.557 0 C-N-CA 124.307 1.043 . . . . 71.299999999999997 112.113 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.18 -29.03 35.78 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.647 2.898 . . . . 52.109999999999999 115.212 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 5.1 pm0 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.608 0.763 . . . . 75.25 112.861 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 0.5 OUTLIER -72.97 8.46 1.55 Allowed 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.188 0.518 . . . . 74.400000000000006 111.614 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 t -82.09 -10.56 59.16 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 72.030000000000001 111.382 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.23 -17.05 18.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 113.419 0.896 . . . . 63.350000000000001 113.419 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.475 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 2.0 pp0? -145.98 159.57 46.07 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.465 -0.779 . . . . 73.5 110.267 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 12.6 Cg_endo -52.7 125.4 17.88 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 123.795 2.997 . . . . 74.319999999999993 115.284 -167.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 109' ' ' LEU . 55.0 Cg_exo -57.44 153.67 39.9 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.925 3.083 . . . . 71.310000000000002 115.023 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.68 -149.41 21.55 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 109.861 -1.295 . . . . 63.509999999999998 109.861 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.1 t -94.48 105.56 17.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.377 -0.972 . . . . 74.109999999999999 108.377 167.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.552 HD12 ' HD2' ' A' ' 80' ' ' TYR . 32.0 pt -108.21 122.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.12 -1.067 . . . . 63.109999999999999 108.12 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.15 101.21 12.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.702 -1.592 . . . . 74.219999999999999 106.702 164.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.12 120.03 49.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.561 -0.745 . . . . 72.420000000000002 109.458 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.49 128.51 65.45 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 123.729 0.812 . . . . 74.010000000000005 110.269 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.625 ' H ' ' HB ' ' A' ' 77' ' ' THR . 77.7 p -112.05 153.28 27.12 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.891 1.276 . . . . 74.140000000000001 108.002 172.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.432 0 CA-C-O 119.141 -0.81 . . . . 53.539999999999999 112.836 178.71 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.825 -0.51 . . . . 51.130000000000003 111.825 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 t -161.72 161.73 29.47 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.399 0.68 . . . . 73.319999999999993 110.136 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.5 m -78.65 124.57 85.19 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.776 0.831 . . . . 73.239999999999995 110.509 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.82 147.85 75.8 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.889 2.392 . . . . 73.239999999999995 112.892 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -100.07 122.96 43.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.265 1.026 . . . . 71.140000000000001 109.173 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.3 t -108.35 84.18 1.9 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.507 -0.923 . . . . 74.120000000000005 108.507 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -81.93 -3.99 55.58 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.453 0.701 . . . . 72.340000000000003 111.687 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -56.21 -55.06 37.77 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.007 0.923 . . . . 72.510000000000005 110.762 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.9 t70 54.96 -89.58 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.258 1.423 . . . . 74.120000000000005 112.127 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 p 173.94 150.45 0.08 Allowed 'General case' 0 C--N 1.368 1.38 0 C-N-CA 125.647 1.579 . . . . 71.129999999999995 109.094 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -157.24 112.08 2.75 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.279 -1.008 . . . . 74.5 108.279 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.9 140.19 20.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.924 0.489 . . . . 75.150000000000006 110.857 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 tp -149.93 129.3 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.552 0.741 . . . . 63.210000000000001 109.143 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 102.6 4.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.329 0.652 . . . . 74.129999999999995 109.623 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 p -127.04 140.94 51.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.077 0.951 . . . . 73.349999999999994 109.383 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -136.68 165.33 26.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.343 0.657 . . . . 72.409999999999997 109.738 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.4 p -121.43 147.0 46.32 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.141 0.977 . . . . 71.140000000000001 109.423 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -125.02 139.22 54.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.73 0.812 . . . . 75.049999999999997 110.377 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.4 p -123.22 175.29 6.75 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.345 1.058 . . . . 73.519999999999996 110.117 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 t -158.67 173.55 16.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.38 0.672 . . . . 74.230000000000004 110.402 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.72 138.4 32.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.699 0.8 . . . . 72.129999999999995 110.539 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.48 157.82 35.58 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.208 1.003 . . . . 74.409999999999997 110.632 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.57 172.98 11.48 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.757 2.304 . . . . 73.010000000000005 112.704 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.3 p -137.47 148.36 46.01 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.604 0.762 . . . . 75.209999999999994 109.595 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -112.12 116.23 30.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.057 0.943 . . . . 74.439999999999998 110.271 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 p -91.51 128.74 37.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.523 0.729 . . . . 75.219999999999999 109.217 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.9 p -72.86 154.53 40.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.177 0.591 . . . . 75.319999999999993 111.145 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.94 141.44 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.892 -0.781 . . . . 74.430000000000007 108.892 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -82.31 149.24 61.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.947 0.499 . . . . 74.310000000000002 110.424 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.57 169.81 16.52 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.625 2.217 . . . . 74.439999999999998 112.288 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -152.27 164.26 37.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.336 0.654 . . . . 74.439999999999998 110.852 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.06 121.8 0.96 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.085 0.954 . . . . 74.400000000000006 109.738 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -77.82 128.34 9.23 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 121.869 1.713 . . . . 74.310000000000002 111.539 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 90.9 mtt-85 -117.29 103.04 9.76 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.447 1.099 . . . . 73.430000000000007 108.071 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.598 ' HB1' HG21 ' A' ' 90' ' ' THR . . . -83.51 -179.26 7.3 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.639 0.733 . . . . 74.400000000000006 111.468 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.66 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.0 mp0 -76.69 106.45 8.36 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.545 -1.207 . . . . 75.049999999999997 108.929 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.18 136.13 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.564 -0.902 . . . . 71.030000000000001 108.564 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.537 ' HG3' HG21 ' A' ' 117' ' ' ILE . 10.6 ptm180 -146.93 115.15 6.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.498 0.666 . . . . 73.5 111.035 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.575 HG22 ' HB1' ' A' ' 53' ' ' ALA . 58.2 t -98.71 116.17 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.101 0.96 . . . . 72.340000000000003 110.215 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 62.9 m-85 -115.69 115.06 25.71 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.705 0.802 . . . . 70.140000000000001 110.606 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.659 ' HB3' ' H ' ' A' ' 45' ' ' THR . 21.7 m-80 -90.16 114.21 26.13 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.087 0.955 . . . . 54.119999999999997 110.054 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -81.52 -53.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 122.267 -0.271 . . . . 74.340000000000003 110.295 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -130.15 7.8 5.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.702 0.401 . . . . 71.450000000000003 111.707 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.17 -61.5 1.91 Allowed Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.895 -0.882 . . . . 70.519999999999996 110.895 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.659 ' H ' ' HB3' ' A' ' 41' ' ' ASN . 6.9 t 43.55 31.8 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 127.231 2.212 . . . . 72.239999999999995 114.195 173.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.84 153.93 51.39 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.587 0.755 . . . . 74.540000000000006 109.448 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.26 -22.66 56.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 124.203 0.939 . . . . 52.520000000000003 114.874 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.54 75.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.131 0.572 . . . . 72.140000000000001 111.233 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -82.96 -42.94 17.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.672 0.789 . . . . 65.140000000000001 111.184 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.56 65.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.586 0.754 . . . . 72.120000000000005 112.1 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -59.42 -28.27 66.79 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.759 1.224 . . . . 65.420000000000002 112.708 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -69.71 -28.44 65.84 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 119.902 -0.094 . . . . 73.310000000000002 110.97 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB1' HG22 ' A' ' 39' ' ' VAL . . . -82.55 -32.0 28.81 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.848 0.859 . . . . 73.319999999999993 111.736 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.83 -56.79 17.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.467 1.107 . . . . 64.150000000000006 110.894 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -23.26 53.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.786 -0.643 . . . . 74.430000000000007 110.894 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 64' ' ' THR . 15.5 tp -63.89 -40.03 95.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.912 0.885 . . . . 72.010000000000005 110.636 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -44.79 96.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.071 -0.968 . . . . 74.420000000000002 109.178 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.5 -11.52 60.04 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.74 -1.118 . . . . 64.200000000000003 112.252 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.99 -13.26 53.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.287 0.635 . . . . 71.010000000000005 110.905 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.36 15.24 18.06 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.793 -0.448 . . . . 63.420000000000002 114.059 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 34.2 m-85 -75.49 158.1 33.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.15 0.58 . . . . 73.140000000000001 110.684 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 m -84.63 -60.62 2.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.655 0.382 . . . . 73.349999999999994 111.171 -162.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 46.5 t -116.75 129.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.937 -0.764 . . . . 72.219999999999999 108.937 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.412 HG22 HD22 ' A' ' 56' ' ' LEU . 25.3 p -138.31 83.73 1.99 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.535 1.134 . . . . 74.299999999999997 108.087 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -100.1 125.09 46.16 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.69 -0.855 . . . . 53.32 108.69 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.435 HG12 ' HB ' ' A' ' 39' ' ' VAL . 29.6 m -117.3 150.31 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.002 0.429 . . . . 75.299999999999997 110.504 -174.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.78 162.23 35.63 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-N 115.456 -0.793 . . . . 75.239999999999995 111.373 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.11 110.67 20.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.81 . . . . 71.510000000000005 109.158 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -145.28 136.84 25.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.608 0.763 . . . . 75.129999999999995 109.998 -170.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -79.7 99.64 7.51 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.937 -0.764 . . . . 52.219999999999999 108.937 171.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HB2' HG13 ' A' ' 74' ' ' VAL . 47.8 mt -93.36 140.82 23.33 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 115.893 -0.594 . . . . 75.140000000000001 109.603 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.57 -10.1 14.6 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.575 2.183 . . . . 75.120000000000005 113.175 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.39 -24.36 25.78 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.621 0.768 . . . . 73.340000000000003 111.325 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 71' ' ' LEU . 7.1 p -91.07 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.226 0.61 . . . . 72.120000000000005 110.66 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.79 -0.83 1.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.895 -1.048 . . . . 71.430000000000007 110.325 167.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.3 155.74 18.26 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 125.292 1.437 . . . . 75.340000000000003 108.44 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -62.4 109.74 1.45 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.494 0.664 . . . . 75.540000000000006 110.623 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.9 m -143.92 143.39 31.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.464 0.705 . . . . 73.519999999999996 110.265 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.727 HG23 HG13 ' A' ' 118' ' ' VAL . 92.7 t -105.94 112.81 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.137 -1.06 . . . . 74.530000000000001 108.137 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -98.92 125.03 44.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.828 -0.804 . . . . 72.5 108.828 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.432 ' HA ' HG13 ' A' ' 116' ' ' VAL . 25.9 p90 -109.34 139.75 43.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.642 0.588 . . . . 72.230000000000004 110.67 175.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 83' ' ' GLU . 2.1 m -82.96 -163.36 0.71 Allowed 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 108.663 -0.866 . . . . 73.109999999999999 108.663 171.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' H ' HG22 ' A' ' 82' ' ' THR . 10.5 pt-20 -136.55 13.27 3.21 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.676 -1.265 . . . . 74.230000000000004 113.408 -160.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.75 108.24 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 N-CA-C 109.337 -0.616 . . . . 75.129999999999995 109.337 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.18 -77.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.761 1.624 . . . . 75.430000000000007 111.448 -172.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.69 57.11 0.31 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.254 -0.739 . . . . 74.310000000000002 111.254 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.59 -17.29 59.85 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.044 0.538 . . . . 74.030000000000001 112.277 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -55.16 -40.56 70.76 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.774 0.43 . . . . 73.219999999999999 110.792 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.23 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.701 0.801 . . . . 61.530000000000001 112.87 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.598 HG21 ' HB1' ' A' ' 35' ' ' ALA . 14.0 t -71.53 -33.2 68.98 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.644 0.378 . . . . 72.319999999999993 111.005 -175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 81' ' ' TYR . . . -80.85 -30.08 35.75 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 74.549999999999997 111.872 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.617 1.167 . . . . 64.25 110.15 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.96 -27.03 68.56 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.453 -0.794 . . . . 72.349999999999994 112.056 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.673 HG13 HG22 ' A' ' 118' ' ' VAL . 24.0 t -81.4 -58.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 C-N-CA 123.129 0.571 . . . . 73.239999999999995 111.046 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -61.82 -29.23 71.69 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.714 -0.676 . . . . 73.129999999999995 113.865 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -79.27 -24.97 42.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.064 0.546 . . . . 74.209999999999994 110.897 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -77.68 -47.99 17.84 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.088 0.471 . . . . 71.239999999999995 110.015 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 120' ' ' VAL . 51.4 tp -68.56 -32.06 71.71 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.137 0.975 . . . . 74.140000000000001 111.44 -177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.93 34.44 24.3 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-N 116.186 -0.461 . . . . 62.149999999999999 112.352 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.81 140.37 49.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.09 0.956 . . . . 73.219999999999999 108.796 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 130.38 41.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.406 0.682 . . . . 74.430000000000007 110.941 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -86.33 120.79 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 123.884 0.874 . . . . 74.120000000000005 110.296 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -126.8 159.21 34.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.466 1.106 . . . . 73.409999999999997 109.874 176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.78 168.68 12.86 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.030000000000001 111.632 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -27.59 65.66 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.929 1.291 . . . . 72.430000000000007 113.781 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt 65.03 173.13 0.08 OUTLIER Pre-proline 0 CA--C 1.568 1.654 0 N-CA-C 113.276 0.843 . . . . 72.329999999999998 113.276 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.76 -17.1 34.34 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.438 2.092 . . . . 74.510000000000005 112.67 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 3.2 mp0 -65.05 -15.67 62.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.524 1.129 . . . . 75.230000000000004 112.967 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -61.89 -23.81 66.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 118.473 0.579 . . . . 74.040000000000006 109.505 -178.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.3 p -51.43 -32.5 26.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.943 0.897 . . . . 75.219999999999999 111.826 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.52 -32.29 7.77 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.737 0.815 . . . . 72.400000000000006 111.138 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 26.0 mt-30 -64.35 133.88 95.8 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.174 0.59 . . . . 63.310000000000002 110.909 -173.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.575 ' HD2' HG22 ' A' ' 117' ' ' ILE . 52.7 Cg_exo -58.17 147.44 83.7 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.357 2.705 . . . . 74.400000000000006 113.331 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.55 131.24 43.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.583 2.855 . . . . 74.329999999999998 113.441 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.47 -178.39 31.4 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.937 -0.865 . . . . 64.049999999999997 110.937 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.432 HG13 ' HA ' ' A' ' 81' ' ' TYR . 4.5 m -76.4 123.9 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 109.733 -0.469 . . . . 72.540000000000006 109.733 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.575 HG22 ' HD2' ' A' ' 113' ' ' PRO . 22.7 pt -107.49 114.17 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.876 0.846 . . . . 71.420000000000002 109.843 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.727 HG13 HG23 ' A' ' 79' ' ' VAL . 58.6 t -92.62 100.83 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.455 -1.313 . . . . 64.329999999999998 107.455 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 10.9 p -107.41 125.57 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.552 0.691 . . . . 73.430000000000007 110.819 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 98' ' ' LEU . 11.3 t -119.67 138.41 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.506 0.723 . . . . 74.540000000000006 111.231 -169.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 t -128.01 132.06 49.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.702 -0.851 . . . . 74.310000000000002 108.702 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 118.723 -1.043 . . . . 74.530000000000001 112.757 -177.603 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.354 -0.299 . . . . 43.229999999999997 112.354 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 p -67.52 100.98 0.92 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.953 0.901 . . . . 75.120000000000005 110.483 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 t -143.3 67.65 16.92 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 123.816 0.846 . . . . 62.0 109.57 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.41 104.22 1.17 Allowed 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.79 2.327 . . . . 73.109999999999999 110.862 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -123.17 113.71 19.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.743 0.817 . . . . 74.540000000000006 109.152 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -116.99 68.45 0.74 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.696 0.76 . . . . 72.310000000000002 110.269 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -83.45 -18.33 38.97 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.161 -0.927 . . . . 74.239999999999995 111.321 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -72.45 -12.21 61.0 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.686 0.395 . . . . 74.510000000000005 111.765 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.36 102.03 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.464 1.106 . . . . 71.230000000000004 111.685 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.4 p -107.57 163.65 12.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.124 0.97 . . . . 65.510000000000005 110.548 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.1 t -112.63 163.38 14.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.617 0.767 . . . . 71.109999999999999 110.144 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 131.96 20.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 109.841 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.7 pt -136.63 121.42 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.657 0.783 . . . . 73.409999999999997 109.737 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -157.17 129.75 7.5 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.259 1.024 . . . . 73.430000000000007 109.36 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -149.03 115.59 5.89 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.725 -0.842 . . . . 72.239999999999995 108.725 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -141.73 109.77 5.84 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.891 -1.151 . . . . 70.150000000000006 107.891 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -139.56 119.37 13.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.476 0.655 . . . . 65.230000000000004 110.292 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 p -142.15 150.24 40.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.844 1.258 . . . . 65.310000000000002 108.689 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.4 p -142.48 152.92 43.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.447 1.099 . . . . 55.130000000000003 108.963 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -159.85 155.34 25.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.065 0.546 . . . . 74.430000000000007 110.664 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.15 157.52 23.34 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.409 1.083 . . . . 73.430000000000007 109.051 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.92 107.15 11.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.43 0.692 . . . . 64.299999999999997 109.568 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.98 -172.82 1.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.98 2.453 . . . . 74.430000000000007 112.167 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -170.21 146.13 2.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.598 0.759 . . . . 54.409999999999997 110.174 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.3 p -92.64 166.8 12.3 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.289 -0.634 . . . . 73.430000000000007 109.289 171.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.4 t -133.72 137.28 45.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.253 0.621 . . . . 74.439999999999998 110.509 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.4 p -167.46 153.01 7.4 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.634 0.774 . . . . 62.409999999999997 110.235 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -167.33 109.81 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 C-N-CA 123.713 0.805 . . . . 73.530000000000001 110.403 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -126.33 120.42 23.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 123.347 0.659 . . . . 73.120000000000005 110.361 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -84.37 124.19 3.17 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.464 2.11 . . . . 74.219999999999999 111.32 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.91 109.68 1.61 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.267 0.627 . . . . 62.200000000000003 110.189 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.46 84.97 2.81 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.834 0.854 . . . . 63.43 109.248 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -78.32 129.0 9.24 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.402 2.068 . . . . 73.239999999999995 111.478 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -93.0 -164.88 1.24 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.652 0.781 . . . . 74.400000000000006 110.168 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.75 155.87 34.81 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 109.524 -0.547 . . . . 61.240000000000002 109.524 169.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . 8.6 pt-20 -66.54 121.56 15.63 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.424 -0.807 . . . . 73.140000000000001 110.224 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 t -92.76 144.3 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.126 -0.943 . . . . 72.409999999999997 109.073 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 5.9 ptp85 -151.25 161.19 43.16 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.92 0.488 . . . . 74.519999999999996 110.885 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 50' ' ' ALA . 58.8 t -126.27 123.89 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.955 . . . . 75.319999999999993 109.081 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -112.31 108.06 17.12 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 124.286 1.035 . . . . 74.420000000000002 109.326 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.422 HD21 ' HB ' ' A' ' 120' ' ' VAL . 16.7 m120 -78.5 112.99 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.772 -1.195 . . . . 55.509999999999998 107.772 170.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 70' ' ' SER . 3.0 tp -75.85 -43.25 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.362 -0.607 . . . . 75.439999999999998 109.362 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -144.17 156.02 44.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.888 0.875 . . . . 74.310000000000002 108.843 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.89 6.94 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.146 -0.808 . . . . 74.109999999999999 113.325 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.2 t 40.79 78.46 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.949 1.7 . . . . 70.209999999999994 113.106 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -121.68 114.49 21.21 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.914 0.485 . . . . 72.120000000000005 110.468 -174.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.01 -11.9 84.92 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.42 -0.809 . . . . 74.040000000000006 113.605 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.62 91.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.237 0.615 . . . . 75.530000000000001 110.9 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 120' ' ' VAL . . . -70.7 -33.39 70.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.689 -0.687 . . . . 53.549999999999997 110.727 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' A' ' 39' ' ' VAL . . . -77.49 -21.87 52.13 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.366 0.666 . . . . 74.109999999999999 112.135 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -66.08 -28.67 69.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.843 1.257 . . . . 73.230000000000004 111.049 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.565 HG21 ' HB3' ' A' ' 98' ' ' LEU . 78.2 p -63.02 -46.47 87.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.136 0.574 . . . . 63.539999999999999 110.713 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.58 65.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.535 0.734 . . . . 75.019999999999996 111.169 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.09 -28.62 69.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.176 0.59 . . . . 71.510000000000005 111.415 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -69.04 -36.98 78.32 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.603 0.361 . . . . 74.329999999999998 110.659 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.6 mp -62.54 -24.29 67.43 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.17 0.588 . . . . 74.230000000000004 111.586 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HZ1' ' HB2' ' A' ' 57' ' ' LYS . 4.6 ttmp? -56.42 -49.02 75.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.262 0.625 . . . . 72.209999999999994 110.314 173.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.02 -24.12 41.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.515 -0.766 . . . . 75.329999999999998 111.613 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -74.5 -17.31 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.374 0.67 . . . . 74.239999999999995 111.928 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 33.73 2.53 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.055 0.382 . . . . 73.219999999999999 114.055 170.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -100.37 157.62 16.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.512 0.725 . . . . 74.400000000000006 109.815 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -62.31 -73.82 0.1 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.881 . . . . 73.230000000000004 112.291 -161.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 75.6 t -123.02 144.29 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.319 -1.363 . . . . 72.129999999999995 107.319 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 p -138.6 101.36 4.32 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.987 -1.486 . . . . 75.510000000000005 106.987 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 9.3 t70 -107.21 149.62 27.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 64.140000000000001 109.967 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 50' ' ' ALA . 88.7 t -127.32 137.14 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.942 0.897 . . . . 63.439999999999998 108.995 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.43 159.6 32.54 Favored Glycine 0 C--N 1.344 1.018 0 O-C-N 123.539 0.524 . . . . 64.439999999999998 111.862 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -123.97 104.74 9.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.461 1.105 . . . . 74.540000000000006 108.314 174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 mp -133.36 134.09 43.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.049 0.54 . . . . 74.209999999999994 110.13 -171.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.48 ' HA ' HD13 ' A' ' 42' ' ' ILE . 24.6 p -85.4 98.68 10.71 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.543 -0.753 . . . . 62.030000000000001 108.975 172.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.632 ' HB2' HG23 ' A' ' 74' ' ' VAL . 82.6 mt -107.35 141.6 23.32 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.434 -0.951 . . . . 75.25 108.434 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.86 -17.87 17.38 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.575 2.183 . . . . 72.129999999999995 113.403 -169.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -94.78 -24.61 17.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.208 1.003 . . . . 73.239999999999995 111.844 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 71' ' ' LEU . 13.1 m -91.88 147.03 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.844 0.457 . . . . 74.099999999999994 109.975 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -164.79 -41.79 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.817 0.847 . . . . 74.519999999999996 109.772 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.58 134.45 33.63 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.007 -0.997 . . . . 72.200000000000003 110.325 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.61 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.8 t -74.83 98.24 3.47 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 122.272 1.034 . . . . 73.239999999999995 109.114 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 80' ' ' TYR . 63.2 m -153.83 155.03 35.03 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.377 -1.283 . . . . 73.010000000000005 108.808 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.672 HG11 HG23 ' A' ' 118' ' ' VAL . 23.5 t -94.57 116.22 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.516 -0.92 . . . . 74.140000000000001 108.516 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 78' ' ' THR . 75.4 m-85 -108.53 132.75 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.4 0.68 . . . . 73.409999999999997 111.904 -171.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 38.9 p90 -144.59 -177.18 5.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.919 0.888 . . . . 74.200000000000003 110.662 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -141.09 -91.72 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 118.891 -0.576 . . . . 74.010000000000005 110.095 165.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.47 -22.18 0.82 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.266 1.21 . . . . 62.219999999999999 114.266 -170.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 95.9 t -58.88 117.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 124.161 0.984 . . . . 72.329999999999998 112.046 -169.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 52.52 25.86 3.88 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.533 1.133 . . . . 72.230000000000004 113.635 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.11 57.59 5.63 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.774 -0.53 . . . . 64.239999999999995 111.774 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 37.1 mt-10 -52.69 -44.95 66.61 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.768 . . . . 73.120000000000005 111.989 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -65.34 -25.38 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.819 0.847 . . . . 74.510000000000005 112.566 -176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.96 0.504 . . . . 62.43 110.615 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.435 HG22 HG13 ' A' ' 116' ' ' VAL . 10.0 t -82.33 -26.99 32.52 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.469 -0.787 . . . . 74.510000000000005 111.177 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB1' HG22 ' A' ' 116' ' ' VAL . . . -69.03 -36.69 78.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.832 0.853 . . . . 74.319999999999993 111.012 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.23 -49.29 78.19 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 124.746 1.279 . . . . 73.109999999999999 109.766 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.86 78.54 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.352 1.032 . . . . 53.5 112.025 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.664 HG13 HG21 ' A' ' 118' ' ' VAL . 64.8 t -63.65 -53.89 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 122.974 0.51 . . . . 61.409999999999997 110.548 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.74 -23.46 69.06 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 124.164 0.915 . . . . 61.43 113.87 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -76.1 -39.35 55.46 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.955 -0.757 . . . . 71.230000000000004 108.955 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.7 m -74.6 -34.45 62.85 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.308 -0.86 . . . . 74.519999999999996 112.119 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 52' ' ' THR . 3.4 pp -93.74 -17.57 23.03 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.127 0.421 . . . . 73.120000000000005 111.932 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.48 52.75 4.08 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 113.966 0.346 . . . . 62.240000000000002 113.966 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.73 168.41 16.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.756 0.822 . . . . 74.310000000000002 109.718 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.46 165.5 25.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.599 0.759 . . . . 72.099999999999994 110.604 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.57 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 31.2 m -123.8 114.81 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 123.55 0.74 . . . . 65.329999999999998 109.586 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 35.5 mm-40 -124.39 174.78 7.53 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.538 1.135 . . . . 74.239999999999995 110.156 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.16 149.48 27.93 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.676 -0.693 . . . . 74.409999999999997 109.874 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.409 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 24.4 ptt180 -88.09 28.38 1.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.757 1.223 . . . . 72.450000000000003 111.641 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.574 ' HG ' ' HD3' ' A' ' 107' ' ' PRO . 4.3 pp -68.12 -32.31 3.93 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 117.597 -1.192 . . . . 64.340000000000003 112.728 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.574 ' HD3' ' HG ' ' A' ' 106' ' ' LEU . 13.1 Cg_exo -75.16 -34.48 3.66 Favored 'Trans proline' 0 C--N 1.405 3.506 0 CA-C-N 122.518 1.935 . . . . 73.219999999999999 111.914 167.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.618 ' HG3' HG11 ' A' ' 74' ' ' VAL . 8.3 mp0 -72.43 -10.5 59.87 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.542 1.137 . . . . 74.030000000000001 111.077 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.456 HD11 ' HG2' ' A' ' 112' ' ' GLN . 13.1 tp -68.78 -12.41 61.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.31 1.044 . . . . 73.310000000000002 111.12 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -61.9 -46.78 87.9 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.619 0.768 . . . . 65.420000000000002 110.909 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.01 -33.82 26.45 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.795 0.838 . . . . 55.049999999999997 109.677 172.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.456 ' HG2' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER 57.57 74.22 0.68 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.983 1.313 . . . . 73.299999999999997 111.028 -179.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.41 132.69 6.0 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 122.712 2.275 . . . . 75.299999999999997 111.656 172.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.32 152.65 52.12 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.705 2.937 . . . . 74.409999999999997 114.409 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.26 -167.5 27.38 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.222 -0.899 . . . . 75.230000000000004 113.616 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.709 HG22 ' HB1' ' A' ' 91' ' ' ALA . 3.2 p -87.06 131.95 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.311 -0.625 . . . . 73.230000000000004 109.311 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.46 149.81 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.859 0.864 . . . . 74.25 109.829 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.672 HG23 HG11 ' A' ' 79' ' ' VAL . 47.7 t -121.55 103.58 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.036 -1.468 . . . . 72.299999999999997 107.036 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.608 HG13 ' HB ' ' A' ' 74' ' ' VAL . 95.5 t -93.51 123.82 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.518 -0.919 . . . . 73.340000000000003 108.518 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.443 HG21 ' HB2' ' A' ' 49' ' ' ALA . 58.0 t -128.74 129.86 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.342 0.657 . . . . 64.340000000000003 109.84 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.61 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.5 t -105.8 155.86 18.88 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.332 0.653 . . . . 74.129999999999995 109.83 168.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.027 0 CA-C-O 119.174 -0.792 . . . . 51.240000000000002 111.764 179.569 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.874 0 N-CA-C 112.109 -0.397 . . . . 71.329999999999998 112.109 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -169.4 163.25 10.54 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.192 0.597 . . . . 50.219999999999999 110.563 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -149.93 141.91 15.3 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.909 0.884 . . . . 71.299999999999997 109.465 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.16 139.97 47.94 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.722 2.281 . . . . 74.519999999999996 112.666 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -101.54 129.01 47.53 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.63 0.772 . . . . 74.030000000000001 109.448 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -141.75 35.39 1.6 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.652 0.781 . . . . 71.540000000000006 110.032 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -85.64 2.44 45.17 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.016 0.526 . . . . 75.340000000000003 111.884 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.0 -69.23 0.36 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.204 0.602 . . . . 70.430000000000007 110.571 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.0 t70 59.84 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.034 1.334 . . . . 75.519999999999996 111.87 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.0 t -103.61 103.74 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.727 -0.842 . . . . 74.450000000000003 108.727 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.9 m -134.47 123.49 24.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.68 0.792 . . . . 72.239999999999995 110.334 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.63 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.696 0.798 . . . . 64.209999999999994 110.23 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.69 143.16 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.072 -1.084 . . . . 74.430000000000007 108.072 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -164.24 111.92 1.11 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 74.219999999999999 110.225 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.1 t -161.71 125.81 3.3 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.305 1.042 . . . . 71.200000000000003 109.333 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.3 ptp -171.57 146.44 2.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.906 0.882 . . . . 75.329999999999998 110.241 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -173.58 141.19 0.84 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.042 0.937 . . . . 64.209999999999994 109.66 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.6 t -167.13 106.23 0.58 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.468 0.707 . . . . 74.120000000000005 110.64 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -161.1 102.92 1.27 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.251 1.421 . . . . 74.299999999999997 109.082 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.1 p -135.58 125.7 26.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.757 0.823 . . . . 74.340000000000003 109.947 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.34 132.05 7.72 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.173 0.989 . . . . 61.420000000000002 109.942 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.48 107.35 10.08 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.617 0.767 . . . . 74.519999999999996 109.983 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.41 144.75 20.57 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.953 2.435 . . . . 74.120000000000005 111.863 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.3 p -122.41 148.41 45.14 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.694 0.398 . . . . 72.040000000000006 110.685 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m -146.28 111.88 5.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.716 0.806 . . . . 74.120000000000005 109.925 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.5 p -124.74 129.45 50.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.92 0.888 . . . . 71.230000000000004 109.473 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 m -150.49 111.45 4.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.739 0.816 . . . . 75.430000000000007 108.873 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.75 131.36 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.484 0.714 . . . . 72.230000000000004 109.992 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -123.79 112.73 28.84 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.146 0.979 . . . . 73.310000000000002 108.747 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.13 120.65 8.45 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.391 2.061 . . . . 74.450000000000003 111.633 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -177.81 122.93 0.11 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.738 0.815 . . . . 73.450000000000003 109.861 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -170.19 95.7 0.47 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 123.848 0.859 . . . . 63.219999999999999 109.086 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.66 127.56 12.52 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.998 1.799 . . . . 72.439999999999998 111.158 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -105.57 -84.53 0.5 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.79 -0.818 . . . . 75.230000000000004 108.79 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 90' ' ' THR . . . -152.7 174.71 13.67 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.293 0.637 . . . . 73.409999999999997 110.17 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.81 108.13 19.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.008 0.923 . . . . 72.140000000000001 110.441 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.507 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 41.3 t -106.88 138.7 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.192 0.997 . . . . 75.299999999999997 109.613 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.53 128.95 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.433 -0.58 . . . . 73.120000000000005 109.433 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.3 t -103.72 128.11 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.34 0.656 . . . . 75.319999999999993 109.389 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.634 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 38.3 m-85 -124.03 131.45 53.56 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.423 0.689 . . . . 74.519999999999996 110.286 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -85.7 112.08 20.7 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.988 -1.115 . . . . 72.519999999999996 107.988 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 71' ' ' LEU . 9.2 tp -75.31 -47.19 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.042 0.449 . . . . 74.450000000000003 111.355 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 m -107.51 3.18 24.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.988 0.915 . . . . 72.219999999999999 110.383 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 136.83 1.48 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.52 -0.632 . . . . 51.100000000000001 111.52 -170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 t -157.28 -178.95 7.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.359 0.664 . . . . 71.519999999999996 110.032 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.72 154.11 42.22 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.222 1.009 . . . . 71.209999999999994 111.071 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.79 -2.49 16.99 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 115.022 0.769 . . . . 53.32 115.022 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.51 -28.12 69.73 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.612 0.765 . . . . 74.329999999999998 111.518 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.2 -42.75 75.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.277 0.631 . . . . 72.430000000000007 110.576 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.36 -28.46 67.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.61 -0.723 . . . . 75.219999999999999 111.667 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -65.28 -24.95 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.601 1.16 . . . . 74.329999999999998 111.752 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 98' ' ' LEU . 68.9 p -71.89 -47.59 51.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.367 0.267 . . . . 75.329999999999998 110.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.1 93.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.308 0.575 . . . . 73.140000000000001 110.639 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.29 -32.96 74.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.532 -1.213 . . . . 63.399999999999999 111.422 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -72.04 -41.07 67.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.054 0.542 . . . . 75.049999999999997 109.66 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -70.91 -26.03 63.03 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.394 -0.821 . . . . 73.519999999999996 111.336 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -61.71 -51.22 69.29 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.077 -0.712 . . . . 71.439999999999998 109.077 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.3 71.36 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.152 -0.931 . . . . 74.209999999999994 111.143 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.43 1.25 16.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.536 0.734 . . . . 73.010000000000005 112.309 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.6 40.19 11.27 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 113.96 0.344 . . . . 61.350000000000001 113.96 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -89.09 155.27 19.56 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.246 0.523 . . . . 73.209999999999994 109.76 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -66.03 -60.33 2.94 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.041 0.756 . . . . 75.200000000000003 113.041 -159.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.27 103.21 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.326 -0.99 . . . . 73.430000000000007 108.326 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 16.8 p -107.96 105.51 15.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 73.430000000000007 109.86 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -115.16 156.64 24.9 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.649 1.18 . . . . 73.400000000000006 109.679 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.77 144.54 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.768 0.427 . . . . 75.120000000000005 111.023 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.57 -158.54 13.61 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.498 -0.641 . . . . 60.409999999999997 111.498 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -107.49 173.42 6.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.23 -0.656 . . . . 74.310000000000002 109.23 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 27.7 tp -144.51 138.99 27.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 111.258 0.096 . . . . 72.129999999999995 111.258 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.7 p -87.57 133.58 33.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.67 -0.863 . . . . 72.230000000000004 108.67 170.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.805 ' HA ' HD12 ' A' ' 42' ' ' ILE . 32.4 tp -44.17 101.45 0.25 Allowed Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 125.177 1.391 . . . . 72.129999999999995 113.949 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.85 -100.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.109 2.539 . . . . 75.219999999999999 109.96 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.07 -22.13 12.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.054 0.942 . . . . 73.129999999999995 111.621 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.97 128.07 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.647 -0.501 . . . . 74.400000000000006 109.647 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.57 16.43 9.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.937 0.895 . . . . 74.409999999999997 111.536 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 156.97 46.17 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.559 0.744 . . . . 72.230000000000004 109.916 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 t -62.34 100.47 0.18 Allowed 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.057 0.932 . . . . 74.310000000000002 110.316 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.2 m -148.12 143.07 26.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 74.450000000000003 109.321 -172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.703 HG11 HG22 ' A' ' 118' ' ' VAL . 42.6 t -95.94 115.86 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.603 -1.258 . . . . 75.439999999999998 107.603 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.539 ' HB3' HG13 ' A' ' 117' ' ' ILE . 32.3 t80 -107.86 113.76 27.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.908 -1.145 . . . . 74.340000000000003 107.908 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.539 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 41.9 p90 -141.32 147.43 38.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.135 0.791 . . . . 74.129999999999995 113.135 -170.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -85.94 -157.82 0.36 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.96 -1.126 . . . . 70.329999999999998 107.96 167.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -124.99 7.18 7.97 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.108 -0.995 . . . . 64.310000000000002 110.907 173.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 98.7 t -66.61 128.41 29.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 123.82 0.848 . . . . 74.310000000000002 109.603 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HG3' HG12 ' A' ' 84' ' ' VAL . 35.4 mt-10 62.1 20.9 12.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.523 0.729 . . . . 74.040000000000006 111.125 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.35 35.5 52.31 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.683 -0.51 . . . . 74.430000000000007 113.387 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 29.4 mt-10 -52.57 -33.47 45.98 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.933 0.716 . . . . 74.239999999999995 112.933 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -64.57 -31.34 72.52 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.839 0.455 . . . . 74.209999999999994 112.182 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.99 -37.41 29.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.505 0.722 . . . . 75.040000000000006 111.554 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.411 HG21 ' HB1' ' A' ' 35' ' ' ALA . 69.5 p -74.41 -36.83 63.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.466 -0.788 . . . . 72.219999999999999 110.894 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -30.72 69.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.498 -1.228 . . . . 63.409999999999997 111.89 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.29 -44.33 92.52 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.333 1.021 . . . . 72.120000000000005 110.136 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.01 75.26 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.516 -0.765 . . . . 61.310000000000002 112.272 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.634 HG13 HG23 ' A' ' 118' ' ' VAL . 64.3 t -74.32 -59.3 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.498 -0.319 . . . . 74.219999999999999 110.519 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.84 -23.05 55.67 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.811 0.694 . . . . 72.109999999999999 114.011 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -67.87 -60.03 2.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.485 1.114 . . . . 73.409999999999997 109.758 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.6 m -71.63 -32.76 68.3 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 114.902 -1.045 . . . . 74.200000000000003 111.141 -172.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.564 ' HB2' HG22 ' A' ' 52' ' ' THR . 48.7 tp -81.11 -27.28 35.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.941 0.896 . . . . 74.219999999999999 110.497 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.74 43.65 83.68 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.564 0.54 . . . . 75.310000000000002 112.667 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.53 25.04 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.774 0.83 . . . . 75.109999999999999 110.173 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.77 139.98 58.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.32 0.648 . . . . 75.409999999999997 110.355 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.539 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.2 m -112.15 131.83 62.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.425 0.69 . . . . 74.439999999999998 109.24 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.53 144.2 46.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.565 0.746 . . . . 74.439999999999998 111.309 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 16.2 tp -66.36 -177.2 0.51 Allowed 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 114.198 -1.364 . . . . 74.349999999999994 110.815 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.583 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 6.7 ppt_? -56.51 -28.6 60.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.863 1.265 . . . . 65.040000000000006 113.733 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 104' ' ' LEU . 74.6 mt 62.1 168.04 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.538 1.135 . . . . 75.420000000000002 113.039 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -73.25 -12.34 25.35 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.285 1.99 . . . . 74.109999999999999 112.605 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' HH ' ' A' ' 80' ' ' TYR . 16.1 mm-40 -69.49 -18.85 63.73 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.227 1.011 . . . . 74.150000000000006 112.624 -169.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.8 -4.26 19.27 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.666 0.617 . . . . 71.319999999999993 112.666 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -60.25 -21.72 62.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.266 0.626 . . . . 61.340000000000003 111.763 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -115.51 -32.99 5.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.84 0.856 . . . . 74.209999999999994 110.83 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -96.41 127.03 41.51 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.065 0.946 . . . . 74.219999999999999 110.846 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.96 134.11 57.94 Favored 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 122.18 1.92 . . . . 75.219999999999999 112.7 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.91 163.12 32.16 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.278 2.652 . . . . 74.310000000000002 113.415 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 130.58 146.36 5.9 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 108.647 -1.781 . . . . 73.099999999999994 108.647 -171.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 53.7 t -65.0 99.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 118.718 1.259 . . . . 72.400000000000006 108.767 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 80' ' ' TYR . 29.4 pt -107.57 106.93 21.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.467 -1.308 . . . . 74.219999999999999 107.467 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.703 HG22 HG11 ' A' ' 79' ' ' VAL . 42.1 t -89.83 101.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.34 -1.356 . . . . 74.420000000000002 107.34 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.0 t -93.67 113.14 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.33 -1.359 . . . . 73.329999999999998 107.33 -174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.53 127.36 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 110.223 -0.288 . . . . 74.329999999999998 110.223 -171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -89.98 160.54 16.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.938 0.895 . . . . 74.430000000000007 109.743 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.958 -0.912 . . . . 61.009999999999998 111.373 178.509 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.113 -0.395 . . . . 64.239999999999995 112.113 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 t -136.85 144.84 43.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.166 0.586 . . . . 71.010000000000005 110.279 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -85.54 141.35 36.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.003 0.921 . . . . 74.420000000000002 110.797 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -60.13 139.65 88.46 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.967 2.445 . . . . 74.099999999999994 112.387 168.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -100.97 136.93 40.04 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.294 0.638 . . . . 73.299999999999997 110.45 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -121.41 56.28 1.05 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.677 -0.86 . . . . 73.150000000000006 108.677 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -84.46 0.6 49.02 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.19 -0.914 . . . . 73.310000000000002 112.308 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.48 -45.24 81.06 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.435 1.094 . . . . 72.0 111.555 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.3 t70 68.95 141.83 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.008 1.323 . . . . 72.519999999999996 112.929 172.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.5 m -92.93 -179.69 5.19 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.0 0.92 . . . . 71.230000000000004 110.393 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -160.76 145.12 13.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.03 0.532 . . . . 63.130000000000003 109.974 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.73 139.47 20.75 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.463 0.705 . . . . 71.230000000000004 109.941 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -108.87 167.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.008 0.923 . . . . 75.420000000000002 111.057 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 t -83.84 -167.29 1.67 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.324 1.049 . . . . 74.329999999999998 110.419 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.9 m -141.04 137.28 32.82 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.034 0.934 . . . . 73.319999999999993 109.246 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.495 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.5 OUTLIER -95.09 127.67 41.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.84 0.856 . . . . 74.340000000000003 110.134 -175.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 m -145.9 144.33 30.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.76 0.824 . . . . 73.109999999999999 109.776 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -145.01 166.06 26.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.88 0.872 . . . . 75.040000000000006 110.638 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -136.95 143.31 42.79 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.662 0.785 . . . . 71.219999999999999 109.83 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 t -103.11 176.45 5.14 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.321 1.048 . . . . 72.209999999999994 110.107 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.8 170.53 15.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.461 0.704 . . . . 74.319999999999993 110.482 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.36 120.06 15.7 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.344 1.057 . . . . 64.409999999999997 109.968 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.04 159.97 37.12 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.626 2.217 . . . . 63.340000000000003 112.422 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -149.42 140.02 22.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 71.400000000000006 109.322 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -145.45 139.68 27.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.227 0.611 . . . . 74.409999999999997 110.038 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -121.41 176.01 5.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.136 0.974 . . . . 72.230000000000004 109.947 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.2 p -146.65 136.76 23.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.814 0.846 . . . . 73.430000000000007 109.646 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.83 147.91 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.402 0.681 . . . . 73.120000000000005 110.251 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -103.86 157.02 34.8 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 123.81 0.844 . . . . 71.049999999999997 109.844 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.43 163.42 23.83 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.477 2.118 . . . . 72.219999999999999 111.708 170.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.95 173.47 7.41 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.248 0.619 . . . . 72.329999999999998 111.213 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.25 147.22 33.84 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.852 0.861 . . . . 74.239999999999995 110.006 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.05 163.23 29.46 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.075 2.517 . . . . 71.129999999999995 112.795 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -140.08 147.19 39.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.188 0.44 . . . . 74.0 112.188 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HB3' ' HG2' ' A' ' 87' ' ' GLU . . . -86.08 177.76 7.45 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.611 1.164 . . . . 73.140000000000001 110.554 173.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -142.25 102.21 4.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.755 0.822 . . . . 72.439999999999998 109.96 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 64' ' ' THR . 11.4 t -114.67 151.35 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-O 121.839 0.828 . . . . 74.299999999999997 111.584 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.615 ' HB3' HG23 ' A' ' 117' ' ' ILE . 33.2 ttm105 -153.64 141.29 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.121 1.369 . . . . 73.129999999999995 108.872 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 49' ' ' ALA . 39.0 t -131.48 119.83 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.7 0.8 . . . . 73.329999999999998 108.904 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HH ' HD13 ' A' ' 117' ' ' ILE . 45.4 p90 -141.6 149.13 40.31 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.09 0.471 . . . . 73.450000000000003 111.125 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -78.81 141.28 37.88 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.09 -0.959 . . . . 74.239999999999995 109.051 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.515 HD11 HG11 ' A' ' 74' ' ' VAL . 9.2 tp -79.61 -36.97 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 122.783 0.433 . . . . 75.109999999999999 110.123 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -96.39 -39.14 9.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.647 0.779 . . . . 70.319999999999993 109.96 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.08 60.82 2.2 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.953 -0.567 . . . . 70.109999999999999 112.004 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m -119.17 -42.64 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.596 0.759 . . . . 72.319999999999993 110.812 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -122.22 148.13 45.35 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.025 0.53 . . . . 75.510000000000005 110.926 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.03 1.57 63.13 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.124 -0.82 . . . . 74.129999999999995 114.274 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.18 -35.03 10.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.742 1.217 . . . . 74.400000000000006 113.368 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HB3' HG11 ' A' ' 39' ' ' VAL . . . -63.07 -52.2 63.68 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.226 0.611 . . . . 61.009999999999998 111.033 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.87 -27.48 68.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.412 -0.813 . . . . 71.400000000000006 111.402 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -70.46 -52.4 22.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.522 0.729 . . . . 74.450000000000003 110.644 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -72.97 -23.96 60.72 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.075 -0.511 . . . . 74.049999999999997 110.954 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.42 -20.67 54.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.974 0.909 . . . . 71.239999999999995 111.816 173.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.45 -41.1 66.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.276 1.03 . . . . 54.130000000000003 109.11 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.51 -38.0 89.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.593 -1.185 . . . . 75.439999999999998 109.556 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.512 HD21 HG11 ' A' ' 37' ' ' VAL . 62.6 tp -63.12 -50.65 69.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.116 0.966 . . . . 72.150000000000006 112.331 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -27.17 66.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.846 0.355 . . . . 73.299999999999997 110.811 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.82 -20.85 34.87 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.679 0.791 . . . . 74.200000000000003 111.202 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.6 -23.48 27.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.541 0.736 . . . . 72.140000000000001 111.623 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.74 48.89 0.32 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.718 -0.49 . . . . 64.540000000000006 112.988 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -57.32 157.46 6.44 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.403 0.681 . . . . 73.099999999999994 111.099 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 35' ' ' ALA . 28.3 m -89.97 -66.34 0.93 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.133 -1.062 . . . . 62.299999999999997 108.133 173.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -144.28 134.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.135 -1.802 . . . . 63.539999999999999 106.135 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 91.4 m -143.25 123.59 13.85 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 122.836 0.454 . . . . 74.109999999999999 109.891 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -102.08 126.01 48.92 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.721 -0.844 . . . . 72.230000000000004 108.721 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 27.1 m -114.76 146.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.873 0.469 . . . . 71.519999999999996 110.25 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.25 -136.04 3.94 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 123.476 0.485 . . . . 75.310000000000002 113.314 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -159.39 117.53 2.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.115 0.966 . . . . 75.25 109.677 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.2 tp -150.65 140.7 22.05 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.257 0.623 . . . . 73.25 109.767 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.474 ' HA ' HD12 ' A' ' 42' ' ' ILE . 39.0 m -88.61 99.35 12.26 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.302 0.641 . . . . 73.439999999999998 110.236 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 40' ' ' TYR . 4.5 mm? -85.05 125.16 71.16 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.351 -0.981 . . . . 75.040000000000006 108.351 168.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 -11.85 32.33 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.67 2.246 . . . . 74.329999999999998 113.321 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.73 -22.79 23.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.84 0.856 . . . . 71.409999999999997 112.334 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.515 HG11 HD11 ' A' ' 42' ' ' ILE . 11.0 p -123.89 154.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.336 0.654 . . . . 65.340000000000003 110.131 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.36 40.61 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.209 1.004 . . . . 73.319999999999993 109.481 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.6 38.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.663 0.785 . . . . 55.109999999999999 110.57 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.598 ' HB ' HG21 ' A' ' 121' ' ' THR . 10.0 t -75.11 99.95 4.1 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.421 1.105 . . . . 62.219999999999999 108.688 172.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.7 m -149.13 131.01 15.17 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.02 -0.991 . . . . 73.109999999999999 109.492 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.743 HG23 HG11 ' A' ' 118' ' ' VAL . 86.9 t -95.62 114.13 31.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.526 -0.916 . . . . 75.430000000000007 108.526 174.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -101.51 137.43 39.84 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.084 -1.08 . . . . 74.409999999999997 108.084 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.472 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 43.9 p90 -134.46 143.08 47.31 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 74.209999999999994 112.689 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.2 m -95.28 169.63 9.95 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 113.845 -1.525 . . . . 73.439999999999998 107.376 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -116.03 13.61 15.91 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.317 0.858 . . . . 74.099999999999994 113.317 -165.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 86.0 t -64.21 115.0 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.9 0.48 . . . . 63.229999999999997 110.552 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 64.31 -77.17 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.937 1.295 . . . . 73.530000000000001 111.231 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.87 45.23 0.24 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.246 -0.342 . . . . 42.439999999999998 112.246 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . 42.4 mt-10 -61.22 -32.7 72.48 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.511 0.724 . . . . 75.409999999999997 112.31 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -56.73 -24.91 52.94 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.624 -0.716 . . . . 73.510000000000005 112.559 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.61 -43.64 75.97 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.616 0.766 . . . . 52.130000000000003 111.915 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.0 p -69.35 -39.64 77.99 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.423 -0.584 . . . . 74.420000000000002 109.423 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.97 96.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.367 1.067 . . . . 73.420000000000002 112.082 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.48 -38.38 87.15 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.377 1.048 . . . . 75.230000000000004 110.305 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.49 69.88 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.81 0.694 . . . . 73.340000000000003 110.655 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.431 HG12 HG23 ' A' ' 118' ' ' VAL . 62.1 t -67.41 -35.42 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.334 0.654 . . . . 74.120000000000005 110.856 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -68.72 -34.89 79.02 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 116.029 -0.532 . . . . 73.329999999999998 112.959 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -72.21 -44.26 63.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.608 0.763 . . . . 73.430000000000007 109.877 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.5 m -67.02 -37.85 84.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.225 1.01 . . . . 74.430000000000007 111.337 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 43.9 tp -81.73 -32.13 31.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.697 0.799 . . . . 74.230000000000004 110.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.91 40.84 15.92 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.934 -0.576 . . . . 72.510000000000005 112.081 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.56 156.27 24.96 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.519 0.728 . . . . 75.450000000000003 111.16 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.37 23.34 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.009 0.923 . . . . 74.530000000000001 110.949 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.472 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 27.4 m -89.86 112.3 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-O 121.737 0.779 . . . . 74.209999999999994 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -113.54 158.3 20.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.506 1.122 . . . . 74.519999999999996 110.256 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.0 mt -66.84 -175.9 0.45 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.748 0.819 . . . . 74.450000000000003 110.743 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 5.4 ppt_? -59.19 -37.55 77.67 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 116.355 -0.384 . . . . 64.239999999999995 111.513 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.533 ' N ' ' HD2' ' A' ' 105' ' ' ARG . 83.8 mt 58.08 172.53 0.05 OUTLIER Pre-proline 0 CA--C 1.573 1.829 0 C-N-CA 123.64 0.776 . . . . 74.109999999999999 112.491 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.72 -12.31 17.55 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.55 2.166 . . . . 72.140000000000001 114.077 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.31 -46.78 82.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.712 1.205 . . . . 64.140000000000001 112.0 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 114' ' ' PRO . 4.1 mm? -69.85 4.83 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.36 1.064 . . . . 75.200000000000003 113.429 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.9 t -72.1 -49.01 39.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.735 0.414 . . . . 74.409999999999997 110.368 171.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.87 -36.14 20.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.606 0.362 . . . . 52.210000000000001 111.36 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.48 ' HG3' HD11 ' A' ' 109' ' ' LEU . 4.8 pt20 -90.42 160.67 38.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 118.624 -0.703 . . . . 71.150000000000006 109.523 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.57 119.7 5.48 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.255 1.97 . . . . 74.219999999999999 112.66 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.604 ' HA ' HD12 ' A' ' 109' ' ' LEU . 56.4 Cg_endo -71.14 117.02 4.94 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.355 2.037 . . . . 65.239999999999995 113.2 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.433 ' H ' HD12 ' A' ' 109' ' ' LEU . . . 164.3 -161.08 34.16 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 110.858 -0.897 . . . . 63.420000000000002 110.858 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 70.6 t -77.07 106.24 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.231 -1.026 . . . . 75.25 108.231 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.615 HG23 ' HB3' ' A' ' 38' ' ' ARG . 2.8 pp -123.89 124.48 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.439 -0.949 . . . . 74.340000000000003 108.439 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.743 HG11 HG23 ' A' ' 79' ' ' VAL . 93.5 t -104.41 106.65 20.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.759 -1.2 . . . . 74.129999999999995 107.759 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.17 123.19 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.212 -0.662 . . . . 72.219999999999999 109.212 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.8 t -103.37 128.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.794 -0.817 . . . . 73.25 108.794 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.598 HG21 ' HB ' ' A' ' 77' ' ' THR . 10.1 t -72.94 132.32 43.31 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.467 -0.938 . . . . 72.530000000000001 108.467 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.082 0 N-CA-C 110.528 -1.029 . . . . 72.540000000000006 110.528 -166.352 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.449 0 N-CA-C 111.654 -0.579 . . . . 44.210000000000001 111.654 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -158.01 169.44 24.55 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.567 0.747 . . . . 63.450000000000003 110.172 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.4 p -146.94 110.86 4.09 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.742 0.817 . . . . 74.549999999999997 109.481 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.5 156.54 41.13 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.578 2.185 . . . . 73.049999999999997 113.23 171.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -125.24 139.62 53.57 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.434 1.094 . . . . 45.32 108.748 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 m -143.4 13.14 1.77 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.583 0.753 . . . . 73.219999999999999 111.218 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.42 -6.66 57.34 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.488 1.115 . . . . 75.209999999999994 111.807 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -57.02 -33.29 67.03 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.617 1.167 . . . . 74.219999999999999 112.103 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 67.9 168.79 0.26 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.41 1.084 . . . . 75.25 111.931 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 t -130.96 125.48 33.5 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.134 -0.691 . . . . 73.540000000000006 109.134 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.7 p -153.15 166.45 32.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.37 0.668 . . . . 64.120000000000005 109.964 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.98 154.55 51.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.509 0.724 . . . . 54.310000000000002 110.382 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 tt -144.48 138.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.786 0.834 . . . . 73.209999999999994 109.467 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 t -164.42 156.53 16.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.904 0.882 . . . . 72.109999999999999 109.743 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 t -162.95 154.77 17.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.201 0.6 . . . . 74.0 110.637 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.9 mtp -111.32 145.23 39.2 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.259 1.024 . . . . 74.099999999999994 109.932 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.7 p -141.7 138.2 32.25 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 73.209999999999994 109.875 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -115.12 171.93 7.37 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.425 0.69 . . . . 65.340000000000003 109.877 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -150.83 134.91 16.79 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.737 0.815 . . . . 74.329999999999998 109.24 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.2 m -99.26 124.73 44.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.054 0.542 . . . . 73.420000000000002 110.151 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.28 18.37 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.832 0.853 . . . . 74.329999999999998 109.109 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.71 109.9 60.59 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.092 0.557 . . . . 75.310000000000002 109.754 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.77 -171.22 1.19 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.514 2.143 . . . . 63.43 112.089 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -167.05 -179.39 4.61 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.086 0.955 . . . . 75.420000000000002 109.432 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -132.45 167.49 19.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.407 0.683 . . . . 73.140000000000001 110.607 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -113.3 136.49 52.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.406 1.082 . . . . 74.430000000000007 109.949 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -87.95 134.09 33.79 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.038 0.535 . . . . 73.109999999999999 109.972 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.61 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.71 0.804 . . . . 75.099999999999994 109.493 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.43 147.48 33.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 123.482 0.713 . . . . 74.019999999999996 110.081 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 149.61 58.93 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.744 2.296 . . . . 72.400000000000006 111.526 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.92 160.37 27.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.194 0.598 . . . . 52.530000000000001 110.187 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.89 156.02 80.63 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.764 . . . . 74.519999999999996 110.874 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -48.27 129.45 19.11 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.453 2.768 . . . . 74.230000000000004 113.418 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -98.68 -59.58 1.71 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.103 0.561 . . . . 73.409999999999997 111.506 -174.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . . . -156.23 168.04 28.53 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.955 0.724 . . . . 53.240000000000002 112.955 -167.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HG3' ' HB ' ' A' ' 63' ' ' VAL . 36.1 tt0 -87.43 124.36 33.34 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 113.969 -1.469 . . . . 72.430000000000007 110.426 176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.1 t -110.65 140.06 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.333 1.053 . . . . 72.349999999999994 108.937 167.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -138.4 109.17 6.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.215 0.531 . . . . 75.140000000000001 109.873 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.575 ' HA ' ' HB ' ' A' ' 118' ' ' VAL . 41.1 t -95.46 134.05 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.384 1.074 . . . . 75.340000000000003 110.014 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.467 ' HE2' HD12 ' A' ' 42' ' ' ILE . 37.5 p90 -156.24 143.89 19.39 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.648 0.379 . . . . 75.129999999999995 110.53 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -97.19 142.99 28.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.503 -0.555 . . . . 75.310000000000002 109.503 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.467 HD12 ' HE2' ' A' ' 40' ' ' TYR . 7.2 mt -120.42 20.34 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 122.306 1.051 . . . . 75.319999999999993 109.891 -177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.2 m -150.18 -137.9 0.08 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.355 1.062 . . . . 73.230000000000004 108.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.07 92.25 0.05 OUTLIER Glycine 0 C--N 1.36 1.874 0 CA-C-N 118.416 0.553 . . . . 65.219999999999999 112.344 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 t -85.0 109.04 17.9 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.802 0.841 . . . . 73.340000000000003 112.122 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -103.59 171.15 7.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.141 -0.936 . . . . 73.140000000000001 109.196 166.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 -2.01 79.65 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.432 -0.349 . . . . 53.32 113.457 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.03 -30.18 71.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.939 0.896 . . . . 72.329999999999998 112.443 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.52 97.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.27 0.628 . . . . 71.129999999999995 110.891 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.62 -25.61 67.46 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.706 0.632 . . . . 74.409999999999997 112.706 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -27.68 66.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.589 1.155 . . . . 74.420000000000002 111.673 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -69.42 -59.31 3.07 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 110.38 -0.23 . . . . 75.129999999999995 110.38 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.56 65.09 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.263 0.625 . . . . 74.530000000000001 112.022 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.37 -44.33 54.66 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.742 1.217 . . . . 74.200000000000003 111.324 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -76.63 -32.7 58.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.831 -0.622 . . . . 74.510000000000005 111.451 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.78 -33.23 75.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.513 0.325 . . . . 74.299999999999997 111.799 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -66.84 -38.58 86.69 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.898 0.38 . . . . 74.219999999999999 110.096 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.61 68.31 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.566 -0.743 . . . . 72.129999999999995 111.212 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -14.59 61.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.806 0.843 . . . . 73.0 111.255 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.09 21.58 32.53 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 119.402 -0.666 . . . . 34.100000000000001 113.226 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -74.53 157.78 34.91 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.294 0.547 . . . . 63.229999999999997 109.735 170.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -69.14 -65.03 0.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.043 -0.526 . . . . 75.129999999999995 111.378 -156.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 93.0 t -127.71 135.69 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.134 -1.062 . . . . 64.030000000000001 108.134 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 p -134.1 102.42 5.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.648 0.779 . . . . 64.209999999999994 109.054 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.8 150.65 22.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.186 0.594 . . . . 62.140000000000001 109.833 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 15.1 m -143.83 139.23 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.75 0.82 . . . . 75.420000000000002 110.198 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.26 -143.18 6.34 Favored Glycine 0 C--N 1.35 1.352 0 C-N-CA 121.228 -0.511 . . . . 55.119999999999997 113.829 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -158.25 128.13 5.96 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.634 0.773 . . . . 75.239999999999995 110.595 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.1 163.56 16.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.766 0.826 . . . . 63.240000000000002 110.865 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -76.85 149.38 36.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.746 1.218 . . . . 74.409999999999997 110.213 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.97 107.36 0.84 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 123.859 0.864 . . . . 73.109999999999999 111.701 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -93.67 -87.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.132 2.554 . . . . 65.439999999999998 111.173 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.82 -15.8 13.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.094 0.958 . . . . 63.509999999999998 110.935 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.14 143.09 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.744 0.818 . . . . 74.129999999999995 111.068 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.42 23.13 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.832 0.853 . . . . 71.329999999999998 111.125 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.03 143.94 37.69 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.375 0.67 . . . . 73.340000000000003 109.317 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -73.71 96.52 2.52 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.378 1.085 . . . . 75.310000000000002 108.703 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 101' ' ' ALA . 5.2 p -151.91 137.79 18.07 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.723 -1.126 . . . . 73.430000000000007 109.844 -170.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 118' ' ' VAL . 60.9 t -96.82 116.85 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.982 -0.748 . . . . 75.340000000000003 108.982 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.27 139.33 41.9 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.928 -0.767 . . . . 74.329999999999998 108.928 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.471 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 39.6 p90 -143.03 147.43 35.08 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.703 0.763 . . . . 72.329999999999998 112.436 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -78.3 166.42 22.71 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 107.396 -1.335 . . . . 73.519999999999996 107.396 160.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.49 22.56 9.92 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.357 -0.839 . . . . 73.409999999999997 112.066 -168.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.17 111.26 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 109.662 -0.496 . . . . 74.319999999999993 109.662 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 63.48 -82.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.331 1.452 . . . . 75.310000000000002 111.492 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.99 35.07 1.19 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 116.206 -0.452 . . . . 70.019999999999996 112.989 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 35' ' ' ALA . 50.3 mt-10 -71.27 -34.29 70.56 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.429 -0.952 . . . . 74.450000000000003 108.429 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -54.56 -36.61 64.53 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.839 -1.073 . . . . 74.030000000000001 112.061 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.59 55.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.654 0.782 . . . . 71.129999999999995 111.187 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.3 p -67.97 -30.0 69.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.067 0.547 . . . . 74.230000000000004 110.831 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.86 -38.16 64.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.067 -0.969 . . . . 75.420000000000002 111.397 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.03 -38.95 90.65 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.785 0.834 . . . . 74.140000000000001 110.808 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -51.96 67.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.907 0.883 . . . . 72.219999999999999 111.275 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.1 t -73.03 -46.1 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.053 0.541 . . . . 74.409999999999997 111.848 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.74 -24.81 57.91 Favored Glycine 0 N--CA 1.468 0.811 0 O-C-N 123.561 0.538 . . . . 71.239999999999995 112.799 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -81.48 -42.21 20.62 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.62 0.768 . . . . 74.109999999999999 109.874 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.5 m -73.76 -28.96 61.95 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.311 0.577 . . . . 74.25 111.344 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.0 tp -92.31 -29.29 16.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.785 1.234 . . . . 71.030000000000001 109.423 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 46.35 18.32 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.738 0.648 . . . . 63.210000000000001 111.958 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.31 148.49 42.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.827 0.851 . . . . 75.340000000000003 109.764 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.498 ' HB3' HG22 ' A' ' 78' ' ' THR . . . -66.38 116.08 7.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.309 0.644 . . . . 62.219999999999999 110.459 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.471 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.9 m -85.25 140.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.256 0.622 . . . . 74.540000000000006 109.329 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -155.2 153.83 31.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.48 0.712 . . . . 63.229999999999997 109.651 -174.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.04 173.01 3.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.82 0.848 . . . . 70.129999999999995 110.811 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -83.58 26.66 0.66 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.998 1.11 . . . . 74.010000000000005 113.998 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.1 mm? -64.17 -53.65 45.81 Favored Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 118.146 -0.93 . . . . 74.230000000000004 111.41 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 22.8 Cg_exo -67.1 -38.25 16.5 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 121.663 1.575 . . . . 73.209999999999994 113.129 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.01 -21.38 61.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.253 0.345 . . . . 74.219999999999999 110.875 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.43 -14.36 56.37 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.328 1.051 . . . . 73.340000000000003 111.372 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 t -57.94 -48.02 81.16 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.268 0.627 . . . . 73.150000000000006 110.483 171.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.97 -31.87 21.84 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.851 0.86 . . . . 75.239999999999995 110.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.32 73.46 0.63 Allowed Pre-proline 0 CA--C 1.561 1.404 0 C-N-CA 125.786 1.634 . . . . 72.0 110.805 -173.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -88.4 148.48 6.4 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.338 2.692 . . . . 72.420000000000002 110.976 165.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -87.41 133.67 3.29 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.362 2.041 . . . . 73.450000000000003 112.787 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.97 -139.7 14.68 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.432 -0.803 . . . . 61.340000000000003 114.033 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.2 t -105.82 113.14 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.328 1.051 . . . . 72.409999999999997 110.258 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.1 pt -101.04 114.38 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 122.049 0.928 . . . . 75.219999999999999 109.075 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.698 HG12 HG23 ' A' ' 79' ' ' VAL . 89.5 t -90.69 108.49 19.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.264 -1.013 . . . . 71.129999999999995 108.264 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.4 117.56 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.333 -0.988 . . . . 74.400000000000006 108.333 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.23 142.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.045 -1.465 . . . . 73.230000000000004 107.045 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.3 p -134.98 110.68 9.25 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.889 -0.782 . . . . 63.229999999999997 108.889 168.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.212 0 CA-C-O 118.904 -0.942 . . . . 72.319999999999993 112.97 178.596 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.884 0 CA-C-O 120.108 -0.274 . . . . 71.109999999999999 112.66 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.8 p -155.92 150.04 25.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.199 1.0 . . . . 72.540000000000006 109.423 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 p -94.3 133.24 27.53 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.649 0.78 . . . . 75.129999999999995 111.568 -176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.68 139.18 51.91 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 122.77 2.313 . . . . 74.25 112.842 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.93 -173.94 2.43 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.878 0.871 . . . . 71.439999999999998 109.614 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -136.78 108.17 6.88 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.96 0.504 . . . . 74.420000000000002 109.871 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -91.67 6.7 44.81 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.299 0.639 . . . . 75.150000000000006 110.289 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.47 -73.23 0.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.073 0.949 . . . . 63.210000000000001 111.39 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 t70 64.43 146.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.176 1.39 . . . . 72.319999999999993 112.901 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 p -134.69 120.61 19.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.48 0.712 . . . . 71.299999999999997 109.982 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.9 p -129.76 152.36 49.34 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.64 0.776 . . . . 73.510000000000005 109.748 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.45 176.4 5.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.769 0.828 . . . . 64.409999999999997 110.825 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.77 -175.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.318 1.047 . . . . 74.430000000000007 109.887 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -150.13 161.5 42.26 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.824 0.85 . . . . 64.129999999999995 110.024 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 p -98.38 153.75 18.34 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.743 0.817 . . . . 74.420000000000002 111.655 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 92.7 mmm -113.31 152.62 29.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.543 1.137 . . . . 72.409999999999997 109.257 171.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -115.65 125.77 53.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.802 0.841 . . . . 71.129999999999995 109.014 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -118.57 142.14 47.9 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.209 0.603 . . . . 73.129999999999995 109.933 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -154.84 164.64 38.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.241 1.017 . . . . 73.099999999999994 109.447 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -149.45 168.06 24.48 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 120.909 0.385 . . . . 74.310000000000002 110.967 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.14 166.25 13.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.164 0.985 . . . . 51.25 109.846 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.34 125.19 22.47 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.262 0.625 . . . . 75.230000000000004 110.909 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.42 -170.57 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.156 2.57 . . . . 75.519999999999996 112.271 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 m -133.34 146.75 51.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.715 0.806 . . . . 74.430000000000007 109.549 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 p -77.4 167.62 21.38 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.648 0.779 . . . . 55.229999999999997 111.44 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 m -110.41 131.44 55.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.514 0.725 . . . . 74.340000000000003 109.532 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.4 t -122.23 130.86 53.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.684 0.793 . . . . 55.030000000000001 109.971 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.33 149.42 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.378 0.671 . . . . 71.409999999999997 111.195 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -82.37 139.24 44.8 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 108.574 -0.898 . . . . 74.040000000000006 108.574 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.65 168.36 11.79 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.501 2.134 . . . . 75.200000000000003 112.216 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.37 169.48 10.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.386 0.674 . . . . 72.219999999999999 110.799 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.43 135.67 56.96 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.408 0.683 . . . . 73.140000000000001 109.857 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.12 129.18 15.77 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.436 2.09 . . . . 70.340000000000003 112.099 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -84.38 -87.23 0.12 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.45 0.7 . . . . 70.310000000000002 111.42 -176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.63 175.35 14.03 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.228 0.611 . . . . 75.519999999999996 109.959 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.2 mt-10 -80.73 117.89 21.8 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.817 -0.629 . . . . 64.150000000000006 110.065 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.412 HG23 HD22 ' A' ' 56' ' ' LEU . 24.2 t -127.3 143.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.56 0.744 . . . . 75.409999999999997 109.422 174.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.85 132.45 15.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.769 0.428 . . . . 75.430000000000007 110.075 173.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 118' ' ' VAL . 4.8 t -103.95 108.7 25.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 123.636 0.774 . . . . 74.329999999999998 109.148 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 23.7 m-85 -107.04 135.94 47.74 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.403 0.681 . . . . 71.430000000000007 109.781 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -101.06 127.3 47.64 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.261 -0.644 . . . . 53.329999999999998 109.261 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.753 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -71.89 -24.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.577 -0.527 . . . . 71.230000000000004 109.577 171.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 p -97.58 -67.03 0.87 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.698 1.199 . . . . 73.140000000000001 111.112 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.27 11.64 35.8 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.362 0.506 . . . . 72.120000000000005 113.096 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -80.23 -61.53 1.95 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.058 0.543 . . . . 75.010000000000005 111.186 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -78.35 123.9 27.51 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.609 -0.723 . . . . 72.349999999999994 111.12 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.9 -0.8 89.84 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 124.295 0.95 . . . . 52.43 114.303 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . . . -64.51 -21.74 66.77 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.781 0.791 . . . . 61.109999999999999 111.524 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.69 68.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.038 1.335 . . . . 71.349999999999994 111.958 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' HB2' HH11 ' A' ' 51' ' ' ARG . . . -62.12 -36.59 82.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.588 0.755 . . . . 63.140000000000001 111.361 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.459 HH11 ' HB2' ' A' ' 50' ' ' ALA . 9.9 mpt_? -73.0 -38.57 66.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.686 0.795 . . . . 75.239999999999995 111.167 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 p -64.71 -29.02 69.99 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.047 0.539 . . . . 62.310000000000002 111.683 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.62 7.21 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.441 0.697 . . . . 74.340000000000003 110.946 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -56.46 -43.8 79.93 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.473 1.509 . . . . 64.019999999999996 112.04 -171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.54 -0.755 . . . . 74.530000000000001 111.786 -176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD22 HG23 ' A' ' 37' ' ' VAL . 9.2 mp -73.2 -27.97 61.93 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.476 0.311 . . . . 72.519999999999996 111.406 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.77 -40.15 91.73 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.641 0.588 . . . . 75.319999999999993 109.842 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.87 -23.03 59.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.211 0.604 . . . . 62.299999999999997 111.528 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.73 -3.3 46.91 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.623 0.769 . . . . 34.340000000000003 112.557 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.44 49.26 2.22 Favored Glycine 0 C--N 1.347 1.159 0 C-N-CA 121.431 -0.414 . . . . 74.010000000000005 112.082 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.21 158.02 4.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.58 1.152 . . . . 72.25 112.654 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -91.79 -57.1 2.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 106.91 -1.515 . . . . 72.129999999999995 106.91 160.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 74.0 t -129.45 136.3 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 73.519999999999996 108.153 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 60.6 m -141.28 114.21 8.49 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.33 -0.989 . . . . 75.5 108.33 169.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -120.25 152.79 37.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.677 0.791 . . . . 73.530000000000001 110.059 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.0 139.62 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.574 -0.899 . . . . 74.25 108.574 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.45 -179.31 36.07 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.399 0.437 . . . . 71.150000000000006 112.235 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -143.96 124.21 13.78 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.405 -0.961 . . . . 71.239999999999995 108.405 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 134.46 11.33 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.746 -0.835 . . . . 74.519999999999996 108.746 -170.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.753 ' HA ' HG13 ' A' ' 42' ' ' ILE . 19.6 t -77.68 99.55 5.86 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.449 -0.945 . . . . 74.430000000000007 108.449 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.3 tp -103.83 120.62 50.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.464 0.706 . . . . 75.519999999999996 109.311 -172.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.86 -28.41 87.14 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.732 2.955 . . . . 74.430000000000007 114.984 -171.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.72 9.05 25.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.476 0.711 . . . . 73.329999999999998 112.063 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.503 HG21 HG13 ' A' ' 119' ' ' VAL . 63.9 t -105.92 111.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.306 0.642 . . . . 75.409999999999997 109.54 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.43 10.37 11.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.694 0.798 . . . . 70.239999999999995 111.092 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -170.04 156.89 6.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.836 0.854 . . . . 61.420000000000002 110.791 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 121' ' ' THR . 2.1 t -69.71 102.37 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.57 0.748 . . . . 71.519999999999996 109.537 173.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.534 HG21 ' HG2' ' A' ' 103' ' ' GLU . 87.8 m -150.21 149.13 29.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.835 -0.62 . . . . 74.150000000000006 110.985 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' A' ' 118' ' ' VAL . 40.4 t -94.59 113.68 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.282 -1.007 . . . . 74.340000000000003 108.282 175.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.543 ' HD1' ' HB2' ' A' ' 103' ' ' GLU . 28.8 m-85 -99.27 135.44 40.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.527 -0.916 . . . . 71.310000000000002 108.527 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.93 138.16 53.24 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.144 0.497 . . . . 75.409999999999997 111.123 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -73.03 153.5 40.86 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 114.935 -1.03 . . . . 74.430000000000007 109.159 170.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.66 ' HB3' HD12 ' A' ' 104' ' ' LEU . 11.6 pt-20 -102.06 26.26 7.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.28 0.474 . . . . 74.219999999999999 112.28 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.2 t -70.8 93.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 108.499 -0.926 . . . . 73.120000000000005 108.499 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 70.52 -77.74 0.05 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.444 1.498 . . . . 71.129999999999995 111.162 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.43 50.06 0.31 Allowed Glycine 0 C--N 1.352 1.453 0 N-CA-C 112.523 -0.231 . . . . 65.150000000000006 112.523 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.24 -18.64 63.9 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 120.843 0.354 . . . . 63.420000000000002 110.675 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.64 -28.25 68.33 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.847 0.859 . . . . 72.340000000000003 111.386 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.77 -36.03 81.76 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.622 0.769 . . . . 74.200000000000003 110.754 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 m -74.7 -38.26 62.4 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.771 -1.104 . . . . 71.219999999999999 110.498 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -20.04 56.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.751 0.82 . . . . 44.329999999999998 112.351 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -58.57 -49.7 76.49 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.898 -0.778 . . . . 74.329999999999998 108.898 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.85 70.74 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 124.442 1.088 . . . . 72.430000000000007 111.45 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.82 -46.85 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.212 0.605 . . . . 74.540000000000006 111.686 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.41 -26.99 62.62 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.681 0.613 . . . . 74.510000000000005 111.913 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -85.4 -31.34 22.96 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.132 0.973 . . . . 74.540000000000006 110.777 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.0 m -76.57 -29.91 56.83 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.914 0.388 . . . . 75.340000000000003 110.435 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 tp -95.79 -32.71 12.56 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.604 0.762 . . . . 71.230000000000004 110.141 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.72 44.62 47.9 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.187 -0.461 . . . . 73.409999999999997 111.985 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.95 177.57 6.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.955 0.902 . . . . 73.420000000000002 110.116 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.81 158.55 35.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.743 -0.662 . . . . 74.530000000000001 109.918 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.557 HG12 ' HB ' ' A' ' 79' ' ' VAL . 27.3 m -127.1 144.15 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.768 0.827 . . . . 74.230000000000004 109.669 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.543 ' HB2' ' HD1' ' A' ' 80' ' ' TYR . 59.9 mm-40 -129.84 149.39 51.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.227 1.011 . . . . 73.129999999999995 109.872 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.66 HD12 ' HB3' ' A' ' 83' ' ' GLU . 51.7 tp -69.24 175.98 3.57 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.803 -1.09 . . . . 72.319999999999993 108.837 165.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.503 ' HB3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -67.62 20.31 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.37 1.619 . . . . 64.120000000000005 115.37 -175.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.84 -46.1 81.57 Favored Pre-proline 0 CA--C 1.564 1.486 0 CA-C-O 117.947 -1.025 . . . . 75.549999999999997 111.871 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.0 -42.12 32.26 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 122.188 1.925 . . . . 64.409999999999997 111.233 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 88.0 mt-10 -60.17 -26.48 66.35 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 115.998 -0.546 . . . . 73.319999999999993 111.134 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.61 -10.18 17.35 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.101 0.96 . . . . 74.230000000000004 112.319 -171.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -56.74 -49.95 73.7 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.843 0.857 . . . . 72.409999999999997 111.625 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.11 -33.44 2.19 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.579 0.752 . . . . 62.049999999999997 111.16 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 73.67 80.08 0.17 Allowed Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 126.029 1.731 . . . . 75.349999999999994 111.746 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 69.1 Cg_endo -81.26 124.34 4.78 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.574 2.183 . . . . 73.530000000000001 110.371 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.91 116.66 4.79 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.033 1.822 . . . . 73.420000000000002 111.21 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.81 156.82 12.69 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.243 0.449 . . . . 74.140000000000001 112.222 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.25 119.75 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.174 1.39 . . . . 73.540000000000006 112.774 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 80' ' ' TYR . 44.4 pt -110.76 106.86 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.763 -0.828 . . . . 73.209999999999994 108.763 172.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.56 ' HB ' HG11 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -96.39 111.81 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.394 -0.965 . . . . 71.420000000000002 108.394 175.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.5 t -114.91 118.69 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.593 -0.276 . . . . 72.120000000000005 110.975 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -99.23 144.17 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.525 0.73 . . . . 73.329999999999998 110.019 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.603 ' H ' ' HB ' ' A' ' 77' ' ' THR . 12.0 t -118.27 165.45 13.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.788 0.835 . . . . 73.010000000000005 109.596 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 N-CA-C 110.53 -1.028 . . . . 63.219999999999999 110.53 179.253 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.551 -0.22 . . . . 71.109999999999999 112.551 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -152.7 95.73 2.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.043 0.937 . . . . 74.140000000000001 108.934 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 m -88.33 131.57 41.97 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.074 0.549 . . . . 74.329999999999998 109.798 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.05 138.05 55.18 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.48 2.12 . . . . 73.5 112.097 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -145.91 111.19 5.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.469 0.708 . . . . 75.310000000000002 109.785 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.6 p -162.85 35.5 0.1 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.707 1.203 . . . . 73.439999999999998 108.682 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.14 14.58 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.248 1.019 . . . . 74.209999999999994 112.698 -172.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -55.93 -65.34 0.62 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.569 1.148 . . . . 72.519999999999996 110.944 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 54.93 83.07 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.278 0.986 . . . . 73.230000000000004 111.201 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.8 p -80.24 138.11 36.75 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.844 -0.616 . . . . 71.049999999999997 110.322 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 p -152.12 133.66 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 72.239999999999995 110.257 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.88 119.25 3.57 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.386 -0.968 . . . . 73.439999999999998 108.386 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -116.75 133.43 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.102 0.561 . . . . 74.209999999999994 110.581 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -147.46 127.02 13.26 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.948 0.899 . . . . 73.200000000000003 108.865 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -145.72 103.12 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.706 0.803 . . . . 62.350000000000001 109.068 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -145.1 149.58 35.3 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.111 0.964 . . . . 75.129999999999995 109.725 -178.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -148.2 160.87 42.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.167 0.587 . . . . 73.239999999999995 109.812 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -147.56 150.48 34.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.58 0.752 . . . . 75.099999999999994 109.477 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -155.89 161.66 40.54 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.592 0.757 . . . . 71.420000000000002 109.957 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.7 t -153.67 178.64 9.64 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.241 1.016 . . . . 62.219999999999999 109.387 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.18 173.44 11.58 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.608 1.163 . . . . 73.329999999999998 109.262 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 121.48 6.38 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.471 0.709 . . . . 73.0 110.146 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.32 141.11 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.78 2.32 . . . . 75.200000000000003 112.325 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.6 p -136.3 142.09 43.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.664 0.786 . . . . 74.329999999999998 110.168 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.7 p -173.83 134.85 0.48 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.277 1.031 . . . . 71.319999999999993 109.913 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.0 p -102.35 -177.26 3.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.864 0.866 . . . . 72.040000000000006 111.065 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -149.12 126.83 11.73 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.487 -0.931 . . . . 72.430000000000007 108.487 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.68 157.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.692 0.797 . . . . 73.549999999999997 110.069 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -113.36 131.44 22.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 73.439999999999998 110.044 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.95 160.98 33.43 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.954 2.436 . . . . 75.439999999999998 112.558 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -124.87 177.58 5.94 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.367 1.067 . . . . 61.32 109.578 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.26 141.76 43.02 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.315 0.646 . . . . 54.109999999999999 110.413 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.75 159.35 24.8 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.89 2.393 . . . . 74.5 112.314 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.549 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 95.5 mtt180 -123.18 150.49 43.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.585 0.754 . . . . 75.329999999999998 110.216 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -171.8 134.22 0.79 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.888 0.875 . . . . 72.040000000000006 110.11 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.24 104.18 13.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.231 0.613 . . . . 74.5 109.387 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.9 t -96.47 127.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.538 -0.912 . . . . 75.319999999999993 108.538 174.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 65' ' ' ASP . 43.5 ttm105 -147.77 111.81 5.15 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.169 -0.332 . . . . 75.310000000000002 110.436 -171.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 130.99 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.169 0.588 . . . . 75.040000000000006 109.586 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 17.1 m-85 -124.95 132.46 53.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.952 0.901 . . . . 73.420000000000002 109.02 167.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.404 ' H ' ' HA ' ' A' ' 68' ' ' ASN . 41.0 m-80 -94.31 121.81 36.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 73.540000000000006 109.707 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.7 tp -78.99 -27.79 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.401 0.68 . . . . 75.129999999999995 109.332 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.467 ' HB3' ' H ' ' A' ' 122' ' ' GLY . 34.6 t -125.21 -162.04 1.07 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.596 1.158 . . . . 71.230000000000004 108.384 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.01 136.37 51.3 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 118.364 0.529 . . . . 53.549999999999997 112.791 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.3 t -78.56 122.67 26.2 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.994 0.518 . . . . 64.219999999999999 110.601 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.93 160.32 18.73 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.12 -0.696 . . . . 74.25 109.12 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.35 -41.57 87.73 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.3 0.375 . . . . 71.310000000000002 112.361 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 52' ' ' THR . . . -63.33 -31.46 72.62 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.208 1.003 . . . . 72.230000000000004 112.307 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.43 -49.72 76.28 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.839 0.712 . . . . 72.150000000000006 111.305 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.93 -32.0 57.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.464 -0.789 . . . . 43.439999999999998 110.669 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.65 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 31.6 tpt180 -71.4 -20.19 62.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.888 0.875 . . . . 72.219999999999999 111.987 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 48' ' ' ALA . 42.1 p -58.95 -52.79 64.22 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.561 0.619 . . . . 64.010000000000005 110.208 174.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.59 -25.67 45.31 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.98 -1.009 . . . . 74.140000000000001 111.515 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.65 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 31.8 t70 -79.06 -22.71 44.95 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.116 0.966 . . . . 63.420000000000002 110.819 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -86.76 -37.96 17.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.603 0.761 . . . . 71.109999999999999 109.126 168.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 tp -71.21 -19.36 62.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.489 0.715 . . . . 72.340000000000003 112.16 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.99 -27.34 69.34 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 110.491 -0.188 . . . . 73.329999999999998 110.491 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.95 60.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.696 0.798 . . . . 74.230000000000004 111.495 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.33 12.51 6.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.739 0.816 . . . . 62.240000000000002 112.723 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.29 46.39 6.98 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 120.313 -0.159 . . . . 75.420000000000002 113.091 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -58.97 152.12 20.42 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.255 1.022 . . . . 74.519999999999996 111.316 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 34' ' ' ARG . 58.7 m -86.4 -55.03 4.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.718 -0.845 . . . . 74.150000000000006 108.718 171.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.61 147.37 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.591 -0.892 . . . . 73.200000000000003 108.591 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 54.0 m -142.84 144.9 32.7 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.523 1.129 . . . . 71.140000000000001 109.801 -172.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 29.6 t70 -143.67 143.9 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.483 1.113 . . . . 63.43 108.34 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.85 133.13 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.363 -0.977 . . . . 71.239999999999995 108.363 173.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.85 -160.8 11.23 Favored Glycine 0 C--O 1.246 0.86 0 N-CA-C 111.609 -0.597 . . . . 75.329999999999998 111.609 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.404 ' HA ' ' H ' ' A' ' 41' ' ' ASN . 26.2 p30 -130.34 140.15 50.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.366 1.066 . . . . 73.530000000000001 108.466 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -157.48 134.43 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.51 -0.552 . . . . 75.200000000000003 109.51 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.5 t -73.39 98.23 2.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.972 -1.122 . . . . 73.239999999999995 107.972 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.74 98.55 9.89 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.832 -1.173 . . . . 74.049999999999997 107.832 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.64 -1.01 10.12 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.725 2.283 . . . . 75.209999999999994 113.156 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.99 -23.55 41.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.784 0.833 . . . . 65.219999999999999 110.551 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.49 HG13 HG21 ' A' ' 119' ' ' VAL . 2.7 p -134.05 140.03 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.428 1.091 . . . . 71.329999999999998 110.84 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.46 62.07 1.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.544 -0.91 . . . . 64.420000000000002 108.544 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.04 155.75 16.5 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.195 -0.911 . . . . 51.32 110.361 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t -82.43 98.62 8.98 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.604 -1.258 . . . . 75.150000000000006 107.604 167.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 m -149.25 139.65 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.999 -1.001 . . . . 74.25 109.173 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.725 HG22 HG12 ' A' ' 118' ' ' VAL . 97.9 t -95.74 116.27 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.205 -1.035 . . . . 74.409999999999997 108.205 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.607 ' HB2' HG13 ' A' ' 117' ' ' ILE . 90.4 m-85 -109.53 154.76 22.25 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.27 -0.641 . . . . 75.109999999999999 109.27 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -139.46 170.43 15.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.738 -0.665 . . . . 74.340000000000003 111.19 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.0 p -110.75 -159.29 0.67 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.627 -0.879 . . . . 75.010000000000005 108.627 164.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.21 21.05 12.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.192 0.997 . . . . 70.549999999999997 110.092 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.38 100.9 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.866 0.866 . . . . 75.299999999999997 110.015 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.549 ' HG2' ' H ' ' A' ' 34' ' ' ARG . 14.0 tp10 70.06 -75.86 0.07 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.588 1.555 . . . . 71.040000000000006 111.62 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.47 40.81 0.81 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.644 -1.383 . . . . 63.140000000000001 109.644 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.54 -39.18 85.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.961 -0.619 . . . . 65.25 110.142 -172.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -67.01 -31.4 71.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.589 -0.732 . . . . 75.099999999999994 110.947 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.2 -43.11 64.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.607 0.763 . . . . 74.109999999999999 111.427 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 94' ' ' VAL . 9.8 t -76.69 -34.55 58.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.65 -0.5 . . . . 64.450000000000003 109.65 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HB1' HG22 ' A' ' 116' ' ' VAL . . . -64.06 -38.74 92.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.362 0.665 . . . . 73.439999999999998 111.963 176.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.581 ' HA ' HG12 ' A' ' 102' ' ' VAL . 25.7 t70 -58.1 -36.04 72.3 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.322 1.014 . . . . 72.549999999999997 110.318 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.9 78.47 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.474 -0.785 . . . . 63.520000000000003 111.226 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 118' ' ' VAL . 22.0 t -71.26 -34.62 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.28 0.632 . . . . 74.430000000000007 112.284 -174.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 79' ' ' VAL . . . -59.48 -34.86 83.03 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 121.954 0.752 . . . . 61.210000000000001 112.006 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -80.63 -30.58 36.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.836 -1.182 . . . . 72.329999999999998 110.658 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 m -74.36 -21.02 59.87 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.04 0.536 . . . . 75.329999999999998 110.942 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 38.7 tp -97.16 -32.18 12.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.178 0.591 . . . . 75.5 110.609 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.6 53.8 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.869 -0.605 . . . . 35.520000000000003 112.027 -170.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.23 -177.69 3.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.375 1.07 . . . . 72.239999999999995 111.082 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.65 154.8 17.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.522 0.729 . . . . 75.209999999999994 110.318 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 92' ' ' ASP . 19.9 m -108.35 129.95 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.452 -0.573 . . . . 75.040000000000006 109.452 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.34 164.03 28.34 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.863 0.865 . . . . 75.519999999999996 111.185 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.28 -175.32 0.11 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.969 -1.014 . . . . 72.140000000000001 112.134 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.32 -27.48 62.46 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.757 -0.64 . . . . 75.430000000000007 112.048 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.64 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 124.549 1.14 . . . . 71.329999999999998 111.714 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.12 -27.16 84.23 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.487 2.124 . . . . 73.129999999999995 112.281 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -79.2 -53.57 6.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.885 1.274 . . . . 74.239999999999995 110.97 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.444 HD11 ' HB ' ' A' ' 74' ' ' VAL . 52.1 mt -82.53 16.05 2.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.84 0.856 . . . . 75.230000000000004 111.611 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.3 m -84.94 -11.13 56.21 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.82 0.448 . . . . 62.450000000000003 110.55 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.37 8.08 29.39 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.481 0.712 . . . . 73.510000000000005 110.994 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -76.66 164.98 56.12 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.925 0.89 . . . . 75.219999999999999 110.708 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.2 122.29 11.32 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.948 1.766 . . . . 74.540000000000006 111.098 163.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.29 136.77 55.49 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.926 3.084 . . . . 70.140000000000001 115.277 -164.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.75 -162.5 15.49 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.583 -0.735 . . . . 72.230000000000004 113.22 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.468 HG22 ' HB1' ' A' ' 91' ' ' ALA . 57.9 t -66.69 115.65 4.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 124.092 0.957 . . . . 64.040000000000006 108.972 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.607 HG13 ' HB2' ' A' ' 80' ' ' TYR . 7.6 pt -106.23 106.67 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.524 -0.917 . . . . 74.450000000000003 108.524 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.725 HG12 HG22 ' A' ' 79' ' ' VAL . 44.5 t -88.52 100.95 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.547 -1.649 . . . . 74.329999999999998 106.547 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 74' ' ' VAL . 49.8 t -93.5 118.46 39.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 N-CA-C 107.109 -1.441 . . . . 73.120000000000005 107.109 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.24 136.6 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 122.972 0.509 . . . . 75.209999999999994 109.762 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -117.54 137.29 52.67 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.565 0.746 . . . . 72.420000000000002 109.386 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.467 ' H ' ' HB3' ' A' ' 43' ' ' SER . . . . . . . . 0 CA--C 1.534 1.265 0 N-CA-C 110.721 -0.951 . . . . 44.409999999999997 110.721 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.879 -0.488 . . . . 63.009999999999998 111.879 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.0 m -141.08 103.22 4.41 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.272 0.629 . . . . 72.219999999999999 110.448 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 p -119.78 99.69 49.22 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.111 0.965 . . . . 70.319999999999993 108.969 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.62 27.27 0.54 Allowed 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 123.355 2.703 . . . . 74.340000000000003 113.386 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.19 105.39 1.38 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.954 0.902 . . . . 74.209999999999994 111.102 -172.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 t -154.86 22.61 0.45 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.335 0.654 . . . . 74.230000000000004 109.991 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -83.69 15.21 3.32 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.063 0.945 . . . . 75.409999999999997 111.773 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -96.97 17.9 15.89 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.907 1.283 . . . . 72.519999999999996 111.728 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -64.5 112.95 3.37 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.887 -0.412 . . . . 73.099999999999994 109.887 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p -114.7 148.53 38.12 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.629 0.772 . . . . 71.5 110.179 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.9 p -158.77 129.82 6.25 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.028 0.931 . . . . 64.219999999999999 109.101 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.38 133.3 8.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.515 0.726 . . . . 72.310000000000002 109.37 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.77 137.34 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.314 0.646 . . . . 74.540000000000006 109.816 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 p -156.87 129.51 7.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.512 0.725 . . . . 73.200000000000003 109.263 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -151.35 136.96 17.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.254 -0.647 . . . . 73.120000000000005 109.254 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.2 mmm -127.59 116.98 21.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.568 0.747 . . . . 74.019999999999996 109.339 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -145.05 99.92 3.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.614 0.765 . . . . 74.109999999999999 110.017 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -155.99 137.71 14.25 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.092 0.957 . . . . 74.319999999999993 109.106 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -155.84 149.49 25.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.92 . . . . 74.519999999999996 109.261 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -140.88 119.66 12.54 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.42 1.088 . . . . 75.439999999999998 109.033 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.78 147.06 25.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.597 0.759 . . . . 74.510000000000005 111.122 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.8 116.8 62.87 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.765 -0.828 . . . . 65.129999999999995 108.765 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 137.65 40.42 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.547 2.165 . . . . 74.450000000000003 112.751 -172.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -77.48 135.95 38.3 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.493 0.717 . . . . 73.209999999999994 109.572 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 p -146.26 148.76 32.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.949 0.5 . . . . 74.129999999999995 110.455 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -152.26 179.86 8.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.94 0.896 . . . . 64.510000000000005 109.31 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.7 p -158.62 156.75 30.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.817 0.847 . . . . 72.209999999999994 109.794 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.45 147.09 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.161 0.585 . . . . 62.219999999999999 109.86 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -111.91 143.95 29.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 108.729 -0.841 . . . . 71.409999999999997 108.729 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.24 138.58 61.86 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.217 1.945 . . . . 74.209999999999994 111.889 171.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.69 132.83 45.11 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.51 -0.552 . . . . 72.239999999999995 109.51 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.15 134.06 29.16 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 123.006 0.522 . . . . 73.450000000000003 109.676 174.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.91 146.44 42.11 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 121.973 1.782 . . . . 73.129999999999995 110.781 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -78.95 -79.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 110.205 -0.294 . . . . 74.430000000000007 110.205 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 90' ' ' THR . . . -164.13 171.55 14.93 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.13 0.572 . . . . 71.219999999999999 109.49 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.46 148.13 24.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.143 0.577 . . . . 63.140000000000001 111.565 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 64' ' ' THR . 87.3 t -137.8 125.8 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.608 1.163 . . . . 72.510000000000005 108.09 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 116' ' ' VAL . 9.6 ptp180 -127.84 111.12 13.27 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.27 -0.894 . . . . 75.340000000000003 109.706 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.68 110.36 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.477 0.711 . . . . 74.349999999999994 110.655 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HB2' HG12 ' A' ' 119' ' ' VAL . 51.1 m-85 -100.91 106.04 17.35 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 109.179 -0.674 . . . . 70.409999999999997 109.179 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 4.5 m-20 -87.28 113.73 23.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.636 -1.246 . . . . 70.349999999999994 107.636 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.612 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.2 tt -70.13 -28.22 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.605 0.717 . . . . 72.439999999999998 110.165 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 41' ' ' ASN . 22.8 t -130.27 159.35 37.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.704 -1.134 . . . . 75.230000000000004 108.44 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.22 -45.04 44.0 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.888 0.743 . . . . 51.310000000000002 113.422 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t 47.86 -164.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.236 1.815 . . . . 62.509999999999998 112.798 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -71.42 136.42 47.69 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 121.716 -0.615 . . . . 74.239999999999995 109.677 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.09 -26.57 65.96 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.884 0.74 . . . . 55.140000000000001 114.443 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . . . -58.27 -26.62 63.17 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.123 0.969 . . . . 75.109999999999999 112.693 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 120' ' ' VAL . . . -59.62 -47.58 85.05 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.661 0.784 . . . . 75.349999999999994 111.579 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HB3' HG11 ' A' ' 66' ' ' VAL . . . -80.97 -29.4 35.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.269 -0.878 . . . . 61.420000000000002 111.077 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . 4.0 tmt_? -74.13 -19.25 60.63 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.577 -1.192 . . . . 74.109999999999999 111.016 -173.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 34.3 p -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 109.65 -0.5 . . . . 64.099999999999994 109.65 172.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.71 -41.52 79.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.514 0.726 . . . . 72.200000000000003 111.628 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.15 -37.69 86.16 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.44 0.696 . . . . 72.510000000000005 111.063 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -77.97 -33.01 51.65 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.113 0.565 . . . . 74.530000000000001 110.589 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 52' ' ' THR . 13.3 tp -63.31 -43.66 97.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.621 0.768 . . . . 71.420000000000002 112.019 -169.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -19.34 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.267 0.84 . . . . 72.200000000000003 113.267 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.21 -27.89 68.75 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.87 0.468 . . . . 71.439999999999998 112.048 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.91 -9.9 59.08 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.129 0.571 . . . . 73.209999999999994 112.266 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.48 47.11 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 113.802 0.281 . . . . 73.430000000000007 113.802 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.482 ' HE2' HG23 ' A' ' 90' ' ' THR . 6.5 m-85 -91.9 157.96 16.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.652 0.781 . . . . 75.230000000000004 109.632 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.458 HG21 HG22 ' A' ' 63' ' ' VAL . 20.2 m -71.59 -77.47 0.09 Allowed 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.445 0.466 . . . . 75.129999999999995 111.903 -162.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 62' ' ' THR . 69.5 t -127.44 103.49 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 108.787 -0.82 . . . . 75.040000000000006 108.787 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 41.2 p -95.46 91.14 6.05 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.599 -0.889 . . . . 71.450000000000003 108.599 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 12.2 t70 -102.17 131.84 48.44 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.973 -1.012 . . . . 72.040000000000006 108.655 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 50' ' ' ALA . 65.7 t -125.98 133.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.93 -0.396 . . . . 74.349999999999994 109.93 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.36 146.62 17.29 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.245 -0.742 . . . . 54.210000000000001 111.245 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 24.9 p-10 -111.89 117.34 32.5 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.609 -0.515 . . . . 73.209999999999994 109.609 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.7 tp -159.15 138.54 11.46 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 122.493 -0.129 . . . . 71.230000000000004 110.831 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.612 ' HA ' HG13 ' A' ' 42' ' ' ILE . 49.3 m -68.69 103.4 1.73 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.491 -0.559 . . . . 73.030000000000001 109.491 171.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.52 ' HB2' HG12 ' A' ' 74' ' ' VAL . 64.1 mt -112.23 132.4 22.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 123.928 0.891 . . . . 75.120000000000005 108.619 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.37 -20.57 54.89 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.608 2.205 . . . . 71.140000000000001 113.935 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.55 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 5.3 p-10 -82.04 -26.96 33.29 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.035 0.383 . . . . 72.420000000000002 112.035 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.601 HG11 HD11 ' A' ' 42' ' ' ILE . 2.4 p -97.8 117.31 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.676 0.75 . . . . 73.310000000000002 109.408 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.76 6.9 4.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.584 1.154 . . . . 75.120000000000005 108.926 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.3 151.58 15.65 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.456 1.102 . . . . 72.319999999999993 109.184 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -74.73 114.38 13.1 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.255 0.55 . . . . 74.340000000000003 110.375 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.2 m -145.73 143.62 29.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.505 1.122 . . . . 72.319999999999993 109.305 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.68 HG23 HG11 ' A' ' 118' ' ' VAL . 92.8 t -110.57 115.53 50.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 109.131 -0.692 . . . . 75.349999999999994 109.131 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.91 154.42 17.31 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.721 0.808 . . . . 74.129999999999995 109.575 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.76 152.9 42.77 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.266 -0.642 . . . . 74.219999999999999 109.266 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -106.71 135.58 48.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.163 -1.051 . . . . 74.030000000000001 108.163 172.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.5 0.31 4.19 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.378 1.251 . . . . 75.239999999999995 114.378 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.35 111.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 123.485 0.714 . . . . 71.019999999999996 110.753 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 70.74 -69.34 0.18 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.41 1.484 . . . . 63.009999999999998 112.037 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.95 51.52 0.06 OUTLIER Glycine 0 C--O 1.241 0.54 0 CA-C-O 119.976 -0.347 . . . . 54.439999999999998 112.767 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HB3' HG21 ' A' ' 116' ' ' VAL . 39.9 mm-40 -66.79 -27.12 67.32 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 111.786 0.291 . . . . 73.530000000000001 111.786 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -56.21 -34.29 66.14 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.56 0.207 . . . . 73.450000000000003 111.56 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.96 -39.19 71.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.288 0.635 . . . . 74.400000000000006 112.24 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.482 HG23 ' HE2' ' A' ' 61' ' ' PHE . 60.7 p -85.22 -44.41 12.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.862 -0.608 . . . . 74.25 110.753 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -58.87 -39.33 81.05 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.209 0.604 . . . . 75.109999999999999 112.466 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.582 ' HA ' HG12 ' A' ' 102' ' ' VAL . 23.5 t70 -72.07 -27.39 62.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.013 -0.994 . . . . 75.540000000000006 110.401 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.67 -52.08 8.42 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.206 0.602 . . . . 72.299999999999997 110.813 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.51 HG13 HG21 ' A' ' 118' ' ' VAL . 69.4 t -60.44 -49.96 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.292 1.037 . . . . 65.329999999999998 111.11 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -63.88 -33.4 87.15 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.302 -0.863 . . . . 71.430000000000007 112.975 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -70.72 -37.47 73.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.151 -0.525 . . . . 62.530000000000001 110.449 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 m -68.29 -34.52 76.32 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.212 0.605 . . . . 72.25 110.927 175.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD11 ' HA ' ' A' ' 49' ' ' ALA . 63.1 tp -77.53 -33.31 54.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.704 0.802 . . . . 75.510000000000005 111.523 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.81 31.45 29.43 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.701 -0.681 . . . . 72.310000000000002 112.522 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.55 146.8 44.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.848 0.859 . . . . 64.310000000000002 109.155 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.39 149.63 33.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.131 0.572 . . . . 74.510000000000005 111.621 -172.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 92' ' ' ASP . 30.6 m -96.37 134.9 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.712 0.768 . . . . 75.030000000000001 111.319 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -134.11 165.67 24.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.438 1.495 . . . . 74.099999999999994 109.181 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.19 -174.19 0.78 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.838 0.855 . . . . 73.200000000000003 111.241 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.557 ' HB2' HD12 ' A' ' 109' ' ' LEU . 15.4 ptt180 -56.58 -40.86 75.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.804 0.842 . . . . 74.209999999999994 111.025 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.9 mt 61.2 164.39 0.1 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 125.15 1.38 . . . . 74.400000000000006 113.307 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.14 -23.56 9.77 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.329 2.686 . . . . 64.109999999999999 114.411 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 mp0 -60.67 -27.38 67.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.986 0.914 . . . . 70.409999999999997 112.825 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.557 HD12 ' HB2' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -66.08 -6.29 12.58 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.945 0.72 . . . . 73.040000000000006 112.945 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.0 p -66.2 -28.21 68.58 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.114 0.566 . . . . 72.519999999999996 112.066 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.61 -33.06 6.47 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.819 0.448 . . . . 54.340000000000003 111.743 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -90.79 136.68 27.51 Favored Pre-proline 0 N--CA 1.484 1.251 0 N-CA-C 109.29 -0.633 . . . . 73.439999999999998 109.29 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.4 95.05 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.633 2.222 . . . . 61.240000000000002 112.616 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.5 161.33 35.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.898 2.399 . . . . 74.140000000000001 114.017 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 119.95 -149.0 17.89 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.661 -0.976 . . . . 74.239999999999995 110.661 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 78.7 t -84.66 121.37 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.107 0.453 . . . . 64.400000000000006 109.783 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.434 HG23 HG11 ' A' ' 119' ' ' VAL . 4.1 mp -118.97 104.95 16.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 108.27 -1.011 . . . . 74.439999999999998 108.27 174.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.68 HG11 HG23 ' A' ' 79' ' ' VAL . 58.2 t -92.48 101.37 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.369 -0.974 . . . . 64.010000000000005 108.369 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 40' ' ' TYR . 27.1 m -98.48 128.06 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.504 -0.554 . . . . 74.120000000000005 109.504 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.716 HG22 ' HB2' ' A' ' 49' ' ' ALA . 15.3 t -127.48 132.18 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.957 0.503 . . . . 71.230000000000004 110.309 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.0 t -105.08 165.9 10.76 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.562 0.745 . . . . 72.349999999999994 109.16 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 119.106 -0.83 . . . . 62.409999999999997 113.065 174.821 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.886 0 N-CA-C 112.316 -0.314 . . . . 53.5 112.316 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p -105.49 146.3 29.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.465 0.706 . . . . 65.420000000000002 111.217 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.8 m -105.59 103.64 44.35 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.375 0.67 . . . . 74.040000000000006 109.553 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.0 169.75 18.88 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.781 2.32 . . . . 65.420000000000002 111.755 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -158.65 151.96 22.82 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.392 0.677 . . . . 72.140000000000001 109.347 -174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -72.64 79.32 1.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.145 -0.687 . . . . 71.329999999999998 109.145 173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -94.48 -0.52 54.64 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.564 1.146 . . . . 71.129999999999995 110.829 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.08 -73.29 0.17 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.934 0.894 . . . . 73.340000000000003 109.922 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 54.26 84.36 0.07 Allowed 'General case' 0 C--N 1.363 1.154 0 C-N-CA 124.947 1.299 . . . . 63.240000000000002 112.307 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.9 p -92.36 111.0 22.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.685 0.794 . . . . 74.299999999999997 110.411 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.2 m -88.59 -179.37 6.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.111 0.964 . . . . 74.209999999999994 111.512 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.92 141.13 30.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.406 -0.816 . . . . 73.439999999999998 109.787 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -121.73 155.65 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.712 0.805 . . . . 73.030000000000001 110.305 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.0 t -160.17 123.07 3.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.925 0.89 . . . . 72.319999999999993 108.797 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.1 m -118.65 133.11 56.1 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.934 0.494 . . . . 74.540000000000006 110.046 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtt -100.47 126.09 46.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.13 0.972 . . . . 74.530000000000001 109.52 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -134.34 109.11 8.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.789 0.836 . . . . 74.150000000000006 109.949 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -105.38 152.64 22.7 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.141 0.976 . . . . 74.129999999999995 109.968 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -153.05 116.07 4.58 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.374 0.67 . . . . 74.519999999999996 110.295 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.6 p -133.87 143.41 48.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.047 0.939 . . . . 71.450000000000003 110.497 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.23 167.48 20.61 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.806 0.842 . . . . 74.549999999999997 110.174 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.6 143.6 36.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 73.420000000000002 110.664 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.225 2.617 . . . . 73.519999999999996 113.48 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -112.99 159.38 19.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.101 0.961 . . . . 71.409999999999997 110.545 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -108.56 144.93 35.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 74.019999999999996 110.257 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -129.59 113.62 15.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.25 0.62 . . . . 70.439999999999998 110.503 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.3 m -102.89 133.94 47.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.969 0.508 . . . . 74.349999999999994 110.268 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.96 126.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 122.998 0.519 . . . . 75.120000000000005 110.331 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -114.95 106.81 51.13 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 108.354 -0.98 . . . . 72.109999999999999 108.354 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.23 162.62 25.98 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.119 2.546 . . . . 73.209999999999994 113.294 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.94 102.28 6.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.405 0.682 . . . . 73.510000000000005 109.586 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.69 105.07 11.9 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.545 0.738 . . . . 74.549999999999997 110.854 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.45 160.98 17.18 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.405 2.07 . . . . 73.030000000000001 112.588 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -87.15 -69.87 0.65 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.074 0.55 . . . . 73.120000000000005 110.879 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -162.0 162.79 29.04 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.364 1.065 . . . . 53.32 108.925 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.49 140.35 29.66 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.145 0.498 . . . . 64.209999999999994 110.446 -177.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 64' ' ' THR . 48.5 t -118.04 160.53 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.254 1.022 . . . . 75.109999999999999 109.128 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.09 127.78 11.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.725 0.41 . . . . 73.219999999999999 110.199 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.574 HG23 ' HB ' ' A' ' 118' ' ' VAL . 94.1 t -106.36 121.3 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.639 0.776 . . . . 72.209999999999994 109.463 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -115.81 133.47 56.0 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.622 0.769 . . . . 74.299999999999997 110.793 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -82.62 116.29 21.96 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.688 -0.856 . . . . 74.040000000000006 108.688 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 74' ' ' VAL . 10.5 tp -80.12 -24.03 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.354 -0.61 . . . . 74.549999999999997 109.354 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' H ' ' A' ' 122' ' ' GLY . 40.4 m -139.18 169.38 17.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.272 1.029 . . . . 73.340000000000003 109.129 170.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 84.49 0.15 Allowed Glycine 0 C--N 1.347 1.183 0 O-C-N 123.551 0.532 . . . . 52.109999999999999 112.231 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 t -97.01 178.8 5.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.631 0.772 . . . . 74.230000000000004 109.89 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.77 151.19 43.72 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.133 0.573 . . . . 74.099999999999994 111.02 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.72 -4.44 46.8 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.059 -0.856 . . . . 71.200000000000003 114.823 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.5 -28.25 69.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.196 0.998 . . . . 64.049999999999997 112.271 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.49 -45.21 91.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.378 0.671 . . . . 71.120000000000005 110.842 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.29 -31.72 62.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.231 -0.895 . . . . 72.150000000000006 111.302 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -68.92 -36.32 77.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.537 1.135 . . . . 73.340000000000003 110.447 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.7 t -73.86 -35.09 64.73 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.411 -0.358 . . . . 75.120000000000005 110.109 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.88 63.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.432 0.693 . . . . 63.420000000000002 110.89 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.81 -48.18 70.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.05 0.94 . . . . 74.230000000000004 110.884 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -78.43 -29.24 46.94 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.478 -0.783 . . . . 75.519999999999996 111.274 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.75 -45.56 74.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.234 1.014 . . . . 75.420000000000002 111.359 -174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -51.63 -46.19 63.57 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.521 1.128 . . . . 73.420000000000002 111.625 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.6 -10.68 60.14 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.801 0.841 . . . . 75.450000000000003 112.556 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.83 7.3 42.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.603 0.761 . . . . 71.319999999999993 112.394 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.43 26.18 5.76 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 120.853 0.14 . . . . 51.119999999999997 113.205 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.528 ' HE2' ' HA ' ' A' ' 90' ' ' THR . 16.4 m-85 -108.09 154.04 22.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.238 1.015 . . . . 74.340000000000003 108.412 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.507 0.323 . . . . 74.439999999999998 111.681 -167.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.62 153.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.067 -1.086 . . . . 74.299999999999997 108.067 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 22.2 p -127.23 114.44 17.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.92 -0.77 . . . . 72.030000000000001 108.92 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -101.25 127.76 47.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.556 0.742 . . . . 44.149999999999999 109.256 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.65 129.68 67.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.088 -0.708 . . . . 74.120000000000005 109.088 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.91 -179.46 30.12 Favored Glycine 0 C--N 1.341 0.808 0 O-C-N 123.601 0.563 . . . . 74.049999999999997 111.91 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.65 125.92 35.26 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.143 -1.058 . . . . 74.25 108.143 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 57.1 mt -140.18 151.46 45.25 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.746 0.818 . . . . 73.450000000000003 110.15 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.2 m -126.85 98.21 5.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.782 0.833 . . . . 75.349999999999994 109.632 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HG22 ' A' ' 74' ' ' VAL . 7.4 mp -121.09 153.46 57.79 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 124.647 1.179 . . . . 72.420000000000002 109.438 -176.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.33 -27.69 6.3 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.512 2.141 . . . . 71.209999999999994 112.745 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.6 -23.05 53.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.75 0.82 . . . . 64.299999999999997 111.19 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 71' ' ' LEU . 33.0 m -120.41 117.98 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 109.088 -0.708 . . . . 73.409999999999997 109.088 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.46 9.46 1.4 Allowed 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.869 -0.519 . . . . 71.349999999999994 111.045 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.79 158.22 44.63 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.356 1.063 . . . . 75.400000000000006 109.345 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.538 ' HB ' HG21 ' A' ' 121' ' ' THR . 7.2 t -69.34 98.22 1.05 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.285 1.04 . . . . 73.019999999999996 108.913 174.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.8 m -150.74 137.09 18.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.49 1.116 . . . . 72.340000000000003 110.217 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.621 HG22 HG11 ' A' ' 118' ' ' VAL . 40.3 t -101.67 119.7 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.314 1.046 . . . . 75.409999999999997 108.861 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -103.75 125.42 50.21 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.252 -0.647 . . . . 72.219999999999999 109.252 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -145.45 160.38 41.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.52 0.728 . . . . 74.319999999999993 110.37 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -109.36 -120.32 0.27 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 108.103 -1.073 . . . . 61.530000000000001 108.103 172.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -137.89 -9.34 1.58 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.251 0.932 . . . . 70.5 112.194 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.43 107.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.33 0.652 . . . . 75.040000000000006 111.735 -167.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 59.77 31.43 20.81 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 70.230000000000004 112.067 173.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.55 38.44 5.58 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.03 -0.986 . . . . 61.25 113.374 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.3 -44.44 71.99 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.189 0.495 . . . . 72.540000000000006 112.303 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -66.31 -24.62 66.57 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 111.888 0.329 . . . . 74.040000000000006 111.888 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.51 -37.2 57.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.386 0.674 . . . . 72.400000000000006 111.252 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HE2' ' A' ' 61' ' ' PHE . 81.8 p -82.01 -28.49 32.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.325 0.584 . . . . 71.140000000000001 110.277 -174.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.39 -31.47 54.21 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.636 1.174 . . . . 74.099999999999994 111.786 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.38 -55.54 32.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.832 1.253 . . . . 74.439999999999998 110.6 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.34 -32.24 71.08 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.676 -1.147 . . . . 75.299999999999997 112.727 -173.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 118' ' ' VAL . 47.4 t -87.87 -53.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.059 0.544 . . . . 74.430000000000007 111.588 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -29.88 75.97 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.814 -0.63 . . . . 70.109999999999999 113.75 -168.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -72.97 -36.14 67.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.095 0.558 . . . . 72.340000000000003 110.552 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.7 m -62.04 -40.23 95.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.716 0.806 . . . . 73.329999999999998 111.257 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.86 -15.31 37.09 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.31 0.485 . . . . 71.200000000000003 112.31 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.12 25.04 75.74 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.891 -0.483 . . . . 75.530000000000001 111.891 -172.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.87 136.85 33.95 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.342 1.057 . . . . 74.409999999999997 109.486 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 113.32 2.6 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.953 0.783 . . . . 71.209999999999994 111.09 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -83.87 101.58 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 122.457 1.123 . . . . 72.239999999999995 109.047 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -112.9 158.36 20.29 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.519 -1.219 . . . . 74.019999999999996 111.343 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.61 177.75 1.49 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.347 -1.297 . . . . 73.109999999999999 110.397 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -59.29 -44.76 92.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.981 -0.554 . . . . 72.109999999999999 110.695 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt 60.77 173.63 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.106 0.962 . . . . 73.349999999999994 111.777 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.61 -27.33 25.35 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.419 2.079 . . . . 72.519999999999996 113.674 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.97 -47.33 83.63 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.077 0.951 . . . . 74.439999999999998 112.325 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.544 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 23.0 tp -71.67 -12.18 61.2 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 120.896 0.379 . . . . 73.430000000000007 111.215 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 t -79.06 -14.09 59.37 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.201 0.601 . . . . 72.549999999999997 110.818 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.13 -25.82 23.93 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.548 0.739 . . . . 70.120000000000005 112.362 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 1.3 pp0? -142.54 155.85 63.65 Favored Pre-proline 0 N--CA 1.495 1.802 0 CA-C-O 118.282 -0.866 . . . . 74.140000000000001 111.132 -173.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -37.47 125.75 0.61 Allowed 'Trans proline' 0 C--N 1.397 3.1 0 C-N-CA 124.736 3.624 . . . . 70.150000000000006 115.867 -169.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -64.61 133.3 36.28 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.089 2.526 . . . . 61.130000000000003 112.175 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.467 ' H ' HD23 ' A' ' 109' ' ' LEU . . . 157.09 177.81 30.56 Favored Glycine 0 C--O 1.245 0.812 0 N-CA-C 110.667 -0.973 . . . . 61.329999999999998 110.667 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.406 HG13 HG11 ' A' ' 37' ' ' VAL . 91.8 t -80.66 100.04 4.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.817 -0.438 . . . . 75.140000000000001 109.817 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 117' ' ' ILE . 41.8 pt -102.89 108.58 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.76 -0.83 . . . . 74.540000000000006 108.76 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.621 HG11 HG22 ' A' ' 79' ' ' VAL . 51.7 t -90.6 100.99 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.373 -1.343 . . . . 72.120000000000005 107.373 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.509 HG13 ' HB ' ' A' ' 74' ' ' VAL . 61.3 t -95.93 118.17 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.827 -0.805 . . . . 50.409999999999997 108.827 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.28 133.72 63.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.107 0.563 . . . . 71.219999999999999 109.619 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.538 HG21 ' HB ' ' A' ' 77' ' ' THR . 11.8 t -98.72 156.17 16.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.505 0.722 . . . . 64.129999999999995 110.577 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.616 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.686 -1.063 . . . . 72.040000000000006 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 CA-C-O 120.104 -0.276 . . . . 73.430000000000007 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 m -134.36 -42.82 0.78 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.375 0.67 . . . . 75.430000000000007 110.401 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 m 68.14 81.21 0.21 Allowed Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.005 1.322 . . . . 70.140000000000001 110.542 -172.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -85.05 170.63 9.62 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.691 2.261 . . . . 75.019999999999996 112.307 171.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -148.3 153.7 39.01 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.729 0.812 . . . . 73.219999999999999 108.813 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.9 t -127.59 40.31 3.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.934 0.893 . . . . 74.340000000000003 108.716 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.11 -3.14 57.0 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.979 0.912 . . . . 72.409999999999997 112.183 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.59 -64.95 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.176 0.59 . . . . 62.32 109.519 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 64.45 177.85 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.171 1.389 . . . . 75.549999999999997 112.954 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 p -160.89 90.46 0.84 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.153 0.581 . . . . 75.109999999999999 110.762 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -90.7 132.78 35.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.132 0.573 . . . . 74.230000000000004 109.979 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 98.54 3.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.101 0.56 . . . . 75.219999999999999 111.128 -172.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -131.41 129.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.755 0.822 . . . . 75.109999999999999 110.335 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 p -175.47 103.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.307 1.043 . . . . 60.409999999999997 110.629 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -166.89 130.92 1.95 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.203 1.001 . . . . 74.109999999999999 109.925 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -132.35 77.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.082 -0.71 . . . . 75.349999999999994 109.082 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -85.42 104.58 15.35 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.087 -0.506 . . . . 74.150000000000006 110.14 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -146.29 145.21 30.28 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 74.030000000000001 109.562 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -149.97 168.82 22.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.769 0.428 . . . . 75.030000000000001 111.085 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.9 t -148.21 169.97 18.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.345 1.058 . . . . 64.439999999999998 109.775 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.08 167.09 22.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.314 1.045 . . . . 74.25 109.995 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.8 124.29 24.03 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.162 0.985 . . . . 64.340000000000003 109.996 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.39 123.65 11.44 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.486 2.791 . . . . 72.409999999999997 113.248 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.6 p -117.4 125.97 51.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.503 0.721 . . . . 73.140000000000001 110.98 -174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -136.98 123.19 20.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.849 0.86 . . . . 73.400000000000006 109.104 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t -155.31 127.91 7.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.47 0.708 . . . . 75.430000000000007 110.063 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.2 m -155.85 127.3 7.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.992 0.917 . . . . 71.519999999999996 109.569 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 m -90.19 156.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.503 0.721 . . . . 72.0 111.148 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.14 158.74 71.81 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 124.64 1.176 . . . . 75.010000000000005 110.201 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.89 158.87 48.86 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.086 2.524 . . . . 73.219999999999999 112.875 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.43 162.65 22.05 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.732 0.813 . . . . 74.540000000000006 111.044 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.39 143.12 79.09 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 123.507 0.723 . . . . 74.340000000000003 111.227 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.66 164.51 28.8 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.761 2.307 . . . . 74.129999999999995 114.212 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -123.63 138.47 54.54 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.341 1.057 . . . . 71.049999999999997 109.178 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB3' ' HD2' ' A' ' 61' ' ' PHE . . . -164.22 81.73 0.41 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.497 -0.557 . . . . 73.129999999999995 109.497 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -96.94 91.51 5.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.676 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.452 HG22 HD22 ' A' ' 56' ' ' LEU . 21.1 t -95.65 139.66 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.271 1.028 . . . . 72.319999999999993 109.283 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.538 ' HG3' ' HB2' ' A' ' 65' ' ' ASP . 43.7 ttm105 -148.3 131.97 16.89 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 66' ' ' VAL . 47.8 t -114.83 135.11 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.721 0.808 . . . . 75.340000000000003 109.819 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -137.32 107.23 6.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.923 0.889 . . . . 75.400000000000006 109.772 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.42 123.16 32.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.106 -1.072 . . . . 74.519999999999996 108.106 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.607 HG21 HG13 ' A' ' 74' ' ' VAL . 18.5 tt -85.86 -38.44 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 118.227 0.467 . . . . 74.099999999999994 110.682 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.0 m -149.63 155.89 40.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.818 0.847 . . . . 71.400000000000006 109.744 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 122' ' ' GLY . . . 93.57 -39.02 3.01 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.515 0.509 . . . . 73.230000000000004 112.718 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t 37.13 80.49 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.449 1.9 . . . . 73.310000000000002 113.131 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.67 173.11 9.23 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.963 -1.017 . . . . 75.400000000000006 111.372 -170.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.59 -45.67 94.09 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.31 -1.314 . . . . 62.420000000000002 114.036 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 -28.01 67.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.352 0.871 . . . . 74.200000000000003 113.352 -169.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -60.33 2.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.669 0.388 . . . . 72.150000000000006 111.029 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.4 69.12 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.735 -0.666 . . . . 74.120000000000005 111.849 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -34.4 77.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.258 1.423 . . . . 74.349999999999994 110.477 -174.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -62.25 -57.26 12.08 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 123.468 0.48 . . . . 73.310000000000002 110.317 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.491 ' HB2' ' HB ' ' A' ' 64' ' ' THR . . . -71.92 -28.37 63.44 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.08 0.152 . . . . 74.420000000000002 111.337 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.7 -31.52 71.53 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.433 0.693 . . . . 74.540000000000006 111.153 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -80.73 -45.38 17.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.32 -0.4 . . . . 71.349999999999994 110.451 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 37' ' ' VAL . 10.9 mp -66.4 -31.58 72.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.635 -0.711 . . . . 74.230000000000004 112.189 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.57 -39.65 91.89 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.885 0.374 . . . . 75.219999999999999 111.05 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.71 -29.75 61.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.456 -0.793 . . . . 70.219999999999999 110.308 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -13.08 61.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.539 0.736 . . . . 62.229999999999997 111.396 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.79 31.36 7.82 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.532 0.52 . . . . 70.120000000000005 113.687 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.404 ' HD2' ' HB3' ' A' ' 35' ' ' ALA . 7.8 m-85 -79.72 155.7 27.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.601 -0.889 . . . . 75.409999999999997 108.601 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.0 m -73.26 -59.92 2.48 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.724 0.41 . . . . 72.120000000000005 111.468 -163.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 99.5 t -114.41 141.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.692 -0.855 . . . . 74.030000000000001 108.692 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 53' ' ' ALA . 14.6 p -145.61 109.87 4.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.96 0.904 . . . . 73.209999999999994 108.807 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.538 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.4 m-20 -103.86 144.47 31.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.786 -0.82 . . . . 75.049999999999997 108.786 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.496 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 61.9 t -133.59 114.83 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.361 -0.977 . . . . 72.140000000000001 108.361 173.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.25 159.38 27.69 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 121.521 -0.371 . . . . 61.210000000000001 113.033 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -113.27 113.97 26.05 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.029 -1.1 . . . . 73.150000000000006 108.029 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.59 144.51 20.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.887 -0.783 . . . . 75.420000000000002 108.887 -167.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.433 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 t -83.62 108.7 16.88 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 65.530000000000001 109.251 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.59 149.31 35.58 Favored Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.631 . . . . 62.020000000000003 110.281 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.18 -20.8 18.54 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.958 2.439 . . . . 75.019999999999996 113.253 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -80.82 -19.16 45.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.252 1.021 . . . . 73.329999999999998 112.12 -174.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.607 HG13 HG21 ' A' ' 42' ' ' ILE . 90.6 t -56.5 133.18 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.114 0.884 . . . . 75.430000000000007 112.375 -167.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.39 -45.13 0.08 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.954 -1.476 . . . . 61.450000000000003 108.268 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.36 158.1 43.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.379 1.072 . . . . 60.009999999999998 109.339 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.489 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.7 t -62.66 111.95 2.3 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.358 0.599 . . . . 74.340000000000003 110.201 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.0 m -149.32 138.57 21.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.561 0.745 . . . . 71.230000000000004 110.485 -172.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 18.3 t -94.66 114.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.687 1.195 . . . . 75.510000000000005 108.444 173.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' HB3' HD22 ' A' ' 109' ' ' LEU . 28.7 m-85 -95.53 154.52 17.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.318 -0.993 . . . . 74.319999999999993 108.318 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -153.44 -179.88 8.17 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.546 0.688 . . . . 74.209999999999994 111.784 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 24.0 m -126.83 139.48 53.07 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 105.999 -1.852 . . . . 74.230000000000004 105.999 161.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.05 -10.21 59.24 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.962 0.727 . . . . 74.329999999999998 112.962 -170.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.31 130.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 63.210000000000001 112.843 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.24 21.05 11.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.72 1.208 . . . . 74.049999999999997 112.723 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.57 62.99 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 116.308 -0.405 . . . . 63.130000000000003 112.861 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 82' ' ' THR . 11.3 tp10 -69.53 -21.92 63.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 64.349999999999994 109.95 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -57.69 -29.28 64.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.405 1.082 . . . . 72.430000000000007 112.936 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -45.11 83.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.704 0.801 . . . . 72.109999999999999 112.023 -174.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.52 HG22 HG23 ' A' ' 116' ' ' VAL . 9.9 t -74.58 -30.99 61.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.23 -0.441 . . . . 71.439999999999998 110.759 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.9 75.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.885 0.474 . . . . 73.299999999999997 111.407 174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.79 -40.58 83.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.524 1.129 . . . . 72.129999999999995 109.57 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.09 60.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.757 -1.11 . . . . 73.420000000000002 110.681 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.01 -32.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.16 0.984 . . . . 73.540000000000006 111.827 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.43 93.53 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.957 -0.457 . . . . 74.540000000000006 111.957 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 -80.31 -25.99 39.05 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.0 0.52 . . . . 73.140000000000001 111.881 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -70.81 -43.12 69.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.951 0.5 . . . . 72.450000000000003 110.231 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 tp -86.22 -30.84 22.07 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.592 -0.731 . . . . 71.129999999999995 110.598 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.03 24.95 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.771 -0.649 . . . . 62.530000000000001 112.165 -174.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.94 167.65 9.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.994 0.917 . . . . 71.019999999999996 111.279 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.34 41.92 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.923 0.889 . . . . 75.099999999999994 111.071 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.05 119.58 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.013 0.435 . . . . 65.549999999999997 110.569 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -113.46 148.26 36.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.343 0.657 . . . . 74.540000000000006 110.997 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.64 -166.89 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.905 1.282 . . . . 64.439999999999998 111.911 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -77.04 28.55 0.14 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 124.508 1.123 . . . . 75.450000000000003 113.037 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pp -47.97 157.77 0.6 Allowed Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 125.458 1.503 . . . . 74.409999999999997 113.19 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.35 -24.29 0.97 Allowed 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 124.44 3.427 . . . . 74.209999999999994 117.847 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.68 -22.29 64.38 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.361 0.664 . . . . 74.230000000000004 112.413 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 80' ' ' TYR . 4.4 mm? -64.6 -8.91 15.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.6 0.76 . . . . 74.540000000000006 111.738 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 t -63.98 -42.01 97.36 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.281 1.032 . . . . 75.340000000000003 112.003 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.471 ' HB2' ' OE1' ' A' ' 112' ' ' GLN . 4.5 m-20 -80.77 -33.57 34.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.898 0.479 . . . . 55.329999999999998 111.562 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.471 ' OE1' ' HB2' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -90.71 157.49 43.84 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.704 0.802 . . . . 73.420000000000002 108.998 178.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.7 125.07 16.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.062 1.842 . . . . 73.420000000000002 110.783 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.22 118.96 5.9 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.146 2.564 . . . . 74.450000000000003 112.719 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.51 -158.7 31.76 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.859 -0.896 . . . . 75.129999999999995 110.859 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.52 HG23 HG22 ' A' ' 90' ' ' THR . 74.1 t -79.25 105.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.196 -0.668 . . . . 73.409999999999997 109.196 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.1 pt -116.68 107.75 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 2.1 p -87.28 105.02 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.54 -0.911 . . . . 64.040000000000006 108.54 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 74' ' ' VAL . 94.7 t -91.51 117.48 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.75 -1.204 . . . . 71.299999999999997 107.75 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.24 127.44 65.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.285 -0.635 . . . . 71.409999999999997 109.285 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.489 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.2 p -104.89 102.9 12.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.778 -1.564 . . . . 63.100000000000001 106.778 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 119.308 -0.718 . . . . 70.519999999999996 112.639 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.857 -0.497 . . . . 74.299999999999997 111.857 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 p -148.51 119.47 7.65 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.918 0.887 . . . . 72.409999999999997 109.639 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 t -162.08 79.47 1.96 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 123.409 0.684 . . . . 75.450000000000003 109.266 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.41 85.92 1.76 Allowed 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.327 2.684 . . . . 63.039999999999999 110.978 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -85.27 96.26 9.46 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 115.586 -0.734 . . . . 73.319999999999993 109.744 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.6 m -141.63 70.14 1.34 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.836 1.254 . . . . 74.420000000000002 108.693 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -91.9 -10.4 39.72 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 114.603 -1.18 . . . . 74.219999999999999 112.027 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -130.37 -55.09 1.1 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.277 0.631 . . . . 74.420000000000002 110.824 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 65.97 -81.53 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.007 1.323 . . . . 75.530000000000001 111.243 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 p -170.73 148.74 3.01 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.586 0.754 . . . . 72.439999999999998 110.03 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -170.37 106.2 0.3 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.36 1.064 . . . . 75.400000000000006 108.209 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.12 131.54 5.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.358 0.663 . . . . 63.240000000000002 110.042 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -169.07 130.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.528 1.131 . . . . 70.150000000000006 109.339 175.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 p -172.2 128.11 0.57 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.296 1.038 . . . . 75.430000000000007 108.617 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.7 t -148.29 110.48 4.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 109.52 -0.548 . . . . 71.409999999999997 109.52 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -136.46 104.72 5.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.684 0.794 . . . . 70.109999999999999 109.406 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -135.1 114.99 12.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.493 1.117 . . . . 75.439999999999998 109.816 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 p -148.06 143.05 26.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.842 1.257 . . . . 73.030000000000001 109.001 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -152.77 137.87 17.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.605 1.162 . . . . 65.030000000000001 108.851 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.7 p -143.92 106.41 4.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.954 0.902 . . . . 72.310000000000002 110.307 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.49 144.4 18.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.099 0.959 . . . . 71.140000000000001 110.08 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.73 105.78 4.27 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 123.724 0.81 . . . . 73.409999999999997 109.563 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.06 113.69 2.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.081 2.521 . . . . 75.030000000000001 112.341 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -152.03 119.12 5.86 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.233 0.539 . . . . 73.340000000000003 110.283 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -153.84 139.91 18.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.722 1.209 . . . . 73.439999999999998 109.251 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -148.44 128.35 13.5 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.028 0.531 . . . . 75.030000000000001 110.412 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.3 m -150.31 89.18 1.56 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.212 1.005 . . . . 73.310000000000002 108.992 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.34 140.74 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.814 0.846 . . . . 75.409999999999997 110.26 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.31 115.68 64.62 Favored Pre-proline 0 N--CA 1.479 1.001 0 N-CA-C 108.753 -0.832 . . . . 73.239999999999995 108.753 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.12 134.84 21.91 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.678 2.252 . . . . 72.349999999999994 111.279 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.4 123.34 8.73 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.215 1.006 . . . . 72.310000000000002 108.476 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.64 147.65 5.38 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.32 0.648 . . . . 75.030000000000001 110.173 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.92 145.8 81.07 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.25 2.633 . . . . 73.230000000000004 113.341 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -134.65 -75.88 0.46 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.736 0.815 . . . . 75.530000000000001 109.969 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.48 101.5 9.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.476 0.71 . . . . 73.420000000000002 110.424 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.3 mp0 -82.35 101.1 10.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.044 0.937 . . . . 73.329999999999998 109.086 176.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.13 140.1 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.883 -0.784 . . . . 73.439999999999998 108.883 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -152.08 129.0 10.98 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.623 0.769 . . . . 75.140000000000001 109.473 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG23 ' HB ' ' A' ' 118' ' ' VAL . 43.7 t -114.79 126.55 72.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.131 -1.063 . . . . 70.349999999999994 108.131 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' CE1' HG21 ' A' ' 119' ' ' VAL . 7.9 p90 -127.56 139.72 52.58 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.475 0.655 . . . . 73.439999999999998 110.005 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.49 HD22 ' HB3' ' A' ' 46' ' ' GLU . 16.4 m120 -84.24 146.78 27.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.708 -1.133 . . . . 75.239999999999995 108.303 166.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.94 -23.23 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.005 0.431 . . . . 74.400000000000006 109.993 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.9 m -118.84 -57.37 2.04 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.737 0.815 . . . . 71.129999999999995 109.758 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 76.94 1.05 Allowed Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.802 -0.519 . . . . 63.210000000000001 111.802 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.2 m -145.13 -37.6 0.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.841 0.856 . . . . 65.530000000000001 110.074 178.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' ASN . 10.9 tp10 -73.96 109.9 7.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.997 0.519 . . . . 75.319999999999993 110.346 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.53 -24.07 59.34 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.395 -0.82 . . . . 55.109999999999999 112.522 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.31 67.6 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.07 0.548 . . . . 73.540000000000006 110.855 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.65 55.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.803 0.841 . . . . 63.25 110.598 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -27.38 66.14 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.616 -0.72 . . . . 65.040000000000006 111.609 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.7 -35.93 79.71 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.441 1.097 . . . . 73.129999999999995 110.825 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -62.35 -53.2 58.5 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 122.426 0.29 . . . . 73.0 111.229 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HB1' HG22 ' A' ' 39' ' ' VAL . . . -68.9 -30.13 68.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.379 0.272 . . . . 70.310000000000002 111.255 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.8 -39.41 94.16 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 70.540000000000006 109.95 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -74.78 -33.52 62.27 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 110.355 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.377 0.671 . . . . 75.239999999999995 111.048 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -63.04 -46.54 87.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 107.948 -1.13 . . . . 75.019999999999996 107.948 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.99 -29.23 69.02 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.263 -0.88 . . . . 75.25 111.122 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.52 -17.02 58.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.484 0.714 . . . . 73.420000000000002 111.601 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.9 37.23 7.98 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 116.492 -0.322 . . . . 74.25 113.878 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.26 159.47 28.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.063 0.545 . . . . 75.150000000000006 110.164 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.4 m -60.9 -68.91 0.26 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.811 0.694 . . . . 62.140000000000001 111.176 -167.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 89.2 t -116.48 138.16 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.806 -1.183 . . . . 75.219999999999999 107.806 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.6 p -136.4 96.28 3.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.277 -1.379 . . . . 71.120000000000005 107.277 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -102.25 145.95 28.71 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.625 -0.88 . . . . 74.349999999999994 108.625 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.09 135.1 55.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.061 0.944 . . . . 72.239999999999995 108.836 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.11 -164.27 27.37 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 121.249 -0.501 . . . . 74.040000000000006 112.3 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -146.28 118.5 8.35 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.268 -1.012 . . . . 74.439999999999998 108.268 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.53 143.03 47.19 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 108.656 -0.868 . . . . 72.209999999999994 108.656 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -86.57 97.16 10.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.117 -0.697 . . . . 75.129999999999995 109.117 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HB2' ' HH ' ' A' ' 40' ' ' TYR . 4.4 mm? -107.87 110.87 62.5 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.518 1.127 . . . . 75.349999999999994 108.454 174.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.1 -12.96 33.23 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.247 1.965 . . . . 71.140000000000001 113.236 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -77.19 -21.43 53.97 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.661 0.385 . . . . 74.200000000000003 111.671 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.22 142.12 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.557 -0.535 . . . . 71.010000000000005 109.557 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.93 22.44 1.58 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.343 1.057 . . . . 61.229999999999997 109.983 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.25 149.25 33.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.581 0.753 . . . . 73.230000000000004 109.582 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.469 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.3 t -76.88 103.55 6.89 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.873 0.844 . . . . 73.439999999999998 109.834 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.2 m -151.47 140.11 20.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.338 -0.847 . . . . 74.209999999999994 110.113 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.66 HG21 HG13 ' A' ' 118' ' ' VAL . 41.7 t -96.46 114.25 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.848 0.859 . . . . 74.430000000000007 109.154 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.83 132.71 45.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.295 1.038 . . . . 74.010000000000005 108.493 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.605 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -137.31 165.82 25.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.991 0.516 . . . . 72.040000000000006 111.904 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.0 t -106.99 148.86 28.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.607 -1.257 . . . . 75.510000000000005 107.607 161.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.538 ' HG2' ' HD2' ' A' ' 88' ' ' ARG . 46.0 mt-10 -97.16 9.04 43.26 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.915 0.486 . . . . 65.120000000000005 111.787 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.31 143.12 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.301 -0.629 . . . . 74.109999999999999 109.301 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 62.11 -83.09 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.721 1.208 . . . . 72.030000000000001 111.969 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.31 37.72 0.21 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.991 -0.443 . . . . 63.140000000000001 111.991 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.48 -35.9 24.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.542 0.337 . . . . 71.109999999999999 111.462 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 83' ' ' GLU . 61.4 ttt180 -61.25 -26.93 68.08 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.948 -0.47 . . . . 75.5 111.294 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.47 99.85 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.628 0.771 . . . . 72.010000000000005 111.956 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -81.49 -24.26 36.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.114 0.483 . . . . 72.409999999999997 110.55 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.7 59.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.929 0.892 . . . . 71.099999999999994 111.612 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.55 -45.52 75.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.417 -1.265 . . . . 75.200000000000003 109.663 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.29 -56.9 14.73 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.648 -1.16 . . . . 72.430000000000007 111.114 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 HG22 ' A' ' 118' ' ' VAL . 86.6 t -71.27 -37.32 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.726 -0.67 . . . . 61.409999999999997 111.823 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 79' ' ' VAL . . . -53.81 -35.44 52.96 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.566 0.541 . . . . 62.340000000000003 112.459 177.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -86.17 -32.8 21.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.673 -0.763 . . . . 70.420000000000002 110.308 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.9 m -65.84 -40.98 92.28 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.353 0.597 . . . . 73.430000000000007 110.399 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.53 -28.44 28.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.656 -1.156 . . . . 73.430000000000007 109.934 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.82 75.69 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.764 -0.653 . . . . 63.43 112.606 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.91 -172.59 3.75 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.83 0.852 . . . . 72.25 110.617 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 161.34 26.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.863 0.465 . . . . 42.240000000000002 109.965 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.605 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 10.0 m -129.96 124.63 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.853 0.861 . . . . 75.409999999999997 109.016 175.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -129.08 158.57 38.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.008 0.923 . . . . 74.530000000000001 110.905 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.8 -163.64 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.027 -1.442 . . . . 75.349999999999994 111.023 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.514 ' HA ' HD13 ' A' ' 109' ' ' LEU . 14.4 ttp180 -75.4 30.77 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.136 1.374 . . . . 74.349999999999994 112.955 -172.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.2 mt -46.0 152.41 0.78 Allowed Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 125.549 1.539 . . . . 73.540000000000006 113.654 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.2 -12.72 0.5 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 124.759 3.639 . . . . 71.25 116.796 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -60.31 -33.69 72.73 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.265 0.555 . . . . 71.230000000000004 110.287 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 105' ' ' ARG . 31.5 mt -76.71 5.6 7.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.298 1.039 . . . . 73.299999999999997 113.299 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.4 p -82.13 -41.36 20.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.735 -0.839 . . . . 75.140000000000001 108.735 170.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.7 -34.86 30.39 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.743 -1.117 . . . . 74.120000000000005 110.243 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -86.16 146.99 43.94 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.355 -0.839 . . . . 73.540000000000006 109.236 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.32 124.04 12.76 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.338 2.025 . . . . 74.409999999999997 111.165 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.26 133.79 51.72 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.726 2.951 . . . . 73.319999999999993 113.76 -171.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.11 -129.14 2.17 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.204 -1.158 . . . . 74.129999999999995 110.204 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.48 105.12 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.325 -0.991 . . . . 72.450000000000003 108.325 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.5 HD12 HD22 ' A' ' 109' ' ' LEU . 2.3 mp -105.59 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 N-CA-C 108.028 -1.101 . . . . 73.340000000000003 108.028 -176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.66 HG13 HG21 ' A' ' 79' ' ' VAL . 58.8 t -88.15 106.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.59 -1.263 . . . . 74.230000000000004 107.59 174.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 40' ' ' TYR . 19.2 t -93.13 130.56 42.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.74 -0.837 . . . . 71.140000000000001 108.74 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.58 129.21 74.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.65 0.78 . . . . 74.109999999999999 109.043 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.469 ' H ' ' HB ' ' A' ' 77' ' ' THR . 13.2 t -77.29 144.04 38.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.074 -1.084 . . . . 75.319999999999993 108.074 171.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 N-CA-C 110.488 -1.045 . . . . 65.219999999999999 110.488 -167.087 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 112.65 -0.18 . . . . 72.25 112.65 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -84.95 103.3 13.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.375 0.67 . . . . 61.219999999999999 111.068 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -75.62 121.81 85.86 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.896 -0.779 . . . . 73.439999999999998 108.896 169.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.14 -174.62 1.43 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.724 2.283 . . . . 72.549999999999997 112.607 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -160.56 175.2 12.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.333 0.653 . . . . 75.340000000000003 109.749 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.0 p -60.14 161.33 7.05 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.103 0.961 . . . . 72.519999999999996 110.803 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -62.8 -73.24 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.18 0.992 . . . . 72.409999999999997 111.042 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -131.66 -76.48 0.51 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.836 0.455 . . . . 74.129999999999995 110.532 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.8 t70 175.28 144.33 0.06 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.113 1.365 . . . . 74.109999999999999 109.004 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -88.85 107.63 19.09 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.03 -0.73 . . . . 65.450000000000003 109.03 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 t -76.8 173.8 11.26 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.599 0.76 . . . . 71.319999999999993 111.489 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.69 157.31 44.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.704 0.802 . . . . 73.430000000000007 110.28 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 pt -102.84 -176.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.518 0.727 . . . . 74.340000000000003 110.785 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -148.68 173.67 12.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.29 0.636 . . . . 54.399999999999999 110.223 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -143.35 146.67 33.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.991 0.516 . . . . 73.109999999999999 111.373 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -121.4 135.22 55.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.841 0.856 . . . . 65.299999999999997 109.499 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.0 m -145.8 128.65 16.36 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.296 1.038 . . . . 74.219999999999999 108.789 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 p -110.24 162.89 14.17 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.65 0.78 . . . . 73.030000000000001 111.586 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -118.79 136.47 53.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.91 0.884 . . . . 72.049999999999997 109.688 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.6 m -78.29 157.68 29.12 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.778 0.831 . . . . 72.239999999999995 110.359 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.81 169.76 16.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 70.319999999999993 109.472 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.61 42.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.399 0.68 . . . . 74.310000000000002 111.095 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.32 176.87 9.43 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.402 2.068 . . . . 63.039999999999999 111.794 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 p -112.92 -175.89 2.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.331 0.652 . . . . 74.219999999999999 110.474 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.9 t -150.2 136.1 18.5 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.519 -0.919 . . . . 73.299999999999997 108.519 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -114.44 138.43 50.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.003 0.521 . . . . 72.140000000000001 109.621 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.7 m -148.15 121.7 9.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.435 0.694 . . . . 73.319999999999993 109.506 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.06 144.58 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.488 0.715 . . . . 74.239999999999995 110.149 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -105.98 157.24 35.21 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 124.084 0.954 . . . . 75.430000000000007 110.102 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -54.19 149.99 34.11 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 72.010000000000005 113.304 171.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.4 159.8 32.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.481 0.712 . . . . 75.010000000000005 112.016 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.41 154.13 94.65 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.412 1.085 . . . . 72.409999999999997 111.98 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.34 159.35 40.22 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.98 2.454 . . . . 71.420000000000002 111.226 173.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.48 -81.9 0.64 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.439 0.533 . . . . 75.439999999999998 112.439 -173.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.12 154.96 46.2 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.219 0.463 . . . . 74.019999999999996 112.196 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 27.3 mm-40 -77.07 114.49 15.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.104 0.962 . . . . 74.109999999999999 109.451 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.604 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 43.1 t -125.76 137.32 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 122.853 0.461 . . . . 75.409999999999997 110.542 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -151.27 148.99 28.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.005 0.922 . . . . 74.140000000000001 110.676 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.51 113.57 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.263 1.025 . . . . 75.209999999999994 109.505 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -103.33 107.85 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.78 0.432 . . . . 75.340000000000003 110.228 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 3.4 t-20 -94.42 119.44 33.16 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.734 -0.839 . . . . 74.230000000000004 108.734 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -102.43 -42.9 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 122.073 -0.392 . . . . 75.540000000000006 110.365 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 p -136.88 158.55 44.21 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.84 -0.8 . . . . 73.450000000000003 108.84 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.75 59.05 4.21 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.591 -1.003 . . . . 74.209999999999994 110.591 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 t -66.22 100.81 0.65 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.602 0.761 . . . . 62.119999999999997 111.491 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -147.83 155.44 41.65 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.249 0.62 . . . . 53.219999999999999 110.133 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.62 -2.53 36.36 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 118.905 -0.942 . . . . 65.129999999999995 114.001 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.98 69.46 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.095 0.958 . . . . 70.310000000000002 111.412 171.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -42.56 97.28 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 124.154 0.909 . . . . 71.420000000000002 110.988 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.22 -35.53 71.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.67 -0.696 . . . . 72.439999999999998 111.089 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.76 -31.24 71.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.901 1.28 . . . . 65.299999999999997 111.63 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 98' ' ' LEU . 48.0 p -76.97 -22.18 53.59 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.7 0.4 . . . . 72.329999999999998 111.59 176.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.19 -54.73 5.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.462 0.705 . . . . 74.450000000000003 111.205 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -54.96 -31.16 60.33 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.16 0.984 . . . . 74.549999999999997 113.147 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -59.88 -39.47 85.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.321 0.648 . . . . 74.430000000000007 111.789 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.0 -38.42 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 118.917 -0.563 . . . . 75.510000000000005 111.893 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -30.93 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.825 0.738 . . . . 74.5 110.596 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.19 -27.97 66.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.479 0.712 . . . . 73.439999999999998 110.808 173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.71 -21.8 37.78 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.63 0.772 . . . . 74.140000000000001 111.989 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.06 25.99 4.85 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 113.968 0.347 . . . . 65.400000000000006 113.968 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.43 158.73 27.27 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.34 0.656 . . . . 64.430000000000007 110.443 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -65.43 -70.1 0.26 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.969 0.793 . . . . 74.329999999999998 110.854 -165.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.02 145.15 35.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.69 -0.856 . . . . 64.420000000000002 108.69 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.486 HG22 ' HB ' ' A' ' 37' ' ' VAL . 41.4 p -137.14 100.61 4.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.527 -1.286 . . . . 73.120000000000005 107.527 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 19.0 t70 -104.9 162.5 13.27 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.897 0.879 . . . . 73.319999999999993 110.183 -172.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 141.44 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.841 0.856 . . . . 73.030000000000001 109.049 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.44 129.02 2.41 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.947 -0.461 . . . . 71.310000000000002 111.947 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 16.8 p-10 -88.66 97.39 11.09 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.447 0.699 . . . . 75.310000000000002 109.823 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.4 135.55 13.03 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.166 -0.333 . . . . 75.409999999999997 110.155 -169.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -81.16 99.41 8.53 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.433 -0.58 . . . . 70.129999999999995 109.433 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.31 151.75 89.98 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.407 -0.59 . . . . 73.329999999999998 109.407 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.04 -7.61 18.32 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.113 1.875 . . . . 61.439999999999998 112.371 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -108.93 -23.05 11.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.342 0.657 . . . . 73.400000000000006 112.43 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.06 130.13 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.36 0.6 . . . . 73.109999999999999 111.252 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.27 -7.67 4.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.431 1.092 . . . . 75.439999999999998 111.215 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.12 159.0 5.77 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.463 1.105 . . . . 72.349999999999994 109.345 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.535 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.4 t -66.75 107.24 2.09 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.694 0.759 . . . . 64.030000000000001 109.996 177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 m -144.91 153.42 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.531 -0.759 . . . . 73.5 109.293 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.635 HG23 ' HA3' ' A' ' 95' ' ' GLY . 4.3 t -112.6 114.28 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.916 -1.142 . . . . 70.329999999999998 107.916 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.567 ' HB2' HG13 ' A' ' 117' ' ' ILE . 52.4 m-85 -105.1 119.38 38.89 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.285 0.493 . . . . 73.120000000000005 110.585 -174.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.469 ' HD2' ' HB1' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -112.01 140.99 46.22 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.85 0.719 . . . . 74.310000000000002 110.462 175.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.1 t -113.78 -40.05 3.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.946 0.898 . . . . 62.030000000000001 111.654 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -89.81 37.38 0.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.858 0.863 . . . . 73.209999999999994 111.856 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -45.87 163.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.518 1.927 . . . . 74.129999999999995 114.746 -174.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 86.69 -55.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.727 2.011 . . . . 75.329999999999998 108.359 -163.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.31 -50.73 1.99 Allowed Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.205 -0.452 . . . . 75.019999999999996 112.574 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.04 -19.94 50.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.653 0.263 . . . . 74.430000000000007 111.299 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -56.81 -27.97 60.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.75 -0.659 . . . . 65.530000000000001 110.972 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.8 -46.64 57.57 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.716 0.806 . . . . 72.430000000000007 112.214 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -79.9 -33.24 40.03 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 122.672 0.389 . . . . 75.140000000000001 110.736 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.59 -48.22 75.76 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 123.799 0.687 . . . . 64.310000000000002 110.353 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.516 ' HA ' HG13 ' A' ' 102' ' ' VAL . 30.5 t70 -57.52 -40.24 78.34 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.272 0.983 . . . . 73.099999999999994 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.54 -46.1 87.51 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.961 0.788 . . . . 73.450000000000003 112.149 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.446 HG13 HG11 ' A' ' 118' ' ' VAL . 61.4 t -65.44 -52.82 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.328 0.651 . . . . 74.310000000000002 110.605 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.635 ' HA3' HG23 ' A' ' 79' ' ' VAL . . . -64.6 -26.84 71.18 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.344 -0.844 . . . . 71.540000000000006 113.281 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 2.6 tmt_? -65.07 -39.29 93.02 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.507 0.723 . . . . 75.450000000000003 109.553 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -66.46 -52.65 43.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.922 -1.035 . . . . 73.310000000000002 111.181 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 52' ' ' THR . 4.0 pp -82.45 -13.71 56.29 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.792 -0.64 . . . . 73.340000000000003 112.402 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.66 72.81 1.2 Allowed Glycine 0 C--N 1.349 1.255 0 O-C-N 123.574 0.546 . . . . 45.25 113.136 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.06 155.11 44.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.703 0.801 . . . . 75.340000000000003 110.001 172.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.97 142.53 33.36 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.492 -0.776 . . . . 74.299999999999997 110.289 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.516 HG13 ' HA ' ' A' ' 92' ' ' ASP . 34.0 m -95.19 148.25 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.417 0.687 . . . . 70.140000000000001 110.748 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -157.5 156.69 32.49 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 123.811 0.844 . . . . 75.019999999999996 110.81 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.63 161.51 23.12 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.402 1.081 . . . . 75.0 110.746 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.66 29.73 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.404 2.001 . . . . 71.239999999999995 116.404 -172.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.0 mm? -54.61 -53.62 58.12 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-N 119.562 1.074 . . . . 74.430000000000007 112.521 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 6.0 Cg_exo -80.26 -13.93 12.2 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 122.378 2.052 . . . . 75.340000000000003 112.953 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.553 ' HG2' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -58.62 -41.61 86.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.498 0.719 . . . . 72.319999999999993 110.153 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.4 tp -64.29 -12.75 44.72 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.56 0.744 . . . . 70.109999999999999 112.566 -172.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -63.64 -47.16 82.47 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.871 0.869 . . . . 74.319999999999993 111.161 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.2 -32.49 7.48 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.353 1.061 . . . . 75.129999999999995 110.944 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.1 71.92 1.04 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 126.782 2.033 . . . . 72.299999999999997 112.708 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.553 ' HD2' ' HG2' ' A' ' 108' ' ' GLU . 1.4 Cg_endo -88.71 140.74 4.34 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.1 2.533 . . . . 75.310000000000002 111.106 162.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.0 129.04 13.72 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.66 2.24 . . . . 74.310000000000002 114.468 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.23 -156.15 32.02 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.022 -0.536 . . . . 41.25 113.988 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 76.8 t -58.1 111.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 124.278 1.031 . . . . 74.200000000000003 110.138 177.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.567 HG13 ' HB2' ' A' ' 80' ' ' TYR . 39.7 pt -117.85 104.3 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.47 -1.307 . . . . 70.540000000000006 107.47 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.581 ' HB ' HG12 ' A' ' 79' ' ' VAL . 2.3 p -101.84 111.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.886 -0.783 . . . . 75.519999999999996 108.886 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -93.17 123.53 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.941 -1.027 . . . . 75.219999999999999 109.473 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.05 127.52 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.593 0.757 . . . . 73.219999999999999 110.108 -172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.535 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.8 p -123.4 119.61 30.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.512 -1.292 . . . . 74.349999999999994 107.512 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.594 0 CA-C-O 119.207 -0.774 . . . . 63.32 112.628 -174.613 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.931 0 N-CA-C 111.956 -0.457 . . . . 72.140000000000001 111.956 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.0 t -139.78 -57.96 0.57 Allowed 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.497 0.719 . . . . 71.150000000000006 109.466 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m 52.67 78.1 0.41 Allowed Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.722 1.209 . . . . 73.099999999999994 111.364 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.99 109.8 2.02 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.685 2.256 . . . . 74.219999999999999 112.4 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.95 117.47 7.66 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.612 0.765 . . . . 73.209999999999994 109.995 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 p -71.03 92.3 0.93 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.349 0.595 . . . . 63.009999999999998 109.576 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -91.44 8.64 35.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.445 1.098 . . . . 64.409999999999997 111.517 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -62.63 -68.58 0.32 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.474 0.709 . . . . 65.310000000000002 110.971 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.3 t70 65.35 113.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.011 1.324 . . . . 73.340000000000003 112.423 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.3 m -86.53 126.66 34.61 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.583 0.753 . . . . 75.450000000000003 109.931 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.3 p -153.49 124.65 7.45 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.939 0.896 . . . . 73.239999999999995 108.684 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.41 123.93 7.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.812 0.845 . . . . 64.530000000000001 109.517 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 tp -157.9 136.26 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.817 0.847 . . . . 73.400000000000006 109.345 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 p -150.77 88.78 1.5 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.86 0.864 . . . . 73.140000000000001 109.318 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.5 p -99.17 131.0 45.51 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.176 -0.675 . . . . 60.329999999999998 109.176 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -131.34 155.37 47.35 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.2 0.524 . . . . 74.010000000000005 111.251 -174.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -153.98 159.35 41.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.135 1.374 . . . . 75.530000000000001 108.352 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -139.59 42.23 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 122.043 0.925 . . . . 62.100000000000001 109.911 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 m -78.66 100.48 7.04 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.1 -0.955 . . . . 74.340000000000003 109.0 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 t -132.79 31.3 3.95 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.829 0.823 . . . . 75.439999999999998 110.128 -174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.23 134.65 37.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.212 -0.904 . . . . 73.530000000000001 110.898 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.84 111.9 4.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.509 0.724 . . . . 62.439999999999998 109.556 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.16 158.18 52.55 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.645 2.23 . . . . 74.340000000000003 111.275 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -159.5 167.26 29.06 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.16 0.584 . . . . 63.520000000000003 110.65 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -143.84 159.5 42.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.689 0.795 . . . . 74.439999999999998 110.291 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 t -127.63 140.21 52.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.555 0.742 . . . . 72.030000000000001 109.781 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 p -169.29 137.0 1.83 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.824 0.849 . . . . 72.209999999999994 109.877 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.11 125.9 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.353 0.661 . . . . 65.109999999999999 110.52 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.37 110.48 58.06 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.376 -0.972 . . . . 74.209999999999994 108.376 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.88 132.67 43.5 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.256 2.637 . . . . 61.219999999999999 113.292 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.95 179.77 6.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.734 0.814 . . . . 73.319999999999993 110.221 172.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.03 94.48 3.76 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.353 0.661 . . . . 73.420000000000002 109.744 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' A' ' 62' ' ' THR . 48.3 Cg_exo -59.72 141.85 97.67 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.938 2.426 . . . . 73.310000000000002 112.6 173.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -98.92 -75.58 0.56 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.342 0.657 . . . . 75.150000000000006 111.871 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.97 168.1 26.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.036 0.534 . . . . 74.310000000000002 110.838 -171.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.04 112.71 24.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.906 0.882 . . . . 75.109999999999999 108.944 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 64' ' ' THR . 99.4 t -116.42 138.95 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.68 0.792 . . . . 75.319999999999993 109.461 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -132.15 118.12 19.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.614 -0.513 . . . . 72.310000000000002 109.614 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.12 107.19 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.342 -0.614 . . . . 75.219999999999999 109.342 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -118.1 152.26 35.93 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 109.102 -0.703 . . . . 74.430000000000007 109.102 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.72 134.44 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.033 -0.728 . . . . 64.310000000000002 109.033 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.14 -39.71 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.812 -0.44 . . . . 74.310000000000002 109.812 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 p -141.73 -61.32 0.46 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.821 0.448 . . . . 64.409999999999997 111.208 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.65 100.69 1.72 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.703 -0.498 . . . . 63.340000000000003 112.064 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -88.17 41.45 1.0 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.155 0.982 . . . . 73.099999999999994 112.858 -168.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.16 137.34 56.2 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.961 0.505 . . . . 72.340000000000003 110.521 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -7.69 58.04 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.529 0.518 . . . . 70.510000000000005 113.643 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.32 64.68 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.267 1.027 . . . . 71.239999999999995 110.954 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.08 -56.96 14.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.922 -1.035 . . . . 74.420000000000002 110.59 171.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.99 67.65 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.518 -0.765 . . . . 74.400000000000006 112.568 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -29.92 68.08 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.039 0.935 . . . . 75.129999999999995 110.96 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.549 HG23 ' HB2' ' A' ' 98' ' ' LEU . 64.4 p -70.13 -36.86 75.1 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 110.085 -0.339 . . . . 72.120000000000005 110.085 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB2' ' OG1' ' A' ' 64' ' ' THR . . . -67.3 -28.5 68.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.602 0.761 . . . . 72.230000000000004 111.562 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.41 -24.47 62.93 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.015 0.926 . . . . 72.200000000000003 110.711 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -70.51 -42.0 71.88 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.906 -0.405 . . . . 72.239999999999995 109.906 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.39 -29.6 67.4 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.806 0.669 . . . . 73.150000000000006 112.806 -174.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HB2' ' HZ1' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.38 -27.47 67.13 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.897 0.38 . . . . 65.25 110.793 175.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.03 27.77 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.028 0.931 . . . . 62.439999999999998 111.746 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.39 -22.8 22.39 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.304 0.642 . . . . 72.019999999999996 112.484 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.47 46.83 0.39 Allowed Glycine 0 C--N 1.352 1.439 0 CA-C-N 117.873 0.306 . . . . 54.509999999999998 113.308 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -62.41 158.22 18.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.103 0.961 . . . . 73.5 111.818 176.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 33' ' ' PRO . 85.7 m -92.54 -60.72 1.76 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.214 -1.032 . . . . 73.230000000000004 108.214 161.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -134.56 140.66 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.611 -1.255 . . . . 71.200000000000003 107.611 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t -130.56 127.12 38.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.372 -0.973 . . . . 71.030000000000001 108.372 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -122.54 144.55 49.01 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.014 -1.106 . . . . 71.409999999999997 108.014 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 m -139.85 143.61 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 122.848 0.459 . . . . 74.319999999999993 110.41 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.1 -138.13 4.63 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.016 -0.538 . . . . 63.25 112.16 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -157.96 123.05 4.39 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.265 0.626 . . . . 72.310000000000002 110.546 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 mp -129.12 156.39 43.96 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.188 0.995 . . . . 75.25 108.882 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 p -106.13 100.88 10.4 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.708 0.803 . . . . 50.130000000000003 110.055 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -119.16 119.54 31.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 123.818 0.847 . . . . 70.099999999999994 109.134 167.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.16 0.33 9.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.757 2.305 . . . . 72.519999999999996 112.713 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.0 -26.77 54.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.047 0.939 . . . . 73.510000000000005 111.104 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 t -125.56 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.755 -0.832 . . . . 75.239999999999995 108.755 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.74 -54.33 2.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.962 0.905 . . . . 45.039999999999999 110.488 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.64 160.33 25.08 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.024 0.93 . . . . 63.340000000000003 110.436 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 t -64.05 104.67 0.75 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.979 0.895 . . . . 61.32 108.887 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 101' ' ' ALA . 25.0 m -136.1 129.84 32.46 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.385 -0.825 . . . . 71.120000000000005 110.564 -171.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.726 HG23 HG13 ' A' ' 118' ' ' VAL . 73.5 t -95.18 113.65 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.049 -1.093 . . . . 60.399999999999999 108.049 175.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.475 ' HE1' ' HA ' ' A' ' 105' ' ' ARG . 10.2 t80 -96.98 136.38 37.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.057 -0.72 . . . . 73.439999999999998 109.057 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.482 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 25.1 p90 -151.73 -179.49 7.48 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.71 1.256 . . . . 73.120000000000005 108.972 172.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 4.3 m -131.7 169.22 16.49 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 106.043 -1.836 . . . . 63.43 106.043 164.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.69 21.25 2.25 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.134 -0.979 . . . . 73.120000000000005 111.826 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.45 99.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.259 1.024 . . . . 73.030000000000001 109.788 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 64.11 -75.99 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 125.56 1.544 . . . . 74.340000000000003 111.88 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.57 39.07 0.51 Allowed Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.013 0.365 . . . . 51.32 114.013 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 82' ' ' THR . 55.4 mt-10 -69.97 -36.45 75.24 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.0 0.429 . . . . 74.120000000000005 110.566 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -62.02 -37.75 86.08 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.781 -1.1 . . . . 74.530000000000001 112.54 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.77 -25.49 49.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.986 0.514 . . . . 74.540000000000006 111.492 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.5 m -78.75 -36.69 42.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.911 0.885 . . . . 74.310000000000002 109.677 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -24.38 40.45 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.928 -1.033 . . . . 65.150000000000006 111.554 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.09 -39.71 90.96 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.11 0.964 . . . . 71.129999999999995 109.977 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -23.98 66.94 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.139 -0.937 . . . . 74.129999999999995 111.996 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 118' ' ' VAL . 58.1 t -84.34 -61.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 122.872 0.469 . . . . 74.310000000000002 111.355 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.73 -27.73 73.42 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.581 0.55 . . . . 54.420000000000002 114.293 -168.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -76.11 -23.46 54.9 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.002 0.521 . . . . 74.319999999999993 110.265 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 85.3 m -84.49 -38.69 19.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.621 0.769 . . . . 73.310000000000002 111.084 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 HG23 ' A' ' 120' ' ' VAL . 46.0 tp -81.37 -31.88 33.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.782 0.833 . . . . 70.329999999999998 111.553 -172.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.67 50.57 5.57 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 111.002 -0.839 . . . . 73.230000000000004 111.002 -170.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.59 143.74 51.12 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.53 0.732 . . . . 74.310000000000002 110.606 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 78' ' ' THR . . . -63.48 114.48 3.92 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.962 0.788 . . . . 73.129999999999995 110.018 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.482 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 16.1 m -88.13 101.75 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.356 0.598 . . . . 74.329999999999998 110.114 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.59 157.24 20.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.518 1.151 . . . . 73.299999999999997 111.957 -175.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.486 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 8.0 tp -93.2 -166.59 1.55 Allowed 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 112.934 -1.939 . . . . 73.019999999999996 108.367 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 48.7 ttp180 -81.43 27.69 0.42 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.588 0.755 . . . . 74.540000000000006 112.542 -175.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.8 mm? -70.87 -66.69 0.73 Allowed Pre-proline 0 CA--C 1.558 1.27 0 CA-C-O 118.045 -0.979 . . . . 74.420000000000002 111.053 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 4.5 Cg_exo -83.85 -23.57 3.12 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 121.878 1.719 . . . . 74.549999999999997 112.988 -173.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.35 -9.96 59.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.949 -0.548 . . . . 71.409999999999997 111.587 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -20.92 66.55 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.849 0.46 . . . . 71.140000000000001 110.526 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -55.66 -45.56 77.66 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.442 0.697 . . . . 72.140000000000001 110.831 171.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -86.13 -32.44 21.31 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.401 0.68 . . . . 62.140000000000001 111.221 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.62 79.15 0.36 Allowed Pre-proline 0 CA--C 1.563 1.446 0 C-N-CA 125.734 1.614 . . . . 71.349999999999994 111.033 -169.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -84.56 125.64 3.38 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.061 2.508 . . . . 72.109999999999999 111.743 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.12 118.69 4.08 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.35 2.033 . . . . 75.439999999999998 110.906 173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.07 166.19 39.43 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 112.014 -0.434 . . . . 41.520000000000003 112.014 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.414 HG11 ' O ' ' A' ' 80' ' ' TYR . 75.9 t -66.94 126.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.023 0.929 . . . . 75.239999999999995 111.481 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.455 HG12 ' CD2' ' A' ' 80' ' ' TYR . 9.4 pt -121.85 111.95 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.162 -1.051 . . . . 75.310000000000002 108.162 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.726 HG13 HG23 ' A' ' 79' ' ' VAL . 61.3 t -94.01 108.49 20.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.845 -0.798 . . . . 75.230000000000004 108.845 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.47 120.95 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.409 -0.814 . . . . 72.239999999999995 109.789 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.593 HG23 HD23 ' A' ' 98' ' ' LEU . 44.7 t -110.28 129.59 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 122.681 0.392 . . . . 73.530000000000001 110.763 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 t -99.87 164.56 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.048 0.451 . . . . 73.400000000000006 110.745 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.806 0 CA-C-O 118.708 -1.051 . . . . 74.219999999999999 111.126 170.267 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 110.15 -0.315 . . . . 74.099999999999994 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -93.53 178.07 5.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.42 0.688 . . . . 53.119999999999997 110.108 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.31 156.5 42.97 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.749 0.82 . . . . 74.209999999999994 109.666 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -128.52 170.56 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.464 0.706 . . . . 44.409999999999997 110.41 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 t -164.63 171.15 14.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.211 1.004 . . . . 73.140000000000001 109.438 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -135.78 163.54 29.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.026 0.93 . . . . 63.409999999999997 109.18 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.7 mtt -127.54 131.62 50.03 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.019 0.928 . . . . 51.439999999999998 108.698 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.5 p -111.9 141.49 45.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.411 0.684 . . . . 41.409999999999997 110.142 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.9 p -127.29 158.74 36.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.806 0.843 . . . . 71.340000000000003 110.108 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 t -143.4 162.27 36.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.628 0.771 . . . . 71.230000000000004 109.311 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.9 m -149.09 137.72 21.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.306 0.643 . . . . 74.109999999999999 109.942 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.51 165.87 12.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.55 0.74 . . . . 55.0 109.861 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.64 136.63 12.48 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.179 0.592 . . . . 73.549999999999997 109.884 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.53 139.26 37.17 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.075 2.516 . . . . 73.200000000000003 112.867 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 p -102.18 128.14 48.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.994 0.918 . . . . 62.310000000000002 109.899 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 m -87.88 121.98 30.96 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.569 0.748 . . . . 70.030000000000001 109.582 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 m -136.23 124.43 23.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.081 0.952 . . . . 55.409999999999997 109.066 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.2 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.044 0.938 . . . . 34.039999999999999 109.755 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.42 140.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.693 0.797 . . . . 55.020000000000003 109.525 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.98 136.88 19.65 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.096 0.959 . . . . 61.439999999999998 109.448 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo . . . . . 0 C--N 1.382 2.315 0 C-N-CA 123.22 2.613 . . . . 60.25 113.841 178.76 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.88 -0.415 . . . . 71.319999999999993 109.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.18 149.34 26.01 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.32 0.581 . . . . 64.239999999999995 110.799 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.481 HG21 HD21 ' A' ' 56' ' ' LEU . 48.1 t -114.9 146.57 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.312 1.045 . . . . 71.230000000000004 108.84 172.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.0 ptp180 -145.18 117.02 8.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.225 0.536 . . . . 53.009999999999998 111.571 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.52 111.9 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.311 0.644 . . . . 62.520000000000003 109.774 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 33.7 m-85 -101.08 118.76 37.63 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.187 0.595 . . . . 73.540000000000006 109.856 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 120' ' ' VAL . 4.6 t-20 -95.9 125.36 40.4 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.345 -1.354 . . . . 71.040000000000006 107.345 169.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.769 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.6 tt -80.39 -34.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 111.931 0.345 . . . . 71.530000000000001 111.931 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -111.43 -20.52 12.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.689 0.396 . . . . 75.230000000000004 111.511 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.9 114.92 0.62 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.808 -0.517 . . . . 74.209999999999994 111.808 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.441 HG22 HD21 ' A' ' 41' ' ' ASN . 13.2 t -145.15 -155.67 0.63 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.059 -0.719 . . . . 64.239999999999995 109.059 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.98 154.78 25.52 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.587 1.155 . . . . 72.310000000000002 112.477 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.33 -1.8 16.56 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 115.455 -0.793 . . . . 74.25 114.691 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.69 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.028 0.931 . . . . 74.129999999999995 111.58 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.26 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.354 -0.839 . . . . 63.100000000000001 110.863 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB2' HG21 ' A' ' 66' ' ' VAL . . . -71.3 -20.47 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.465 0.706 . . . . 75.030000000000001 111.753 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -28.97 69.07 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.603 0.761 . . . . 74.299999999999997 111.354 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.492 ' HB ' HG13 ' A' ' 94' ' ' VAL . 68.5 p -62.87 -40.99 99.19 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.486 0.492 . . . . 74.530000000000001 110.346 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 64' ' ' THR . . . -66.27 -37.41 85.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.055 0.942 . . . . 74.239999999999995 111.809 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -65.44 -51.73 58.12 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.584 -0.735 . . . . 74.409999999999997 110.946 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -67.76 -26.22 66.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.572 -1.194 . . . . 73.549999999999997 110.836 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 37' ' ' VAL . 18.3 tp -76.3 -49.85 15.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.949 -1.023 . . . . 62.210000000000001 111.198 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 34.9 ttpt -63.19 -35.82 81.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.915 0.486 . . . . 74.310000000000002 110.685 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -22.49 62.14 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 54.219999999999999 111.341 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.67 57.83 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.413 0.685 . . . . 75.439999999999998 111.36 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.37 41.17 0.98 Allowed Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.445 -0.343 . . . . 75.530000000000001 113.069 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -106.25 156.9 18.0 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.304 0.642 . . . . 74.209999999999994 109.927 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.4 m -66.95 -69.48 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.275 0.984 . . . . 53.329999999999998 111.361 -161.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.29 136.76 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.188 -1.042 . . . . 72.209999999999994 108.188 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.48 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 73.7 p -129.55 94.9 3.87 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.937 -0.764 . . . . 61.130000000000003 108.937 172.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -103.63 131.56 50.67 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.644 0.778 . . . . 72.150000000000006 109.663 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 50' ' ' ALA . 6.4 p -116.3 131.11 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 121.712 -0.617 . . . . 75.310000000000002 110.638 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -150.27 159.76 28.25 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.648 -0.705 . . . . 54.240000000000002 111.618 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -95.04 119.8 34.17 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.744 -0.836 . . . . 33.43 108.744 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.5 tt -150.64 133.93 16.25 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.004 -1.11 . . . . 74.319999999999993 108.004 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.769 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.9 m -80.85 100.07 8.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.361 0.665 . . . . 73.329999999999998 109.882 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.61 106.21 8.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.166 -0.679 . . . . 54.450000000000003 109.166 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.71 0.47 9.99 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.695 2.263 . . . . 71.230000000000004 112.465 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -95.83 -23.4 16.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.249 1.019 . . . . 74.310000000000002 110.647 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.762 HG21 HG11 ' A' ' 119' ' ' VAL . 14.3 m -97.27 155.49 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.291 0.636 . . . . 74.340000000000003 109.865 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.29 9.28 2.28 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.702 0.801 . . . . 73.109999999999999 110.586 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.46 156.51 33.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.74 1.216 . . . . 70.430000000000007 108.611 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -59.2 111.89 1.51 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.053 -0.721 . . . . 74.140000000000001 109.053 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.8 m -138.45 127.95 24.72 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.313 -0.858 . . . . 63.329999999999998 110.611 -168.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 118' ' ' VAL . 50.3 t -102.4 113.19 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.784 -1.191 . . . . 72.129999999999995 107.784 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 117' ' ' ILE . 1.4 t80 -98.87 142.47 30.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.969 1.308 . . . . 73.209999999999994 109.926 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 22.5 p90 -133.06 164.56 26.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.459 -0.792 . . . . 72.319999999999993 111.2 168.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.1 m -107.48 172.41 6.84 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 106.895 -1.521 . . . . 74.099999999999994 106.895 163.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.53 28.41 8.76 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.91 0.484 . . . . 62.219999999999999 111.176 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 84.6 t -77.17 126.25 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.416 -0.957 . . . . 74.319999999999993 108.416 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.92 -80.48 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.267 1.027 . . . . 73.340000000000003 110.912 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.56 35.6 0.23 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.9 -0.48 . . . . 74.439999999999998 111.9 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 48.9 mt-10 -61.8 -19.64 62.74 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.172 0.589 . . . . 73.219999999999999 112.269 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' CG ' ' A' ' 81' ' ' TYR . 41.0 ptt85 -63.08 -28.8 70.33 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.287 0.477 . . . . 65.319999999999993 112.287 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.37 82.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.723 0.809 . . . . 63.520000000000003 111.798 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.7 t -67.67 -46.52 72.13 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.422 -0.354 . . . . 74.219999999999999 111.151 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 81' ' ' TYR . . . -71.98 -27.72 62.94 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.744 0.417 . . . . 53.039999999999999 111.934 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.04 -33.8 76.91 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.529 0.732 . . . . 73.299999999999997 110.496 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.42 -47.64 19.26 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.662 -0.699 . . . . 72.209999999999994 110.509 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.492 HG13 ' HB ' ' A' ' 52' ' ' THR . 98.8 t -68.95 -33.66 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.468 0.707 . . . . 72.430000000000007 111.757 -175.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -58.54 -29.08 63.3 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.347 -0.388 . . . . 72.430000000000007 112.561 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -86.96 -30.89 20.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.282 0.633 . . . . 74.25 111.018 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.2 m -64.34 -43.24 95.23 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.644 0.735 . . . . 65.349999999999994 110.546 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.486 HD21 HG22 ' A' ' 120' ' ' VAL . 57.3 tp -85.29 -32.15 22.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.59 -1.186 . . . . 70.450000000000003 110.204 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 66.8 1.96 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.432 -1.067 . . . . 63.520000000000003 110.432 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.97 166.44 24.47 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.553 1.141 . . . . 44.520000000000003 110.359 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.32 110.99 7.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.429 0.691 . . . . 64.049999999999997 109.325 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.623 HG22 ' HA3' ' A' ' 95' ' ' GLY . 5.4 t -86.63 134.03 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.26 -1.015 . . . . 73.239999999999995 108.26 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -140.39 153.12 46.23 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-O 121.402 0.62 . . . . 62.340000000000003 111.013 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.415 ' HA ' ' CE1' ' A' ' 81' ' ' TYR . 6.2 mp -76.78 -163.62 0.36 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 114.342 -1.299 . . . . 41.350000000000001 110.331 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -70.63 28.61 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 72.450000000000003 112.823 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 33.8 tp -70.88 -48.72 14.49 Favored Pre-proline 0 CA--C 1.568 1.641 0 O-C-N 121.601 -0.687 . . . . 72.099999999999994 111.265 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 106' ' ' LEU . 51.0 Cg_exo -58.39 -12.91 14.87 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 122.819 2.346 . . . . 74.439999999999998 114.006 170.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -66.37 -35.08 79.42 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.25 0.62 . . . . 52.109999999999999 109.651 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.1 tp -82.7 -34.15 27.4 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.911 0.386 . . . . 75.310000000000002 110.098 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -68.62 -48.78 63.21 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.454 -0.793 . . . . 52.439999999999998 111.335 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -126.86 -33.99 2.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.635 0.774 . . . . 64.349999999999994 111.554 -172.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.91 72.96 0.33 Allowed Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.766 1.226 . . . . 63.32 109.503 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.549 ' HB3' HD13 ' A' ' 117' ' ' ILE . 5.9 Cg_exo -81.92 148.38 15.43 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 123.407 2.738 . . . . 71.340000000000003 112.148 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.72 119.2 5.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.284 2.656 . . . . 63.439999999999998 112.938 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.17 -113.33 5.75 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.927 0.767 . . . . 54.130000000000003 112.867 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 37' ' ' VAL . 39.1 t -116.45 136.87 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.964 1.306 . . . . 71.310000000000002 108.098 173.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.584 HG22 ' HG3' ' A' ' 38' ' ' ARG . 11.8 pt -128.68 149.95 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.304 -0.628 . . . . 74.120000000000005 109.304 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 79' ' ' VAL . 59.2 t -117.54 102.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.114 -1.439 . . . . 72.430000000000007 107.114 175.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.762 HG11 HG21 ' A' ' 74' ' ' VAL . 23.8 t -94.18 126.04 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.108 -0.701 . . . . 53.219999999999999 109.108 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.519 ' HB ' ' ND2' ' A' ' 41' ' ' ASN . 21.5 t -115.82 128.09 73.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.558 -0.904 . . . . 62.530000000000001 108.558 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.419 HG22 HG21 ' A' ' 42' ' ' ILE . 19.7 p -95.17 137.48 34.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.214 0.605 . . . . 75.5 109.492 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 119.022 -0.877 . . . . 73.439999999999998 111.96 -177.829 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.623 -0.51 . . . . 71.439999999999998 109.623 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 p -130.42 111.02 11.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.225 1.01 . . . . 63.240000000000002 109.066 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.15 113.35 1.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.075 0.55 . . . . 74.120000000000005 109.756 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -150.8 114.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.726 0.81 . . . . 71.120000000000005 109.708 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -133.59 120.37 20.64 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.081 0.952 . . . . 65.040000000000006 108.636 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -151.79 109.22 3.6 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.743 0.817 . . . . 74.329999999999998 109.395 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.42 145.38 11.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.295 1.038 . . . . 74.219999999999999 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 142.85 24.79 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.098 0.475 . . . . 75.349999999999994 111.001 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -139.95 131.01 26.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 74.329999999999998 109.107 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -157.41 137.4 12.51 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.048 0.939 . . . . 74.120000000000005 109.311 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.7 m -147.56 102.95 3.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.426 0.69 . . . . 74.239999999999995 109.593 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 107.97 19.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.464 0.706 . . . . 65.299999999999997 109.261 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.26 111.7 44.92 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.589 0.756 . . . . 73.349999999999994 109.747 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.59 169.46 15.3 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.967 2.444 . . . . 63.409999999999997 112.304 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -152.86 119.99 5.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.583 0.753 . . . . 71.439999999999998 109.545 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 m -90.41 172.3 8.83 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.994 0.517 . . . . 54.119999999999997 109.836 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 m -132.04 144.22 50.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.119 0.568 . . . . 54.420000000000002 110.655 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 161.93 27.19 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.484 1.114 . . . . 63.439999999999998 110.145 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.89 140.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.103 0.561 . . . . 73.200000000000003 109.803 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.44 113.18 64.7 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.416 -0.957 . . . . 73.439999999999998 108.416 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.37 1.7 0 C-N-CA 122.494 2.129 . . . . 74.409999999999997 111.511 176.262 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.99 -0.374 . . . . 61.329999999999998 109.99 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -98.77 107.74 20.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.038 0.535 . . . . 65.319999999999993 110.044 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 56' ' ' LEU . 22.1 t -95.64 135.89 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.194 0.598 . . . . 61.219999999999999 109.742 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HD3' ' HE2' ' A' ' 40' ' ' TYR . 7.9 ptp180 -150.74 134.85 16.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.854 0.861 . . . . 74.25 110.573 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 118' ' ' VAL . 41.0 t -100.5 133.28 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 55.310000000000002 109.545 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.53 ' HE2' ' HD3' ' A' ' 38' ' ' ARG . 69.6 m-85 -130.12 107.77 9.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.683 0.793 . . . . 73.299999999999997 109.735 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -84.39 118.03 23.99 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.988 -0.745 . . . . 72.030000000000001 108.988 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.708 HG13 ' HA ' ' A' ' 70' ' ' SER . 17.0 tt -78.86 -33.21 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.113 -0.329 . . . . 62.25 110.113 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -99.1 -162.48 0.96 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.18 0.992 . . . . 53.420000000000002 109.619 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.71 116.12 8.5 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 123.575 0.547 . . . . 71.239999999999995 112.312 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -69.96 101.63 1.82 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.738 0.78 . . . . 73.049999999999997 110.692 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.77 145.53 27.2 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.999 -0.546 . . . . 64.340000000000003 109.862 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -58.02 -38.41 89.12 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 124.42 1.075 . . . . 55.039999999999999 114.377 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.61 68.43 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.775 0.83 . . . . 24.329999999999998 112.398 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.71 71.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.715 0.806 . . . . 72.299999999999997 111.731 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.41 -23.62 37.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.318 0.647 . . . . 74.129999999999995 111.441 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 41.9 mmm-85 -64.75 -21.71 66.82 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.141 0.577 . . . . 63.130000000000003 112.004 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' HD13 ' A' ' 56' ' ' LEU . 80.5 p -61.54 -45.97 91.91 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.905 0.482 . . . . 60.100000000000001 110.052 173.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.9 84.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.66 0.784 . . . . 55.030000000000001 111.363 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -42.49 95.91 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.181 0.926 . . . . 74.530000000000001 111.968 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -63.2 -46.21 88.1 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.852 -0.613 . . . . 74.319999999999993 110.636 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 37' ' ' VAL . 10.5 mp -72.68 -26.85 61.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.506 -0.77 . . . . 51.310000000000002 111.634 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.16 -51.17 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.076 -1.083 . . . . 75.409999999999997 108.076 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.99 59.38 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.708 -1.133 . . . . 72.129999999999995 112.128 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.76 -22.45 37.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.054 0.542 . . . . 74.349999999999994 110.571 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 44.03 5.54 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.054 -0.521 . . . . 22.109999999999999 113.782 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.65 158.64 30.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 72.140000000000001 109.448 169.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 m -58.02 -52.29 66.11 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.165 0.916 . . . . 74.530000000000001 111.302 -159.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.72 139.55 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.328 -0.99 . . . . 63.32 108.328 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 p -134.68 113.77 12.03 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.351 1.061 . . . . 74.010000000000005 108.485 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 22.8 t70 -128.38 154.91 45.5 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.817 0.847 . . . . 55.140000000000001 109.373 -171.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.62 153.66 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.392 0.615 . . . . 73.120000000000005 110.503 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.42 169.96 42.32 Favored Glycine 0 C--O 1.245 0.806 0 CA-C-N 114.783 -1.099 . . . . 55.32 110.51 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -146.32 116.61 7.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.262 -1.014 . . . . 54.329999999999998 108.262 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 mt -148.89 136.35 20.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.693 0.797 . . . . 73.439999999999998 109.411 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.708 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 m -76.52 97.94 4.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.404 -0.961 . . . . 52.350000000000001 108.404 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.8 119.8 70.0 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.861 -0.792 . . . . 71.310000000000002 108.861 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.76 -2.92 12.86 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.267 1.978 . . . . 70.409999999999997 112.712 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.09 -26.16 17.58 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.003 0.921 . . . . 73.209999999999994 111.829 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 76' ' ' ALA . 7.3 p -138.08 140.21 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.308 0.643 . . . . 73.140000000000001 110.189 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.3 33.21 3.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.336 0.654 . . . . 74.349999999999994 110.073 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' H ' HG22 ' A' ' 74' ' ' VAL . . . -135.14 149.87 50.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.527 0.731 . . . . 53.439999999999998 109.848 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.586 ' HB ' ' H ' ' A' ' 121' ' ' THR . 5.6 t -78.89 102.49 8.26 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 121.972 0.891 . . . . 74.299999999999997 108.73 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.5 m -149.8 143.35 25.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.169 -0.923 . . . . 61.530000000000001 108.971 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 23.2 t -93.92 114.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.527 -1.286 . . . . 74.349999999999994 107.527 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' HB2' HG12 ' A' ' 117' ' ' ILE . 96.8 m-85 -101.08 142.52 32.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.629 -1.249 . . . . 73.430000000000007 107.629 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -130.73 151.95 50.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.629 -0.508 . . . . 72.439999999999998 109.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.413 HG22 HG23 ' A' ' 84' ' ' VAL . 28.0 m -92.37 147.1 23.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.526 -1.287 . . . . 74.430000000000007 107.526 168.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.34 22.74 1.2 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.396 0.678 . . . . 74.439999999999998 112.661 -173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.413 HG23 HG22 ' A' ' 82' ' ' THR . 84.3 t -62.31 99.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.067 -0.716 . . . . 71.310000000000002 109.067 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.25 12.6 2.64 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.445 1.098 . . . . 62.340000000000003 112.182 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.32 62.65 2.05 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 120.243 -0.198 . . . . 72.239999999999995 113.401 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.71 -16.74 51.75 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.38 0.672 . . . . 73.310000000000002 111.524 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -26.1 6.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.047 0.939 . . . . 74.329999999999998 112.758 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.51 -53.21 60.73 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.774 0.671 . . . . 71.230000000000004 111.148 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.8 t -74.34 -32.61 62.87 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 116.293 -0.412 . . . . 62.119999999999997 110.694 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.56 75.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.393 0.677 . . . . 74.439999999999998 112.241 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.495 ' HA ' HG11 ' A' ' 102' ' ' VAL . 29.2 t70 -64.96 -43.13 93.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.219 1.008 . . . . 63.310000000000002 110.01 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.38 80.15 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.366 1.041 . . . . 70.319999999999993 111.846 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 90' ' ' THR . 65.3 t -64.58 -56.4 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 123.649 0.593 . . . . 74.310000000000002 110.389 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.72 67.55 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.89 0.744 . . . . 72.230000000000004 113.842 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -69.63 -47.16 64.35 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.256 1.022 . . . . 74.040000000000006 109.666 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.6 m -75.81 -35.92 59.89 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.972 -1.013 . . . . 72.439999999999998 111.03 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.01 -30.49 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.569 -0.741 . . . . 75.030000000000001 110.193 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.01 55.53 4.38 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.447 -0.661 . . . . 62.340000000000003 111.447 -175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.1 160.76 39.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.64 0.776 . . . . 74.439999999999998 110.266 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 142.18 52.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.065 0.946 . . . . 50.109999999999999 110.442 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 92' ' ' ASP . 35.9 m -103.11 131.45 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.48 -0.933 . . . . 61.439999999999998 108.48 171.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 49.5 mt-10 -140.83 159.73 41.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.478 1.111 . . . . 74.310000000000002 109.528 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.48 158.61 35.76 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.225 -0.657 . . . . 74.010000000000005 109.225 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 14.0 ptt180 -50.06 -41.74 48.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.044 1.338 . . . . 73.310000000000002 112.585 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.9 mt 67.34 158.76 0.14 Allowed Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 123.533 0.733 . . . . 72.019999999999996 110.222 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.36 -24.14 41.46 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.41 2.073 . . . . 72.430000000000007 113.701 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.2 -54.97 6.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.277 1.031 . . . . 61.530000000000001 111.54 -174.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 2.7 mm? -76.47 -20.14 57.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 116.508 -0.314 . . . . 74.099999999999994 110.258 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -69.02 -11.54 60.88 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.041 0.536 . . . . 74.530000000000001 111.856 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.34 -32.2 19.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.388 0.675 . . . . 75.129999999999995 110.713 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.55 HE22 HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -89.57 168.04 16.01 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 117.639 -1.172 . . . . 44.409999999999997 109.0 174.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 30.3 Cg_exo -29.34 122.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.406 3.568 1 C-N-CA 125.309 4.006 . . . . 63.130000000000003 116.685 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.11 161.12 47.03 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.15 2.567 . . . . 75.25 113.07 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 -158.95 14.04 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.253 -0.885 . . . . 64.519999999999996 111.207 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 70.7 t -83.54 108.35 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.891 0.877 . . . . 52.340000000000003 109.626 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.624 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.31 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.592 -0.892 . . . . 61.539999999999999 108.592 173.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.529 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.4 p -95.53 105.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.447 -0.946 . . . . 61.219999999999999 108.447 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 4.0 p -94.07 123.48 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.619 -0.882 . . . . 75.25 108.619 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.65 132.51 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.397 0.679 . . . . 73.5 109.946 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.586 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.0 t -119.89 151.61 38.63 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.058 -1.09 . . . . 62.420000000000002 108.058 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.297 0 CA-C-O 118.978 -0.901 . . . . 71.129999999999995 112.147 178.563 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 109.76 -0.459 . . . . 65.120000000000005 109.76 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -71.43 104.75 3.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.379 -0.828 . . . . 61.520000000000003 108.941 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.63 118.36 4.99 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.372 0.669 . . . . 61.229999999999997 110.134 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.95 155.99 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.292 1.037 . . . . 61.140000000000001 109.138 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.4 m -150.89 144.15 24.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.919 0.887 . . . . 73.420000000000002 109.386 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -160.88 160.85 31.49 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.878 0.871 . . . . 72.209999999999994 110.272 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 53.2 ttp -171.76 113.28 0.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.78 -1.193 . . . . 74.040000000000006 107.78 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -61.45 114.11 3.04 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.253 0.621 . . . . 73.340000000000003 110.563 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -70.22 -41.75 73.2 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.401 0.68 . . . . 52.409999999999997 111.393 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.2 m 68.55 152.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.981 1.313 . . . . 74.420000000000002 110.946 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.3 t -158.67 174.69 14.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.093 0.557 . . . . 72.510000000000005 110.329 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.18 148.87 28.77 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.113 0.965 . . . . 43.509999999999998 109.415 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.69 107.2 34.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 108.896 -0.779 . . . . 53.009999999999998 108.896 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.99 132.22 3.26 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.761 2.307 . . . . 73.019999999999996 112.472 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.3 p -123.21 124.34 42.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.877 0.471 . . . . 72.120000000000005 110.643 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m -149.02 118.23 6.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.495 1.118 . . . . 72.349999999999994 108.027 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 p -132.82 145.69 51.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.045 0.938 . . . . 74.530000000000001 109.216 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.3 p -144.91 120.15 10.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.182 0.593 . . . . 73.329999999999998 110.102 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 139.67 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.54 -0.911 . . . . 63.310000000000002 108.54 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.55 157.55 41.13 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 123.344 0.658 . . . . 73.25 110.322 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.383 2.379 0 C-N-CA 123.062 2.508 . . . . 72.010000000000005 113.042 177.138 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 108.358 -0.979 . . . . 52.240000000000002 108.358 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.676 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -95.86 87.8 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.581 . . . . 61.119999999999997 109.616 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 94' ' ' VAL . 47.1 t -117.59 142.12 33.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.184 -0.462 . . . . 71.099999999999994 110.782 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -143.6 158.52 43.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.293 -0.412 . . . . 72.519999999999996 111.383 172.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.08 129.11 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.37 0.668 . . . . 63.420000000000002 110.244 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 19.0 m-85 -109.86 107.83 17.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.316 1.046 . . . . 73.340000000000003 108.323 163.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -93.31 112.73 24.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.169 -1.789 . . . . 75.340000000000003 106.169 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.671 HG13 ' HA ' ' A' ' 70' ' ' SER . 13.5 tt -73.11 -45.21 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.037 -0.414 . . . . 64.400000000000006 111.33 -172.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -29.41 28.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 72.019999999999996 110.591 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.33 54.28 13.95 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 123.734 0.646 . . . . 72.420000000000002 113.016 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.91 0.484 . . . . 72.230000000000004 110.584 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' A' ' 49' ' ' ALA . 10.1 tp10 -63.77 121.81 14.9 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.403 0.52 . . . . 75.030000000000001 112.403 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.75 -23.8 51.8 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.861 -0.608 . . . . 73.430000000000007 112.291 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 52' ' ' THR . . . -65.09 -27.07 68.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.157 0.583 . . . . 53.039999999999999 110.852 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' H ' ' HG3' ' A' ' 46' ' ' GLU . . . -57.17 -47.34 81.46 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 124.032 0.833 . . . . 74.540000000000006 110.931 173.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.22 77.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.73 -0.668 . . . . 73.25 111.368 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -69.99 -22.68 63.11 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.326 1.051 . . . . 74.120000000000005 111.139 -172.303 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' HG13 ' A' ' 94' ' ' VAL . 75.5 p -67.98 -49.82 59.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.262 0.225 . . . . 61.119999999999997 111.488 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -22.03 61.63 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.233 0.539 . . . . 62.140000000000001 111.209 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.94 -47.83 60.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.247 . . . . 65.400000000000006 110.512 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -70.71 -30.86 67.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.654 -0.498 . . . . 71.340000000000003 109.654 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HG22 ' A' ' 64' ' ' THR . 53.4 tp -66.16 -33.29 75.45 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.337 -0.847 . . . . 73.450000000000003 111.295 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 11.4 tmtt? -58.4 -43.13 88.46 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.725 -0.843 . . . . 62.520000000000003 108.725 174.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.3 -18.88 54.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.211 1.004 . . . . 71.340000000000003 112.319 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.34 42.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 55.210000000000001 112.038 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.12 46.72 0.69 Allowed Glycine 0 C--N 1.348 1.232 0 O-C-N 123.106 0.254 . . . . 60.229999999999997 112.503 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 3.6 p90 -60.4 158.04 12.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.518 1.127 . . . . 71.140000000000001 112.145 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 m -109.69 -43.52 4.03 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.714 -0.847 . . . . 64.099999999999994 108.714 164.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.676 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 83.3 t -135.63 128.37 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.194 0.998 . . . . 73.549999999999997 108.597 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.482 HG22 HD23 ' A' ' 56' ' ' LEU . 3.2 p -130.31 116.79 18.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 52.530000000000001 108.534 173.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 16.0 t70 -121.19 158.76 27.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.419 -0.956 . . . . 71.120000000000005 108.419 172.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.24 140.1 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.452 0.701 . . . . 73.109999999999999 109.986 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.87 146.5 11.36 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.725 -0.55 . . . . 61.100000000000001 111.725 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.11 113.1 26.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.532 0.733 . . . . 70.040000000000006 109.481 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.4 mp -145.22 136.05 24.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.97 -0.456 . . . . 71.010000000000005 110.303 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.671 ' HA ' HG13 ' A' ' 42' ' ' ILE . 26.9 p -73.64 99.96 3.23 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 123.853 0.721 . . . . 73.230000000000004 109.722 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HB2' HG22 ' A' ' 74' ' ' VAL . 62.2 mt -93.17 123.75 59.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.926 -0.398 . . . . 62.409999999999997 109.926 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.71 -6.6 16.21 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.067 2.511 . . . . 75.340000000000003 113.853 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -90.06 -23.61 21.39 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.0 0.52 . . . . 63.350000000000001 110.676 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 119' ' ' VAL . 28.9 m -104.0 148.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.641 0.734 . . . . 73.400000000000006 110.901 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.09 13.29 1.63 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.452 -1.249 . . . . 75.409999999999997 109.024 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.02 154.74 26.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.984 1.314 . . . . 74.019999999999996 108.366 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -71.93 111.73 7.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.05 0.54 . . . . 75.219999999999999 109.993 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -144.28 134.21 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.683 0.793 . . . . 54.219999999999999 111.166 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.675 HG22 HG23 ' A' ' 118' ' ' VAL . 21.0 t -99.28 117.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.304 1.042 . . . . 71.400000000000006 109.173 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HE1' HD12 ' A' ' 106' ' ' LEU . 92.0 m-85 -94.89 120.06 34.48 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 109.155 -0.684 . . . . 74.099999999999994 109.155 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.648 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 11.4 p90 -134.53 175.54 9.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.899 0.857 . . . . 70.530000000000001 111.623 175.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 m -139.13 161.3 37.73 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.138 -1.43 . . . . 75.519999999999996 107.138 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -92.27 30.46 1.46 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.051 0.54 . . . . 61.539999999999999 111.369 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.64 100.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 123.655 0.782 . . . . 60.109999999999999 109.489 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.03 -75.33 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.808 1.243 . . . . 74.420000000000002 111.417 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.61 22.95 1.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.384 -0.371 . . . . 63.420000000000002 112.718 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.73 -28.6 65.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.998 0.519 . . . . 60.210000000000001 111.847 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 2.2 tmt_? -66.41 -48.24 70.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.051 -0.722 . . . . 73.430000000000007 109.051 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.87 -38.16 85.81 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.715 0.806 . . . . 72.129999999999995 111.535 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.64 HG21 ' HB1' ' A' ' 35' ' ' ALA . 28.4 m -66.64 -49.0 67.64 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 64.340000000000003 109.721 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.5 -32.3 73.56 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.744 -1.116 . . . . 42.25 112.763 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.82 -43.72 97.85 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.171 0.919 . . . . 73.420000000000002 110.031 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.58 98.65 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.146 0.904 . . . . 75.319999999999993 111.325 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.54 HG13 ' HB ' ' A' ' 52' ' ' THR . 86.3 t -64.35 -53.57 41.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 C-N-CA 124.202 1.001 . . . . 75.519999999999996 111.45 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.517 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -71.96 -21.79 78.96 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.29 -0.868 . . . . 54.409999999999997 113.463 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -73.81 -41.92 61.67 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.38 -0.6 . . . . 74.010000000000005 109.38 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -61.46 -39.82 92.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.409 -0.814 . . . . 70.519999999999996 110.942 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 100' ' ' ALA . 2.6 tm? -74.91 -35.77 62.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.822 0.449 . . . . 73.230000000000004 110.812 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.55 51.84 7.9 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.275 -0.73 . . . . 75.030000000000001 111.275 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.765 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -109.37 168.0 9.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.425 1.09 . . . . 62.530000000000001 109.996 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.39 104.02 5.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.954 -0.758 . . . . 75.400000000000006 108.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.648 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.3 m -83.35 130.97 34.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.281 -1.007 . . . . 64.129999999999995 108.281 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -153.46 159.79 42.41 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.372 0.606 . . . . 54.039999999999999 110.875 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.29 -178.01 0.16 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.981 1.313 . . . . 74.420000000000002 111.731 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 106' ' ' LEU . 8.4 ptm180 -53.92 -43.52 69.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.84 0.856 . . . . 73.109999999999999 112.91 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.436 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 77.3 mt 62.4 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.566 1.578 0 C-N-CA 124.501 1.12 . . . . 73.109999999999999 111.591 -172.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.08 -17.61 39.19 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.302 2.001 . . . . 74.340000000000003 113.0 167.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -26.11 63.76 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.876 0.87 . . . . 73.140000000000001 111.606 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.95 -23.54 66.63 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 111.78 0.289 . . . . 51.420000000000002 111.78 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 m -60.03 -36.62 77.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.181 0.592 . . . . 64.409999999999997 110.893 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.05 -32.31 22.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.838 0.855 . . . . 33.25 111.261 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -80.0 157.46 73.69 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.587 0.755 . . . . 72.230000000000004 109.176 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 26.1 Cg_exo -64.14 125.53 15.39 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.12 1.88 . . . . 63.100000000000001 111.389 170.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 56.5 Cg_exo -53.62 120.27 7.56 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.357 2.705 . . . . 74.530000000000001 113.706 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.74 -178.39 22.62 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.284 -1.126 . . . . 73.430000000000007 110.284 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.5 123.82 34.81 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.178 0.513 . . . . 63.399999999999999 110.849 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.53 135.52 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.105 -1.072 . . . . 74.120000000000005 108.105 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.675 HG23 HG22 ' A' ' 79' ' ' VAL . 2.4 p -105.24 106.0 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.388 -1.338 . . . . 73.340000000000003 107.388 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 74' ' ' VAL . 15.8 t -93.35 121.97 44.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.954 -0.758 . . . . 73.239999999999995 108.954 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 98' ' ' LEU . 41.1 t -116.99 129.47 73.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.164 0.986 . . . . 61.340000000000003 109.583 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -91.56 162.29 14.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.909 0.756 . . . . 73.219999999999999 110.273 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.592 0 CA-C-N 115.485 -0.78 . . . . 70.200000000000003 113.435 -179.271 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.774 0.321 . . . . 74.349999999999994 111.032 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -119.45 133.52 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.776 0.83 . . . . 72.439999999999998 109.546 172.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 148.62 24.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.87 0.868 . . . . 64.420000000000002 109.944 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -156.61 134.67 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.241 0.616 . . . . 73.340000000000003 109.952 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.5 p -146.05 166.4 26.2 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.308 0.643 . . . . 72.010000000000005 110.469 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -156.55 162.55 39.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.103 0.961 . . . . 74.329999999999998 109.769 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 146.07 32.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.35 0.66 . . . . 62.240000000000002 110.704 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.0 m -147.21 135.38 21.54 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 70.109999999999999 110.393 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 m -97.27 148.26 23.29 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.451 1.1 . . . . 72.450000000000003 110.824 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -126.17 100.64 6.41 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.266 1.027 . . . . 73.299999999999997 108.353 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 t -77.3 149.0 35.39 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.975 0.51 . . . . 74.109999999999999 110.905 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.71 167.85 16.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.551 0.74 . . . . 73.219999999999999 110.847 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . . . -91.14 146.08 32.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.659 0.783 . . . . 50.420000000000002 110.845 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 22' ' ' ALA . 11.8 Cg_exo -71.46 166.34 29.64 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.986 2.457 . . . . 75.25 112.646 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 t -157.66 154.76 28.88 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.968 0.507 . . . . 71.430000000000007 111.04 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.8 m -146.64 130.36 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.983 0.913 . . . . 74.299999999999997 109.61 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 p -120.44 151.1 39.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.941 0.896 . . . . 63.109999999999999 110.314 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 p -158.69 146.48 18.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.666 0.786 . . . . 33.399999999999999 109.871 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.54 155.55 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.642 0.777 . . . . 70.439999999999998 109.783 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -107.64 140.75 21.87 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.652 0.781 . . . . 71.099999999999994 110.213 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo . . . . . 0 C--N 1.378 2.113 0 C-N-CA 123.16 2.573 . . . . 73.209999999999994 113.054 178.937 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.989 -0.745 . . . . 55.229999999999997 108.989 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -118.53 132.8 56.21 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.716 0.806 . . . . 73.200000000000003 109.568 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HA ' HG13 ' A' ' 116' ' ' VAL . 12.1 t -95.78 142.36 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.961 0.904 . . . . 71.420000000000002 110.225 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.501 ' HG3' HG22 ' A' ' 117' ' ' ILE . 7.9 ptm180 -151.23 126.4 9.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.096 0.406 . . . . 74.299999999999997 112.096 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 118' ' ' VAL . 16.6 t -101.0 111.2 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.086 0.954 . . . . 54.140000000000001 110.5 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -99.41 107.3 19.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.182 0.515 . . . . 61.5 110.236 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -98.0 110.91 23.4 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.388 -1.338 . . . . 75.409999999999997 107.388 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.644 ' HB ' HG12 ' A' ' 74' ' ' VAL . 4.8 tt -78.34 -50.7 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.953 0.406 . . . . 73.140000000000001 111.121 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -83.85 -2.68 56.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.274 -0.875 . . . . 64.209999999999994 111.504 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.32 59.6 8.69 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 111.623 -0.591 . . . . 62.009999999999998 111.623 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -78.59 -172.71 3.05 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.909 0.884 . . . . 73.450000000000003 111.063 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 43.2 tt0 -53.71 139.79 31.42 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.371 1.068 . . . . 62.299999999999997 111.384 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.92 -9.66 53.76 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.722 0.649 . . . . 71.010000000000005 114.722 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.564 ' H ' ' HG2' ' A' ' 46' ' ' GLU . . . -67.23 -22.48 65.69 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.354 0.577 . . . . 62.219999999999999 111.25 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -68.58 -39.68 80.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.291 0.636 . . . . 74.530000000000001 110.405 171.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.58 52.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.327 0.651 . . . . 72.030000000000001 111.355 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.435 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 24.0 tpp180 -70.82 -15.77 62.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.226 1.01 . . . . 74.510000000000005 111.205 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' HD13 ' A' ' 56' ' ' LEU . 78.4 p -61.63 -47.01 87.35 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.874 -0.417 . . . . 63.210000000000001 109.874 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.49 61.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.204 0.601 . . . . 64.200000000000003 111.2 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 25.5 t70 -60.04 -35.37 74.96 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.206 0.602 . . . . 52.43 111.465 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.479 HH21 HD11 ' A' ' 56' ' ' LEU . 52.6 ttp180 -64.41 -40.83 96.55 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.598 0.759 . . . . 65.129999999999995 110.232 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 52' ' ' THR . 9.8 mp -65.23 -34.44 78.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.451 -0.795 . . . . 65.25 110.645 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.62 -41.0 93.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.861 0.464 . . . . 72.409999999999997 110.722 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.42 65.85 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.599 -0.728 . . . . 73.209999999999994 111.233 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.41 -21.28 42.4 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.421 0.688 . . . . 71.209999999999994 111.011 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.55 44.46 2.5 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.463 -0.335 . . . . 60.240000000000002 113.544 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -87.67 158.44 18.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.643 0.777 . . . . 73.340000000000003 108.963 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -58.79 -69.5 0.19 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.191 0.932 . . . . 62.030000000000001 112.3 -160.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.97 137.48 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.039 -1.097 . . . . 72.400000000000006 108.039 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 p -128.51 108.59 10.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.769 0.828 . . . . 55.530000000000001 109.14 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 8.3 t70 -104.27 159.03 16.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.584 1.154 . . . . 64.239999999999995 109.397 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.79 115.54 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.838 0.855 . . . . 72.129999999999995 109.128 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.24 93.45 0.69 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.626 -0.716 . . . . 73.010000000000005 111.927 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -77.46 82.88 3.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.374 0.607 . . . . 73.510000000000005 109.495 173.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -160.15 143.97 14.15 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.199 -0.455 . . . . 73.230000000000004 111.006 -171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -82.66 100.74 10.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.009 0.924 . . . . 62.299999999999997 110.268 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -101.09 153.8 37.54 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.284 0.634 . . . . 53.25 109.535 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.76 -15.92 23.17 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.037 2.491 . . . . 74.530000000000001 114.566 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.37 -23.33 13.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.3 0.64 . . . . 71.319999999999993 110.914 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.745 HG13 HG13 ' A' ' 119' ' ' VAL . 79.5 t -93.52 123.06 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.133 1.373 . . . . 73.540000000000006 110.043 -177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' HA ' HD13 ' A' ' 42' ' ' ILE . . . -159.04 -74.15 0.08 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.012 0.525 . . . . 74.439999999999998 111.543 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.57 147.89 25.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.469 0.708 . . . . 71.409999999999997 110.284 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.2 t -66.15 100.24 0.59 Allowed 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.033 0.92 . . . . 73.109999999999999 109.997 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 m -152.23 135.64 15.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 74.239999999999995 109.096 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 118' ' ' VAL . 20.3 t -96.06 111.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.407 -0.96 . . . . 72.109999999999999 108.407 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -96.7 124.33 40.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.604 -0.887 . . . . 73.140000000000001 108.604 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -121.82 151.22 40.85 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.144 0.577 . . . . 74.140000000000001 112.156 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.712 HG23 ' HD3' ' A' ' 105' ' ' ARG . 3.3 m -103.21 166.82 10.21 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.084 -1.08 . . . . 61.329999999999998 108.084 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 14.63 18.25 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.974 -0.454 . . . . 73.120000000000005 111.887 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.15 110.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.779 0.832 . . . . 75.420000000000002 110.61 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 67.23 -76.48 0.05 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.831 1.252 . . . . 61.509999999999998 112.076 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.36 35.16 0.48 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.491 -1.044 . . . . 71.040000000000006 110.491 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HA ' HG22 ' A' ' 90' ' ' THR . 29.7 tt0 -75.9 -18.93 59.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 65.430000000000007 111.736 -170.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.57 -35.54 79.21 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 110.245 -0.28 . . . . 74.439999999999998 110.245 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.95 56.82 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.557 0.743 . . . . 71.439999999999998 112.192 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 87' ' ' GLU . 12.6 t -85.0 -25.62 27.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.484 -0.562 . . . . 71.420000000000002 109.484 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.588 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -73.89 -38.71 64.3 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.916 0.886 . . . . 52.439999999999998 111.299 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.48 -56.33 17.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.746 -1.57 . . . . 64.040000000000006 110.52 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.6 -47.39 79.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.177 0.923 . . . . 61.43 111.914 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.25 -51.51 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.697 0.799 . . . . 61.329999999999998 111.963 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.93 -27.43 73.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 116.035 -0.53 . . . . 33.130000000000003 113.271 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -79.28 -26.44 42.32 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.407 0.683 . . . . 63.409999999999997 110.463 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.7 m -83.33 -32.69 26.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.143 0.977 . . . . 63.219999999999999 110.987 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 tp -85.89 -31.99 21.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.219 0.608 . . . . 71.439999999999998 110.611 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.86 27.12 35.48 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.508 -0.769 . . . . 71.209999999999994 112.464 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.36 144.2 37.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.741 0.816 . . . . 74.450000000000003 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.63 127.14 31.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.031 0.933 . . . . 71.049999999999997 111.09 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.419 HG12 ' HB ' ' A' ' 79' ' ' VAL . 18.8 m -92.43 106.68 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.136 0.974 . . . . 74.200000000000003 110.632 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.74 166.43 11.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.951 1.3 . . . . 55.439999999999998 109.414 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mp -67.22 175.92 2.44 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.198 0.523 . . . . 72.200000000000003 111.057 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HD3' HG23 ' A' ' 82' ' ' THR . 32.0 ptt-85 -55.95 -44.82 78.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.406 1.082 . . . . 74.219999999999999 112.412 -173.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.9 mt 60.63 170.13 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.521 1.128 . . . . 54.149999999999999 111.202 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.52 -18.13 14.39 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.079 1.853 . . . . 70.25 113.659 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.19 -55.69 26.08 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.181 1.392 . . . . 64.040000000000006 112.076 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 8.1 tt -68.04 -25.78 65.54 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 122.57 0.348 . . . . 74.040000000000006 110.381 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 t -76.35 -19.57 58.06 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.551 0.741 . . . . 62.539999999999999 111.912 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.08 -33.24 33.52 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.957 0.503 . . . . 65.209999999999994 111.247 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.405 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pp0? -104.89 167.31 10.04 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.227 1.011 . . . . 71.310000000000002 109.362 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 19.1 Cg_endo -57.16 132.48 51.53 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.037 2.491 . . . . 74.420000000000002 114.48 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 71.1 Cg_exo -50.79 160.5 1.78 Allowed 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 124.175 3.25 . . . . 61.240000000000002 116.072 -173.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.35 147.55 8.32 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 110.255 -1.138 . . . . 74.409999999999997 110.255 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 91' ' ' ALA . 2.4 p -60.58 118.82 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.466 0.706 . . . . 63.450000000000003 110.848 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.501 HG22 ' HG3' ' A' ' 38' ' ' ARG . 39.5 pt -103.8 107.43 22.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 122.033 0.92 . . . . 64.310000000000002 109.861 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.2 p -90.14 105.12 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.501 -1.296 . . . . 71.510000000000005 107.501 169.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.745 HG13 HG13 ' A' ' 74' ' ' VAL . 52.9 t -92.26 131.3 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.612 -1.176 . . . . 44.219999999999999 108.241 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.58 HG21 ' HB1' ' A' ' 49' ' ' ALA . 3.5 t -130.38 130.13 65.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.214 0.605 . . . . 72.439999999999998 109.939 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -91.37 167.37 12.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.463 0.705 . . . . 53.439999999999998 110.145 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.337 0 CA-C-O 119.515 -0.603 . . . . 72.239999999999995 112.963 178.161 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.6 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.885 -0.413 . . . . 75.400000000000006 109.885 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 t -139.95 143.42 36.55 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.44 0.696 . . . . 45.240000000000002 109.184 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.9 153.59 31.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.562 0.745 . . . . 61.109999999999999 110.693 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.13 118.94 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.963 0.905 . . . . 71.420000000000002 110.031 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 m -144.76 109.73 5.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.974 0.91 . . . . 52.420000000000002 109.091 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 m -120.85 141.8 50.25 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.724 0.81 . . . . 61.340000000000003 109.678 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -125.03 146.11 49.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.126 0.97 . . . . 65.219999999999999 109.662 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.9 m -146.45 127.04 14.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.218 0.607 . . . . 73.340000000000003 110.002 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 p -111.81 137.46 49.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.796 0.838 . . . . 64.439999999999998 109.77 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 p -81.19 132.18 35.34 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.093 0.957 . . . . 72.439999999999998 111.492 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.5 p -113.19 160.52 18.17 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.573 1.149 . . . . 71.030000000000001 109.076 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.66 144.47 22.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.823 0.449 . . . . 63.130000000000003 111.149 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.63 124.14 43.46 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.752 0.821 . . . . 54.240000000000002 109.891 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.21 162.76 38.89 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.681 2.254 . . . . 51.100000000000001 112.819 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -83.01 146.62 28.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.211 1.005 . . . . 72.519999999999996 110.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 m -143.9 103.8 4.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.945 0.898 . . . . 74.319999999999993 109.292 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 p -108.81 141.12 41.3 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 64.140000000000001 109.605 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -159.01 94.32 1.21 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.034 0.933 . . . . 74.230000000000004 108.592 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.17 123.96 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 63.329999999999998 109.611 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.71 161.38 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.935 0.894 . . . . 55.109999999999999 110.633 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo . . . . . 0 C--N 1.382 2.331 0 C-N-CA 122.91 2.406 . . . . 60.039999999999999 114.264 176.04 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 109.005 -0.739 . . . . 61.229999999999997 109.005 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.87 135.96 53.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.925 0.89 . . . . 53.229999999999997 109.234 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 64' ' ' THR . 90.7 t -132.83 123.54 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.277 -1.009 . . . . 73.450000000000003 108.277 171.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . 4.1 ptp85 -141.34 110.93 6.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.511 -0.743 . . . . 75.430000000000007 112.024 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 53' ' ' ALA . 35.8 t -92.71 120.52 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.023 . . . . 64.549999999999997 109.951 -175.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 66.3 m-85 -130.09 132.96 46.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.354 0.662 . . . . 71.140000000000001 109.794 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -88.84 141.08 28.8 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.887 -1.153 . . . . 64.109999999999999 107.887 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 121' ' ' THR . 6.3 tp -59.3 -46.32 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.459 0.704 . . . . 65.209999999999994 111.289 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.9 m -106.73 -9.94 16.28 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 70.5 111.858 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.91 63.29 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.223 0.327 . . . . 64.349999999999994 113.45 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.8 m -91.45 -52.73 4.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.275 0.63 . . . . 73.030000000000001 111.215 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.01 120.15 19.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.059 0.392 . . . . 52.119999999999997 112.059 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.96 50.97 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.303 -0.862 . . . . 72.209999999999994 112.746 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.24 73.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.248 0.619 . . . . 74.310000000000002 110.925 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.44 -52.07 64.81 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.18 0.925 . . . . 74.540000000000006 110.424 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.77 -37.67 88.4 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.772 -1.104 . . . . 52.409999999999997 111.631 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -64.87 -38.78 92.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.603 1.161 . . . . 63.039999999999999 111.617 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 97' ' ' THR . 68.9 p -75.76 -23.35 55.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.174 -0.466 . . . . 54.0 111.128 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -77.53 -33.7 54.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.077 0.951 . . . . 53.32 111.551 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -52.66 -32.41 42.02 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.977 0.911 . . . . 73.200000000000003 112.031 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.73 -52.26 66.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.3 1.04 . . . . 54.340000000000003 110.356 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.45 -37.63 71.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.277 0.631 . . . . 74.450000000000003 111.295 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -71.9 -36.44 70.01 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.485 0.49 . . . . 70.019999999999996 110.708 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.45 72.78 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.357 0.41 . . . . 75.239999999999995 110.902 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.19 -21.72 58.51 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.358 -0.837 . . . . 73.319999999999993 110.862 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.44 10.53 86.13 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-N 115.639 -0.71 . . . . 53.210000000000001 113.835 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -95.41 135.62 36.81 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.856 -0.794 . . . . 73.030000000000001 108.856 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 90' ' ' THR . 70.9 p 59.24 155.29 0.02 OUTLIER 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.871 2.068 . . . . 74.400000000000006 113.653 -173.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.64 87.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 N-CA-C 108.165 -1.05 . . . . 71.109999999999999 108.165 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 26.3 m -89.0 102.45 15.09 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.367 0.667 . . . . 64.129999999999995 110.679 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 38.9 m-20 -102.48 142.63 33.35 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.76 -0.83 . . . . 65.319999999999993 108.76 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 ' HB1' ' A' ' 53' ' ' ALA . 43.4 t -132.61 143.16 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.326 0.651 . . . . 54.439999999999998 110.168 -171.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.63 -126.78 2.07 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 112.541 -0.223 . . . . 64.439999999999998 112.541 165.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -144.77 145.05 31.48 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.944 0.898 . . . . 74.25 109.912 -177.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 tp -156.26 146.45 21.42 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.746 -0.835 . . . . 72.530000000000001 108.746 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.4 p -81.11 98.73 8.15 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.107 0.563 . . . . 73.109999999999999 110.453 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.47 88.21 7.28 Favored Pre-proline 0 N--CA 1.483 1.195 0 N-CA-C 108.801 -0.814 . . . . 64.099999999999994 108.801 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.71 -6.93 14.54 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.438 2.092 . . . . 61.229999999999997 112.992 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.5 -23.44 56.75 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.742 0.417 . . . . 70.439999999999998 111.145 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.477 HG11 HG11 ' A' ' 119' ' ' VAL . 2.6 p -121.32 119.45 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.693 0.797 . . . . 72.120000000000005 109.902 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.57 20.45 17.15 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.175 0.99 . . . . 73.430000000000007 111.403 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.31 139.85 45.97 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.689 0.796 . . . . 72.239999999999995 110.098 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 t -69.18 101.88 1.56 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.548 0.69 . . . . 55.020000000000003 110.283 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -138.35 145.43 41.12 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.414 0.686 . . . . 63.329999999999998 110.905 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.714 HG13 HG22 ' A' ' 118' ' ' VAL . 48.8 t -95.97 118.44 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.599 1.16 . . . . 63.310000000000002 108.085 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -110.02 129.05 55.73 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.894 0.478 . . . . 74.049999999999997 110.166 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.435 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -126.4 154.47 43.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.151 0.981 . . . . 71.430000000000007 110.091 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 83' ' ' GLU . 11.8 m -102.0 -112.06 0.21 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.514 -0.921 . . . . 74.239999999999995 108.514 168.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' HG22 ' A' ' 82' ' ' THR . 14.7 pt-20 -143.21 -19.91 0.63 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.784 1.174 . . . . 72.340000000000003 113.738 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.54 116.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.725 0.81 . . . . 64.230000000000004 112.072 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 64.49 -77.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.054 0 C-N-CA 125.149 1.38 . . . . 73.319999999999993 111.198 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.6 52.63 0.33 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.066 -1.214 . . . . 62.5 110.066 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.18 -40.67 64.54 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.074 0.55 . . . . 61.439999999999998 112.04 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -73.57 -25.76 60.52 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.447 0.536 . . . . 72.439999999999998 112.447 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.21 -39.56 63.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.087 0.555 . . . . 73.519999999999996 111.437 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 62' ' ' THR . 6.6 t -82.89 -31.95 27.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.128 0.571 . . . . 41.310000000000002 111.404 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.23 73.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.448 0.699 . . . . 74.319999999999993 110.927 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.02 -38.51 76.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.549 1.14 . . . . 71.420000000000002 111.58 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.65 98.08 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 123.741 0.65 . . . . 62.450000000000003 111.556 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 118' ' ' VAL . 20.7 t -73.64 -48.47 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.939 -0.393 . . . . 74.209999999999994 109.939 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.57 -21.34 49.38 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.869 0.73 . . . . 71.310000000000002 113.549 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -80.53 -58.55 3.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 74.239999999999995 109.818 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 52' ' ' THR . 24.2 m -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 124.41 1.069 . . . . 74.329999999999998 111.354 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.1 tp -96.18 -29.68 13.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.072 0.949 . . . . 72.540000000000006 110.461 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.57 47.43 10.22 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.32 -0.4 . . . . 61.229999999999997 112.565 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.05 152.63 38.39 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 64.230000000000004 110.234 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.07 34.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.754 0.822 . . . . 54.509999999999998 111.017 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.435 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 14.4 m -94.01 98.92 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.982 0.896 . . . . 64.219999999999999 109.434 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -111.72 163.42 14.16 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.455 1.102 . . . . 70.25 110.606 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 tp -71.98 169.94 14.85 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.165 -0.925 . . . . 63.329999999999998 109.967 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.512 ' HD3' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -55.39 -38.06 68.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.327 1.051 . . . . 65.319999999999993 113.106 -176.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.512 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 97.3 mt 59.71 176.43 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 124.322 1.014 . . . . 52.240000000000002 112.957 172.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -53.27 -16.45 7.0 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.216 1.944 . . . . 74.439999999999998 114.193 164.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -54.71 -30.39 55.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.725 1.21 . . . . 71.150000000000006 111.403 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 10.3 tt -62.45 -28.97 70.18 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 71.099999999999994 111.192 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -62.39 -23.17 66.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.14 0.576 . . . . 74.409999999999997 111.707 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -111.29 -33.02 6.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.463 0.705 . . . . 70.230000000000004 111.862 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.799 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 9.0 pt20 -84.07 161.32 55.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.086 0.554 . . . . 64.030000000000001 110.841 -171.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HD2' HG21 ' A' ' 117' ' ' ILE . 40.8 Cg_exo -61.1 152.11 73.84 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.491 2.128 . . . . 72.329999999999998 113.402 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.73 161.54 38.51 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.171 2.581 . . . . 74.209999999999994 112.894 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.76 -166.88 52.43 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.879 -0.6 . . . . 51.119999999999997 111.712 -173.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.25 130.0 35.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 109.145 -0.687 . . . . 71.230000000000004 109.145 172.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 112' ' ' GLN . 17.1 pt -114.31 150.85 16.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.612 -1.255 . . . . 74.430000000000007 107.612 164.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.714 HG22 HG13 ' A' ' 79' ' ' VAL . 61.4 t -119.64 100.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 106.127 -1.805 . . . . 74.430000000000007 106.127 163.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.477 HG11 HG11 ' A' ' 74' ' ' VAL . 6.7 p -95.95 125.09 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.91 -0.774 . . . . 72.140000000000001 108.91 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.56 128.07 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 109.439 -0.578 . . . . 74.230000000000004 109.439 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.441 ' HA ' HG22 ' A' ' 42' ' ' ILE . 72.6 p -107.95 101.47 10.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.185 -1.042 . . . . 70.219999999999999 108.185 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.63 -0.713 . . . . 62.140000000000001 111.704 -174.298 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 121.356 0.598 . . . . 64.439999999999998 110.636 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.4 m -142.84 103.11 4.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.129 . . . . 54.310000000000002 108.618 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.33 144.35 33.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.066 0.546 . . . . 64.519999999999996 110.126 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 tt -164.9 138.94 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.397 1.079 . . . . 61.130000000000003 108.309 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -143.2 135.63 27.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.324 -0.621 . . . . 73.239999999999995 109.324 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -146.72 135.78 22.51 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.703 0.801 . . . . 54.200000000000003 109.374 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -161.95 141.15 9.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.749 0.82 . . . . 74.5 109.037 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.9 t -165.86 148.4 7.39 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.588 0.755 . . . . 62.310000000000002 109.715 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 t -166.62 147.04 5.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.688 1.195 . . . . 64.010000000000005 107.95 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.0 t -159.13 148.1 18.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.192 0.197 . . . . 73.230000000000004 110.724 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 t -159.75 141.82 13.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.685 0.794 . . . . 65.299999999999997 109.482 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.78 133.91 4.24 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.48 0.712 . . . . 60.25 110.058 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.19 106.06 4.14 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.513 0.725 . . . . 44.030000000000001 109.283 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -90.76 159.99 4.16 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.679 2.253 . . . . 71.019999999999996 111.825 171.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.8 t -156.25 153.95 29.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.016 0.526 . . . . 73.530000000000001 110.474 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.5 p -153.79 166.75 31.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.703 0.801 . . . . 54.409999999999997 109.625 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -142.22 143.89 33.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.568 0.747 . . . . 70.439999999999998 109.055 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 p -148.48 82.96 1.47 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.837 0.855 . . . . 71.230000000000004 108.886 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.5 139.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.602 0.761 . . . . 70.209999999999994 110.915 -174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -118.21 102.94 50.21 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.047 0.939 . . . . 73.310000000000002 109.002 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 C--N 1.376 1.994 0 C-N-CA 122.985 2.457 . . . . 71.0 112.69 176.054 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.791 -0.818 . . . . 43.229999999999997 108.791 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 41.9 mt-10 -115.27 94.44 4.73 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.475 -0.784 . . . . 71.340000000000003 110.682 -169.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.694 HG11 HG21 ' A' ' 94' ' ' VAL . 22.5 t -112.86 147.16 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 123.798 0.839 . . . . 75.040000000000006 111.416 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 31.2 ttp-105 -150.78 110.04 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.486 0.714 . . . . 71.329999999999998 109.719 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' ' 118' ' ' VAL . 60.6 t -87.52 126.42 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.455 0.702 . . . . 73.049999999999997 111.129 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 10.9 m-85 -119.95 107.93 13.71 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.727 0.811 . . . . 75.439999999999998 110.561 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 47.7 t30 -97.91 138.5 35.15 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.278 -0.638 . . . . 74.010000000000005 109.278 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.436 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -97.0 -11.79 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.1 0.476 . . . . 74.409999999999997 111.414 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -156.49 119.44 4.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.259 -1.015 . . . . 73.209999999999994 108.259 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.83 -88.81 0.01 OUTLIER Glycine 0 C--N 1.362 2.002 0 O-C-N 125.154 1.534 . . . . 53.350000000000001 114.52 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 m 51.7 -79.3 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.327 1.451 . . . . 60.340000000000003 113.525 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -86.53 117.6 25.41 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.131 0.972 . . . . 55.210000000000001 110.357 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.99 -18.37 68.74 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.531 0.519 . . . . 55.530000000000001 111.938 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 52' ' ' THR . . . -46.97 -32.37 3.83 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.748 1.619 . . . . 51.310000000000002 113.37 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.28 8.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.533 0.733 . . . . 45.329999999999998 111.911 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.4 60.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.486 0.315 . . . . 51.43 111.078 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.69 -31.32 69.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.378 1.071 . . . . 63.509999999999998 111.253 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.63 ' HB ' HG13 ' A' ' 94' ' ' VAL . 29.1 p -66.35 -56.88 8.97 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 121.988 0.115 . . . . 63.520000000000003 110.817 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.39 66.1 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.905 0.383 . . . . 52.399999999999999 111.651 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.45 -45.93 87.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.402 1.081 . . . . 64.099999999999994 111.597 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -67.42 -43.74 80.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 110.431 -0.211 . . . . 73.049999999999997 110.431 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.9 -32.24 69.35 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.753 0.658 . . . . 72.510000000000005 111.821 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -60.38 -45.21 94.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.275 0.63 . . . . 61.350000000000001 110.7 176.139 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -19.44 45.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.427 0.691 . . . . 73.239999999999995 111.345 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.47 59.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.688 0.795 . . . . 52.039999999999999 111.321 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.87 42.77 5.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.594 -0.275 . . . . 62.240000000000002 113.465 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -90.7 157.0 17.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.794 0.837 . . . . 55.340000000000003 109.821 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 m -72.09 -50.97 23.86 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.643 0.735 . . . . 73.530000000000001 110.71 -164.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 54.9 t -129.21 126.72 64.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 114.138 -1.392 . . . . 63.32 107.446 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.0 p -141.02 84.54 1.94 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.285 -1.005 . . . . 72.299999999999997 108.285 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -103.42 158.12 16.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 43.049999999999997 110.494 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.19 146.85 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.34 1.056 . . . . 75.430000000000007 109.246 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -165.28 137.51 4.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.086 -0.806 . . . . 54.5 111.086 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 4.3 p-10 -105.64 108.39 19.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.554 -0.536 . . . . 64.200000000000003 109.554 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pp -156.26 161.37 40.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.123 0.569 . . . . 74.540000000000006 110.785 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.436 ' HA ' HG13 ' A' ' 42' ' ' ILE . 41.3 m -96.43 127.37 42.36 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.783 0.833 . . . . 74.0 109.636 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.647 ' HB2' HG23 ' A' ' 74' ' ' VAL . 86.4 mt -120.71 149.08 49.71 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.922 0.889 . . . . 74.540000000000006 108.679 171.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.01 -4.29 15.19 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.957 2.438 . . . . 74.230000000000004 113.184 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.47 -6.17 24.31 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.067 0.947 . . . . 74.519999999999996 112.273 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' HB2' ' A' ' 71' ' ' LEU . 90.0 t -74.86 112.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 122.906 0.482 . . . . 74.530000000000001 109.814 177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.86 -41.47 3.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.928 0.891 . . . . 64.209999999999994 110.281 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.7 158.94 41.78 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.952 0.901 . . . . 43.130000000000003 109.212 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.589 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.0 t -61.09 100.49 0.12 Allowed 'General case' 0 C--O 1.243 0.755 0 CA-C-O 122.71 1.243 . . . . 62.409999999999997 109.574 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.0 m -151.3 145.49 25.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.293 -1.322 . . . . 75.129999999999995 109.123 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.706 HG22 HG13 ' A' ' 118' ' ' VAL . 58.2 t -93.74 113.78 29.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.017 -1.105 . . . . 74.019999999999996 108.017 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -94.3 111.12 22.84 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.05 -1.463 . . . . 74.340000000000003 107.05 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 8.2 p90 -120.57 140.6 51.26 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.664 0.745 . . . . 75.109999999999999 112.933 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 84' ' ' VAL . 29.7 m -84.97 152.93 23.11 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.738 -1.208 . . . . 75.019999999999996 107.738 162.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -109.18 19.27 19.65 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.139 0.422 . . . . 71.209999999999994 112.139 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 82' ' ' THR . 77.1 t -69.31 129.0 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.841 -0.8 . . . . 51.549999999999997 108.841 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 61.04 -81.42 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.119 1.368 . . . . 71.219999999999999 111.401 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.87 33.12 0.3 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.094 -0.503 . . . . 71.519999999999996 111.875 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -69.1 -31.76 70.69 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 122.719 0.408 . . . . 75.140000000000001 111.247 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -73.4 -29.26 62.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.45 0.3 . . . . 70.519999999999996 110.717 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.6 -43.48 55.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.084 0.554 . . . . 74.140000000000001 110.611 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 t -74.24 -22.39 59.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.048 0.539 . . . . 74.219999999999999 109.904 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -70.85 -44.09 67.13 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.387 1.075 . . . . 75.409999999999997 111.513 172.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.74 -35.31 72.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.289 -1.323 . . . . 72.319999999999993 111.721 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.53 83.69 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.71 0.631 . . . . 71.040000000000006 110.987 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.694 HG21 HG11 ' A' ' 37' ' ' VAL . 24.7 t -78.05 -45.9 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.068 -0.969 . . . . 64.430000000000007 111.514 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.4 -26.73 68.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.656 0.597 . . . . 73.230000000000004 112.999 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -75.59 -45.67 36.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.463 0.705 . . . . 65.530000000000001 110.123 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.2 m -61.01 -41.51 96.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.707 0.803 . . . . 73.0 111.122 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 120' ' ' VAL . 47.9 tp -75.82 -31.76 59.52 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.946 -1.025 . . . . 73.510000000000005 110.714 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 45.73 31.31 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.494 -0.642 . . . . 75.0 111.494 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.21 175.35 7.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.937 0.895 . . . . 73.219999999999999 110.282 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.24 164.62 25.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.762 0.425 . . . . 72.439999999999998 110.322 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.602 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.9 m -138.04 140.0 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.216 1.006 . . . . 72.349999999999994 108.333 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -155.63 174.25 15.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.789 0.836 . . . . 75.129999999999995 110.028 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.5 179.82 1.23 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.649 -0.705 . . . . 62.119999999999997 111.94 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -83.11 18.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.66 0.985 . . . . 74.0 113.66 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.13 -47.72 89.73 Favored Pre-proline 0 CA--C 1.558 1.26 0 CA-C-O 118.619 -0.705 . . . . 63.350000000000001 111.761 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.75 -37.79 11.43 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 121.577 1.518 . . . . 55.32 111.517 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.33 -29.82 64.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 74.209999999999994 111.572 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -17.15 64.4 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.305 1.042 . . . . 71.219999999999999 112.404 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -65.91 -45.09 83.21 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.27 0.557 . . . . 75.239999999999995 110.983 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.21 -33.06 29.53 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.477 -0.783 . . . . 74.209999999999994 109.436 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 48.39 71.49 1.58 Allowed Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.054 1.742 . . . . 61.420000000000002 111.311 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.433 ' HB2' ' NH2' ' A' ' 38' ' ' ARG . 44.0 Cg_endo -94.84 162.26 1.76 Allowed 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 123.805 3.003 . . . . 65.219999999999999 113.194 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.26 120.23 0.81 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.759 2.306 . . . . 64.209999999999994 111.265 168.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.19 162.86 20.98 Favored Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.563 -1.015 . . . . 60.450000000000003 110.563 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 91' ' ' ALA . 1.9 p -84.28 137.04 21.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 117.32 0.56 . . . . 74.329999999999998 110.529 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 38' ' ' ARG . 35.5 pt -106.43 123.1 61.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 CA-C-O 121.577 0.703 . . . . 42.420000000000002 109.809 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 79' ' ' VAL . 98.9 t -95.94 103.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.463 -1.31 . . . . 64.120000000000005 107.463 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 69.2 t -94.06 128.77 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 109.866 -0.42 . . . . 52.350000000000001 109.866 -174.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.456 HG22 HD21 ' A' ' 98' ' ' LEU . 22.5 t -113.93 139.39 39.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 107.975 -1.12 . . . . 74.109999999999999 107.975 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.589 ' H ' ' HB ' ' A' ' 77' ' ' THR . 40.3 p -120.06 104.14 9.87 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.927 -0.768 . . . . 73.219999999999999 108.927 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.451 0 CA-C-O 119.352 -0.694 . . . . 71.200000000000003 112.445 175.137 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.637 -0.135 . . . . 64.140000000000001 110.637 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -159.35 120.75 3.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.625 0.77 . . . . 73.349999999999994 109.461 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.19 97.13 1.01 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.834 0.854 . . . . 73.420000000000002 109.679 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -148.6 129.1 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.727 0.811 . . . . 73.430000000000007 109.809 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.4 p -168.67 127.09 1.09 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.391 1.076 . . . . 60.520000000000003 109.226 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -149.06 161.88 41.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.109 0.564 . . . . 71.030000000000001 109.963 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.24 149.01 52.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 51.32 110.191 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -152.69 159.62 43.16 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.261 0.625 . . . . 71.25 109.815 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.7 t -149.68 159.66 44.16 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.347 0.659 . . . . 73.439999999999998 109.757 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -162.57 168.32 21.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.046 0.939 . . . . 75.109999999999999 108.841 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.0 t -162.76 142.3 9.11 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.351 0.661 . . . . 71.409999999999997 109.832 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.52 133.49 21.36 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.81 -0.811 . . . . 72.209999999999994 108.81 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.47 123.33 6.36 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 123.53 0.732 . . . . 72.450000000000003 109.676 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.95 -170.67 1.05 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.725 2.283 . . . . 33.340000000000003 111.415 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -137.08 161.15 36.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.104 0.562 . . . . 63.399999999999999 109.781 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 t -147.53 157.43 43.56 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.773 0.829 . . . . 71.430000000000007 109.228 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.9 t -145.4 163.39 34.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.112 0.565 . . . . 72.319999999999993 110.516 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -141.76 165.39 27.59 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.985 0.914 . . . . 74.209999999999994 109.864 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.14 152.3 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.809 0.844 . . . . 64.450000000000003 109.698 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.92 114.06 39.47 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.738 0.815 . . . . 73.329999999999998 109.238 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 C--N 1.377 2.069 0 C-N-CA 123.272 2.648 . . . . 71.310000000000002 113.371 173.916 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . . . . . . . . 0 CA--C 1.545 0.771 0 CA-C-O 120.592 0.234 . . . . 52.009999999999998 110.646 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.0 mt-10 -84.84 90.61 7.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.528 0.731 . . . . 71.439999999999998 109.934 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.8 t -97.67 122.01 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.08 0.467 . . . . 75.439999999999998 109.873 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.9 ptm180 -142.79 131.46 22.6 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.155 -0.341 . . . . 74.219999999999999 110.99 -167.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' A' ' 118' ' ' VAL . 40.0 t -93.27 131.43 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.588 0.755 . . . . 62.100000000000001 109.875 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 70.3 m-85 -126.02 104.21 8.15 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.939 -0.764 . . . . 71.239999999999995 108.939 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.422 HD21 HG22 ' A' ' 45' ' ' THR . 44.0 t30 -97.21 130.14 44.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.623 -0.88 . . . . 64.540000000000006 108.623 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.639 HG13 ' HA ' ' A' ' 70' ' ' SER . 20.3 tt -102.35 -35.41 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.513 0.197 . . . . 64.120000000000005 111.491 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 m -100.07 151.29 21.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.066 0.546 . . . . 74.439999999999998 110.152 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.56 87.08 0.26 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.533 -0.627 . . . . 73.209999999999994 111.533 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.422 HG22 HD21 ' A' ' 41' ' ' ASN . 11.4 t -126.03 -173.05 2.75 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.783 0.833 . . . . 73.519999999999996 109.543 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -72.65 170.37 14.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.37 1.068 . . . . 72.049999999999997 111.622 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -1.13 50.85 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 118.976 -0.902 . . . . 73.150000000000006 113.979 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.17 28.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 42.109999999999999 112.82 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.94 48.46 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.296 -0.866 . . . . 44.409999999999997 111.157 174.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.21 -21.98 60.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.19 0.596 . . . . 53.100000000000001 111.672 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -63.1 -28.8 70.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.699 1.199 . . . . 53.509999999999998 111.444 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.568 ' HB ' HG13 ' A' ' 94' ' ' VAL . 63.0 p -63.39 -42.35 98.8 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 123.419 0.45 . . . . 72.239999999999995 110.583 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.99 78.42 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.307 0.643 . . . . 74.230000000000004 111.015 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 49.0 m-20 -57.49 -38.58 74.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.075 0.859 . . . . 64.430000000000007 111.932 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.15 -52.89 56.91 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.748 0.655 . . . . 62.229999999999997 110.591 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.4 -28.39 65.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.636 -0.711 . . . . 72.510000000000005 111.351 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 38.4 ttpt -62.36 -43.76 98.06 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.581 0.752 . . . . 74.430000000000007 109.867 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.05 64.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.454 -0.794 . . . . 72.120000000000005 111.157 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -21.06 56.64 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.961 0.726 . . . . 72.400000000000006 112.961 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.79 49.15 0.29 Allowed Glycine 0 C--N 1.358 1.763 0 CA-C-N 118.007 0.367 . . . . 63.130000000000003 113.085 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -57.16 158.04 5.58 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.352 1.061 . . . . 74.540000000000006 112.173 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.3 m -91.46 -60.36 1.91 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.37 -0.974 . . . . 74.030000000000001 108.37 168.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 65.3 t -135.55 136.82 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.188 -1.412 . . . . 62.420000000000002 107.188 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.3 p -130.56 146.37 52.07 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.321 0.649 . . . . 75.109999999999999 110.175 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 10.8 t70 -143.51 146.58 33.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.968 -1.015 . . . . 75.450000000000003 108.396 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.02 138.48 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.064 -0.717 . . . . 65.319999999999993 109.064 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.93 143.78 9.27 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.459 -0.337 . . . . 65.150000000000006 112.427 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -109.07 110.91 22.29 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.121 -1.066 . . . . 63.420000000000002 108.121 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.5 tp -151.02 148.91 28.93 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.255 -0.646 . . . . 54.119999999999997 109.255 -169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.639 ' HA ' HG13 ' A' ' 42' ' ' ILE . 12.0 p -77.05 98.65 5.06 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.889 -0.596 . . . . 72.340000000000003 109.997 172.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.2 110.21 31.56 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.22 -1.03 . . . . 72.329999999999998 108.22 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.38 -6.4 17.08 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.456 2.104 . . . . 73.340000000000003 112.532 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 6.2 p-10 -92.55 -23.84 18.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.84 0.856 . . . . 75.109999999999999 111.269 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.98 149.06 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 109.954 -0.387 . . . . 65.409999999999997 109.954 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.99 -5.22 1.69 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.631 0.772 . . . . 33.420000000000002 111.643 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.94 147.42 8.21 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.255 1.022 . . . . 72.129999999999995 109.839 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 121' ' ' THR . 7.8 t -64.42 111.21 2.56 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.416 0.686 . . . . 74.219999999999999 111.296 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -150.2 151.88 33.75 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.835 -0.62 . . . . 60.310000000000002 109.581 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 102' ' ' VAL . 28.9 t -102.22 116.49 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.591 -0.892 . . . . 53.439999999999998 108.591 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HD2' HD11 ' A' ' 117' ' ' ILE . 16.2 m-85 -102.41 148.22 25.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.937 -0.764 . . . . 65.349999999999994 108.937 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.59 169.33 17.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.863 0.84 . . . . 73.349999999999994 112.534 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.4 ' HB ' ' OE1' ' A' ' 87' ' ' GLU . 8.1 m -118.74 166.04 13.27 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 113.751 -1.568 . . . . 45.100000000000001 107.048 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.19 23.13 9.52 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.928 0.714 . . . . 74.420000000000002 112.928 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.61 98.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.202 0.525 . . . . 44.020000000000003 110.038 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.27 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.414 1.485 . . . . 71.239999999999995 111.9 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.03 25.87 2.36 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.075 -0.847 . . . . 71.120000000000005 112.963 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.746 ' HG2' ' HA ' ' A' ' 35' ' ' ALA . 31.3 mt-10 -62.98 -36.81 84.77 Favored 'General case' 0 C--N 1.362 1.127 0 CA-C-N 117.618 0.709 . . . . 75.340000000000003 111.025 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -70.8 -32.36 69.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.214 0.321 . . . . 72.239999999999995 111.754 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.33 -31.83 66.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.231 0.612 . . . . 72.219999999999999 110.515 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.4 m -76.6 -33.27 58.42 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.032 0.933 . . . . 74.439999999999998 109.982 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.47 -34.22 70.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.126 0.971 . . . . 50.439999999999998 111.376 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -50.91 -47.04 60.9 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.604 1.19 . . . . 71.140000000000001 110.765 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.1 83.87 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 124.534 1.146 . . . . 73.099999999999994 111.69 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 52' ' ' THR . 89.4 t -66.74 -52.27 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.12 0.968 . . . . 64.239999999999995 112.11 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -27.08 70.43 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.575 0.547 . . . . 74.299999999999997 111.754 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -78.34 -23.57 46.92 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.396 0.678 . . . . 71.239999999999995 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -78.64 -51.3 10.07 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 122.615 0.366 . . . . 72.129999999999995 110.627 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.1 tp -74.15 -26.61 60.41 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.346 0.658 . . . . 75.219999999999999 111.295 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.29 62.46 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.746 -0.661 . . . . 74.219999999999999 112.064 -172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.4 163.0 13.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.74 0.816 . . . . 63.32 110.666 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.37 134.49 38.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.128 0.571 . . . . 74.310000000000002 110.19 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 79' ' ' VAL . 34.7 m -99.22 138.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.978 -0.749 . . . . 53.350000000000001 108.978 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -154.56 168.74 25.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.7 -0.852 . . . . 61.340000000000003 108.7 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 22.5 tp -65.66 173.03 3.0 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.13 0.572 . . . . 74.120000000000005 109.851 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.5 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.4 ppt_? -49.33 -39.18 30.6 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.167 1.173 . . . . 73.409999999999997 114.167 -167.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 80' ' ' TYR . 41.0 mt 64.56 154.23 0.12 Allowed Pre-proline 0 CA--C 1.565 1.557 0 C-N-CA 124.307 1.043 . . . . 71.299999999999997 112.113 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.18 -29.03 35.78 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.647 2.898 . . . . 44.119999999999997 115.212 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 5.1 pm0 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.608 0.763 . . . . 75.25 112.861 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 0.5 OUTLIER -72.97 8.46 1.55 Allowed 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.188 0.518 . . . . 73.010000000000005 111.614 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 t -82.09 -10.56 59.16 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 61.409999999999997 111.382 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.23 -17.05 18.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 113.419 0.896 . . . . 63.350000000000001 113.419 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 2.0 pp0? -145.98 159.57 46.07 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.465 -0.779 . . . . 73.5 110.267 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 12.6 Cg_endo -52.7 125.4 17.88 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 123.795 2.997 . . . . 74.120000000000005 115.284 -167.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -57.44 153.67 39.9 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.925 3.083 . . . . 62.439999999999998 115.023 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.68 -149.41 21.55 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 109.861 -1.295 . . . . 51.130000000000003 109.861 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.1 t -94.48 105.56 17.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.377 -0.972 . . . . 74.109999999999999 108.377 167.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.562 HD11 ' HD2' ' A' ' 80' ' ' TYR . 32.0 pt -108.21 122.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.12 -1.067 . . . . 54.530000000000001 108.12 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.6 p -96.15 101.21 12.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.702 -1.592 . . . . 74.219999999999999 106.702 164.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 7.1 p -100.12 120.03 49.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.561 -0.745 . . . . 72.420000000000002 109.458 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.49 128.51 65.45 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 123.729 0.812 . . . . 64.019999999999996 110.269 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.677 ' H ' ' HB ' ' A' ' 77' ' ' THR . 77.7 p -112.05 153.28 27.12 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.891 1.276 . . . . 72.129999999999995 108.002 172.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.432 0 CA-C-O 119.141 -0.81 . . . . 41.119999999999997 112.836 178.71 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.094 -0.706 . . . . 71.129999999999995 109.094 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -157.24 112.08 2.75 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.279 -1.008 . . . . 73.099999999999994 108.279 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.9 140.19 20.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.924 0.489 . . . . 75.150000000000006 110.857 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 tp -149.93 129.3 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.552 0.741 . . . . 63.210000000000001 109.143 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 102.6 4.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.329 0.652 . . . . 74.129999999999995 109.623 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 p -127.04 140.94 51.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.077 0.951 . . . . 73.340000000000003 109.383 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -136.68 165.33 26.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.343 0.657 . . . . 72.409999999999997 109.738 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.4 p -121.43 147.0 46.32 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.141 0.977 . . . . 71.140000000000001 109.423 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -125.02 139.22 54.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.73 0.812 . . . . 75.049999999999997 110.377 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.4 p -123.22 175.29 6.75 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.345 1.058 . . . . 54.32 110.117 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 t -158.67 173.55 16.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.38 0.672 . . . . 65.340000000000003 110.402 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.72 138.4 32.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.699 0.8 . . . . 72.129999999999995 110.539 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.48 157.82 35.58 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.208 1.003 . . . . 74.409999999999997 110.632 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.57 172.98 11.48 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.757 2.304 . . . . 73.010000000000005 112.704 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.3 p -137.47 148.36 46.01 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.604 0.762 . . . . 75.209999999999994 109.595 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -112.12 116.23 30.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.057 0.943 . . . . 74.439999999999998 110.271 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 p -91.51 128.74 37.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.523 0.729 . . . . 73.230000000000004 109.217 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.9 p -72.86 154.53 40.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.177 0.591 . . . . 72.349999999999994 111.145 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.94 141.44 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.892 -0.781 . . . . 74.430000000000007 108.892 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -82.31 149.24 61.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.947 0.499 . . . . 74.310000000000002 110.424 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 C--N 1.376 1.998 0 C-N-CA 122.625 2.217 . . . . 70.310000000000002 112.288 177.42 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.646 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.245 0.86 0 CA-C-O 121.639 0.733 . . . . 74.400000000000006 111.468 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.664 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.0 mp0 -76.69 106.45 8.36 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.545 -1.207 . . . . 75.049999999999997 108.929 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.18 136.13 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.564 -0.902 . . . . 53.310000000000002 108.564 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HG3' HG22 ' A' ' 117' ' ' ILE . 10.6 ptm180 -146.93 115.15 6.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.498 0.666 . . . . 73.5 111.035 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 53' ' ' ALA . 58.2 t -98.71 116.17 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.101 0.96 . . . . 72.340000000000003 110.215 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 62.9 m-85 -115.69 115.06 25.71 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.705 0.802 . . . . 51.100000000000001 110.606 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.737 ' HB3' ' H ' ' A' ' 45' ' ' THR . 21.7 m-80 -90.16 114.21 26.13 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.087 0.955 . . . . 54.119999999999997 110.054 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -81.52 -53.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 122.267 -0.271 . . . . 65.530000000000001 110.295 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -130.15 7.8 5.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.702 0.401 . . . . 71.450000000000003 111.707 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.17 -61.5 1.91 Allowed Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.895 -0.882 . . . . 70.519999999999996 110.895 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.737 ' H ' ' HB3' ' A' ' 41' ' ' ASN . 6.9 t 43.55 31.8 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 127.231 2.212 . . . . 72.239999999999995 114.195 173.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.84 153.93 51.39 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.587 0.755 . . . . 41.340000000000003 109.448 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.26 -22.66 56.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 124.203 0.939 . . . . 43.210000000000001 114.874 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.54 75.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.131 0.572 . . . . 71.319999999999993 111.233 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 52' ' ' THR . . . -82.96 -42.94 17.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.672 0.789 . . . . 52.210000000000001 111.184 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.56 65.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.586 0.754 . . . . 51.549999999999997 112.1 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -59.42 -28.27 66.79 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.759 1.224 . . . . 63.43 112.708 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 49' ' ' ALA . 6.0 t -69.71 -28.44 65.84 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 119.902 -0.094 . . . . 73.310000000000002 110.97 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -82.55 -32.0 28.81 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.848 0.859 . . . . 73.319999999999993 111.736 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.83 -56.79 17.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.467 1.107 . . . . 64.150000000000006 110.894 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -23.26 53.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.786 -0.643 . . . . 73.430000000000007 110.894 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.427 HD23 HG22 ' A' ' 64' ' ' THR . 15.5 tp -63.89 -40.03 95.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.912 0.885 . . . . 72.010000000000005 110.636 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -61.76 -44.79 96.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.071 -0.968 . . . . 74.420000000000002 109.178 176.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.5 -11.52 60.04 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.74 -1.118 . . . . 63.200000000000003 112.252 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.99 -13.26 53.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.287 0.635 . . . . 71.010000000000005 110.905 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.36 15.24 18.06 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.793 -0.448 . . . . 63.420000000000002 114.059 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -75.49 158.1 33.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.15 0.58 . . . . 73.140000000000001 110.684 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 m -84.63 -60.62 2.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.655 0.382 . . . . 73.349999999999994 111.171 -162.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 46.5 t -116.75 129.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.937 -0.764 . . . . 41.0 108.937 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 HD23 ' A' ' 56' ' ' LEU . 25.3 p -138.31 83.73 1.99 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.535 1.134 . . . . 74.299999999999997 108.087 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -100.1 125.09 46.16 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.69 -0.855 . . . . 53.32 108.69 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 39' ' ' VAL . 29.6 m -117.3 150.31 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.002 0.429 . . . . 74.140000000000001 110.504 -174.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.78 162.23 35.63 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-N 115.456 -0.793 . . . . 55.140000000000001 111.373 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.11 110.67 20.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.81 . . . . 55.520000000000003 109.158 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -145.28 136.84 25.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.608 0.763 . . . . 72.319999999999993 109.998 -170.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -79.7 99.64 7.51 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.937 -0.764 . . . . 52.219999999999999 108.937 171.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.53 ' HB2' HG12 ' A' ' 74' ' ' VAL . 47.8 mt -93.36 140.82 23.33 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 115.893 -0.594 . . . . 75.140000000000001 109.603 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.57 -10.1 14.6 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.575 2.183 . . . . 75.120000000000005 113.175 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.39 -24.36 25.78 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.621 0.768 . . . . 73.340000000000003 111.325 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 71' ' ' LEU . 7.1 p -91.07 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.226 0.61 . . . . 72.120000000000005 110.66 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.79 -0.83 1.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.895 -1.048 . . . . 71.430000000000007 110.325 167.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.3 155.74 18.26 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 125.292 1.437 . . . . 62.100000000000001 108.44 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -62.4 109.74 1.45 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.494 0.664 . . . . 75.140000000000001 110.623 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.9 m -143.92 143.39 31.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.464 0.705 . . . . 71.140000000000001 110.265 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.791 HG22 HG13 ' A' ' 118' ' ' VAL . 92.7 t -105.94 112.81 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.137 -1.06 . . . . 73.430000000000007 108.137 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -98.92 125.03 44.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.828 -0.804 . . . . 64.040000000000006 108.828 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 25.9 p90 -109.34 139.75 43.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.642 0.588 . . . . 72.120000000000005 110.67 175.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 83' ' ' GLU . 2.1 m -82.96 -163.36 0.71 Allowed 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 108.663 -0.866 . . . . 55.210000000000001 108.663 171.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' H ' HG22 ' A' ' 82' ' ' THR . 10.5 pt-20 -136.55 13.27 3.21 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.676 -1.265 . . . . 74.230000000000004 113.408 -160.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.75 108.24 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 N-CA-C 109.337 -0.616 . . . . 72.430000000000007 109.337 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.18 -77.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.761 1.624 . . . . 75.430000000000007 111.448 -172.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.69 57.11 0.31 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.254 -0.739 . . . . 61.520000000000003 111.254 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.59 -17.29 59.85 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.044 0.538 . . . . 74.030000000000001 112.277 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -55.16 -40.56 70.76 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.774 0.43 . . . . 73.219999999999999 110.792 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.23 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.701 0.801 . . . . 53.399999999999999 112.87 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.646 HG21 ' HB3' ' A' ' 35' ' ' ALA . 14.0 t -71.53 -33.2 68.98 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.644 0.378 . . . . 72.319999999999993 111.005 -175.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 81' ' ' TYR . . . -80.85 -30.08 35.75 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 74.549999999999997 111.872 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.617 1.167 . . . . 64.25 110.15 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.96 -27.03 68.56 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.453 -0.794 . . . . 50.520000000000003 112.056 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.715 HG11 HG21 ' A' ' 118' ' ' VAL . 24.0 t -81.4 -58.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 C-N-CA 123.129 0.571 . . . . 73.239999999999995 111.046 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -61.82 -29.23 71.69 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.714 -0.676 . . . . 62.509999999999998 113.865 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -79.27 -24.97 42.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.064 0.546 . . . . 73.310000000000002 110.897 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -77.68 -47.99 17.84 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.088 0.471 . . . . 52.149999999999999 110.015 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 120' ' ' VAL . 51.4 tp -68.56 -32.06 71.71 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.137 0.975 . . . . 50.329999999999998 111.44 -177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.93 34.44 24.3 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-N 116.186 -0.461 . . . . 62.149999999999999 112.352 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.81 140.37 49.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.09 0.956 . . . . 71.439999999999998 108.796 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 130.38 41.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.406 0.682 . . . . 73.349999999999994 110.941 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -86.33 120.79 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 123.884 0.874 . . . . 74.120000000000005 110.296 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -126.8 159.21 34.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.466 1.106 . . . . 73.409999999999997 109.874 176.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.78 168.68 12.86 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.030000000000001 111.632 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -27.59 65.66 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.929 1.291 . . . . 72.430000000000007 113.781 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt 65.03 173.13 0.08 OUTLIER Pre-proline 0 CA--C 1.568 1.654 0 N-CA-C 113.276 0.843 . . . . 72.329999999999998 113.276 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.76 -17.1 34.34 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.438 2.092 . . . . 74.510000000000005 112.67 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 3.2 mp0 -65.05 -15.67 62.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.524 1.129 . . . . 73.420000000000002 112.967 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -61.89 -23.81 66.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 118.473 0.579 . . . . 74.040000000000006 109.505 -178.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.3 p -51.43 -32.5 26.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.943 0.897 . . . . 75.219999999999999 111.826 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.52 -32.29 7.77 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.737 0.815 . . . . 53.009999999999998 111.138 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.555 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 96.2 mt-30 -64.35 133.88 95.8 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.174 0.59 . . . . 62.409999999999997 110.909 -173.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HD2' HG21 ' A' ' 117' ' ' ILE . 52.7 Cg_exo -58.17 147.44 83.7 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.357 2.705 . . . . 71.329999999999998 113.331 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 47.3 Cg_exo -57.55 131.24 43.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.583 2.855 . . . . 72.310000000000002 113.441 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.47 -178.39 31.4 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.937 -0.865 . . . . 63.530000000000001 110.937 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 m -76.4 123.9 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 109.733 -0.469 . . . . 72.540000000000006 109.733 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.568 HG21 ' HD2' ' A' ' 113' ' ' PRO . 22.7 pt -107.49 114.17 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.876 0.846 . . . . 65.519999999999996 109.843 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.791 HG13 HG22 ' A' ' 79' ' ' VAL . 58.6 t -92.62 100.83 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.455 -1.313 . . . . 64.329999999999998 107.455 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 10.9 p -107.41 125.57 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.552 0.691 . . . . 72.310000000000002 110.819 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.403 HG22 HD21 ' A' ' 98' ' ' LEU . 11.3 t -119.67 138.41 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.506 0.723 . . . . 64.209999999999994 111.231 -169.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 t -128.01 132.06 49.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.702 -0.851 . . . . 61.229999999999997 108.702 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 118.723 -1.043 . . . . 64.319999999999993 112.757 -177.603 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.84 0.352 . . . . 60.240000000000002 110.548 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.1 t -112.63 163.38 14.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.617 0.767 . . . . 71.109999999999999 110.144 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 131.96 20.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 109.841 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.7 pt -136.63 121.42 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.657 0.783 . . . . 72.430000000000007 109.737 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -157.17 129.75 7.5 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.259 1.024 . . . . 73.430000000000007 109.36 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -149.03 115.59 5.89 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.725 -0.842 . . . . 64.120000000000005 108.725 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -141.73 109.77 5.84 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.891 -1.151 . . . . 70.150000000000006 107.891 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -139.56 119.37 13.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.476 0.655 . . . . 65.230000000000004 110.292 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 p -142.15 150.24 40.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.844 1.258 . . . . 65.310000000000002 108.689 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.4 p -142.48 152.92 43.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.447 1.099 . . . . 53.329999999999998 108.963 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -159.85 155.34 25.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.065 0.546 . . . . 74.430000000000007 110.664 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.15 157.52 23.34 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.409 1.083 . . . . 35.229999999999997 109.051 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.92 107.15 11.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.43 0.692 . . . . 64.299999999999997 109.568 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.98 -172.82 1.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.98 2.453 . . . . 74.430000000000007 112.167 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -170.21 146.13 2.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.598 0.759 . . . . 54.409999999999997 110.174 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.3 p -92.64 166.8 12.3 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.289 -0.634 . . . . 73.430000000000007 109.289 171.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.4 t -133.72 137.28 45.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.253 0.621 . . . . 74.439999999999998 110.509 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.4 p -167.46 153.01 7.4 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.634 0.774 . . . . 62.409999999999997 110.235 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -167.33 109.81 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 C-N-CA 123.713 0.805 . . . . 73.530000000000001 110.403 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -126.33 120.42 23.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 123.347 0.659 . . . . 64.239999999999995 110.361 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 C--N 1.369 1.644 0 C-N-CA 122.464 2.11 . . . . 64.239999999999995 111.32 172.219 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.826 0 N-CA-C 109.524 -0.547 . . . . 53.030000000000001 109.524 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . 8.6 pt-20 -66.54 121.56 15.63 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.424 -0.807 . . . . 73.140000000000001 110.224 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 t -92.76 144.3 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.126 -0.943 . . . . 72.409999999999997 109.073 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 5.9 ptp85 -151.25 161.19 43.16 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.92 0.488 . . . . 74.420000000000002 110.885 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 50' ' ' ALA . 58.8 t -126.27 123.89 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.955 . . . . 75.319999999999993 109.081 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -112.31 108.06 17.12 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 124.286 1.035 . . . . 74.340000000000003 109.326 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -78.5 112.99 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.772 -1.195 . . . . 51.530000000000001 107.772 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 70' ' ' SER . 3.0 tp -75.85 -43.25 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.362 -0.607 . . . . 52.210000000000001 109.362 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -144.17 156.02 44.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.888 0.875 . . . . 74.310000000000002 108.843 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.89 6.94 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.146 -0.808 . . . . 74.109999999999999 113.325 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.2 t 40.79 78.46 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.949 1.7 . . . . 54.340000000000003 113.106 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -121.68 114.49 21.21 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.914 0.485 . . . . 70.040000000000006 110.468 -174.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.01 -11.9 84.92 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.42 -0.809 . . . . 71.219999999999999 113.605 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.62 91.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.237 0.615 . . . . 75.530000000000001 110.9 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -70.7 -33.39 70.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.689 -0.687 . . . . 41.229999999999997 110.727 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' HG21 ' A' ' 39' ' ' VAL . . . -77.49 -21.87 52.13 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.366 0.666 . . . . 71.340000000000003 112.135 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -66.08 -28.67 69.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.843 1.257 . . . . 63.439999999999998 111.049 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 98' ' ' LEU . 78.2 p -63.02 -46.47 87.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.136 0.574 . . . . 63.539999999999999 110.713 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.58 65.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.535 0.734 . . . . 63.109999999999999 111.169 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.09 -28.62 69.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.176 0.59 . . . . 71.510000000000005 111.415 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -69.04 -36.98 78.32 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.603 0.361 . . . . 74.329999999999998 110.659 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.6 mp -62.54 -24.29 67.43 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.17 0.588 . . . . 63.109999999999999 111.586 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -56.42 -49.02 75.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.262 0.625 . . . . 64.109999999999999 110.314 173.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.02 -24.12 41.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.515 -0.766 . . . . 75.329999999999998 111.613 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -74.5 -17.31 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.374 0.67 . . . . 65.230000000000004 111.928 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 33.73 2.53 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.055 0.382 . . . . 65.219999999999999 114.055 170.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -100.37 157.62 16.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.512 0.725 . . . . 62.200000000000003 109.815 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -62.31 -73.82 0.1 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.881 . . . . 64.409999999999997 112.291 -161.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 75.6 t -123.02 144.29 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.319 -1.363 . . . . 64.099999999999994 107.319 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 p -138.6 101.36 4.32 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.987 -1.486 . . . . 75.510000000000005 106.987 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 9.3 t70 -107.21 149.62 27.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 64.140000000000001 109.967 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.418 HG22 ' HB1' ' A' ' 50' ' ' ALA . 88.7 t -127.32 137.14 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.942 0.897 . . . . 61.329999999999998 108.995 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.43 159.6 32.54 Favored Glycine 0 C--N 1.344 1.018 0 O-C-N 123.539 0.524 . . . . 61.0 111.862 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -123.97 104.74 9.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.461 1.105 . . . . 74.420000000000002 108.314 174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 mp -133.36 134.09 43.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.049 0.54 . . . . 54.140000000000001 110.13 -171.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.496 ' HA ' HD12 ' A' ' 42' ' ' ILE . 24.6 p -85.4 98.68 10.71 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.543 -0.753 . . . . 62.030000000000001 108.975 172.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.652 ' HB2' HG22 ' A' ' 74' ' ' VAL . 82.6 mt -107.35 141.6 23.32 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.434 -0.951 . . . . 75.25 108.434 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.86 -17.87 17.38 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.575 2.183 . . . . 72.129999999999995 113.403 -169.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -94.78 -24.61 17.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.208 1.003 . . . . 73.239999999999995 111.844 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 108' ' ' GLU . 13.1 m -91.88 147.03 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.844 0.457 . . . . 41.009999999999998 109.975 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -164.79 -41.79 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.817 0.847 . . . . 35.119999999999997 109.772 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.58 134.45 33.63 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.007 -0.997 . . . . 41.219999999999999 110.325 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.627 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.8 t -74.83 98.24 3.47 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 122.272 1.034 . . . . 73.239999999999995 109.114 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' A' ' 80' ' ' TYR . 63.2 m -153.83 155.03 35.03 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.377 -1.283 . . . . 73.010000000000005 108.808 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.694 HG13 HG22 ' A' ' 118' ' ' VAL . 23.5 t -94.57 116.22 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.516 -0.92 . . . . 64.530000000000001 108.516 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CZ ' ' HB ' ' A' ' 78' ' ' THR . 75.4 m-85 -108.53 132.75 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.4 0.68 . . . . 73.409999999999997 111.904 -171.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.588 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 38.9 p90 -144.59 -177.18 5.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.919 0.888 . . . . 74.200000000000003 110.662 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -141.09 -91.72 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 118.891 -0.576 . . . . 74.010000000000005 110.095 165.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.47 -22.18 0.82 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.266 1.21 . . . . 60.109999999999999 114.266 -170.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 95.9 t -58.88 117.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 124.161 0.984 . . . . 54.119999999999997 112.046 -169.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 52.52 25.86 3.88 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.533 1.133 . . . . 61.149999999999999 113.635 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.11 57.59 5.63 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.774 -0.53 . . . . 44.130000000000003 111.774 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.1 mt-10 -52.69 -44.95 66.61 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.768 . . . . 72.439999999999998 111.989 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -65.34 -25.38 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.819 0.847 . . . . 73.319999999999993 112.566 -176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.96 0.504 . . . . 52.509999999999998 110.615 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.426 HG23 HG11 ' A' ' 116' ' ' VAL . 10.0 t -82.33 -26.99 32.52 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.469 -0.787 . . . . 71.209999999999994 111.177 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.728 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -69.03 -36.69 78.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.832 0.853 . . . . 44.039999999999999 111.012 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.23 -49.29 78.19 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 124.746 1.279 . . . . 73.030000000000001 109.766 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.86 78.54 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.352 1.032 . . . . 53.5 112.025 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 118' ' ' VAL . 64.8 t -63.65 -53.89 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 122.974 0.51 . . . . 61.409999999999997 110.548 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.74 -23.46 69.06 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 124.164 0.915 . . . . 61.020000000000003 113.87 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -76.1 -39.35 55.46 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.955 -0.757 . . . . 71.230000000000004 108.955 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.7 m -74.6 -34.45 62.85 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.308 -0.86 . . . . 74.519999999999996 112.119 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.573 ' HB3' HG21 ' A' ' 52' ' ' THR . 3.4 pp -93.74 -17.57 23.03 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.127 0.421 . . . . 62.450000000000003 111.932 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.48 52.75 4.08 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 113.966 0.346 . . . . 52.32 113.966 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.73 168.41 16.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.756 0.822 . . . . 63.439999999999998 109.718 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.46 165.5 25.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.599 0.759 . . . . 63.43 110.604 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.588 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 31.2 m -123.8 114.81 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 123.55 0.74 . . . . 55.119999999999997 109.586 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 35.5 mm-40 -124.39 174.78 7.53 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.538 1.135 . . . . 74.239999999999995 110.156 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.16 149.48 27.93 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.676 -0.693 . . . . 74.409999999999997 109.874 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 24.4 ptt180 -88.09 28.38 1.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.757 1.223 . . . . 72.019999999999996 111.641 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.596 ' HG ' ' HD3' ' A' ' 107' ' ' PRO . 4.3 pp -68.12 -32.31 3.93 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 117.597 -1.192 . . . . 55.130000000000003 112.728 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.596 ' HD3' ' HG ' ' A' ' 106' ' ' LEU . 13.1 Cg_exo -75.16 -34.48 3.66 Favored 'Trans proline' 0 C--N 1.405 3.506 0 CA-C-N 122.518 1.935 . . . . 73.219999999999999 111.914 167.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.711 ' HG3' HG12 ' A' ' 74' ' ' VAL . 8.3 mp0 -72.43 -10.5 59.87 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.542 1.137 . . . . 74.030000000000001 111.077 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 112' ' ' GLN . 13.1 tp -68.78 -12.41 61.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.31 1.044 . . . . 73.310000000000002 111.12 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -61.9 -46.78 87.9 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.619 0.768 . . . . 42.200000000000003 110.909 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.01 -33.82 26.45 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.795 0.838 . . . . 53.539999999999999 109.677 172.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.469 ' HG2' HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER 57.57 74.22 0.68 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.983 1.313 . . . . 71.0 111.028 -179.162 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 79.3 Cg_endo -83.41 132.69 6.0 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 122.712 2.275 . . . . 75.299999999999997 111.656 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 51.8 Cg_exo -58.32 152.65 52.12 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.705 2.937 . . . . 63.350000000000001 114.409 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.26 -167.5 27.38 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.222 -0.899 . . . . 72.409999999999997 113.616 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.728 HG21 ' HB2' ' A' ' 91' ' ' ALA . 3.2 p -87.06 131.95 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.311 -0.625 . . . . 73.230000000000004 109.311 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.46 149.81 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.859 0.864 . . . . 60.100000000000001 109.829 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 79' ' ' VAL . 47.7 t -121.55 103.58 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.036 -1.468 . . . . 60.149999999999999 107.036 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.595 HG11 ' HB ' ' A' ' 74' ' ' VAL . 95.5 t -93.51 123.82 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.518 -0.919 . . . . 73.340000000000003 108.518 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.472 HG21 ' HB1' ' A' ' 49' ' ' ALA . 58.0 t -128.74 129.86 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.342 0.657 . . . . 54.310000000000002 109.84 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.627 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.5 t -105.8 155.86 18.88 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.332 0.653 . . . . 74.129999999999995 109.83 168.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.027 0 CA-C-O 119.174 -0.792 . . . . 37.369999999999997 111.764 179.569 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 108.727 -0.842 . . . . 74.450000000000003 108.727 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.9 m -134.47 123.49 24.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.68 0.792 . . . . 55.350000000000001 110.334 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.63 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.696 0.798 . . . . 55.100000000000001 110.23 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.69 143.16 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.072 -1.084 . . . . 74.430000000000007 108.072 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -164.24 111.92 1.11 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 74.219999999999999 110.225 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.1 t -161.71 125.81 3.3 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.305 1.042 . . . . 71.200000000000003 109.333 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.3 ptp -171.57 146.44 2.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.906 0.882 . . . . 73.030000000000001 110.241 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -173.58 141.19 0.84 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.042 0.937 . . . . 64.209999999999994 109.66 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.6 t -167.13 106.23 0.58 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.468 0.707 . . . . 74.120000000000005 110.64 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -161.1 102.92 1.27 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.251 1.421 . . . . 74.299999999999997 109.082 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.1 p -135.58 125.7 26.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.757 0.823 . . . . 74.340000000000003 109.947 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.34 132.05 7.72 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.173 0.989 . . . . 54.229999999999997 109.942 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.48 107.35 10.08 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.617 0.767 . . . . 74.519999999999996 109.983 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.41 144.75 20.57 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.953 2.435 . . . . 61.310000000000002 111.863 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.3 p -122.41 148.41 45.14 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.694 0.398 . . . . 70.150000000000006 110.685 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m -146.28 111.88 5.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.716 0.806 . . . . 53.530000000000001 109.925 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.5 p -124.74 129.45 50.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.92 0.888 . . . . 55.329999999999998 109.473 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 m -150.49 111.45 4.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.739 0.816 . . . . 75.430000000000007 108.873 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.75 131.36 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.484 0.714 . . . . 72.230000000000004 109.992 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -123.79 112.73 28.84 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.146 0.979 . . . . 73.310000000000002 108.747 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 C--N 1.376 1.978 0 C-N-CA 122.391 2.061 . . . . 74.230000000000004 111.633 177.208 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.245 0.853 0 CA-C-O 121.018 0.437 . . . . 63.520000000000003 110.17 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.81 108.13 19.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.008 0.923 . . . . 71.329999999999998 110.441 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 41.3 t -106.88 138.7 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.192 0.997 . . . . 61.409999999999997 109.613 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.53 128.95 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.433 -0.58 . . . . 73.120000000000005 109.433 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 53' ' ' ALA . 98.3 t -103.72 128.11 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.34 0.656 . . . . 75.319999999999993 109.389 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.654 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 38.3 m-85 -124.03 131.45 53.56 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.423 0.689 . . . . 74.519999999999996 110.286 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -85.7 112.08 20.7 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.988 -1.115 . . . . 72.519999999999996 107.988 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.825 HD11 ' HA ' ' A' ' 71' ' ' LEU . 9.2 tp -75.31 -47.19 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.042 0.449 . . . . 74.030000000000001 111.355 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 m -107.51 3.18 24.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.988 0.915 . . . . 72.219999999999999 110.383 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 136.83 1.48 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.52 -0.632 . . . . 51.100000000000001 111.52 -170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 t -157.28 -178.95 7.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.359 0.664 . . . . 71.519999999999996 110.032 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.72 154.11 42.22 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.222 1.009 . . . . 32.109999999999999 111.071 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.79 -2.49 16.99 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 115.022 0.769 . . . . 42.439999999999998 115.022 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.51 -28.12 69.73 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.612 0.765 . . . . 74.329999999999998 111.518 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.2 -42.75 75.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.277 0.631 . . . . 42.310000000000002 110.576 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.36 -28.46 67.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.61 -0.723 . . . . 73.540000000000006 111.667 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -65.28 -24.95 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.601 1.16 . . . . 74.329999999999998 111.752 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 98' ' ' LEU . 68.9 p -71.89 -47.59 51.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.367 0.267 . . . . 75.329999999999998 110.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -61.73 -40.1 93.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.308 0.575 . . . . 73.140000000000001 110.639 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.29 -32.96 74.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.532 -1.213 . . . . 63.399999999999999 111.422 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -72.04 -41.07 67.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.054 0.542 . . . . 73.340000000000003 109.66 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -70.91 -26.03 63.03 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.394 -0.821 . . . . 72.299999999999997 111.336 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -61.71 -51.22 69.29 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.077 -0.712 . . . . 71.439999999999998 109.077 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.3 71.36 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.152 -0.931 . . . . 74.209999999999994 111.143 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.43 1.25 16.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.536 0.734 . . . . 73.010000000000005 112.309 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.6 40.19 11.27 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 113.96 0.344 . . . . 54.530000000000001 113.96 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -89.09 155.27 19.56 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.246 0.523 . . . . 73.209999999999994 109.76 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -66.03 -60.33 2.94 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.041 0.756 . . . . 75.200000000000003 113.041 -159.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.27 103.21 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.326 -0.99 . . . . 63.5 108.326 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 16.8 p -107.96 105.51 15.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 73.430000000000007 109.86 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -115.16 156.64 24.9 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.649 1.18 . . . . 73.400000000000006 109.679 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.77 144.54 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.768 0.427 . . . . 72.409999999999997 111.023 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.57 -158.54 13.61 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.498 -0.641 . . . . 60.409999999999997 111.498 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -107.49 173.42 6.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.23 -0.656 . . . . 74.310000000000002 109.23 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 27.7 tp -144.51 138.99 27.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 111.258 0.096 . . . . 63.25 111.258 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.7 p -87.57 133.58 33.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.67 -0.863 . . . . 72.230000000000004 108.67 170.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.825 ' HA ' HD11 ' A' ' 42' ' ' ILE . 32.4 tp -44.17 101.45 0.25 Allowed Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 125.177 1.391 . . . . 72.129999999999995 113.949 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.85 -100.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.109 2.539 . . . . 32.329999999999998 109.96 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.07 -22.13 12.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.054 0.942 . . . . 45.109999999999999 111.621 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.97 128.07 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.647 -0.501 . . . . 74.400000000000006 109.647 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.57 16.43 9.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.937 0.895 . . . . 71.439999999999998 111.536 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 156.97 46.17 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.559 0.744 . . . . 45.340000000000003 109.916 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 t -62.34 100.47 0.18 Allowed 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.057 0.932 . . . . 74.310000000000002 110.316 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.2 m -148.12 143.07 26.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 72.340000000000003 109.321 -172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 118' ' ' VAL . 42.6 t -95.94 115.86 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.603 -1.258 . . . . 42.030000000000001 107.603 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.553 ' HB3' HG13 ' A' ' 117' ' ' ILE . 32.3 t80 -107.86 113.76 27.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.908 -1.145 . . . . 74.340000000000003 107.908 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.548 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 41.9 p90 -141.32 147.43 38.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.135 0.791 . . . . 74.129999999999995 113.135 -170.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -85.94 -157.82 0.36 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.96 -1.126 . . . . 70.329999999999998 107.96 167.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 82' ' ' THR . 47.2 mt-10 -124.99 7.18 7.97 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.108 -0.995 . . . . 64.310000000000002 110.907 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 98.7 t -66.61 128.41 29.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 123.82 0.848 . . . . 74.310000000000002 109.603 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 84' ' ' VAL . 35.4 mt-10 62.1 20.9 12.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.523 0.729 . . . . 74.040000000000006 111.125 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.35 35.5 52.31 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.683 -0.51 . . . . 63.32 113.387 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 29.4 mt-10 -52.57 -33.47 45.98 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.933 0.716 . . . . 74.239999999999995 112.933 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -64.57 -31.34 72.52 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.839 0.455 . . . . 74.209999999999994 112.182 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.99 -37.41 29.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.505 0.722 . . . . 75.040000000000006 111.554 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.466 HG21 ' HB3' ' A' ' 35' ' ' ALA . 69.5 p -74.41 -36.83 63.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.466 -0.788 . . . . 72.219999999999999 110.894 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -30.72 69.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.498 -1.228 . . . . 63.409999999999997 111.89 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.29 -44.33 92.52 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.333 1.021 . . . . 72.120000000000005 110.136 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.01 75.26 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.516 -0.765 . . . . 53.130000000000003 112.272 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.667 HG11 HG21 ' A' ' 118' ' ' VAL . 64.3 t -74.32 -59.3 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.498 -0.319 . . . . 74.219999999999999 110.519 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.84 -23.05 55.67 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.811 0.694 . . . . 72.109999999999999 114.011 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -67.87 -60.03 2.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.485 1.114 . . . . 73.409999999999997 109.758 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.6 m -71.63 -32.76 68.3 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 114.902 -1.045 . . . . 74.200000000000003 111.141 -172.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.57 ' HB2' HG21 ' A' ' 52' ' ' THR . 48.7 tp -81.11 -27.28 35.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.941 0.896 . . . . 72.239999999999995 110.497 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.74 43.65 83.68 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.564 0.54 . . . . 74.420000000000002 112.667 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.53 25.04 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.774 0.83 . . . . 75.109999999999999 110.173 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.77 139.98 58.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.32 0.648 . . . . 75.409999999999997 110.355 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.548 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.2 m -112.15 131.83 62.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.425 0.69 . . . . 52.109999999999999 109.24 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.53 144.2 46.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.565 0.746 . . . . 74.439999999999998 111.309 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.636 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 16.2 tp -66.36 -177.2 0.51 Allowed 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 114.198 -1.364 . . . . 73.420000000000002 110.815 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.636 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 6.7 ppt_? -56.51 -28.6 60.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.863 1.265 . . . . 65.040000000000006 113.733 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 104' ' ' LEU . 74.6 mt 62.1 168.04 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.538 1.135 . . . . 74.200000000000003 113.039 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -73.25 -12.34 25.35 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.285 1.99 . . . . 44.399999999999999 112.605 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -69.49 -18.85 63.73 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.227 1.011 . . . . 64.530000000000001 112.624 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.8 -4.26 19.27 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.666 0.617 . . . . 63.340000000000003 112.666 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -60.25 -21.72 62.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.266 0.626 . . . . 61.340000000000003 111.763 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -115.51 -32.99 5.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.84 0.856 . . . . 74.209999999999994 110.83 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -96.41 127.03 41.51 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.065 0.946 . . . . 74.219999999999999 110.846 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.96 134.11 57.94 Favored 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 122.18 1.92 . . . . 75.219999999999999 112.7 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.91 163.12 32.16 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.278 2.652 . . . . 70.420000000000002 113.415 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 130.58 146.36 5.9 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 108.647 -1.781 . . . . 43.450000000000003 108.647 -171.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 53.7 t -65.0 99.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 118.718 1.259 . . . . 55.420000000000002 108.767 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.553 HG13 ' HB3' ' A' ' 80' ' ' TYR . 29.4 pt -107.57 106.93 21.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.467 -1.308 . . . . 71.120000000000005 107.467 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.718 HG22 HG13 ' A' ' 79' ' ' VAL . 42.1 t -89.83 101.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.34 -1.356 . . . . 60.229999999999997 107.34 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.401 HG13 ' HB ' ' A' ' 42' ' ' ILE . 65.0 t -93.67 113.14 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.33 -1.359 . . . . 73.329999999999998 107.33 -174.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.53 127.36 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 110.223 -0.288 . . . . 72.209999999999994 110.223 -171.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -89.98 160.54 16.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.938 0.895 . . . . 74.430000000000007 109.743 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.958 -0.912 . . . . 61.009999999999998 111.373 178.509 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.393 -0.225 . . . . 71.230000000000004 110.393 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -160.76 145.12 13.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.03 0.532 . . . . 63.130000000000003 109.974 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.73 139.47 20.75 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.463 0.705 . . . . 71.230000000000004 109.941 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -108.87 167.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.008 0.923 . . . . 73.329999999999998 111.057 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 t -83.84 -167.29 1.67 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.324 1.049 . . . . 63.210000000000001 110.419 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.9 m -141.04 137.28 32.82 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.034 0.934 . . . . 73.319999999999993 109.246 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.495 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.5 OUTLIER -95.09 127.67 41.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.84 0.856 . . . . 74.120000000000005 110.134 -175.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 m -145.9 144.33 30.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.76 0.824 . . . . 73.109999999999999 109.776 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -145.01 166.06 26.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.88 0.872 . . . . 75.040000000000006 110.638 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -136.95 143.31 42.79 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.662 0.785 . . . . 45.100000000000001 109.83 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 t -103.11 176.45 5.14 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.321 1.048 . . . . 72.209999999999994 110.107 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.8 170.53 15.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.461 0.704 . . . . 50.210000000000001 110.482 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.36 120.06 15.7 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.344 1.057 . . . . 64.150000000000006 109.968 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.04 159.97 37.12 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.626 2.217 . . . . 43.520000000000003 112.422 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -149.42 140.02 22.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 71.400000000000006 109.322 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -145.45 139.68 27.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.227 0.611 . . . . 74.409999999999997 110.038 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -121.41 176.01 5.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.136 0.974 . . . . 72.230000000000004 109.947 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.2 p -146.65 136.76 23.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.814 0.846 . . . . 73.430000000000007 109.646 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.83 147.91 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.402 0.681 . . . . 62.240000000000002 110.251 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -103.86 157.02 34.8 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 123.81 0.844 . . . . 63.520000000000003 109.844 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo . . . . . 0 C--N 1.377 2.032 0 C-N-CA 122.477 2.118 . . . . 72.219999999999999 111.708 170.986 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 87' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 110.554 -0.165 . . . . 34.140000000000001 110.554 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -142.25 102.21 4.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.755 0.822 . . . . 72.439999999999998 109.96 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 64' ' ' THR . 11.4 t -114.67 151.35 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-O 121.839 0.828 . . . . 74.299999999999997 111.584 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.619 ' HB3' HG22 ' A' ' 117' ' ' ILE . 33.2 ttm105 -153.64 141.29 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.121 1.369 . . . . 72.510000000000005 108.872 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' HB1' ' A' ' 49' ' ' ALA . 39.0 t -131.48 119.83 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.7 0.8 . . . . 73.329999999999998 108.904 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' CE2' HD23 ' A' ' 71' ' ' LEU . 45.4 p90 -141.6 149.13 40.31 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.09 0.471 . . . . 73.450000000000003 111.125 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -78.81 141.28 37.88 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.09 -0.959 . . . . 74.239999999999995 109.051 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.556 HD13 HG13 ' A' ' 74' ' ' VAL . 9.2 tp -79.61 -36.97 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 122.783 0.433 . . . . 73.150000000000006 110.123 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -96.39 -39.14 9.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.647 0.779 . . . . 43.509999999999998 109.96 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.08 60.82 2.2 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.953 -0.567 . . . . 70.109999999999999 112.004 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m -119.17 -42.64 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.596 0.759 . . . . 62.0 110.812 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -122.22 148.13 45.35 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.025 0.53 . . . . 75.510000000000005 110.926 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.03 1.57 63.13 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.124 -0.82 . . . . 54.520000000000003 114.274 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.18 -35.03 10.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.742 1.217 . . . . 74.400000000000006 113.368 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB1' HG12 ' A' ' 39' ' ' VAL . . . -63.07 -52.2 63.68 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.226 0.611 . . . . 61.009999999999998 111.033 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.87 -27.48 68.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.412 -0.813 . . . . 71.400000000000006 111.402 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 18.4 ttm180 -70.46 -52.4 22.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.522 0.729 . . . . 74.109999999999999 110.644 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -72.97 -23.96 60.72 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.075 -0.511 . . . . 74.049999999999997 110.954 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.42 -20.67 54.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.974 0.909 . . . . 33.32 111.816 173.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 51' ' ' ARG . 15.4 t70 -72.45 -41.1 66.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.276 1.03 . . . . 54.130000000000003 109.11 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.51 -38.0 89.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.593 -1.185 . . . . 75.439999999999998 109.556 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 HG11 ' A' ' 37' ' ' VAL . 62.6 tp -63.12 -50.65 69.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.116 0.966 . . . . 52.200000000000003 112.331 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -67.66 -27.17 66.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.846 0.355 . . . . 70.439999999999998 110.811 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.82 -20.85 34.87 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.679 0.791 . . . . 71.209999999999994 111.202 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.6 -23.48 27.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.541 0.736 . . . . 72.140000000000001 111.623 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.74 48.89 0.32 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.718 -0.49 . . . . 63.25 112.988 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 1.5 p90 -57.32 157.46 6.44 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.403 0.681 . . . . 73.099999999999994 111.099 174.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 m -89.97 -66.34 0.93 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.133 -1.062 . . . . 62.299999999999997 108.133 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -144.28 134.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.135 -1.802 . . . . 63.539999999999999 106.135 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 91.4 m -143.25 123.59 13.85 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 122.836 0.454 . . . . 74.109999999999999 109.891 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -102.08 126.01 48.92 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.721 -0.844 . . . . 72.109999999999999 108.721 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.76 146.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.873 0.469 . . . . 71.519999999999996 110.25 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.25 -136.04 3.94 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 123.476 0.485 . . . . 75.310000000000002 113.314 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -159.39 117.53 2.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.115 0.966 . . . . 62.240000000000002 109.677 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.2 tp -150.65 140.7 22.05 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.257 0.623 . . . . 73.25 109.767 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.444 ' HA ' HD12 ' A' ' 42' ' ' ILE . 39.0 m -88.61 99.35 12.26 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.302 0.641 . . . . 73.439999999999998 110.236 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' CE2' ' A' ' 40' ' ' TYR . 4.5 mm? -85.05 125.16 71.16 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.351 -0.981 . . . . 73.25 108.351 168.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 -11.85 32.33 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.67 2.246 . . . . 64.239999999999995 113.321 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.73 -22.79 23.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.84 0.856 . . . . 71.409999999999997 112.334 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 42' ' ' ILE . 11.0 p -123.89 154.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.336 0.654 . . . . 65.340000000000003 110.131 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.36 40.61 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.209 1.004 . . . . 73.319999999999993 109.481 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.6 38.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.663 0.785 . . . . 55.109999999999999 110.57 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.747 ' HB ' HG22 ' A' ' 121' ' ' THR . 10.0 t -75.11 99.95 4.1 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.421 1.105 . . . . 42.119999999999997 108.688 172.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.7 m -149.13 131.01 15.17 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.02 -0.991 . . . . 51.210000000000001 109.492 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.755 HG22 HG13 ' A' ' 118' ' ' VAL . 86.9 t -95.62 114.13 31.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.526 -0.916 . . . . 75.430000000000007 108.526 174.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -101.51 137.43 39.84 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.084 -1.08 . . . . 71.519999999999996 108.084 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.488 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 43.9 p90 -134.46 143.08 47.31 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 74.209999999999994 112.689 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.2 m -95.28 169.63 9.95 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 113.845 -1.525 . . . . 65.150000000000006 107.376 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -116.03 13.61 15.91 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.317 0.858 . . . . 55.229999999999997 113.317 -165.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 86.0 t -64.21 115.0 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.9 0.48 . . . . 60.450000000000003 110.552 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 64.31 -77.17 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.937 1.295 . . . . 73.530000000000001 111.231 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.87 45.23 0.24 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.246 -0.342 . . . . 42.439999999999998 112.246 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . 42.4 mt-10 -61.22 -32.7 72.48 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.511 0.724 . . . . 72.420000000000002 112.31 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -56.73 -24.91 52.94 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.624 -0.716 . . . . 64.329999999999998 112.559 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.61 -43.64 75.97 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.616 0.766 . . . . 52.130000000000003 111.915 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.0 p -69.35 -39.64 77.99 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.423 -0.584 . . . . 74.420000000000002 109.423 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.97 96.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.367 1.067 . . . . 30.23 112.082 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.48 -38.38 87.15 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.377 1.048 . . . . 60.009999999999998 110.305 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.49 69.88 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.81 0.694 . . . . 73.340000000000003 110.655 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 118' ' ' VAL . 62.1 t -67.41 -35.42 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.334 0.654 . . . . 74.120000000000005 110.856 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -68.72 -34.89 79.02 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 116.029 -0.532 . . . . 73.329999999999998 112.959 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -72.21 -44.26 63.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.608 0.763 . . . . 70.510000000000005 109.877 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.5 m -67.02 -37.85 84.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.225 1.01 . . . . 74.430000000000007 111.337 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 43.9 tp -81.73 -32.13 31.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.697 0.799 . . . . 73.329999999999998 110.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.91 40.84 15.92 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.934 -0.576 . . . . 72.510000000000005 112.081 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.56 156.27 24.96 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.519 0.728 . . . . 74.400000000000006 111.16 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.37 23.34 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.009 0.923 . . . . 74.530000000000001 110.949 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.488 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 27.4 m -89.86 112.3 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-O 121.737 0.779 . . . . 74.209999999999994 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -113.54 158.3 20.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.506 1.122 . . . . 74.519999999999996 110.256 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.0 mt -66.84 -175.9 0.45 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.748 0.819 . . . . 70.219999999999999 110.743 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 5.4 ppt_? -59.19 -37.55 77.67 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 116.355 -0.384 . . . . 64.239999999999995 111.513 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.539 ' N ' ' HD2' ' A' ' 105' ' ' ARG . 83.8 mt 58.08 172.53 0.05 OUTLIER Pre-proline 0 CA--C 1.573 1.829 0 C-N-CA 123.64 0.776 . . . . 74.109999999999999 112.491 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.72 -12.31 17.55 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.55 2.166 . . . . 61.149999999999999 114.077 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.31 -46.78 82.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.712 1.205 . . . . 64.140000000000001 112.0 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.657 HD12 ' HA ' ' A' ' 114' ' ' PRO . 4.1 mm? -69.85 4.83 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.36 1.064 . . . . 65.430000000000007 113.429 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.9 t -72.1 -49.01 39.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.735 0.414 . . . . 74.409999999999997 110.368 171.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.87 -36.14 20.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.606 0.362 . . . . 50.530000000000001 111.36 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.484 ' HG3' HD13 ' A' ' 109' ' ' LEU . 4.8 pt20 -90.42 160.67 38.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 118.624 -0.703 . . . . 71.150000000000006 109.523 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.57 119.7 5.48 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.255 1.97 . . . . 74.219999999999999 112.66 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.657 ' HA ' HD12 ' A' ' 109' ' ' LEU . 56.4 Cg_endo -71.14 117.02 4.94 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.355 2.037 . . . . 65.239999999999995 113.2 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.437 ' H ' HD12 ' A' ' 109' ' ' LEU . . . 164.3 -161.08 34.16 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 110.858 -0.897 . . . . 63.420000000000002 110.858 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 70.6 t -77.07 106.24 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.231 -1.026 . . . . 75.25 108.231 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.619 HG22 ' HB3' ' A' ' 38' ' ' ARG . 2.8 pp -123.89 124.48 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.439 -0.949 . . . . 63.420000000000002 108.439 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.755 HG13 HG22 ' A' ' 79' ' ' VAL . 93.5 t -104.41 106.65 20.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.759 -1.2 . . . . 60.149999999999999 107.759 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.17 123.19 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.212 -0.662 . . . . 72.120000000000005 109.212 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.8 t -103.37 128.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.794 -0.817 . . . . 64.120000000000005 108.794 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.747 HG22 ' HB ' ' A' ' 77' ' ' THR . 10.1 t -72.94 132.32 43.31 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.467 -0.938 . . . . 43.219999999999999 108.467 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.082 0 N-CA-C 110.528 -1.029 . . . . 72.540000000000006 110.528 -166.352 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.241 0.609 0 N-CA-C 109.134 -0.691 . . . . 73.540000000000006 109.134 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.7 p -153.15 166.45 32.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.37 0.668 . . . . 60.509999999999998 109.964 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.98 154.55 51.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.509 0.724 . . . . 54.030000000000001 110.382 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 tt -144.48 138.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.786 0.834 . . . . 70.430000000000007 109.467 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 t -164.42 156.53 16.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.904 0.882 . . . . 72.109999999999999 109.743 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 t -162.95 154.77 17.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.201 0.6 . . . . 61.5 110.637 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.9 mtp -111.32 145.23 39.2 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.259 1.024 . . . . 72.400000000000006 109.932 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.7 p -141.7 138.2 32.25 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 73.209999999999994 109.875 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -115.12 171.93 7.37 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.425 0.69 . . . . 65.340000000000003 109.877 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -150.83 134.91 16.79 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.737 0.815 . . . . 74.329999999999998 109.24 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.2 m -99.26 124.73 44.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.054 0.542 . . . . 73.420000000000002 110.151 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.28 18.37 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.832 0.853 . . . . 74.329999999999998 109.109 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.71 109.9 60.59 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.092 0.557 . . . . 54.100000000000001 109.754 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.77 -171.22 1.19 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.514 2.143 . . . . 63.43 112.089 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -167.05 -179.39 4.61 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.086 0.955 . . . . 75.420000000000002 109.432 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -132.45 167.49 19.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.407 0.683 . . . . 70.439999999999998 110.607 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -113.3 136.49 52.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.406 1.082 . . . . 61.219999999999999 109.949 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -87.95 134.09 33.79 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.038 0.535 . . . . 73.109999999999999 109.972 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.61 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.71 0.804 . . . . 75.099999999999994 109.493 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.43 147.48 33.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 123.482 0.713 . . . . 52.119999999999997 110.081 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 C--N 1.379 2.15 0 C-N-CA 122.744 2.296 . . . . 64.209999999999994 111.526 173.957 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 112.955 0.724 . . . . 53.240000000000002 112.955 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 124.36 33.34 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 113.969 -1.469 . . . . 54.520000000000003 110.426 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.1 t -110.65 140.06 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.333 1.053 . . . . 72.299999999999997 108.937 167.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -138.4 109.17 6.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.215 0.531 . . . . 71.510000000000005 109.873 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.586 ' HA ' ' HB ' ' A' ' 118' ' ' VAL . 41.1 t -95.46 134.05 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.384 1.074 . . . . 73.340000000000003 110.014 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.519 ' HE2' HD11 ' A' ' 42' ' ' ILE . 37.5 p90 -156.24 143.89 19.39 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.648 0.379 . . . . 75.129999999999995 110.53 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -97.19 142.99 28.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.503 -0.555 . . . . 75.310000000000002 109.503 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.519 HD11 ' HE2' ' A' ' 40' ' ' TYR . 7.2 mt -120.42 20.34 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 122.306 1.051 . . . . 70.099999999999994 109.891 -177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.2 m -150.18 -137.9 0.08 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.355 1.062 . . . . 73.230000000000004 108.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.07 92.25 0.05 OUTLIER Glycine 0 C--N 1.36 1.874 0 CA-C-N 118.416 0.553 . . . . 61.130000000000003 112.344 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 t -85.0 109.04 17.9 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.802 0.841 . . . . 73.340000000000003 112.122 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -103.59 171.15 7.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.141 -0.936 . . . . 73.140000000000001 109.196 166.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 -2.01 79.65 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.432 -0.349 . . . . 53.32 113.457 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.03 -30.18 71.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.939 0.896 . . . . 65.430000000000007 112.443 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.52 97.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.27 0.628 . . . . 64.230000000000004 110.891 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.62 -25.61 67.46 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.706 0.632 . . . . 62.310000000000002 112.706 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -27.68 66.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.589 1.155 . . . . 74.239999999999995 111.673 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -69.42 -59.31 3.07 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 110.38 -0.23 . . . . 75.129999999999995 110.38 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.56 65.09 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.263 0.625 . . . . 62.039999999999999 112.022 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.37 -44.33 54.66 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.742 1.217 . . . . 74.200000000000003 111.324 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -76.63 -32.7 58.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.831 -0.622 . . . . 74.340000000000003 111.451 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.78 -33.23 75.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.513 0.325 . . . . 72.409999999999997 111.799 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -66.84 -38.58 86.69 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.898 0.38 . . . . 74.219999999999999 110.096 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.61 68.31 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.566 -0.743 . . . . 63.229999999999997 111.212 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -14.59 61.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.806 0.843 . . . . 73.0 111.255 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.09 21.58 32.53 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 119.402 -0.666 . . . . 34.100000000000001 113.226 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -74.53 157.78 34.91 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.294 0.547 . . . . 63.229999999999997 109.735 170.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -69.14 -65.03 0.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.043 -0.526 . . . . 75.129999999999995 111.378 -156.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.0 t -127.71 135.69 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.134 -1.062 . . . . 63.149999999999999 108.134 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 p -134.1 102.42 5.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.648 0.779 . . . . 54.100000000000001 109.054 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.8 150.65 22.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.186 0.594 . . . . 62.140000000000001 109.833 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 15.1 m -143.83 139.23 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.75 0.82 . . . . 75.420000000000002 110.198 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.26 -143.18 6.34 Favored Glycine 0 C--N 1.35 1.352 0 C-N-CA 121.228 -0.511 . . . . 42.340000000000003 113.829 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -158.25 128.13 5.96 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.634 0.773 . . . . 75.239999999999995 110.595 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.1 163.56 16.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.766 0.826 . . . . 63.240000000000002 110.865 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -76.85 149.38 36.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.746 1.218 . . . . 74.409999999999997 110.213 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.97 107.36 0.84 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 123.859 0.864 . . . . 73.109999999999999 111.701 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -93.67 -87.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.132 2.554 . . . . 54.32 111.173 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.82 -15.8 13.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.094 0.958 . . . . 63.509999999999998 110.935 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.14 143.09 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.744 0.818 . . . . 74.129999999999995 111.068 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.42 23.13 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.832 0.853 . . . . 71.329999999999998 111.125 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.03 143.94 37.69 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.375 0.67 . . . . 73.340000000000003 109.317 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -73.71 96.52 2.52 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.378 1.085 . . . . 65.409999999999997 108.703 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 101' ' ' ALA . 5.2 p -151.91 137.79 18.07 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.723 -1.126 . . . . 55.340000000000003 109.844 -170.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 118' ' ' VAL . 60.9 t -96.82 116.85 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.982 -0.748 . . . . 60.030000000000001 108.982 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.27 139.33 41.9 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.928 -0.767 . . . . 73.120000000000005 108.928 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.484 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 39.6 p90 -143.03 147.43 35.08 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.703 0.763 . . . . 72.329999999999998 112.436 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -78.3 166.42 22.71 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 107.396 -1.335 . . . . 72.230000000000004 107.396 160.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.49 22.56 9.92 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.357 -0.839 . . . . 73.409999999999997 112.066 -168.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.17 111.26 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 109.662 -0.496 . . . . 72.109999999999999 109.662 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 63.48 -82.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.331 1.452 . . . . 75.310000000000002 111.492 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.99 35.07 1.19 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 116.206 -0.452 . . . . 70.019999999999996 112.989 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 50.3 mt-10 -71.27 -34.29 70.56 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.429 -0.952 . . . . 72.010000000000005 108.429 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -54.56 -36.61 64.53 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.839 -1.073 . . . . 71.239999999999995 112.061 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.59 55.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.654 0.782 . . . . 64.040000000000006 111.187 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.427 HG21 ' HB3' ' A' ' 35' ' ' ALA . 81.3 p -67.97 -30.0 69.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.067 0.547 . . . . 62.310000000000002 110.831 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.86 -38.16 64.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.067 -0.969 . . . . 75.420000000000002 111.397 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.03 -38.95 90.65 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.785 0.834 . . . . 61.140000000000001 110.808 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -51.96 67.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.907 0.883 . . . . 72.219999999999999 111.275 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 118' ' ' VAL . 97.1 t -73.03 -46.1 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.053 0.541 . . . . 63.409999999999997 111.848 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.74 -24.81 57.91 Favored Glycine 0 N--CA 1.468 0.811 0 O-C-N 123.561 0.538 . . . . 71.239999999999995 112.799 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -81.48 -42.21 20.62 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.62 0.768 . . . . 74.109999999999999 109.874 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.5 m -73.76 -28.96 61.95 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.311 0.577 . . . . 44.119999999999997 111.344 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.0 tp -92.31 -29.29 16.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.785 1.234 . . . . 62.340000000000003 109.423 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 46.35 18.32 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.738 0.648 . . . . 51.100000000000001 111.958 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.31 148.49 42.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.827 0.851 . . . . 75.340000000000003 109.764 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 78' ' ' THR . . . -66.38 116.08 7.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.309 0.644 . . . . 54.130000000000003 110.459 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.484 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.9 m -85.25 140.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.256 0.622 . . . . 73.519999999999996 109.329 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -155.2 153.83 31.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.48 0.712 . . . . 53.32 109.651 -174.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.04 173.01 3.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.82 0.848 . . . . 70.129999999999995 110.811 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -83.58 26.66 0.66 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.998 1.11 . . . . 73.120000000000005 113.998 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.1 mm? -64.17 -53.65 45.81 Favored Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 118.146 -0.93 . . . . 74.230000000000004 111.41 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 22.8 Cg_exo -67.1 -38.25 16.5 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 121.663 1.575 . . . . 73.209999999999994 113.129 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.01 -21.38 61.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.253 0.345 . . . . 74.219999999999999 110.875 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.43 -14.36 56.37 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.328 1.051 . . . . 64.010000000000005 111.372 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 t -57.94 -48.02 81.16 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.268 0.627 . . . . 64.140000000000001 110.483 171.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.97 -31.87 21.84 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.851 0.86 . . . . 75.239999999999995 110.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.32 73.46 0.63 Allowed Pre-proline 0 CA--C 1.561 1.404 0 C-N-CA 125.786 1.634 . . . . 70.450000000000003 110.805 -173.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -88.4 148.48 6.4 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.338 2.692 . . . . 72.420000000000002 110.976 165.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -87.41 133.67 3.29 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.362 2.041 . . . . 71.299999999999997 112.787 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.97 -139.7 14.68 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.432 -0.803 . . . . 61.340000000000003 114.033 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.2 t -105.82 113.14 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.328 1.051 . . . . 72.409999999999997 110.258 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 117' ' ' ILE . 31.1 pt -101.04 114.38 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 122.049 0.928 . . . . 75.219999999999999 109.075 171.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.713 HG13 HG22 ' A' ' 79' ' ' VAL . 89.5 t -90.69 108.49 19.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.264 -1.013 . . . . 71.129999999999995 108.264 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.4 117.56 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.333 -0.988 . . . . 54.409999999999997 108.333 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.23 142.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.045 -1.465 . . . . 73.230000000000004 107.045 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.3 p -134.98 110.68 9.25 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.889 -0.782 . . . . 63.229999999999997 108.889 168.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.212 0 CA-C-O 118.904 -0.942 . . . . 72.319999999999993 112.97 178.596 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 p . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.982 -0.377 . . . . 71.299999999999997 109.982 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.9 p -129.76 152.36 49.34 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.64 0.776 . . . . 72.230000000000004 109.748 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.45 176.4 5.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.769 0.828 . . . . 42.25 110.825 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.77 -175.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.318 1.047 . . . . 73.530000000000001 109.887 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -150.13 161.5 42.26 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.824 0.85 . . . . 63.229999999999997 110.024 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 p -98.38 153.75 18.34 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.743 0.817 . . . . 72.230000000000004 111.655 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 92.7 mmm -113.31 152.62 29.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.543 1.137 . . . . 64.400000000000006 109.257 171.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -115.65 125.77 53.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.802 0.841 . . . . 51.119999999999997 109.014 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -118.57 142.14 47.9 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.209 0.603 . . . . 55.439999999999998 109.933 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -154.84 164.64 38.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.241 1.017 . . . . 72.349999999999994 109.447 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -149.45 168.06 24.48 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 120.909 0.385 . . . . 71.349999999999994 110.967 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.14 166.25 13.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.164 0.985 . . . . 51.0 109.846 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.34 125.19 22.47 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.262 0.625 . . . . 73.109999999999999 110.909 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.42 -170.57 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.156 2.57 . . . . 75.519999999999996 112.271 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 m -133.34 146.75 51.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.715 0.806 . . . . 74.430000000000007 109.549 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 p -77.4 167.62 21.38 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.648 0.779 . . . . 55.229999999999997 111.44 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 m -110.41 131.44 55.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.514 0.725 . . . . 74.340000000000003 109.532 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.4 t -122.23 130.86 53.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.684 0.793 . . . . 52.130000000000003 109.971 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.33 149.42 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.378 0.671 . . . . 54.329999999999998 111.195 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -82.37 139.24 44.8 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 108.574 -0.898 . . . . 74.040000000000006 108.574 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo . . . . . 0 C--N 1.377 2.042 0 C-N-CA 122.501 2.134 . . . . 75.200000000000003 112.216 173.742 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 N-CA-C 109.959 -0.385 . . . . 75.519999999999996 109.959 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.2 mt-10 -80.73 117.89 21.8 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.817 -0.629 . . . . 64.150000000000006 110.065 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.41 HG21 HD23 ' A' ' 56' ' ' LEU . 24.2 t -127.3 143.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.56 0.744 . . . . 54.020000000000003 109.422 174.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.85 132.45 15.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.769 0.428 . . . . 75.430000000000007 110.075 173.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' A' ' 118' ' ' VAL . 4.8 t -103.95 108.7 25.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 123.636 0.774 . . . . 61.32 109.148 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 23.7 m-85 -107.04 135.94 47.74 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.403 0.681 . . . . 71.219999999999999 109.781 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -101.06 127.3 47.64 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.261 -0.644 . . . . 51.009999999999998 109.261 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.752 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -71.89 -24.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.577 -0.527 . . . . 71.230000000000004 109.577 171.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 p -97.58 -67.03 0.87 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.698 1.199 . . . . 54.5 111.112 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.27 11.64 35.8 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.362 0.506 . . . . 72.120000000000005 113.096 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -80.23 -61.53 1.95 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.058 0.543 . . . . 75.010000000000005 111.186 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -78.35 123.9 27.51 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.609 -0.723 . . . . 72.349999999999994 111.12 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.9 -0.8 89.84 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 124.295 0.95 . . . . 52.43 114.303 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . . . -64.51 -21.74 66.77 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.781 0.791 . . . . 61.109999999999999 111.524 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.69 68.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.038 1.335 . . . . 40.119999999999997 111.958 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB3' HH11 ' A' ' 51' ' ' ARG . . . -62.12 -36.59 82.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.588 0.755 . . . . 63.140000000000001 111.361 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.488 HH11 ' HB3' ' A' ' 50' ' ' ALA . 9.9 mpt_? -73.0 -38.57 66.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.686 0.795 . . . . 75.239999999999995 111.167 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 p -64.71 -29.02 69.99 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.047 0.539 . . . . 62.310000000000002 111.683 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.62 7.21 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.441 0.697 . . . . 54.030000000000001 110.946 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -56.46 -43.8 79.93 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.473 1.509 . . . . 64.019999999999996 112.04 -171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.54 -0.755 . . . . 72.120000000000005 111.786 -176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.41 HD23 HG21 ' A' ' 37' ' ' VAL . 9.2 mp -73.2 -27.97 61.93 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.476 0.311 . . . . 64.120000000000005 111.406 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.77 -40.15 91.73 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.641 0.588 . . . . 54.399999999999999 109.842 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.87 -23.03 59.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.211 0.604 . . . . 22.300000000000001 111.528 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.73 -3.3 46.91 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.623 0.769 . . . . 34.130000000000003 112.557 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.44 49.26 2.22 Favored Glycine 0 C--N 1.347 1.159 0 C-N-CA 121.431 -0.414 . . . . 52.329999999999998 112.082 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.21 158.02 4.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.58 1.152 . . . . 72.25 112.654 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -91.79 -57.1 2.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 106.91 -1.515 . . . . 72.129999999999995 106.91 160.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 74.0 t -129.45 136.3 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 73.519999999999996 108.153 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.6 m -141.28 114.21 8.49 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.33 -0.989 . . . . 75.5 108.33 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -120.25 152.79 37.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.677 0.791 . . . . 73.530000000000001 110.059 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.0 139.62 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.574 -0.899 . . . . 74.25 108.574 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.45 -179.31 36.07 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.399 0.437 . . . . 71.150000000000006 112.235 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -143.96 124.21 13.78 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.405 -0.961 . . . . 71.239999999999995 108.405 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 134.46 11.33 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.746 -0.835 . . . . 74.519999999999996 108.746 -170.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.752 ' HA ' HG13 ' A' ' 42' ' ' ILE . 19.6 t -77.68 99.55 5.86 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.449 -0.945 . . . . 74.430000000000007 108.449 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 20.3 tp -103.83 120.62 50.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.464 0.706 . . . . 75.519999999999996 109.311 -172.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 31.2 Cg_exo -59.86 -28.41 87.14 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.732 2.955 . . . . 74.310000000000002 114.984 -171.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.72 9.05 25.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.476 0.711 . . . . 73.329999999999998 112.063 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.524 HG21 HG11 ' A' ' 119' ' ' VAL . 63.9 t -105.92 111.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.306 0.642 . . . . 74.239999999999995 109.54 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.43 10.37 11.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.694 0.798 . . . . 62.450000000000003 111.092 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -170.04 156.89 6.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.836 0.854 . . . . 32.43 110.791 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.656 ' HB ' ' H ' ' A' ' 121' ' ' THR . 2.1 t -69.71 102.37 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.57 0.748 . . . . 71.519999999999996 109.537 173.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.542 HG21 ' HG2' ' A' ' 103' ' ' GLU . 87.8 m -150.21 149.13 29.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.835 -0.62 . . . . 64.140000000000001 110.985 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.564 HG13 ' HB ' ' A' ' 118' ' ' VAL . 40.4 t -94.59 113.68 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.282 -1.007 . . . . 74.340000000000003 108.282 175.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.554 ' HD1' ' HB2' ' A' ' 103' ' ' GLU . 28.8 m-85 -99.27 135.44 40.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.527 -0.916 . . . . 71.310000000000002 108.527 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.93 138.16 53.24 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.144 0.497 . . . . 62.439999999999998 111.123 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -73.03 153.5 40.86 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 114.935 -1.03 . . . . 55.439999999999998 109.159 170.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.671 ' HB3' HD11 ' A' ' 104' ' ' LEU . 11.6 pt-20 -102.06 26.26 7.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.28 0.474 . . . . 74.219999999999999 112.28 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.2 t -70.8 93.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 108.499 -0.926 . . . . 55.219999999999999 108.499 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 70.52 -77.74 0.05 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.444 1.498 . . . . 60.119999999999997 111.162 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.43 50.06 0.31 Allowed Glycine 0 C--N 1.352 1.453 0 N-CA-C 112.523 -0.231 . . . . 65.150000000000006 112.523 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.24 -18.64 63.9 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 120.843 0.354 . . . . 63.420000000000002 110.675 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.64 -28.25 68.33 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.847 0.859 . . . . 72.010000000000005 111.386 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.77 -36.03 81.76 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.622 0.769 . . . . 62.219999999999999 110.754 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 m -74.7 -38.26 62.4 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.771 -1.104 . . . . 64.310000000000002 110.498 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -20.04 56.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.751 0.82 . . . . 44.329999999999998 112.351 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -58.57 -49.7 76.49 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.898 -0.778 . . . . 74.329999999999998 108.898 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.85 70.74 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 124.442 1.088 . . . . 71.030000000000001 111.45 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.82 -46.85 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.212 0.605 . . . . 70.140000000000001 111.686 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.41 -26.99 62.62 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.681 0.613 . . . . 74.510000000000005 111.913 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -85.4 -31.34 22.96 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.132 0.973 . . . . 64.019999999999996 110.777 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.0 m -76.57 -29.91 56.83 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.914 0.388 . . . . 43.030000000000001 110.435 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 tp -95.79 -32.71 12.56 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.604 0.762 . . . . 71.230000000000004 110.141 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.72 44.62 47.9 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.187 -0.461 . . . . 72.400000000000006 111.985 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.95 177.57 6.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.955 0.902 . . . . 73.420000000000002 110.116 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.81 158.55 35.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.743 -0.662 . . . . 74.530000000000001 109.918 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.56 HG12 ' HB ' ' A' ' 79' ' ' VAL . 27.3 m -127.1 144.15 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.768 0.827 . . . . 64.420000000000002 109.669 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.554 ' HB2' ' HD1' ' A' ' 80' ' ' TYR . 59.9 mm-40 -129.84 149.39 51.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.227 1.011 . . . . 73.120000000000005 109.872 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 83' ' ' GLU . 51.7 tp -69.24 175.98 3.57 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.803 -1.09 . . . . 72.319999999999993 108.837 165.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -67.62 20.31 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.37 1.619 . . . . 64.120000000000005 115.37 -175.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.84 -46.1 81.57 Favored Pre-proline 0 CA--C 1.564 1.486 0 CA-C-O 117.947 -1.025 . . . . 70.239999999999995 111.871 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.0 -42.12 32.26 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 122.188 1.925 . . . . 64.409999999999997 111.233 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 88.0 mt-10 -60.17 -26.48 66.35 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 115.998 -0.546 . . . . 73.319999999999993 111.134 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.61 -10.18 17.35 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.101 0.96 . . . . 61.100000000000001 112.319 -171.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -56.74 -49.95 73.7 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.843 0.857 . . . . 51.409999999999997 111.625 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.11 -33.44 2.19 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.579 0.752 . . . . 62.049999999999997 111.16 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 73.67 80.08 0.17 Allowed Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 126.029 1.731 . . . . 72.439999999999998 111.746 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 69.1 Cg_endo -81.26 124.34 4.78 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.574 2.183 . . . . 73.450000000000003 110.371 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.91 116.66 4.79 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.033 1.822 . . . . 73.420000000000002 111.21 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.81 156.82 12.69 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.243 0.449 . . . . 74.140000000000001 112.222 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.25 119.75 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.174 1.39 . . . . 73.540000000000006 112.774 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.517 HG13 ' HB2' ' A' ' 80' ' ' TYR . 44.4 pt -110.76 106.86 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.763 -0.828 . . . . 73.209999999999994 108.763 172.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -96.39 111.81 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.394 -0.965 . . . . 65.540000000000006 108.394 175.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.5 t -114.91 118.69 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.593 -0.276 . . . . 64.209999999999994 110.975 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -99.23 144.17 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.525 0.73 . . . . 73.239999999999995 110.019 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.656 ' H ' ' HB ' ' A' ' 77' ' ' THR . 12.0 t -118.27 165.45 13.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.788 0.835 . . . . 73.010000000000005 109.596 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 N-CA-C 110.53 -1.028 . . . . 63.219999999999999 110.53 179.253 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 110.322 -0.251 . . . . 63.450000000000003 110.322 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 p -152.12 133.66 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 72.239999999999995 110.257 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.88 119.25 3.57 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.386 -0.968 . . . . 73.439999999999998 108.386 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -116.75 133.43 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.102 0.561 . . . . 74.209999999999994 110.581 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -147.46 127.02 13.26 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.948 0.899 . . . . 64.329999999999998 108.865 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -145.72 103.12 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.706 0.803 . . . . 52.119999999999997 109.068 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -145.1 149.58 35.3 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.111 0.964 . . . . 72.340000000000003 109.725 -178.093 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -148.2 160.87 42.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.167 0.587 . . . . 55.340000000000003 109.812 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -147.56 150.48 34.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.58 0.752 . . . . 75.099999999999994 109.477 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -155.89 161.66 40.54 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.592 0.757 . . . . 71.420000000000002 109.957 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.7 t -153.67 178.64 9.64 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.241 1.016 . . . . 54.109999999999999 109.387 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.18 173.44 11.58 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.608 1.163 . . . . 62.119999999999997 109.262 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 121.48 6.38 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.471 0.709 . . . . 73.0 110.146 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.32 141.11 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.78 2.32 . . . . 75.200000000000003 112.325 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.6 p -136.3 142.09 43.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.664 0.786 . . . . 60.299999999999997 110.168 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.7 p -173.83 134.85 0.48 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.277 1.031 . . . . 53.409999999999997 109.913 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.0 p -102.35 -177.26 3.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.864 0.866 . . . . 72.040000000000006 111.065 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -149.12 126.83 11.73 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.487 -0.931 . . . . 72.430000000000007 108.487 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.68 157.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.692 0.797 . . . . 73.549999999999997 110.069 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -113.36 131.44 22.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 64.409999999999997 110.044 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 C--N 1.378 2.086 0 C-N-CA 122.954 2.436 . . . . 73.450000000000003 112.558 178.546 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.11 -0.33 . . . . 72.040000000000006 110.11 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.24 104.18 13.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.231 0.613 . . . . 74.5 109.387 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.9 t -96.47 127.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.538 -0.912 . . . . 63.439999999999998 108.538 174.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' ASP . 43.5 ttm105 -147.77 111.81 5.15 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.169 -0.332 . . . . 75.310000000000002 110.436 -171.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 130.99 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.169 0.588 . . . . 62.399999999999999 109.586 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 17.1 m-85 -124.95 132.46 53.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.952 0.901 . . . . 73.200000000000003 109.02 167.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 68' ' ' ASN . 41.0 m-80 -94.31 121.81 36.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 32.450000000000003 109.707 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.7 tp -78.99 -27.79 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.401 0.68 . . . . 74.420000000000002 109.332 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 122' ' ' GLY . 34.6 t -125.21 -162.04 1.07 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.596 1.158 . . . . 64.430000000000007 108.384 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.01 136.37 51.3 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 118.364 0.529 . . . . 53.549999999999997 112.791 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.3 t -78.56 122.67 26.2 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.994 0.518 . . . . 32.240000000000002 110.601 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.93 160.32 18.73 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.12 -0.696 . . . . 74.25 109.12 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.35 -41.57 87.73 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.3 0.375 . . . . 71.310000000000002 112.361 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 52' ' ' THR . . . -63.33 -31.46 72.62 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.208 1.003 . . . . 72.230000000000004 112.307 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HB2' HG11 ' A' ' 120' ' ' VAL . . . -58.43 -49.72 76.28 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.839 0.712 . . . . 71.239999999999995 111.305 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.93 -32.0 57.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.464 -0.789 . . . . 32.399999999999999 110.669 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.661 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 31.6 tpt180 -71.4 -20.19 62.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.888 0.875 . . . . 72.219999999999999 111.987 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 48' ' ' ALA . 42.1 p -58.95 -52.79 64.22 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.561 0.619 . . . . 61.420000000000002 110.208 174.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.59 -25.67 45.31 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.98 -1.009 . . . . 74.140000000000001 111.515 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 31.8 t70 -79.06 -22.71 44.95 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.116 0.966 . . . . 63.420000000000002 110.819 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -86.76 -37.96 17.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.603 0.761 . . . . 52.299999999999997 109.126 168.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 tp -71.21 -19.36 62.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.489 0.715 . . . . 72.340000000000003 112.16 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.99 -27.34 69.34 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 110.491 -0.188 . . . . 73.329999999999998 110.491 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.95 60.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.696 0.798 . . . . 74.230000000000004 111.495 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.33 12.51 6.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.739 0.816 . . . . 62.240000000000002 112.723 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.29 46.39 6.98 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 120.313 -0.159 . . . . 61.210000000000001 113.091 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -58.97 152.12 20.42 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.255 1.022 . . . . 74.519999999999996 111.316 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 35' ' ' ALA . 58.7 m -86.4 -55.03 4.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.718 -0.845 . . . . 74.150000000000006 108.718 171.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.61 147.37 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.591 -0.892 . . . . 70.329999999999998 108.591 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 54.0 m -142.84 144.9 32.7 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.523 1.129 . . . . 62.240000000000002 109.801 -172.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 29.6 t70 -143.67 143.9 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.483 1.113 . . . . 63.43 108.34 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.85 133.13 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.363 -0.977 . . . . 71.129999999999995 108.363 173.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.85 -160.8 11.23 Favored Glycine 0 C--O 1.246 0.86 0 N-CA-C 111.609 -0.597 . . . . 75.329999999999998 111.609 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.458 ' HA ' ' H ' ' A' ' 41' ' ' ASN . 26.2 p30 -130.34 140.15 50.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.366 1.066 . . . . 73.530000000000001 108.466 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -157.48 134.43 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.51 -0.552 . . . . 74.209999999999994 109.51 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.5 t -73.39 98.23 2.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.972 -1.122 . . . . 53.32 107.972 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.74 98.55 9.89 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.832 -1.173 . . . . 74.049999999999997 107.832 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.64 -1.01 10.12 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.725 2.283 . . . . 64.310000000000002 113.156 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.99 -23.55 41.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.784 0.833 . . . . 65.219999999999999 110.551 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 119' ' ' VAL . 2.7 p -134.05 140.03 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.428 1.091 . . . . 71.329999999999998 110.84 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.46 62.07 1.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.544 -0.91 . . . . 64.420000000000002 108.544 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.04 155.75 16.5 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.195 -0.911 . . . . 31.120000000000001 110.361 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.3 t -82.43 98.62 8.98 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.604 -1.258 . . . . 75.150000000000006 107.604 167.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 m -149.25 139.65 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.999 -1.001 . . . . 74.25 109.173 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 118' ' ' VAL . 97.9 t -95.74 116.27 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.205 -1.035 . . . . 74.409999999999997 108.205 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.617 ' HB2' HG13 ' A' ' 117' ' ' ILE . 90.4 m-85 -109.53 154.76 22.25 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.27 -0.641 . . . . 75.109999999999999 109.27 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -139.46 170.43 15.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.738 -0.665 . . . . 71.299999999999997 111.19 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.0 p -110.75 -159.29 0.67 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.627 -0.879 . . . . 63.130000000000003 108.627 164.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.21 21.05 12.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.192 0.997 . . . . 70.549999999999997 110.092 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.38 100.9 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.866 0.866 . . . . 75.299999999999997 110.015 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 70.06 -75.86 0.07 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.588 1.555 . . . . 71.040000000000006 111.62 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.47 40.81 0.81 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.644 -1.383 . . . . 63.140000000000001 109.644 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.54 -39.18 85.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.961 -0.619 . . . . 43.109999999999999 110.142 -172.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -67.01 -31.4 71.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.589 -0.732 . . . . 75.099999999999994 110.947 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.2 -43.11 64.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.607 0.763 . . . . 65.349999999999994 111.427 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 94' ' ' VAL . 9.8 t -76.69 -34.55 58.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.65 -0.5 . . . . 33.539999999999999 109.65 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.06 -38.74 92.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.362 0.665 . . . . 73.439999999999998 111.963 176.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.584 ' HA ' HG11 ' A' ' 102' ' ' VAL . 25.7 t70 -58.1 -36.04 72.3 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.322 1.014 . . . . 72.549999999999997 110.318 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.9 78.47 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.474 -0.785 . . . . 63.140000000000001 111.226 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 118' ' ' VAL . 22.0 t -71.26 -34.62 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.28 0.632 . . . . 63.240000000000002 112.284 -174.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -59.48 -34.86 83.03 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 121.954 0.752 . . . . 25.030000000000001 112.006 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -80.63 -30.58 36.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.836 -1.182 . . . . 71.409999999999997 110.658 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 m -74.36 -21.02 59.87 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.04 0.536 . . . . 75.329999999999998 110.942 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 38.7 tp -97.16 -32.18 12.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.178 0.591 . . . . 72.519999999999996 110.609 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.6 53.8 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.869 -0.605 . . . . 35.520000000000003 112.027 -170.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.23 -177.69 3.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.375 1.07 . . . . 72.239999999999995 111.082 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.65 154.8 17.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.522 0.729 . . . . 62.43 110.318 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.584 HG11 ' HA ' ' A' ' 92' ' ' ASP . 19.9 m -108.35 129.95 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.452 -0.573 . . . . 25.23 109.452 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.34 164.03 28.34 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.863 0.865 . . . . 75.519999999999996 111.185 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.28 -175.32 0.11 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.969 -1.014 . . . . 71.409999999999997 112.134 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.32 -27.48 62.46 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.757 -0.64 . . . . 72.510000000000005 112.048 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.64 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 124.549 1.14 . . . . 71.329999999999998 111.714 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.12 -27.16 84.23 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.487 2.124 . . . . 73.129999999999995 112.281 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -79.2 -53.57 6.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.885 1.274 . . . . 72.519999999999996 110.97 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.455 HD11 ' HB ' ' A' ' 74' ' ' VAL . 52.1 mt -82.53 16.05 2.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.84 0.856 . . . . 61.340000000000003 111.611 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.3 m -84.94 -11.13 56.21 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.82 0.448 . . . . 62.450000000000003 110.55 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.37 8.08 29.39 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.481 0.712 . . . . 73.510000000000005 110.994 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -76.66 164.98 56.12 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.925 0.89 . . . . 75.219999999999999 110.708 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.2 122.29 11.32 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.948 1.766 . . . . 74.540000000000006 111.098 163.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.29 136.77 55.49 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.926 3.084 . . . . 61.399999999999999 115.277 -164.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.75 -162.5 15.49 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.583 -0.735 . . . . 72.019999999999996 113.22 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 91' ' ' ALA . 57.9 t -66.69 115.65 4.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 124.092 0.957 . . . . 54.119999999999997 108.972 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.617 HG13 ' HB2' ' A' ' 80' ' ' TYR . 7.6 pt -106.23 106.67 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.524 -0.917 . . . . 74.450000000000003 108.524 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 79' ' ' VAL . 44.5 t -88.52 100.95 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.547 -1.649 . . . . 73.120000000000005 106.547 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 74' ' ' VAL . 49.8 t -93.5 118.46 39.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 N-CA-C 107.109 -1.441 . . . . 65.030000000000001 107.109 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 49' ' ' ALA . 48.0 t -119.24 136.6 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 122.972 0.509 . . . . 72.099999999999994 109.762 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.406 ' H ' ' HB ' ' A' ' 77' ' ' THR . 15.2 t -117.54 137.29 52.67 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.565 0.746 . . . . 63.240000000000002 109.386 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 43' ' ' SER . . . . . . . . 0 CA--C 1.534 1.265 0 N-CA-C 110.721 -0.951 . . . . 37.409999999999997 110.721 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 110.179 -0.304 . . . . 71.5 110.179 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.9 p -158.77 129.82 6.25 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.028 0.931 . . . . 64.219999999999999 109.101 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.38 133.3 8.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.515 0.726 . . . . 72.310000000000002 109.37 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.77 137.34 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.314 0.646 . . . . 71.530000000000001 109.816 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 p -156.87 129.51 7.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.512 0.725 . . . . 73.200000000000003 109.263 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -151.35 136.96 17.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.254 -0.647 . . . . 71.219999999999999 109.254 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.2 mmm -127.59 116.98 21.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.568 0.747 . . . . 74.019999999999996 109.339 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -145.05 99.92 3.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.614 0.765 . . . . 72.349999999999994 110.017 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -155.99 137.71 14.25 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.092 0.957 . . . . 74.319999999999993 109.106 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -155.84 149.49 25.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.92 . . . . 74.519999999999996 109.261 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -140.88 119.66 12.54 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.42 1.088 . . . . 75.439999999999998 109.033 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.78 147.06 25.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.597 0.759 . . . . 74.239999999999995 111.122 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.8 116.8 62.87 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.765 -0.828 . . . . 65.129999999999995 108.765 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 137.65 40.42 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.547 2.165 . . . . 74.450000000000003 112.751 -172.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -77.48 135.95 38.3 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.493 0.717 . . . . 64.439999999999998 109.572 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 p -146.26 148.76 32.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.949 0.5 . . . . 74.129999999999995 110.455 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -152.26 179.86 8.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.94 0.896 . . . . 64.510000000000005 109.31 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.7 p -158.62 156.75 30.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.817 0.847 . . . . 72.209999999999994 109.794 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.45 147.09 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.161 0.585 . . . . 62.219999999999999 109.86 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -111.91 143.95 29.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 108.729 -0.841 . . . . 71.140000000000001 108.729 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 C--N 1.371 1.751 0 C-N-CA 122.217 1.945 . . . . 74.209999999999994 111.889 171.182 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.245 0.863 0 N-CA-C 109.49 -0.559 . . . . 62.210000000000001 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.46 148.13 24.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.143 0.577 . . . . 63.140000000000001 111.565 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 64' ' ' THR . 87.3 t -137.8 125.8 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.608 1.163 . . . . 43.119999999999997 108.09 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 116' ' ' VAL . 9.6 ptp180 -127.84 111.12 13.27 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.27 -0.894 . . . . 75.340000000000003 109.706 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.68 110.36 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.477 0.711 . . . . 74.349999999999994 110.655 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.483 ' HB2' HG12 ' A' ' 119' ' ' VAL . 51.1 m-85 -100.91 106.04 17.35 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 109.179 -0.674 . . . . 70.010000000000005 109.179 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 4.5 m-20 -87.28 113.73 23.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.636 -1.246 . . . . 70.349999999999994 107.636 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.2 tt -70.13 -28.22 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.605 0.717 . . . . 72.439999999999998 110.165 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 41' ' ' ASN . 22.8 t -130.27 159.35 37.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.704 -1.134 . . . . 63.43 108.44 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.22 -45.04 44.0 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.888 0.743 . . . . 51.310000000000002 113.422 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t 47.86 -164.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.236 1.815 . . . . 62.509999999999998 112.798 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 39.6 tt0 -71.42 136.42 47.69 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 121.716 -0.615 . . . . 74.239999999999995 109.677 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.09 -26.57 65.96 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.884 0.74 . . . . 40.43 114.443 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . . . -58.27 -26.62 63.17 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.123 0.969 . . . . 75.109999999999999 112.693 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -59.62 -47.58 85.05 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.661 0.784 . . . . 55.450000000000003 111.579 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 66' ' ' VAL . . . -80.97 -29.4 35.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.269 -0.878 . . . . 61.420000000000002 111.077 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . 4.0 tmt_? -74.13 -19.25 60.63 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.577 -1.192 . . . . 63.210000000000001 111.016 -173.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 34.3 p -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 109.65 -0.5 . . . . 64.099999999999994 109.65 172.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.71 -41.52 79.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.514 0.726 . . . . 70.5 111.628 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.15 -37.69 86.16 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.44 0.696 . . . . 72.510000000000005 111.063 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -77.97 -33.01 51.65 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.113 0.565 . . . . 74.530000000000001 110.589 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' THR . 13.3 tp -63.31 -43.66 97.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.621 0.768 . . . . 64.299999999999997 112.019 -169.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -19.34 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.267 0.84 . . . . 63.299999999999997 113.267 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.21 -27.89 68.75 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.87 0.468 . . . . 45.119999999999997 112.048 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.91 -9.9 59.08 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.129 0.571 . . . . 52.109999999999999 112.266 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.48 47.11 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 113.802 0.281 . . . . 73.430000000000007 113.802 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.506 ' HE2' HG22 ' A' ' 90' ' ' THR . 6.5 m-85 -91.9 157.96 16.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.652 0.781 . . . . 75.230000000000004 109.632 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 HG23 ' A' ' 63' ' ' VAL . 20.2 m -71.59 -77.47 0.09 Allowed 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.445 0.466 . . . . 62.310000000000002 111.903 -162.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.467 HG23 HG22 ' A' ' 62' ' ' THR . 69.5 t -127.44 103.49 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 108.787 -0.82 . . . . 75.040000000000006 108.787 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 41.2 p -95.46 91.14 6.05 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.599 -0.889 . . . . 63.119999999999997 108.599 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 12.2 t70 -102.17 131.84 48.44 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.973 -1.012 . . . . 72.040000000000006 108.655 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 50' ' ' ALA . 65.7 t -125.98 133.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.93 -0.396 . . . . 43.140000000000001 109.93 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.36 146.62 17.29 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.245 -0.742 . . . . 43.109999999999999 111.245 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 24.9 p-10 -111.89 117.34 32.5 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.609 -0.515 . . . . 73.209999999999994 109.609 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.7 tp -159.15 138.54 11.46 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 122.493 -0.129 . . . . 70.129999999999995 110.831 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.614 ' HA ' HG13 ' A' ' 42' ' ' ILE . 49.3 m -68.69 103.4 1.73 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.491 -0.559 . . . . 73.030000000000001 109.491 171.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 74' ' ' VAL . 64.1 mt -112.23 132.4 22.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 123.928 0.891 . . . . 62.009999999999998 108.619 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.37 -20.57 54.89 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.608 2.205 . . . . 71.140000000000001 113.935 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.558 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 5.3 p-10 -82.04 -26.96 33.29 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.035 0.383 . . . . 72.340000000000003 112.035 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.561 HG13 HD12 ' A' ' 42' ' ' ILE . 2.4 p -97.8 117.31 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.676 0.75 . . . . 73.310000000000002 109.408 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.76 6.9 4.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.584 1.154 . . . . 75.120000000000005 108.926 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.3 151.58 15.65 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.456 1.102 . . . . 72.319999999999993 109.184 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -74.73 114.38 13.1 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.255 0.55 . . . . 61.439999999999998 110.375 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.2 m -145.73 143.62 29.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.505 1.122 . . . . 72.319999999999993 109.305 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.696 HG22 HG13 ' A' ' 118' ' ' VAL . 92.8 t -110.57 115.53 50.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 109.131 -0.692 . . . . 75.349999999999994 109.131 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.91 154.42 17.31 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.721 0.808 . . . . 74.129999999999995 109.575 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.76 152.9 42.77 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.266 -0.642 . . . . 74.219999999999999 109.266 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -106.71 135.58 48.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.163 -1.051 . . . . 63.420000000000002 108.163 172.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.5 0.31 4.19 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.378 1.251 . . . . 75.239999999999995 114.378 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.35 111.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 123.485 0.714 . . . . 71.019999999999996 110.753 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 70.74 -69.34 0.18 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.41 1.484 . . . . 63.009999999999998 112.037 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.95 51.52 0.06 OUTLIER Glycine 0 C--O 1.241 0.54 0 CA-C-O 119.976 -0.347 . . . . 54.439999999999998 112.767 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HB3' HG23 ' A' ' 116' ' ' VAL . 39.9 mm-40 -66.79 -27.12 67.32 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 111.786 0.291 . . . . 73.530000000000001 111.786 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -56.21 -34.29 66.14 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.56 0.207 . . . . 73.450000000000003 111.56 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.96 -39.19 71.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.288 0.635 . . . . 74.400000000000006 112.24 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.506 HG22 ' HE2' ' A' ' 61' ' ' PHE . 60.7 p -85.22 -44.41 12.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.862 -0.608 . . . . 72.329999999999998 110.753 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -58.87 -39.33 81.05 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.209 0.604 . . . . 75.109999999999999 112.466 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.568 ' HA ' HG11 ' A' ' 102' ' ' VAL . 23.5 t70 -72.07 -27.39 62.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.013 -0.994 . . . . 61.350000000000001 110.401 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.67 -52.08 8.42 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.206 0.602 . . . . 72.299999999999997 110.813 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 118' ' ' VAL . 69.4 t -60.44 -49.96 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.292 1.037 . . . . 44.509999999999998 111.11 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -63.88 -33.4 87.15 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.302 -0.863 . . . . 71.430000000000007 112.975 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -70.72 -37.47 73.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.151 -0.525 . . . . 61.109999999999999 110.449 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 m -68.29 -34.52 76.32 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.212 0.605 . . . . 72.25 110.927 175.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.1 tp -77.53 -33.31 54.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.704 0.802 . . . . 75.510000000000005 111.523 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.81 31.45 29.43 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.701 -0.681 . . . . 72.310000000000002 112.522 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.55 146.8 44.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.848 0.859 . . . . 64.310000000000002 109.155 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.39 149.63 33.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.131 0.572 . . . . 74.510000000000005 111.621 -172.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 92' ' ' ASP . 30.6 m -96.37 134.9 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.712 0.768 . . . . 54.039999999999999 111.319 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -134.11 165.67 24.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.438 1.495 . . . . 74.099999999999994 109.181 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.19 -174.19 0.78 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.838 0.855 . . . . 73.200000000000003 111.241 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.569 ' HB2' HD13 ' A' ' 109' ' ' LEU . 15.4 ptt180 -56.58 -40.86 75.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.804 0.842 . . . . 74.209999999999994 111.025 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.9 mt 61.2 164.39 0.1 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 125.15 1.38 . . . . 70.439999999999998 113.307 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.14 -23.56 9.77 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.329 2.686 . . . . 64.109999999999999 114.411 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 mp0 -60.67 -27.38 67.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.986 0.914 . . . . 70.409999999999997 112.825 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -66.08 -6.29 12.58 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.945 0.72 . . . . 54.119999999999997 112.945 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.0 p -66.2 -28.21 68.58 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.114 0.566 . . . . 70.230000000000004 112.066 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.61 -33.06 6.47 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.819 0.448 . . . . 51.210000000000001 111.743 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 13.4 pt20 -90.79 136.68 27.51 Favored Pre-proline 0 N--CA 1.484 1.251 0 N-CA-C 109.29 -0.633 . . . . 73.439999999999998 109.29 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.4 95.05 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.633 2.222 . . . . 61.240000000000002 112.616 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.5 161.33 35.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.898 2.399 . . . . 70.120000000000005 114.017 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 119.95 -149.0 17.89 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.661 -0.976 . . . . 74.239999999999995 110.661 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 78.7 t -84.66 121.37 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.107 0.453 . . . . 62.229999999999997 109.783 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.46 HG22 HG13 ' A' ' 119' ' ' VAL . 4.1 mp -118.97 104.95 16.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 108.27 -1.011 . . . . 74.439999999999998 108.27 174.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.696 HG13 HG22 ' A' ' 79' ' ' VAL . 58.2 t -92.48 101.37 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.369 -0.974 . . . . 64.010000000000005 108.369 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 40' ' ' TYR . 27.1 m -98.48 128.06 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.504 -0.554 . . . . 74.120000000000005 109.504 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.732 HG21 ' HB1' ' A' ' 49' ' ' ALA . 15.3 t -127.48 132.18 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.957 0.503 . . . . 71.230000000000004 110.309 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.0 t -105.08 165.9 10.76 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.562 0.745 . . . . 53.340000000000003 109.16 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 119.106 -0.83 . . . . 52.329999999999998 113.065 174.821 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 120.767 0.318 . . . . 74.299999999999997 110.411 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.2 m -88.59 -179.37 6.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.111 0.964 . . . . 74.209999999999994 111.512 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.92 141.13 30.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.406 -0.816 . . . . 73.439999999999998 109.787 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -121.73 155.65 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.712 0.805 . . . . 51.210000000000001 110.305 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.0 t -160.17 123.07 3.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.925 0.89 . . . . 23.219999999999999 108.797 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.1 m -118.65 133.11 56.1 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.934 0.494 . . . . 74.540000000000006 110.046 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtt -100.47 126.09 46.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.13 0.972 . . . . 73.109999999999999 109.52 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -134.34 109.11 8.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.789 0.836 . . . . 74.150000000000006 109.949 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -105.38 152.64 22.7 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.141 0.976 . . . . 61.039999999999999 109.968 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -153.05 116.07 4.58 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.374 0.67 . . . . 74.519999999999996 110.295 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.6 p -133.87 143.41 48.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.047 0.939 . . . . 63.310000000000002 110.497 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.23 167.48 20.61 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.806 0.842 . . . . 53.020000000000003 110.174 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.6 143.6 36.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 64.219999999999999 110.664 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.225 2.617 . . . . 73.519999999999996 113.48 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -112.99 159.38 19.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.101 0.961 . . . . 63.32 110.545 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -108.56 144.93 35.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 74.019999999999996 110.257 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -129.59 113.62 15.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.25 0.62 . . . . 70.439999999999998 110.503 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.3 m -102.89 133.94 47.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.969 0.508 . . . . 73.409999999999997 110.268 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.96 126.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 122.998 0.519 . . . . 75.030000000000001 110.331 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -114.95 106.81 51.13 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 108.354 -0.98 . . . . 71.530000000000001 108.354 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.37 1.697 0 C-N-CA 123.119 2.546 . . . . 73.209999999999994 113.294 175.844 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.429 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.925 -0.768 . . . . 52.219999999999999 108.925 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.49 140.35 29.66 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.145 0.498 . . . . 64.209999999999994 110.446 -177.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 64' ' ' THR . 48.5 t -118.04 160.53 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.254 1.022 . . . . 73.530000000000001 109.128 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.09 127.78 11.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.725 0.41 . . . . 72.299999999999997 110.199 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 118' ' ' VAL . 94.1 t -106.36 121.3 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.639 0.776 . . . . 72.209999999999994 109.463 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -115.81 133.47 56.0 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.622 0.769 . . . . 71.510000000000005 110.793 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -82.62 116.29 21.96 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.688 -0.856 . . . . 74.040000000000006 108.688 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 74' ' ' VAL . 10.5 tp -80.12 -24.03 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.354 -0.61 . . . . 73.420000000000002 109.354 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.677 ' HB2' ' H ' ' A' ' 122' ' ' GLY . 40.4 m -139.18 169.38 17.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.272 1.029 . . . . 72.109999999999999 109.129 170.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 84.49 0.15 Allowed Glycine 0 C--N 1.347 1.183 0 O-C-N 123.551 0.532 . . . . 52.109999999999999 112.231 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 t -97.01 178.8 5.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.631 0.772 . . . . 74.230000000000004 109.89 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.77 151.19 43.72 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.133 0.573 . . . . 64.109999999999999 111.02 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.72 -4.44 46.8 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.059 -0.856 . . . . 71.200000000000003 114.823 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.5 -28.25 69.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.196 0.998 . . . . 64.049999999999997 112.271 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.49 -45.21 91.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.378 0.671 . . . . 71.120000000000005 110.842 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.29 -31.72 62.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.231 -0.895 . . . . 64.439999999999998 111.302 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -68.92 -36.32 77.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.537 1.135 . . . . 72.219999999999999 110.447 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.7 t -73.86 -35.09 64.73 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.411 -0.358 . . . . 72.219999999999999 110.109 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.88 63.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.432 0.693 . . . . 63.420000000000002 110.89 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.81 -48.18 70.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.05 0.94 . . . . 74.230000000000004 110.884 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -78.43 -29.24 46.94 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.478 -0.783 . . . . 62.229999999999997 111.274 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.75 -45.56 74.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.234 1.014 . . . . 74.049999999999997 111.359 -174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -51.63 -46.19 63.57 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.521 1.128 . . . . 62.119999999999997 111.625 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.6 -10.68 60.14 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.801 0.841 . . . . 62.350000000000001 112.556 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.83 7.3 42.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.603 0.761 . . . . 65.109999999999999 112.394 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.43 26.18 5.76 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 120.853 0.14 . . . . 24.109999999999999 113.205 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.528 ' HE2' ' HA ' ' A' ' 90' ' ' THR . 16.4 m-85 -108.09 154.04 22.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.238 1.015 . . . . 73.239999999999995 108.412 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.507 0.323 . . . . 70.409999999999997 111.681 -167.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.62 153.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.067 -1.086 . . . . 73.329999999999998 108.067 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 22.2 p -127.23 114.44 17.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.92 -0.77 . . . . 51.229999999999997 108.92 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -101.25 127.76 47.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.556 0.742 . . . . 44.149999999999999 109.256 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.65 129.68 67.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.088 -0.708 . . . . 63.450000000000003 109.088 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.91 -179.46 30.12 Favored Glycine 0 C--N 1.341 0.808 0 O-C-N 123.601 0.563 . . . . 72.209999999999994 111.91 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.65 125.92 35.26 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.143 -1.058 . . . . 71.140000000000001 108.143 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 57.1 mt -140.18 151.46 45.25 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.746 0.818 . . . . 72.409999999999997 110.15 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' HD12 ' A' ' 42' ' ' ILE . 24.2 m -126.85 98.21 5.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.782 0.833 . . . . 74.219999999999999 109.632 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HB2' HG22 ' A' ' 74' ' ' VAL . 7.4 mp -121.09 153.46 57.79 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 124.647 1.179 . . . . 61.32 109.438 -176.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.33 -27.69 6.3 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.512 2.141 . . . . 51.350000000000001 112.745 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.6 -23.05 53.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.75 0.82 . . . . 64.299999999999997 111.19 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 71' ' ' LEU . 33.0 m -120.41 117.98 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 109.088 -0.708 . . . . 73.409999999999997 109.088 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -144.46 9.46 1.4 Allowed 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.869 -0.519 . . . . 71.349999999999994 111.045 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.79 158.22 44.63 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.356 1.063 . . . . 75.400000000000006 109.345 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.573 ' HB ' HG22 ' A' ' 121' ' ' THR . 7.2 t -69.34 98.22 1.05 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.285 1.04 . . . . 73.019999999999996 108.913 174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.8 m -150.74 137.09 18.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.49 1.116 . . . . 72.340000000000003 110.217 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 118' ' ' VAL . 40.3 t -101.67 119.7 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.314 1.046 . . . . 75.409999999999997 108.861 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' CE1' HG12 ' A' ' 74' ' ' VAL . 93.4 m-85 -103.75 125.42 50.21 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.252 -0.647 . . . . 72.219999999999999 109.252 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -145.45 160.38 41.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.52 0.728 . . . . 74.319999999999993 110.37 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -109.36 -120.32 0.27 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 108.103 -1.073 . . . . 61.530000000000001 108.103 172.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -137.89 -9.34 1.58 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.251 0.932 . . . . 70.5 112.194 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.43 107.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.33 0.652 . . . . 75.040000000000006 111.735 -167.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 59.77 31.43 20.81 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 53.450000000000003 112.067 173.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.55 38.44 5.58 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.03 -0.986 . . . . 52.25 113.374 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.3 -44.44 71.99 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.189 0.495 . . . . 72.540000000000006 112.303 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -66.31 -24.62 66.57 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 111.888 0.329 . . . . 73.010000000000005 111.888 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.51 -37.2 57.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.386 0.674 . . . . 50.130000000000003 111.252 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HE2' ' A' ' 61' ' ' PHE . 81.8 p -82.01 -28.49 32.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.325 0.584 . . . . 54.329999999999998 110.277 -174.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.39 -31.47 54.21 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.636 1.174 . . . . 74.099999999999994 111.786 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.38 -55.54 32.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.832 1.253 . . . . 71.329999999999998 110.6 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.34 -32.24 71.08 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.676 -1.147 . . . . 74.540000000000006 112.727 -173.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.494 HG11 HG21 ' A' ' 118' ' ' VAL . 47.4 t -87.87 -53.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.059 0.544 . . . . 73.439999999999998 111.588 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -29.88 75.97 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.814 -0.63 . . . . 70.109999999999999 113.75 -168.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -72.97 -36.14 67.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.095 0.558 . . . . 62.509999999999998 110.552 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.7 m -62.04 -40.23 95.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.716 0.806 . . . . 62.310000000000002 111.257 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.86 -15.31 37.09 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.31 0.485 . . . . 71.200000000000003 112.31 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.12 25.04 75.74 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.891 -0.483 . . . . 71.310000000000002 111.891 -172.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.87 136.85 33.95 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.342 1.057 . . . . 63.200000000000003 109.486 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 113.32 2.6 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.953 0.783 . . . . 32.329999999999998 111.09 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -83.87 101.58 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 122.457 1.123 . . . . 64.349999999999994 109.047 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -112.9 158.36 20.29 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.519 -1.219 . . . . 74.019999999999996 111.343 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.61 177.75 1.49 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.347 -1.297 . . . . 65.299999999999997 110.397 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -59.29 -44.76 92.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.981 -0.554 . . . . 72.109999999999999 110.695 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt 60.77 173.63 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.106 0.962 . . . . 72.549999999999997 111.777 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.61 -27.33 25.35 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.419 2.079 . . . . 62.310000000000002 113.674 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.97 -47.33 83.63 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.077 0.951 . . . . 74.439999999999998 112.325 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.543 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 23.0 tp -71.67 -12.18 61.2 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 120.896 0.379 . . . . 73.430000000000007 111.215 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 t -79.06 -14.09 59.37 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.201 0.601 . . . . 72.549999999999997 110.818 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.13 -25.82 23.93 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.548 0.739 . . . . 62.350000000000001 112.362 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 1.3 pp0? -142.54 155.85 63.65 Favored Pre-proline 0 N--CA 1.495 1.802 0 CA-C-O 118.282 -0.866 . . . . 74.140000000000001 111.132 -173.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 30.9 Cg_exo -37.47 125.75 0.61 Allowed 'Trans proline' 0 C--N 1.397 3.1 0 C-N-CA 124.736 3.624 . . . . 70.150000000000006 115.867 -169.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 18.8 Cg_exo -64.61 133.3 36.28 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.089 2.526 . . . . 53.329999999999998 112.175 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.496 ' H ' HD21 ' A' ' 109' ' ' LEU . . . 157.09 177.81 30.56 Favored Glycine 0 C--O 1.245 0.812 0 N-CA-C 110.667 -0.973 . . . . 61.329999999999998 110.667 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.8 t -80.66 100.04 4.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.817 -0.438 . . . . 75.140000000000001 109.817 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 117' ' ' ILE . 41.8 pt -102.89 108.58 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.76 -0.83 . . . . 74.409999999999997 108.76 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.627 HG13 HG22 ' A' ' 79' ' ' VAL . 51.7 t -90.6 100.99 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.373 -1.343 . . . . 71.319999999999993 107.373 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.531 HG11 ' HB ' ' A' ' 74' ' ' VAL . 61.3 t -95.93 118.17 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.827 -0.805 . . . . 40.109999999999999 108.827 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.28 133.72 63.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.107 0.563 . . . . 65.329999999999998 109.619 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 77' ' ' THR . 11.8 t -98.72 156.17 16.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.505 0.722 . . . . 64.129999999999995 110.577 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.677 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.686 -1.063 . . . . 37.850000000000001 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 p . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 120.718 0.294 . . . . 73.219999999999999 110.762 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -90.7 132.78 35.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.132 0.573 . . . . 74.230000000000004 109.979 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 98.54 3.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.101 0.56 . . . . 75.219999999999999 111.128 -172.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -131.41 129.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.755 0.822 . . . . 73.540000000000006 110.335 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 p -175.47 103.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.307 1.043 . . . . 60.409999999999997 110.629 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -166.89 130.92 1.95 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.203 1.001 . . . . 63.140000000000001 109.925 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -132.35 77.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.082 -0.71 . . . . 64.030000000000001 109.082 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -85.42 104.58 15.35 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.087 -0.506 . . . . 42.049999999999997 110.14 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -146.29 145.21 30.28 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 74.030000000000001 109.562 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -149.97 168.82 22.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.769 0.428 . . . . 64.510000000000005 111.085 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.9 t -148.21 169.97 18.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.345 1.058 . . . . 64.439999999999998 109.775 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.08 167.09 22.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.314 1.045 . . . . 64.209999999999994 109.995 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.8 124.29 24.03 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.162 0.985 . . . . 64.0 109.996 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.39 123.65 11.44 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.486 2.791 . . . . 72.409999999999997 113.248 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.6 p -117.4 125.97 51.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.503 0.721 . . . . 53.240000000000002 110.98 -174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -136.98 123.19 20.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.849 0.86 . . . . 73.400000000000006 109.104 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t -155.31 127.91 7.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.47 0.708 . . . . 75.430000000000007 110.063 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.2 m -155.85 127.3 7.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.992 0.917 . . . . 44.340000000000003 109.569 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 m -90.19 156.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.503 0.721 . . . . 72.0 111.148 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.14 158.74 71.81 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 124.64 1.176 . . . . 63.350000000000001 110.201 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--N 1.382 2.308 0 C-N-CA 123.086 2.524 . . . . 73.030000000000001 112.875 172.426 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 61' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 109.497 -0.557 . . . . 73.129999999999995 109.497 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -96.94 91.51 5.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.676 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 56' ' ' LEU . 21.1 t -95.65 139.66 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.271 1.028 . . . . 53.009999999999998 109.283 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HG3' ' HB2' ' A' ' 65' ' ' ASP . 43.7 ttm105 -148.3 131.97 16.89 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 66' ' ' VAL . 47.8 t -114.83 135.11 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.721 0.808 . . . . 75.340000000000003 109.819 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -137.32 107.23 6.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.923 0.889 . . . . 73.409999999999997 109.772 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.42 123.16 32.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.106 -1.072 . . . . 74.519999999999996 108.106 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.627 HG21 HG11 ' A' ' 74' ' ' VAL . 18.5 tt -85.86 -38.44 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 118.227 0.467 . . . . 55.329999999999998 110.682 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.0 m -149.63 155.89 40.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.818 0.847 . . . . 63.140000000000001 109.744 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 122' ' ' GLY . . . 93.57 -39.02 3.01 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.515 0.509 . . . . 73.230000000000004 112.718 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t 37.13 80.49 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.449 1.9 . . . . 52.219999999999999 113.131 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.67 173.11 9.23 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.963 -1.017 . . . . 72.219999999999999 111.372 -170.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.59 -45.67 94.09 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.31 -1.314 . . . . 62.420000000000002 114.036 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 -28.01 67.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.352 0.871 . . . . 74.200000000000003 113.352 -169.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -60.33 2.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.669 0.388 . . . . 72.150000000000006 111.029 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.4 69.12 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.735 -0.666 . . . . 73.219999999999999 111.849 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -34.4 77.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.258 1.423 . . . . 74.349999999999994 110.477 -174.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.448 ' O ' HD13 ' A' ' 56' ' ' LEU . 77.0 p -62.25 -57.26 12.08 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 123.468 0.48 . . . . 51.32 110.317 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 64' ' ' THR . . . -71.92 -28.37 63.44 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.08 0.152 . . . . 70.439999999999998 111.337 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.7 -31.52 71.53 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.433 0.693 . . . . 74.540000000000006 111.153 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -80.73 -45.38 17.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.32 -0.4 . . . . 71.219999999999999 110.451 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 37' ' ' VAL . 10.9 mp -66.4 -31.58 72.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.635 -0.711 . . . . 72.150000000000006 112.189 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.57 -39.65 91.89 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.885 0.374 . . . . 75.219999999999999 111.05 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.71 -29.75 61.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.456 -0.793 . . . . 51.450000000000003 110.308 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -13.08 61.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.539 0.736 . . . . 60.0 111.396 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.79 31.36 7.82 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.532 0.52 . . . . 30.010000000000002 113.687 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.403 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 7.8 m-85 -79.72 155.7 27.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.601 -0.889 . . . . 75.409999999999997 108.601 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 35' ' ' ALA . 37.0 m -73.26 -59.92 2.48 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.724 0.41 . . . . 72.120000000000005 111.468 -163.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 99.5 t -114.41 141.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.692 -0.855 . . . . 74.030000000000001 108.692 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.529 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 14.6 p -145.61 109.87 4.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.96 0.904 . . . . 72.349999999999994 108.807 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.55 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.4 m-20 -103.86 144.47 31.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.786 -0.82 . . . . 75.049999999999997 108.786 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.493 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 61.9 t -133.59 114.83 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.361 -0.977 . . . . 71.439999999999998 108.361 173.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.25 159.38 27.69 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 121.521 -0.371 . . . . 53.329999999999998 113.033 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -113.27 113.97 26.05 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.029 -1.1 . . . . 63.229999999999997 108.029 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.59 144.51 20.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.887 -0.783 . . . . 60.140000000000001 108.887 -167.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.408 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 t -83.62 108.7 16.88 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 62.420000000000002 109.251 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.59 149.31 35.58 Favored Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.631 . . . . 62.020000000000003 110.281 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.18 -20.8 18.54 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.958 2.439 . . . . 55.329999999999998 113.253 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -80.82 -19.16 45.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.252 1.021 . . . . 50.229999999999997 112.12 -174.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 42' ' ' ILE . 90.6 t -56.5 133.18 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.114 0.884 . . . . 74.150000000000006 112.375 -167.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.39 -45.13 0.08 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.954 -1.476 . . . . 53.140000000000001 108.268 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.36 158.1 43.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.379 1.072 . . . . 60.009999999999998 109.339 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.527 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.7 t -62.66 111.95 2.3 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.358 0.599 . . . . 74.340000000000003 110.201 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.0 m -149.32 138.57 21.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.561 0.745 . . . . 64.420000000000002 110.485 -172.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 118' ' ' VAL . 18.3 t -94.66 114.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.687 1.195 . . . . 71.319999999999993 108.444 173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.476 ' HB3' HD21 ' A' ' 109' ' ' LEU . 28.7 m-85 -95.53 154.52 17.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.318 -0.993 . . . . 71.519999999999996 108.318 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -153.44 -179.88 8.17 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.546 0.688 . . . . 74.129999999999995 111.784 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.498 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 24.0 m -126.83 139.48 53.07 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 105.999 -1.852 . . . . 74.230000000000004 105.999 161.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.05 -10.21 59.24 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.962 0.727 . . . . 74.329999999999998 112.962 -170.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.31 130.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 63.210000000000001 112.843 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.24 21.05 11.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.72 1.208 . . . . 74.049999999999997 112.723 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.57 62.99 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 116.308 -0.405 . . . . 63.130000000000003 112.861 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 82' ' ' THR . 11.3 tp10 -69.53 -21.92 63.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 64.349999999999994 109.95 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -57.69 -29.28 64.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.405 1.082 . . . . 72.430000000000007 112.936 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -45.11 83.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.704 0.801 . . . . 53.240000000000002 112.023 -174.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.531 HG23 HG21 ' A' ' 116' ' ' VAL . 9.9 t -74.58 -30.99 61.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.23 -0.441 . . . . 55.299999999999997 110.759 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -69.23 -34.9 75.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.885 0.474 . . . . 63.130000000000003 111.407 174.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.79 -40.58 83.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.524 1.129 . . . . 71.400000000000006 109.57 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.09 60.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.757 -1.11 . . . . 42.140000000000001 110.681 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.01 -32.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.16 0.984 . . . . 62.140000000000001 111.827 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.43 93.53 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.957 -0.457 . . . . 74.540000000000006 111.957 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 -80.31 -25.99 39.05 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.0 0.52 . . . . 73.140000000000001 111.881 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -70.81 -43.12 69.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.951 0.5 . . . . 45.140000000000001 110.231 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 tp -86.22 -30.84 22.07 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.592 -0.731 . . . . 62.140000000000001 110.598 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.03 24.95 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.771 -0.649 . . . . 21.129999999999999 112.165 -174.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.94 167.65 9.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.994 0.917 . . . . 65.140000000000001 111.279 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.34 41.92 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.923 0.889 . . . . 75.099999999999994 111.071 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.05 119.58 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.013 0.435 . . . . 44.340000000000003 110.569 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -113.46 148.26 36.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.343 0.657 . . . . 74.540000000000006 110.997 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.64 -166.89 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.905 1.282 . . . . 63.340000000000003 111.911 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -77.04 28.55 0.14 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 124.508 1.123 . . . . 75.450000000000003 113.037 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pp -47.97 157.77 0.6 Allowed Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 125.458 1.503 . . . . 60.229999999999997 113.19 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.35 -24.29 0.97 Allowed 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 124.44 3.427 . . . . 74.209999999999994 117.847 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.68 -22.29 64.38 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.361 0.664 . . . . 74.230000000000004 112.413 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 80' ' ' TYR . 4.4 mm? -64.6 -8.91 15.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.6 0.76 . . . . 42.310000000000002 111.738 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 t -63.98 -42.01 97.36 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.281 1.032 . . . . 74.540000000000006 112.003 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.477 ' HB2' ' OE1' ' A' ' 112' ' ' GLN . 4.5 m-20 -80.77 -33.57 34.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.898 0.479 . . . . 55.329999999999998 111.562 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -90.71 157.49 43.84 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.704 0.802 . . . . 71.209999999999994 108.998 178.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.7 125.07 16.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.062 1.842 . . . . 72.519999999999996 110.783 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.22 118.96 5.9 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.146 2.564 . . . . 72.200000000000003 112.719 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.51 -158.7 31.76 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.859 -0.896 . . . . 75.129999999999995 110.859 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.531 HG21 HG23 ' A' ' 90' ' ' THR . 74.1 t -79.25 105.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.196 -0.668 . . . . 73.409999999999997 109.196 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' ' 117' ' ' ILE . 31.1 pt -116.68 107.75 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 79' ' ' VAL . 2.1 p -87.28 105.02 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.54 -0.911 . . . . 61.020000000000003 108.54 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 74' ' ' VAL . 94.7 t -91.51 117.48 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.75 -1.204 . . . . 71.299999999999997 107.75 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.24 127.44 65.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.527 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.2 p -104.89 102.9 12.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.778 -1.564 . . . . 63.100000000000001 106.778 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 119.308 -0.718 . . . . 70.519999999999996 112.639 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.241 0.655 0 N-CA-C 110.03 -0.359 . . . . 72.439999999999998 110.03 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -170.37 106.2 0.3 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.36 1.064 . . . . 75.400000000000006 108.209 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.12 131.54 5.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.358 0.663 . . . . 63.240000000000002 110.042 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -169.07 130.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.528 1.131 . . . . 61.210000000000001 109.339 175.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 p -172.2 128.11 0.57 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.296 1.038 . . . . 62.439999999999998 108.617 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.7 t -148.29 110.48 4.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 109.52 -0.548 . . . . 71.409999999999997 109.52 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -136.46 104.72 5.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.684 0.794 . . . . 55.219999999999999 109.406 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -135.1 114.99 12.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.493 1.117 . . . . 54.240000000000002 109.816 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 p -148.06 143.05 26.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.842 1.257 . . . . 70.409999999999997 109.001 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -152.77 137.87 17.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.605 1.162 . . . . 50.409999999999997 108.851 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.7 p -143.92 106.41 4.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.954 0.902 . . . . 61.200000000000003 110.307 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.49 144.4 18.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.099 0.959 . . . . 71.140000000000001 110.08 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.73 105.78 4.27 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 123.724 0.81 . . . . 63.009999999999998 109.563 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.06 113.69 2.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.081 2.521 . . . . 75.030000000000001 112.341 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -152.03 119.12 5.86 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.233 0.539 . . . . 62.409999999999997 110.283 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -153.84 139.91 18.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.722 1.209 . . . . 72.319999999999993 109.251 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -148.44 128.35 13.5 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.028 0.531 . . . . 74.140000000000001 110.412 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.3 m -150.31 89.18 1.56 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.212 1.005 . . . . 55.439999999999998 108.992 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.34 140.74 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.814 0.846 . . . . 71.329999999999998 110.26 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.31 115.68 64.62 Favored Pre-proline 0 N--CA 1.479 1.001 0 N-CA-C 108.753 -0.832 . . . . 73.239999999999995 108.753 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.375 1.945 0 C-N-CA 122.678 2.252 . . . . 72.349999999999994 111.279 174.137 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.773 0.321 . . . . 73.420000000000002 110.424 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.448 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.3 mp0 -82.35 101.1 10.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.044 0.937 . . . . 73.329999999999998 109.086 176.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.13 140.1 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.883 -0.784 . . . . 71.25 108.883 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -152.08 129.0 10.98 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.623 0.769 . . . . 64.230000000000004 109.473 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 118' ' ' VAL . 43.7 t -114.79 126.55 72.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.131 -1.063 . . . . 70.349999999999994 108.131 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.475 ' CE1' HG22 ' A' ' 119' ' ' VAL . 7.9 p90 -127.56 139.72 52.58 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.475 0.655 . . . . 72.200000000000003 110.005 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -84.24 146.78 27.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.708 -1.133 . . . . 75.239999999999995 108.303 166.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 121' ' ' THR . 10.2 tp -76.94 -23.23 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.005 0.431 . . . . 64.299999999999997 109.993 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.9 m -118.84 -57.37 2.04 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.737 0.815 . . . . 71.129999999999995 109.758 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 76.94 1.05 Allowed Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.802 -0.519 . . . . 63.210000000000001 111.802 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.2 m -145.13 -37.6 0.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.841 0.856 . . . . 65.530000000000001 110.074 178.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -73.96 109.9 7.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.997 0.519 . . . . 75.319999999999993 110.346 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.53 -24.07 59.34 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.395 -0.82 . . . . 55.109999999999999 112.522 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.31 67.6 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.07 0.548 . . . . 73.540000000000006 110.855 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.65 55.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.803 0.841 . . . . 63.25 110.598 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -27.38 66.14 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.616 -0.72 . . . . 65.040000000000006 111.609 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.7 -35.93 79.71 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.441 1.097 . . . . 72.439999999999998 110.825 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -62.35 -53.2 58.5 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 122.426 0.29 . . . . 70.349999999999994 111.229 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -68.9 -30.13 68.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.379 0.272 . . . . 70.310000000000002 111.255 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.8 -39.41 94.16 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 70.420000000000002 109.95 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -74.78 -33.52 62.27 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 110.355 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.377 0.671 . . . . 75.239999999999995 111.048 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -63.04 -46.54 87.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 107.948 -1.13 . . . . 75.019999999999996 107.948 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.99 -29.23 69.02 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.263 -0.88 . . . . 60.200000000000003 111.122 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.52 -17.02 58.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.484 0.714 . . . . 40.43 111.601 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.9 37.23 7.98 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 116.492 -0.322 . . . . 44.210000000000001 113.878 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.26 159.47 28.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.063 0.545 . . . . 74.049999999999997 110.164 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.4 m -60.9 -68.91 0.26 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.811 0.694 . . . . 62.140000000000001 111.176 -167.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 89.2 t -116.48 138.16 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.806 -1.183 . . . . 71.519999999999996 107.806 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.6 p -136.4 96.28 3.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.277 -1.379 . . . . 63.219999999999999 107.277 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -102.25 145.95 28.71 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.625 -0.88 . . . . 74.349999999999994 108.625 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.09 135.1 55.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.061 0.944 . . . . 72.239999999999995 108.836 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.11 -164.27 27.37 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 121.249 -0.501 . . . . 52.329999999999998 112.3 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -146.28 118.5 8.35 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.268 -1.012 . . . . 74.439999999999998 108.268 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.53 143.03 47.19 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 108.656 -0.868 . . . . 70.439999999999998 108.656 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -86.57 97.16 10.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.117 -0.697 . . . . 45.350000000000001 109.117 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.87 110.87 62.5 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.518 1.127 . . . . 73.109999999999999 108.454 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.1 -12.96 33.23 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.247 1.965 . . . . 53.140000000000001 113.236 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -77.19 -21.43 53.97 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.661 0.385 . . . . 74.200000000000003 111.671 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.22 142.12 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.557 -0.535 . . . . 62.219999999999999 109.557 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.93 22.44 1.58 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.343 1.057 . . . . 61.229999999999997 109.983 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.25 149.25 33.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.581 0.753 . . . . 72.040000000000006 109.582 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.3 t -76.88 103.55 6.89 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.873 0.844 . . . . 73.439999999999998 109.834 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.2 m -151.47 140.11 20.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.338 -0.847 . . . . 74.209999999999994 110.113 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.677 HG22 HG13 ' A' ' 118' ' ' VAL . 41.7 t -96.46 114.25 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.848 0.859 . . . . 64.140000000000001 109.154 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.83 132.71 45.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.295 1.038 . . . . 74.010000000000005 108.493 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.605 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -137.31 165.82 25.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.991 0.516 . . . . 72.040000000000006 111.904 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.0 t -106.99 148.86 28.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.607 -1.257 . . . . 53.539999999999999 107.607 161.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.538 ' HG2' ' HD2' ' A' ' 88' ' ' ARG . 46.0 mt-10 -97.16 9.04 43.26 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.915 0.486 . . . . 65.120000000000005 111.787 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.31 143.12 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.301 -0.629 . . . . 53.420000000000002 109.301 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 62.11 -83.09 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.721 1.208 . . . . 72.030000000000001 111.969 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.31 37.72 0.21 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.991 -0.443 . . . . 63.140000000000001 111.991 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.48 -35.9 24.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.542 0.337 . . . . 62.130000000000003 111.462 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 83' ' ' GLU . 61.4 ttt180 -61.25 -26.93 68.08 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.948 -0.47 . . . . 75.5 111.294 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.47 99.85 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.628 0.771 . . . . 70.340000000000003 111.956 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -81.49 -24.26 36.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.114 0.483 . . . . 51.200000000000003 110.55 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.7 59.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.929 0.892 . . . . 71.099999999999994 111.612 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.55 -45.52 75.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.417 -1.265 . . . . 75.200000000000003 109.663 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.29 -56.9 14.73 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.648 -1.16 . . . . 53.329999999999998 111.114 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 118' ' ' VAL . 86.6 t -71.27 -37.32 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.726 -0.67 . . . . 41.520000000000003 111.823 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.81 -35.44 52.96 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.566 0.541 . . . . 62.340000000000003 112.459 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -86.17 -32.8 21.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.673 -0.763 . . . . 63.420000000000002 110.308 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.9 m -65.84 -40.98 92.28 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.353 0.597 . . . . 45.409999999999997 110.399 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.53 -28.44 28.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.656 -1.156 . . . . 72.209999999999994 109.934 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.82 75.69 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.764 -0.653 . . . . 63.43 112.606 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.91 -172.59 3.75 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.83 0.852 . . . . 53.039999999999999 110.617 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 161.34 26.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.863 0.465 . . . . 31.420000000000002 109.965 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.605 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 10.0 m -129.96 124.63 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.853 0.861 . . . . 53.140000000000001 109.016 175.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -129.08 158.57 38.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.008 0.923 . . . . 60.329999999999998 110.905 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.8 -163.64 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.027 -1.442 . . . . 74.239999999999995 111.023 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.557 ' HA ' HD12 ' A' ' 109' ' ' LEU . 14.4 ttp180 -75.4 30.77 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.136 1.374 . . . . 62.329999999999998 112.955 -172.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.2 mt -46.0 152.41 0.78 Allowed Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 125.549 1.539 . . . . 71.129999999999995 113.654 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.2 -12.72 0.5 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 124.759 3.639 . . . . 60.0 116.796 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -60.31 -33.69 72.73 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.265 0.555 . . . . 71.230000000000004 110.287 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.595 HD22 HD13 ' A' ' 117' ' ' ILE . 31.5 mt -76.71 5.6 7.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.298 1.039 . . . . 73.299999999999997 113.299 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.4 p -82.13 -41.36 20.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.735 -0.839 . . . . 73.239999999999995 108.735 170.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.7 -34.86 30.39 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.743 -1.117 . . . . 61.219999999999999 110.243 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -86.16 146.99 43.94 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.355 -0.839 . . . . 73.540000000000006 109.236 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 37.7 Cg_endo -64.32 124.04 12.76 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.338 2.025 . . . . 74.409999999999997 111.165 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 32.0 Cg_exo -60.26 133.79 51.72 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.726 2.951 . . . . 73.319999999999993 113.76 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.11 -129.14 2.17 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.204 -1.158 . . . . 42.450000000000003 110.204 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.48 105.12 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.325 -0.991 . . . . 72.450000000000003 108.325 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.595 HD13 HD22 ' A' ' 109' ' ' LEU . 2.3 mp -105.59 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 N-CA-C 108.028 -1.101 . . . . 41.200000000000003 108.028 -176.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.677 HG13 HG22 ' A' ' 79' ' ' VAL . 58.8 t -88.15 106.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.59 -1.263 . . . . 71.310000000000002 107.59 174.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 40' ' ' TYR . 19.2 t -93.13 130.56 42.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.74 -0.837 . . . . 71.120000000000005 108.74 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.58 129.21 74.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.65 0.78 . . . . 55.100000000000001 109.043 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.506 ' H ' ' HB ' ' A' ' 77' ' ' THR . 13.2 t -77.29 144.04 38.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.074 -1.084 . . . . 75.319999999999993 108.074 171.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 N-CA-C 110.488 -1.045 . . . . 65.219999999999999 110.488 -167.087 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.03 -0.73 . . . . 64.099999999999994 109.03 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 t -76.8 173.8 11.26 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.599 0.76 . . . . 64.120000000000005 111.489 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.69 157.31 44.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.704 0.802 . . . . 55.100000000000001 110.28 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 pt -102.84 -176.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.518 0.727 . . . . 72.530000000000001 110.785 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -148.68 173.67 12.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.29 0.636 . . . . 54.399999999999999 110.223 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -143.35 146.67 33.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.991 0.516 . . . . 73.109999999999999 111.373 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -121.4 135.22 55.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.841 0.856 . . . . 60.130000000000003 109.499 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.0 m -145.8 128.65 16.36 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.296 1.038 . . . . 71.349999999999994 108.789 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 p -110.24 162.89 14.17 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.65 0.78 . . . . 73.030000000000001 111.586 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -118.79 136.47 53.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.91 0.884 . . . . 72.049999999999997 109.688 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.6 m -78.29 157.68 29.12 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.778 0.831 . . . . 64.230000000000004 110.359 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.81 169.76 16.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 70.319999999999993 109.472 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.61 42.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.399 0.68 . . . . 63.219999999999999 111.095 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.32 176.87 9.43 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.402 2.068 . . . . 63.039999999999999 111.794 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 p -112.92 -175.89 2.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.331 0.652 . . . . 74.219999999999999 110.474 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.9 t -150.2 136.1 18.5 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.519 -0.919 . . . . 72.099999999999994 108.519 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -114.44 138.43 50.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.003 0.521 . . . . 72.140000000000001 109.621 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.7 m -148.15 121.7 9.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.435 0.694 . . . . 72.349999999999994 109.506 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.06 144.58 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.488 0.715 . . . . 72.439999999999998 110.149 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 10.8 mptt -105.98 157.24 35.21 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 124.084 0.954 . . . . 75.430000000000007 110.102 -176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo . . . . . 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 72.010000000000005 113.304 171.415 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 112.196 0.443 . . . . 70.040000000000006 112.196 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 27.3 mm-40 -77.07 114.49 15.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.104 0.962 . . . . 74.109999999999999 109.451 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 43.1 t -125.76 137.32 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 122.853 0.461 . . . . 73.040000000000006 110.542 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -151.27 148.99 28.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.005 0.922 . . . . 74.140000000000001 110.676 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.51 113.57 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.263 1.025 . . . . 75.209999999999994 109.505 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -103.33 107.85 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.78 0.432 . . . . 75.340000000000003 110.228 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 3.4 t-20 -94.42 119.44 33.16 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.734 -0.839 . . . . 73.140000000000001 108.734 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -102.43 -42.9 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 122.073 -0.392 . . . . 73.340000000000003 110.365 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 p -136.88 158.55 44.21 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.84 -0.8 . . . . 73.450000000000003 108.84 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.75 59.05 4.21 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.591 -1.003 . . . . 73.129999999999995 110.591 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 t -66.22 100.81 0.65 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.602 0.761 . . . . 62.009999999999998 111.491 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -147.83 155.44 41.65 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.249 0.62 . . . . 53.219999999999999 110.133 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.62 -2.53 36.36 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 118.905 -0.942 . . . . 65.129999999999995 114.001 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.98 69.46 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.095 0.958 . . . . 70.310000000000002 111.412 171.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -42.56 97.28 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 124.154 0.909 . . . . 51.43 110.988 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.22 -35.53 71.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.67 -0.696 . . . . 71.5 111.089 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.76 -31.24 71.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.901 1.28 . . . . 64.450000000000003 111.63 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.525 ' HB ' HG13 ' A' ' 94' ' ' VAL . 48.0 p -76.97 -22.18 53.59 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.7 0.4 . . . . 72.329999999999998 111.59 176.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.19 -54.73 5.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.462 0.705 . . . . 74.450000000000003 111.205 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -54.96 -31.16 60.33 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.16 0.984 . . . . 74.549999999999997 113.147 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -59.88 -39.47 85.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.321 0.648 . . . . 74.430000000000007 111.789 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.0 -38.42 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 118.917 -0.563 . . . . 75.510000000000005 111.893 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -30.93 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.825 0.738 . . . . 73.349999999999994 110.596 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.19 -27.97 66.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.479 0.712 . . . . 71.150000000000006 110.808 173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.71 -21.8 37.78 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.63 0.772 . . . . 51.119999999999997 111.989 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.06 25.99 4.85 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 113.968 0.347 . . . . 65.400000000000006 113.968 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.43 158.73 27.27 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.34 0.656 . . . . 64.120000000000005 110.443 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -65.43 -70.1 0.26 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.969 0.793 . . . . 71.340000000000003 110.854 -165.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.02 145.15 35.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.69 -0.856 . . . . 64.420000000000002 108.69 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 37' ' ' VAL . 41.4 p -137.14 100.61 4.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.527 -1.286 . . . . 71.239999999999995 107.527 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 19.0 t70 -104.9 162.5 13.27 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.897 0.879 . . . . 73.319999999999993 110.183 -172.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 141.44 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.841 0.856 . . . . 73.030000000000001 109.049 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.44 129.02 2.41 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.947 -0.461 . . . . 65.140000000000001 111.947 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 16.8 p-10 -88.66 97.39 11.09 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.447 0.699 . . . . 73.530000000000001 109.823 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.4 135.55 13.03 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.166 -0.333 . . . . 73.540000000000006 110.155 -169.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -81.16 99.41 8.53 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.433 -0.58 . . . . 70.129999999999995 109.433 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.31 151.75 89.98 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.407 -0.59 . . . . 73.329999999999998 109.407 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.04 -7.61 18.32 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.113 1.875 . . . . 54.439999999999998 112.371 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -108.93 -23.05 11.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.342 0.657 . . . . 73.400000000000006 112.43 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.06 130.13 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.36 0.6 . . . . 65.549999999999997 111.252 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.27 -7.67 4.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.431 1.092 . . . . 75.439999999999998 111.215 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.12 159.0 5.77 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.463 1.105 . . . . 55.140000000000001 109.345 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.4 t -66.75 107.24 2.09 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.694 0.759 . . . . 63.32 109.996 177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 m -144.91 153.42 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.531 -0.759 . . . . 73.5 109.293 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.685 HG21 ' HA3' ' A' ' 95' ' ' GLY . 4.3 t -112.6 114.28 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.916 -1.142 . . . . 64.129999999999995 107.916 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.582 ' HB2' HG13 ' A' ' 117' ' ' ILE . 52.4 m-85 -105.1 119.38 38.89 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.285 0.493 . . . . 73.120000000000005 110.585 -174.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HD2' ' HB3' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -112.01 140.99 46.22 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.85 0.719 . . . . 74.310000000000002 110.462 175.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.1 t -113.78 -40.05 3.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.946 0.898 . . . . 62.030000000000001 111.654 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -89.81 37.38 0.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.858 0.863 . . . . 73.209999999999994 111.856 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -45.87 163.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.518 1.927 . . . . 74.129999999999995 114.746 -174.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 86.69 -55.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.727 2.011 . . . . 75.329999999999998 108.359 -163.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.31 -50.73 1.99 Allowed Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.205 -0.452 . . . . 75.019999999999996 112.574 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.04 -19.94 50.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.653 0.263 . . . . 72.409999999999997 111.299 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -56.81 -27.97 60.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.75 -0.659 . . . . 65.530000000000001 110.972 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.8 -46.64 57.57 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.716 0.806 . . . . 72.430000000000007 112.214 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 94' ' ' VAL . 6.2 t -79.9 -33.24 40.03 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 122.672 0.389 . . . . 75.140000000000001 110.736 -171.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.59 -48.22 75.76 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 123.799 0.687 . . . . 64.310000000000002 110.353 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.534 ' HA ' HG11 ' A' ' 102' ' ' VAL . 30.5 t70 -57.52 -40.24 78.34 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.272 0.983 . . . . 73.099999999999994 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.54 -46.1 87.51 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.961 0.788 . . . . 54.200000000000003 112.149 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 52' ' ' THR . 61.4 t -65.44 -52.82 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.328 0.651 . . . . 74.310000000000002 110.605 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.685 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -64.6 -26.84 71.18 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.344 -0.844 . . . . 62.399999999999999 113.281 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 2.6 tmt_? -65.07 -39.29 93.02 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.507 0.723 . . . . 75.450000000000003 109.553 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -66.46 -52.65 43.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.922 -1.035 . . . . 73.310000000000002 111.181 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 118' ' ' VAL . 4.0 pp -82.45 -13.71 56.29 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.792 -0.64 . . . . 73.340000000000003 112.402 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.66 72.81 1.2 Allowed Glycine 0 C--N 1.349 1.255 0 O-C-N 123.574 0.546 . . . . 45.25 113.136 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.06 155.11 44.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.703 0.801 . . . . 75.340000000000003 110.001 172.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.97 142.53 33.36 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.492 -0.776 . . . . 74.299999999999997 110.289 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.534 HG11 ' HA ' ' A' ' 92' ' ' ASP . 34.0 m -95.19 148.25 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.417 0.687 . . . . 70.140000000000001 110.748 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -157.5 156.69 32.49 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 123.811 0.844 . . . . 70.209999999999994 110.81 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.63 161.51 23.12 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.402 1.081 . . . . 74.049999999999997 110.746 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.424 ' HG3' ' H ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -69.66 29.73 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.404 2.001 . . . . 71.239999999999995 116.404 -172.643 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.406 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.0 mm? -54.61 -53.62 58.12 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-N 119.562 1.074 . . . . 74.430000000000007 112.521 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 6.0 Cg_exo -80.26 -13.93 12.2 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 122.378 2.052 . . . . 75.340000000000003 112.953 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HG2' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -58.62 -41.61 86.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.498 0.719 . . . . 72.319999999999993 110.153 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.4 tp -64.29 -12.75 44.72 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.56 0.744 . . . . 70.030000000000001 112.566 -172.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -63.64 -47.16 82.47 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.871 0.869 . . . . 74.319999999999993 111.161 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.2 -32.49 7.48 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.353 1.061 . . . . 75.129999999999995 110.944 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.1 71.92 1.04 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 126.782 2.033 . . . . 54.520000000000003 112.708 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HD2' ' HG2' ' A' ' 108' ' ' GLU . 1.4 Cg_endo -88.71 140.74 4.34 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.1 2.533 . . . . 74.030000000000001 111.106 162.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.0 129.04 13.72 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.66 2.24 . . . . 74.109999999999999 114.468 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.23 -156.15 32.02 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.022 -0.536 . . . . 41.25 113.988 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 76.8 t -58.1 111.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 124.278 1.031 . . . . 74.200000000000003 110.138 177.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 80' ' ' TYR . 39.7 pt -117.85 104.3 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.47 -1.307 . . . . 64.519999999999996 107.47 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 79' ' ' VAL . 2.3 p -101.84 111.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.886 -0.783 . . . . 65.129999999999995 108.886 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -93.17 123.53 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.941 -1.027 . . . . 71.420000000000002 109.473 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.05 127.52 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.593 0.757 . . . . 72.540000000000006 110.108 -172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.574 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.8 p -123.4 119.61 30.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.512 -1.292 . . . . 54.109999999999999 107.512 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.594 0 CA-C-O 119.207 -0.774 . . . . 63.32 112.628 -174.613 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 109.931 -0.396 . . . . 75.450000000000003 109.931 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.3 p -153.49 124.65 7.45 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.939 0.896 . . . . 73.239999999999995 108.684 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.41 123.93 7.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.812 0.845 . . . . 64.530000000000001 109.517 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 tp -157.9 136.26 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.817 0.847 . . . . 73.400000000000006 109.345 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 p -150.77 88.78 1.5 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.86 0.864 . . . . 73.140000000000001 109.318 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.5 p -99.17 131.0 45.51 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.176 -0.675 . . . . 51.329999999999998 109.176 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -131.34 155.37 47.35 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.2 0.524 . . . . 73.409999999999997 111.251 -174.462 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -153.98 159.35 41.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.135 1.374 . . . . 75.530000000000001 108.352 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -139.59 42.23 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 122.043 0.925 . . . . 33.43 109.911 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 m -78.66 100.48 7.04 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.1 -0.955 . . . . 74.340000000000003 109.0 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 t -132.79 31.3 3.95 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.829 0.823 . . . . 72.430000000000007 110.128 -174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.23 134.65 37.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.212 -0.904 . . . . 70.430000000000007 110.898 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.84 111.9 4.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.509 0.724 . . . . 62.350000000000001 109.556 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.16 158.18 52.55 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.645 2.23 . . . . 74.340000000000003 111.275 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -159.5 167.26 29.06 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.16 0.584 . . . . 63.520000000000003 110.65 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -143.84 159.5 42.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.689 0.795 . . . . 74.439999999999998 110.291 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 t -127.63 140.21 52.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.555 0.742 . . . . 60.119999999999997 109.781 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 p -169.29 137.0 1.83 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.824 0.849 . . . . 43.420000000000002 109.877 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.11 125.9 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.353 0.661 . . . . 65.109999999999999 110.52 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.37 110.48 58.06 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.376 -0.972 . . . . 73.239999999999995 108.376 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 C--N 1.377 2.061 0 C-N-CA 123.256 2.637 . . . . 54.439999999999998 113.292 -174.964 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.845 0.355 . . . . 45.119999999999997 110.838 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.04 112.71 24.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.906 0.882 . . . . 75.109999999999999 108.944 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 64' ' ' THR . 99.4 t -116.42 138.95 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.68 0.792 . . . . 71.329999999999998 109.461 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -132.15 118.12 19.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.614 -0.513 . . . . 63.100000000000001 109.614 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.12 107.19 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.342 -0.614 . . . . 72.540000000000006 109.342 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 33.6 p90 -118.1 152.26 35.93 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 109.102 -0.703 . . . . 74.430000000000007 109.102 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -93.72 134.44 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.033 -0.728 . . . . 64.310000000000002 109.033 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.14 -39.71 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.812 -0.44 . . . . 74.310000000000002 109.812 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 p -141.73 -61.32 0.46 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.821 0.448 . . . . 64.409999999999997 111.208 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.65 100.69 1.72 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.703 -0.498 . . . . 44.399999999999999 112.064 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -88.17 41.45 1.0 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.155 0.982 . . . . 52.109999999999999 112.858 -168.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.16 137.34 56.2 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.961 0.505 . . . . 72.340000000000003 110.521 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -7.69 58.04 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.529 0.518 . . . . 70.510000000000005 113.643 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.32 64.68 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.267 1.027 . . . . 61.030000000000001 110.954 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.08 -56.96 14.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.922 -1.035 . . . . 51.350000000000001 110.59 171.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.99 67.65 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.518 -0.765 . . . . 74.400000000000006 112.568 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -29.92 68.08 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.039 0.935 . . . . 75.129999999999995 110.96 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 98' ' ' LEU . 64.4 p -70.13 -36.86 75.1 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 110.085 -0.339 . . . . 63.219999999999999 110.085 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB1' ' OG1' ' A' ' 64' ' ' THR . . . -67.3 -28.5 68.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.602 0.761 . . . . 72.230000000000004 111.562 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.41 -24.47 62.93 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.015 0.926 . . . . 72.200000000000003 110.711 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -70.51 -42.0 71.88 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.906 -0.405 . . . . 72.239999999999995 109.906 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.8 mp -69.39 -29.6 67.4 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.806 0.669 . . . . 73.150000000000006 112.806 -174.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.46 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.38 -27.47 67.13 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.897 0.38 . . . . 61.530000000000001 110.793 175.341 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.03 27.77 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.028 0.931 . . . . 62.439999999999998 111.746 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -89.39 -22.8 22.39 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.304 0.642 . . . . 72.019999999999996 112.484 -174.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.47 46.83 0.39 Allowed Glycine 0 C--N 1.352 1.439 0 CA-C-N 117.873 0.306 . . . . 54.509999999999998 113.308 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -62.41 158.22 18.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.103 0.961 . . . . 73.5 111.818 176.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.7 m -92.54 -60.72 1.76 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.214 -1.032 . . . . 73.230000000000004 108.214 161.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -134.56 140.66 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.611 -1.255 . . . . 71.200000000000003 107.611 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t -130.56 127.12 38.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.372 -0.973 . . . . 65.120000000000005 108.372 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -122.54 144.55 49.01 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.014 -1.106 . . . . 64.120000000000005 108.014 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 m -139.85 143.61 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 122.848 0.459 . . . . 63.539999999999999 110.41 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.1 -138.13 4.63 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.016 -0.538 . . . . 63.25 112.16 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -157.96 123.05 4.39 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.265 0.626 . . . . 72.310000000000002 110.546 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 10.0 mp -129.12 156.39 43.96 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.188 0.995 . . . . 45.340000000000003 108.882 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 p -106.13 100.88 10.4 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.708 0.803 . . . . 50.130000000000003 110.055 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -119.16 119.54 31.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 123.818 0.847 . . . . 34.520000000000003 109.134 167.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.16 0.33 9.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.757 2.305 . . . . 72.209999999999994 112.713 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.0 -26.77 54.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.047 0.939 . . . . 73.510000000000005 111.104 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 t -125.56 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.755 -0.832 . . . . 75.239999999999995 108.755 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.74 -54.33 2.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.962 0.905 . . . . 35.100000000000001 110.488 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.64 160.33 25.08 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.024 0.93 . . . . 62.43 110.436 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 t -64.05 104.67 0.75 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.979 0.895 . . . . 61.32 108.887 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.0 m -136.1 129.84 32.46 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.385 -0.825 . . . . 70.129999999999995 110.564 -171.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.73 HG22 HG13 ' A' ' 118' ' ' VAL . 73.5 t -95.18 113.65 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.049 -1.093 . . . . 60.399999999999999 108.049 175.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.466 ' CD2' HG12 ' A' ' 117' ' ' ILE . 10.2 t80 -96.98 136.38 37.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.057 -0.72 . . . . 73.439999999999998 109.057 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.475 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 25.1 p90 -151.73 -179.49 7.48 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.71 1.256 . . . . 73.0 108.972 172.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 4.3 m -131.7 169.22 16.49 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 106.043 -1.836 . . . . 55.32 106.043 164.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.69 21.25 2.25 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.134 -0.979 . . . . 73.120000000000005 111.826 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.45 99.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.259 1.024 . . . . 63.539999999999999 109.788 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 64.11 -75.99 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 125.56 1.544 . . . . 74.340000000000003 111.88 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.57 39.07 0.51 Allowed Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.013 0.365 . . . . 51.32 114.013 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 82' ' ' THR . 55.4 mt-10 -69.97 -36.45 75.24 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.0 0.429 . . . . 54.219999999999999 110.566 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -62.02 -37.75 86.08 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.781 -1.1 . . . . 64.150000000000006 112.54 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.77 -25.49 49.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.986 0.514 . . . . 44.329999999999998 111.492 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.5 m -78.75 -36.69 42.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.911 0.885 . . . . 74.310000000000002 109.677 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -24.38 40.45 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.928 -1.033 . . . . 65.150000000000006 111.554 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.09 -39.71 90.96 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.11 0.964 . . . . 53.210000000000001 109.977 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -23.98 66.94 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.139 -0.937 . . . . 74.129999999999995 111.996 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.675 HG11 HG21 ' A' ' 118' ' ' VAL . 58.1 t -84.34 -61.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 122.872 0.469 . . . . 74.109999999999999 111.355 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.415 ' CA ' HG21 ' A' ' 79' ' ' VAL . . . -66.73 -27.73 73.42 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.581 0.55 . . . . 53.140000000000001 114.293 -168.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -76.11 -23.46 54.9 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.002 0.521 . . . . 74.319999999999993 110.265 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 85.3 m -84.49 -38.69 19.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.621 0.769 . . . . 73.310000000000002 111.084 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.655 HD21 HG22 ' A' ' 120' ' ' VAL . 46.0 tp -81.37 -31.88 33.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.782 0.833 . . . . 63.340000000000003 111.553 -172.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.67 50.57 5.57 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 111.002 -0.839 . . . . 64.200000000000003 111.002 -170.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.59 143.74 51.12 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.53 0.732 . . . . 74.310000000000002 110.606 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.48 114.48 3.92 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.962 0.788 . . . . 62.229999999999997 110.018 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.475 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 16.1 m -88.13 101.75 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.356 0.598 . . . . 71.420000000000002 110.114 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.59 157.24 20.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.518 1.151 . . . . 73.299999999999997 111.957 -175.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 8.0 tp -93.2 -166.59 1.55 Allowed 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 112.934 -1.939 . . . . 70.329999999999998 108.367 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.503 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 48.7 ttp180 -81.43 27.69 0.42 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.588 0.755 . . . . 74.200000000000003 112.542 -175.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.8 mm? -70.87 -66.69 0.73 Allowed Pre-proline 0 CA--C 1.558 1.27 0 CA-C-O 118.045 -0.979 . . . . 71.019999999999996 111.053 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 4.5 Cg_exo -83.85 -23.57 3.12 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 121.878 1.719 . . . . 74.340000000000003 112.988 -173.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.35 -9.96 59.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.949 -0.548 . . . . 71.319999999999993 111.587 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -20.92 66.55 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.849 0.46 . . . . 71.140000000000001 110.526 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -55.66 -45.56 77.66 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.442 0.697 . . . . 63.340000000000003 110.831 171.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -86.13 -32.44 21.31 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.401 0.68 . . . . 62.140000000000001 111.221 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.62 79.15 0.36 Allowed Pre-proline 0 CA--C 1.563 1.446 0 C-N-CA 125.734 1.614 . . . . 63.439999999999998 111.033 -169.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 3.6 Cg_exo -84.56 125.64 3.38 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.061 2.508 . . . . 72.109999999999999 111.743 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 3.6 Cg_exo -79.12 118.69 4.08 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.35 2.033 . . . . 75.439999999999998 110.906 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.07 166.19 39.43 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 112.014 -0.434 . . . . 32.210000000000001 112.014 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 80' ' ' TYR . 75.9 t -66.94 126.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.023 0.929 . . . . 73.409999999999997 111.481 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.466 HG12 ' CD2' ' A' ' 80' ' ' TYR . 9.4 pt -121.85 111.95 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.162 -1.051 . . . . 62.520000000000003 108.162 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.73 HG13 HG22 ' A' ' 79' ' ' VAL . 61.3 t -94.01 108.49 20.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.845 -0.798 . . . . 75.230000000000004 108.845 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.47 120.95 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.409 -0.814 . . . . 72.239999999999995 109.789 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.655 HG22 HD21 ' A' ' 98' ' ' LEU . 44.7 t -110.28 129.59 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 122.681 0.392 . . . . 73.109999999999999 110.763 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 t -99.87 164.56 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.048 0.451 . . . . 73.400000000000006 110.745 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.806 0 CA-C-O 118.708 -1.051 . . . . 74.219999999999999 111.126 170.267 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 CA-C-O 119.508 -0.607 . . . . 74.549999999999997 112.018 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -64.4 126.35 27.54 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.998 0.919 . . . . 42.329999999999998 111.456 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -120.33 135.94 24.84 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.667 0.787 . . . . 75.140000000000001 109.188 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.25 127.18 20.36 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.007 2.471 . . . . 52.140000000000001 111.808 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -91.75 154.77 18.73 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.958 0.903 . . . . 75.049999999999997 109.49 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.9 m -56.08 132.38 50.06 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.187 0.995 . . . . 73.230000000000004 111.117 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -54.02 -79.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 O-C-N 124.194 0.934 . . . . 71.129999999999995 112.009 -170.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -134.69 -74.69 0.47 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.214 -0.662 . . . . 62.509999999999998 109.214 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -177.23 132.21 0.17 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.215 1.406 . . . . 74.340000000000003 108.196 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.0 m -87.66 134.87 33.57 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.086 0.555 . . . . 74.099999999999994 110.15 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -93.53 178.07 5.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.42 0.688 . . . . 53.119999999999997 110.108 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.31 156.5 42.97 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.749 0.82 . . . . 74.209999999999994 109.666 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -128.52 170.56 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.464 0.706 . . . . 44.409999999999997 110.41 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 t -164.63 171.15 14.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.211 1.004 . . . . 73.140000000000001 109.438 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -135.78 163.54 29.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.026 0.93 . . . . 63.409999999999997 109.18 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.7 mtt -127.54 131.62 50.03 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.019 0.928 . . . . 51.439999999999998 108.698 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.5 p -111.9 141.49 45.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.411 0.684 . . . . 41.409999999999997 110.142 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.9 p -127.29 158.74 36.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.806 0.843 . . . . 71.340000000000003 110.108 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 t -143.4 162.27 36.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.628 0.771 . . . . 71.230000000000004 109.311 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.9 m -149.09 137.72 21.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.306 0.643 . . . . 74.109999999999999 109.942 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.51 165.87 12.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.55 0.74 . . . . 55.0 109.861 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.64 136.63 12.48 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.179 0.592 . . . . 73.549999999999997 109.884 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.53 139.26 37.17 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.075 2.516 . . . . 73.200000000000003 112.867 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 p -102.18 128.14 48.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.994 0.918 . . . . 62.310000000000002 109.899 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 m -87.88 121.98 30.96 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.569 0.748 . . . . 70.030000000000001 109.582 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 m -136.23 124.43 23.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.081 0.952 . . . . 55.409999999999997 109.066 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.2 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.044 0.938 . . . . 34.039999999999999 109.755 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.42 140.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.693 0.797 . . . . 55.020000000000003 109.525 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.98 136.88 19.65 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.096 0.959 . . . . 61.439999999999998 109.448 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.26 149.33 45.98 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.22 2.613 . . . . 60.25 113.841 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.93 161.55 18.98 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.995 0.918 . . . . 32.25 111.112 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.05 121.64 33.53 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 123.629 0.772 . . . . 71.310000000000002 110.312 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.14 136.14 46.55 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.209 2.606 . . . . 74.239999999999995 111.554 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -82.5 -86.19 0.1 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.103 0.561 . . . . 75.140000000000001 111.143 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.23 132.21 27.77 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.069 0.548 . . . . 71.319999999999993 109.88 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.18 149.34 26.01 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.32 0.581 . . . . 64.239999999999995 110.799 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG21 HD21 ' A' ' 56' ' ' LEU . 48.1 t -114.9 146.57 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.312 1.045 . . . . 71.230000000000004 108.84 172.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.0 ptp180 -145.18 117.02 8.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.225 0.536 . . . . 53.009999999999998 111.571 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.52 111.9 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.311 0.644 . . . . 62.520000000000003 109.774 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 33.7 m-85 -101.08 118.76 37.63 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.187 0.595 . . . . 73.540000000000006 109.856 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 120' ' ' VAL . 4.6 t-20 -95.9 125.36 40.4 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.345 -1.354 . . . . 71.040000000000006 107.345 169.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.769 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.6 tt -80.39 -34.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 111.931 0.345 . . . . 71.530000000000001 111.931 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -111.43 -20.52 12.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.689 0.396 . . . . 75.230000000000004 111.511 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.9 114.92 0.62 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.808 -0.517 . . . . 74.209999999999994 111.808 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.441 HG22 HD21 ' A' ' 41' ' ' ASN . 13.2 t -145.15 -155.67 0.63 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.059 -0.719 . . . . 64.239999999999995 109.059 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.98 154.78 25.52 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.587 1.155 . . . . 72.310000000000002 112.477 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.33 -1.8 16.56 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 115.455 -0.793 . . . . 74.25 114.691 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.69 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.028 0.931 . . . . 74.129999999999995 111.58 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.26 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.354 -0.839 . . . . 63.100000000000001 110.863 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB2' HG21 ' A' ' 66' ' ' VAL . . . -71.3 -20.47 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.465 0.706 . . . . 75.030000000000001 111.753 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -28.97 69.07 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.603 0.761 . . . . 74.299999999999997 111.354 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.492 ' HB ' HG13 ' A' ' 94' ' ' VAL . 68.5 p -62.87 -40.99 99.19 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.486 0.492 . . . . 74.530000000000001 110.346 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 64' ' ' THR . . . -66.27 -37.41 85.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.055 0.942 . . . . 74.239999999999995 111.809 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -65.44 -51.73 58.12 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.584 -0.735 . . . . 74.409999999999997 110.946 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -67.76 -26.22 66.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.572 -1.194 . . . . 73.549999999999997 110.836 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 37' ' ' VAL . 18.3 tp -76.3 -49.85 15.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.949 -1.023 . . . . 62.210000000000001 111.198 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 34.9 ttpt -63.19 -35.82 81.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.915 0.486 . . . . 74.310000000000002 110.685 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -22.49 62.14 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 54.219999999999999 111.341 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.67 57.83 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.413 0.685 . . . . 75.439999999999998 111.36 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.37 41.17 0.98 Allowed Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.445 -0.343 . . . . 75.530000000000001 113.069 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -106.25 156.9 18.0 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.304 0.642 . . . . 74.209999999999994 109.927 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.4 m -66.95 -69.48 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.275 0.984 . . . . 53.329999999999998 111.361 -161.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.29 136.76 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.188 -1.042 . . . . 72.209999999999994 108.188 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.48 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 73.7 p -129.55 94.9 3.87 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.937 -0.764 . . . . 61.130000000000003 108.937 172.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -103.63 131.56 50.67 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.644 0.778 . . . . 72.150000000000006 109.663 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 50' ' ' ALA . 6.4 p -116.3 131.11 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 121.712 -0.617 . . . . 75.310000000000002 110.638 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -150.27 159.76 28.25 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.648 -0.705 . . . . 54.240000000000002 111.618 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -95.04 119.8 34.17 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.744 -0.836 . . . . 33.43 108.744 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.5 tt -150.64 133.93 16.25 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.004 -1.11 . . . . 74.319999999999993 108.004 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.769 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.9 m -80.85 100.07 8.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.361 0.665 . . . . 73.329999999999998 109.882 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.61 106.21 8.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.166 -0.679 . . . . 54.450000000000003 109.166 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.71 0.47 9.99 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.695 2.263 . . . . 71.230000000000004 112.465 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -95.83 -23.4 16.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.249 1.019 . . . . 74.310000000000002 110.647 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.762 HG21 HG11 ' A' ' 119' ' ' VAL . 14.3 m -97.27 155.49 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.291 0.636 . . . . 74.340000000000003 109.865 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.29 9.28 2.28 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.702 0.801 . . . . 73.109999999999999 110.586 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.46 156.51 33.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.74 1.216 . . . . 70.430000000000007 108.611 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -59.2 111.89 1.51 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.053 -0.721 . . . . 74.140000000000001 109.053 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.8 m -138.45 127.95 24.72 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.313 -0.858 . . . . 63.329999999999998 110.611 -168.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 118' ' ' VAL . 50.3 t -102.4 113.19 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.784 -1.191 . . . . 72.129999999999995 107.784 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 117' ' ' ILE . 1.4 t80 -98.87 142.47 30.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.969 1.308 . . . . 73.209999999999994 109.926 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 22.5 p90 -133.06 164.56 26.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.459 -0.792 . . . . 72.319999999999993 111.2 168.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.1 m -107.48 172.41 6.84 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 106.895 -1.521 . . . . 74.099999999999994 106.895 163.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.53 28.41 8.76 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.91 0.484 . . . . 62.219999999999999 111.176 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 84.6 t -77.17 126.25 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.416 -0.957 . . . . 74.319999999999993 108.416 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.92 -80.48 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.267 1.027 . . . . 73.340000000000003 110.912 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.56 35.6 0.23 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.9 -0.48 . . . . 74.439999999999998 111.9 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 48.9 mt-10 -61.8 -19.64 62.74 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.172 0.589 . . . . 73.219999999999999 112.269 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' CG ' ' A' ' 81' ' ' TYR . 41.0 ptt85 -63.08 -28.8 70.33 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.287 0.477 . . . . 65.319999999999993 112.287 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.37 82.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.723 0.809 . . . . 63.520000000000003 111.798 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.7 t -67.67 -46.52 72.13 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.422 -0.354 . . . . 74.219999999999999 111.151 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 81' ' ' TYR . . . -71.98 -27.72 62.94 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.744 0.417 . . . . 53.039999999999999 111.934 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.04 -33.8 76.91 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.529 0.732 . . . . 73.299999999999997 110.496 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.42 -47.64 19.26 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.662 -0.699 . . . . 72.209999999999994 110.509 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.492 HG13 ' HB ' ' A' ' 52' ' ' THR . 98.8 t -68.95 -33.66 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.468 0.707 . . . . 72.430000000000007 111.757 -175.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -58.54 -29.08 63.3 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.347 -0.388 . . . . 72.430000000000007 112.561 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -86.96 -30.89 20.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.282 0.633 . . . . 74.25 111.018 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.2 m -64.34 -43.24 95.23 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.644 0.735 . . . . 65.349999999999994 110.546 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.486 HD21 HG22 ' A' ' 120' ' ' VAL . 57.3 tp -85.29 -32.15 22.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.59 -1.186 . . . . 70.450000000000003 110.204 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 66.8 1.96 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.432 -1.067 . . . . 63.520000000000003 110.432 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.97 166.44 24.47 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.553 1.141 . . . . 44.520000000000003 110.359 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.32 110.99 7.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.429 0.691 . . . . 64.049999999999997 109.325 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.623 HG22 ' HA3' ' A' ' 95' ' ' GLY . 5.4 t -86.63 134.03 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.26 -1.015 . . . . 73.239999999999995 108.26 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -140.39 153.12 46.23 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-O 121.402 0.62 . . . . 62.340000000000003 111.013 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.415 ' HA ' ' CE1' ' A' ' 81' ' ' TYR . 6.2 mp -76.78 -163.62 0.36 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 114.342 -1.299 . . . . 41.350000000000001 110.331 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -70.63 28.61 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 72.450000000000003 112.823 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 33.8 tp -70.88 -48.72 14.49 Favored Pre-proline 0 CA--C 1.568 1.641 0 O-C-N 121.601 -0.687 . . . . 72.099999999999994 111.265 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 106' ' ' LEU . 51.0 Cg_exo -58.39 -12.91 14.87 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 122.819 2.346 . . . . 74.439999999999998 114.006 170.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -66.37 -35.08 79.42 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.25 0.62 . . . . 52.109999999999999 109.651 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.1 tp -82.7 -34.15 27.4 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.911 0.386 . . . . 75.310000000000002 110.098 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -68.62 -48.78 63.21 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.454 -0.793 . . . . 52.439999999999998 111.335 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -126.86 -33.99 2.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.635 0.774 . . . . 64.349999999999994 111.554 -172.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.91 72.96 0.33 Allowed Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.766 1.226 . . . . 63.32 109.503 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.549 ' HB3' HD13 ' A' ' 117' ' ' ILE . 5.9 Cg_exo -81.92 148.38 15.43 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 123.407 2.738 . . . . 71.340000000000003 112.148 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.72 119.2 5.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.284 2.656 . . . . 63.439999999999998 112.938 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.17 -113.33 5.75 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.927 0.767 . . . . 54.130000000000003 112.867 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 37' ' ' VAL . 39.1 t -116.45 136.87 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.964 1.306 . . . . 71.310000000000002 108.098 173.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.584 HG22 ' HG3' ' A' ' 38' ' ' ARG . 11.8 pt -128.68 149.95 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.304 -0.628 . . . . 74.120000000000005 109.304 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 79' ' ' VAL . 59.2 t -117.54 102.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.114 -1.439 . . . . 72.430000000000007 107.114 175.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.762 HG11 HG21 ' A' ' 74' ' ' VAL . 23.8 t -94.18 126.04 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.108 -0.701 . . . . 53.219999999999999 109.108 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.519 ' HB ' ' ND2' ' A' ' 41' ' ' ASN . 21.5 t -115.82 128.09 73.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.558 -0.904 . . . . 62.530000000000001 108.558 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.419 HG22 HG21 ' A' ' 42' ' ' ILE . 19.7 p -95.17 137.48 34.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.214 0.605 . . . . 75.5 109.492 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 119.022 -0.877 . . . . 73.439999999999998 111.96 -177.829 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.585 -0.206 . . . . 73.349999999999994 112.585 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 p -87.92 14.77 8.21 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.856 0.862 . . . . 72.349999999999994 112.659 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -110.14 97.07 28.56 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.481 0.712 . . . . 70.219999999999999 109.729 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -94.1 -161.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.506 2.804 . . . . 70.430000000000007 112.062 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -148.03 144.45 27.93 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.466 0.706 . . . . 53.0 109.692 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.9 m 52.57 77.71 0.15 Allowed 'General case' 0 C--N 1.358 0.958 0 C-N-CA 125.075 1.35 . . . . 74.510000000000005 111.764 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.64 -44.57 85.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.316 1.047 . . . . 61.420000000000002 111.002 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -123.82 -69.83 0.79 Allowed 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.137 -0.938 . . . . 64.099999999999994 108.77 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.6 t70 56.38 90.5 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.593 1.157 . . . . 63.119999999999997 111.985 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 m -143.13 122.16 12.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.217 0.607 . . . . 71.439999999999998 109.623 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 p -130.42 111.02 11.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.225 1.01 . . . . 63.240000000000002 109.066 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.15 113.35 1.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.075 0.55 . . . . 74.120000000000005 109.756 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -150.8 114.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.726 0.81 . . . . 71.120000000000005 109.708 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -133.59 120.37 20.64 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.081 0.952 . . . . 65.040000000000006 108.636 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -151.79 109.22 3.6 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.743 0.817 . . . . 74.329999999999998 109.395 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.42 145.38 11.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.295 1.038 . . . . 74.219999999999999 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 142.85 24.79 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.098 0.475 . . . . 75.349999999999994 111.001 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -139.95 131.01 26.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 74.329999999999998 109.107 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -157.41 137.4 12.51 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.048 0.939 . . . . 74.120000000000005 109.311 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.7 m -147.56 102.95 3.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.426 0.69 . . . . 74.239999999999995 109.593 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 107.97 19.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.464 0.706 . . . . 65.299999999999997 109.261 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.26 111.7 44.92 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.589 0.756 . . . . 73.349999999999994 109.747 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.59 169.46 15.3 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.967 2.444 . . . . 63.409999999999997 112.304 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -152.86 119.99 5.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.583 0.753 . . . . 71.439999999999998 109.545 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 m -90.41 172.3 8.83 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.994 0.517 . . . . 54.119999999999997 109.836 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 m -132.04 144.22 50.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.119 0.568 . . . . 54.420000000000002 110.655 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 161.93 27.19 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.484 1.114 . . . . 63.439999999999998 110.145 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.89 140.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.103 0.561 . . . . 73.200000000000003 109.803 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.44 113.18 64.7 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.416 -0.957 . . . . 73.439999999999998 108.416 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.67 134.57 22.34 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.494 2.129 . . . . 74.409999999999997 111.511 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.49 114.39 21.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.487 0.715 . . . . 55.340000000000003 110.011 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.48 116.15 44.53 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.158 0.583 . . . . 73.340000000000003 110.406 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.08 150.29 33.46 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.573 2.182 . . . . 71.340000000000003 111.483 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' N ' HG21 ' A' ' 62' ' ' THR . 67.8 ttt180 -158.92 -75.49 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.149 0.28 . . . . 75.329999999999998 110.833 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.2 98.32 7.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.569 0.748 . . . . 61.329999999999998 109.99 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -98.77 107.74 20.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.038 0.535 . . . . 65.319999999999993 110.044 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 56' ' ' LEU . 22.1 t -95.64 135.89 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.194 0.598 . . . . 61.219999999999999 109.742 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HD3' ' HE2' ' A' ' 40' ' ' TYR . 7.9 ptp180 -150.74 134.85 16.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.854 0.861 . . . . 74.25 110.573 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 118' ' ' VAL . 41.0 t -100.5 133.28 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 55.310000000000002 109.545 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.53 ' HE2' ' HD3' ' A' ' 38' ' ' ARG . 69.6 m-85 -130.12 107.77 9.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.683 0.793 . . . . 73.299999999999997 109.735 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -84.39 118.03 23.99 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.988 -0.745 . . . . 72.030000000000001 108.988 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.708 HG13 ' HA ' ' A' ' 70' ' ' SER . 17.0 tt -78.86 -33.21 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.113 -0.329 . . . . 62.25 110.113 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -99.1 -162.48 0.96 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.18 0.992 . . . . 53.420000000000002 109.619 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.71 116.12 8.5 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 123.575 0.547 . . . . 71.239999999999995 112.312 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -69.96 101.63 1.82 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.738 0.78 . . . . 73.049999999999997 110.692 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.77 145.53 27.2 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.999 -0.546 . . . . 64.340000000000003 109.862 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -58.02 -38.41 89.12 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 124.42 1.075 . . . . 55.039999999999999 114.377 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.61 68.43 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.775 0.83 . . . . 24.329999999999998 112.398 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.71 71.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.715 0.806 . . . . 72.299999999999997 111.731 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.41 -23.62 37.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.318 0.647 . . . . 74.129999999999995 111.441 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 41.9 mmm-85 -64.75 -21.71 66.82 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.141 0.577 . . . . 63.130000000000003 112.004 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' HD13 ' A' ' 56' ' ' LEU . 80.5 p -61.54 -45.97 91.91 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.905 0.482 . . . . 60.100000000000001 110.052 173.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.9 84.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.66 0.784 . . . . 55.030000000000001 111.363 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -42.49 95.91 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.181 0.926 . . . . 74.530000000000001 111.968 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -63.2 -46.21 88.1 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.852 -0.613 . . . . 74.319999999999993 110.636 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 37' ' ' VAL . 10.5 mp -72.68 -26.85 61.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.506 -0.77 . . . . 51.310000000000002 111.634 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.16 -51.17 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.076 -1.083 . . . . 75.409999999999997 108.076 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.99 59.38 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.708 -1.133 . . . . 72.129999999999995 112.128 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.76 -22.45 37.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.054 0.542 . . . . 74.349999999999994 110.571 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 44.03 5.54 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.054 -0.521 . . . . 22.109999999999999 113.782 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.65 158.64 30.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 72.140000000000001 109.448 169.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.421 HG21 ' N ' ' A' ' 34' ' ' ARG . 24.3 m -58.02 -52.29 66.11 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.165 0.916 . . . . 74.530000000000001 111.302 -159.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.72 139.55 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.328 -0.99 . . . . 63.32 108.328 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 p -134.68 113.77 12.03 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.351 1.061 . . . . 74.010000000000005 108.485 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 22.8 t70 -128.38 154.91 45.5 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.817 0.847 . . . . 55.140000000000001 109.373 -171.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.62 153.66 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.392 0.615 . . . . 73.120000000000005 110.503 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.42 169.96 42.32 Favored Glycine 0 C--O 1.245 0.806 0 CA-C-N 114.783 -1.099 . . . . 55.32 110.51 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -146.32 116.61 7.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.262 -1.014 . . . . 54.329999999999998 108.262 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 mt -148.89 136.35 20.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.693 0.797 . . . . 73.439999999999998 109.411 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.708 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 m -76.52 97.94 4.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.404 -0.961 . . . . 52.350000000000001 108.404 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.8 119.8 70.0 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.861 -0.792 . . . . 71.310000000000002 108.861 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.76 -2.92 12.86 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.267 1.978 . . . . 70.409999999999997 112.712 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.09 -26.16 17.58 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.003 0.921 . . . . 73.209999999999994 111.829 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 76' ' ' ALA . 7.3 p -138.08 140.21 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.308 0.643 . . . . 73.140000000000001 110.189 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.3 33.21 3.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.336 0.654 . . . . 74.349999999999994 110.073 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' H ' HG22 ' A' ' 74' ' ' VAL . . . -135.14 149.87 50.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.527 0.731 . . . . 53.439999999999998 109.848 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.586 ' HB ' ' H ' ' A' ' 121' ' ' THR . 5.6 t -78.89 102.49 8.26 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 121.972 0.891 . . . . 74.299999999999997 108.73 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.5 m -149.8 143.35 25.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.169 -0.923 . . . . 61.530000000000001 108.971 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 23.2 t -93.92 114.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.527 -1.286 . . . . 74.349999999999994 107.527 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' HB2' HG12 ' A' ' 117' ' ' ILE . 96.8 m-85 -101.08 142.52 32.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.629 -1.249 . . . . 73.430000000000007 107.629 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -130.73 151.95 50.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.629 -0.508 . . . . 72.439999999999998 109.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.413 HG22 HG23 ' A' ' 84' ' ' VAL . 28.0 m -92.37 147.1 23.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.526 -1.287 . . . . 74.430000000000007 107.526 168.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.34 22.74 1.2 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.396 0.678 . . . . 74.439999999999998 112.661 -173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.413 HG23 HG22 ' A' ' 82' ' ' THR . 84.3 t -62.31 99.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.067 -0.716 . . . . 71.310000000000002 109.067 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.25 12.6 2.64 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.445 1.098 . . . . 62.340000000000003 112.182 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.32 62.65 2.05 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 120.243 -0.198 . . . . 72.239999999999995 113.401 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.71 -16.74 51.75 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.38 0.672 . . . . 73.310000000000002 111.524 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -26.1 6.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.047 0.939 . . . . 74.329999999999998 112.758 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.51 -53.21 60.73 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.774 0.671 . . . . 71.230000000000004 111.148 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.8 t -74.34 -32.61 62.87 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 116.293 -0.412 . . . . 62.119999999999997 110.694 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.56 75.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.393 0.677 . . . . 74.439999999999998 112.241 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.495 ' HA ' HG11 ' A' ' 102' ' ' VAL . 29.2 t70 -64.96 -43.13 93.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.219 1.008 . . . . 63.310000000000002 110.01 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.38 80.15 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.366 1.041 . . . . 70.319999999999993 111.846 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 90' ' ' THR . 65.3 t -64.58 -56.4 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 123.649 0.593 . . . . 74.310000000000002 110.389 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.72 67.55 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.89 0.744 . . . . 72.230000000000004 113.842 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -69.63 -47.16 64.35 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.256 1.022 . . . . 74.040000000000006 109.666 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.6 m -75.81 -35.92 59.89 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.972 -1.013 . . . . 72.439999999999998 111.03 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.01 -30.49 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.569 -0.741 . . . . 75.030000000000001 110.193 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.01 55.53 4.38 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.447 -0.661 . . . . 62.340000000000003 111.447 -175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.1 160.76 39.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.64 0.776 . . . . 74.439999999999998 110.266 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 142.18 52.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.065 0.946 . . . . 50.109999999999999 110.442 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 92' ' ' ASP . 35.9 m -103.11 131.45 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.48 -0.933 . . . . 61.439999999999998 108.48 171.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 49.5 mt-10 -140.83 159.73 41.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.478 1.111 . . . . 74.310000000000002 109.528 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.48 158.61 35.76 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.225 -0.657 . . . . 74.010000000000005 109.225 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 14.0 ptt180 -50.06 -41.74 48.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.044 1.338 . . . . 73.310000000000002 112.585 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.9 mt 67.34 158.76 0.14 Allowed Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 123.533 0.733 . . . . 72.019999999999996 110.222 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.36 -24.14 41.46 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.41 2.073 . . . . 72.430000000000007 113.701 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.2 -54.97 6.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.277 1.031 . . . . 61.530000000000001 111.54 -174.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 2.7 mm? -76.47 -20.14 57.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 116.508 -0.314 . . . . 74.099999999999994 110.258 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -69.02 -11.54 60.88 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.041 0.536 . . . . 74.530000000000001 111.856 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.34 -32.2 19.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.388 0.675 . . . . 75.129999999999995 110.713 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.55 HE22 HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -89.57 168.04 16.01 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 117.639 -1.172 . . . . 44.409999999999997 109.0 174.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 30.3 Cg_exo -29.34 122.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.406 3.568 1 C-N-CA 125.309 4.006 . . . . 63.130000000000003 116.685 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.11 161.12 47.03 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.15 2.567 . . . . 75.25 113.07 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 -158.95 14.04 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.253 -0.885 . . . . 64.519999999999996 111.207 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 70.7 t -83.54 108.35 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.891 0.877 . . . . 52.340000000000003 109.626 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.624 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.31 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.592 -0.892 . . . . 61.539999999999999 108.592 173.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.529 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.4 p -95.53 105.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.447 -0.946 . . . . 61.219999999999999 108.447 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 4.0 p -94.07 123.48 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.619 -0.882 . . . . 75.25 108.619 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.65 132.51 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.397 0.679 . . . . 73.5 109.946 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.586 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.0 t -119.89 151.61 38.63 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.058 -1.09 . . . . 62.420000000000002 108.058 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.297 0 CA-C-O 118.978 -0.901 . . . . 71.129999999999995 112.147 178.563 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.992 0 N-CA-C 112.008 -0.437 . . . . 32.210000000000001 112.008 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -86.38 80.06 8.81 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.445 0.698 . . . . 63.520000000000003 109.231 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 m -100.24 110.19 59.04 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 115.432 -0.804 . . . . 73.230000000000004 110.192 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.39 82.82 1.99 Allowed 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.179 1.919 . . . . 53.549999999999997 111.493 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -118.55 121.61 40.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.751 -0.659 . . . . 70.310000000000002 109.424 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.7 m -76.3 146.25 39.02 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.197 0.599 . . . . 53.219999999999999 110.497 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.17 -38.29 82.75 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.04 0.936 . . . . 75.510000000000005 111.055 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.29 -73.33 0.16 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.493 -0.776 . . . . 65.200000000000003 109.307 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.6 t70 61.49 151.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.08 1.352 . . . . 73.239999999999995 112.553 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.3 m -113.49 102.66 10.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.84 0.856 . . . . 65.120000000000005 109.76 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -71.43 104.75 3.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.379 -0.828 . . . . 61.520000000000003 108.941 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.63 118.36 4.99 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.372 0.669 . . . . 61.229999999999997 110.134 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.95 155.99 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.292 1.037 . . . . 61.140000000000001 109.138 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.4 m -150.89 144.15 24.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.919 0.887 . . . . 73.420000000000002 109.386 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -160.88 160.85 31.49 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.878 0.871 . . . . 72.209999999999994 110.272 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 53.2 ttp -171.76 113.28 0.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.78 -1.193 . . . . 74.040000000000006 107.78 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -61.45 114.11 3.04 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.253 0.621 . . . . 73.340000000000003 110.563 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -70.22 -41.75 73.2 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.401 0.68 . . . . 52.409999999999997 111.393 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.2 m 68.55 152.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.981 1.313 . . . . 74.420000000000002 110.946 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.3 t -158.67 174.69 14.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.093 0.557 . . . . 72.510000000000005 110.329 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.18 148.87 28.77 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.113 0.965 . . . . 43.509999999999998 109.415 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.69 107.2 34.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 108.896 -0.779 . . . . 53.009999999999998 108.896 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.99 132.22 3.26 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.761 2.307 . . . . 73.019999999999996 112.472 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.3 p -123.21 124.34 42.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.877 0.471 . . . . 72.120000000000005 110.643 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m -149.02 118.23 6.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.495 1.118 . . . . 72.349999999999994 108.027 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 p -132.82 145.69 51.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.045 0.938 . . . . 74.530000000000001 109.216 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.3 p -144.91 120.15 10.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.182 0.593 . . . . 73.329999999999998 110.102 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 139.67 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.54 -0.911 . . . . 63.310000000000002 108.54 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.55 157.55 41.13 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 123.344 0.658 . . . . 73.25 110.322 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.71 170.07 13.32 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.062 2.508 . . . . 72.010000000000005 113.042 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.61 168.63 19.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.924 0.89 . . . . 75.230000000000004 111.129 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.21 146.25 37.73 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.921 -0.582 . . . . 72.239999999999995 109.899 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.53 172.2 16.77 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.617 2.211 . . . . 45.420000000000002 112.363 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -97.03 158.12 15.58 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.272 1.029 . . . . 64.219999999999999 112.269 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 90' ' ' THR . . . -174.15 82.55 0.04 OUTLIER 'General case' 0 C--N 1.35 0.597 0 C-N-CA 125.12 1.368 . . . . 52.240000000000002 108.358 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.676 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -95.86 87.8 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.581 . . . . 61.119999999999997 109.616 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 94' ' ' VAL . 47.1 t -117.59 142.12 33.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.184 -0.462 . . . . 71.099999999999994 110.782 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -143.6 158.52 43.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.293 -0.412 . . . . 72.519999999999996 111.383 172.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.08 129.11 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.37 0.668 . . . . 63.420000000000002 110.244 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 19.0 m-85 -109.86 107.83 17.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.316 1.046 . . . . 73.340000000000003 108.323 163.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -93.31 112.73 24.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.169 -1.789 . . . . 75.340000000000003 106.169 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.671 HG13 ' HA ' ' A' ' 70' ' ' SER . 13.5 tt -73.11 -45.21 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.037 -0.414 . . . . 64.400000000000006 111.33 -172.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -29.41 28.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 72.019999999999996 110.591 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.33 54.28 13.95 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 123.734 0.646 . . . . 72.420000000000002 113.016 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.91 0.484 . . . . 72.230000000000004 110.584 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' A' ' 49' ' ' ALA . 10.1 tp10 -63.77 121.81 14.9 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.403 0.52 . . . . 75.030000000000001 112.403 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.75 -23.8 51.8 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.861 -0.608 . . . . 73.430000000000007 112.291 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 52' ' ' THR . . . -65.09 -27.07 68.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.157 0.583 . . . . 53.039999999999999 110.852 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' H ' ' HG3' ' A' ' 46' ' ' GLU . . . -57.17 -47.34 81.46 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 124.032 0.833 . . . . 74.540000000000006 110.931 173.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.22 77.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.73 -0.668 . . . . 73.25 111.368 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -69.99 -22.68 63.11 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.326 1.051 . . . . 74.120000000000005 111.139 -172.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' HG13 ' A' ' 94' ' ' VAL . 75.5 p -67.98 -49.82 59.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.262 0.225 . . . . 61.119999999999997 111.488 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -22.03 61.63 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.233 0.539 . . . . 62.140000000000001 111.209 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.94 -47.83 60.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.247 . . . . 65.400000000000006 110.512 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -70.71 -30.86 67.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.654 -0.498 . . . . 71.340000000000003 109.654 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HG22 ' A' ' 64' ' ' THR . 53.4 tp -66.16 -33.29 75.45 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.337 -0.847 . . . . 73.450000000000003 111.295 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 11.4 tmtt? -58.4 -43.13 88.46 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.725 -0.843 . . . . 62.520000000000003 108.725 174.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.3 -18.88 54.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.211 1.004 . . . . 71.340000000000003 112.319 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.34 42.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 55.210000000000001 112.038 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.12 46.72 0.69 Allowed Glycine 0 C--N 1.348 1.232 0 O-C-N 123.106 0.254 . . . . 60.229999999999997 112.503 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 3.6 p90 -60.4 158.04 12.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.518 1.127 . . . . 71.140000000000001 112.145 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 m -109.69 -43.52 4.03 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.714 -0.847 . . . . 64.099999999999994 108.714 164.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.676 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 83.3 t -135.63 128.37 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.194 0.998 . . . . 73.549999999999997 108.597 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.482 HG22 HD23 ' A' ' 56' ' ' LEU . 3.2 p -130.31 116.79 18.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 52.530000000000001 108.534 173.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 16.0 t70 -121.19 158.76 27.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.419 -0.956 . . . . 71.120000000000005 108.419 172.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.24 140.1 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.452 0.701 . . . . 73.109999999999999 109.986 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.87 146.5 11.36 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.725 -0.55 . . . . 61.100000000000001 111.725 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.11 113.1 26.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.532 0.733 . . . . 70.040000000000006 109.481 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.4 mp -145.22 136.05 24.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.97 -0.456 . . . . 71.010000000000005 110.303 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.671 ' HA ' HG13 ' A' ' 42' ' ' ILE . 26.9 p -73.64 99.96 3.23 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 123.853 0.721 . . . . 73.230000000000004 109.722 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HB2' HG22 ' A' ' 74' ' ' VAL . 62.2 mt -93.17 123.75 59.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.926 -0.398 . . . . 62.409999999999997 109.926 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.71 -6.6 16.21 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.067 2.511 . . . . 75.340000000000003 113.853 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -90.06 -23.61 21.39 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.0 0.52 . . . . 63.350000000000001 110.676 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 119' ' ' VAL . 28.9 m -104.0 148.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.641 0.734 . . . . 73.400000000000006 110.901 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.09 13.29 1.63 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.452 -1.249 . . . . 75.409999999999997 109.024 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.02 154.74 26.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.984 1.314 . . . . 74.019999999999996 108.366 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -71.93 111.73 7.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.05 0.54 . . . . 75.219999999999999 109.993 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -144.28 134.21 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.683 0.793 . . . . 54.219999999999999 111.166 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.675 HG22 HG23 ' A' ' 118' ' ' VAL . 21.0 t -99.28 117.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.304 1.042 . . . . 71.400000000000006 109.173 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HE1' HD12 ' A' ' 106' ' ' LEU . 92.0 m-85 -94.89 120.06 34.48 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 109.155 -0.684 . . . . 74.099999999999994 109.155 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.648 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 11.4 p90 -134.53 175.54 9.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.899 0.857 . . . . 70.530000000000001 111.623 175.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 m -139.13 161.3 37.73 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.138 -1.43 . . . . 75.519999999999996 107.138 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -92.27 30.46 1.46 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.051 0.54 . . . . 61.539999999999999 111.369 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.64 100.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 123.655 0.782 . . . . 60.109999999999999 109.489 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.03 -75.33 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.808 1.243 . . . . 74.420000000000002 111.417 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.61 22.95 1.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.384 -0.371 . . . . 63.420000000000002 112.718 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.73 -28.6 65.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.998 0.519 . . . . 60.210000000000001 111.847 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 2.2 tmt_? -66.41 -48.24 70.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.051 -0.722 . . . . 73.430000000000007 109.051 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.87 -38.16 85.81 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.715 0.806 . . . . 72.129999999999995 111.535 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.64 HG21 ' HB1' ' A' ' 35' ' ' ALA . 28.4 m -66.64 -49.0 67.64 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 64.340000000000003 109.721 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.5 -32.3 73.56 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.744 -1.116 . . . . 42.25 112.763 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.82 -43.72 97.85 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.171 0.919 . . . . 73.420000000000002 110.031 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.58 98.65 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.146 0.904 . . . . 75.319999999999993 111.325 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.54 HG13 ' HB ' ' A' ' 52' ' ' THR . 86.3 t -64.35 -53.57 41.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 C-N-CA 124.202 1.001 . . . . 75.519999999999996 111.45 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.517 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -71.96 -21.79 78.96 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.29 -0.868 . . . . 54.409999999999997 113.463 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -73.81 -41.92 61.67 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.38 -0.6 . . . . 74.010000000000005 109.38 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -61.46 -39.82 92.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.409 -0.814 . . . . 70.519999999999996 110.942 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 100' ' ' ALA . 2.6 tm? -74.91 -35.77 62.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.822 0.449 . . . . 73.230000000000004 110.812 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.55 51.84 7.9 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.275 -0.73 . . . . 75.030000000000001 111.275 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.765 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -109.37 168.0 9.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.425 1.09 . . . . 62.530000000000001 109.996 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.39 104.02 5.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.954 -0.758 . . . . 75.400000000000006 108.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.648 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.3 m -83.35 130.97 34.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.281 -1.007 . . . . 64.129999999999995 108.281 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -153.46 159.79 42.41 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.372 0.606 . . . . 54.039999999999999 110.875 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.29 -178.01 0.16 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.981 1.313 . . . . 74.420000000000002 111.731 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 106' ' ' LEU . 8.4 ptm180 -53.92 -43.52 69.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.84 0.856 . . . . 73.109999999999999 112.91 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.436 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 77.3 mt 62.4 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.566 1.578 0 C-N-CA 124.501 1.12 . . . . 73.109999999999999 111.591 -172.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.08 -17.61 39.19 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.302 2.001 . . . . 74.340000000000003 113.0 167.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -26.11 63.76 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.876 0.87 . . . . 73.140000000000001 111.606 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.95 -23.54 66.63 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 111.78 0.289 . . . . 51.420000000000002 111.78 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 m -60.03 -36.62 77.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.181 0.592 . . . . 64.409999999999997 110.893 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.05 -32.31 22.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.838 0.855 . . . . 33.25 111.261 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -80.0 157.46 73.69 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.587 0.755 . . . . 72.230000000000004 109.176 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 26.1 Cg_exo -64.14 125.53 15.39 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.12 1.88 . . . . 63.100000000000001 111.389 170.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 56.5 Cg_exo -53.62 120.27 7.56 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.357 2.705 . . . . 74.530000000000001 113.706 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.74 -178.39 22.62 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.284 -1.126 . . . . 73.430000000000007 110.284 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.5 123.82 34.81 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.178 0.513 . . . . 63.399999999999999 110.849 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.53 135.52 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.105 -1.072 . . . . 74.120000000000005 108.105 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.675 HG23 HG22 ' A' ' 79' ' ' VAL . 2.4 p -105.24 106.0 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.388 -1.338 . . . . 73.340000000000003 107.388 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 74' ' ' VAL . 15.8 t -93.35 121.97 44.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.954 -0.758 . . . . 73.239999999999995 108.954 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 98' ' ' LEU . 41.1 t -116.99 129.47 73.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.164 0.986 . . . . 61.340000000000003 109.583 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -91.56 162.29 14.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.909 0.756 . . . . 73.219999999999999 110.273 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.592 0 CA-C-N 115.485 -0.78 . . . . 70.200000000000003 113.435 -179.271 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.973 0 N-CA-C 112.553 -0.219 . . . . 64.140000000000001 112.553 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 p -152.79 65.94 0.8 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.07 0.948 . . . . 34.210000000000001 109.892 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -63.84 133.4 95.55 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.896 0.878 . . . . 72.140000000000001 110.978 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.25 156.47 55.1 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.689 2.259 . . . . 73.140000000000001 111.962 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -149.71 147.42 28.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.054 0.542 . . . . 71.349999999999994 110.404 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.1 t -168.82 41.93 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.532 1.133 . . . . 74.519999999999996 109.004 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.64 -9.43 56.99 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.892 0.877 . . . . 30.34 111.6 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -44.25 -57.59 3.38 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.342 1.457 . . . . 72.219999999999999 112.855 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 57.72 99.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.608 1.163 . . . . 72.519999999999996 111.864 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.9 m -84.65 89.36 7.46 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.035 -0.415 . . . . 74.349999999999994 111.032 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -119.45 133.52 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.776 0.83 . . . . 72.439999999999998 109.546 172.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 148.62 24.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.87 0.868 . . . . 64.420000000000002 109.944 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -156.61 134.67 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.241 0.616 . . . . 73.340000000000003 109.952 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.5 p -146.05 166.4 26.2 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.308 0.643 . . . . 72.010000000000005 110.469 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -156.55 162.55 39.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.103 0.961 . . . . 74.329999999999998 109.769 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 146.07 32.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.35 0.66 . . . . 62.240000000000002 110.704 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.0 m -147.21 135.38 21.54 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 70.109999999999999 110.393 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 m -97.27 148.26 23.29 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.451 1.1 . . . . 72.450000000000003 110.824 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -126.17 100.64 6.41 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.266 1.027 . . . . 73.299999999999997 108.353 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 t -77.3 149.0 35.39 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.975 0.51 . . . . 74.109999999999999 110.905 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.71 167.85 16.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.551 0.74 . . . . 73.219999999999999 110.847 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . . . -91.14 146.08 32.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.659 0.783 . . . . 50.420000000000002 110.845 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 22' ' ' ALA . 11.8 Cg_exo -71.46 166.34 29.64 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.986 2.457 . . . . 75.25 112.646 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 t -157.66 154.76 28.88 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.968 0.507 . . . . 71.430000000000007 111.04 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.8 m -146.64 130.36 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.983 0.913 . . . . 74.299999999999997 109.61 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 p -120.44 151.1 39.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.941 0.896 . . . . 63.109999999999999 110.314 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 p -158.69 146.48 18.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.666 0.786 . . . . 33.399999999999999 109.871 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.54 155.55 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.642 0.777 . . . . 70.439999999999998 109.783 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -107.64 140.75 21.87 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.652 0.781 . . . . 71.099999999999994 110.213 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -83.7 145.99 11.75 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.16 2.573 . . . . 73.209999999999994 113.054 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.49 168.67 12.41 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.71 0.804 . . . . 45.240000000000002 111.723 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.12 142.23 42.46 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 124.185 0.994 . . . . 63.240000000000002 109.969 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.42 128.93 19.14 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.504 2.136 . . . . 64.329999999999998 112.298 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.521 ' HB3' ' HG2' ' A' ' 85' ' ' GLU . 69.3 mtt85 -77.59 -71.35 0.42 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.664 0.786 . . . . 63.43 110.851 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.57 127.98 5.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.989 -0.745 . . . . 55.229999999999997 108.989 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -118.53 132.8 56.21 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.716 0.806 . . . . 73.200000000000003 109.568 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HA ' HG13 ' A' ' 116' ' ' VAL . 12.1 t -95.78 142.36 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.961 0.904 . . . . 71.420000000000002 110.225 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.501 ' HG3' HG22 ' A' ' 117' ' ' ILE . 7.9 ptm180 -151.23 126.4 9.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.096 0.406 . . . . 74.299999999999997 112.096 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 118' ' ' VAL . 16.6 t -101.0 111.2 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.086 0.954 . . . . 54.140000000000001 110.5 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -99.41 107.3 19.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.182 0.515 . . . . 61.5 110.236 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -98.0 110.91 23.4 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.388 -1.338 . . . . 75.409999999999997 107.388 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.644 ' HB ' HG12 ' A' ' 74' ' ' VAL . 4.8 tt -78.34 -50.7 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.953 0.406 . . . . 73.140000000000001 111.121 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -83.85 -2.68 56.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.274 -0.875 . . . . 64.209999999999994 111.504 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.32 59.6 8.69 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 111.623 -0.591 . . . . 62.009999999999998 111.623 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -78.59 -172.71 3.05 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.909 0.884 . . . . 73.450000000000003 111.063 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 43.2 tt0 -53.71 139.79 31.42 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.371 1.068 . . . . 62.299999999999997 111.384 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.92 -9.66 53.76 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.722 0.649 . . . . 71.010000000000005 114.722 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.564 ' H ' ' HG2' ' A' ' 46' ' ' GLU . . . -67.23 -22.48 65.69 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.354 0.577 . . . . 62.219999999999999 111.25 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -68.58 -39.68 80.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.291 0.636 . . . . 74.530000000000001 110.405 171.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.58 52.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.327 0.651 . . . . 72.030000000000001 111.355 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.435 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 24.0 tpp180 -70.82 -15.77 62.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.226 1.01 . . . . 74.510000000000005 111.205 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' HD13 ' A' ' 56' ' ' LEU . 78.4 p -61.63 -47.01 87.35 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.874 -0.417 . . . . 63.210000000000001 109.874 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.49 61.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.204 0.601 . . . . 64.200000000000003 111.2 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 25.5 t70 -60.04 -35.37 74.96 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.206 0.602 . . . . 52.43 111.465 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.479 HH21 HD11 ' A' ' 56' ' ' LEU . 52.6 ttp180 -64.41 -40.83 96.55 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.598 0.759 . . . . 65.129999999999995 110.232 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 52' ' ' THR . 9.8 mp -65.23 -34.44 78.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.451 -0.795 . . . . 65.25 110.645 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.62 -41.0 93.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.861 0.464 . . . . 72.409999999999997 110.722 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.42 65.85 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.599 -0.728 . . . . 73.209999999999994 111.233 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.41 -21.28 42.4 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.421 0.688 . . . . 71.209999999999994 111.011 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.55 44.46 2.5 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.463 -0.335 . . . . 60.240000000000002 113.544 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -87.67 158.44 18.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.643 0.777 . . . . 73.340000000000003 108.963 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -58.79 -69.5 0.19 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.191 0.932 . . . . 62.030000000000001 112.3 -160.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.97 137.48 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.039 -1.097 . . . . 72.400000000000006 108.039 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 p -128.51 108.59 10.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.769 0.828 . . . . 55.530000000000001 109.14 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 8.3 t70 -104.27 159.03 16.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.584 1.154 . . . . 64.239999999999995 109.397 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.79 115.54 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.838 0.855 . . . . 72.129999999999995 109.128 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.24 93.45 0.69 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.626 -0.716 . . . . 73.010000000000005 111.927 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -77.46 82.88 3.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.374 0.607 . . . . 73.510000000000005 109.495 173.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -160.15 143.97 14.15 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.199 -0.455 . . . . 73.230000000000004 111.006 -171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -82.66 100.74 10.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.009 0.924 . . . . 62.299999999999997 110.268 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -101.09 153.8 37.54 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.284 0.634 . . . . 53.25 109.535 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.76 -15.92 23.17 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.037 2.491 . . . . 74.530000000000001 114.566 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.37 -23.33 13.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.3 0.64 . . . . 71.319999999999993 110.914 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.745 HG13 HG13 ' A' ' 119' ' ' VAL . 79.5 t -93.52 123.06 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.133 1.373 . . . . 73.540000000000006 110.043 -177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' HA ' HD13 ' A' ' 42' ' ' ILE . . . -159.04 -74.15 0.08 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.012 0.525 . . . . 74.439999999999998 111.543 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.57 147.89 25.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.469 0.708 . . . . 71.409999999999997 110.284 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.2 t -66.15 100.24 0.59 Allowed 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.033 0.92 . . . . 73.109999999999999 109.997 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 m -152.23 135.64 15.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 74.239999999999995 109.096 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 118' ' ' VAL . 20.3 t -96.06 111.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.407 -0.96 . . . . 72.109999999999999 108.407 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -96.7 124.33 40.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.604 -0.887 . . . . 73.140000000000001 108.604 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -121.82 151.22 40.85 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.144 0.577 . . . . 74.140000000000001 112.156 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.712 HG23 ' HD3' ' A' ' 105' ' ' ARG . 3.3 m -103.21 166.82 10.21 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.084 -1.08 . . . . 61.329999999999998 108.084 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 14.63 18.25 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.974 -0.454 . . . . 73.120000000000005 111.887 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.15 110.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.779 0.832 . . . . 75.420000000000002 110.61 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.521 ' HG2' ' HB3' ' A' ' 34' ' ' ARG . 14.4 tp10 67.23 -76.48 0.05 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.831 1.252 . . . . 61.509999999999998 112.076 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.36 35.16 0.48 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.491 -1.044 . . . . 71.040000000000006 110.491 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HA ' HG22 ' A' ' 90' ' ' THR . 29.7 tt0 -75.9 -18.93 59.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 65.430000000000007 111.736 -170.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.57 -35.54 79.21 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 110.245 -0.28 . . . . 74.439999999999998 110.245 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.95 56.82 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.557 0.743 . . . . 71.439999999999998 112.192 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 87' ' ' GLU . 12.6 t -85.0 -25.62 27.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.484 -0.562 . . . . 71.420000000000002 109.484 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.588 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -73.89 -38.71 64.3 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.916 0.886 . . . . 52.439999999999998 111.299 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.48 -56.33 17.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.746 -1.57 . . . . 64.040000000000006 110.52 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.6 -47.39 79.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.177 0.923 . . . . 61.43 111.914 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.25 -51.51 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.697 0.799 . . . . 61.329999999999998 111.963 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.93 -27.43 73.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 116.035 -0.53 . . . . 33.130000000000003 113.271 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -79.28 -26.44 42.32 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.407 0.683 . . . . 63.409999999999997 110.463 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.7 m -83.33 -32.69 26.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.143 0.977 . . . . 63.219999999999999 110.987 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 tp -85.89 -31.99 21.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.219 0.608 . . . . 71.439999999999998 110.611 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.86 27.12 35.48 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.508 -0.769 . . . . 71.209999999999994 112.464 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.36 144.2 37.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.741 0.816 . . . . 74.450000000000003 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.63 127.14 31.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.031 0.933 . . . . 71.049999999999997 111.09 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.419 HG12 ' HB ' ' A' ' 79' ' ' VAL . 18.8 m -92.43 106.68 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.136 0.974 . . . . 74.200000000000003 110.632 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.74 166.43 11.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.951 1.3 . . . . 55.439999999999998 109.414 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mp -67.22 175.92 2.44 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.198 0.523 . . . . 72.200000000000003 111.057 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HD3' HG23 ' A' ' 82' ' ' THR . 32.0 ptt-85 -55.95 -44.82 78.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.406 1.082 . . . . 74.219999999999999 112.412 -173.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.9 mt 60.63 170.13 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.521 1.128 . . . . 54.149999999999999 111.202 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.52 -18.13 14.39 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.079 1.853 . . . . 70.25 113.659 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.19 -55.69 26.08 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.181 1.392 . . . . 64.040000000000006 112.076 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 8.1 tt -68.04 -25.78 65.54 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 122.57 0.348 . . . . 74.040000000000006 110.381 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 t -76.35 -19.57 58.06 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.551 0.741 . . . . 62.539999999999999 111.912 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.08 -33.24 33.52 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.957 0.503 . . . . 65.209999999999994 111.247 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.405 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pp0? -104.89 167.31 10.04 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.227 1.011 . . . . 71.310000000000002 109.362 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 19.1 Cg_endo -57.16 132.48 51.53 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.037 2.491 . . . . 74.420000000000002 114.48 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 71.1 Cg_exo -50.79 160.5 1.78 Allowed 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 124.175 3.25 . . . . 61.240000000000002 116.072 -173.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.35 147.55 8.32 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 110.255 -1.138 . . . . 74.409999999999997 110.255 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 91' ' ' ALA . 2.4 p -60.58 118.82 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.466 0.706 . . . . 63.450000000000003 110.848 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.501 HG22 ' HG3' ' A' ' 38' ' ' ARG . 39.5 pt -103.8 107.43 22.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 122.033 0.92 . . . . 64.310000000000002 109.861 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.2 p -90.14 105.12 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.501 -1.296 . . . . 71.510000000000005 107.501 169.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.745 HG13 HG13 ' A' ' 74' ' ' VAL . 52.9 t -92.26 131.3 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.612 -1.176 . . . . 44.219999999999999 108.241 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.58 HG21 ' HB1' ' A' ' 49' ' ' ALA . 3.5 t -130.38 130.13 65.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.214 0.605 . . . . 72.439999999999998 109.939 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -91.37 167.37 12.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.463 0.705 . . . . 53.439999999999998 110.145 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.337 0 CA-C-O 119.515 -0.603 . . . . 72.239999999999995 112.963 178.161 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.981 0 CA-C-O 119.873 -0.404 . . . . 61.130000000000003 112.124 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 p -82.05 107.19 14.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.82 0.848 . . . . 71.219999999999999 110.546 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.2 t -147.86 126.28 6.07 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.725 0.81 . . . . 64.340000000000003 109.912 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.64 157.79 48.05 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.757 2.305 . . . . 73.230000000000004 113.551 -174.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -118.89 94.17 4.35 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.248 -1.019 . . . . 74.519999999999996 108.248 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.5 p -102.55 23.26 12.2 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.702 0.801 . . . . 74.299999999999997 111.488 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.26 -30.81 71.71 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.802 0.841 . . . . 73.439999999999998 111.377 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -96.21 19.71 11.43 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.168 0.987 . . . . 74.109999999999999 111.057 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.55 90.39 2.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.884 -0.784 . . . . 73.099999999999994 108.884 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.6 p -115.22 116.05 27.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.689 0.795 . . . . 75.400000000000006 109.885 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 t -139.95 143.42 36.55 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.44 0.696 . . . . 45.240000000000002 109.184 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.9 153.59 31.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.562 0.745 . . . . 61.109999999999999 110.693 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.13 118.94 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.963 0.905 . . . . 71.420000000000002 110.031 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 m -144.76 109.73 5.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.974 0.91 . . . . 52.420000000000002 109.091 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 m -120.85 141.8 50.25 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.724 0.81 . . . . 61.340000000000003 109.678 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -125.03 146.11 49.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.126 0.97 . . . . 65.219999999999999 109.662 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.9 m -146.45 127.04 14.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.218 0.607 . . . . 73.340000000000003 110.002 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 p -111.81 137.46 49.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.796 0.838 . . . . 64.439999999999998 109.77 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 p -81.19 132.18 35.34 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.093 0.957 . . . . 72.439999999999998 111.492 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.5 p -113.19 160.52 18.17 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.573 1.149 . . . . 71.030000000000001 109.076 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.66 144.47 22.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.823 0.449 . . . . 63.130000000000003 111.149 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.63 124.14 43.46 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.752 0.821 . . . . 54.240000000000002 109.891 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.21 162.76 38.89 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.681 2.254 . . . . 51.100000000000001 112.819 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -83.01 146.62 28.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.211 1.005 . . . . 72.519999999999996 110.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 m -143.9 103.8 4.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.945 0.898 . . . . 74.319999999999993 109.292 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 p -108.81 141.12 41.3 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 64.140000000000001 109.605 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -159.01 94.32 1.21 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.034 0.933 . . . . 74.230000000000004 108.592 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.17 123.96 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 63.329999999999998 109.611 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.71 161.38 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.935 0.894 . . . . 55.109999999999999 110.633 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -56.05 164.88 4.45 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.91 2.406 . . . . 60.039999999999999 114.264 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.42 159.38 34.63 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.75 -1.114 . . . . 54.539999999999999 111.797 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.2 80.42 7.86 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.478 0.711 . . . . 40.240000000000002 109.888 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.43 128.99 8.27 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.193 1.929 . . . . 52.420000000000002 111.049 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.651 ' HB3' ' HG3' ' A' ' 85' ' ' GLU . 21.2 mmm180 -129.39 -20.53 3.31 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.476 0.71 . . . . 65.530000000000001 110.567 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.47 -172.67 3.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.869 0.867 . . . . 61.229999999999997 109.005 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.87 135.96 53.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.925 0.89 . . . . 53.229999999999997 109.234 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 64' ' ' THR . 90.7 t -132.83 123.54 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.277 -1.009 . . . . 73.450000000000003 108.277 171.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . 4.1 ptp85 -141.34 110.93 6.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.511 -0.743 . . . . 75.430000000000007 112.024 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 53' ' ' ALA . 35.8 t -92.71 120.52 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.023 . . . . 64.549999999999997 109.951 -175.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 66.3 m-85 -130.09 132.96 46.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.354 0.662 . . . . 71.140000000000001 109.794 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -88.84 141.08 28.8 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.887 -1.153 . . . . 64.109999999999999 107.887 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 121' ' ' THR . 6.3 tp -59.3 -46.32 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.459 0.704 . . . . 65.209999999999994 111.289 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.9 m -106.73 -9.94 16.28 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 70.5 111.858 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.91 63.29 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.223 0.327 . . . . 64.349999999999994 113.45 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.8 m -91.45 -52.73 4.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.275 0.63 . . . . 73.030000000000001 111.215 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.01 120.15 19.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.059 0.392 . . . . 52.119999999999997 112.059 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.96 50.97 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.303 -0.862 . . . . 72.209999999999994 112.746 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.24 73.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.248 0.619 . . . . 74.310000000000002 110.925 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.44 -52.07 64.81 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.18 0.925 . . . . 74.540000000000006 110.424 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.77 -37.67 88.4 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.772 -1.104 . . . . 52.409999999999997 111.631 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -64.87 -38.78 92.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.603 1.161 . . . . 63.039999999999999 111.617 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 97' ' ' THR . 68.9 p -75.76 -23.35 55.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.174 -0.466 . . . . 54.0 111.128 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -77.53 -33.7 54.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.077 0.951 . . . . 53.32 111.551 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -52.66 -32.41 42.02 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.977 0.911 . . . . 73.200000000000003 112.031 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.73 -52.26 66.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.3 1.04 . . . . 54.340000000000003 110.356 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.45 -37.63 71.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.277 0.631 . . . . 74.450000000000003 111.295 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -71.9 -36.44 70.01 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.485 0.49 . . . . 70.019999999999996 110.708 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.45 72.78 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.357 0.41 . . . . 75.239999999999995 110.902 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.19 -21.72 58.51 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.358 -0.837 . . . . 73.319999999999993 110.862 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.44 10.53 86.13 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-N 115.639 -0.71 . . . . 53.210000000000001 113.835 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -95.41 135.62 36.81 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.856 -0.794 . . . . 73.030000000000001 108.856 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 90' ' ' THR . 70.9 p 59.24 155.29 0.02 OUTLIER 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.871 2.068 . . . . 74.400000000000006 113.653 -173.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.64 87.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 N-CA-C 108.165 -1.05 . . . . 71.109999999999999 108.165 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 26.3 m -89.0 102.45 15.09 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.367 0.667 . . . . 64.129999999999995 110.679 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 38.9 m-20 -102.48 142.63 33.35 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.76 -0.83 . . . . 65.319999999999993 108.76 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 ' HB1' ' A' ' 53' ' ' ALA . 43.4 t -132.61 143.16 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.326 0.651 . . . . 54.439999999999998 110.168 -171.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.63 -126.78 2.07 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 112.541 -0.223 . . . . 64.439999999999998 112.541 165.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -144.77 145.05 31.48 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.944 0.898 . . . . 74.25 109.912 -177.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 tp -156.26 146.45 21.42 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.746 -0.835 . . . . 72.530000000000001 108.746 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.4 p -81.11 98.73 8.15 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.107 0.563 . . . . 73.109999999999999 110.453 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.47 88.21 7.28 Favored Pre-proline 0 N--CA 1.483 1.195 0 N-CA-C 108.801 -0.814 . . . . 64.099999999999994 108.801 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.71 -6.93 14.54 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.438 2.092 . . . . 61.229999999999997 112.992 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.5 -23.44 56.75 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.742 0.417 . . . . 70.439999999999998 111.145 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.477 HG11 HG11 ' A' ' 119' ' ' VAL . 2.6 p -121.32 119.45 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.693 0.797 . . . . 72.120000000000005 109.902 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.57 20.45 17.15 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.175 0.99 . . . . 73.430000000000007 111.403 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.31 139.85 45.97 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.689 0.796 . . . . 72.239999999999995 110.098 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 t -69.18 101.88 1.56 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.548 0.69 . . . . 55.020000000000003 110.283 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -138.35 145.43 41.12 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.414 0.686 . . . . 63.329999999999998 110.905 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.714 HG13 HG22 ' A' ' 118' ' ' VAL . 48.8 t -95.97 118.44 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.599 1.16 . . . . 63.310000000000002 108.085 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -110.02 129.05 55.73 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.894 0.478 . . . . 74.049999999999997 110.166 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.435 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -126.4 154.47 43.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.151 0.981 . . . . 71.430000000000007 110.091 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 83' ' ' GLU . 11.8 m -102.0 -112.06 0.21 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.514 -0.921 . . . . 74.239999999999995 108.514 168.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' HG22 ' A' ' 82' ' ' THR . 14.7 pt-20 -143.21 -19.91 0.63 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.784 1.174 . . . . 72.340000000000003 113.738 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.54 116.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.725 0.81 . . . . 64.230000000000004 112.072 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.651 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 57.3 mm-40 64.49 -77.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.054 0 C-N-CA 125.149 1.38 . . . . 73.319999999999993 111.198 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.6 52.63 0.33 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.066 -1.214 . . . . 62.5 110.066 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.18 -40.67 64.54 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.074 0.55 . . . . 61.439999999999998 112.04 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -73.57 -25.76 60.52 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.447 0.536 . . . . 72.439999999999998 112.447 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.21 -39.56 63.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.087 0.555 . . . . 73.519999999999996 111.437 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 62' ' ' THR . 6.6 t -82.89 -31.95 27.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.128 0.571 . . . . 41.310000000000002 111.404 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.23 73.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.448 0.699 . . . . 74.319999999999993 110.927 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.02 -38.51 76.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.549 1.14 . . . . 71.420000000000002 111.58 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.65 98.08 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 123.741 0.65 . . . . 62.450000000000003 111.556 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 118' ' ' VAL . 20.7 t -73.64 -48.47 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.939 -0.393 . . . . 74.209999999999994 109.939 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.57 -21.34 49.38 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.869 0.73 . . . . 71.310000000000002 113.549 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -80.53 -58.55 3.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 74.239999999999995 109.818 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 52' ' ' THR . 24.2 m -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 124.41 1.069 . . . . 74.329999999999998 111.354 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.1 tp -96.18 -29.68 13.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.072 0.949 . . . . 72.540000000000006 110.461 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.57 47.43 10.22 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.32 -0.4 . . . . 61.229999999999997 112.565 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.05 152.63 38.39 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 64.230000000000004 110.234 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.07 34.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.754 0.822 . . . . 54.509999999999998 111.017 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.435 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 14.4 m -94.01 98.92 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.982 0.896 . . . . 64.219999999999999 109.434 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -111.72 163.42 14.16 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.455 1.102 . . . . 70.25 110.606 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 tp -71.98 169.94 14.85 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.165 -0.925 . . . . 63.329999999999998 109.967 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' HD3' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -55.39 -38.06 68.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.327 1.051 . . . . 65.319999999999993 113.106 -176.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.512 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 97.3 mt 59.71 176.43 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 124.322 1.014 . . . . 52.240000000000002 112.957 172.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -53.27 -16.45 7.0 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.216 1.944 . . . . 74.439999999999998 114.193 164.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -54.71 -30.39 55.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.725 1.21 . . . . 71.150000000000006 111.403 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 10.3 tt -62.45 -28.97 70.18 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 71.099999999999994 111.192 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -62.39 -23.17 66.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.14 0.576 . . . . 74.409999999999997 111.707 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -111.29 -33.02 6.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.463 0.705 . . . . 70.230000000000004 111.862 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.799 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 9.0 pt20 -84.07 161.32 55.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.086 0.554 . . . . 64.030000000000001 110.841 -171.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HD2' HG21 ' A' ' 117' ' ' ILE . 40.8 Cg_exo -61.1 152.11 73.84 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.491 2.128 . . . . 72.329999999999998 113.402 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.73 161.54 38.51 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.171 2.581 . . . . 74.209999999999994 112.894 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.76 -166.88 52.43 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.879 -0.6 . . . . 51.119999999999997 111.712 -173.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.25 130.0 35.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 109.145 -0.687 . . . . 71.230000000000004 109.145 172.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 112' ' ' GLN . 17.1 pt -114.31 150.85 16.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.612 -1.255 . . . . 74.430000000000007 107.612 164.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.714 HG22 HG13 ' A' ' 79' ' ' VAL . 61.4 t -119.64 100.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 106.127 -1.805 . . . . 74.430000000000007 106.127 163.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.477 HG11 HG11 ' A' ' 74' ' ' VAL . 6.7 p -95.95 125.09 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.91 -0.774 . . . . 72.140000000000001 108.91 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.56 128.07 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 109.439 -0.578 . . . . 74.230000000000004 109.439 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.441 ' HA ' HG22 ' A' ' 42' ' ' ILE . 72.6 p -107.95 101.47 10.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.185 -1.042 . . . . 70.219999999999999 108.185 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.63 -0.713 . . . . 62.140000000000001 111.704 -174.298 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.049 0 CA-C-O 119.764 -0.464 . . . . 54.32 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 p -79.11 131.24 36.17 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.716 0.806 . . . . 74.030000000000001 111.224 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -142.27 87.26 9.62 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.557 -0.905 . . . . 75.310000000000002 108.557 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.17 157.14 46.52 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.488 2.125 . . . . 71.409999999999997 111.69 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -152.51 143.47 23.01 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.659 0.784 . . . . 74.400000000000006 110.047 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.9 p -167.26 80.5 0.2 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.373 1.069 . . . . 61.030000000000001 108.875 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.15 14.98 12.67 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.513 0.725 . . . . 64.409999999999997 110.586 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.69 -72.85 0.09 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.723 1.209 . . . . 41.210000000000001 110.649 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t70 52.36 95.21 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.049 1.34 . . . . 72.319999999999993 112.776 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -118.93 100.75 7.57 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.356 0.598 . . . . 64.439999999999998 110.636 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.4 m -142.84 103.11 4.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.129 . . . . 54.310000000000002 108.618 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.33 144.35 33.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.066 0.546 . . . . 64.519999999999996 110.126 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 tt -164.9 138.94 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.397 1.079 . . . . 61.130000000000003 108.309 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -143.2 135.63 27.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.324 -0.621 . . . . 73.239999999999995 109.324 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -146.72 135.78 22.51 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.703 0.801 . . . . 54.200000000000003 109.374 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -161.95 141.15 9.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.749 0.82 . . . . 74.5 109.037 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.9 t -165.86 148.4 7.39 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.588 0.755 . . . . 62.310000000000002 109.715 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 t -166.62 147.04 5.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.688 1.195 . . . . 64.010000000000005 107.95 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.0 t -159.13 148.1 18.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.192 0.197 . . . . 73.230000000000004 110.724 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 t -159.75 141.82 13.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.685 0.794 . . . . 65.299999999999997 109.482 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.78 133.91 4.24 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.48 0.712 . . . . 60.25 110.058 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.19 106.06 4.14 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.513 0.725 . . . . 44.030000000000001 109.283 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -90.76 159.99 4.16 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.679 2.253 . . . . 71.019999999999996 111.825 171.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.8 t -156.25 153.95 29.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.016 0.526 . . . . 73.530000000000001 110.474 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.5 p -153.79 166.75 31.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.703 0.801 . . . . 54.409999999999997 109.625 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -142.22 143.89 33.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.568 0.747 . . . . 70.439999999999998 109.055 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 p -148.48 82.96 1.47 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.837 0.855 . . . . 71.230000000000004 108.886 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.5 139.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.602 0.761 . . . . 70.209999999999994 110.915 -174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -118.21 102.94 50.21 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.047 0.939 . . . . 73.310000000000002 109.002 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.42 165.48 32.34 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.985 2.457 . . . . 71.0 112.69 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.29 153.63 23.43 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.859 0.864 . . . . 54.439999999999998 111.014 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.51 120.06 69.6 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.678 0.791 . . . . 64.140000000000001 110.434 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.95 152.23 36.24 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.747 2.298 . . . . 74.150000000000006 112.51 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.425 ' HB3' ' HG2' ' A' ' 85' ' ' GLU . 42.0 ttt180 -166.46 97.04 0.58 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.732 0.813 . . . . 64.010000000000005 109.985 -175.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.16 82.34 2.05 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.791 -0.818 . . . . 43.229999999999997 108.791 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 41.9 mt-10 -115.27 94.44 4.73 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.475 -0.784 . . . . 71.340000000000003 110.682 -169.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.694 HG11 HG21 ' A' ' 94' ' ' VAL . 22.5 t -112.86 147.16 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 123.798 0.839 . . . . 75.040000000000006 111.416 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 31.2 ttp-105 -150.78 110.04 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.486 0.714 . . . . 71.329999999999998 109.719 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' ' 118' ' ' VAL . 60.6 t -87.52 126.42 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.455 0.702 . . . . 73.049999999999997 111.129 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 10.9 m-85 -119.95 107.93 13.71 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.727 0.811 . . . . 75.439999999999998 110.561 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 47.7 t30 -97.91 138.5 35.15 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.278 -0.638 . . . . 74.010000000000005 109.278 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.436 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -97.0 -11.79 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.1 0.476 . . . . 74.409999999999997 111.414 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -156.49 119.44 4.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.259 -1.015 . . . . 73.209999999999994 108.259 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.83 -88.81 0.01 OUTLIER Glycine 0 C--N 1.362 2.002 0 O-C-N 125.154 1.534 . . . . 53.350000000000001 114.52 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 m 51.7 -79.3 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.327 1.451 . . . . 60.340000000000003 113.525 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -86.53 117.6 25.41 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.131 0.972 . . . . 55.210000000000001 110.357 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.99 -18.37 68.74 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.531 0.519 . . . . 55.530000000000001 111.938 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 52' ' ' THR . . . -46.97 -32.37 3.83 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.748 1.619 . . . . 51.310000000000002 113.37 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.28 8.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.533 0.733 . . . . 45.329999999999998 111.911 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.4 60.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.486 0.315 . . . . 51.43 111.078 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.69 -31.32 69.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.378 1.071 . . . . 63.509999999999998 111.253 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.63 ' HB ' HG13 ' A' ' 94' ' ' VAL . 29.1 p -66.35 -56.88 8.97 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 121.988 0.115 . . . . 63.520000000000003 110.817 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.39 66.1 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.905 0.383 . . . . 52.399999999999999 111.651 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.45 -45.93 87.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.402 1.081 . . . . 64.099999999999994 111.597 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -67.42 -43.74 80.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 110.431 -0.211 . . . . 73.049999999999997 110.431 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.9 -32.24 69.35 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.753 0.658 . . . . 72.510000000000005 111.821 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -60.38 -45.21 94.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.275 0.63 . . . . 61.350000000000001 110.7 176.139 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -19.44 45.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.427 0.691 . . . . 73.239999999999995 111.345 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.47 59.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.688 0.795 . . . . 52.039999999999999 111.321 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.87 42.77 5.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.594 -0.275 . . . . 62.240000000000002 113.465 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -90.7 157.0 17.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.794 0.837 . . . . 55.340000000000003 109.821 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 m -72.09 -50.97 23.86 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.643 0.735 . . . . 73.530000000000001 110.71 -164.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 54.9 t -129.21 126.72 64.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 114.138 -1.392 . . . . 63.32 107.446 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.0 p -141.02 84.54 1.94 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.285 -1.005 . . . . 72.299999999999997 108.285 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -103.42 158.12 16.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 43.049999999999997 110.494 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.19 146.85 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.34 1.056 . . . . 75.430000000000007 109.246 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -165.28 137.51 4.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.086 -0.806 . . . . 54.5 111.086 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 4.3 p-10 -105.64 108.39 19.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.554 -0.536 . . . . 64.200000000000003 109.554 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pp -156.26 161.37 40.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.123 0.569 . . . . 74.540000000000006 110.785 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.436 ' HA ' HG13 ' A' ' 42' ' ' ILE . 41.3 m -96.43 127.37 42.36 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.783 0.833 . . . . 74.0 109.636 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.647 ' HB2' HG23 ' A' ' 74' ' ' VAL . 86.4 mt -120.71 149.08 49.71 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.922 0.889 . . . . 74.540000000000006 108.679 171.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.01 -4.29 15.19 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.957 2.438 . . . . 74.230000000000004 113.184 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.47 -6.17 24.31 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.067 0.947 . . . . 74.519999999999996 112.273 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' HB2' ' A' ' 71' ' ' LEU . 90.0 t -74.86 112.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 122.906 0.482 . . . . 74.530000000000001 109.814 177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.86 -41.47 3.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.928 0.891 . . . . 64.209999999999994 110.281 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.7 158.94 41.78 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.952 0.901 . . . . 43.130000000000003 109.212 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.589 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.0 t -61.09 100.49 0.12 Allowed 'General case' 0 C--O 1.243 0.755 0 CA-C-O 122.71 1.243 . . . . 62.409999999999997 109.574 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.0 m -151.3 145.49 25.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.293 -1.322 . . . . 75.129999999999995 109.123 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.706 HG22 HG13 ' A' ' 118' ' ' VAL . 58.2 t -93.74 113.78 29.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.017 -1.105 . . . . 74.019999999999996 108.017 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -94.3 111.12 22.84 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.05 -1.463 . . . . 74.340000000000003 107.05 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 8.2 p90 -120.57 140.6 51.26 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.664 0.745 . . . . 75.109999999999999 112.933 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 84' ' ' VAL . 29.7 m -84.97 152.93 23.11 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.738 -1.208 . . . . 75.019999999999996 107.738 162.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -109.18 19.27 19.65 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.139 0.422 . . . . 71.209999999999994 112.139 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 82' ' ' THR . 77.1 t -69.31 129.0 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.841 -0.8 . . . . 51.549999999999997 108.841 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 34' ' ' ARG . 13.7 tp10 61.04 -81.42 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.119 1.368 . . . . 71.219999999999999 111.401 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.87 33.12 0.3 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.094 -0.503 . . . . 71.519999999999996 111.875 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -69.1 -31.76 70.69 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 122.719 0.408 . . . . 75.140000000000001 111.247 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -73.4 -29.26 62.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.45 0.3 . . . . 70.519999999999996 110.717 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.6 -43.48 55.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.084 0.554 . . . . 74.140000000000001 110.611 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 t -74.24 -22.39 59.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.048 0.539 . . . . 74.219999999999999 109.904 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -70.85 -44.09 67.13 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.387 1.075 . . . . 75.409999999999997 111.513 172.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.74 -35.31 72.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.289 -1.323 . . . . 72.319999999999993 111.721 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.53 83.69 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.71 0.631 . . . . 71.040000000000006 110.987 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.694 HG21 HG11 ' A' ' 37' ' ' VAL . 24.7 t -78.05 -45.9 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.068 -0.969 . . . . 64.430000000000007 111.514 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.4 -26.73 68.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.656 0.597 . . . . 73.230000000000004 112.999 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -75.59 -45.67 36.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.463 0.705 . . . . 65.530000000000001 110.123 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.2 m -61.01 -41.51 96.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.707 0.803 . . . . 73.0 111.122 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 120' ' ' VAL . 47.9 tp -75.82 -31.76 59.52 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.946 -1.025 . . . . 73.510000000000005 110.714 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 45.73 31.31 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.494 -0.642 . . . . 75.0 111.494 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.21 175.35 7.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.937 0.895 . . . . 73.219999999999999 110.282 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.24 164.62 25.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.762 0.425 . . . . 72.439999999999998 110.322 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.602 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.9 m -138.04 140.0 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.216 1.006 . . . . 72.349999999999994 108.333 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -155.63 174.25 15.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.789 0.836 . . . . 75.129999999999995 110.028 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.5 179.82 1.23 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.649 -0.705 . . . . 62.119999999999997 111.94 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -83.11 18.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.66 0.985 . . . . 74.0 113.66 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.13 -47.72 89.73 Favored Pre-proline 0 CA--C 1.558 1.26 0 CA-C-O 118.619 -0.705 . . . . 63.350000000000001 111.761 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.75 -37.79 11.43 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 121.577 1.518 . . . . 55.32 111.517 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.33 -29.82 64.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 74.209999999999994 111.572 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -17.15 64.4 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.305 1.042 . . . . 71.219999999999999 112.404 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -65.91 -45.09 83.21 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.27 0.557 . . . . 75.239999999999995 110.983 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.21 -33.06 29.53 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.477 -0.783 . . . . 74.209999999999994 109.436 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 48.39 71.49 1.58 Allowed Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.054 1.742 . . . . 61.420000000000002 111.311 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.433 ' HB2' ' NH2' ' A' ' 38' ' ' ARG . 44.0 Cg_endo -94.84 162.26 1.76 Allowed 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 123.805 3.003 . . . . 65.219999999999999 113.194 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.26 120.23 0.81 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.759 2.306 . . . . 64.209999999999994 111.265 168.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.19 162.86 20.98 Favored Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.563 -1.015 . . . . 60.450000000000003 110.563 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 91' ' ' ALA . 1.9 p -84.28 137.04 21.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 117.32 0.56 . . . . 74.329999999999998 110.529 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 38' ' ' ARG . 35.5 pt -106.43 123.1 61.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 CA-C-O 121.577 0.703 . . . . 42.420000000000002 109.809 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 79' ' ' VAL . 98.9 t -95.94 103.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.463 -1.31 . . . . 64.120000000000005 107.463 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 69.2 t -94.06 128.77 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 109.866 -0.42 . . . . 52.350000000000001 109.866 -174.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.456 HG22 HD21 ' A' ' 98' ' ' LEU . 22.5 t -113.93 139.39 39.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 107.975 -1.12 . . . . 74.109999999999999 107.975 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.589 ' H ' ' HB ' ' A' ' 77' ' ' THR . 40.3 p -120.06 104.14 9.87 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.927 -0.768 . . . . 73.219999999999999 108.927 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.451 0 CA-C-O 119.352 -0.694 . . . . 71.200000000000003 112.445 175.137 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.907 -0.477 . . . . 63.009999999999998 111.907 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -67.37 111.25 3.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.363 0.665 . . . . 73.219999999999999 110.573 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m -128.62 139.08 34.53 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.446 0.698 . . . . 45.549999999999997 110.285 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.27 -170.39 0.96 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.834 2.356 . . . . 61.509999999999998 112.512 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -146.13 112.36 5.8 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.442 -0.577 . . . . 52.420000000000002 109.442 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.4 p -101.59 74.36 1.51 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.622 -0.881 . . . . 73.010000000000005 108.622 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -92.94 12.68 23.02 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 114.958 -1.019 . . . . 70.340000000000003 111.284 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.63 -70.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.641 0.776 . . . . 74.420000000000002 111.949 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.4 t70 62.71 113.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.804 1.242 . . . . 73.25 111.901 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.7 m -144.73 101.7 3.69 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.13 0.572 . . . . 64.140000000000001 110.637 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -159.35 120.75 3.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.625 0.77 . . . . 73.349999999999994 109.461 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.19 97.13 1.01 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.834 0.854 . . . . 73.420000000000002 109.679 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -148.6 129.1 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.727 0.811 . . . . 73.430000000000007 109.809 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.4 p -168.67 127.09 1.09 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.391 1.076 . . . . 60.520000000000003 109.226 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -149.06 161.88 41.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.109 0.564 . . . . 71.030000000000001 109.963 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.24 149.01 52.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 51.32 110.191 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -152.69 159.62 43.16 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.261 0.625 . . . . 71.25 109.815 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.7 t -149.68 159.66 44.16 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.347 0.659 . . . . 73.439999999999998 109.757 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -162.57 168.32 21.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.046 0.939 . . . . 75.109999999999999 108.841 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.0 t -162.76 142.3 9.11 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.351 0.661 . . . . 71.409999999999997 109.832 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.52 133.49 21.36 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.81 -0.811 . . . . 72.209999999999994 108.81 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.47 123.33 6.36 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 123.53 0.732 . . . . 72.450000000000003 109.676 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.95 -170.67 1.05 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.725 2.283 . . . . 33.340000000000003 111.415 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -137.08 161.15 36.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.104 0.562 . . . . 63.399999999999999 109.781 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 t -147.53 157.43 43.56 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.773 0.829 . . . . 71.430000000000007 109.228 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.9 t -145.4 163.39 34.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.112 0.565 . . . . 72.319999999999993 110.516 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -141.76 165.39 27.59 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.985 0.914 . . . . 74.209999999999994 109.864 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.14 152.3 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.809 0.844 . . . . 64.450000000000003 109.698 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.92 114.06 39.47 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.738 0.815 . . . . 73.329999999999998 109.238 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.45 170.54 6.62 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.272 2.648 . . . . 71.310000000000002 113.371 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.16 148.41 50.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.342 0.657 . . . . 75.319999999999993 110.565 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.65 132.05 26.98 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 123.609 0.763 . . . . 72.120000000000005 110.459 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.52 171.12 18.11 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.935 2.423 . . . . 72.019999999999996 112.122 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.622 ' HA ' HG21 ' A' ' 62' ' ' THR . 10.1 mpt_? -85.66 137.1 33.07 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.587 0.755 . . . . 73.129999999999995 110.636 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . . . -163.43 92.18 0.71 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.079 0.862 . . . . 52.009999999999998 110.646 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.0 mt-10 -84.84 90.61 7.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.528 0.731 . . . . 71.439999999999998 109.934 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.8 t -97.67 122.01 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.08 0.467 . . . . 75.439999999999998 109.873 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.9 ptm180 -142.79 131.46 22.6 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.155 -0.341 . . . . 74.219999999999999 110.99 -167.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' A' ' 118' ' ' VAL . 40.0 t -93.27 131.43 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.588 0.755 . . . . 62.100000000000001 109.875 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 70.3 m-85 -126.02 104.21 8.15 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.939 -0.764 . . . . 71.239999999999995 108.939 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.422 HD21 HG22 ' A' ' 45' ' ' THR . 44.0 t30 -97.21 130.14 44.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.623 -0.88 . . . . 64.540000000000006 108.623 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.639 HG13 ' HA ' ' A' ' 70' ' ' SER . 20.3 tt -102.35 -35.41 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.513 0.197 . . . . 64.120000000000005 111.491 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 m -100.07 151.29 21.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.066 0.546 . . . . 74.439999999999998 110.152 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.56 87.08 0.26 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.533 -0.627 . . . . 73.209999999999994 111.533 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.422 HG22 HD21 ' A' ' 41' ' ' ASN . 11.4 t -126.03 -173.05 2.75 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.783 0.833 . . . . 73.519999999999996 109.543 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -72.65 170.37 14.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.37 1.068 . . . . 72.049999999999997 111.622 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -1.13 50.85 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 118.976 -0.902 . . . . 73.150000000000006 113.979 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.17 28.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 42.109999999999999 112.82 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.94 48.46 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.296 -0.866 . . . . 44.409999999999997 111.157 174.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.21 -21.98 60.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.19 0.596 . . . . 53.100000000000001 111.672 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -63.1 -28.8 70.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.699 1.199 . . . . 53.509999999999998 111.444 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.568 ' HB ' HG13 ' A' ' 94' ' ' VAL . 63.0 p -63.39 -42.35 98.8 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 123.419 0.45 . . . . 72.239999999999995 110.583 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.99 78.42 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.307 0.643 . . . . 74.230000000000004 111.015 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 49.0 m-20 -57.49 -38.58 74.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.075 0.859 . . . . 64.430000000000007 111.932 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.15 -52.89 56.91 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.748 0.655 . . . . 62.229999999999997 110.591 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.4 -28.39 65.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.636 -0.711 . . . . 72.510000000000005 111.351 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 38.4 ttpt -62.36 -43.76 98.06 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.581 0.752 . . . . 74.430000000000007 109.867 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.05 64.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.454 -0.794 . . . . 72.120000000000005 111.157 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -21.06 56.64 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.961 0.726 . . . . 72.400000000000006 112.961 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.79 49.15 0.29 Allowed Glycine 0 C--N 1.358 1.763 0 CA-C-N 118.007 0.367 . . . . 63.130000000000003 113.085 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -57.16 158.04 5.58 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.352 1.061 . . . . 74.540000000000006 112.173 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.622 HG21 ' HA ' ' A' ' 34' ' ' ARG . 17.3 m -91.46 -60.36 1.91 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.37 -0.974 . . . . 74.030000000000001 108.37 168.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 65.3 t -135.55 136.82 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.188 -1.412 . . . . 62.420000000000002 107.188 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.3 p -130.56 146.37 52.07 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.321 0.649 . . . . 75.109999999999999 110.175 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 10.8 t70 -143.51 146.58 33.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.968 -1.015 . . . . 75.450000000000003 108.396 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.02 138.48 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.064 -0.717 . . . . 65.319999999999993 109.064 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.93 143.78 9.27 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.459 -0.337 . . . . 65.150000000000006 112.427 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -109.07 110.91 22.29 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.121 -1.066 . . . . 63.420000000000002 108.121 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.5 tp -151.02 148.91 28.93 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.255 -0.646 . . . . 54.119999999999997 109.255 -169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.639 ' HA ' HG13 ' A' ' 42' ' ' ILE . 12.0 p -77.05 98.65 5.06 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.889 -0.596 . . . . 72.340000000000003 109.997 172.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.2 110.21 31.56 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.22 -1.03 . . . . 72.329999999999998 108.22 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.38 -6.4 17.08 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.456 2.104 . . . . 73.340000000000003 112.532 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 6.2 p-10 -92.55 -23.84 18.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.84 0.856 . . . . 75.109999999999999 111.269 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.98 149.06 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 109.954 -0.387 . . . . 65.409999999999997 109.954 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.99 -5.22 1.69 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.631 0.772 . . . . 33.420000000000002 111.643 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.94 147.42 8.21 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.255 1.022 . . . . 72.129999999999995 109.839 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 121' ' ' THR . 7.8 t -64.42 111.21 2.56 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.416 0.686 . . . . 74.219999999999999 111.296 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -150.2 151.88 33.75 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.835 -0.62 . . . . 60.310000000000002 109.581 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 102' ' ' VAL . 28.9 t -102.22 116.49 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.591 -0.892 . . . . 53.439999999999998 108.591 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HD2' HD11 ' A' ' 117' ' ' ILE . 16.2 m-85 -102.41 148.22 25.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.937 -0.764 . . . . 65.349999999999994 108.937 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.59 169.33 17.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.863 0.84 . . . . 73.349999999999994 112.534 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.4 ' HB ' ' OE1' ' A' ' 87' ' ' GLU . 8.1 m -118.74 166.04 13.27 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 113.751 -1.568 . . . . 45.100000000000001 107.048 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.19 23.13 9.52 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.928 0.714 . . . . 74.420000000000002 112.928 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.61 98.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.202 0.525 . . . . 44.020000000000003 110.038 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.27 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.414 1.485 . . . . 71.239999999999995 111.9 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.03 25.87 2.36 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.075 -0.847 . . . . 71.120000000000005 112.963 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.746 ' HG2' ' HA ' ' A' ' 35' ' ' ALA . 31.3 mt-10 -62.98 -36.81 84.77 Favored 'General case' 0 C--N 1.362 1.127 0 CA-C-N 117.618 0.709 . . . . 75.340000000000003 111.025 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -70.8 -32.36 69.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.214 0.321 . . . . 72.239999999999995 111.754 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.33 -31.83 66.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.231 0.612 . . . . 72.219999999999999 110.515 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.4 m -76.6 -33.27 58.42 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.032 0.933 . . . . 74.439999999999998 109.982 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.47 -34.22 70.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.126 0.971 . . . . 50.439999999999998 111.376 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -50.91 -47.04 60.9 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.604 1.19 . . . . 71.140000000000001 110.765 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.1 83.87 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 124.534 1.146 . . . . 73.099999999999994 111.69 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 52' ' ' THR . 89.4 t -66.74 -52.27 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.12 0.968 . . . . 64.239999999999995 112.11 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -27.08 70.43 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.575 0.547 . . . . 74.299999999999997 111.754 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -78.34 -23.57 46.92 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.396 0.678 . . . . 71.239999999999995 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -78.64 -51.3 10.07 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 122.615 0.366 . . . . 72.129999999999995 110.627 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.1 tp -74.15 -26.61 60.41 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.346 0.658 . . . . 75.219999999999999 111.295 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.29 62.46 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.746 -0.661 . . . . 74.219999999999999 112.064 -172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.4 163.0 13.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.74 0.816 . . . . 63.32 110.666 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.37 134.49 38.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.128 0.571 . . . . 74.310000000000002 110.19 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 79' ' ' VAL . 34.7 m -99.22 138.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.978 -0.749 . . . . 53.350000000000001 108.978 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -154.56 168.74 25.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.7 -0.852 . . . . 61.340000000000003 108.7 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 22.5 tp -65.66 173.03 3.0 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.13 0.572 . . . . 74.120000000000005 109.851 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.5 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.4 ppt_? -49.33 -39.18 30.6 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.167 1.173 . . . . 73.409999999999997 114.167 -167.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 80' ' ' TYR . 41.0 mt 64.56 154.23 0.12 Allowed Pre-proline 0 CA--C 1.565 1.557 0 C-N-CA 124.307 1.043 . . . . 71.299999999999997 112.113 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.18 -29.03 35.78 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.647 2.898 . . . . 44.119999999999997 115.212 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 5.1 pm0 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.608 0.763 . . . . 75.25 112.861 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 0.5 OUTLIER -72.97 8.46 1.55 Allowed 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.188 0.518 . . . . 73.010000000000005 111.614 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 t -82.09 -10.56 59.16 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 61.409999999999997 111.382 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.23 -17.05 18.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 113.419 0.896 . . . . 63.350000000000001 113.419 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 2.0 pp0? -145.98 159.57 46.07 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.465 -0.779 . . . . 73.5 110.267 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 12.6 Cg_endo -52.7 125.4 17.88 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 123.795 2.997 . . . . 74.120000000000005 115.284 -167.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -57.44 153.67 39.9 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.925 3.083 . . . . 62.439999999999998 115.023 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.68 -149.41 21.55 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 109.861 -1.295 . . . . 51.130000000000003 109.861 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.1 t -94.48 105.56 17.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.377 -0.972 . . . . 74.109999999999999 108.377 167.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.562 HD11 ' HD2' ' A' ' 80' ' ' TYR . 32.0 pt -108.21 122.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.12 -1.067 . . . . 54.530000000000001 108.12 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.6 p -96.15 101.21 12.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.702 -1.592 . . . . 74.219999999999999 106.702 164.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 7.1 p -100.12 120.03 49.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.561 -0.745 . . . . 72.420000000000002 109.458 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.49 128.51 65.45 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 123.729 0.812 . . . . 64.019999999999996 110.269 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.677 ' H ' ' HB ' ' A' ' 77' ' ' THR . 77.7 p -112.05 153.28 27.12 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.891 1.276 . . . . 72.129999999999995 108.002 172.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.432 0 CA-C-O 119.141 -0.81 . . . . 41.119999999999997 112.836 178.71 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.825 -0.51 . . . . 32.140000000000001 111.825 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 t -161.72 161.73 29.47 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.399 0.68 . . . . 73.319999999999993 110.136 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.5 m -78.65 124.57 85.19 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.776 0.831 . . . . 73.239999999999995 110.509 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.82 147.85 75.8 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.889 2.392 . . . . 65.209999999999994 112.892 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -100.07 122.96 43.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.265 1.026 . . . . 71.140000000000001 109.173 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.3 t -108.35 84.18 1.9 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.507 -0.923 . . . . 70.430000000000007 108.507 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -81.93 -3.99 55.58 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.453 0.701 . . . . 72.340000000000003 111.687 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -56.21 -55.06 37.77 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.007 0.923 . . . . 72.030000000000001 110.762 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.9 t70 54.96 -89.58 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.258 1.423 . . . . 74.120000000000005 112.127 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 p 173.94 150.45 0.08 Allowed 'General case' 0 C--N 1.368 1.38 0 C-N-CA 125.647 1.579 . . . . 71.129999999999995 109.094 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -157.24 112.08 2.75 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.279 -1.008 . . . . 73.099999999999994 108.279 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.9 140.19 20.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.924 0.489 . . . . 75.150000000000006 110.857 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 tp -149.93 129.3 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.552 0.741 . . . . 63.210000000000001 109.143 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 102.6 4.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.329 0.652 . . . . 74.129999999999995 109.623 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 p -127.04 140.94 51.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.077 0.951 . . . . 73.340000000000003 109.383 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -136.68 165.33 26.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.343 0.657 . . . . 72.409999999999997 109.738 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.4 p -121.43 147.0 46.32 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.141 0.977 . . . . 71.140000000000001 109.423 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -125.02 139.22 54.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.73 0.812 . . . . 75.049999999999997 110.377 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.4 p -123.22 175.29 6.75 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.345 1.058 . . . . 54.32 110.117 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 t -158.67 173.55 16.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.38 0.672 . . . . 65.340000000000003 110.402 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.72 138.4 32.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.699 0.8 . . . . 72.129999999999995 110.539 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.48 157.82 35.58 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.208 1.003 . . . . 74.409999999999997 110.632 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.57 172.98 11.48 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.757 2.304 . . . . 73.010000000000005 112.704 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.3 p -137.47 148.36 46.01 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.604 0.762 . . . . 75.209999999999994 109.595 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -112.12 116.23 30.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.057 0.943 . . . . 74.439999999999998 110.271 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 p -91.51 128.74 37.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.523 0.729 . . . . 73.230000000000004 109.217 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.9 p -72.86 154.53 40.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.177 0.591 . . . . 72.349999999999994 111.145 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.94 141.44 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.892 -0.781 . . . . 74.430000000000007 108.892 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -82.31 149.24 61.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.947 0.499 . . . . 74.310000000000002 110.424 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.57 169.81 16.52 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.625 2.217 . . . . 70.310000000000002 112.288 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -152.27 164.26 37.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.336 0.654 . . . . 74.439999999999998 110.852 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.06 121.8 0.96 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.085 0.954 . . . . 74.400000000000006 109.738 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -77.82 128.34 9.23 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 121.869 1.713 . . . . 74.049999999999997 111.539 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 90.9 mtt-85 -117.29 103.04 9.76 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.447 1.099 . . . . 71.329999999999998 108.071 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.646 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -83.51 -179.26 7.3 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.639 0.733 . . . . 74.400000000000006 111.468 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.664 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.0 mp0 -76.69 106.45 8.36 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.545 -1.207 . . . . 75.049999999999997 108.929 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.18 136.13 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.564 -0.902 . . . . 53.310000000000002 108.564 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HG3' HG22 ' A' ' 117' ' ' ILE . 10.6 ptm180 -146.93 115.15 6.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.498 0.666 . . . . 73.5 111.035 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 53' ' ' ALA . 58.2 t -98.71 116.17 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.101 0.96 . . . . 72.340000000000003 110.215 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 62.9 m-85 -115.69 115.06 25.71 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.705 0.802 . . . . 51.100000000000001 110.606 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.737 ' HB3' ' H ' ' A' ' 45' ' ' THR . 21.7 m-80 -90.16 114.21 26.13 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.087 0.955 . . . . 54.119999999999997 110.054 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -81.52 -53.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 122.267 -0.271 . . . . 65.530000000000001 110.295 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -130.15 7.8 5.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.702 0.401 . . . . 71.450000000000003 111.707 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.17 -61.5 1.91 Allowed Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.895 -0.882 . . . . 70.519999999999996 110.895 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.737 ' H ' ' HB3' ' A' ' 41' ' ' ASN . 6.9 t 43.55 31.8 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 127.231 2.212 . . . . 72.239999999999995 114.195 173.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.84 153.93 51.39 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.587 0.755 . . . . 41.340000000000003 109.448 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.26 -22.66 56.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 124.203 0.939 . . . . 43.210000000000001 114.874 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.54 75.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.131 0.572 . . . . 71.319999999999993 111.233 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 52' ' ' THR . . . -82.96 -42.94 17.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.672 0.789 . . . . 52.210000000000001 111.184 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.56 65.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.586 0.754 . . . . 51.549999999999997 112.1 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -59.42 -28.27 66.79 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.759 1.224 . . . . 63.43 112.708 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 49' ' ' ALA . 6.0 t -69.71 -28.44 65.84 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 119.902 -0.094 . . . . 73.310000000000002 110.97 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -82.55 -32.0 28.81 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.848 0.859 . . . . 73.319999999999993 111.736 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.83 -56.79 17.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.467 1.107 . . . . 64.150000000000006 110.894 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -23.26 53.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.786 -0.643 . . . . 73.430000000000007 110.894 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.427 HD23 HG22 ' A' ' 64' ' ' THR . 15.5 tp -63.89 -40.03 95.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.912 0.885 . . . . 72.010000000000005 110.636 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -61.76 -44.79 96.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.071 -0.968 . . . . 74.420000000000002 109.178 176.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.5 -11.52 60.04 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.74 -1.118 . . . . 63.200000000000003 112.252 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.99 -13.26 53.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.287 0.635 . . . . 71.010000000000005 110.905 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.36 15.24 18.06 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.793 -0.448 . . . . 63.420000000000002 114.059 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 34.2 m-85 -75.49 158.1 33.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.15 0.58 . . . . 73.140000000000001 110.684 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 m -84.63 -60.62 2.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.655 0.382 . . . . 73.349999999999994 111.171 -162.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 46.5 t -116.75 129.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.937 -0.764 . . . . 41.0 108.937 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 HD23 ' A' ' 56' ' ' LEU . 25.3 p -138.31 83.73 1.99 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.535 1.134 . . . . 74.299999999999997 108.087 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -100.1 125.09 46.16 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.69 -0.855 . . . . 53.32 108.69 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 39' ' ' VAL . 29.6 m -117.3 150.31 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.002 0.429 . . . . 74.140000000000001 110.504 -174.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.78 162.23 35.63 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-N 115.456 -0.793 . . . . 55.140000000000001 111.373 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.11 110.67 20.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.81 . . . . 55.520000000000003 109.158 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -145.28 136.84 25.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.608 0.763 . . . . 72.319999999999993 109.998 -170.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -79.7 99.64 7.51 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.937 -0.764 . . . . 52.219999999999999 108.937 171.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.53 ' HB2' HG12 ' A' ' 74' ' ' VAL . 47.8 mt -93.36 140.82 23.33 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 115.893 -0.594 . . . . 75.140000000000001 109.603 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.57 -10.1 14.6 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.575 2.183 . . . . 75.120000000000005 113.175 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.39 -24.36 25.78 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.621 0.768 . . . . 73.340000000000003 111.325 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 71' ' ' LEU . 7.1 p -91.07 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.226 0.61 . . . . 72.120000000000005 110.66 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.79 -0.83 1.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.895 -1.048 . . . . 71.430000000000007 110.325 167.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.3 155.74 18.26 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 125.292 1.437 . . . . 62.100000000000001 108.44 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -62.4 109.74 1.45 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.494 0.664 . . . . 75.140000000000001 110.623 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.9 m -143.92 143.39 31.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.464 0.705 . . . . 71.140000000000001 110.265 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.791 HG22 HG13 ' A' ' 118' ' ' VAL . 92.7 t -105.94 112.81 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.137 -1.06 . . . . 73.430000000000007 108.137 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -98.92 125.03 44.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.828 -0.804 . . . . 64.040000000000006 108.828 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 25.9 p90 -109.34 139.75 43.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.642 0.588 . . . . 72.120000000000005 110.67 175.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 83' ' ' GLU . 2.1 m -82.96 -163.36 0.71 Allowed 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 108.663 -0.866 . . . . 55.210000000000001 108.663 171.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' H ' HG22 ' A' ' 82' ' ' THR . 10.5 pt-20 -136.55 13.27 3.21 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.676 -1.265 . . . . 74.230000000000004 113.408 -160.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.75 108.24 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 N-CA-C 109.337 -0.616 . . . . 72.430000000000007 109.337 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.18 -77.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.761 1.624 . . . . 75.430000000000007 111.448 -172.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.69 57.11 0.31 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.254 -0.739 . . . . 61.520000000000003 111.254 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.59 -17.29 59.85 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.044 0.538 . . . . 74.030000000000001 112.277 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -55.16 -40.56 70.76 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.774 0.43 . . . . 73.219999999999999 110.792 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.23 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.701 0.801 . . . . 53.399999999999999 112.87 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.646 HG21 ' HB3' ' A' ' 35' ' ' ALA . 14.0 t -71.53 -33.2 68.98 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.644 0.378 . . . . 72.319999999999993 111.005 -175.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 81' ' ' TYR . . . -80.85 -30.08 35.75 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 74.549999999999997 111.872 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.617 1.167 . . . . 64.25 110.15 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.96 -27.03 68.56 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.453 -0.794 . . . . 50.520000000000003 112.056 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.715 HG11 HG21 ' A' ' 118' ' ' VAL . 24.0 t -81.4 -58.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 C-N-CA 123.129 0.571 . . . . 73.239999999999995 111.046 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -61.82 -29.23 71.69 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.714 -0.676 . . . . 62.509999999999998 113.865 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -79.27 -24.97 42.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.064 0.546 . . . . 73.310000000000002 110.897 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -77.68 -47.99 17.84 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.088 0.471 . . . . 52.149999999999999 110.015 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 120' ' ' VAL . 51.4 tp -68.56 -32.06 71.71 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.137 0.975 . . . . 50.329999999999998 111.44 -177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.93 34.44 24.3 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-N 116.186 -0.461 . . . . 62.149999999999999 112.352 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.81 140.37 49.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.09 0.956 . . . . 71.439999999999998 108.796 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 130.38 41.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.406 0.682 . . . . 73.349999999999994 110.941 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -86.33 120.79 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 123.884 0.874 . . . . 74.120000000000005 110.296 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -126.8 159.21 34.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.466 1.106 . . . . 73.409999999999997 109.874 176.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.78 168.68 12.86 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.030000000000001 111.632 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -27.59 65.66 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.929 1.291 . . . . 72.430000000000007 113.781 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt 65.03 173.13 0.08 OUTLIER Pre-proline 0 CA--C 1.568 1.654 0 N-CA-C 113.276 0.843 . . . . 72.329999999999998 113.276 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.76 -17.1 34.34 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.438 2.092 . . . . 74.510000000000005 112.67 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 3.2 mp0 -65.05 -15.67 62.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.524 1.129 . . . . 73.420000000000002 112.967 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -61.89 -23.81 66.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 118.473 0.579 . . . . 74.040000000000006 109.505 -178.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.3 p -51.43 -32.5 26.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.943 0.897 . . . . 75.219999999999999 111.826 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.52 -32.29 7.77 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.737 0.815 . . . . 53.009999999999998 111.138 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.555 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 96.2 mt-30 -64.35 133.88 95.8 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.174 0.59 . . . . 62.409999999999997 110.909 -173.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HD2' HG21 ' A' ' 117' ' ' ILE . 52.7 Cg_exo -58.17 147.44 83.7 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.357 2.705 . . . . 71.329999999999998 113.331 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 47.3 Cg_exo -57.55 131.24 43.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.583 2.855 . . . . 72.310000000000002 113.441 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.47 -178.39 31.4 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.937 -0.865 . . . . 63.530000000000001 110.937 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 m -76.4 123.9 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 109.733 -0.469 . . . . 72.540000000000006 109.733 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.568 HG21 ' HD2' ' A' ' 113' ' ' PRO . 22.7 pt -107.49 114.17 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.876 0.846 . . . . 65.519999999999996 109.843 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.791 HG13 HG22 ' A' ' 79' ' ' VAL . 58.6 t -92.62 100.83 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.455 -1.313 . . . . 64.329999999999998 107.455 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 10.9 p -107.41 125.57 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.552 0.691 . . . . 72.310000000000002 110.819 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.403 HG22 HD21 ' A' ' 98' ' ' LEU . 11.3 t -119.67 138.41 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.506 0.723 . . . . 64.209999999999994 111.231 -169.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 t -128.01 132.06 49.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.702 -0.851 . . . . 61.229999999999997 108.702 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 118.723 -1.043 . . . . 64.319999999999993 112.757 -177.603 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.354 -0.299 . . . . 32.009999999999998 112.354 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 p -67.52 100.98 0.92 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.953 0.901 . . . . 72.299999999999997 110.483 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 t -143.3 67.65 16.92 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 123.816 0.846 . . . . 55.420000000000002 109.57 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.41 104.22 1.17 Allowed 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.79 2.327 . . . . 64.340000000000003 110.862 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -123.17 113.71 19.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.743 0.817 . . . . 74.540000000000006 109.152 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -116.99 68.45 0.74 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.696 0.76 . . . . 65.049999999999997 110.269 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -83.45 -18.33 38.97 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.161 -0.927 . . . . 72.400000000000006 111.321 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -72.45 -12.21 61.0 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.686 0.395 . . . . 65.010000000000005 111.765 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.36 102.03 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.464 1.106 . . . . 71.230000000000004 111.685 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.4 p -107.57 163.65 12.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.124 0.97 . . . . 60.240000000000002 110.548 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.1 t -112.63 163.38 14.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.617 0.767 . . . . 71.109999999999999 110.144 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 131.96 20.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 109.841 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.7 pt -136.63 121.42 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.657 0.783 . . . . 72.430000000000007 109.737 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -157.17 129.75 7.5 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.259 1.024 . . . . 73.430000000000007 109.36 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -149.03 115.59 5.89 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.725 -0.842 . . . . 64.120000000000005 108.725 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -141.73 109.77 5.84 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.891 -1.151 . . . . 70.150000000000006 107.891 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -139.56 119.37 13.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.476 0.655 . . . . 65.230000000000004 110.292 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 p -142.15 150.24 40.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.844 1.258 . . . . 65.310000000000002 108.689 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.4 p -142.48 152.92 43.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.447 1.099 . . . . 53.329999999999998 108.963 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -159.85 155.34 25.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.065 0.546 . . . . 74.430000000000007 110.664 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.15 157.52 23.34 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.409 1.083 . . . . 35.229999999999997 109.051 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.92 107.15 11.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.43 0.692 . . . . 64.299999999999997 109.568 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.98 -172.82 1.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.98 2.453 . . . . 74.430000000000007 112.167 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -170.21 146.13 2.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.598 0.759 . . . . 54.409999999999997 110.174 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.3 p -92.64 166.8 12.3 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.289 -0.634 . . . . 73.430000000000007 109.289 171.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.4 t -133.72 137.28 45.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.253 0.621 . . . . 74.439999999999998 110.509 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.4 p -167.46 153.01 7.4 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.634 0.774 . . . . 62.409999999999997 110.235 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -167.33 109.81 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 C-N-CA 123.713 0.805 . . . . 73.530000000000001 110.403 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -126.33 120.42 23.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 123.347 0.659 . . . . 64.239999999999995 110.361 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -84.37 124.19 3.17 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.464 2.11 . . . . 64.239999999999995 111.32 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.91 109.68 1.61 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.267 0.627 . . . . 45.329999999999998 110.189 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.46 84.97 2.81 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.834 0.854 . . . . 63.43 109.248 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -78.32 129.0 9.24 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.402 2.068 . . . . 63.200000000000003 111.478 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -93.0 -164.88 1.24 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.652 0.781 . . . . 74.400000000000006 110.168 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.75 155.87 34.81 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 109.524 -0.547 . . . . 53.030000000000001 109.524 169.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . 8.6 pt-20 -66.54 121.56 15.63 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.424 -0.807 . . . . 73.140000000000001 110.224 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 t -92.76 144.3 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.126 -0.943 . . . . 72.409999999999997 109.073 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 5.9 ptp85 -151.25 161.19 43.16 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.92 0.488 . . . . 74.420000000000002 110.885 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 50' ' ' ALA . 58.8 t -126.27 123.89 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.955 . . . . 75.319999999999993 109.081 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -112.31 108.06 17.12 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 124.286 1.035 . . . . 74.340000000000003 109.326 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -78.5 112.99 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.772 -1.195 . . . . 51.530000000000001 107.772 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 70' ' ' SER . 3.0 tp -75.85 -43.25 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.362 -0.607 . . . . 52.210000000000001 109.362 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -144.17 156.02 44.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.888 0.875 . . . . 74.310000000000002 108.843 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.89 6.94 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.146 -0.808 . . . . 74.109999999999999 113.325 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.2 t 40.79 78.46 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.949 1.7 . . . . 54.340000000000003 113.106 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -121.68 114.49 21.21 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.914 0.485 . . . . 70.040000000000006 110.468 -174.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.01 -11.9 84.92 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.42 -0.809 . . . . 71.219999999999999 113.605 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.62 91.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.237 0.615 . . . . 75.530000000000001 110.9 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -70.7 -33.39 70.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.689 -0.687 . . . . 41.229999999999997 110.727 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' HG21 ' A' ' 39' ' ' VAL . . . -77.49 -21.87 52.13 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.366 0.666 . . . . 71.340000000000003 112.135 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -66.08 -28.67 69.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.843 1.257 . . . . 63.439999999999998 111.049 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 98' ' ' LEU . 78.2 p -63.02 -46.47 87.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.136 0.574 . . . . 63.539999999999999 110.713 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.58 65.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.535 0.734 . . . . 63.109999999999999 111.169 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.09 -28.62 69.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.176 0.59 . . . . 71.510000000000005 111.415 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -69.04 -36.98 78.32 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.603 0.361 . . . . 74.329999999999998 110.659 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.6 mp -62.54 -24.29 67.43 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.17 0.588 . . . . 63.109999999999999 111.586 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -56.42 -49.02 75.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.262 0.625 . . . . 64.109999999999999 110.314 173.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.02 -24.12 41.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.515 -0.766 . . . . 75.329999999999998 111.613 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -74.5 -17.31 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.374 0.67 . . . . 65.230000000000004 111.928 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 33.73 2.53 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.055 0.382 . . . . 65.219999999999999 114.055 170.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -100.37 157.62 16.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.512 0.725 . . . . 62.200000000000003 109.815 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -62.31 -73.82 0.1 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.881 . . . . 64.409999999999997 112.291 -161.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 75.6 t -123.02 144.29 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.319 -1.363 . . . . 64.099999999999994 107.319 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 p -138.6 101.36 4.32 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.987 -1.486 . . . . 75.510000000000005 106.987 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 9.3 t70 -107.21 149.62 27.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 64.140000000000001 109.967 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.418 HG22 ' HB1' ' A' ' 50' ' ' ALA . 88.7 t -127.32 137.14 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.942 0.897 . . . . 61.329999999999998 108.995 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.43 159.6 32.54 Favored Glycine 0 C--N 1.344 1.018 0 O-C-N 123.539 0.524 . . . . 61.0 111.862 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -123.97 104.74 9.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.461 1.105 . . . . 74.420000000000002 108.314 174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 mp -133.36 134.09 43.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.049 0.54 . . . . 54.140000000000001 110.13 -171.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.496 ' HA ' HD12 ' A' ' 42' ' ' ILE . 24.6 p -85.4 98.68 10.71 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.543 -0.753 . . . . 62.030000000000001 108.975 172.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.652 ' HB2' HG22 ' A' ' 74' ' ' VAL . 82.6 mt -107.35 141.6 23.32 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.434 -0.951 . . . . 75.25 108.434 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.86 -17.87 17.38 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.575 2.183 . . . . 72.129999999999995 113.403 -169.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -94.78 -24.61 17.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.208 1.003 . . . . 73.239999999999995 111.844 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 108' ' ' GLU . 13.1 m -91.88 147.03 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.844 0.457 . . . . 41.009999999999998 109.975 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -164.79 -41.79 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.817 0.847 . . . . 35.119999999999997 109.772 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.58 134.45 33.63 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.007 -0.997 . . . . 41.219999999999999 110.325 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.627 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.8 t -74.83 98.24 3.47 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 122.272 1.034 . . . . 73.239999999999995 109.114 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' A' ' 80' ' ' TYR . 63.2 m -153.83 155.03 35.03 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.377 -1.283 . . . . 73.010000000000005 108.808 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.694 HG13 HG22 ' A' ' 118' ' ' VAL . 23.5 t -94.57 116.22 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.516 -0.92 . . . . 64.530000000000001 108.516 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CZ ' ' HB ' ' A' ' 78' ' ' THR . 75.4 m-85 -108.53 132.75 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.4 0.68 . . . . 73.409999999999997 111.904 -171.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.588 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 38.9 p90 -144.59 -177.18 5.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.919 0.888 . . . . 74.200000000000003 110.662 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -141.09 -91.72 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 118.891 -0.576 . . . . 74.010000000000005 110.095 165.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.47 -22.18 0.82 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.266 1.21 . . . . 60.109999999999999 114.266 -170.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 95.9 t -58.88 117.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 124.161 0.984 . . . . 54.119999999999997 112.046 -169.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 52.52 25.86 3.88 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.533 1.133 . . . . 61.149999999999999 113.635 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.11 57.59 5.63 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.774 -0.53 . . . . 44.130000000000003 111.774 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.1 mt-10 -52.69 -44.95 66.61 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.768 . . . . 72.439999999999998 111.989 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -65.34 -25.38 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.819 0.847 . . . . 73.319999999999993 112.566 -176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.96 0.504 . . . . 52.509999999999998 110.615 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.426 HG23 HG11 ' A' ' 116' ' ' VAL . 10.0 t -82.33 -26.99 32.52 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.469 -0.787 . . . . 71.209999999999994 111.177 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.728 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -69.03 -36.69 78.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.832 0.853 . . . . 44.039999999999999 111.012 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.23 -49.29 78.19 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 124.746 1.279 . . . . 73.030000000000001 109.766 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.86 78.54 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.352 1.032 . . . . 53.5 112.025 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 118' ' ' VAL . 64.8 t -63.65 -53.89 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 122.974 0.51 . . . . 61.409999999999997 110.548 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.74 -23.46 69.06 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 124.164 0.915 . . . . 61.020000000000003 113.87 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -76.1 -39.35 55.46 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.955 -0.757 . . . . 71.230000000000004 108.955 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.7 m -74.6 -34.45 62.85 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.308 -0.86 . . . . 74.519999999999996 112.119 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.573 ' HB3' HG21 ' A' ' 52' ' ' THR . 3.4 pp -93.74 -17.57 23.03 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.127 0.421 . . . . 62.450000000000003 111.932 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.48 52.75 4.08 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 113.966 0.346 . . . . 52.32 113.966 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.73 168.41 16.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.756 0.822 . . . . 63.439999999999998 109.718 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.46 165.5 25.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.599 0.759 . . . . 63.43 110.604 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.588 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 31.2 m -123.8 114.81 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 123.55 0.74 . . . . 55.119999999999997 109.586 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 35.5 mm-40 -124.39 174.78 7.53 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.538 1.135 . . . . 74.239999999999995 110.156 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.16 149.48 27.93 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.676 -0.693 . . . . 74.409999999999997 109.874 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 24.4 ptt180 -88.09 28.38 1.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.757 1.223 . . . . 72.019999999999996 111.641 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.596 ' HG ' ' HD3' ' A' ' 107' ' ' PRO . 4.3 pp -68.12 -32.31 3.93 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 117.597 -1.192 . . . . 55.130000000000003 112.728 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.596 ' HD3' ' HG ' ' A' ' 106' ' ' LEU . 13.1 Cg_exo -75.16 -34.48 3.66 Favored 'Trans proline' 0 C--N 1.405 3.506 0 CA-C-N 122.518 1.935 . . . . 73.219999999999999 111.914 167.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.711 ' HG3' HG12 ' A' ' 74' ' ' VAL . 8.3 mp0 -72.43 -10.5 59.87 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.542 1.137 . . . . 74.030000000000001 111.077 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 112' ' ' GLN . 13.1 tp -68.78 -12.41 61.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.31 1.044 . . . . 73.310000000000002 111.12 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -61.9 -46.78 87.9 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.619 0.768 . . . . 42.200000000000003 110.909 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.01 -33.82 26.45 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.795 0.838 . . . . 53.539999999999999 109.677 172.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.469 ' HG2' HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER 57.57 74.22 0.68 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.983 1.313 . . . . 71.0 111.028 -179.162 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 79.3 Cg_endo -83.41 132.69 6.0 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 122.712 2.275 . . . . 75.299999999999997 111.656 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 51.8 Cg_exo -58.32 152.65 52.12 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.705 2.937 . . . . 63.350000000000001 114.409 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.26 -167.5 27.38 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.222 -0.899 . . . . 72.409999999999997 113.616 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.728 HG21 ' HB2' ' A' ' 91' ' ' ALA . 3.2 p -87.06 131.95 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.311 -0.625 . . . . 73.230000000000004 109.311 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.46 149.81 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.859 0.864 . . . . 60.100000000000001 109.829 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 79' ' ' VAL . 47.7 t -121.55 103.58 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.036 -1.468 . . . . 60.149999999999999 107.036 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.595 HG11 ' HB ' ' A' ' 74' ' ' VAL . 95.5 t -93.51 123.82 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.518 -0.919 . . . . 73.340000000000003 108.518 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.472 HG21 ' HB1' ' A' ' 49' ' ' ALA . 58.0 t -128.74 129.86 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.342 0.657 . . . . 54.310000000000002 109.84 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.627 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.5 t -105.8 155.86 18.88 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.332 0.653 . . . . 74.129999999999995 109.83 168.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.027 0 CA-C-O 119.174 -0.792 . . . . 37.369999999999997 111.764 179.569 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.874 0 N-CA-C 112.109 -0.397 . . . . 61.140000000000001 112.109 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -169.4 163.25 10.54 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.192 0.597 . . . . 40.549999999999997 110.563 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -149.93 141.91 15.3 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.909 0.884 . . . . 71.299999999999997 109.465 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.16 139.97 47.94 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.722 2.281 . . . . 74.519999999999996 112.666 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -101.54 129.01 47.53 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.63 0.772 . . . . 73.120000000000005 109.448 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -141.75 35.39 1.6 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.652 0.781 . . . . 71.540000000000006 110.032 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -85.64 2.44 45.17 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.016 0.526 . . . . 74.120000000000005 111.884 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.0 -69.23 0.36 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.204 0.602 . . . . 70.430000000000007 110.571 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.0 t70 59.84 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.034 1.334 . . . . 54.530000000000001 111.87 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.0 t -103.61 103.74 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.727 -0.842 . . . . 74.450000000000003 108.727 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.9 m -134.47 123.49 24.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.68 0.792 . . . . 55.350000000000001 110.334 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.63 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.696 0.798 . . . . 55.100000000000001 110.23 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.69 143.16 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.072 -1.084 . . . . 74.430000000000007 108.072 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -164.24 111.92 1.11 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 74.219999999999999 110.225 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.1 t -161.71 125.81 3.3 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.305 1.042 . . . . 71.200000000000003 109.333 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.3 ptp -171.57 146.44 2.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.906 0.882 . . . . 73.030000000000001 110.241 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -173.58 141.19 0.84 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.042 0.937 . . . . 64.209999999999994 109.66 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.6 t -167.13 106.23 0.58 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.468 0.707 . . . . 74.120000000000005 110.64 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -161.1 102.92 1.27 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.251 1.421 . . . . 74.299999999999997 109.082 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.1 p -135.58 125.7 26.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.757 0.823 . . . . 74.340000000000003 109.947 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.34 132.05 7.72 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.173 0.989 . . . . 54.229999999999997 109.942 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.48 107.35 10.08 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.617 0.767 . . . . 74.519999999999996 109.983 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.41 144.75 20.57 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.953 2.435 . . . . 61.310000000000002 111.863 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.3 p -122.41 148.41 45.14 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.694 0.398 . . . . 70.150000000000006 110.685 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m -146.28 111.88 5.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.716 0.806 . . . . 53.530000000000001 109.925 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.5 p -124.74 129.45 50.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.92 0.888 . . . . 55.329999999999998 109.473 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 m -150.49 111.45 4.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.739 0.816 . . . . 75.430000000000007 108.873 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.75 131.36 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.484 0.714 . . . . 72.230000000000004 109.992 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -123.79 112.73 28.84 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.146 0.979 . . . . 73.310000000000002 108.747 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.13 120.65 8.45 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.391 2.061 . . . . 74.230000000000004 111.633 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -177.81 122.93 0.11 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.738 0.815 . . . . 63.210000000000001 109.861 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -170.19 95.7 0.47 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 123.848 0.859 . . . . 63.219999999999999 109.086 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.66 127.56 12.52 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.998 1.799 . . . . 72.439999999999998 111.158 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -105.57 -84.53 0.5 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.79 -0.818 . . . . 64.5 108.79 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -152.7 174.71 13.67 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.293 0.637 . . . . 63.520000000000003 110.17 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.81 108.13 19.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.008 0.923 . . . . 71.329999999999998 110.441 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 41.3 t -106.88 138.7 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.192 0.997 . . . . 61.409999999999997 109.613 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.53 128.95 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.433 -0.58 . . . . 73.120000000000005 109.433 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 53' ' ' ALA . 98.3 t -103.72 128.11 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.34 0.656 . . . . 75.319999999999993 109.389 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.654 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 38.3 m-85 -124.03 131.45 53.56 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.423 0.689 . . . . 74.519999999999996 110.286 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -85.7 112.08 20.7 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.988 -1.115 . . . . 72.519999999999996 107.988 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.825 HD11 ' HA ' ' A' ' 71' ' ' LEU . 9.2 tp -75.31 -47.19 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.042 0.449 . . . . 74.030000000000001 111.355 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 m -107.51 3.18 24.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.988 0.915 . . . . 72.219999999999999 110.383 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 136.83 1.48 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.52 -0.632 . . . . 51.100000000000001 111.52 -170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 t -157.28 -178.95 7.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.359 0.664 . . . . 71.519999999999996 110.032 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.72 154.11 42.22 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.222 1.009 . . . . 32.109999999999999 111.071 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.79 -2.49 16.99 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 115.022 0.769 . . . . 42.439999999999998 115.022 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.51 -28.12 69.73 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.612 0.765 . . . . 74.329999999999998 111.518 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.2 -42.75 75.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.277 0.631 . . . . 42.310000000000002 110.576 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.36 -28.46 67.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.61 -0.723 . . . . 73.540000000000006 111.667 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -65.28 -24.95 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.601 1.16 . . . . 74.329999999999998 111.752 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 98' ' ' LEU . 68.9 p -71.89 -47.59 51.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.367 0.267 . . . . 75.329999999999998 110.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -61.73 -40.1 93.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.308 0.575 . . . . 73.140000000000001 110.639 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.29 -32.96 74.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.532 -1.213 . . . . 63.399999999999999 111.422 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -72.04 -41.07 67.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.054 0.542 . . . . 73.340000000000003 109.66 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -70.91 -26.03 63.03 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.394 -0.821 . . . . 72.299999999999997 111.336 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -61.71 -51.22 69.29 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.077 -0.712 . . . . 71.439999999999998 109.077 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.3 71.36 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.152 -0.931 . . . . 74.209999999999994 111.143 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.43 1.25 16.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.536 0.734 . . . . 73.010000000000005 112.309 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.6 40.19 11.27 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 113.96 0.344 . . . . 54.530000000000001 113.96 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -89.09 155.27 19.56 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.246 0.523 . . . . 73.209999999999994 109.76 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -66.03 -60.33 2.94 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.041 0.756 . . . . 75.200000000000003 113.041 -159.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.27 103.21 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.326 -0.99 . . . . 63.5 108.326 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 16.8 p -107.96 105.51 15.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 73.430000000000007 109.86 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -115.16 156.64 24.9 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.649 1.18 . . . . 73.400000000000006 109.679 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.77 144.54 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.768 0.427 . . . . 72.409999999999997 111.023 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.57 -158.54 13.61 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.498 -0.641 . . . . 60.409999999999997 111.498 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -107.49 173.42 6.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.23 -0.656 . . . . 74.310000000000002 109.23 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 27.7 tp -144.51 138.99 27.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 111.258 0.096 . . . . 63.25 111.258 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.7 p -87.57 133.58 33.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.67 -0.863 . . . . 72.230000000000004 108.67 170.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.825 ' HA ' HD11 ' A' ' 42' ' ' ILE . 32.4 tp -44.17 101.45 0.25 Allowed Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 125.177 1.391 . . . . 72.129999999999995 113.949 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.85 -100.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.109 2.539 . . . . 32.329999999999998 109.96 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.07 -22.13 12.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.054 0.942 . . . . 45.109999999999999 111.621 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.97 128.07 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.647 -0.501 . . . . 74.400000000000006 109.647 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.57 16.43 9.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.937 0.895 . . . . 71.439999999999998 111.536 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 156.97 46.17 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.559 0.744 . . . . 45.340000000000003 109.916 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 t -62.34 100.47 0.18 Allowed 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.057 0.932 . . . . 74.310000000000002 110.316 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.2 m -148.12 143.07 26.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 72.340000000000003 109.321 -172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 118' ' ' VAL . 42.6 t -95.94 115.86 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.603 -1.258 . . . . 42.030000000000001 107.603 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.553 ' HB3' HG13 ' A' ' 117' ' ' ILE . 32.3 t80 -107.86 113.76 27.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.908 -1.145 . . . . 74.340000000000003 107.908 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.548 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 41.9 p90 -141.32 147.43 38.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.135 0.791 . . . . 74.129999999999995 113.135 -170.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -85.94 -157.82 0.36 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.96 -1.126 . . . . 70.329999999999998 107.96 167.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 82' ' ' THR . 47.2 mt-10 -124.99 7.18 7.97 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.108 -0.995 . . . . 64.310000000000002 110.907 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 98.7 t -66.61 128.41 29.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 123.82 0.848 . . . . 74.310000000000002 109.603 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 84' ' ' VAL . 35.4 mt-10 62.1 20.9 12.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.523 0.729 . . . . 74.040000000000006 111.125 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.35 35.5 52.31 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.683 -0.51 . . . . 63.32 113.387 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 29.4 mt-10 -52.57 -33.47 45.98 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.933 0.716 . . . . 74.239999999999995 112.933 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -64.57 -31.34 72.52 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.839 0.455 . . . . 74.209999999999994 112.182 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.99 -37.41 29.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.505 0.722 . . . . 75.040000000000006 111.554 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.466 HG21 ' HB3' ' A' ' 35' ' ' ALA . 69.5 p -74.41 -36.83 63.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.466 -0.788 . . . . 72.219999999999999 110.894 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -30.72 69.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.498 -1.228 . . . . 63.409999999999997 111.89 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.29 -44.33 92.52 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.333 1.021 . . . . 72.120000000000005 110.136 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.01 75.26 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.516 -0.765 . . . . 53.130000000000003 112.272 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.667 HG11 HG21 ' A' ' 118' ' ' VAL . 64.3 t -74.32 -59.3 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.498 -0.319 . . . . 74.219999999999999 110.519 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.84 -23.05 55.67 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.811 0.694 . . . . 72.109999999999999 114.011 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -67.87 -60.03 2.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.485 1.114 . . . . 73.409999999999997 109.758 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.6 m -71.63 -32.76 68.3 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 114.902 -1.045 . . . . 74.200000000000003 111.141 -172.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.57 ' HB2' HG21 ' A' ' 52' ' ' THR . 48.7 tp -81.11 -27.28 35.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.941 0.896 . . . . 72.239999999999995 110.497 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.74 43.65 83.68 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.564 0.54 . . . . 74.420000000000002 112.667 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.53 25.04 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.774 0.83 . . . . 75.109999999999999 110.173 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.77 139.98 58.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.32 0.648 . . . . 75.409999999999997 110.355 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.548 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.2 m -112.15 131.83 62.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.425 0.69 . . . . 52.109999999999999 109.24 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.53 144.2 46.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.565 0.746 . . . . 74.439999999999998 111.309 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.636 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 16.2 tp -66.36 -177.2 0.51 Allowed 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 114.198 -1.364 . . . . 73.420000000000002 110.815 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.636 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 6.7 ppt_? -56.51 -28.6 60.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.863 1.265 . . . . 65.040000000000006 113.733 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 104' ' ' LEU . 74.6 mt 62.1 168.04 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.538 1.135 . . . . 74.200000000000003 113.039 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -73.25 -12.34 25.35 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.285 1.99 . . . . 44.399999999999999 112.605 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -69.49 -18.85 63.73 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.227 1.011 . . . . 64.530000000000001 112.624 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.8 -4.26 19.27 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.666 0.617 . . . . 63.340000000000003 112.666 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -60.25 -21.72 62.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.266 0.626 . . . . 61.340000000000003 111.763 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -115.51 -32.99 5.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.84 0.856 . . . . 74.209999999999994 110.83 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -96.41 127.03 41.51 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.065 0.946 . . . . 74.219999999999999 110.846 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.96 134.11 57.94 Favored 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 122.18 1.92 . . . . 75.219999999999999 112.7 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.91 163.12 32.16 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.278 2.652 . . . . 70.420000000000002 113.415 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 130.58 146.36 5.9 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 108.647 -1.781 . . . . 43.450000000000003 108.647 -171.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 53.7 t -65.0 99.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 118.718 1.259 . . . . 55.420000000000002 108.767 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.553 HG13 ' HB3' ' A' ' 80' ' ' TYR . 29.4 pt -107.57 106.93 21.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.467 -1.308 . . . . 71.120000000000005 107.467 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG22 HG13 ' A' ' 79' ' ' VAL . 42.1 t -89.83 101.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.34 -1.356 . . . . 60.229999999999997 107.34 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.401 HG13 ' HB ' ' A' ' 42' ' ' ILE . 65.0 t -93.67 113.14 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.33 -1.359 . . . . 73.329999999999998 107.33 -174.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.53 127.36 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 110.223 -0.288 . . . . 72.209999999999994 110.223 -171.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -89.98 160.54 16.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.938 0.895 . . . . 74.430000000000007 109.743 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.958 -0.912 . . . . 61.009999999999998 111.373 178.509 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.113 -0.395 . . . . 55.130000000000003 112.113 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 t -136.85 144.84 43.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.166 0.586 . . . . 61.130000000000003 110.279 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -85.54 141.35 36.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.003 0.921 . . . . 74.420000000000002 110.797 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -60.13 139.65 88.46 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.967 2.445 . . . . 73.239999999999995 112.387 168.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -100.97 136.93 40.04 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.294 0.638 . . . . 73.299999999999997 110.45 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -121.41 56.28 1.05 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.677 -0.86 . . . . 72.150000000000006 108.677 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -84.46 0.6 49.02 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.19 -0.914 . . . . 72.049999999999997 112.308 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.48 -45.24 81.06 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.435 1.094 . . . . 72.0 111.555 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.3 t70 68.95 141.83 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.008 1.323 . . . . 53.140000000000001 112.929 172.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.5 m -92.93 -179.69 5.19 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.0 0.92 . . . . 71.230000000000004 110.393 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -160.76 145.12 13.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.03 0.532 . . . . 63.130000000000003 109.974 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.73 139.47 20.75 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.463 0.705 . . . . 71.230000000000004 109.941 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -108.87 167.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.008 0.923 . . . . 73.329999999999998 111.057 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 t -83.84 -167.29 1.67 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.324 1.049 . . . . 63.210000000000001 110.419 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.9 m -141.04 137.28 32.82 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.034 0.934 . . . . 73.319999999999993 109.246 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.495 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.5 OUTLIER -95.09 127.67 41.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.84 0.856 . . . . 74.120000000000005 110.134 -175.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 m -145.9 144.33 30.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.76 0.824 . . . . 73.109999999999999 109.776 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -145.01 166.06 26.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.88 0.872 . . . . 75.040000000000006 110.638 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -136.95 143.31 42.79 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.662 0.785 . . . . 45.100000000000001 109.83 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 t -103.11 176.45 5.14 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.321 1.048 . . . . 72.209999999999994 110.107 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.8 170.53 15.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.461 0.704 . . . . 50.210000000000001 110.482 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.36 120.06 15.7 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.344 1.057 . . . . 64.150000000000006 109.968 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.04 159.97 37.12 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.626 2.217 . . . . 43.520000000000003 112.422 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -149.42 140.02 22.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 71.400000000000006 109.322 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -145.45 139.68 27.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.227 0.611 . . . . 74.409999999999997 110.038 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -121.41 176.01 5.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.136 0.974 . . . . 72.230000000000004 109.947 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.2 p -146.65 136.76 23.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.814 0.846 . . . . 73.430000000000007 109.646 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.83 147.91 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.402 0.681 . . . . 62.240000000000002 110.251 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -103.86 157.02 34.8 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 123.81 0.844 . . . . 63.520000000000003 109.844 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.43 163.42 23.83 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.477 2.118 . . . . 72.219999999999999 111.708 170.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.95 173.47 7.41 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.248 0.619 . . . . 72.329999999999998 111.213 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.25 147.22 33.84 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.852 0.861 . . . . 71.439999999999998 110.006 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.05 163.23 29.46 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.075 2.517 . . . . 71.129999999999995 112.795 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -140.08 147.19 39.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.188 0.44 . . . . 74.0 112.188 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.491 ' H ' HG21 ' A' ' 62' ' ' THR . . . -86.08 177.76 7.45 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.611 1.164 . . . . 34.140000000000001 110.554 173.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -142.25 102.21 4.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.755 0.822 . . . . 72.439999999999998 109.96 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 64' ' ' THR . 11.4 t -114.67 151.35 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-O 121.839 0.828 . . . . 74.299999999999997 111.584 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.619 ' HB3' HG22 ' A' ' 117' ' ' ILE . 33.2 ttm105 -153.64 141.29 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.121 1.369 . . . . 72.510000000000005 108.872 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' HB1' ' A' ' 49' ' ' ALA . 39.0 t -131.48 119.83 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.7 0.8 . . . . 73.329999999999998 108.904 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' CE2' HD23 ' A' ' 71' ' ' LEU . 45.4 p90 -141.6 149.13 40.31 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.09 0.471 . . . . 73.450000000000003 111.125 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -78.81 141.28 37.88 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.09 -0.959 . . . . 74.239999999999995 109.051 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.556 HD13 HG13 ' A' ' 74' ' ' VAL . 9.2 tp -79.61 -36.97 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 122.783 0.433 . . . . 73.150000000000006 110.123 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -96.39 -39.14 9.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.647 0.779 . . . . 43.509999999999998 109.96 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.08 60.82 2.2 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.953 -0.567 . . . . 70.109999999999999 112.004 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m -119.17 -42.64 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.596 0.759 . . . . 62.0 110.812 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -122.22 148.13 45.35 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.025 0.53 . . . . 75.510000000000005 110.926 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.03 1.57 63.13 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.124 -0.82 . . . . 54.520000000000003 114.274 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.18 -35.03 10.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.742 1.217 . . . . 74.400000000000006 113.368 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB1' HG12 ' A' ' 39' ' ' VAL . . . -63.07 -52.2 63.68 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.226 0.611 . . . . 61.009999999999998 111.033 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.87 -27.48 68.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.412 -0.813 . . . . 71.400000000000006 111.402 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 18.4 ttm180 -70.46 -52.4 22.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.522 0.729 . . . . 74.109999999999999 110.644 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -72.97 -23.96 60.72 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.075 -0.511 . . . . 74.049999999999997 110.954 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.42 -20.67 54.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.974 0.909 . . . . 33.32 111.816 173.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 51' ' ' ARG . 15.4 t70 -72.45 -41.1 66.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.276 1.03 . . . . 54.130000000000003 109.11 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.51 -38.0 89.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.593 -1.185 . . . . 75.439999999999998 109.556 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 HG11 ' A' ' 37' ' ' VAL . 62.6 tp -63.12 -50.65 69.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.116 0.966 . . . . 52.200000000000003 112.331 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -67.66 -27.17 66.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.846 0.355 . . . . 70.439999999999998 110.811 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.82 -20.85 34.87 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.679 0.791 . . . . 71.209999999999994 111.202 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.6 -23.48 27.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.541 0.736 . . . . 72.140000000000001 111.623 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.74 48.89 0.32 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.718 -0.49 . . . . 63.25 112.988 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 1.5 p90 -57.32 157.46 6.44 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.403 0.681 . . . . 73.099999999999994 111.099 174.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.491 HG21 ' H ' ' A' ' 35' ' ' ALA . 28.3 m -89.97 -66.34 0.93 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.133 -1.062 . . . . 62.299999999999997 108.133 173.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -144.28 134.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.135 -1.802 . . . . 63.539999999999999 106.135 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 91.4 m -143.25 123.59 13.85 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 122.836 0.454 . . . . 74.109999999999999 109.891 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -102.08 126.01 48.92 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.721 -0.844 . . . . 72.109999999999999 108.721 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.76 146.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.873 0.469 . . . . 71.519999999999996 110.25 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.25 -136.04 3.94 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 123.476 0.485 . . . . 75.310000000000002 113.314 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -159.39 117.53 2.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.115 0.966 . . . . 62.240000000000002 109.677 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.2 tp -150.65 140.7 22.05 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.257 0.623 . . . . 73.25 109.767 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.444 ' HA ' HD12 ' A' ' 42' ' ' ILE . 39.0 m -88.61 99.35 12.26 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.302 0.641 . . . . 73.439999999999998 110.236 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' CE2' ' A' ' 40' ' ' TYR . 4.5 mm? -85.05 125.16 71.16 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.351 -0.981 . . . . 73.25 108.351 168.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 -11.85 32.33 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.67 2.246 . . . . 64.239999999999995 113.321 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.73 -22.79 23.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.84 0.856 . . . . 71.409999999999997 112.334 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 42' ' ' ILE . 11.0 p -123.89 154.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.336 0.654 . . . . 65.340000000000003 110.131 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.36 40.61 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.209 1.004 . . . . 73.319999999999993 109.481 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.6 38.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.663 0.785 . . . . 55.109999999999999 110.57 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.747 ' HB ' HG22 ' A' ' 121' ' ' THR . 10.0 t -75.11 99.95 4.1 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.421 1.105 . . . . 42.119999999999997 108.688 172.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.7 m -149.13 131.01 15.17 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.02 -0.991 . . . . 51.210000000000001 109.492 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.755 HG22 HG13 ' A' ' 118' ' ' VAL . 86.9 t -95.62 114.13 31.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.526 -0.916 . . . . 75.430000000000007 108.526 174.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -101.51 137.43 39.84 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.084 -1.08 . . . . 71.519999999999996 108.084 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.488 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 43.9 p90 -134.46 143.08 47.31 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 74.209999999999994 112.689 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.2 m -95.28 169.63 9.95 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 113.845 -1.525 . . . . 65.150000000000006 107.376 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -116.03 13.61 15.91 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.317 0.858 . . . . 55.229999999999997 113.317 -165.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 86.0 t -64.21 115.0 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.9 0.48 . . . . 60.450000000000003 110.552 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 64.31 -77.17 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.937 1.295 . . . . 73.530000000000001 111.231 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.87 45.23 0.24 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.246 -0.342 . . . . 42.439999999999998 112.246 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . 42.4 mt-10 -61.22 -32.7 72.48 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.511 0.724 . . . . 72.420000000000002 112.31 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -56.73 -24.91 52.94 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.624 -0.716 . . . . 64.329999999999998 112.559 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.61 -43.64 75.97 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.616 0.766 . . . . 52.130000000000003 111.915 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.0 p -69.35 -39.64 77.99 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.423 -0.584 . . . . 74.420000000000002 109.423 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.97 96.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.367 1.067 . . . . 30.23 112.082 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.48 -38.38 87.15 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.377 1.048 . . . . 60.009999999999998 110.305 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.49 69.88 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.81 0.694 . . . . 73.340000000000003 110.655 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 118' ' ' VAL . 62.1 t -67.41 -35.42 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.334 0.654 . . . . 74.120000000000005 110.856 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -68.72 -34.89 79.02 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 116.029 -0.532 . . . . 73.329999999999998 112.959 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -72.21 -44.26 63.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.608 0.763 . . . . 70.510000000000005 109.877 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.5 m -67.02 -37.85 84.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.225 1.01 . . . . 74.430000000000007 111.337 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 43.9 tp -81.73 -32.13 31.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.697 0.799 . . . . 73.329999999999998 110.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.91 40.84 15.92 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.934 -0.576 . . . . 72.510000000000005 112.081 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.56 156.27 24.96 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.519 0.728 . . . . 74.400000000000006 111.16 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.37 23.34 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.009 0.923 . . . . 74.530000000000001 110.949 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.488 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 27.4 m -89.86 112.3 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-O 121.737 0.779 . . . . 74.209999999999994 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -113.54 158.3 20.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.506 1.122 . . . . 74.519999999999996 110.256 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.0 mt -66.84 -175.9 0.45 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.748 0.819 . . . . 70.219999999999999 110.743 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 5.4 ppt_? -59.19 -37.55 77.67 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 116.355 -0.384 . . . . 64.239999999999995 111.513 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.539 ' N ' ' HD2' ' A' ' 105' ' ' ARG . 83.8 mt 58.08 172.53 0.05 OUTLIER Pre-proline 0 CA--C 1.573 1.829 0 C-N-CA 123.64 0.776 . . . . 74.109999999999999 112.491 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.72 -12.31 17.55 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.55 2.166 . . . . 61.149999999999999 114.077 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.31 -46.78 82.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.712 1.205 . . . . 64.140000000000001 112.0 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.657 HD12 ' HA ' ' A' ' 114' ' ' PRO . 4.1 mm? -69.85 4.83 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.36 1.064 . . . . 65.430000000000007 113.429 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.9 t -72.1 -49.01 39.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.735 0.414 . . . . 74.409999999999997 110.368 171.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.87 -36.14 20.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.606 0.362 . . . . 50.530000000000001 111.36 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.484 ' HG3' HD13 ' A' ' 109' ' ' LEU . 4.8 pt20 -90.42 160.67 38.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 118.624 -0.703 . . . . 71.150000000000006 109.523 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.57 119.7 5.48 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.255 1.97 . . . . 74.219999999999999 112.66 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.657 ' HA ' HD12 ' A' ' 109' ' ' LEU . 56.4 Cg_endo -71.14 117.02 4.94 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.355 2.037 . . . . 65.239999999999995 113.2 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.437 ' H ' HD12 ' A' ' 109' ' ' LEU . . . 164.3 -161.08 34.16 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 110.858 -0.897 . . . . 63.420000000000002 110.858 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 70.6 t -77.07 106.24 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.231 -1.026 . . . . 75.25 108.231 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.619 HG22 ' HB3' ' A' ' 38' ' ' ARG . 2.8 pp -123.89 124.48 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.439 -0.949 . . . . 63.420000000000002 108.439 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.755 HG13 HG22 ' A' ' 79' ' ' VAL . 93.5 t -104.41 106.65 20.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.759 -1.2 . . . . 60.149999999999999 107.759 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.17 123.19 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.212 -0.662 . . . . 72.120000000000005 109.212 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.8 t -103.37 128.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.794 -0.817 . . . . 64.120000000000005 108.794 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.747 HG22 ' HB ' ' A' ' 77' ' ' THR . 10.1 t -72.94 132.32 43.31 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.467 -0.938 . . . . 43.219999999999999 108.467 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.082 0 N-CA-C 110.528 -1.029 . . . . 72.540000000000006 110.528 -166.352 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.449 0 N-CA-C 111.654 -0.579 . . . . 44.210000000000001 111.654 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -158.01 169.44 24.55 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.567 0.747 . . . . 63.450000000000003 110.172 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.4 p -146.94 110.86 4.09 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.742 0.817 . . . . 71.310000000000002 109.481 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.5 156.54 41.13 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.578 2.185 . . . . 71.010000000000005 113.23 171.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -125.24 139.62 53.57 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.434 1.094 . . . . 43.310000000000002 108.748 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 m -143.4 13.14 1.77 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.583 0.753 . . . . 73.219999999999999 111.218 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.42 -6.66 57.34 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.488 1.115 . . . . 65.25 111.807 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -57.02 -33.29 67.03 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.617 1.167 . . . . 74.219999999999999 112.103 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 67.9 168.79 0.26 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.41 1.084 . . . . 75.25 111.931 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 t -130.96 125.48 33.5 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.134 -0.691 . . . . 73.540000000000006 109.134 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.7 p -153.15 166.45 32.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.37 0.668 . . . . 60.509999999999998 109.964 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.98 154.55 51.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.509 0.724 . . . . 54.030000000000001 110.382 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 tt -144.48 138.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.786 0.834 . . . . 70.430000000000007 109.467 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 t -164.42 156.53 16.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.904 0.882 . . . . 72.109999999999999 109.743 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 t -162.95 154.77 17.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.201 0.6 . . . . 61.5 110.637 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.9 mtp -111.32 145.23 39.2 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.259 1.024 . . . . 72.400000000000006 109.932 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.7 p -141.7 138.2 32.25 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 73.209999999999994 109.875 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -115.12 171.93 7.37 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.425 0.69 . . . . 65.340000000000003 109.877 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -150.83 134.91 16.79 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.737 0.815 . . . . 74.329999999999998 109.24 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.2 m -99.26 124.73 44.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.054 0.542 . . . . 73.420000000000002 110.151 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.28 18.37 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.832 0.853 . . . . 74.329999999999998 109.109 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.71 109.9 60.59 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.092 0.557 . . . . 54.100000000000001 109.754 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.77 -171.22 1.19 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.514 2.143 . . . . 63.43 112.089 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -167.05 -179.39 4.61 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.086 0.955 . . . . 75.420000000000002 109.432 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -132.45 167.49 19.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.407 0.683 . . . . 70.439999999999998 110.607 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -113.3 136.49 52.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.406 1.082 . . . . 61.219999999999999 109.949 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -87.95 134.09 33.79 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.038 0.535 . . . . 73.109999999999999 109.972 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.61 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.71 0.804 . . . . 75.099999999999994 109.493 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.43 147.48 33.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 123.482 0.713 . . . . 52.119999999999997 110.081 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 149.61 58.93 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.744 2.296 . . . . 64.209999999999994 111.526 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.92 160.37 27.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.194 0.598 . . . . 51.340000000000003 110.187 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.89 156.02 80.63 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.764 . . . . 74.519999999999996 110.874 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -48.27 129.45 19.11 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.453 2.768 . . . . 74.230000000000004 113.418 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -98.68 -59.58 1.71 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.103 0.561 . . . . 70.450000000000003 111.506 -174.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -156.23 168.04 28.53 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.955 0.724 . . . . 53.240000000000002 112.955 -167.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 124.36 33.34 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 113.969 -1.469 . . . . 54.520000000000003 110.426 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.1 t -110.65 140.06 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.333 1.053 . . . . 72.299999999999997 108.937 167.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -138.4 109.17 6.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.215 0.531 . . . . 71.510000000000005 109.873 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.586 ' HA ' ' HB ' ' A' ' 118' ' ' VAL . 41.1 t -95.46 134.05 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.384 1.074 . . . . 73.340000000000003 110.014 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.519 ' HE2' HD11 ' A' ' 42' ' ' ILE . 37.5 p90 -156.24 143.89 19.39 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.648 0.379 . . . . 75.129999999999995 110.53 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -97.19 142.99 28.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.503 -0.555 . . . . 75.310000000000002 109.503 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.519 HD11 ' HE2' ' A' ' 40' ' ' TYR . 7.2 mt -120.42 20.34 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 122.306 1.051 . . . . 70.099999999999994 109.891 -177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.2 m -150.18 -137.9 0.08 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.355 1.062 . . . . 73.230000000000004 108.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.07 92.25 0.05 OUTLIER Glycine 0 C--N 1.36 1.874 0 CA-C-N 118.416 0.553 . . . . 61.130000000000003 112.344 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 t -85.0 109.04 17.9 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.802 0.841 . . . . 73.340000000000003 112.122 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -103.59 171.15 7.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.141 -0.936 . . . . 73.140000000000001 109.196 166.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 -2.01 79.65 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.432 -0.349 . . . . 53.32 113.457 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.03 -30.18 71.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.939 0.896 . . . . 65.430000000000007 112.443 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.52 97.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.27 0.628 . . . . 64.230000000000004 110.891 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.62 -25.61 67.46 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.706 0.632 . . . . 62.310000000000002 112.706 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -27.68 66.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.589 1.155 . . . . 74.239999999999995 111.673 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -69.42 -59.31 3.07 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 110.38 -0.23 . . . . 75.129999999999995 110.38 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.56 65.09 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.263 0.625 . . . . 62.039999999999999 112.022 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.37 -44.33 54.66 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.742 1.217 . . . . 74.200000000000003 111.324 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -76.63 -32.7 58.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.831 -0.622 . . . . 74.340000000000003 111.451 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.78 -33.23 75.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.513 0.325 . . . . 72.409999999999997 111.799 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -66.84 -38.58 86.69 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.898 0.38 . . . . 74.219999999999999 110.096 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.61 68.31 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.566 -0.743 . . . . 63.229999999999997 111.212 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -14.59 61.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.806 0.843 . . . . 73.0 111.255 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.09 21.58 32.53 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 119.402 -0.666 . . . . 34.100000000000001 113.226 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -74.53 157.78 34.91 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.294 0.547 . . . . 63.229999999999997 109.735 170.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -69.14 -65.03 0.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.043 -0.526 . . . . 75.129999999999995 111.378 -156.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.0 t -127.71 135.69 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.134 -1.062 . . . . 63.149999999999999 108.134 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 p -134.1 102.42 5.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.648 0.779 . . . . 54.100000000000001 109.054 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.8 150.65 22.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.186 0.594 . . . . 62.140000000000001 109.833 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 15.1 m -143.83 139.23 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.75 0.82 . . . . 75.420000000000002 110.198 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.26 -143.18 6.34 Favored Glycine 0 C--N 1.35 1.352 0 C-N-CA 121.228 -0.511 . . . . 42.340000000000003 113.829 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -158.25 128.13 5.96 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.634 0.773 . . . . 75.239999999999995 110.595 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.1 163.56 16.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.766 0.826 . . . . 63.240000000000002 110.865 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -76.85 149.38 36.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.746 1.218 . . . . 74.409999999999997 110.213 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.97 107.36 0.84 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 123.859 0.864 . . . . 73.109999999999999 111.701 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -93.67 -87.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.132 2.554 . . . . 54.32 111.173 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.82 -15.8 13.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.094 0.958 . . . . 63.509999999999998 110.935 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.14 143.09 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.744 0.818 . . . . 74.129999999999995 111.068 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.42 23.13 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.832 0.853 . . . . 71.329999999999998 111.125 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.03 143.94 37.69 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.375 0.67 . . . . 73.340000000000003 109.317 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -73.71 96.52 2.52 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.378 1.085 . . . . 65.409999999999997 108.703 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 101' ' ' ALA . 5.2 p -151.91 137.79 18.07 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.723 -1.126 . . . . 55.340000000000003 109.844 -170.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 118' ' ' VAL . 60.9 t -96.82 116.85 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.982 -0.748 . . . . 60.030000000000001 108.982 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.27 139.33 41.9 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.928 -0.767 . . . . 73.120000000000005 108.928 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.484 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 39.6 p90 -143.03 147.43 35.08 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.703 0.763 . . . . 72.329999999999998 112.436 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -78.3 166.42 22.71 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 107.396 -1.335 . . . . 72.230000000000004 107.396 160.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.49 22.56 9.92 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.357 -0.839 . . . . 73.409999999999997 112.066 -168.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.17 111.26 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 109.662 -0.496 . . . . 72.109999999999999 109.662 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 63.48 -82.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.331 1.452 . . . . 75.310000000000002 111.492 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.99 35.07 1.19 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 116.206 -0.452 . . . . 70.019999999999996 112.989 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 50.3 mt-10 -71.27 -34.29 70.56 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.429 -0.952 . . . . 72.010000000000005 108.429 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -54.56 -36.61 64.53 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.839 -1.073 . . . . 71.239999999999995 112.061 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.59 55.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.654 0.782 . . . . 64.040000000000006 111.187 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.427 HG21 ' HB3' ' A' ' 35' ' ' ALA . 81.3 p -67.97 -30.0 69.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.067 0.547 . . . . 62.310000000000002 110.831 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.86 -38.16 64.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.067 -0.969 . . . . 75.420000000000002 111.397 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.03 -38.95 90.65 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.785 0.834 . . . . 61.140000000000001 110.808 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -51.96 67.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.907 0.883 . . . . 72.219999999999999 111.275 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 118' ' ' VAL . 97.1 t -73.03 -46.1 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.053 0.541 . . . . 63.409999999999997 111.848 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.74 -24.81 57.91 Favored Glycine 0 N--CA 1.468 0.811 0 O-C-N 123.561 0.538 . . . . 71.239999999999995 112.799 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -81.48 -42.21 20.62 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.62 0.768 . . . . 74.109999999999999 109.874 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.5 m -73.76 -28.96 61.95 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.311 0.577 . . . . 44.119999999999997 111.344 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.0 tp -92.31 -29.29 16.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.785 1.234 . . . . 62.340000000000003 109.423 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 46.35 18.32 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.738 0.648 . . . . 51.100000000000001 111.958 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.31 148.49 42.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.827 0.851 . . . . 75.340000000000003 109.764 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 78' ' ' THR . . . -66.38 116.08 7.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.309 0.644 . . . . 54.130000000000003 110.459 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.484 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.9 m -85.25 140.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.256 0.622 . . . . 73.519999999999996 109.329 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -155.2 153.83 31.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.48 0.712 . . . . 53.32 109.651 -174.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.04 173.01 3.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.82 0.848 . . . . 70.129999999999995 110.811 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -83.58 26.66 0.66 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.998 1.11 . . . . 73.120000000000005 113.998 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.1 mm? -64.17 -53.65 45.81 Favored Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 118.146 -0.93 . . . . 74.230000000000004 111.41 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 22.8 Cg_exo -67.1 -38.25 16.5 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 121.663 1.575 . . . . 73.209999999999994 113.129 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.01 -21.38 61.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.253 0.345 . . . . 74.219999999999999 110.875 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.43 -14.36 56.37 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.328 1.051 . . . . 64.010000000000005 111.372 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 t -57.94 -48.02 81.16 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.268 0.627 . . . . 64.140000000000001 110.483 171.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.97 -31.87 21.84 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.851 0.86 . . . . 75.239999999999995 110.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.32 73.46 0.63 Allowed Pre-proline 0 CA--C 1.561 1.404 0 C-N-CA 125.786 1.634 . . . . 70.450000000000003 110.805 -173.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -88.4 148.48 6.4 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.338 2.692 . . . . 72.420000000000002 110.976 165.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -87.41 133.67 3.29 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.362 2.041 . . . . 71.299999999999997 112.787 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.97 -139.7 14.68 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.432 -0.803 . . . . 61.340000000000003 114.033 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.2 t -105.82 113.14 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.328 1.051 . . . . 72.409999999999997 110.258 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 117' ' ' ILE . 31.1 pt -101.04 114.38 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 122.049 0.928 . . . . 75.219999999999999 109.075 171.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.713 HG13 HG22 ' A' ' 79' ' ' VAL . 89.5 t -90.69 108.49 19.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.264 -1.013 . . . . 71.129999999999995 108.264 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.4 117.56 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.333 -0.988 . . . . 54.409999999999997 108.333 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.23 142.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.045 -1.465 . . . . 73.230000000000004 107.045 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.3 p -134.98 110.68 9.25 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.889 -0.782 . . . . 63.229999999999997 108.889 168.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.212 0 CA-C-O 118.904 -0.942 . . . . 72.319999999999993 112.97 178.596 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.884 0 CA-C-O 120.108 -0.274 . . . . 71.109999999999999 112.66 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.8 p -155.92 150.04 25.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.199 1.0 . . . . 72.540000000000006 109.423 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 p -94.3 133.24 27.53 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.649 0.78 . . . . 75.129999999999995 111.568 -176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.68 139.18 51.91 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 122.77 2.313 . . . . 74.25 112.842 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.93 -173.94 2.43 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.878 0.871 . . . . 71.439999999999998 109.614 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -136.78 108.17 6.88 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.96 0.504 . . . . 51.399999999999999 109.871 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -91.67 6.7 44.81 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.299 0.639 . . . . 72.319999999999993 110.289 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.47 -73.23 0.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.073 0.949 . . . . 63.210000000000001 111.39 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 t70 64.43 146.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.176 1.39 . . . . 71.239999999999995 112.901 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 p -134.69 120.61 19.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.48 0.712 . . . . 71.299999999999997 109.982 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.9 p -129.76 152.36 49.34 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.64 0.776 . . . . 72.230000000000004 109.748 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.45 176.4 5.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.769 0.828 . . . . 42.25 110.825 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.77 -175.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.318 1.047 . . . . 73.530000000000001 109.887 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -150.13 161.5 42.26 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.824 0.85 . . . . 63.229999999999997 110.024 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 p -98.38 153.75 18.34 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.743 0.817 . . . . 72.230000000000004 111.655 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 92.7 mmm -113.31 152.62 29.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.543 1.137 . . . . 64.400000000000006 109.257 171.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -115.65 125.77 53.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.802 0.841 . . . . 51.119999999999997 109.014 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -118.57 142.14 47.9 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.209 0.603 . . . . 55.439999999999998 109.933 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -154.84 164.64 38.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.241 1.017 . . . . 72.349999999999994 109.447 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -149.45 168.06 24.48 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 120.909 0.385 . . . . 71.349999999999994 110.967 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.14 166.25 13.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.164 0.985 . . . . 51.0 109.846 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.34 125.19 22.47 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.262 0.625 . . . . 73.109999999999999 110.909 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.42 -170.57 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.156 2.57 . . . . 75.519999999999996 112.271 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 m -133.34 146.75 51.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.715 0.806 . . . . 74.430000000000007 109.549 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 p -77.4 167.62 21.38 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.648 0.779 . . . . 55.229999999999997 111.44 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 m -110.41 131.44 55.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.514 0.725 . . . . 74.340000000000003 109.532 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.4 t -122.23 130.86 53.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.684 0.793 . . . . 52.130000000000003 109.971 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.33 149.42 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.378 0.671 . . . . 54.329999999999998 111.195 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -82.37 139.24 44.8 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 108.574 -0.898 . . . . 74.040000000000006 108.574 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.65 168.36 11.79 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.501 2.134 . . . . 75.200000000000003 112.216 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.37 169.48 10.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.386 0.674 . . . . 63.420000000000002 110.799 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.43 135.67 56.96 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.408 0.683 . . . . 73.140000000000001 109.857 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.12 129.18 15.77 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.436 2.09 . . . . 61.030000000000001 112.099 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -84.38 -87.23 0.12 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.45 0.7 . . . . 63.030000000000001 111.42 -176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.63 175.35 14.03 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.228 0.611 . . . . 75.519999999999996 109.959 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.2 mt-10 -80.73 117.89 21.8 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.817 -0.629 . . . . 64.150000000000006 110.065 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.41 HG21 HD23 ' A' ' 56' ' ' LEU . 24.2 t -127.3 143.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.56 0.744 . . . . 54.020000000000003 109.422 174.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.85 132.45 15.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.769 0.428 . . . . 75.430000000000007 110.075 173.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' A' ' 118' ' ' VAL . 4.8 t -103.95 108.7 25.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 123.636 0.774 . . . . 61.32 109.148 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 23.7 m-85 -107.04 135.94 47.74 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.403 0.681 . . . . 71.219999999999999 109.781 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -101.06 127.3 47.64 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.261 -0.644 . . . . 51.009999999999998 109.261 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.752 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -71.89 -24.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.577 -0.527 . . . . 71.230000000000004 109.577 171.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 p -97.58 -67.03 0.87 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.698 1.199 . . . . 54.5 111.112 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.27 11.64 35.8 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.362 0.506 . . . . 72.120000000000005 113.096 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -80.23 -61.53 1.95 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.058 0.543 . . . . 75.010000000000005 111.186 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -78.35 123.9 27.51 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.609 -0.723 . . . . 72.349999999999994 111.12 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.9 -0.8 89.84 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 124.295 0.95 . . . . 52.43 114.303 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . . . -64.51 -21.74 66.77 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.781 0.791 . . . . 61.109999999999999 111.524 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.69 68.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.038 1.335 . . . . 40.119999999999997 111.958 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB3' HH11 ' A' ' 51' ' ' ARG . . . -62.12 -36.59 82.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.588 0.755 . . . . 63.140000000000001 111.361 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.488 HH11 ' HB3' ' A' ' 50' ' ' ALA . 9.9 mpt_? -73.0 -38.57 66.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.686 0.795 . . . . 75.239999999999995 111.167 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 p -64.71 -29.02 69.99 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.047 0.539 . . . . 62.310000000000002 111.683 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.62 7.21 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.441 0.697 . . . . 54.030000000000001 110.946 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -56.46 -43.8 79.93 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.473 1.509 . . . . 64.019999999999996 112.04 -171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.54 -0.755 . . . . 72.120000000000005 111.786 -176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.41 HD23 HG21 ' A' ' 37' ' ' VAL . 9.2 mp -73.2 -27.97 61.93 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.476 0.311 . . . . 64.120000000000005 111.406 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.77 -40.15 91.73 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.641 0.588 . . . . 54.399999999999999 109.842 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.87 -23.03 59.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.211 0.604 . . . . 22.300000000000001 111.528 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.73 -3.3 46.91 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.623 0.769 . . . . 34.130000000000003 112.557 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.44 49.26 2.22 Favored Glycine 0 C--N 1.347 1.159 0 C-N-CA 121.431 -0.414 . . . . 52.329999999999998 112.082 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.21 158.02 4.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.58 1.152 . . . . 72.25 112.654 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -91.79 -57.1 2.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 106.91 -1.515 . . . . 72.129999999999995 106.91 160.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 74.0 t -129.45 136.3 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 73.519999999999996 108.153 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.6 m -141.28 114.21 8.49 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.33 -0.989 . . . . 75.5 108.33 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -120.25 152.79 37.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.677 0.791 . . . . 73.530000000000001 110.059 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.0 139.62 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.574 -0.899 . . . . 74.25 108.574 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.45 -179.31 36.07 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.399 0.437 . . . . 71.150000000000006 112.235 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -143.96 124.21 13.78 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.405 -0.961 . . . . 71.239999999999995 108.405 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 134.46 11.33 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.746 -0.835 . . . . 74.519999999999996 108.746 -170.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.752 ' HA ' HG13 ' A' ' 42' ' ' ILE . 19.6 t -77.68 99.55 5.86 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.449 -0.945 . . . . 74.430000000000007 108.449 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 20.3 tp -103.83 120.62 50.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.464 0.706 . . . . 75.519999999999996 109.311 -172.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 31.2 Cg_exo -59.86 -28.41 87.14 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.732 2.955 . . . . 74.310000000000002 114.984 -171.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.72 9.05 25.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.476 0.711 . . . . 73.329999999999998 112.063 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.524 HG21 HG11 ' A' ' 119' ' ' VAL . 63.9 t -105.92 111.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.306 0.642 . . . . 74.239999999999995 109.54 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.43 10.37 11.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.694 0.798 . . . . 62.450000000000003 111.092 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -170.04 156.89 6.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.836 0.854 . . . . 32.43 110.791 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.656 ' HB ' ' H ' ' A' ' 121' ' ' THR . 2.1 t -69.71 102.37 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.57 0.748 . . . . 71.519999999999996 109.537 173.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.542 HG21 ' HG2' ' A' ' 103' ' ' GLU . 87.8 m -150.21 149.13 29.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.835 -0.62 . . . . 64.140000000000001 110.985 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.564 HG13 ' HB ' ' A' ' 118' ' ' VAL . 40.4 t -94.59 113.68 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.282 -1.007 . . . . 74.340000000000003 108.282 175.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.554 ' HD1' ' HB2' ' A' ' 103' ' ' GLU . 28.8 m-85 -99.27 135.44 40.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.527 -0.916 . . . . 71.310000000000002 108.527 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.93 138.16 53.24 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.144 0.497 . . . . 62.439999999999998 111.123 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -73.03 153.5 40.86 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 114.935 -1.03 . . . . 55.439999999999998 109.159 170.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.671 ' HB3' HD11 ' A' ' 104' ' ' LEU . 11.6 pt-20 -102.06 26.26 7.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.28 0.474 . . . . 74.219999999999999 112.28 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.2 t -70.8 93.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 108.499 -0.926 . . . . 55.219999999999999 108.499 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 70.52 -77.74 0.05 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.444 1.498 . . . . 60.119999999999997 111.162 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.43 50.06 0.31 Allowed Glycine 0 C--N 1.352 1.453 0 N-CA-C 112.523 -0.231 . . . . 65.150000000000006 112.523 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.24 -18.64 63.9 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 120.843 0.354 . . . . 63.420000000000002 110.675 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.64 -28.25 68.33 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.847 0.859 . . . . 72.010000000000005 111.386 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.77 -36.03 81.76 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.622 0.769 . . . . 62.219999999999999 110.754 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 m -74.7 -38.26 62.4 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.771 -1.104 . . . . 64.310000000000002 110.498 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -20.04 56.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.751 0.82 . . . . 44.329999999999998 112.351 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -58.57 -49.7 76.49 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.898 -0.778 . . . . 74.329999999999998 108.898 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.85 70.74 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 124.442 1.088 . . . . 71.030000000000001 111.45 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.82 -46.85 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.212 0.605 . . . . 70.140000000000001 111.686 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.41 -26.99 62.62 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.681 0.613 . . . . 74.510000000000005 111.913 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -85.4 -31.34 22.96 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.132 0.973 . . . . 64.019999999999996 110.777 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.0 m -76.57 -29.91 56.83 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.914 0.388 . . . . 43.030000000000001 110.435 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 tp -95.79 -32.71 12.56 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.604 0.762 . . . . 71.230000000000004 110.141 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.72 44.62 47.9 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.187 -0.461 . . . . 72.400000000000006 111.985 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.95 177.57 6.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.955 0.902 . . . . 73.420000000000002 110.116 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.81 158.55 35.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.743 -0.662 . . . . 74.530000000000001 109.918 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.56 HG12 ' HB ' ' A' ' 79' ' ' VAL . 27.3 m -127.1 144.15 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.768 0.827 . . . . 64.420000000000002 109.669 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.554 ' HB2' ' HD1' ' A' ' 80' ' ' TYR . 59.9 mm-40 -129.84 149.39 51.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.227 1.011 . . . . 73.120000000000005 109.872 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 83' ' ' GLU . 51.7 tp -69.24 175.98 3.57 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.803 -1.09 . . . . 72.319999999999993 108.837 165.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -67.62 20.31 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.37 1.619 . . . . 64.120000000000005 115.37 -175.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.84 -46.1 81.57 Favored Pre-proline 0 CA--C 1.564 1.486 0 CA-C-O 117.947 -1.025 . . . . 70.239999999999995 111.871 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.0 -42.12 32.26 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 122.188 1.925 . . . . 64.409999999999997 111.233 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 88.0 mt-10 -60.17 -26.48 66.35 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 115.998 -0.546 . . . . 73.319999999999993 111.134 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.61 -10.18 17.35 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.101 0.96 . . . . 61.100000000000001 112.319 -171.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -56.74 -49.95 73.7 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.843 0.857 . . . . 51.409999999999997 111.625 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.11 -33.44 2.19 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.579 0.752 . . . . 62.049999999999997 111.16 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 73.67 80.08 0.17 Allowed Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 126.029 1.731 . . . . 72.439999999999998 111.746 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 69.1 Cg_endo -81.26 124.34 4.78 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.574 2.183 . . . . 73.450000000000003 110.371 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.91 116.66 4.79 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.033 1.822 . . . . 73.420000000000002 111.21 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.81 156.82 12.69 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.243 0.449 . . . . 74.140000000000001 112.222 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.25 119.75 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.174 1.39 . . . . 73.540000000000006 112.774 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.517 HG13 ' HB2' ' A' ' 80' ' ' TYR . 44.4 pt -110.76 106.86 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.763 -0.828 . . . . 73.209999999999994 108.763 172.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -96.39 111.81 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.394 -0.965 . . . . 65.540000000000006 108.394 175.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.5 t -114.91 118.69 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.593 -0.276 . . . . 64.209999999999994 110.975 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -99.23 144.17 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.525 0.73 . . . . 73.239999999999995 110.019 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.656 ' H ' ' HB ' ' A' ' 77' ' ' THR . 12.0 t -118.27 165.45 13.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.788 0.835 . . . . 73.010000000000005 109.596 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 N-CA-C 110.53 -1.028 . . . . 63.219999999999999 110.53 179.253 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.551 -0.22 . . . . 71.109999999999999 112.551 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -152.7 95.73 2.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.043 0.937 . . . . 74.140000000000001 108.934 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 m -88.33 131.57 41.97 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.074 0.549 . . . . 74.329999999999998 109.798 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.05 138.05 55.18 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.48 2.12 . . . . 73.329999999999998 112.097 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -145.91 111.19 5.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.469 0.708 . . . . 72.010000000000005 109.785 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.6 p -162.85 35.5 0.1 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.707 1.203 . . . . 73.299999999999997 108.682 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.14 14.58 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.248 1.019 . . . . 74.209999999999994 112.698 -172.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -55.93 -65.34 0.62 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.569 1.148 . . . . 72.519999999999996 110.944 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 54.93 83.07 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.278 0.986 . . . . 73.230000000000004 111.201 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.8 p -80.24 138.11 36.75 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.844 -0.616 . . . . 63.450000000000003 110.322 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 p -152.12 133.66 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 72.239999999999995 110.257 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.88 119.25 3.57 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.386 -0.968 . . . . 73.439999999999998 108.386 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -116.75 133.43 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.102 0.561 . . . . 74.209999999999994 110.581 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -147.46 127.02 13.26 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.948 0.899 . . . . 64.329999999999998 108.865 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -145.72 103.12 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.706 0.803 . . . . 52.119999999999997 109.068 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -145.1 149.58 35.3 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.111 0.964 . . . . 72.340000000000003 109.725 -178.093 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -148.2 160.87 42.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.167 0.587 . . . . 55.340000000000003 109.812 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -147.56 150.48 34.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.58 0.752 . . . . 75.099999999999994 109.477 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -155.89 161.66 40.54 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.592 0.757 . . . . 71.420000000000002 109.957 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.7 t -153.67 178.64 9.64 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.241 1.016 . . . . 54.109999999999999 109.387 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.18 173.44 11.58 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.608 1.163 . . . . 62.119999999999997 109.262 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 121.48 6.38 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.471 0.709 . . . . 73.0 110.146 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.32 141.11 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.78 2.32 . . . . 75.200000000000003 112.325 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.6 p -136.3 142.09 43.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.664 0.786 . . . . 60.299999999999997 110.168 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.7 p -173.83 134.85 0.48 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.277 1.031 . . . . 53.409999999999997 109.913 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.0 p -102.35 -177.26 3.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.864 0.866 . . . . 72.040000000000006 111.065 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -149.12 126.83 11.73 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.487 -0.931 . . . . 72.430000000000007 108.487 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.68 157.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.692 0.797 . . . . 73.549999999999997 110.069 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -113.36 131.44 22.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 64.409999999999997 110.044 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.95 160.98 33.43 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.954 2.436 . . . . 73.450000000000003 112.558 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -124.87 177.58 5.94 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.367 1.067 . . . . 61.32 109.578 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.26 141.76 43.02 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.315 0.646 . . . . 54.109999999999999 110.413 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.75 159.35 24.8 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.89 2.393 . . . . 74.329999999999998 112.314 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.594 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 95.5 mtt180 -123.18 150.49 43.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.585 0.754 . . . . 75.329999999999998 110.216 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -171.8 134.22 0.79 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.888 0.875 . . . . 72.040000000000006 110.11 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.24 104.18 13.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.231 0.613 . . . . 74.5 109.387 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.9 t -96.47 127.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.538 -0.912 . . . . 63.439999999999998 108.538 174.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' ASP . 43.5 ttm105 -147.77 111.81 5.15 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.169 -0.332 . . . . 75.310000000000002 110.436 -171.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 130.99 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.169 0.588 . . . . 62.399999999999999 109.586 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 17.1 m-85 -124.95 132.46 53.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.952 0.901 . . . . 73.200000000000003 109.02 167.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 68' ' ' ASN . 41.0 m-80 -94.31 121.81 36.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 32.450000000000003 109.707 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.7 tp -78.99 -27.79 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.401 0.68 . . . . 74.420000000000002 109.332 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 122' ' ' GLY . 34.6 t -125.21 -162.04 1.07 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.596 1.158 . . . . 64.430000000000007 108.384 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.01 136.37 51.3 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 118.364 0.529 . . . . 53.549999999999997 112.791 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.3 t -78.56 122.67 26.2 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.994 0.518 . . . . 32.240000000000002 110.601 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.93 160.32 18.73 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.12 -0.696 . . . . 74.25 109.12 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.35 -41.57 87.73 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.3 0.375 . . . . 71.310000000000002 112.361 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 52' ' ' THR . . . -63.33 -31.46 72.62 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.208 1.003 . . . . 72.230000000000004 112.307 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HB2' HG11 ' A' ' 120' ' ' VAL . . . -58.43 -49.72 76.28 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.839 0.712 . . . . 71.239999999999995 111.305 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.93 -32.0 57.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.464 -0.789 . . . . 32.399999999999999 110.669 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.661 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 31.6 tpt180 -71.4 -20.19 62.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.888 0.875 . . . . 72.219999999999999 111.987 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 48' ' ' ALA . 42.1 p -58.95 -52.79 64.22 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.561 0.619 . . . . 61.420000000000002 110.208 174.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.59 -25.67 45.31 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.98 -1.009 . . . . 74.140000000000001 111.515 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 31.8 t70 -79.06 -22.71 44.95 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.116 0.966 . . . . 63.420000000000002 110.819 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -86.76 -37.96 17.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.603 0.761 . . . . 52.299999999999997 109.126 168.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 tp -71.21 -19.36 62.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.489 0.715 . . . . 72.340000000000003 112.16 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.99 -27.34 69.34 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 110.491 -0.188 . . . . 73.329999999999998 110.491 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.95 60.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.696 0.798 . . . . 74.230000000000004 111.495 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.33 12.51 6.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.739 0.816 . . . . 62.240000000000002 112.723 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.29 46.39 6.98 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 120.313 -0.159 . . . . 61.210000000000001 113.091 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -58.97 152.12 20.42 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.255 1.022 . . . . 74.519999999999996 111.316 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.483 HG21 ' HA ' ' A' ' 34' ' ' ARG . 58.7 m -86.4 -55.03 4.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.718 -0.845 . . . . 74.150000000000006 108.718 171.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.61 147.37 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.591 -0.892 . . . . 70.329999999999998 108.591 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 54.0 m -142.84 144.9 32.7 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.523 1.129 . . . . 62.240000000000002 109.801 -172.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 29.6 t70 -143.67 143.9 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.483 1.113 . . . . 63.43 108.34 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.85 133.13 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.363 -0.977 . . . . 71.129999999999995 108.363 173.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.85 -160.8 11.23 Favored Glycine 0 C--O 1.246 0.86 0 N-CA-C 111.609 -0.597 . . . . 75.329999999999998 111.609 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.458 ' HA ' ' H ' ' A' ' 41' ' ' ASN . 26.2 p30 -130.34 140.15 50.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.366 1.066 . . . . 73.530000000000001 108.466 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -157.48 134.43 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.51 -0.552 . . . . 74.209999999999994 109.51 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.5 t -73.39 98.23 2.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.972 -1.122 . . . . 53.32 107.972 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.74 98.55 9.89 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.832 -1.173 . . . . 74.049999999999997 107.832 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.64 -1.01 10.12 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.725 2.283 . . . . 64.310000000000002 113.156 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.99 -23.55 41.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.784 0.833 . . . . 65.219999999999999 110.551 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 119' ' ' VAL . 2.7 p -134.05 140.03 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.428 1.091 . . . . 71.329999999999998 110.84 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.46 62.07 1.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.544 -0.91 . . . . 64.420000000000002 108.544 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.04 155.75 16.5 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.195 -0.911 . . . . 31.120000000000001 110.361 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.3 t -82.43 98.62 8.98 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.604 -1.258 . . . . 75.150000000000006 107.604 167.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 m -149.25 139.65 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.999 -1.001 . . . . 74.25 109.173 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 118' ' ' VAL . 97.9 t -95.74 116.27 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.205 -1.035 . . . . 74.409999999999997 108.205 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.617 ' HB2' HG13 ' A' ' 117' ' ' ILE . 90.4 m-85 -109.53 154.76 22.25 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.27 -0.641 . . . . 75.109999999999999 109.27 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -139.46 170.43 15.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.738 -0.665 . . . . 71.299999999999997 111.19 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.0 p -110.75 -159.29 0.67 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.627 -0.879 . . . . 63.130000000000003 108.627 164.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.21 21.05 12.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.192 0.997 . . . . 70.549999999999997 110.092 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.38 100.9 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.866 0.866 . . . . 75.299999999999997 110.015 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.594 ' HG2' ' H ' ' A' ' 34' ' ' ARG . 14.0 tp10 70.06 -75.86 0.07 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.588 1.555 . . . . 71.040000000000006 111.62 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.47 40.81 0.81 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.644 -1.383 . . . . 63.140000000000001 109.644 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.54 -39.18 85.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.961 -0.619 . . . . 43.109999999999999 110.142 -172.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -67.01 -31.4 71.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.589 -0.732 . . . . 75.099999999999994 110.947 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.2 -43.11 64.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.607 0.763 . . . . 65.349999999999994 111.427 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 94' ' ' VAL . 9.8 t -76.69 -34.55 58.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.65 -0.5 . . . . 33.539999999999999 109.65 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.06 -38.74 92.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.362 0.665 . . . . 73.439999999999998 111.963 176.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.584 ' HA ' HG11 ' A' ' 102' ' ' VAL . 25.7 t70 -58.1 -36.04 72.3 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.322 1.014 . . . . 72.549999999999997 110.318 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.9 78.47 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.474 -0.785 . . . . 63.140000000000001 111.226 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 118' ' ' VAL . 22.0 t -71.26 -34.62 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.28 0.632 . . . . 63.240000000000002 112.284 -174.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -59.48 -34.86 83.03 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 121.954 0.752 . . . . 25.030000000000001 112.006 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -80.63 -30.58 36.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.836 -1.182 . . . . 71.409999999999997 110.658 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 m -74.36 -21.02 59.87 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.04 0.536 . . . . 75.329999999999998 110.942 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 38.7 tp -97.16 -32.18 12.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.178 0.591 . . . . 72.519999999999996 110.609 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.6 53.8 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.869 -0.605 . . . . 35.520000000000003 112.027 -170.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.23 -177.69 3.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.375 1.07 . . . . 72.239999999999995 111.082 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.65 154.8 17.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.522 0.729 . . . . 62.43 110.318 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.584 HG11 ' HA ' ' A' ' 92' ' ' ASP . 19.9 m -108.35 129.95 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.452 -0.573 . . . . 25.23 109.452 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.34 164.03 28.34 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.863 0.865 . . . . 75.519999999999996 111.185 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.28 -175.32 0.11 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.969 -1.014 . . . . 71.409999999999997 112.134 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.32 -27.48 62.46 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.757 -0.64 . . . . 72.510000000000005 112.048 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.64 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 124.549 1.14 . . . . 71.329999999999998 111.714 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.12 -27.16 84.23 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.487 2.124 . . . . 73.129999999999995 112.281 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -79.2 -53.57 6.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.885 1.274 . . . . 72.519999999999996 110.97 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.455 HD11 ' HB ' ' A' ' 74' ' ' VAL . 52.1 mt -82.53 16.05 2.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.84 0.856 . . . . 61.340000000000003 111.611 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.3 m -84.94 -11.13 56.21 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.82 0.448 . . . . 62.450000000000003 110.55 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.37 8.08 29.39 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.481 0.712 . . . . 73.510000000000005 110.994 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -76.66 164.98 56.12 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.925 0.89 . . . . 75.219999999999999 110.708 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.2 122.29 11.32 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.948 1.766 . . . . 74.540000000000006 111.098 163.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.29 136.77 55.49 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.926 3.084 . . . . 61.399999999999999 115.277 -164.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.75 -162.5 15.49 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.583 -0.735 . . . . 72.019999999999996 113.22 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 91' ' ' ALA . 57.9 t -66.69 115.65 4.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 124.092 0.957 . . . . 54.119999999999997 108.972 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.617 HG13 ' HB2' ' A' ' 80' ' ' TYR . 7.6 pt -106.23 106.67 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.524 -0.917 . . . . 74.450000000000003 108.524 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 79' ' ' VAL . 44.5 t -88.52 100.95 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.547 -1.649 . . . . 73.120000000000005 106.547 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 74' ' ' VAL . 49.8 t -93.5 118.46 39.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 N-CA-C 107.109 -1.441 . . . . 65.030000000000001 107.109 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 49' ' ' ALA . 48.0 t -119.24 136.6 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 122.972 0.509 . . . . 72.099999999999994 109.762 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.406 ' H ' ' HB ' ' A' ' 77' ' ' THR . 15.2 t -117.54 137.29 52.67 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.565 0.746 . . . . 63.240000000000002 109.386 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 43' ' ' SER . . . . . . . . 0 CA--C 1.534 1.265 0 N-CA-C 110.721 -0.951 . . . . 37.409999999999997 110.721 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.879 -0.488 . . . . 45.030000000000001 111.879 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.0 m -141.08 103.22 4.41 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.272 0.629 . . . . 72.219999999999999 110.448 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 p -119.78 99.69 49.22 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.111 0.965 . . . . 70.319999999999993 108.969 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.62 27.27 0.54 Allowed 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 123.355 2.703 . . . . 74.340000000000003 113.386 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.19 105.39 1.38 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.954 0.902 . . . . 74.209999999999994 111.102 -172.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 t -154.86 22.61 0.45 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.335 0.654 . . . . 65.049999999999997 109.991 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -83.69 15.21 3.32 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.063 0.945 . . . . 75.409999999999997 111.773 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -96.97 17.9 15.89 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.907 1.283 . . . . 70.519999999999996 111.728 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -64.5 112.95 3.37 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.887 -0.412 . . . . 73.099999999999994 109.887 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p -114.7 148.53 38.12 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.629 0.772 . . . . 71.5 110.179 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.9 p -158.77 129.82 6.25 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.028 0.931 . . . . 64.219999999999999 109.101 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.38 133.3 8.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.515 0.726 . . . . 72.310000000000002 109.37 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.77 137.34 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.314 0.646 . . . . 71.530000000000001 109.816 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 p -156.87 129.51 7.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.512 0.725 . . . . 73.200000000000003 109.263 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -151.35 136.96 17.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.254 -0.647 . . . . 71.219999999999999 109.254 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.2 mmm -127.59 116.98 21.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.568 0.747 . . . . 74.019999999999996 109.339 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -145.05 99.92 3.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.614 0.765 . . . . 72.349999999999994 110.017 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -155.99 137.71 14.25 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.092 0.957 . . . . 74.319999999999993 109.106 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -155.84 149.49 25.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.92 . . . . 74.519999999999996 109.261 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -140.88 119.66 12.54 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.42 1.088 . . . . 75.439999999999998 109.033 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.78 147.06 25.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.597 0.759 . . . . 74.239999999999995 111.122 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.8 116.8 62.87 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.765 -0.828 . . . . 65.129999999999995 108.765 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 137.65 40.42 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.547 2.165 . . . . 74.450000000000003 112.751 -172.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -77.48 135.95 38.3 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.493 0.717 . . . . 64.439999999999998 109.572 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 p -146.26 148.76 32.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.949 0.5 . . . . 74.129999999999995 110.455 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -152.26 179.86 8.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.94 0.896 . . . . 64.510000000000005 109.31 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.7 p -158.62 156.75 30.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.817 0.847 . . . . 72.209999999999994 109.794 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.45 147.09 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.161 0.585 . . . . 62.219999999999999 109.86 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -111.91 143.95 29.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 108.729 -0.841 . . . . 71.140000000000001 108.729 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.24 138.58 61.86 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.217 1.945 . . . . 74.209999999999994 111.889 171.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.69 132.83 45.11 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.51 -0.552 . . . . 72.239999999999995 109.51 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.15 134.06 29.16 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 123.006 0.522 . . . . 73.120000000000005 109.676 174.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.91 146.44 42.11 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 121.973 1.782 . . . . 70.530000000000001 110.781 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -78.95 -79.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 110.205 -0.294 . . . . 73.120000000000005 110.205 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -164.13 171.55 14.93 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.13 0.572 . . . . 62.210000000000001 109.49 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.46 148.13 24.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.143 0.577 . . . . 63.140000000000001 111.565 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 64' ' ' THR . 87.3 t -137.8 125.8 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.608 1.163 . . . . 43.119999999999997 108.09 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 116' ' ' VAL . 9.6 ptp180 -127.84 111.12 13.27 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.27 -0.894 . . . . 75.340000000000003 109.706 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.68 110.36 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.477 0.711 . . . . 74.349999999999994 110.655 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.483 ' HB2' HG12 ' A' ' 119' ' ' VAL . 51.1 m-85 -100.91 106.04 17.35 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 109.179 -0.674 . . . . 70.010000000000005 109.179 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 4.5 m-20 -87.28 113.73 23.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.636 -1.246 . . . . 70.349999999999994 107.636 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.2 tt -70.13 -28.22 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.605 0.717 . . . . 72.439999999999998 110.165 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 41' ' ' ASN . 22.8 t -130.27 159.35 37.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.704 -1.134 . . . . 63.43 108.44 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.22 -45.04 44.0 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.888 0.743 . . . . 51.310000000000002 113.422 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t 47.86 -164.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.236 1.815 . . . . 62.509999999999998 112.798 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 39.6 tt0 -71.42 136.42 47.69 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 121.716 -0.615 . . . . 74.239999999999995 109.677 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.09 -26.57 65.96 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.884 0.74 . . . . 40.43 114.443 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . . . -58.27 -26.62 63.17 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.123 0.969 . . . . 75.109999999999999 112.693 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -59.62 -47.58 85.05 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.661 0.784 . . . . 55.450000000000003 111.579 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 66' ' ' VAL . . . -80.97 -29.4 35.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.269 -0.878 . . . . 61.420000000000002 111.077 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . 4.0 tmt_? -74.13 -19.25 60.63 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.577 -1.192 . . . . 63.210000000000001 111.016 -173.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 34.3 p -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 109.65 -0.5 . . . . 64.099999999999994 109.65 172.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.71 -41.52 79.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.514 0.726 . . . . 70.5 111.628 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.15 -37.69 86.16 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.44 0.696 . . . . 72.510000000000005 111.063 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -77.97 -33.01 51.65 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.113 0.565 . . . . 74.530000000000001 110.589 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' THR . 13.3 tp -63.31 -43.66 97.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.621 0.768 . . . . 64.299999999999997 112.019 -169.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -19.34 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.267 0.84 . . . . 63.299999999999997 113.267 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.21 -27.89 68.75 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.87 0.468 . . . . 45.119999999999997 112.048 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.91 -9.9 59.08 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.129 0.571 . . . . 52.109999999999999 112.266 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.48 47.11 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 113.802 0.281 . . . . 73.430000000000007 113.802 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.506 ' HE2' HG22 ' A' ' 90' ' ' THR . 6.5 m-85 -91.9 157.96 16.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.652 0.781 . . . . 75.230000000000004 109.632 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 HG23 ' A' ' 63' ' ' VAL . 20.2 m -71.59 -77.47 0.09 Allowed 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.445 0.466 . . . . 62.310000000000002 111.903 -162.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.467 HG23 HG22 ' A' ' 62' ' ' THR . 69.5 t -127.44 103.49 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 108.787 -0.82 . . . . 75.040000000000006 108.787 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 41.2 p -95.46 91.14 6.05 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.599 -0.889 . . . . 63.119999999999997 108.599 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 12.2 t70 -102.17 131.84 48.44 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.973 -1.012 . . . . 72.040000000000006 108.655 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 50' ' ' ALA . 65.7 t -125.98 133.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.93 -0.396 . . . . 43.140000000000001 109.93 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.36 146.62 17.29 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.245 -0.742 . . . . 43.109999999999999 111.245 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 24.9 p-10 -111.89 117.34 32.5 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.609 -0.515 . . . . 73.209999999999994 109.609 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.7 tp -159.15 138.54 11.46 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 122.493 -0.129 . . . . 70.129999999999995 110.831 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.614 ' HA ' HG13 ' A' ' 42' ' ' ILE . 49.3 m -68.69 103.4 1.73 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.491 -0.559 . . . . 73.030000000000001 109.491 171.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 74' ' ' VAL . 64.1 mt -112.23 132.4 22.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 123.928 0.891 . . . . 62.009999999999998 108.619 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.37 -20.57 54.89 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.608 2.205 . . . . 71.140000000000001 113.935 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.558 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 5.3 p-10 -82.04 -26.96 33.29 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.035 0.383 . . . . 72.340000000000003 112.035 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.561 HG13 HD12 ' A' ' 42' ' ' ILE . 2.4 p -97.8 117.31 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.676 0.75 . . . . 73.310000000000002 109.408 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.76 6.9 4.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.584 1.154 . . . . 75.120000000000005 108.926 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.3 151.58 15.65 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.456 1.102 . . . . 72.319999999999993 109.184 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -74.73 114.38 13.1 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.255 0.55 . . . . 61.439999999999998 110.375 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.2 m -145.73 143.62 29.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.505 1.122 . . . . 72.319999999999993 109.305 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.696 HG22 HG13 ' A' ' 118' ' ' VAL . 92.8 t -110.57 115.53 50.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 109.131 -0.692 . . . . 75.349999999999994 109.131 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.91 154.42 17.31 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.721 0.808 . . . . 74.129999999999995 109.575 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.76 152.9 42.77 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.266 -0.642 . . . . 74.219999999999999 109.266 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -106.71 135.58 48.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.163 -1.051 . . . . 63.420000000000002 108.163 172.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.5 0.31 4.19 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.378 1.251 . . . . 75.239999999999995 114.378 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.35 111.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 123.485 0.714 . . . . 71.019999999999996 110.753 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 70.74 -69.34 0.18 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.41 1.484 . . . . 63.009999999999998 112.037 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.95 51.52 0.06 OUTLIER Glycine 0 C--O 1.241 0.54 0 CA-C-O 119.976 -0.347 . . . . 54.439999999999998 112.767 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HB3' HG23 ' A' ' 116' ' ' VAL . 39.9 mm-40 -66.79 -27.12 67.32 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 111.786 0.291 . . . . 73.530000000000001 111.786 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -56.21 -34.29 66.14 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.56 0.207 . . . . 73.450000000000003 111.56 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.96 -39.19 71.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.288 0.635 . . . . 74.400000000000006 112.24 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.506 HG22 ' HE2' ' A' ' 61' ' ' PHE . 60.7 p -85.22 -44.41 12.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.862 -0.608 . . . . 72.329999999999998 110.753 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -58.87 -39.33 81.05 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.209 0.604 . . . . 75.109999999999999 112.466 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.568 ' HA ' HG11 ' A' ' 102' ' ' VAL . 23.5 t70 -72.07 -27.39 62.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.013 -0.994 . . . . 61.350000000000001 110.401 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.67 -52.08 8.42 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.206 0.602 . . . . 72.299999999999997 110.813 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 118' ' ' VAL . 69.4 t -60.44 -49.96 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.292 1.037 . . . . 44.509999999999998 111.11 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -63.88 -33.4 87.15 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.302 -0.863 . . . . 71.430000000000007 112.975 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -70.72 -37.47 73.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.151 -0.525 . . . . 61.109999999999999 110.449 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 m -68.29 -34.52 76.32 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.212 0.605 . . . . 72.25 110.927 175.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.1 tp -77.53 -33.31 54.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.704 0.802 . . . . 75.510000000000005 111.523 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.81 31.45 29.43 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.701 -0.681 . . . . 72.310000000000002 112.522 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.55 146.8 44.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.848 0.859 . . . . 64.310000000000002 109.155 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.39 149.63 33.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.131 0.572 . . . . 74.510000000000005 111.621 -172.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 92' ' ' ASP . 30.6 m -96.37 134.9 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.712 0.768 . . . . 54.039999999999999 111.319 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -134.11 165.67 24.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.438 1.495 . . . . 74.099999999999994 109.181 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.19 -174.19 0.78 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.838 0.855 . . . . 73.200000000000003 111.241 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.569 ' HB2' HD13 ' A' ' 109' ' ' LEU . 15.4 ptt180 -56.58 -40.86 75.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.804 0.842 . . . . 74.209999999999994 111.025 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.9 mt 61.2 164.39 0.1 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 125.15 1.38 . . . . 70.439999999999998 113.307 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.14 -23.56 9.77 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.329 2.686 . . . . 64.109999999999999 114.411 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 mp0 -60.67 -27.38 67.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.986 0.914 . . . . 70.409999999999997 112.825 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -66.08 -6.29 12.58 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.945 0.72 . . . . 54.119999999999997 112.945 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.0 p -66.2 -28.21 68.58 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.114 0.566 . . . . 70.230000000000004 112.066 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.61 -33.06 6.47 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.819 0.448 . . . . 51.210000000000001 111.743 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 13.4 pt20 -90.79 136.68 27.51 Favored Pre-proline 0 N--CA 1.484 1.251 0 N-CA-C 109.29 -0.633 . . . . 73.439999999999998 109.29 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.4 95.05 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.633 2.222 . . . . 61.240000000000002 112.616 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.5 161.33 35.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.898 2.399 . . . . 70.120000000000005 114.017 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 119.95 -149.0 17.89 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.661 -0.976 . . . . 74.239999999999995 110.661 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 78.7 t -84.66 121.37 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.107 0.453 . . . . 62.229999999999997 109.783 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.46 HG22 HG13 ' A' ' 119' ' ' VAL . 4.1 mp -118.97 104.95 16.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 108.27 -1.011 . . . . 74.439999999999998 108.27 174.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.696 HG13 HG22 ' A' ' 79' ' ' VAL . 58.2 t -92.48 101.37 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.369 -0.974 . . . . 64.010000000000005 108.369 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 40' ' ' TYR . 27.1 m -98.48 128.06 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.504 -0.554 . . . . 74.120000000000005 109.504 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.732 HG21 ' HB1' ' A' ' 49' ' ' ALA . 15.3 t -127.48 132.18 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.957 0.503 . . . . 71.230000000000004 110.309 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.0 t -105.08 165.9 10.76 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.562 0.745 . . . . 53.340000000000003 109.16 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 119.106 -0.83 . . . . 52.329999999999998 113.065 174.821 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.886 0 N-CA-C 112.316 -0.314 . . . . 41.200000000000003 112.316 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p -105.49 146.3 29.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.465 0.706 . . . . 42.420000000000002 111.217 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.8 m -105.59 103.64 44.35 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.375 0.67 . . . . 74.040000000000006 109.553 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.0 169.75 18.88 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.781 2.32 . . . . 65.420000000000002 111.755 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -158.65 151.96 22.82 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.392 0.677 . . . . 52.039999999999999 109.347 -174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -72.64 79.32 1.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.145 -0.687 . . . . 71.329999999999998 109.145 173.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -94.48 -0.52 54.64 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.564 1.146 . . . . 71.129999999999995 110.829 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.08 -73.29 0.17 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.934 0.894 . . . . 73.340000000000003 109.922 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 54.26 84.36 0.07 Allowed 'General case' 0 C--N 1.363 1.154 0 C-N-CA 124.947 1.299 . . . . 63.240000000000002 112.307 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.9 p -92.36 111.0 22.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.685 0.794 . . . . 74.299999999999997 110.411 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.2 m -88.59 -179.37 6.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.111 0.964 . . . . 74.209999999999994 111.512 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.92 141.13 30.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.406 -0.816 . . . . 73.439999999999998 109.787 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -121.73 155.65 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.712 0.805 . . . . 51.210000000000001 110.305 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.0 t -160.17 123.07 3.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.925 0.89 . . . . 23.219999999999999 108.797 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.1 m -118.65 133.11 56.1 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.934 0.494 . . . . 74.540000000000006 110.046 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtt -100.47 126.09 46.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.13 0.972 . . . . 73.109999999999999 109.52 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -134.34 109.11 8.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.789 0.836 . . . . 74.150000000000006 109.949 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -105.38 152.64 22.7 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.141 0.976 . . . . 61.039999999999999 109.968 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -153.05 116.07 4.58 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.374 0.67 . . . . 74.519999999999996 110.295 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.6 p -133.87 143.41 48.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.047 0.939 . . . . 63.310000000000002 110.497 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.23 167.48 20.61 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.806 0.842 . . . . 53.020000000000003 110.174 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.6 143.6 36.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 64.219999999999999 110.664 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.225 2.617 . . . . 73.519999999999996 113.48 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -112.99 159.38 19.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.101 0.961 . . . . 63.32 110.545 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -108.56 144.93 35.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 74.019999999999996 110.257 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -129.59 113.62 15.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.25 0.62 . . . . 70.439999999999998 110.503 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.3 m -102.89 133.94 47.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.969 0.508 . . . . 73.409999999999997 110.268 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.96 126.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 122.998 0.519 . . . . 75.030000000000001 110.331 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -114.95 106.81 51.13 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 108.354 -0.98 . . . . 71.530000000000001 108.354 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.23 162.62 25.98 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.119 2.546 . . . . 73.209999999999994 113.294 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.94 102.28 6.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.405 0.682 . . . . 65.109999999999999 109.586 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.69 105.07 11.9 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.545 0.738 . . . . 74.140000000000001 110.854 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.45 160.98 17.18 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.405 2.07 . . . . 73.030000000000001 112.588 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -87.15 -69.87 0.65 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.074 0.55 . . . . 65.340000000000003 110.879 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.429 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -162.0 162.79 29.04 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.364 1.065 . . . . 52.219999999999999 108.925 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.49 140.35 29.66 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.145 0.498 . . . . 64.209999999999994 110.446 -177.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 64' ' ' THR . 48.5 t -118.04 160.53 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.254 1.022 . . . . 73.530000000000001 109.128 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.09 127.78 11.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.725 0.41 . . . . 72.299999999999997 110.199 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 118' ' ' VAL . 94.1 t -106.36 121.3 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.639 0.776 . . . . 72.209999999999994 109.463 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -115.81 133.47 56.0 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.622 0.769 . . . . 71.510000000000005 110.793 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -82.62 116.29 21.96 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.688 -0.856 . . . . 74.040000000000006 108.688 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 74' ' ' VAL . 10.5 tp -80.12 -24.03 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.354 -0.61 . . . . 73.420000000000002 109.354 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.677 ' HB2' ' H ' ' A' ' 122' ' ' GLY . 40.4 m -139.18 169.38 17.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.272 1.029 . . . . 72.109999999999999 109.129 170.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 84.49 0.15 Allowed Glycine 0 C--N 1.347 1.183 0 O-C-N 123.551 0.532 . . . . 52.109999999999999 112.231 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 t -97.01 178.8 5.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.631 0.772 . . . . 74.230000000000004 109.89 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.77 151.19 43.72 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.133 0.573 . . . . 64.109999999999999 111.02 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.72 -4.44 46.8 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.059 -0.856 . . . . 71.200000000000003 114.823 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.5 -28.25 69.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.196 0.998 . . . . 64.049999999999997 112.271 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.49 -45.21 91.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.378 0.671 . . . . 71.120000000000005 110.842 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.29 -31.72 62.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.231 -0.895 . . . . 64.439999999999998 111.302 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -68.92 -36.32 77.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.537 1.135 . . . . 72.219999999999999 110.447 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.7 t -73.86 -35.09 64.73 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.411 -0.358 . . . . 72.219999999999999 110.109 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.88 63.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.432 0.693 . . . . 63.420000000000002 110.89 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.81 -48.18 70.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.05 0.94 . . . . 74.230000000000004 110.884 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -78.43 -29.24 46.94 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.478 -0.783 . . . . 62.229999999999997 111.274 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.75 -45.56 74.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.234 1.014 . . . . 74.049999999999997 111.359 -174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -51.63 -46.19 63.57 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.521 1.128 . . . . 62.119999999999997 111.625 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.6 -10.68 60.14 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.801 0.841 . . . . 62.350000000000001 112.556 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.83 7.3 42.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.603 0.761 . . . . 65.109999999999999 112.394 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.43 26.18 5.76 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 120.853 0.14 . . . . 24.109999999999999 113.205 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.528 ' HE2' ' HA ' ' A' ' 90' ' ' THR . 16.4 m-85 -108.09 154.04 22.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.238 1.015 . . . . 73.239999999999995 108.412 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.507 0.323 . . . . 70.409999999999997 111.681 -167.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.62 153.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.067 -1.086 . . . . 73.329999999999998 108.067 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 22.2 p -127.23 114.44 17.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.92 -0.77 . . . . 51.229999999999997 108.92 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -101.25 127.76 47.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.556 0.742 . . . . 44.149999999999999 109.256 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.65 129.68 67.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.088 -0.708 . . . . 63.450000000000003 109.088 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.91 -179.46 30.12 Favored Glycine 0 C--N 1.341 0.808 0 O-C-N 123.601 0.563 . . . . 72.209999999999994 111.91 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.65 125.92 35.26 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.143 -1.058 . . . . 71.140000000000001 108.143 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 57.1 mt -140.18 151.46 45.25 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.746 0.818 . . . . 72.409999999999997 110.15 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' HD12 ' A' ' 42' ' ' ILE . 24.2 m -126.85 98.21 5.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.782 0.833 . . . . 74.219999999999999 109.632 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HB2' HG22 ' A' ' 74' ' ' VAL . 7.4 mp -121.09 153.46 57.79 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 124.647 1.179 . . . . 61.32 109.438 -176.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.33 -27.69 6.3 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.512 2.141 . . . . 51.350000000000001 112.745 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.6 -23.05 53.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.75 0.82 . . . . 64.299999999999997 111.19 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 71' ' ' LEU . 33.0 m -120.41 117.98 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 109.088 -0.708 . . . . 73.409999999999997 109.088 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -144.46 9.46 1.4 Allowed 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.869 -0.519 . . . . 71.349999999999994 111.045 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.79 158.22 44.63 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.356 1.063 . . . . 75.400000000000006 109.345 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.573 ' HB ' HG22 ' A' ' 121' ' ' THR . 7.2 t -69.34 98.22 1.05 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.285 1.04 . . . . 73.019999999999996 108.913 174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.8 m -150.74 137.09 18.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.49 1.116 . . . . 72.340000000000003 110.217 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 118' ' ' VAL . 40.3 t -101.67 119.7 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.314 1.046 . . . . 75.409999999999997 108.861 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' CE1' HG12 ' A' ' 74' ' ' VAL . 93.4 m-85 -103.75 125.42 50.21 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.252 -0.647 . . . . 72.219999999999999 109.252 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -145.45 160.38 41.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.52 0.728 . . . . 74.319999999999993 110.37 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -109.36 -120.32 0.27 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 108.103 -1.073 . . . . 61.530000000000001 108.103 172.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -137.89 -9.34 1.58 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.251 0.932 . . . . 70.5 112.194 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.43 107.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.33 0.652 . . . . 75.040000000000006 111.735 -167.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 59.77 31.43 20.81 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 53.450000000000003 112.067 173.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.55 38.44 5.58 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.03 -0.986 . . . . 52.25 113.374 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.3 -44.44 71.99 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.189 0.495 . . . . 72.540000000000006 112.303 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -66.31 -24.62 66.57 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 111.888 0.329 . . . . 73.010000000000005 111.888 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.51 -37.2 57.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.386 0.674 . . . . 50.130000000000003 111.252 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HE2' ' A' ' 61' ' ' PHE . 81.8 p -82.01 -28.49 32.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.325 0.584 . . . . 54.329999999999998 110.277 -174.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.39 -31.47 54.21 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.636 1.174 . . . . 74.099999999999994 111.786 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.38 -55.54 32.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.832 1.253 . . . . 71.329999999999998 110.6 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.34 -32.24 71.08 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.676 -1.147 . . . . 74.540000000000006 112.727 -173.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG11 HG21 ' A' ' 118' ' ' VAL . 47.4 t -87.87 -53.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.059 0.544 . . . . 73.439999999999998 111.588 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -29.88 75.97 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.814 -0.63 . . . . 70.109999999999999 113.75 -168.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -72.97 -36.14 67.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.095 0.558 . . . . 62.509999999999998 110.552 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.7 m -62.04 -40.23 95.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.716 0.806 . . . . 62.310000000000002 111.257 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.86 -15.31 37.09 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.31 0.485 . . . . 71.200000000000003 112.31 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.12 25.04 75.74 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.891 -0.483 . . . . 71.310000000000002 111.891 -172.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.87 136.85 33.95 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.342 1.057 . . . . 63.200000000000003 109.486 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 113.32 2.6 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.953 0.783 . . . . 32.329999999999998 111.09 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -83.87 101.58 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 122.457 1.123 . . . . 64.349999999999994 109.047 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -112.9 158.36 20.29 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.519 -1.219 . . . . 74.019999999999996 111.343 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.61 177.75 1.49 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.347 -1.297 . . . . 65.299999999999997 110.397 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -59.29 -44.76 92.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.981 -0.554 . . . . 72.109999999999999 110.695 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt 60.77 173.63 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.106 0.962 . . . . 72.549999999999997 111.777 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.61 -27.33 25.35 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.419 2.079 . . . . 62.310000000000002 113.674 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.97 -47.33 83.63 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.077 0.951 . . . . 74.439999999999998 112.325 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.543 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 23.0 tp -71.67 -12.18 61.2 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 120.896 0.379 . . . . 73.430000000000007 111.215 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 t -79.06 -14.09 59.37 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.201 0.601 . . . . 72.549999999999997 110.818 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.13 -25.82 23.93 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.548 0.739 . . . . 62.350000000000001 112.362 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 1.3 pp0? -142.54 155.85 63.65 Favored Pre-proline 0 N--CA 1.495 1.802 0 CA-C-O 118.282 -0.866 . . . . 74.140000000000001 111.132 -173.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 30.9 Cg_exo -37.47 125.75 0.61 Allowed 'Trans proline' 0 C--N 1.397 3.1 0 C-N-CA 124.736 3.624 . . . . 70.150000000000006 115.867 -169.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 18.8 Cg_exo -64.61 133.3 36.28 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.089 2.526 . . . . 53.329999999999998 112.175 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.496 ' H ' HD21 ' A' ' 109' ' ' LEU . . . 157.09 177.81 30.56 Favored Glycine 0 C--O 1.245 0.812 0 N-CA-C 110.667 -0.973 . . . . 61.329999999999998 110.667 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.8 t -80.66 100.04 4.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.817 -0.438 . . . . 75.140000000000001 109.817 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 117' ' ' ILE . 41.8 pt -102.89 108.58 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.76 -0.83 . . . . 74.409999999999997 108.76 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.627 HG13 HG22 ' A' ' 79' ' ' VAL . 51.7 t -90.6 100.99 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.373 -1.343 . . . . 71.319999999999993 107.373 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.531 HG11 ' HB ' ' A' ' 74' ' ' VAL . 61.3 t -95.93 118.17 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.827 -0.805 . . . . 40.109999999999999 108.827 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.28 133.72 63.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.107 0.563 . . . . 65.329999999999998 109.619 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 77' ' ' THR . 11.8 t -98.72 156.17 16.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.505 0.722 . . . . 64.129999999999995 110.577 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.677 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.686 -1.063 . . . . 37.850000000000001 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 CA-C-O 120.104 -0.276 . . . . 73.430000000000007 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 m -134.36 -42.82 0.78 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.375 0.67 . . . . 71.099999999999994 110.401 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 m 68.14 81.21 0.21 Allowed Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.005 1.322 . . . . 70.140000000000001 110.542 -172.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -85.05 170.63 9.62 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.691 2.261 . . . . 71.540000000000006 112.307 171.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -148.3 153.7 39.01 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.729 0.812 . . . . 73.219999999999999 108.813 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.9 t -127.59 40.31 3.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.934 0.893 . . . . 74.340000000000003 108.716 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.11 -3.14 57.0 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.979 0.912 . . . . 72.409999999999997 112.183 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.59 -64.95 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.176 0.59 . . . . 55.009999999999998 109.519 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 64.45 177.85 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.171 1.389 . . . . 75.549999999999997 112.954 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 p -160.89 90.46 0.84 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.153 0.581 . . . . 73.219999999999999 110.762 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -90.7 132.78 35.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.132 0.573 . . . . 74.230000000000004 109.979 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 98.54 3.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.101 0.56 . . . . 75.219999999999999 111.128 -172.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -131.41 129.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.755 0.822 . . . . 73.540000000000006 110.335 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 p -175.47 103.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.307 1.043 . . . . 60.409999999999997 110.629 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -166.89 130.92 1.95 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.203 1.001 . . . . 63.140000000000001 109.925 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -132.35 77.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.082 -0.71 . . . . 64.030000000000001 109.082 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -85.42 104.58 15.35 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.087 -0.506 . . . . 42.049999999999997 110.14 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -146.29 145.21 30.28 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 74.030000000000001 109.562 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -149.97 168.82 22.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.769 0.428 . . . . 64.510000000000005 111.085 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.9 t -148.21 169.97 18.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.345 1.058 . . . . 64.439999999999998 109.775 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.08 167.09 22.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.314 1.045 . . . . 64.209999999999994 109.995 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.8 124.29 24.03 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.162 0.985 . . . . 64.0 109.996 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.39 123.65 11.44 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.486 2.791 . . . . 72.409999999999997 113.248 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.6 p -117.4 125.97 51.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.503 0.721 . . . . 53.240000000000002 110.98 -174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -136.98 123.19 20.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.849 0.86 . . . . 73.400000000000006 109.104 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t -155.31 127.91 7.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.47 0.708 . . . . 75.430000000000007 110.063 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.2 m -155.85 127.3 7.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.992 0.917 . . . . 44.340000000000003 109.569 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 m -90.19 156.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.503 0.721 . . . . 72.0 111.148 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.14 158.74 71.81 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 124.64 1.176 . . . . 63.350000000000001 110.201 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.89 158.87 48.86 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.086 2.524 . . . . 73.030000000000001 112.875 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.43 162.65 22.05 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.732 0.813 . . . . 74.540000000000006 111.044 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.39 143.12 79.09 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 123.507 0.723 . . . . 51.200000000000003 111.227 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.66 164.51 28.8 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.761 2.307 . . . . 74.129999999999995 114.212 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -123.63 138.47 54.54 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.341 1.057 . . . . 63.210000000000001 109.178 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 61' ' ' PHE . . . -164.22 81.73 0.41 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.497 -0.557 . . . . 73.129999999999995 109.497 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -96.94 91.51 5.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.676 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 56' ' ' LEU . 21.1 t -95.65 139.66 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.271 1.028 . . . . 53.009999999999998 109.283 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HG3' ' HB2' ' A' ' 65' ' ' ASP . 43.7 ttm105 -148.3 131.97 16.89 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 66' ' ' VAL . 47.8 t -114.83 135.11 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.721 0.808 . . . . 75.340000000000003 109.819 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -137.32 107.23 6.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.923 0.889 . . . . 73.409999999999997 109.772 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.42 123.16 32.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.106 -1.072 . . . . 74.519999999999996 108.106 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.627 HG21 HG11 ' A' ' 74' ' ' VAL . 18.5 tt -85.86 -38.44 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 118.227 0.467 . . . . 55.329999999999998 110.682 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.0 m -149.63 155.89 40.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.818 0.847 . . . . 63.140000000000001 109.744 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 122' ' ' GLY . . . 93.57 -39.02 3.01 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.515 0.509 . . . . 73.230000000000004 112.718 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t 37.13 80.49 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.449 1.9 . . . . 52.219999999999999 113.131 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.67 173.11 9.23 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.963 -1.017 . . . . 72.219999999999999 111.372 -170.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.59 -45.67 94.09 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.31 -1.314 . . . . 62.420000000000002 114.036 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 -28.01 67.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.352 0.871 . . . . 74.200000000000003 113.352 -169.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -60.33 2.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.669 0.388 . . . . 72.150000000000006 111.029 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.4 69.12 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.735 -0.666 . . . . 73.219999999999999 111.849 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -34.4 77.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.258 1.423 . . . . 74.349999999999994 110.477 -174.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.448 ' O ' HD13 ' A' ' 56' ' ' LEU . 77.0 p -62.25 -57.26 12.08 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 123.468 0.48 . . . . 51.32 110.317 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 64' ' ' THR . . . -71.92 -28.37 63.44 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.08 0.152 . . . . 70.439999999999998 111.337 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.7 -31.52 71.53 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.433 0.693 . . . . 74.540000000000006 111.153 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -80.73 -45.38 17.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.32 -0.4 . . . . 71.219999999999999 110.451 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 37' ' ' VAL . 10.9 mp -66.4 -31.58 72.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.635 -0.711 . . . . 72.150000000000006 112.189 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.57 -39.65 91.89 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.885 0.374 . . . . 75.219999999999999 111.05 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.71 -29.75 61.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.456 -0.793 . . . . 51.450000000000003 110.308 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -13.08 61.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.539 0.736 . . . . 60.0 111.396 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.79 31.36 7.82 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.532 0.52 . . . . 30.010000000000002 113.687 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.403 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 7.8 m-85 -79.72 155.7 27.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.601 -0.889 . . . . 75.409999999999997 108.601 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 35' ' ' ALA . 37.0 m -73.26 -59.92 2.48 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.724 0.41 . . . . 72.120000000000005 111.468 -163.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 99.5 t -114.41 141.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.692 -0.855 . . . . 74.030000000000001 108.692 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.529 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 14.6 p -145.61 109.87 4.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.96 0.904 . . . . 72.349999999999994 108.807 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.55 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.4 m-20 -103.86 144.47 31.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.786 -0.82 . . . . 75.049999999999997 108.786 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.493 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 61.9 t -133.59 114.83 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.361 -0.977 . . . . 71.439999999999998 108.361 173.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.25 159.38 27.69 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 121.521 -0.371 . . . . 53.329999999999998 113.033 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -113.27 113.97 26.05 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.029 -1.1 . . . . 63.229999999999997 108.029 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.59 144.51 20.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.887 -0.783 . . . . 60.140000000000001 108.887 -167.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.408 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 t -83.62 108.7 16.88 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 62.420000000000002 109.251 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.59 149.31 35.58 Favored Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.631 . . . . 62.020000000000003 110.281 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.18 -20.8 18.54 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.958 2.439 . . . . 55.329999999999998 113.253 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -80.82 -19.16 45.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.252 1.021 . . . . 50.229999999999997 112.12 -174.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 42' ' ' ILE . 90.6 t -56.5 133.18 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.114 0.884 . . . . 74.150000000000006 112.375 -167.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.39 -45.13 0.08 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.954 -1.476 . . . . 53.140000000000001 108.268 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.36 158.1 43.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.379 1.072 . . . . 60.009999999999998 109.339 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.527 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.7 t -62.66 111.95 2.3 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.358 0.599 . . . . 74.340000000000003 110.201 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.0 m -149.32 138.57 21.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.561 0.745 . . . . 64.420000000000002 110.485 -172.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 118' ' ' VAL . 18.3 t -94.66 114.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.687 1.195 . . . . 71.319999999999993 108.444 173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.476 ' HB3' HD21 ' A' ' 109' ' ' LEU . 28.7 m-85 -95.53 154.52 17.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.318 -0.993 . . . . 71.519999999999996 108.318 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -153.44 -179.88 8.17 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.546 0.688 . . . . 74.129999999999995 111.784 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.498 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 24.0 m -126.83 139.48 53.07 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 105.999 -1.852 . . . . 74.230000000000004 105.999 161.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.05 -10.21 59.24 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.962 0.727 . . . . 74.329999999999998 112.962 -170.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.31 130.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 63.210000000000001 112.843 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.24 21.05 11.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.72 1.208 . . . . 74.049999999999997 112.723 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.57 62.99 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 116.308 -0.405 . . . . 63.130000000000003 112.861 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 82' ' ' THR . 11.3 tp10 -69.53 -21.92 63.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 64.349999999999994 109.95 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -57.69 -29.28 64.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.405 1.082 . . . . 72.430000000000007 112.936 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -45.11 83.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.704 0.801 . . . . 53.240000000000002 112.023 -174.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.531 HG23 HG21 ' A' ' 116' ' ' VAL . 9.9 t -74.58 -30.99 61.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.23 -0.441 . . . . 55.299999999999997 110.759 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -69.23 -34.9 75.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.885 0.474 . . . . 63.130000000000003 111.407 174.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.79 -40.58 83.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.524 1.129 . . . . 71.400000000000006 109.57 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.09 60.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.757 -1.11 . . . . 42.140000000000001 110.681 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.01 -32.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.16 0.984 . . . . 62.140000000000001 111.827 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.43 93.53 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.957 -0.457 . . . . 74.540000000000006 111.957 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 -80.31 -25.99 39.05 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.0 0.52 . . . . 73.140000000000001 111.881 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -70.81 -43.12 69.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.951 0.5 . . . . 45.140000000000001 110.231 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 tp -86.22 -30.84 22.07 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.592 -0.731 . . . . 62.140000000000001 110.598 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.03 24.95 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.771 -0.649 . . . . 21.129999999999999 112.165 -174.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.94 167.65 9.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.994 0.917 . . . . 65.140000000000001 111.279 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.34 41.92 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.923 0.889 . . . . 75.099999999999994 111.071 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.05 119.58 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.013 0.435 . . . . 44.340000000000003 110.569 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -113.46 148.26 36.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.343 0.657 . . . . 74.540000000000006 110.997 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.64 -166.89 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.905 1.282 . . . . 63.340000000000003 111.911 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -77.04 28.55 0.14 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 124.508 1.123 . . . . 75.450000000000003 113.037 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pp -47.97 157.77 0.6 Allowed Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 125.458 1.503 . . . . 60.229999999999997 113.19 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.35 -24.29 0.97 Allowed 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 124.44 3.427 . . . . 74.209999999999994 117.847 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.68 -22.29 64.38 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.361 0.664 . . . . 74.230000000000004 112.413 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 80' ' ' TYR . 4.4 mm? -64.6 -8.91 15.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.6 0.76 . . . . 42.310000000000002 111.738 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 t -63.98 -42.01 97.36 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.281 1.032 . . . . 74.540000000000006 112.003 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.477 ' HB2' ' OE1' ' A' ' 112' ' ' GLN . 4.5 m-20 -80.77 -33.57 34.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.898 0.479 . . . . 55.329999999999998 111.562 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -90.71 157.49 43.84 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.704 0.802 . . . . 71.209999999999994 108.998 178.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.7 125.07 16.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.062 1.842 . . . . 72.519999999999996 110.783 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.22 118.96 5.9 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.146 2.564 . . . . 72.200000000000003 112.719 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.51 -158.7 31.76 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.859 -0.896 . . . . 75.129999999999995 110.859 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.531 HG21 HG23 ' A' ' 90' ' ' THR . 74.1 t -79.25 105.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.196 -0.668 . . . . 73.409999999999997 109.196 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' ' 117' ' ' ILE . 31.1 pt -116.68 107.75 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.849 -0.797 . . . . 74.420000000000002 108.849 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 79' ' ' VAL . 2.1 p -87.28 105.02 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.54 -0.911 . . . . 61.020000000000003 108.54 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 74' ' ' VAL . 94.7 t -91.51 117.48 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.75 -1.204 . . . . 71.299999999999997 107.75 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.24 127.44 65.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.527 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.2 p -104.89 102.9 12.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.778 -1.564 . . . . 63.100000000000001 106.778 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 119.308 -0.718 . . . . 70.519999999999996 112.639 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.857 -0.497 . . . . 74.299999999999997 111.857 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 p -148.51 119.47 7.65 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.918 0.887 . . . . 61.340000000000003 109.639 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 t -162.08 79.47 1.96 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 123.409 0.684 . . . . 75.450000000000003 109.266 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.41 85.92 1.76 Allowed 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.327 2.684 . . . . 63.039999999999999 110.978 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -85.27 96.26 9.46 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 115.586 -0.734 . . . . 72.310000000000002 109.744 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.6 m -141.63 70.14 1.34 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.836 1.254 . . . . 73.420000000000002 108.693 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -91.9 -10.4 39.72 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 114.603 -1.18 . . . . 43.5 112.027 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -130.37 -55.09 1.1 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.277 0.631 . . . . 74.420000000000002 110.824 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 65.97 -81.53 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.007 1.323 . . . . 75.530000000000001 111.243 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 p -170.73 148.74 3.01 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.586 0.754 . . . . 72.439999999999998 110.03 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -170.37 106.2 0.3 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.36 1.064 . . . . 75.400000000000006 108.209 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.12 131.54 5.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.358 0.663 . . . . 63.240000000000002 110.042 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -169.07 130.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.528 1.131 . . . . 61.210000000000001 109.339 175.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 p -172.2 128.11 0.57 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.296 1.038 . . . . 62.439999999999998 108.617 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.7 t -148.29 110.48 4.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 109.52 -0.548 . . . . 71.409999999999997 109.52 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -136.46 104.72 5.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.684 0.794 . . . . 55.219999999999999 109.406 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -135.1 114.99 12.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.493 1.117 . . . . 54.240000000000002 109.816 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 p -148.06 143.05 26.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.842 1.257 . . . . 70.409999999999997 109.001 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -152.77 137.87 17.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.605 1.162 . . . . 50.409999999999997 108.851 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.7 p -143.92 106.41 4.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.954 0.902 . . . . 61.200000000000003 110.307 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.49 144.4 18.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.099 0.959 . . . . 71.140000000000001 110.08 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.73 105.78 4.27 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 123.724 0.81 . . . . 63.009999999999998 109.563 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.06 113.69 2.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.081 2.521 . . . . 75.030000000000001 112.341 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -152.03 119.12 5.86 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.233 0.539 . . . . 62.409999999999997 110.283 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -153.84 139.91 18.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.722 1.209 . . . . 72.319999999999993 109.251 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -148.44 128.35 13.5 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.028 0.531 . . . . 74.140000000000001 110.412 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.3 m -150.31 89.18 1.56 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.212 1.005 . . . . 55.439999999999998 108.992 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.34 140.74 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.814 0.846 . . . . 71.329999999999998 110.26 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.31 115.68 64.62 Favored Pre-proline 0 N--CA 1.479 1.001 0 N-CA-C 108.753 -0.832 . . . . 73.239999999999995 108.753 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.12 134.84 21.91 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.678 2.252 . . . . 72.349999999999994 111.279 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.4 123.34 8.73 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.215 1.006 . . . . 72.310000000000002 108.476 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.64 147.65 5.38 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.32 0.648 . . . . 74.219999999999999 110.173 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.92 145.8 81.07 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.25 2.633 . . . . 63.299999999999997 113.341 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -134.65 -75.88 0.46 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.736 0.815 . . . . 74.109999999999999 109.969 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.48 101.5 9.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.476 0.71 . . . . 73.420000000000002 110.424 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.448 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.3 mp0 -82.35 101.1 10.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.044 0.937 . . . . 73.329999999999998 109.086 176.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.13 140.1 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.883 -0.784 . . . . 71.25 108.883 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -152.08 129.0 10.98 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.623 0.769 . . . . 64.230000000000004 109.473 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 118' ' ' VAL . 43.7 t -114.79 126.55 72.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.131 -1.063 . . . . 70.349999999999994 108.131 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' CE1' HG22 ' A' ' 119' ' ' VAL . 7.9 p90 -127.56 139.72 52.58 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.475 0.655 . . . . 72.200000000000003 110.005 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -84.24 146.78 27.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.708 -1.133 . . . . 75.239999999999995 108.303 166.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 121' ' ' THR . 10.2 tp -76.94 -23.23 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.005 0.431 . . . . 64.299999999999997 109.993 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.9 m -118.84 -57.37 2.04 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.737 0.815 . . . . 71.129999999999995 109.758 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 76.94 1.05 Allowed Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.802 -0.519 . . . . 63.210000000000001 111.802 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.2 m -145.13 -37.6 0.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.841 0.856 . . . . 65.530000000000001 110.074 178.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -73.96 109.9 7.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.997 0.519 . . . . 75.319999999999993 110.346 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.53 -24.07 59.34 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.395 -0.82 . . . . 55.109999999999999 112.522 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.31 67.6 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.07 0.548 . . . . 73.540000000000006 110.855 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.65 55.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.803 0.841 . . . . 63.25 110.598 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -27.38 66.14 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.616 -0.72 . . . . 65.040000000000006 111.609 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.7 -35.93 79.71 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.441 1.097 . . . . 72.439999999999998 110.825 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -62.35 -53.2 58.5 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 122.426 0.29 . . . . 70.349999999999994 111.229 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -68.9 -30.13 68.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.379 0.272 . . . . 70.310000000000002 111.255 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.8 -39.41 94.16 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 70.420000000000002 109.95 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -74.78 -33.52 62.27 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 110.355 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.377 0.671 . . . . 75.239999999999995 111.048 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -63.04 -46.54 87.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 107.948 -1.13 . . . . 75.019999999999996 107.948 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.99 -29.23 69.02 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.263 -0.88 . . . . 60.200000000000003 111.122 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.52 -17.02 58.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.484 0.714 . . . . 40.43 111.601 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.9 37.23 7.98 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 116.492 -0.322 . . . . 44.210000000000001 113.878 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.26 159.47 28.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.063 0.545 . . . . 74.049999999999997 110.164 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.4 m -60.9 -68.91 0.26 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.811 0.694 . . . . 62.140000000000001 111.176 -167.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 89.2 t -116.48 138.16 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.806 -1.183 . . . . 71.519999999999996 107.806 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.6 p -136.4 96.28 3.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.277 -1.379 . . . . 63.219999999999999 107.277 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -102.25 145.95 28.71 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.625 -0.88 . . . . 74.349999999999994 108.625 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.09 135.1 55.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.061 0.944 . . . . 72.239999999999995 108.836 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.11 -164.27 27.37 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 121.249 -0.501 . . . . 52.329999999999998 112.3 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -146.28 118.5 8.35 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.268 -1.012 . . . . 74.439999999999998 108.268 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.53 143.03 47.19 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 108.656 -0.868 . . . . 70.439999999999998 108.656 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -86.57 97.16 10.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.117 -0.697 . . . . 45.350000000000001 109.117 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.87 110.87 62.5 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.518 1.127 . . . . 73.109999999999999 108.454 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.1 -12.96 33.23 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.247 1.965 . . . . 53.140000000000001 113.236 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -77.19 -21.43 53.97 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.661 0.385 . . . . 74.200000000000003 111.671 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.22 142.12 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.557 -0.535 . . . . 62.219999999999999 109.557 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.93 22.44 1.58 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.343 1.057 . . . . 61.229999999999997 109.983 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.25 149.25 33.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.581 0.753 . . . . 72.040000000000006 109.582 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.3 t -76.88 103.55 6.89 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.873 0.844 . . . . 73.439999999999998 109.834 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.2 m -151.47 140.11 20.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.338 -0.847 . . . . 74.209999999999994 110.113 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.677 HG22 HG13 ' A' ' 118' ' ' VAL . 41.7 t -96.46 114.25 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.848 0.859 . . . . 64.140000000000001 109.154 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.83 132.71 45.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.295 1.038 . . . . 74.010000000000005 108.493 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.605 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -137.31 165.82 25.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.991 0.516 . . . . 72.040000000000006 111.904 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.0 t -106.99 148.86 28.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.607 -1.257 . . . . 53.539999999999999 107.607 161.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.538 ' HG2' ' HD2' ' A' ' 88' ' ' ARG . 46.0 mt-10 -97.16 9.04 43.26 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.915 0.486 . . . . 65.120000000000005 111.787 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.31 143.12 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.301 -0.629 . . . . 53.420000000000002 109.301 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 62.11 -83.09 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.721 1.208 . . . . 72.030000000000001 111.969 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.31 37.72 0.21 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.991 -0.443 . . . . 63.140000000000001 111.991 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.48 -35.9 24.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.542 0.337 . . . . 62.130000000000003 111.462 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 83' ' ' GLU . 61.4 ttt180 -61.25 -26.93 68.08 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.948 -0.47 . . . . 75.5 111.294 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.47 99.85 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.628 0.771 . . . . 70.340000000000003 111.956 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -81.49 -24.26 36.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.114 0.483 . . . . 51.200000000000003 110.55 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.7 59.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.929 0.892 . . . . 71.099999999999994 111.612 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.55 -45.52 75.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.417 -1.265 . . . . 75.200000000000003 109.663 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.29 -56.9 14.73 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.648 -1.16 . . . . 53.329999999999998 111.114 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 118' ' ' VAL . 86.6 t -71.27 -37.32 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.726 -0.67 . . . . 41.520000000000003 111.823 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.81 -35.44 52.96 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.566 0.541 . . . . 62.340000000000003 112.459 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -86.17 -32.8 21.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.673 -0.763 . . . . 63.420000000000002 110.308 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.9 m -65.84 -40.98 92.28 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.353 0.597 . . . . 45.409999999999997 110.399 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.53 -28.44 28.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.656 -1.156 . . . . 72.209999999999994 109.934 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.82 75.69 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.764 -0.653 . . . . 63.43 112.606 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.91 -172.59 3.75 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.83 0.852 . . . . 53.039999999999999 110.617 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 161.34 26.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.863 0.465 . . . . 31.420000000000002 109.965 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.605 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 10.0 m -129.96 124.63 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.853 0.861 . . . . 53.140000000000001 109.016 175.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -129.08 158.57 38.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.008 0.923 . . . . 60.329999999999998 110.905 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.8 -163.64 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.027 -1.442 . . . . 74.239999999999995 111.023 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.557 ' HA ' HD12 ' A' ' 109' ' ' LEU . 14.4 ttp180 -75.4 30.77 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.136 1.374 . . . . 62.329999999999998 112.955 -172.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.2 mt -46.0 152.41 0.78 Allowed Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 125.549 1.539 . . . . 71.129999999999995 113.654 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.2 -12.72 0.5 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 124.759 3.639 . . . . 60.0 116.796 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -60.31 -33.69 72.73 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.265 0.555 . . . . 71.230000000000004 110.287 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.595 HD22 HD13 ' A' ' 117' ' ' ILE . 31.5 mt -76.71 5.6 7.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.298 1.039 . . . . 73.299999999999997 113.299 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.4 p -82.13 -41.36 20.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.735 -0.839 . . . . 73.239999999999995 108.735 170.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.7 -34.86 30.39 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.743 -1.117 . . . . 61.219999999999999 110.243 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -86.16 146.99 43.94 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.355 -0.839 . . . . 73.540000000000006 109.236 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 37.7 Cg_endo -64.32 124.04 12.76 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.338 2.025 . . . . 74.409999999999997 111.165 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 32.0 Cg_exo -60.26 133.79 51.72 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.726 2.951 . . . . 73.319999999999993 113.76 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.11 -129.14 2.17 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.204 -1.158 . . . . 42.450000000000003 110.204 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.48 105.12 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.325 -0.991 . . . . 72.450000000000003 108.325 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.595 HD13 HD22 ' A' ' 109' ' ' LEU . 2.3 mp -105.59 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 N-CA-C 108.028 -1.101 . . . . 41.200000000000003 108.028 -176.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.677 HG13 HG22 ' A' ' 79' ' ' VAL . 58.8 t -88.15 106.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.59 -1.263 . . . . 71.310000000000002 107.59 174.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 40' ' ' TYR . 19.2 t -93.13 130.56 42.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.74 -0.837 . . . . 71.120000000000005 108.74 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.58 129.21 74.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.65 0.78 . . . . 55.100000000000001 109.043 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.506 ' H ' ' HB ' ' A' ' 77' ' ' THR . 13.2 t -77.29 144.04 38.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.074 -1.084 . . . . 75.319999999999993 108.074 171.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 N-CA-C 110.488 -1.045 . . . . 65.219999999999999 110.488 -167.087 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 112.65 -0.18 . . . . 72.25 112.65 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -84.95 103.3 13.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.375 0.67 . . . . 51.530000000000001 111.068 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -75.62 121.81 85.86 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.896 -0.779 . . . . 64.230000000000004 108.896 169.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.14 -174.62 1.43 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.724 2.283 . . . . 54.210000000000001 112.607 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -160.56 175.2 12.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.333 0.653 . . . . 55.109999999999999 109.749 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.0 p -60.14 161.33 7.05 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.103 0.961 . . . . 55.200000000000003 110.803 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -62.8 -73.24 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.18 0.992 . . . . 72.409999999999997 111.042 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -131.66 -76.48 0.51 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.836 0.455 . . . . 73.319999999999993 110.532 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.8 t70 175.28 144.33 0.06 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.113 1.365 . . . . 74.109999999999999 109.004 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -88.85 107.63 19.09 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.03 -0.73 . . . . 64.099999999999994 109.03 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 t -76.8 173.8 11.26 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.599 0.76 . . . . 64.120000000000005 111.489 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.69 157.31 44.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.704 0.802 . . . . 55.100000000000001 110.28 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 pt -102.84 -176.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.518 0.727 . . . . 72.530000000000001 110.785 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -148.68 173.67 12.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.29 0.636 . . . . 54.399999999999999 110.223 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -143.35 146.67 33.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.991 0.516 . . . . 73.109999999999999 111.373 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -121.4 135.22 55.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.841 0.856 . . . . 60.130000000000003 109.499 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.0 m -145.8 128.65 16.36 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.296 1.038 . . . . 71.349999999999994 108.789 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 p -110.24 162.89 14.17 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.65 0.78 . . . . 73.030000000000001 111.586 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -118.79 136.47 53.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.91 0.884 . . . . 72.049999999999997 109.688 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.6 m -78.29 157.68 29.12 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.778 0.831 . . . . 64.230000000000004 110.359 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.81 169.76 16.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 70.319999999999993 109.472 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.61 42.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.399 0.68 . . . . 63.219999999999999 111.095 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.32 176.87 9.43 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.402 2.068 . . . . 63.039999999999999 111.794 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 p -112.92 -175.89 2.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.331 0.652 . . . . 74.219999999999999 110.474 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.9 t -150.2 136.1 18.5 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.519 -0.919 . . . . 72.099999999999994 108.519 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -114.44 138.43 50.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.003 0.521 . . . . 72.140000000000001 109.621 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.7 m -148.15 121.7 9.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.435 0.694 . . . . 72.349999999999994 109.506 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.06 144.58 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.488 0.715 . . . . 72.439999999999998 110.149 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 10.8 mptt -105.98 157.24 35.21 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 124.084 0.954 . . . . 75.430000000000007 110.102 -176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -54.19 149.99 34.11 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 72.010000000000005 113.304 171.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.4 159.8 32.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.481 0.712 . . . . 70.450000000000003 112.016 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.41 154.13 94.65 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.412 1.085 . . . . 72.409999999999997 111.98 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.34 159.35 40.22 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.98 2.454 . . . . 71.409999999999997 111.226 173.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.48 -81.9 0.64 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.439 0.533 . . . . 65.540000000000006 112.439 -173.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.12 154.96 46.2 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.219 0.463 . . . . 70.040000000000006 112.196 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 27.3 mm-40 -77.07 114.49 15.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.104 0.962 . . . . 74.109999999999999 109.451 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 43.1 t -125.76 137.32 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 122.853 0.461 . . . . 73.040000000000006 110.542 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -151.27 148.99 28.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.005 0.922 . . . . 74.140000000000001 110.676 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.51 113.57 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.263 1.025 . . . . 75.209999999999994 109.505 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -103.33 107.85 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.78 0.432 . . . . 75.340000000000003 110.228 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 3.4 t-20 -94.42 119.44 33.16 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.734 -0.839 . . . . 73.140000000000001 108.734 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -102.43 -42.9 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 122.073 -0.392 . . . . 73.340000000000003 110.365 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 p -136.88 158.55 44.21 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.84 -0.8 . . . . 73.450000000000003 108.84 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.75 59.05 4.21 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.591 -1.003 . . . . 73.129999999999995 110.591 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 t -66.22 100.81 0.65 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.602 0.761 . . . . 62.009999999999998 111.491 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -147.83 155.44 41.65 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.249 0.62 . . . . 53.219999999999999 110.133 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.62 -2.53 36.36 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 118.905 -0.942 . . . . 65.129999999999995 114.001 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.98 69.46 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.095 0.958 . . . . 70.310000000000002 111.412 171.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -42.56 97.28 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 124.154 0.909 . . . . 51.43 110.988 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.22 -35.53 71.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.67 -0.696 . . . . 71.5 111.089 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.76 -31.24 71.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.901 1.28 . . . . 64.450000000000003 111.63 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.525 ' HB ' HG13 ' A' ' 94' ' ' VAL . 48.0 p -76.97 -22.18 53.59 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.7 0.4 . . . . 72.329999999999998 111.59 176.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.19 -54.73 5.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.462 0.705 . . . . 74.450000000000003 111.205 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -54.96 -31.16 60.33 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.16 0.984 . . . . 74.549999999999997 113.147 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -59.88 -39.47 85.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.321 0.648 . . . . 74.430000000000007 111.789 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.0 -38.42 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 118.917 -0.563 . . . . 75.510000000000005 111.893 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -30.93 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.825 0.738 . . . . 73.349999999999994 110.596 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.19 -27.97 66.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.479 0.712 . . . . 71.150000000000006 110.808 173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.71 -21.8 37.78 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.63 0.772 . . . . 51.119999999999997 111.989 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.06 25.99 4.85 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 113.968 0.347 . . . . 65.400000000000006 113.968 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.43 158.73 27.27 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.34 0.656 . . . . 64.120000000000005 110.443 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -65.43 -70.1 0.26 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.969 0.793 . . . . 71.340000000000003 110.854 -165.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.02 145.15 35.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.69 -0.856 . . . . 64.420000000000002 108.69 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 37' ' ' VAL . 41.4 p -137.14 100.61 4.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.527 -1.286 . . . . 71.239999999999995 107.527 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 19.0 t70 -104.9 162.5 13.27 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.897 0.879 . . . . 73.319999999999993 110.183 -172.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 141.44 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.841 0.856 . . . . 73.030000000000001 109.049 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.44 129.02 2.41 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.947 -0.461 . . . . 65.140000000000001 111.947 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 16.8 p-10 -88.66 97.39 11.09 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.447 0.699 . . . . 73.530000000000001 109.823 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.4 135.55 13.03 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.166 -0.333 . . . . 73.540000000000006 110.155 -169.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -81.16 99.41 8.53 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.433 -0.58 . . . . 70.129999999999995 109.433 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.31 151.75 89.98 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.407 -0.59 . . . . 73.329999999999998 109.407 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.04 -7.61 18.32 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.113 1.875 . . . . 54.439999999999998 112.371 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -108.93 -23.05 11.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.342 0.657 . . . . 73.400000000000006 112.43 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.06 130.13 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.36 0.6 . . . . 65.549999999999997 111.252 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.27 -7.67 4.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.431 1.092 . . . . 75.439999999999998 111.215 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.12 159.0 5.77 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.463 1.105 . . . . 55.140000000000001 109.345 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.4 t -66.75 107.24 2.09 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.694 0.759 . . . . 63.32 109.996 177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 m -144.91 153.42 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.531 -0.759 . . . . 73.5 109.293 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.685 HG21 ' HA3' ' A' ' 95' ' ' GLY . 4.3 t -112.6 114.28 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.916 -1.142 . . . . 64.129999999999995 107.916 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.582 ' HB2' HG13 ' A' ' 117' ' ' ILE . 52.4 m-85 -105.1 119.38 38.89 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.285 0.493 . . . . 73.120000000000005 110.585 -174.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HD2' ' HB3' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -112.01 140.99 46.22 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.85 0.719 . . . . 74.310000000000002 110.462 175.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.1 t -113.78 -40.05 3.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.946 0.898 . . . . 62.030000000000001 111.654 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -89.81 37.38 0.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.858 0.863 . . . . 73.209999999999994 111.856 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -45.87 163.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.518 1.927 . . . . 74.129999999999995 114.746 -174.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 86.69 -55.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.727 2.011 . . . . 75.329999999999998 108.359 -163.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.31 -50.73 1.99 Allowed Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.205 -0.452 . . . . 75.019999999999996 112.574 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.04 -19.94 50.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.653 0.263 . . . . 72.409999999999997 111.299 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -56.81 -27.97 60.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.75 -0.659 . . . . 65.530000000000001 110.972 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.8 -46.64 57.57 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.716 0.806 . . . . 72.430000000000007 112.214 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 94' ' ' VAL . 6.2 t -79.9 -33.24 40.03 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 122.672 0.389 . . . . 75.140000000000001 110.736 -171.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.59 -48.22 75.76 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 123.799 0.687 . . . . 64.310000000000002 110.353 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.534 ' HA ' HG11 ' A' ' 102' ' ' VAL . 30.5 t70 -57.52 -40.24 78.34 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.272 0.983 . . . . 73.099999999999994 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.54 -46.1 87.51 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.961 0.788 . . . . 54.200000000000003 112.149 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 52' ' ' THR . 61.4 t -65.44 -52.82 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.328 0.651 . . . . 74.310000000000002 110.605 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.685 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -64.6 -26.84 71.18 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.344 -0.844 . . . . 62.399999999999999 113.281 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 2.6 tmt_? -65.07 -39.29 93.02 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.507 0.723 . . . . 75.450000000000003 109.553 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -66.46 -52.65 43.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.922 -1.035 . . . . 73.310000000000002 111.181 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 118' ' ' VAL . 4.0 pp -82.45 -13.71 56.29 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.792 -0.64 . . . . 73.340000000000003 112.402 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.66 72.81 1.2 Allowed Glycine 0 C--N 1.349 1.255 0 O-C-N 123.574 0.546 . . . . 45.25 113.136 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.06 155.11 44.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.703 0.801 . . . . 75.340000000000003 110.001 172.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.97 142.53 33.36 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.492 -0.776 . . . . 74.299999999999997 110.289 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.534 HG11 ' HA ' ' A' ' 92' ' ' ASP . 34.0 m -95.19 148.25 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.417 0.687 . . . . 70.140000000000001 110.748 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -157.5 156.69 32.49 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 123.811 0.844 . . . . 70.209999999999994 110.81 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.63 161.51 23.12 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.402 1.081 . . . . 74.049999999999997 110.746 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.424 ' HG3' ' H ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -69.66 29.73 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.404 2.001 . . . . 71.239999999999995 116.404 -172.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.406 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.0 mm? -54.61 -53.62 58.12 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-N 119.562 1.074 . . . . 74.430000000000007 112.521 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 6.0 Cg_exo -80.26 -13.93 12.2 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 122.378 2.052 . . . . 75.340000000000003 112.953 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HG2' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -58.62 -41.61 86.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.498 0.719 . . . . 72.319999999999993 110.153 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.4 tp -64.29 -12.75 44.72 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.56 0.744 . . . . 70.030000000000001 112.566 -172.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -63.64 -47.16 82.47 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.871 0.869 . . . . 74.319999999999993 111.161 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.2 -32.49 7.48 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.353 1.061 . . . . 75.129999999999995 110.944 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.1 71.92 1.04 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 126.782 2.033 . . . . 54.520000000000003 112.708 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HD2' ' HG2' ' A' ' 108' ' ' GLU . 1.4 Cg_endo -88.71 140.74 4.34 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.1 2.533 . . . . 74.030000000000001 111.106 162.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.0 129.04 13.72 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.66 2.24 . . . . 74.109999999999999 114.468 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.23 -156.15 32.02 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.022 -0.536 . . . . 41.25 113.988 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 76.8 t -58.1 111.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 124.278 1.031 . . . . 74.200000000000003 110.138 177.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 80' ' ' TYR . 39.7 pt -117.85 104.3 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.47 -1.307 . . . . 64.519999999999996 107.47 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 79' ' ' VAL . 2.3 p -101.84 111.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.886 -0.783 . . . . 65.129999999999995 108.886 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -93.17 123.53 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.941 -1.027 . . . . 71.420000000000002 109.473 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.05 127.52 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.593 0.757 . . . . 72.540000000000006 110.108 -172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.574 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.8 p -123.4 119.61 30.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.512 -1.292 . . . . 54.109999999999999 107.512 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.594 0 CA-C-O 119.207 -0.774 . . . . 63.32 112.628 -174.613 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.931 0 N-CA-C 111.956 -0.457 . . . . 72.140000000000001 111.956 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.0 t -139.78 -57.96 0.57 Allowed 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.497 0.719 . . . . 71.150000000000006 109.466 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m 52.67 78.1 0.41 Allowed Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.722 1.209 . . . . 63.450000000000003 111.364 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.99 109.8 2.02 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.685 2.256 . . . . 62.119999999999997 112.4 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.95 117.47 7.66 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.612 0.765 . . . . 63.109999999999999 109.995 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 p -71.03 92.3 0.93 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.349 0.595 . . . . 63.009999999999998 109.576 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -91.44 8.64 35.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.445 1.098 . . . . 64.409999999999997 111.517 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -62.63 -68.58 0.32 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.474 0.709 . . . . 53.149999999999999 110.971 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.3 t70 65.35 113.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.011 1.324 . . . . 52.539999999999999 112.423 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.3 m -86.53 126.66 34.61 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.583 0.753 . . . . 75.450000000000003 109.931 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.3 p -153.49 124.65 7.45 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.939 0.896 . . . . 73.239999999999995 108.684 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.41 123.93 7.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.812 0.845 . . . . 64.530000000000001 109.517 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 tp -157.9 136.26 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.817 0.847 . . . . 73.400000000000006 109.345 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 p -150.77 88.78 1.5 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.86 0.864 . . . . 73.140000000000001 109.318 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.5 p -99.17 131.0 45.51 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.176 -0.675 . . . . 51.329999999999998 109.176 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -131.34 155.37 47.35 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.2 0.524 . . . . 73.409999999999997 111.251 -174.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -153.98 159.35 41.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.135 1.374 . . . . 75.530000000000001 108.352 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -139.59 42.23 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 122.043 0.925 . . . . 33.43 109.911 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 m -78.66 100.48 7.04 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.1 -0.955 . . . . 74.340000000000003 109.0 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 t -132.79 31.3 3.95 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.829 0.823 . . . . 72.430000000000007 110.128 -174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.23 134.65 37.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.212 -0.904 . . . . 70.430000000000007 110.898 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.84 111.9 4.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.509 0.724 . . . . 62.350000000000001 109.556 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.16 158.18 52.55 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.645 2.23 . . . . 74.340000000000003 111.275 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -159.5 167.26 29.06 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.16 0.584 . . . . 63.520000000000003 110.65 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -143.84 159.5 42.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.689 0.795 . . . . 74.439999999999998 110.291 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 t -127.63 140.21 52.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.555 0.742 . . . . 60.119999999999997 109.781 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 p -169.29 137.0 1.83 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.824 0.849 . . . . 43.420000000000002 109.877 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.11 125.9 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.353 0.661 . . . . 65.109999999999999 110.52 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.37 110.48 58.06 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.376 -0.972 . . . . 73.239999999999995 108.376 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.88 132.67 43.5 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.256 2.637 . . . . 54.439999999999998 113.292 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.95 179.77 6.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.734 0.814 . . . . 73.319999999999993 110.221 172.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.03 94.48 3.76 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.353 0.661 . . . . 72.519999999999996 109.744 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 62' ' ' THR . 48.3 Cg_exo -59.72 141.85 97.67 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.938 2.426 . . . . 73.310000000000002 112.6 173.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -98.92 -75.58 0.56 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.342 0.657 . . . . 74.439999999999998 111.871 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.97 168.1 26.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.036 0.534 . . . . 45.119999999999997 110.838 -171.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.04 112.71 24.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.906 0.882 . . . . 75.109999999999999 108.944 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 64' ' ' THR . 99.4 t -116.42 138.95 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.68 0.792 . . . . 71.329999999999998 109.461 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -132.15 118.12 19.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.614 -0.513 . . . . 63.100000000000001 109.614 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.12 107.19 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.342 -0.614 . . . . 72.540000000000006 109.342 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 33.6 p90 -118.1 152.26 35.93 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 109.102 -0.703 . . . . 74.430000000000007 109.102 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -93.72 134.44 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.033 -0.728 . . . . 64.310000000000002 109.033 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.14 -39.71 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.812 -0.44 . . . . 74.310000000000002 109.812 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 p -141.73 -61.32 0.46 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.821 0.448 . . . . 64.409999999999997 111.208 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.65 100.69 1.72 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.703 -0.498 . . . . 44.399999999999999 112.064 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -88.17 41.45 1.0 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.155 0.982 . . . . 52.109999999999999 112.858 -168.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.16 137.34 56.2 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.961 0.505 . . . . 72.340000000000003 110.521 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -7.69 58.04 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.529 0.518 . . . . 70.510000000000005 113.643 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.32 64.68 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.267 1.027 . . . . 61.030000000000001 110.954 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.08 -56.96 14.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.922 -1.035 . . . . 51.350000000000001 110.59 171.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.99 67.65 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.518 -0.765 . . . . 74.400000000000006 112.568 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -29.92 68.08 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.039 0.935 . . . . 75.129999999999995 110.96 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 98' ' ' LEU . 64.4 p -70.13 -36.86 75.1 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 110.085 -0.339 . . . . 63.219999999999999 110.085 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB1' ' OG1' ' A' ' 64' ' ' THR . . . -67.3 -28.5 68.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.602 0.761 . . . . 72.230000000000004 111.562 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.41 -24.47 62.93 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.015 0.926 . . . . 72.200000000000003 110.711 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -70.51 -42.0 71.88 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.906 -0.405 . . . . 72.239999999999995 109.906 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.8 mp -69.39 -29.6 67.4 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.806 0.669 . . . . 73.150000000000006 112.806 -174.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.46 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.38 -27.47 67.13 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.897 0.38 . . . . 61.530000000000001 110.793 175.341 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.03 27.77 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.028 0.931 . . . . 62.439999999999998 111.746 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -89.39 -22.8 22.39 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.304 0.642 . . . . 72.019999999999996 112.484 -174.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.47 46.83 0.39 Allowed Glycine 0 C--N 1.352 1.439 0 CA-C-N 117.873 0.306 . . . . 54.509999999999998 113.308 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -62.41 158.22 18.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.103 0.961 . . . . 73.5 111.818 176.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 33' ' ' PRO . 85.7 m -92.54 -60.72 1.76 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.214 -1.032 . . . . 73.230000000000004 108.214 161.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -134.56 140.66 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.611 -1.255 . . . . 71.200000000000003 107.611 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t -130.56 127.12 38.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.372 -0.973 . . . . 65.120000000000005 108.372 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -122.54 144.55 49.01 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.014 -1.106 . . . . 64.120000000000005 108.014 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 m -139.85 143.61 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 122.848 0.459 . . . . 63.539999999999999 110.41 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.1 -138.13 4.63 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.016 -0.538 . . . . 63.25 112.16 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -157.96 123.05 4.39 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.265 0.626 . . . . 72.310000000000002 110.546 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 10.0 mp -129.12 156.39 43.96 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.188 0.995 . . . . 45.340000000000003 108.882 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 p -106.13 100.88 10.4 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.708 0.803 . . . . 50.130000000000003 110.055 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -119.16 119.54 31.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 123.818 0.847 . . . . 34.520000000000003 109.134 167.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.16 0.33 9.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.757 2.305 . . . . 72.209999999999994 112.713 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.0 -26.77 54.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.047 0.939 . . . . 73.510000000000005 111.104 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 t -125.56 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.755 -0.832 . . . . 75.239999999999995 108.755 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.74 -54.33 2.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.962 0.905 . . . . 35.100000000000001 110.488 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.64 160.33 25.08 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.024 0.93 . . . . 62.43 110.436 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 t -64.05 104.67 0.75 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.979 0.895 . . . . 61.32 108.887 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.0 m -136.1 129.84 32.46 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.385 -0.825 . . . . 70.129999999999995 110.564 -171.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.73 HG22 HG13 ' A' ' 118' ' ' VAL . 73.5 t -95.18 113.65 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.049 -1.093 . . . . 60.399999999999999 108.049 175.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.466 ' CD2' HG12 ' A' ' 117' ' ' ILE . 10.2 t80 -96.98 136.38 37.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.057 -0.72 . . . . 73.439999999999998 109.057 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.475 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 25.1 p90 -151.73 -179.49 7.48 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.71 1.256 . . . . 73.0 108.972 172.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 4.3 m -131.7 169.22 16.49 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 106.043 -1.836 . . . . 55.32 106.043 164.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.69 21.25 2.25 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.134 -0.979 . . . . 73.120000000000005 111.826 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.45 99.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.259 1.024 . . . . 63.539999999999999 109.788 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 64.11 -75.99 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 125.56 1.544 . . . . 74.340000000000003 111.88 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.57 39.07 0.51 Allowed Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.013 0.365 . . . . 51.32 114.013 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 82' ' ' THR . 55.4 mt-10 -69.97 -36.45 75.24 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.0 0.429 . . . . 54.219999999999999 110.566 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -62.02 -37.75 86.08 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.781 -1.1 . . . . 64.150000000000006 112.54 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.77 -25.49 49.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.986 0.514 . . . . 44.329999999999998 111.492 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.5 m -78.75 -36.69 42.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.911 0.885 . . . . 74.310000000000002 109.677 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -24.38 40.45 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.928 -1.033 . . . . 65.150000000000006 111.554 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.09 -39.71 90.96 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.11 0.964 . . . . 53.210000000000001 109.977 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -23.98 66.94 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.139 -0.937 . . . . 74.129999999999995 111.996 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.675 HG11 HG21 ' A' ' 118' ' ' VAL . 58.1 t -84.34 -61.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 122.872 0.469 . . . . 74.109999999999999 111.355 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.415 ' CA ' HG21 ' A' ' 79' ' ' VAL . . . -66.73 -27.73 73.42 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.581 0.55 . . . . 53.140000000000001 114.293 -168.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -76.11 -23.46 54.9 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.002 0.521 . . . . 74.319999999999993 110.265 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 85.3 m -84.49 -38.69 19.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.621 0.769 . . . . 73.310000000000002 111.084 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.655 HD21 HG22 ' A' ' 120' ' ' VAL . 46.0 tp -81.37 -31.88 33.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.782 0.833 . . . . 63.340000000000003 111.553 -172.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.67 50.57 5.57 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 111.002 -0.839 . . . . 64.200000000000003 111.002 -170.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.59 143.74 51.12 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.53 0.732 . . . . 74.310000000000002 110.606 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.48 114.48 3.92 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.962 0.788 . . . . 62.229999999999997 110.018 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.475 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 16.1 m -88.13 101.75 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.356 0.598 . . . . 71.420000000000002 110.114 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.59 157.24 20.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.518 1.151 . . . . 73.299999999999997 111.957 -175.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 8.0 tp -93.2 -166.59 1.55 Allowed 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 112.934 -1.939 . . . . 70.329999999999998 108.367 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.503 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 48.7 ttp180 -81.43 27.69 0.42 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.588 0.755 . . . . 74.200000000000003 112.542 -175.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.8 mm? -70.87 -66.69 0.73 Allowed Pre-proline 0 CA--C 1.558 1.27 0 CA-C-O 118.045 -0.979 . . . . 71.019999999999996 111.053 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 4.5 Cg_exo -83.85 -23.57 3.12 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 121.878 1.719 . . . . 74.340000000000003 112.988 -173.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.35 -9.96 59.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.949 -0.548 . . . . 71.319999999999993 111.587 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -20.92 66.55 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.849 0.46 . . . . 71.140000000000001 110.526 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -55.66 -45.56 77.66 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.442 0.697 . . . . 63.340000000000003 110.831 171.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -86.13 -32.44 21.31 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.401 0.68 . . . . 62.140000000000001 111.221 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.62 79.15 0.36 Allowed Pre-proline 0 CA--C 1.563 1.446 0 C-N-CA 125.734 1.614 . . . . 63.439999999999998 111.033 -169.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 3.6 Cg_exo -84.56 125.64 3.38 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.061 2.508 . . . . 72.109999999999999 111.743 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 3.6 Cg_exo -79.12 118.69 4.08 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.35 2.033 . . . . 75.439999999999998 110.906 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.07 166.19 39.43 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 112.014 -0.434 . . . . 32.210000000000001 112.014 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 80' ' ' TYR . 75.9 t -66.94 126.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.023 0.929 . . . . 73.409999999999997 111.481 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.466 HG12 ' CD2' ' A' ' 80' ' ' TYR . 9.4 pt -121.85 111.95 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.162 -1.051 . . . . 62.520000000000003 108.162 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.73 HG13 HG22 ' A' ' 79' ' ' VAL . 61.3 t -94.01 108.49 20.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.845 -0.798 . . . . 75.230000000000004 108.845 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.47 120.95 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.409 -0.814 . . . . 72.239999999999995 109.789 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.655 HG22 HD21 ' A' ' 98' ' ' LEU . 44.7 t -110.28 129.59 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 122.681 0.392 . . . . 73.109999999999999 110.763 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 t -99.87 164.56 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.048 0.451 . . . . 73.400000000000006 110.745 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.806 0 CA-C-O 118.708 -1.051 . . . . 74.219999999999999 111.126 170.267 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 110.15 -0.315 . . . . 74.1 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -93.53 178.07 5.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.42 0.688 . . . . 53.12 110.108 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.31 156.5 42.97 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.749 0.82 . . . . 74.21 109.666 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -128.52 170.56 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.464 0.706 . . . . 44.41 110.41 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 t -164.63 171.15 14.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.211 1.004 . . . . 73.14 109.438 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -135.78 163.54 29.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.026 0.93 . . . . 63.41 109.18 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.7 mtt -127.54 131.62 50.03 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.019 0.928 . . . . 51.44 108.698 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.5 p -111.9 141.49 45.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.411 0.684 . . . . 41.41 110.142 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.9 p -127.29 158.74 36.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.806 0.843 . . . . 71.34 110.108 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 t -143.4 162.27 36.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.628 0.771 . . . . 71.23 109.311 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.9 m -149.09 137.72 21.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.306 0.643 . . . . 74.11 109.942 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.51 165.87 12.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.55 0.74 . . . . 55.0 109.861 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.64 136.63 12.48 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.179 0.592 . . . . 73.55 109.884 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.53 139.26 37.17 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.075 2.516 . . . . 73.2 112.867 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 p -102.18 128.14 48.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.994 0.918 . . . . 62.31 109.899 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 m -87.88 121.98 30.96 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.569 0.748 . . . . 70.03 109.582 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 m -136.23 124.43 23.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.081 0.952 . . . . 55.41 109.066 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.2 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.044 0.938 . . . . 34.04 109.755 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.42 140.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.693 0.797 . . . . 55.02 109.525 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.98 136.88 19.65 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.096 0.959 . . . . 61.44 109.448 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo . . . . . 0 C--N 1.382 2.315 0 C-N-CA 123.22 2.613 . . . . 60.25 113.841 178.76 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 109.88 -0.415 . . . . 71.32 109.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.18 149.34 26.01 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.32 0.581 . . . . 64.24 110.799 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.481 HG21 HD21 ' A' ' 56' ' ' LEU . 48.1 t -114.9 146.57 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.312 1.045 . . . . 71.23 108.84 172.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.0 ptp180 -145.18 117.02 8.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.225 0.536 . . . . 53.01 111.571 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.52 111.9 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.311 0.644 . . . . 62.52 109.774 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 33.7 m-85 -101.08 118.76 37.63 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.187 0.595 . . . . 73.54 109.856 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 120' ' ' VAL . 4.6 t-20 -95.9 125.36 40.4 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.345 -1.354 . . . . 71.04 107.345 169.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.769 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.6 tt -80.39 -34.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 111.931 0.345 . . . . 71.53 111.931 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -111.43 -20.52 12.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.689 0.396 . . . . 75.23 111.511 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.9 114.92 0.62 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.808 -0.517 . . . . 74.21 111.808 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.441 HG22 HD21 ' A' ' 41' ' ' ASN . 13.2 t -145.15 -155.67 0.63 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.059 -0.719 . . . . 64.24 109.059 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.98 154.78 25.52 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.587 1.155 . . . . 72.31 112.477 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.33 -1.8 16.56 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 115.455 -0.793 . . . . 74.25 114.691 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.69 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.028 0.931 . . . . 74.13 111.58 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.26 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.354 -0.839 . . . . 63.1 110.863 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB2' HG21 ' A' ' 66' ' ' VAL . . . -71.3 -20.47 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.465 0.706 . . . . 75.03 111.753 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -28.97 69.07 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.603 0.761 . . . . 74.3 111.354 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.492 ' HB ' HG13 ' A' ' 94' ' ' VAL . 68.5 p -62.87 -40.99 99.19 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.486 0.492 . . . . 74.53 110.346 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 64' ' ' THR . . . -66.27 -37.41 85.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.055 0.942 . . . . 74.24 111.809 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -65.44 -51.73 58.12 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.584 -0.735 . . . . 74.41 110.946 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -67.76 -26.22 66.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.572 -1.194 . . . . 73.55 110.836 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 37' ' ' VAL . 18.3 tp -76.3 -49.85 15.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.949 -1.023 . . . . 62.21 111.198 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 34.9 ttpt -63.19 -35.82 81.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.915 0.486 . . . . 74.31 110.685 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -22.49 62.14 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 54.22 111.341 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.67 57.83 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.413 0.685 . . . . 75.44 111.36 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.37 41.17 0.98 Allowed Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.445 -0.343 . . . . 75.53 113.069 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -106.25 156.9 18.0 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.304 0.642 . . . . 74.21 109.927 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.4 m -66.95 -69.48 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.275 0.984 . . . . 53.33 111.361 -161.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.29 136.76 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.188 -1.042 . . . . 72.21 108.188 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.48 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 73.7 p -129.55 94.9 3.87 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.937 -0.764 . . . . 61.13 108.937 172.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -103.63 131.56 50.67 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.644 0.778 . . . . 72.15 109.663 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 50' ' ' ALA . 6.4 p -116.3 131.11 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 121.712 -0.617 . . . . 75.31 110.638 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -150.27 159.76 28.25 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.648 -0.705 . . . . 54.24 111.618 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -95.04 119.8 34.17 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.744 -0.836 . . . . 33.43 108.744 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.5 tt -150.64 133.93 16.25 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.004 -1.11 . . . . 74.32 108.004 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.769 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.9 m -80.85 100.07 8.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.361 0.665 . . . . 73.33 109.882 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.61 106.21 8.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.166 -0.679 . . . . 54.45 109.166 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.71 0.47 9.99 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.695 2.263 . . . . 71.23 112.465 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -95.83 -23.4 16.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.249 1.019 . . . . 74.31 110.647 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.762 HG21 HG11 ' A' ' 119' ' ' VAL . 14.3 m -97.27 155.49 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.291 0.636 . . . . 74.34 109.865 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.29 9.28 2.28 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.702 0.801 . . . . 73.11 110.586 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.46 156.51 33.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.74 1.216 . . . . 70.43 108.611 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -59.2 111.89 1.51 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.053 -0.721 . . . . 74.14 109.053 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.8 m -138.45 127.95 24.72 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.313 -0.858 . . . . 63.33 110.611 -168.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 118' ' ' VAL . 50.3 t -102.4 113.19 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.784 -1.191 . . . . 72.13 107.784 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 117' ' ' ILE . 1.4 t80 -98.87 142.47 30.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.969 1.308 . . . . 73.21 109.926 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 22.5 p90 -133.06 164.56 26.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.459 -0.792 . . . . 72.32 111.2 168.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.1 m -107.48 172.41 6.84 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 106.895 -1.521 . . . . 74.1 106.895 163.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.53 28.41 8.76 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.91 0.484 . . . . 62.22 111.176 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 84.6 t -77.17 126.25 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.416 -0.957 . . . . 74.32 108.416 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.92 -80.48 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.267 1.027 . . . . 73.34 110.912 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.56 35.6 0.23 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.9 -0.48 . . . . 74.44 111.9 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 48.9 mt-10 -61.8 -19.64 62.74 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.172 0.589 . . . . 73.22 112.269 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' CG ' ' A' ' 81' ' ' TYR . 41.0 ptt85 -63.08 -28.8 70.33 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.287 0.477 . . . . 65.32 112.287 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.37 82.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.723 0.809 . . . . 63.52 111.798 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.7 t -67.67 -46.52 72.13 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.422 -0.354 . . . . 74.22 111.151 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 81' ' ' TYR . . . -71.98 -27.72 62.94 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.744 0.417 . . . . 53.04 111.934 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.04 -33.8 76.91 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.529 0.732 . . . . 73.3 110.496 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.42 -47.64 19.26 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.662 -0.699 . . . . 72.21 110.509 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.492 HG13 ' HB ' ' A' ' 52' ' ' THR . 98.8 t -68.95 -33.66 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.468 0.707 . . . . 72.43 111.757 -175.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -58.54 -29.08 63.3 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.347 -0.388 . . . . 72.43 112.561 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -86.96 -30.89 20.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.282 0.633 . . . . 74.25 111.018 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.2 m -64.34 -43.24 95.23 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.644 0.735 . . . . 65.35 110.546 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.486 HD21 HG22 ' A' ' 120' ' ' VAL . 57.3 tp -85.29 -32.15 22.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.59 -1.186 . . . . 70.45 110.204 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 66.8 1.96 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.432 -1.067 . . . . 63.52 110.432 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.97 166.44 24.47 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.553 1.141 . . . . 44.52 110.359 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.32 110.99 7.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.429 0.691 . . . . 64.05 109.325 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.623 HG22 ' HA3' ' A' ' 95' ' ' GLY . 5.4 t -86.63 134.03 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.26 -1.015 . . . . 73.24 108.26 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -140.39 153.12 46.23 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-O 121.402 0.62 . . . . 62.34 111.013 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.415 ' HA ' ' CE1' ' A' ' 81' ' ' TYR . 6.2 mp -76.78 -163.62 0.36 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 114.342 -1.299 . . . . 41.35 110.331 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -70.63 28.61 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 72.45 112.823 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 33.8 tp -70.88 -48.72 14.49 Favored Pre-proline 0 CA--C 1.568 1.641 0 O-C-N 121.601 -0.687 . . . . 72.1 111.265 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 106' ' ' LEU . 51.0 Cg_exo -58.39 -12.91 14.87 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 122.819 2.346 . . . . 74.44 114.006 170.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -66.37 -35.08 79.42 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.25 0.62 . . . . 52.11 109.651 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.1 tp -82.7 -34.15 27.4 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.911 0.386 . . . . 75.31 110.098 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -68.62 -48.78 63.21 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.454 -0.793 . . . . 52.44 111.335 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -126.86 -33.99 2.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.635 0.774 . . . . 64.35 111.554 -172.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.91 72.96 0.33 Allowed Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.766 1.226 . . . . 63.32 109.503 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.549 ' HB3' HD13 ' A' ' 117' ' ' ILE . 5.9 Cg_exo -81.92 148.38 15.43 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 123.407 2.738 . . . . 71.34 112.148 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.72 119.2 5.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.284 2.656 . . . . 63.44 112.938 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.17 -113.33 5.75 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.927 0.767 . . . . 54.13 112.867 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 37' ' ' VAL . 39.1 t -116.45 136.87 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.964 1.306 . . . . 71.31 108.098 173.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.584 HG22 ' HG3' ' A' ' 38' ' ' ARG . 11.8 pt -128.68 149.95 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.304 -0.628 . . . . 74.12 109.304 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 79' ' ' VAL . 59.2 t -117.54 102.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.114 -1.439 . . . . 72.43 107.114 175.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.762 HG11 HG21 ' A' ' 74' ' ' VAL . 23.8 t -94.18 126.04 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.108 -0.701 . . . . 53.22 109.108 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.519 ' HB ' ' ND2' ' A' ' 41' ' ' ASN . 21.5 t -115.82 128.09 73.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.558 -0.904 . . . . 62.53 108.558 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.419 HG22 HG21 ' A' ' 42' ' ' ILE . 19.7 p -95.17 137.48 34.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.214 0.605 . . . . 75.5 109.492 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 119.022 -0.877 . . . . 73.44 111.96 -177.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.623 -0.51 . . . . 71.44 109.623 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 p -130.42 111.02 11.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.225 1.01 . . . . 63.24 109.066 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.15 113.35 1.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.075 0.55 . . . . 74.12 109.756 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -150.8 114.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.726 0.81 . . . . 71.12 109.708 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -133.59 120.37 20.64 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.081 0.952 . . . . 65.04 108.636 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -151.79 109.22 3.6 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.743 0.817 . . . . 74.33 109.395 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.42 145.38 11.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.295 1.038 . . . . 74.22 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 142.85 24.79 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.098 0.475 . . . . 75.35 111.001 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -139.95 131.01 26.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 74.33 109.107 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -157.41 137.4 12.51 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.048 0.939 . . . . 74.12 109.311 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.7 m -147.56 102.95 3.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.426 0.69 . . . . 74.24 109.593 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 107.97 19.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.464 0.706 . . . . 65.3 109.261 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.26 111.7 44.92 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.589 0.756 . . . . 73.35 109.747 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.59 169.46 15.3 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.967 2.444 . . . . 63.41 112.304 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -152.86 119.99 5.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.583 0.753 . . . . 71.44 109.545 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 m -90.41 172.3 8.83 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.994 0.517 . . . . 54.12 109.836 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 m -132.04 144.22 50.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.119 0.568 . . . . 54.42 110.655 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 161.93 27.19 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.484 1.114 . . . . 63.44 110.145 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.89 140.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.103 0.561 . . . . 73.2 109.803 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.44 113.18 64.7 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.416 -0.957 . . . . 73.44 108.416 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.37 1.7 0 C-N-CA 122.494 2.129 . . . . 74.41 111.511 176.262 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.99 -0.374 . . . . 61.33 109.99 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -98.77 107.74 20.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.038 0.535 . . . . 65.32 110.044 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 56' ' ' LEU . 22.1 t -95.64 135.89 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.194 0.598 . . . . 61.22 109.742 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HD3' ' HE2' ' A' ' 40' ' ' TYR . 7.9 ptp180 -150.74 134.85 16.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.854 0.861 . . . . 74.25 110.573 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 118' ' ' VAL . 41.0 t -100.5 133.28 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 55.31 109.545 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.53 ' HE2' ' HD3' ' A' ' 38' ' ' ARG . 69.6 m-85 -130.12 107.77 9.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.683 0.793 . . . . 73.3 109.735 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -84.39 118.03 23.99 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.988 -0.745 . . . . 72.03 108.988 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.708 HG13 ' HA ' ' A' ' 70' ' ' SER . 17.0 tt -78.86 -33.21 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.113 -0.329 . . . . 62.25 110.113 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -99.1 -162.48 0.96 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.18 0.992 . . . . 53.42 109.619 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.71 116.12 8.5 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 123.575 0.547 . . . . 71.24 112.312 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -69.96 101.63 1.82 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.738 0.78 . . . . 73.05 110.692 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.77 145.53 27.2 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.999 -0.546 . . . . 64.34 109.862 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -58.02 -38.41 89.12 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 124.42 1.075 . . . . 55.04 114.377 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.61 68.43 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.775 0.83 . . . . 24.33 112.398 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.71 71.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.715 0.806 . . . . 72.3 111.731 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.41 -23.62 37.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.318 0.647 . . . . 74.13 111.441 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 41.9 mmm-85 -64.75 -21.71 66.82 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.141 0.577 . . . . 63.13 112.004 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' HD13 ' A' ' 56' ' ' LEU . 80.5 p -61.54 -45.97 91.91 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.905 0.482 . . . . 60.1 110.052 173.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.9 84.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.66 0.784 . . . . 55.03 111.363 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -42.49 95.91 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.181 0.926 . . . . 74.53 111.968 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -63.2 -46.21 88.1 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.852 -0.613 . . . . 74.32 110.636 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 37' ' ' VAL . 10.5 mp -72.68 -26.85 61.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.506 -0.77 . . . . 51.31 111.634 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.16 -51.17 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.076 -1.083 . . . . 75.41 108.076 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.99 59.38 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.708 -1.133 . . . . 72.13 112.128 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.76 -22.45 37.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.054 0.542 . . . . 74.35 110.571 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 44.03 5.54 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.054 -0.521 . . . . 22.11 113.782 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.65 158.64 30.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 72.14 109.448 169.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 m -58.02 -52.29 66.11 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.165 0.916 . . . . 74.53 111.302 -159.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.72 139.55 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.328 -0.99 . . . . 63.32 108.328 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 p -134.68 113.77 12.03 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.351 1.061 . . . . 74.01 108.485 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 22.8 t70 -128.38 154.91 45.5 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.817 0.847 . . . . 55.14 109.373 -171.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.62 153.66 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.392 0.615 . . . . 73.12 110.503 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.42 169.96 42.32 Favored Glycine 0 C--O 1.245 0.806 0 CA-C-N 114.783 -1.099 . . . . 55.32 110.51 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -146.32 116.61 7.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.262 -1.014 . . . . 54.33 108.262 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 mt -148.89 136.35 20.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.693 0.797 . . . . 73.44 109.411 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.708 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 m -76.52 97.94 4.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.404 -0.961 . . . . 52.35 108.404 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.8 119.8 70.0 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.861 -0.792 . . . . 71.31 108.861 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.76 -2.92 12.86 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.267 1.978 . . . . 70.41 112.712 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.09 -26.16 17.58 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.003 0.921 . . . . 73.21 111.829 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 76' ' ' ALA . 7.3 p -138.08 140.21 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.308 0.643 . . . . 73.14 110.189 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.3 33.21 3.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.336 0.654 . . . . 74.35 110.073 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' H ' HG22 ' A' ' 74' ' ' VAL . . . -135.14 149.87 50.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.527 0.731 . . . . 53.44 109.848 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.586 ' HB ' ' H ' ' A' ' 121' ' ' THR . 5.6 t -78.89 102.49 8.26 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 121.972 0.891 . . . . 74.3 108.73 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.5 m -149.8 143.35 25.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.169 -0.923 . . . . 61.53 108.971 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 23.2 t -93.92 114.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.527 -1.286 . . . . 74.35 107.527 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' HB2' HG12 ' A' ' 117' ' ' ILE . 96.8 m-85 -101.08 142.52 32.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.629 -1.249 . . . . 73.43 107.629 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -130.73 151.95 50.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.629 -0.508 . . . . 72.44 109.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.413 HG22 HG23 ' A' ' 84' ' ' VAL . 28.0 m -92.37 147.1 23.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.526 -1.287 . . . . 74.43 107.526 168.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.34 22.74 1.2 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.396 0.678 . . . . 74.44 112.661 -173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.413 HG23 HG22 ' A' ' 82' ' ' THR . 84.3 t -62.31 99.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.067 -0.716 . . . . 71.31 109.067 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.25 12.6 2.64 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.445 1.098 . . . . 62.34 112.182 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.32 62.65 2.05 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 120.243 -0.198 . . . . 72.24 113.401 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.71 -16.74 51.75 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.38 0.672 . . . . 73.31 111.524 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -26.1 6.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.047 0.939 . . . . 74.33 112.758 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.51 -53.21 60.73 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.774 0.671 . . . . 71.23 111.148 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.8 t -74.34 -32.61 62.87 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 116.293 -0.412 . . . . 62.12 110.694 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.56 75.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.393 0.677 . . . . 74.44 112.241 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.495 ' HA ' HG11 ' A' ' 102' ' ' VAL . 29.2 t70 -64.96 -43.13 93.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.219 1.008 . . . . 63.31 110.01 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.38 80.15 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.366 1.041 . . . . 70.32 111.846 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 90' ' ' THR . 65.3 t -64.58 -56.4 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 123.649 0.593 . . . . 74.31 110.389 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.72 67.55 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.89 0.744 . . . . 72.23 113.842 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -69.63 -47.16 64.35 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.256 1.022 . . . . 74.04 109.666 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.6 m -75.81 -35.92 59.89 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.972 -1.013 . . . . 72.44 111.03 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.01 -30.49 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.569 -0.741 . . . . 75.03 110.193 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.01 55.53 4.38 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.447 -0.661 . . . . 62.34 111.447 -175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.1 160.76 39.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.64 0.776 . . . . 74.44 110.266 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 142.18 52.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.065 0.946 . . . . 50.11 110.442 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 92' ' ' ASP . 35.9 m -103.11 131.45 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.48 -0.933 . . . . 61.44 108.48 171.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 49.5 mt-10 -140.83 159.73 41.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.478 1.111 . . . . 74.31 109.528 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.48 158.61 35.76 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.225 -0.657 . . . . 74.01 109.225 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 14.0 ptt180 -50.06 -41.74 48.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.044 1.338 . . . . 73.31 112.585 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.9 mt 67.34 158.76 0.14 Allowed Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 123.533 0.733 . . . . 72.02 110.222 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.36 -24.14 41.46 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.41 2.073 . . . . 72.43 113.701 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.2 -54.97 6.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.277 1.031 . . . . 61.53 111.54 -174.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 2.7 mm? -76.47 -20.14 57.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 116.508 -0.314 . . . . 74.1 110.258 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -69.02 -11.54 60.88 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.041 0.536 . . . . 74.53 111.856 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.34 -32.2 19.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.388 0.675 . . . . 75.13 110.713 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.485 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.5 pp0? -89.57 168.04 16.01 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 117.639 -1.172 . . . . 44.41 109.0 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 30.3 Cg_exo -29.34 122.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.406 3.568 1 C-N-CA 125.309 4.006 . . . . 63.13 116.685 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.11 161.12 47.03 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.15 2.567 . . . . 75.25 113.07 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 -158.95 14.04 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.253 -0.885 . . . . 64.52 111.207 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 70.7 t -83.54 108.35 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.891 0.877 . . . . 52.34 109.626 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.624 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.31 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.592 -0.892 . . . . 61.54 108.592 173.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.529 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.4 p -95.53 105.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.447 -0.946 . . . . 61.22 108.447 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 4.0 p -94.07 123.48 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.619 -0.882 . . . . 75.25 108.619 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.65 132.51 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.397 0.679 . . . . 73.5 109.946 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.586 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.0 t -119.89 151.61 38.63 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.058 -1.09 . . . . 62.42 108.058 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.297 0 CA-C-O 118.978 -0.901 . . . . 71.13 112.147 178.563 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 109.76 -0.459 . . . . 65.12 109.76 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -71.43 104.75 3.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.379 -0.828 . . . . 61.52 108.941 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.63 118.36 4.99 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.372 0.669 . . . . 61.23 110.134 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.95 155.99 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.292 1.037 . . . . 61.14 109.138 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.4 m -150.89 144.15 24.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.919 0.887 . . . . 73.42 109.386 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -160.88 160.85 31.49 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.878 0.871 . . . . 72.21 110.272 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 53.2 ttp -171.76 113.28 0.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.78 -1.193 . . . . 74.04 107.78 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -61.45 114.11 3.04 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.253 0.621 . . . . 73.34 110.563 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -70.22 -41.75 73.2 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.401 0.68 . . . . 52.41 111.393 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.2 m 68.55 152.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.981 1.313 . . . . 74.42 110.946 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.3 t -158.67 174.69 14.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.093 0.557 . . . . 72.51 110.329 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.18 148.87 28.77 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.113 0.965 . . . . 43.51 109.415 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.69 107.2 34.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 108.896 -0.779 . . . . 53.01 108.896 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.99 132.22 3.26 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.761 2.307 . . . . 73.02 112.472 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.3 p -123.21 124.34 42.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.877 0.471 . . . . 72.12 110.643 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m -149.02 118.23 6.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.495 1.118 . . . . 72.35 108.027 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 p -132.82 145.69 51.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.045 0.938 . . . . 74.53 109.216 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.3 p -144.91 120.15 10.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.182 0.593 . . . . 73.33 110.102 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 139.67 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.54 -0.911 . . . . 63.31 108.54 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.55 157.55 41.13 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 123.344 0.658 . . . . 73.25 110.322 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.383 2.379 0 C-N-CA 123.062 2.508 . . . . 72.01 113.042 177.138 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 108.358 -0.979 . . . . 52.24 108.358 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.676 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -95.86 87.8 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.581 . . . . 61.12 109.616 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 94' ' ' VAL . 47.1 t -117.59 142.12 33.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.184 -0.462 . . . . 71.1 110.782 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -143.6 158.52 43.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.293 -0.412 . . . . 72.52 111.383 172.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.08 129.11 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.37 0.668 . . . . 63.42 110.244 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 19.0 m-85 -109.86 107.83 17.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.316 1.046 . . . . 73.34 108.323 163.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -93.31 112.73 24.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.169 -1.789 . . . . 75.34 106.169 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.671 HG13 ' HA ' ' A' ' 70' ' ' SER . 13.5 tt -73.11 -45.21 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.037 -0.414 . . . . 64.4 111.33 -172.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -29.41 28.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 72.02 110.591 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.33 54.28 13.95 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 123.734 0.646 . . . . 72.42 113.016 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.91 0.484 . . . . 72.23 110.584 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' A' ' 49' ' ' ALA . 10.1 tp10 -63.77 121.81 14.9 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.403 0.52 . . . . 75.03 112.403 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.75 -23.8 51.8 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.861 -0.608 . . . . 73.43 112.291 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 52' ' ' THR . . . -65.09 -27.07 68.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.157 0.583 . . . . 53.04 110.852 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' H ' ' HG3' ' A' ' 46' ' ' GLU . . . -57.17 -47.34 81.46 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 124.032 0.833 . . . . 74.54 110.931 173.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.22 77.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.73 -0.668 . . . . 73.25 111.368 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -69.99 -22.68 63.11 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.326 1.051 . . . . 74.12 111.139 -172.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' HG13 ' A' ' 94' ' ' VAL . 75.5 p -67.98 -49.82 59.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.262 0.225 . . . . 61.12 111.488 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -22.03 61.63 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.233 0.539 . . . . 62.14 111.209 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.94 -47.83 60.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.247 . . . . 65.4 110.512 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -70.71 -30.86 67.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.654 -0.498 . . . . 71.34 109.654 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HG22 ' A' ' 64' ' ' THR . 53.4 tp -66.16 -33.29 75.45 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.337 -0.847 . . . . 73.45 111.295 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 11.4 tmtt? -58.4 -43.13 88.46 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.725 -0.843 . . . . 62.52 108.725 174.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.3 -18.88 54.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.211 1.004 . . . . 71.34 112.319 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.34 42.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 55.21 112.038 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.12 46.72 0.69 Allowed Glycine 0 C--N 1.348 1.232 0 O-C-N 123.106 0.254 . . . . 60.23 112.503 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 3.6 p90 -60.4 158.04 12.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.518 1.127 . . . . 71.14 112.145 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 m -109.69 -43.52 4.03 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.714 -0.847 . . . . 64.1 108.714 164.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.676 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 83.3 t -135.63 128.37 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.194 0.998 . . . . 73.55 108.597 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.482 HG22 HD23 ' A' ' 56' ' ' LEU . 3.2 p -130.31 116.79 18.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 52.53 108.534 173.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 16.0 t70 -121.19 158.76 27.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.419 -0.956 . . . . 71.12 108.419 172.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.24 140.1 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.452 0.701 . . . . 73.11 109.986 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.87 146.5 11.36 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.725 -0.55 . . . . 61.1 111.725 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.11 113.1 26.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.532 0.733 . . . . 70.04 109.481 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.4 mp -145.22 136.05 24.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.97 -0.456 . . . . 71.01 110.303 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.671 ' HA ' HG13 ' A' ' 42' ' ' ILE . 26.9 p -73.64 99.96 3.23 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 123.853 0.721 . . . . 73.23 109.722 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HB2' HG22 ' A' ' 74' ' ' VAL . 62.2 mt -93.17 123.75 59.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.926 -0.398 . . . . 62.41 109.926 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.71 -6.6 16.21 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.067 2.511 . . . . 75.34 113.853 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -90.06 -23.61 21.39 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.0 0.52 . . . . 63.35 110.676 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 119' ' ' VAL . 28.9 m -104.0 148.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.641 0.734 . . . . 73.4 110.901 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.09 13.29 1.63 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.452 -1.249 . . . . 75.41 109.024 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.02 154.74 26.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.984 1.314 . . . . 74.02 108.366 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -71.93 111.73 7.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.05 0.54 . . . . 75.22 109.993 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -144.28 134.21 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.683 0.793 . . . . 54.22 111.166 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.675 HG22 HG23 ' A' ' 118' ' ' VAL . 21.0 t -99.28 117.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.304 1.042 . . . . 71.4 109.173 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HE1' HD12 ' A' ' 106' ' ' LEU . 92.0 m-85 -94.89 120.06 34.48 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 109.155 -0.684 . . . . 74.1 109.155 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.648 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 11.4 p90 -134.53 175.54 9.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.899 0.857 . . . . 70.53 111.623 175.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 m -139.13 161.3 37.73 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.138 -1.43 . . . . 75.52 107.138 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -92.27 30.46 1.46 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.051 0.54 . . . . 61.54 111.369 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.64 100.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 123.655 0.782 . . . . 60.11 109.489 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.03 -75.33 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.808 1.243 . . . . 74.42 111.417 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.61 22.95 1.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.384 -0.371 . . . . 63.42 112.718 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.73 -28.6 65.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.998 0.519 . . . . 60.21 111.847 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 2.2 tmt_? -66.41 -48.24 70.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.051 -0.722 . . . . 73.43 109.051 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.87 -38.16 85.81 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.715 0.806 . . . . 72.13 111.535 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.64 HG21 ' HB1' ' A' ' 35' ' ' ALA . 28.4 m -66.64 -49.0 67.64 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 64.34 109.721 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.5 -32.3 73.56 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.744 -1.116 . . . . 42.25 112.763 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.82 -43.72 97.85 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.171 0.919 . . . . 73.42 110.031 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.58 98.65 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.146 0.904 . . . . 75.32 111.325 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.54 HG13 ' HB ' ' A' ' 52' ' ' THR . 86.3 t -64.35 -53.57 41.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 C-N-CA 124.202 1.001 . . . . 75.52 111.45 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.517 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -71.96 -21.79 78.96 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.29 -0.868 . . . . 54.41 113.463 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -73.81 -41.92 61.67 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.38 -0.6 . . . . 74.01 109.38 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -61.46 -39.82 92.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.409 -0.814 . . . . 70.52 110.942 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 100' ' ' ALA . 2.6 tm? -74.91 -35.77 62.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.822 0.449 . . . . 73.23 110.812 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.55 51.84 7.9 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.275 -0.73 . . . . 75.03 111.275 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.765 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -109.37 168.0 9.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.425 1.09 . . . . 62.53 109.996 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.39 104.02 5.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.954 -0.758 . . . . 75.4 108.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.648 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.3 m -83.35 130.97 34.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.281 -1.007 . . . . 64.13 108.281 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -153.46 159.79 42.41 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.372 0.606 . . . . 54.04 110.875 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.29 -178.01 0.16 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.981 1.313 . . . . 74.42 111.731 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 106' ' ' LEU . 8.4 ptm180 -53.92 -43.52 69.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.84 0.856 . . . . 73.11 112.91 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.436 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 77.3 mt 62.4 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.566 1.578 0 C-N-CA 124.501 1.12 . . . . 73.11 111.591 -172.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.08 -17.61 39.19 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.302 2.001 . . . . 74.34 113.0 167.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -26.11 63.76 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.876 0.87 . . . . 73.14 111.606 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.95 -23.54 66.63 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 111.78 0.289 . . . . 51.42 111.78 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 m -60.03 -36.62 77.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.181 0.592 . . . . 64.41 110.893 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.05 -32.31 22.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.838 0.855 . . . . 33.25 111.261 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -80.0 157.46 73.69 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.587 0.755 . . . . 72.23 109.176 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 26.1 Cg_exo -64.14 125.53 15.39 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.12 1.88 . . . . 63.1 111.389 170.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 56.5 Cg_exo -53.62 120.27 7.56 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.357 2.705 . . . . 74.53 113.706 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.74 -178.39 22.62 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.284 -1.126 . . . . 73.43 110.284 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.5 123.82 34.81 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.178 0.513 . . . . 63.4 110.849 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.53 135.52 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.105 -1.072 . . . . 74.12 108.105 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.675 HG23 HG22 ' A' ' 79' ' ' VAL . 2.4 p -105.24 106.0 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.388 -1.338 . . . . 73.34 107.388 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 74' ' ' VAL . 15.8 t -93.35 121.97 44.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.954 -0.758 . . . . 73.24 108.954 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 98' ' ' LEU . 41.1 t -116.99 129.47 73.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.164 0.986 . . . . 61.34 109.583 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -91.56 162.29 14.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.909 0.756 . . . . 73.22 110.273 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.592 0 CA-C-N 115.485 -0.78 . . . . 70.2 113.435 -179.271 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.774 0.321 . . . . 74.35 111.032 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -119.45 133.52 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.776 0.83 . . . . 72.44 109.546 172.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 148.62 24.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.87 0.868 . . . . 64.42 109.944 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -156.61 134.67 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.241 0.616 . . . . 73.34 109.952 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.5 p -146.05 166.4 26.2 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.308 0.643 . . . . 72.01 110.469 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -156.55 162.55 39.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.103 0.961 . . . . 74.33 109.769 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 146.07 32.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.35 0.66 . . . . 62.24 110.704 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.0 m -147.21 135.38 21.54 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 70.11 110.393 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 m -97.27 148.26 23.29 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.451 1.1 . . . . 72.45 110.824 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -126.17 100.64 6.41 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.266 1.027 . . . . 73.3 108.353 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 t -77.3 149.0 35.39 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.975 0.51 . . . . 74.11 110.905 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.71 167.85 16.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.551 0.74 . . . . 73.22 110.847 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . . . -91.14 146.08 32.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.659 0.783 . . . . 50.42 110.845 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 22' ' ' ALA . 11.8 Cg_exo -71.46 166.34 29.64 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.986 2.457 . . . . 75.25 112.646 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 t -157.66 154.76 28.88 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.968 0.507 . . . . 71.43 111.04 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.8 m -146.64 130.36 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.983 0.913 . . . . 74.3 109.61 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 p -120.44 151.1 39.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.941 0.896 . . . . 63.11 110.314 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 p -158.69 146.48 18.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.666 0.786 . . . . 33.4 109.871 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.54 155.55 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.642 0.777 . . . . 70.44 109.783 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -107.64 140.75 21.87 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.652 0.781 . . . . 71.1 110.213 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo . . . . . 0 C--N 1.378 2.113 0 C-N-CA 123.16 2.573 . . . . 73.21 113.054 178.937 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.989 -0.745 . . . . 55.23 108.989 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -118.53 132.8 56.21 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.716 0.806 . . . . 73.2 109.568 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HA ' HG13 ' A' ' 116' ' ' VAL . 12.1 t -95.78 142.36 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.961 0.904 . . . . 71.42 110.225 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.501 ' HG3' HG22 ' A' ' 117' ' ' ILE . 7.9 ptm180 -151.23 126.4 9.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.096 0.406 . . . . 74.3 112.096 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 118' ' ' VAL . 16.6 t -101.0 111.2 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.086 0.954 . . . . 54.14 110.5 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -99.41 107.3 19.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.182 0.515 . . . . 61.5 110.236 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -98.0 110.91 23.4 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.388 -1.338 . . . . 75.41 107.388 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.644 ' HB ' HG12 ' A' ' 74' ' ' VAL . 4.8 tt -78.34 -50.7 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.953 0.406 . . . . 73.14 111.121 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -83.85 -2.68 56.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.274 -0.875 . . . . 64.21 111.504 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.32 59.6 8.69 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 111.623 -0.591 . . . . 62.01 111.623 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -78.59 -172.71 3.05 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.909 0.884 . . . . 73.45 111.063 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 43.2 tt0 -53.71 139.79 31.42 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.371 1.068 . . . . 62.3 111.384 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.92 -9.66 53.76 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.722 0.649 . . . . 71.01 114.722 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.564 ' H ' ' HG2' ' A' ' 46' ' ' GLU . . . -67.23 -22.48 65.69 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.354 0.577 . . . . 62.22 111.25 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -68.58 -39.68 80.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.291 0.636 . . . . 74.53 110.405 171.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.58 52.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.327 0.651 . . . . 72.03 111.355 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.435 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 24.0 tpp180 -70.82 -15.77 62.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.226 1.01 . . . . 74.51 111.205 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' HD13 ' A' ' 56' ' ' LEU . 78.4 p -61.63 -47.01 87.35 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.874 -0.417 . . . . 63.21 109.874 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.49 61.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.204 0.601 . . . . 64.2 111.2 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 25.5 t70 -60.04 -35.37 74.96 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.206 0.602 . . . . 52.43 111.465 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.479 HH21 HD11 ' A' ' 56' ' ' LEU . 52.6 ttp180 -64.41 -40.83 96.55 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.598 0.759 . . . . 65.13 110.232 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 52' ' ' THR . 9.8 mp -65.23 -34.44 78.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.451 -0.795 . . . . 65.25 110.645 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.62 -41.0 93.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.861 0.464 . . . . 72.41 110.722 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.42 65.85 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.599 -0.728 . . . . 73.21 111.233 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.41 -21.28 42.4 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.421 0.688 . . . . 71.21 111.011 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.55 44.46 2.5 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.463 -0.335 . . . . 60.24 113.544 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -87.67 158.44 18.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.643 0.777 . . . . 73.34 108.963 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -58.79 -69.5 0.19 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.191 0.932 . . . . 62.03 112.3 -160.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.97 137.48 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.039 -1.097 . . . . 72.4 108.039 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 p -128.51 108.59 10.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.769 0.828 . . . . 55.53 109.14 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 8.3 t70 -104.27 159.03 16.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.584 1.154 . . . . 64.24 109.397 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.79 115.54 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.838 0.855 . . . . 72.13 109.128 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.24 93.45 0.69 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.626 -0.716 . . . . 73.01 111.927 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -77.46 82.88 3.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.374 0.607 . . . . 73.51 109.495 173.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -160.15 143.97 14.15 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.199 -0.455 . . . . 73.23 111.006 -171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -82.66 100.74 10.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.009 0.924 . . . . 62.3 110.268 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -101.09 153.8 37.54 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.284 0.634 . . . . 53.25 109.535 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.76 -15.92 23.17 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.037 2.491 . . . . 74.53 114.566 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.37 -23.33 13.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.3 0.64 . . . . 71.32 110.914 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.745 HG13 HG13 ' A' ' 119' ' ' VAL . 79.5 t -93.52 123.06 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.133 1.373 . . . . 73.54 110.043 -177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' HA ' HD13 ' A' ' 42' ' ' ILE . . . -159.04 -74.15 0.08 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.012 0.525 . . . . 74.44 111.543 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.57 147.89 25.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.469 0.708 . . . . 71.41 110.284 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.2 t -66.15 100.24 0.59 Allowed 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.033 0.92 . . . . 73.11 109.997 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 m -152.23 135.64 15.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 74.24 109.096 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 118' ' ' VAL . 20.3 t -96.06 111.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.407 -0.96 . . . . 72.11 108.407 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -96.7 124.33 40.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.604 -0.887 . . . . 73.14 108.604 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -121.82 151.22 40.85 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.144 0.577 . . . . 74.14 112.156 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.712 HG23 ' HD3' ' A' ' 105' ' ' ARG . 3.3 m -103.21 166.82 10.21 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.084 -1.08 . . . . 61.33 108.084 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 14.63 18.25 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.974 -0.454 . . . . 73.12 111.887 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.15 110.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.779 0.832 . . . . 75.42 110.61 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 67.23 -76.48 0.05 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.831 1.252 . . . . 61.51 112.076 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.36 35.16 0.48 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.491 -1.044 . . . . 71.04 110.491 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HA ' HG22 ' A' ' 90' ' ' THR . 29.7 tt0 -75.9 -18.93 59.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 65.43 111.736 -170.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.57 -35.54 79.21 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 110.245 -0.28 . . . . 74.44 110.245 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.95 56.82 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.557 0.743 . . . . 71.44 112.192 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 87' ' ' GLU . 12.6 t -85.0 -25.62 27.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.484 -0.562 . . . . 71.42 109.484 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.588 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -73.89 -38.71 64.3 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.916 0.886 . . . . 52.44 111.299 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.48 -56.33 17.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.746 -1.57 . . . . 64.04 110.52 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.6 -47.39 79.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.177 0.923 . . . . 61.43 111.914 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.25 -51.51 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.697 0.799 . . . . 61.33 111.963 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.93 -27.43 73.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 116.035 -0.53 . . . . 33.13 113.271 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -79.28 -26.44 42.32 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.407 0.683 . . . . 63.41 110.463 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.7 m -83.33 -32.69 26.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.143 0.977 . . . . 63.22 110.987 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 tp -85.89 -31.99 21.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.219 0.608 . . . . 71.44 110.611 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.86 27.12 35.48 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.508 -0.769 . . . . 71.21 112.464 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.36 144.2 37.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.741 0.816 . . . . 74.45 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.63 127.14 31.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.031 0.933 . . . . 71.05 111.09 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.419 HG12 ' HB ' ' A' ' 79' ' ' VAL . 18.8 m -92.43 106.68 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.136 0.974 . . . . 74.2 110.632 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.74 166.43 11.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.951 1.3 . . . . 55.44 109.414 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mp -67.22 175.92 2.44 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.198 0.523 . . . . 72.2 111.057 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HD3' HG23 ' A' ' 82' ' ' THR . 32.0 ptt-85 -55.95 -44.82 78.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.406 1.082 . . . . 74.22 112.412 -173.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.9 mt 60.63 170.13 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.521 1.128 . . . . 54.15 111.202 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.52 -18.13 14.39 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.079 1.853 . . . . 70.25 113.659 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.19 -55.69 26.08 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.181 1.392 . . . . 64.04 112.076 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 8.1 tt -68.04 -25.78 65.54 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 122.57 0.348 . . . . 74.04 110.381 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 t -76.35 -19.57 58.06 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.551 0.741 . . . . 62.54 111.912 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.08 -33.24 33.52 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.957 0.503 . . . . 65.21 111.247 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.405 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pp0? -104.89 167.31 10.04 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.227 1.011 . . . . 71.31 109.362 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 19.1 Cg_endo -57.16 132.48 51.53 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.037 2.491 . . . . 74.42 114.48 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 71.1 Cg_exo -50.79 160.5 1.78 Allowed 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 124.175 3.25 . . . . 61.24 116.072 -173.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.35 147.55 8.32 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 110.255 -1.138 . . . . 74.41 110.255 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 91' ' ' ALA . 2.4 p -60.58 118.82 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.466 0.706 . . . . 63.45 110.848 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.501 HG22 ' HG3' ' A' ' 38' ' ' ARG . 39.5 pt -103.8 107.43 22.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 122.033 0.92 . . . . 64.31 109.861 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.2 p -90.14 105.12 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.501 -1.296 . . . . 71.51 107.501 169.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.745 HG13 HG13 ' A' ' 74' ' ' VAL . 52.9 t -92.26 131.3 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.612 -1.176 . . . . 44.22 108.241 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.58 HG21 ' HB1' ' A' ' 49' ' ' ALA . 3.5 t -130.38 130.13 65.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.214 0.605 . . . . 72.44 109.939 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -91.37 167.37 12.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.463 0.705 . . . . 53.44 110.145 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.337 0 CA-C-O 119.515 -0.603 . . . . 72.24 112.963 178.161 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.6 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.885 -0.413 . . . . 75.4 109.885 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 t -139.95 143.42 36.55 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.44 0.696 . . . . 45.24 109.184 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.9 153.59 31.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.562 0.745 . . . . 61.11 110.693 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.13 118.94 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.963 0.905 . . . . 71.42 110.031 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 m -144.76 109.73 5.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.974 0.91 . . . . 52.42 109.091 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 m -120.85 141.8 50.25 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.724 0.81 . . . . 61.34 109.678 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -125.03 146.11 49.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.126 0.97 . . . . 65.22 109.662 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.9 m -146.45 127.04 14.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.218 0.607 . . . . 73.34 110.002 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 p -111.81 137.46 49.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.796 0.838 . . . . 64.44 109.77 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 p -81.19 132.18 35.34 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.093 0.957 . . . . 72.44 111.492 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.5 p -113.19 160.52 18.17 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.573 1.149 . . . . 71.03 109.076 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.66 144.47 22.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.823 0.449 . . . . 63.13 111.149 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.63 124.14 43.46 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.752 0.821 . . . . 54.24 109.891 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.21 162.76 38.89 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.681 2.254 . . . . 51.1 112.819 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -83.01 146.62 28.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.211 1.005 . . . . 72.52 110.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 m -143.9 103.8 4.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.945 0.898 . . . . 74.32 109.292 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 p -108.81 141.12 41.3 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 64.14 109.605 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -159.01 94.32 1.21 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.034 0.933 . . . . 74.23 108.592 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.17 123.96 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 63.33 109.611 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.71 161.38 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.935 0.894 . . . . 55.11 110.633 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo . . . . . 0 C--N 1.382 2.331 0 C-N-CA 122.91 2.406 . . . . 60.04 114.264 176.04 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 109.005 -0.739 . . . . 61.23 109.005 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.87 135.96 53.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.925 0.89 . . . . 53.23 109.234 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 64' ' ' THR . 90.7 t -132.83 123.54 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.277 -1.009 . . . . 73.45 108.277 171.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . 4.1 ptp85 -141.34 110.93 6.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.511 -0.743 . . . . 75.43 112.024 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 53' ' ' ALA . 35.8 t -92.71 120.52 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.023 . . . . 64.55 109.951 -175.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 66.3 m-85 -130.09 132.96 46.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.354 0.662 . . . . 71.14 109.794 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -88.84 141.08 28.8 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.887 -1.153 . . . . 64.11 107.887 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 121' ' ' THR . 6.3 tp -59.3 -46.32 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.459 0.704 . . . . 65.21 111.289 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.9 m -106.73 -9.94 16.28 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 70.5 111.858 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.91 63.29 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.223 0.327 . . . . 64.35 113.45 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.8 m -91.45 -52.73 4.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.275 0.63 . . . . 73.03 111.215 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.01 120.15 19.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.059 0.392 . . . . 52.12 112.059 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.96 50.97 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.303 -0.862 . . . . 72.21 112.746 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.24 73.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.248 0.619 . . . . 74.31 110.925 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.44 -52.07 64.81 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.18 0.925 . . . . 74.54 110.424 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.77 -37.67 88.4 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.772 -1.104 . . . . 52.41 111.631 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -64.87 -38.78 92.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.603 1.161 . . . . 63.04 111.617 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 97' ' ' THR . 68.9 p -75.76 -23.35 55.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.174 -0.466 . . . . 54.0 111.128 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -77.53 -33.7 54.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.077 0.951 . . . . 53.32 111.551 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -52.66 -32.41 42.02 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.977 0.911 . . . . 73.2 112.031 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.73 -52.26 66.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.3 1.04 . . . . 54.34 110.356 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.45 -37.63 71.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.277 0.631 . . . . 74.45 111.295 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -71.9 -36.44 70.01 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.485 0.49 . . . . 70.02 110.708 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.45 72.78 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.357 0.41 . . . . 75.24 110.902 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.19 -21.72 58.51 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.358 -0.837 . . . . 73.32 110.862 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.44 10.53 86.13 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-N 115.639 -0.71 . . . . 53.21 113.835 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -95.41 135.62 36.81 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.856 -0.794 . . . . 73.03 108.856 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 90' ' ' THR . 70.9 p 59.24 155.29 0.02 OUTLIER 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.871 2.068 . . . . 74.4 113.653 -173.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.64 87.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 N-CA-C 108.165 -1.05 . . . . 71.11 108.165 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 26.3 m -89.0 102.45 15.09 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.367 0.667 . . . . 64.13 110.679 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 38.9 m-20 -102.48 142.63 33.35 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.76 -0.83 . . . . 65.32 108.76 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 ' HB1' ' A' ' 53' ' ' ALA . 43.4 t -132.61 143.16 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.326 0.651 . . . . 54.44 110.168 -171.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.63 -126.78 2.07 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 112.541 -0.223 . . . . 64.44 112.541 165.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -144.77 145.05 31.48 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.944 0.898 . . . . 74.25 109.912 -177.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 tp -156.26 146.45 21.42 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.746 -0.835 . . . . 72.53 108.746 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.4 p -81.11 98.73 8.15 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.107 0.563 . . . . 73.11 110.453 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.47 88.21 7.28 Favored Pre-proline 0 N--CA 1.483 1.195 0 N-CA-C 108.801 -0.814 . . . . 64.1 108.801 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.71 -6.93 14.54 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.438 2.092 . . . . 61.23 112.992 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.5 -23.44 56.75 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.742 0.417 . . . . 70.44 111.145 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.477 HG11 HG11 ' A' ' 119' ' ' VAL . 2.6 p -121.32 119.45 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.693 0.797 . . . . 72.12 109.902 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.57 20.45 17.15 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.175 0.99 . . . . 73.43 111.403 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.31 139.85 45.97 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.689 0.796 . . . . 72.24 110.098 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 t -69.18 101.88 1.56 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.548 0.69 . . . . 55.02 110.283 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -138.35 145.43 41.12 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.414 0.686 . . . . 63.33 110.905 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.714 HG13 HG22 ' A' ' 118' ' ' VAL . 48.8 t -95.97 118.44 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.599 1.16 . . . . 63.31 108.085 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -110.02 129.05 55.73 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.894 0.478 . . . . 74.05 110.166 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.435 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -126.4 154.47 43.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.151 0.981 . . . . 71.43 110.091 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 83' ' ' GLU . 11.8 m -102.0 -112.06 0.21 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.514 -0.921 . . . . 74.24 108.514 168.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' HG22 ' A' ' 82' ' ' THR . 14.7 pt-20 -143.21 -19.91 0.63 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.784 1.174 . . . . 72.34 113.738 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.54 116.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.725 0.81 . . . . 64.23 112.072 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 64.49 -77.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.054 0 C-N-CA 125.149 1.38 . . . . 73.32 111.198 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.6 52.63 0.33 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.066 -1.214 . . . . 62.5 110.066 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.18 -40.67 64.54 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.074 0.55 . . . . 61.44 112.04 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -73.57 -25.76 60.52 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.447 0.536 . . . . 72.44 112.447 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.21 -39.56 63.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.087 0.555 . . . . 73.52 111.437 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 62' ' ' THR . 6.6 t -82.89 -31.95 27.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.128 0.571 . . . . 41.31 111.404 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.23 73.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.448 0.699 . . . . 74.32 110.927 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.02 -38.51 76.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.549 1.14 . . . . 71.42 111.58 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.65 98.08 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 123.741 0.65 . . . . 62.45 111.556 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 118' ' ' VAL . 20.7 t -73.64 -48.47 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.939 -0.393 . . . . 74.21 109.939 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.57 -21.34 49.38 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.869 0.73 . . . . 71.31 113.549 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -80.53 -58.55 3.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 74.24 109.818 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 52' ' ' THR . 24.2 m -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 124.41 1.069 . . . . 74.33 111.354 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.1 tp -96.18 -29.68 13.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.072 0.949 . . . . 72.54 110.461 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.57 47.43 10.22 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.32 -0.4 . . . . 61.23 112.565 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.05 152.63 38.39 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 64.23 110.234 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.07 34.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.754 0.822 . . . . 54.51 111.017 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.435 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 14.4 m -94.01 98.92 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.982 0.896 . . . . 64.22 109.434 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -111.72 163.42 14.16 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.455 1.102 . . . . 70.25 110.606 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 tp -71.98 169.94 14.85 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.165 -0.925 . . . . 63.33 109.967 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.512 ' HD3' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -55.39 -38.06 68.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.327 1.051 . . . . 65.32 113.106 -176.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.512 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 97.3 mt 59.71 176.43 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 124.322 1.014 . . . . 52.24 112.957 172.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -53.27 -16.45 7.0 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.216 1.944 . . . . 74.44 114.193 164.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -54.71 -30.39 55.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.725 1.21 . . . . 71.15 111.403 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 10.3 tt -62.45 -28.97 70.18 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 71.1 111.192 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -62.39 -23.17 66.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.14 0.576 . . . . 74.41 111.707 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -111.29 -33.02 6.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.463 0.705 . . . . 70.23 111.862 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.799 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 9.0 pt20 -84.07 161.32 55.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.086 0.554 . . . . 64.03 110.841 -171.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HD2' HG21 ' A' ' 117' ' ' ILE . 40.8 Cg_exo -61.1 152.11 73.84 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.491 2.128 . . . . 72.33 113.402 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.73 161.54 38.51 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.171 2.581 . . . . 74.21 112.894 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.76 -166.88 52.43 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.879 -0.6 . . . . 51.12 111.712 -173.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.25 130.0 35.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 109.145 -0.687 . . . . 71.23 109.145 172.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 112' ' ' GLN . 17.1 pt -114.31 150.85 16.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.612 -1.255 . . . . 74.43 107.612 164.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.714 HG22 HG13 ' A' ' 79' ' ' VAL . 61.4 t -119.64 100.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 106.127 -1.805 . . . . 74.43 106.127 163.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.477 HG11 HG11 ' A' ' 74' ' ' VAL . 6.7 p -95.95 125.09 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.91 -0.774 . . . . 72.14 108.91 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.56 128.07 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 109.439 -0.578 . . . . 74.23 109.439 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.441 ' HA ' HG22 ' A' ' 42' ' ' ILE . 72.6 p -107.95 101.47 10.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.185 -1.042 . . . . 70.22 108.185 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.63 -0.713 . . . . 62.14 111.704 -174.298 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 121.356 0.598 . . . . 64.44 110.636 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.4 m -142.84 103.11 4.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.129 . . . . 54.31 108.618 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.33 144.35 33.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.066 0.546 . . . . 64.52 110.126 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 tt -164.9 138.94 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.397 1.079 . . . . 61.13 108.309 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -143.2 135.63 27.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.324 -0.621 . . . . 73.24 109.324 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -146.72 135.78 22.51 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.703 0.801 . . . . 54.2 109.374 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -161.95 141.15 9.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.749 0.82 . . . . 74.5 109.037 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.9 t -165.86 148.4 7.39 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.588 0.755 . . . . 62.31 109.715 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 t -166.62 147.04 5.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.688 1.195 . . . . 64.01 107.95 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.0 t -159.13 148.1 18.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.192 0.197 . . . . 73.23 110.724 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 t -159.75 141.82 13.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.685 0.794 . . . . 65.3 109.482 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.78 133.91 4.24 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.48 0.712 . . . . 60.25 110.058 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.19 106.06 4.14 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.513 0.725 . . . . 44.03 109.283 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -90.76 159.99 4.16 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.679 2.253 . . . . 71.02 111.825 171.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.8 t -156.25 153.95 29.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.016 0.526 . . . . 73.53 110.474 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.5 p -153.79 166.75 31.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.703 0.801 . . . . 54.41 109.625 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -142.22 143.89 33.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.568 0.747 . . . . 70.44 109.055 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 p -148.48 82.96 1.47 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.837 0.855 . . . . 71.23 108.886 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.5 139.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.602 0.761 . . . . 70.21 110.915 -174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -118.21 102.94 50.21 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.047 0.939 . . . . 73.31 109.002 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 C--N 1.376 1.994 0 C-N-CA 122.985 2.457 . . . . 71.0 112.69 176.054 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.791 -0.818 . . . . 43.23 108.791 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 41.9 mt-10 -115.27 94.44 4.73 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.475 -0.784 . . . . 71.34 110.682 -169.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.694 HG11 HG21 ' A' ' 94' ' ' VAL . 22.5 t -112.86 147.16 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 123.798 0.839 . . . . 75.04 111.416 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 31.2 ttp-105 -150.78 110.04 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.486 0.714 . . . . 71.33 109.719 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' ' 118' ' ' VAL . 60.6 t -87.52 126.42 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.455 0.702 . . . . 73.05 111.129 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 10.9 m-85 -119.95 107.93 13.71 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.727 0.811 . . . . 75.44 110.561 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 47.7 t30 -97.91 138.5 35.15 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.278 -0.638 . . . . 74.01 109.278 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.436 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -97.0 -11.79 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.1 0.476 . . . . 74.41 111.414 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -156.49 119.44 4.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.259 -1.015 . . . . 73.21 108.259 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.83 -88.81 0.01 OUTLIER Glycine 0 C--N 1.362 2.002 0 O-C-N 125.154 1.534 . . . . 53.35 114.52 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 m 51.7 -79.3 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.327 1.451 . . . . 60.34 113.525 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -86.53 117.6 25.41 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.131 0.972 . . . . 55.21 110.357 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.99 -18.37 68.74 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.531 0.519 . . . . 55.53 111.938 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 52' ' ' THR . . . -46.97 -32.37 3.83 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.748 1.619 . . . . 51.31 113.37 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.28 8.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.533 0.733 . . . . 45.33 111.911 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.4 60.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.486 0.315 . . . . 51.43 111.078 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.69 -31.32 69.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.378 1.071 . . . . 63.51 111.253 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.63 ' HB ' HG13 ' A' ' 94' ' ' VAL . 29.1 p -66.35 -56.88 8.97 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 121.988 0.115 . . . . 63.52 110.817 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.39 66.1 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.905 0.383 . . . . 52.4 111.651 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.45 -45.93 87.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.402 1.081 . . . . 64.1 111.597 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -67.42 -43.74 80.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 110.431 -0.211 . . . . 73.05 110.431 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.9 -32.24 69.35 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.753 0.658 . . . . 72.51 111.821 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -60.38 -45.21 94.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.275 0.63 . . . . 61.35 110.7 176.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -19.44 45.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.427 0.691 . . . . 73.24 111.345 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.47 59.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.688 0.795 . . . . 52.04 111.321 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.87 42.77 5.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.594 -0.275 . . . . 62.24 113.465 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -90.7 157.0 17.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.794 0.837 . . . . 55.34 109.821 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 m -72.09 -50.97 23.86 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.643 0.735 . . . . 73.53 110.71 -164.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 54.9 t -129.21 126.72 64.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 114.138 -1.392 . . . . 63.32 107.446 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.0 p -141.02 84.54 1.94 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.285 -1.005 . . . . 72.3 108.285 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -103.42 158.12 16.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 43.05 110.494 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.19 146.85 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.34 1.056 . . . . 75.43 109.246 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -165.28 137.51 4.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.086 -0.806 . . . . 54.5 111.086 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 4.3 p-10 -105.64 108.39 19.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.554 -0.536 . . . . 64.2 109.554 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pp -156.26 161.37 40.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.123 0.569 . . . . 74.54 110.785 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.436 ' HA ' HG13 ' A' ' 42' ' ' ILE . 41.3 m -96.43 127.37 42.36 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.783 0.833 . . . . 74.0 109.636 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.647 ' HB2' HG23 ' A' ' 74' ' ' VAL . 86.4 mt -120.71 149.08 49.71 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.922 0.889 . . . . 74.54 108.679 171.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.01 -4.29 15.19 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.957 2.438 . . . . 74.23 113.184 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.47 -6.17 24.31 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.067 0.947 . . . . 74.52 112.273 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' HB2' ' A' ' 71' ' ' LEU . 90.0 t -74.86 112.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 122.906 0.482 . . . . 74.53 109.814 177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.86 -41.47 3.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.928 0.891 . . . . 64.21 110.281 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.7 158.94 41.78 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.952 0.901 . . . . 43.13 109.212 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.589 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.0 t -61.09 100.49 0.12 Allowed 'General case' 0 C--O 1.243 0.755 0 CA-C-O 122.71 1.243 . . . . 62.41 109.574 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.0 m -151.3 145.49 25.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.293 -1.322 . . . . 75.13 109.123 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.706 HG22 HG13 ' A' ' 118' ' ' VAL . 58.2 t -93.74 113.78 29.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.017 -1.105 . . . . 74.02 108.017 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -94.3 111.12 22.84 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.05 -1.463 . . . . 74.34 107.05 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 8.2 p90 -120.57 140.6 51.26 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.664 0.745 . . . . 75.11 112.933 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 84' ' ' VAL . 29.7 m -84.97 152.93 23.11 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.738 -1.208 . . . . 75.02 107.738 162.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -109.18 19.27 19.65 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.139 0.422 . . . . 71.21 112.139 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 82' ' ' THR . 77.1 t -69.31 129.0 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.841 -0.8 . . . . 51.55 108.841 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 61.04 -81.42 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.119 1.368 . . . . 71.22 111.401 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.87 33.12 0.3 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.094 -0.503 . . . . 71.52 111.875 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -69.1 -31.76 70.69 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 122.719 0.408 . . . . 75.14 111.247 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -73.4 -29.26 62.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.45 0.3 . . . . 70.52 110.717 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.6 -43.48 55.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.084 0.554 . . . . 74.14 110.611 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 t -74.24 -22.39 59.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.048 0.539 . . . . 74.22 109.904 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -70.85 -44.09 67.13 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.387 1.075 . . . . 75.41 111.513 172.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.74 -35.31 72.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.289 -1.323 . . . . 72.32 111.721 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.53 83.69 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.71 0.631 . . . . 71.04 110.987 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.694 HG21 HG11 ' A' ' 37' ' ' VAL . 24.7 t -78.05 -45.9 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.068 -0.969 . . . . 64.43 111.514 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.4 -26.73 68.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.656 0.597 . . . . 73.23 112.999 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -75.59 -45.67 36.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.463 0.705 . . . . 65.53 110.123 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.2 m -61.01 -41.51 96.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.707 0.803 . . . . 73.0 111.122 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 120' ' ' VAL . 47.9 tp -75.82 -31.76 59.52 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.946 -1.025 . . . . 73.51 110.714 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 45.73 31.31 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.494 -0.642 . . . . 75.0 111.494 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.21 175.35 7.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.937 0.895 . . . . 73.22 110.282 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.24 164.62 25.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.762 0.425 . . . . 72.44 110.322 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.602 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.9 m -138.04 140.0 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.216 1.006 . . . . 72.35 108.333 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -155.63 174.25 15.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.789 0.836 . . . . 75.13 110.028 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.5 179.82 1.23 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.649 -0.705 . . . . 62.12 111.94 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -83.11 18.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.66 0.985 . . . . 74.0 113.66 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.13 -47.72 89.73 Favored Pre-proline 0 CA--C 1.558 1.26 0 CA-C-O 118.619 -0.705 . . . . 63.35 111.761 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.75 -37.79 11.43 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 121.577 1.518 . . . . 55.32 111.517 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.33 -29.82 64.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 74.21 111.572 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -17.15 64.4 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.305 1.042 . . . . 71.22 112.404 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -65.91 -45.09 83.21 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.27 0.557 . . . . 75.24 110.983 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.21 -33.06 29.53 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.477 -0.783 . . . . 74.21 109.436 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 48.39 71.49 1.58 Allowed Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.054 1.742 . . . . 61.42 111.311 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.433 ' HB2' ' NH2' ' A' ' 38' ' ' ARG . 44.0 Cg_endo -94.84 162.26 1.76 Allowed 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 123.805 3.003 . . . . 65.22 113.194 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.26 120.23 0.81 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.759 2.306 . . . . 64.21 111.265 168.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.19 162.86 20.98 Favored Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.563 -1.015 . . . . 60.45 110.563 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 91' ' ' ALA . 1.9 p -84.28 137.04 21.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 117.32 0.56 . . . . 74.33 110.529 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 38' ' ' ARG . 35.5 pt -106.43 123.1 61.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 CA-C-O 121.577 0.703 . . . . 42.42 109.809 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 79' ' ' VAL . 98.9 t -95.94 103.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.463 -1.31 . . . . 64.12 107.463 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 69.2 t -94.06 128.77 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 109.866 -0.42 . . . . 52.35 109.866 -174.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.456 HG22 HD21 ' A' ' 98' ' ' LEU . 22.5 t -113.93 139.39 39.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 107.975 -1.12 . . . . 74.11 107.975 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.589 ' H ' ' HB ' ' A' ' 77' ' ' THR . 40.3 p -120.06 104.14 9.87 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.927 -0.768 . . . . 73.22 108.927 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.451 0 CA-C-O 119.352 -0.694 . . . . 71.2 112.445 175.137 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.637 -0.135 . . . . 64.14 110.637 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -159.35 120.75 3.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.625 0.77 . . . . 73.35 109.461 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.19 97.13 1.01 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.834 0.854 . . . . 73.42 109.679 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -148.6 129.1 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.727 0.811 . . . . 73.43 109.809 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.4 p -168.67 127.09 1.09 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.391 1.076 . . . . 60.52 109.226 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -149.06 161.88 41.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.109 0.564 . . . . 71.03 109.963 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.24 149.01 52.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 51.32 110.191 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -152.69 159.62 43.16 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.261 0.625 . . . . 71.25 109.815 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.7 t -149.68 159.66 44.16 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.347 0.659 . . . . 73.44 109.757 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -162.57 168.32 21.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.046 0.939 . . . . 75.11 108.841 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.0 t -162.76 142.3 9.11 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.351 0.661 . . . . 71.41 109.832 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.52 133.49 21.36 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.81 -0.811 . . . . 72.21 108.81 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.47 123.33 6.36 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 123.53 0.732 . . . . 72.45 109.676 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.95 -170.67 1.05 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.725 2.283 . . . . 33.34 111.415 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -137.08 161.15 36.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.104 0.562 . . . . 63.4 109.781 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 t -147.53 157.43 43.56 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.773 0.829 . . . . 71.43 109.228 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.9 t -145.4 163.39 34.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.112 0.565 . . . . 72.32 110.516 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -141.76 165.39 27.59 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.985 0.914 . . . . 74.21 109.864 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.14 152.3 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.809 0.844 . . . . 64.45 109.698 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.92 114.06 39.47 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.738 0.815 . . . . 73.33 109.238 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 C--N 1.377 2.069 0 C-N-CA 123.272 2.648 . . . . 71.31 113.371 173.916 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . . . . . . . . 0 CA--C 1.545 0.771 0 CA-C-O 120.592 0.234 . . . . 52.01 110.646 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.0 mt-10 -84.84 90.61 7.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.528 0.731 . . . . 71.44 109.934 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.8 t -97.67 122.01 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.08 0.467 . . . . 75.44 109.873 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.9 ptm180 -142.79 131.46 22.6 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.155 -0.341 . . . . 74.22 110.99 -167.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' A' ' 118' ' ' VAL . 40.0 t -93.27 131.43 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.588 0.755 . . . . 62.1 109.875 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 70.3 m-85 -126.02 104.21 8.15 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.939 -0.764 . . . . 71.24 108.939 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.422 HD21 HG22 ' A' ' 45' ' ' THR . 44.0 t30 -97.21 130.14 44.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.623 -0.88 . . . . 64.54 108.623 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.639 HG13 ' HA ' ' A' ' 70' ' ' SER . 20.3 tt -102.35 -35.41 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.513 0.197 . . . . 64.12 111.491 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 m -100.07 151.29 21.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.066 0.546 . . . . 74.44 110.152 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.56 87.08 0.26 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.533 -0.627 . . . . 73.21 111.533 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.422 HG22 HD21 ' A' ' 41' ' ' ASN . 11.4 t -126.03 -173.05 2.75 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.783 0.833 . . . . 73.52 109.543 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -72.65 170.37 14.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.37 1.068 . . . . 72.05 111.622 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -1.13 50.85 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 118.976 -0.902 . . . . 73.15 113.979 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.17 28.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 42.11 112.82 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.94 48.46 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.296 -0.866 . . . . 44.41 111.157 174.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.21 -21.98 60.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.19 0.596 . . . . 53.1 111.672 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -63.1 -28.8 70.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.699 1.199 . . . . 53.51 111.444 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.568 ' HB ' HG13 ' A' ' 94' ' ' VAL . 63.0 p -63.39 -42.35 98.8 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 123.419 0.45 . . . . 72.24 110.583 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.99 78.42 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.307 0.643 . . . . 74.23 111.015 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 49.0 m-20 -57.49 -38.58 74.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.075 0.859 . . . . 64.43 111.932 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.15 -52.89 56.91 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.748 0.655 . . . . 62.23 110.591 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.4 -28.39 65.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.636 -0.711 . . . . 72.51 111.351 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 38.4 ttpt -62.36 -43.76 98.06 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.581 0.752 . . . . 74.43 109.867 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.05 64.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.454 -0.794 . . . . 72.12 111.157 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -21.06 56.64 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.961 0.726 . . . . 72.4 112.961 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.79 49.15 0.29 Allowed Glycine 0 C--N 1.358 1.763 0 CA-C-N 118.007 0.367 . . . . 63.13 113.085 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -57.16 158.04 5.58 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.352 1.061 . . . . 74.54 112.173 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.3 m -91.46 -60.36 1.91 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.37 -0.974 . . . . 74.03 108.37 168.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 65.3 t -135.55 136.82 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.188 -1.412 . . . . 62.42 107.188 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.3 p -130.56 146.37 52.07 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.321 0.649 . . . . 75.11 110.175 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 10.8 t70 -143.51 146.58 33.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.968 -1.015 . . . . 75.45 108.396 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.02 138.48 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.064 -0.717 . . . . 65.32 109.064 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.93 143.78 9.27 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.459 -0.337 . . . . 65.15 112.427 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -109.07 110.91 22.29 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.121 -1.066 . . . . 63.42 108.121 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.5 tp -151.02 148.91 28.93 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.255 -0.646 . . . . 54.12 109.255 -169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.639 ' HA ' HG13 ' A' ' 42' ' ' ILE . 12.0 p -77.05 98.65 5.06 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.889 -0.596 . . . . 72.34 109.997 172.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.2 110.21 31.56 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.22 -1.03 . . . . 72.33 108.22 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.38 -6.4 17.08 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.456 2.104 . . . . 73.34 112.532 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 6.2 p-10 -92.55 -23.84 18.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.84 0.856 . . . . 75.11 111.269 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.98 149.06 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 109.954 -0.387 . . . . 65.41 109.954 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.99 -5.22 1.69 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.631 0.772 . . . . 33.42 111.643 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.94 147.42 8.21 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.255 1.022 . . . . 72.13 109.839 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 121' ' ' THR . 7.8 t -64.42 111.21 2.56 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.416 0.686 . . . . 74.22 111.296 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -150.2 151.88 33.75 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.835 -0.62 . . . . 60.31 109.581 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 102' ' ' VAL . 28.9 t -102.22 116.49 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.591 -0.892 . . . . 53.44 108.591 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HD2' HD11 ' A' ' 117' ' ' ILE . 16.2 m-85 -102.41 148.22 25.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.937 -0.764 . . . . 65.35 108.937 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.59 169.33 17.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.863 0.84 . . . . 73.35 112.534 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.4 ' HB ' ' OE1' ' A' ' 87' ' ' GLU . 8.1 m -118.74 166.04 13.27 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 113.751 -1.568 . . . . 45.1 107.048 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.19 23.13 9.52 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.928 0.714 . . . . 74.42 112.928 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.61 98.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.202 0.525 . . . . 44.02 110.038 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.27 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.414 1.485 . . . . 71.24 111.9 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.03 25.87 2.36 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.075 -0.847 . . . . 71.12 112.963 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.746 ' HG2' ' HA ' ' A' ' 35' ' ' ALA . 31.3 mt-10 -62.98 -36.81 84.77 Favored 'General case' 0 C--N 1.362 1.127 0 CA-C-N 117.618 0.709 . . . . 75.34 111.025 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -70.8 -32.36 69.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.214 0.321 . . . . 72.24 111.754 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.33 -31.83 66.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.231 0.612 . . . . 72.22 110.515 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.4 m -76.6 -33.27 58.42 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.032 0.933 . . . . 74.44 109.982 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.47 -34.22 70.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.126 0.971 . . . . 50.44 111.376 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -50.91 -47.04 60.9 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.604 1.19 . . . . 71.14 110.765 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.1 83.87 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 124.534 1.146 . . . . 73.1 111.69 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 52' ' ' THR . 89.4 t -66.74 -52.27 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.12 0.968 . . . . 64.24 112.11 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -27.08 70.43 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.575 0.547 . . . . 74.3 111.754 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -78.34 -23.57 46.92 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.396 0.678 . . . . 71.24 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -78.64 -51.3 10.07 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 122.615 0.366 . . . . 72.13 110.627 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.1 tp -74.15 -26.61 60.41 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.346 0.658 . . . . 75.22 111.295 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.29 62.46 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.746 -0.661 . . . . 74.22 112.064 -172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.4 163.0 13.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.74 0.816 . . . . 63.32 110.666 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.37 134.49 38.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.128 0.571 . . . . 74.31 110.19 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 79' ' ' VAL . 34.7 m -99.22 138.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.978 -0.749 . . . . 53.35 108.978 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -154.56 168.74 25.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.7 -0.852 . . . . 61.34 108.7 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 22.5 tp -65.66 173.03 3.0 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.13 0.572 . . . . 74.12 109.851 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.5 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.4 ppt_? -49.33 -39.18 30.6 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.167 1.173 . . . . 73.41 114.167 -167.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 80' ' ' TYR . 41.0 mt 64.56 154.23 0.12 Allowed Pre-proline 0 CA--C 1.565 1.557 0 C-N-CA 124.307 1.043 . . . . 71.3 112.113 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.18 -29.03 35.78 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.647 2.898 . . . . 44.12 115.212 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 5.1 pm0 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.608 0.763 . . . . 75.25 112.861 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 0.5 OUTLIER -72.97 8.46 1.55 Allowed 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.188 0.518 . . . . 73.01 111.614 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 t -82.09 -10.56 59.16 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 61.41 111.382 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.23 -17.05 18.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 113.419 0.896 . . . . 63.35 113.419 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 2.0 pp0? -145.98 159.57 46.07 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.465 -0.779 . . . . 73.5 110.267 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 12.6 Cg_endo -52.7 125.4 17.88 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 123.795 2.997 . . . . 74.12 115.284 -167.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -57.44 153.67 39.9 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.925 3.083 . . . . 62.44 115.023 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.68 -149.41 21.55 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 109.861 -1.295 . . . . 51.13 109.861 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.1 t -94.48 105.56 17.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.377 -0.972 . . . . 74.11 108.377 167.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.562 HD11 ' HD2' ' A' ' 80' ' ' TYR . 32.0 pt -108.21 122.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.12 -1.067 . . . . 54.53 108.12 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.6 p -96.15 101.21 12.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.702 -1.592 . . . . 74.22 106.702 164.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 7.1 p -100.12 120.03 49.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.561 -0.745 . . . . 72.42 109.458 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.49 128.51 65.45 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 123.729 0.812 . . . . 64.02 110.269 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.677 ' H ' ' HB ' ' A' ' 77' ' ' THR . 77.7 p -112.05 153.28 27.12 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.891 1.276 . . . . 72.13 108.002 172.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.432 0 CA-C-O 119.141 -0.81 . . . . 41.12 112.836 178.71 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.094 -0.706 . . . . 71.13 109.094 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -157.24 112.08 2.75 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.279 -1.008 . . . . 73.1 108.279 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.9 140.19 20.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.924 0.489 . . . . 75.15 110.857 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 tp -149.93 129.3 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.552 0.741 . . . . 63.21 109.143 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 102.6 4.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.329 0.652 . . . . 74.13 109.623 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 p -127.04 140.94 51.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.077 0.951 . . . . 73.34 109.383 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -136.68 165.33 26.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.343 0.657 . . . . 72.41 109.738 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.4 p -121.43 147.0 46.32 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.141 0.977 . . . . 71.14 109.423 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -125.02 139.22 54.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.73 0.812 . . . . 75.05 110.377 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.4 p -123.22 175.29 6.75 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.345 1.058 . . . . 54.32 110.117 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 t -158.67 173.55 16.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.38 0.672 . . . . 65.34 110.402 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.72 138.4 32.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.699 0.8 . . . . 72.13 110.539 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.48 157.82 35.58 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.208 1.003 . . . . 74.41 110.632 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.57 172.98 11.48 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.757 2.304 . . . . 73.01 112.704 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.3 p -137.47 148.36 46.01 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.604 0.762 . . . . 75.21 109.595 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -112.12 116.23 30.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.057 0.943 . . . . 74.44 110.271 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 p -91.51 128.74 37.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.523 0.729 . . . . 73.23 109.217 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.9 p -72.86 154.53 40.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.177 0.591 . . . . 72.35 111.145 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.94 141.44 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.892 -0.781 . . . . 74.43 108.892 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -82.31 149.24 61.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.947 0.499 . . . . 74.31 110.424 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 C--N 1.376 1.998 0 C-N-CA 122.625 2.217 . . . . 70.31 112.288 177.42 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.646 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.245 0.86 0 CA-C-O 121.639 0.733 . . . . 74.4 111.468 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.664 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.0 mp0 -76.69 106.45 8.36 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.545 -1.207 . . . . 75.05 108.929 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.18 136.13 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.564 -0.902 . . . . 53.31 108.564 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HG3' HG22 ' A' ' 117' ' ' ILE . 10.6 ptm180 -146.93 115.15 6.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.498 0.666 . . . . 73.5 111.035 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 53' ' ' ALA . 58.2 t -98.71 116.17 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.101 0.96 . . . . 72.34 110.215 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 62.9 m-85 -115.69 115.06 25.71 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.705 0.802 . . . . 51.1 110.606 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.737 ' HB3' ' H ' ' A' ' 45' ' ' THR . 21.7 m-80 -90.16 114.21 26.13 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.087 0.955 . . . . 54.12 110.054 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -81.52 -53.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 122.267 -0.271 . . . . 65.53 110.295 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -130.15 7.8 5.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.702 0.401 . . . . 71.45 111.707 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.17 -61.5 1.91 Allowed Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.895 -0.882 . . . . 70.52 110.895 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.737 ' H ' ' HB3' ' A' ' 41' ' ' ASN . 6.9 t 43.55 31.8 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 127.231 2.212 . . . . 72.24 114.195 173.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.84 153.93 51.39 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.587 0.755 . . . . 41.34 109.448 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.26 -22.66 56.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 124.203 0.939 . . . . 43.21 114.874 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.54 75.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.131 0.572 . . . . 71.32 111.233 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 52' ' ' THR . . . -82.96 -42.94 17.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.672 0.789 . . . . 52.21 111.184 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.56 65.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.586 0.754 . . . . 51.55 112.1 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -59.42 -28.27 66.79 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.759 1.224 . . . . 63.43 112.708 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 49' ' ' ALA . 6.0 t -69.71 -28.44 65.84 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 119.902 -0.094 . . . . 73.31 110.97 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -82.55 -32.0 28.81 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.848 0.859 . . . . 73.32 111.736 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.83 -56.79 17.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.467 1.107 . . . . 64.15 110.894 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -23.26 53.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.786 -0.643 . . . . 73.43 110.894 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.427 HD23 HG22 ' A' ' 64' ' ' THR . 15.5 tp -63.89 -40.03 95.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.912 0.885 . . . . 72.01 110.636 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -61.76 -44.79 96.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.071 -0.968 . . . . 74.42 109.178 176.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.5 -11.52 60.04 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.74 -1.118 . . . . 63.2 112.252 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.99 -13.26 53.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.287 0.635 . . . . 71.01 110.905 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.36 15.24 18.06 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.793 -0.448 . . . . 63.42 114.059 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -75.49 158.1 33.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.15 0.58 . . . . 73.14 110.684 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 m -84.63 -60.62 2.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.655 0.382 . . . . 73.35 111.171 -162.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 46.5 t -116.75 129.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.937 -0.764 . . . . 41.0 108.937 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 HD23 ' A' ' 56' ' ' LEU . 25.3 p -138.31 83.73 1.99 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.535 1.134 . . . . 74.3 108.087 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -100.1 125.09 46.16 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.69 -0.855 . . . . 53.32 108.69 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 39' ' ' VAL . 29.6 m -117.3 150.31 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.002 0.429 . . . . 74.14 110.504 -174.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.78 162.23 35.63 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-N 115.456 -0.793 . . . . 55.14 111.373 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.11 110.67 20.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.81 . . . . 55.52 109.158 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -145.28 136.84 25.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.608 0.763 . . . . 72.32 109.998 -170.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -79.7 99.64 7.51 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.937 -0.764 . . . . 52.22 108.937 171.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.53 ' HB2' HG12 ' A' ' 74' ' ' VAL . 47.8 mt -93.36 140.82 23.33 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 115.893 -0.594 . . . . 75.14 109.603 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.57 -10.1 14.6 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.575 2.183 . . . . 75.12 113.175 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.39 -24.36 25.78 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.621 0.768 . . . . 73.34 111.325 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 71' ' ' LEU . 7.1 p -91.07 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.226 0.61 . . . . 72.12 110.66 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.79 -0.83 1.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.895 -1.048 . . . . 71.43 110.325 167.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.3 155.74 18.26 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 125.292 1.437 . . . . 62.1 108.44 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -62.4 109.74 1.45 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.494 0.664 . . . . 75.14 110.623 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.9 m -143.92 143.39 31.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.464 0.705 . . . . 71.14 110.265 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.791 HG22 HG13 ' A' ' 118' ' ' VAL . 92.7 t -105.94 112.81 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.137 -1.06 . . . . 73.43 108.137 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -98.92 125.03 44.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.828 -0.804 . . . . 64.04 108.828 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 25.9 p90 -109.34 139.75 43.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.642 0.588 . . . . 72.12 110.67 175.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 83' ' ' GLU . 2.1 m -82.96 -163.36 0.71 Allowed 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 108.663 -0.866 . . . . 55.21 108.663 171.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' H ' HG22 ' A' ' 82' ' ' THR . 10.5 pt-20 -136.55 13.27 3.21 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.676 -1.265 . . . . 74.23 113.408 -160.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.75 108.24 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 N-CA-C 109.337 -0.616 . . . . 72.43 109.337 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.18 -77.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.761 1.624 . . . . 75.43 111.448 -172.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.69 57.11 0.31 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.254 -0.739 . . . . 61.52 111.254 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.59 -17.29 59.85 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.044 0.538 . . . . 74.03 112.277 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -55.16 -40.56 70.76 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.774 0.43 . . . . 73.22 110.792 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.23 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.701 0.801 . . . . 53.4 112.87 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.646 HG21 ' HB3' ' A' ' 35' ' ' ALA . 14.0 t -71.53 -33.2 68.98 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.644 0.378 . . . . 72.32 111.005 -175.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 81' ' ' TYR . . . -80.85 -30.08 35.75 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 74.55 111.872 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.617 1.167 . . . . 64.25 110.15 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.96 -27.03 68.56 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.453 -0.794 . . . . 50.52 112.056 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.715 HG11 HG21 ' A' ' 118' ' ' VAL . 24.0 t -81.4 -58.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 C-N-CA 123.129 0.571 . . . . 73.24 111.046 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -61.82 -29.23 71.69 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.714 -0.676 . . . . 62.51 113.865 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -79.27 -24.97 42.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.064 0.546 . . . . 73.31 110.897 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -77.68 -47.99 17.84 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.088 0.471 . . . . 52.15 110.015 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 120' ' ' VAL . 51.4 tp -68.56 -32.06 71.71 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.137 0.975 . . . . 50.33 111.44 -177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.93 34.44 24.3 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-N 116.186 -0.461 . . . . 62.15 112.352 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.81 140.37 49.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.09 0.956 . . . . 71.44 108.796 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 130.38 41.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.406 0.682 . . . . 73.35 110.941 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -86.33 120.79 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 123.884 0.874 . . . . 74.12 110.296 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -126.8 159.21 34.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.466 1.106 . . . . 73.41 109.874 176.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.78 168.68 12.86 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.03 111.632 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -27.59 65.66 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.929 1.291 . . . . 72.43 113.781 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt 65.03 173.13 0.08 OUTLIER Pre-proline 0 CA--C 1.568 1.654 0 N-CA-C 113.276 0.843 . . . . 72.33 113.276 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.76 -17.1 34.34 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.438 2.092 . . . . 74.51 112.67 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 3.2 mp0 -65.05 -15.67 62.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.524 1.129 . . . . 73.42 112.967 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -61.89 -23.81 66.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 118.473 0.579 . . . . 74.04 109.505 -178.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.3 p -51.43 -32.5 26.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.943 0.897 . . . . 75.22 111.826 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.52 -32.29 7.77 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.737 0.815 . . . . 53.01 111.138 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.555 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 26.0 mt-30 -64.35 133.88 95.8 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.174 0.59 . . . . 62.41 110.909 -173.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HD2' HG21 ' A' ' 117' ' ' ILE . 52.7 Cg_exo -58.17 147.44 83.7 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.357 2.705 . . . . 71.33 113.331 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 47.3 Cg_exo -57.55 131.24 43.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.583 2.855 . . . . 72.31 113.441 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.47 -178.39 31.4 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.937 -0.865 . . . . 63.53 110.937 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 m -76.4 123.9 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 109.733 -0.469 . . . . 72.54 109.733 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.568 HG21 ' HD2' ' A' ' 113' ' ' PRO . 22.7 pt -107.49 114.17 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.876 0.846 . . . . 65.52 109.843 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.791 HG13 HG22 ' A' ' 79' ' ' VAL . 58.6 t -92.62 100.83 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.455 -1.313 . . . . 64.33 107.455 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 10.9 p -107.41 125.57 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.552 0.691 . . . . 72.31 110.819 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.403 HG22 HD21 ' A' ' 98' ' ' LEU . 11.3 t -119.67 138.41 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.506 0.723 . . . . 64.21 111.231 -169.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 t -128.01 132.06 49.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.702 -0.851 . . . . 61.23 108.702 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 118.723 -1.043 . . . . 64.32 112.757 -177.603 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.84 0.352 . . . . 60.24 110.548 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.1 t -112.63 163.38 14.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.617 0.767 . . . . 71.11 110.144 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 131.96 20.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.758 0.823 . . . . 74.24 109.841 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.7 pt -136.63 121.42 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.657 0.783 . . . . 72.43 109.737 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -157.17 129.75 7.5 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.259 1.024 . . . . 73.43 109.36 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -149.03 115.59 5.89 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.725 -0.842 . . . . 64.12 108.725 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -141.73 109.77 5.84 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.891 -1.151 . . . . 70.15 107.891 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -139.56 119.37 13.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.476 0.655 . . . . 65.23 110.292 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 p -142.15 150.24 40.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.844 1.258 . . . . 65.31 108.689 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.4 p -142.48 152.92 43.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.447 1.099 . . . . 53.33 108.963 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -159.85 155.34 25.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.065 0.546 . . . . 74.43 110.664 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.15 157.52 23.34 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.409 1.083 . . . . 35.23 109.051 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.92 107.15 11.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.43 0.692 . . . . 64.3 109.568 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.98 -172.82 1.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.98 2.453 . . . . 74.43 112.167 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -170.21 146.13 2.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.598 0.759 . . . . 54.41 110.174 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.3 p -92.64 166.8 12.3 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.289 -0.634 . . . . 73.43 109.289 171.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.4 t -133.72 137.28 45.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.253 0.621 . . . . 74.44 110.509 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.4 p -167.46 153.01 7.4 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.634 0.774 . . . . 62.41 110.235 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -167.33 109.81 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 C-N-CA 123.713 0.805 . . . . 73.53 110.403 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -126.33 120.42 23.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 123.347 0.659 . . . . 64.24 110.361 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 C--N 1.369 1.644 0 C-N-CA 122.464 2.11 . . . . 64.24 111.32 172.219 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.826 0 N-CA-C 109.524 -0.547 . . . . 53.03 109.524 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . 8.6 pt-20 -66.54 121.56 15.63 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.424 -0.807 . . . . 73.14 110.224 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 t -92.76 144.3 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.126 -0.943 . . . . 72.41 109.073 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 5.9 ptp85 -151.25 161.19 43.16 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.92 0.488 . . . . 74.42 110.885 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 50' ' ' ALA . 58.8 t -126.27 123.89 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.955 . . . . 75.32 109.081 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -112.31 108.06 17.12 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 124.286 1.035 . . . . 74.34 109.326 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.457 HD22 ' HB ' ' A' ' 120' ' ' VAL . 16.7 m120 -78.5 112.99 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.772 -1.195 . . . . 51.53 107.772 170.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 70' ' ' SER . 3.0 tp -75.85 -43.25 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.362 -0.607 . . . . 52.21 109.362 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -144.17 156.02 44.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.888 0.875 . . . . 74.31 108.843 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.89 6.94 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.146 -0.808 . . . . 74.11 113.325 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.2 t 40.79 78.46 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.949 1.7 . . . . 54.34 113.106 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -121.68 114.49 21.21 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.914 0.485 . . . . 70.04 110.468 -174.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.01 -11.9 84.92 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.42 -0.809 . . . . 71.22 113.605 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.62 91.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.237 0.615 . . . . 75.53 110.9 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -70.7 -33.39 70.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.689 -0.687 . . . . 41.23 110.727 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' HG21 ' A' ' 39' ' ' VAL . . . -77.49 -21.87 52.13 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.366 0.666 . . . . 71.34 112.135 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -66.08 -28.67 69.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.843 1.257 . . . . 63.44 111.049 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 98' ' ' LEU . 78.2 p -63.02 -46.47 87.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.136 0.574 . . . . 63.54 110.713 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.58 65.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.535 0.734 . . . . 63.11 111.169 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.09 -28.62 69.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.176 0.59 . . . . 71.51 111.415 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -69.04 -36.98 78.32 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.603 0.361 . . . . 74.33 110.659 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.6 mp -62.54 -24.29 67.43 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.17 0.588 . . . . 63.11 111.586 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -56.42 -49.02 75.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.262 0.625 . . . . 64.11 110.314 173.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.02 -24.12 41.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.515 -0.766 . . . . 75.33 111.613 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -74.5 -17.31 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.374 0.67 . . . . 65.23 111.928 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 33.73 2.53 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.055 0.382 . . . . 65.22 114.055 170.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -100.37 157.62 16.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.512 0.725 . . . . 62.2 109.815 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -62.31 -73.82 0.1 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.881 . . . . 64.41 112.291 -161.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 75.6 t -123.02 144.29 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.319 -1.363 . . . . 64.1 107.319 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 p -138.6 101.36 4.32 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.987 -1.486 . . . . 75.51 106.987 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 9.3 t70 -107.21 149.62 27.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 64.14 109.967 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.418 HG22 ' HB1' ' A' ' 50' ' ' ALA . 88.7 t -127.32 137.14 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.942 0.897 . . . . 61.33 108.995 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.43 159.6 32.54 Favored Glycine 0 C--N 1.344 1.018 0 O-C-N 123.539 0.524 . . . . 61.0 111.862 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -123.97 104.74 9.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.461 1.105 . . . . 74.42 108.314 174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 mp -133.36 134.09 43.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.049 0.54 . . . . 54.14 110.13 -171.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.496 ' HA ' HD12 ' A' ' 42' ' ' ILE . 24.6 p -85.4 98.68 10.71 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.543 -0.753 . . . . 62.03 108.975 172.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.652 ' HB2' HG22 ' A' ' 74' ' ' VAL . 82.6 mt -107.35 141.6 23.32 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.434 -0.951 . . . . 75.25 108.434 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.86 -17.87 17.38 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.575 2.183 . . . . 72.13 113.403 -169.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -94.78 -24.61 17.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.208 1.003 . . . . 73.24 111.844 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 108' ' ' GLU . 13.1 m -91.88 147.03 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.844 0.457 . . . . 41.01 109.975 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -164.79 -41.79 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.817 0.847 . . . . 35.12 109.772 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.58 134.45 33.63 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.007 -0.997 . . . . 41.22 110.325 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.627 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.8 t -74.83 98.24 3.47 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 122.272 1.034 . . . . 73.24 109.114 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' A' ' 80' ' ' TYR . 63.2 m -153.83 155.03 35.03 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.377 -1.283 . . . . 73.01 108.808 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.694 HG13 HG22 ' A' ' 118' ' ' VAL . 23.5 t -94.57 116.22 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.516 -0.92 . . . . 64.53 108.516 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CZ ' ' HB ' ' A' ' 78' ' ' THR . 75.4 m-85 -108.53 132.75 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.4 0.68 . . . . 73.41 111.904 -171.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.588 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 38.9 p90 -144.59 -177.18 5.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.919 0.888 . . . . 74.2 110.662 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -141.09 -91.72 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 118.891 -0.576 . . . . 74.01 110.095 165.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.47 -22.18 0.82 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.266 1.21 . . . . 60.11 114.266 -170.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 95.9 t -58.88 117.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 124.161 0.984 . . . . 54.12 112.046 -169.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 52.52 25.86 3.88 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.533 1.133 . . . . 61.15 113.635 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.11 57.59 5.63 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.774 -0.53 . . . . 44.13 111.774 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.1 mt-10 -52.69 -44.95 66.61 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.768 . . . . 72.44 111.989 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -65.34 -25.38 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.819 0.847 . . . . 73.32 112.566 -176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.96 0.504 . . . . 52.51 110.615 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.426 HG23 HG11 ' A' ' 116' ' ' VAL . 10.0 t -82.33 -26.99 32.52 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.469 -0.787 . . . . 71.21 111.177 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.728 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -69.03 -36.69 78.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.832 0.853 . . . . 44.04 111.012 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.23 -49.29 78.19 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 124.746 1.279 . . . . 73.03 109.766 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.86 78.54 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.352 1.032 . . . . 53.5 112.025 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 118' ' ' VAL . 64.8 t -63.65 -53.89 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 122.974 0.51 . . . . 61.41 110.548 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.74 -23.46 69.06 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 124.164 0.915 . . . . 61.02 113.87 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -76.1 -39.35 55.46 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.955 -0.757 . . . . 71.23 108.955 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.7 m -74.6 -34.45 62.85 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.308 -0.86 . . . . 74.52 112.119 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.573 ' HB3' HG21 ' A' ' 52' ' ' THR . 3.4 pp -93.74 -17.57 23.03 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.127 0.421 . . . . 62.45 111.932 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.48 52.75 4.08 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 113.966 0.346 . . . . 52.32 113.966 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.73 168.41 16.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.756 0.822 . . . . 63.44 109.718 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.46 165.5 25.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.599 0.759 . . . . 63.43 110.604 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.588 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 31.2 m -123.8 114.81 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 123.55 0.74 . . . . 55.12 109.586 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 35.5 mm-40 -124.39 174.78 7.53 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.538 1.135 . . . . 74.24 110.156 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.16 149.48 27.93 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.676 -0.693 . . . . 74.41 109.874 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 24.4 ptt180 -88.09 28.38 1.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.757 1.223 . . . . 72.02 111.641 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.596 ' HG ' ' HD3' ' A' ' 107' ' ' PRO . 4.3 pp -68.12 -32.31 3.93 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 117.597 -1.192 . . . . 55.13 112.728 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.596 ' HD3' ' HG ' ' A' ' 106' ' ' LEU . 13.1 Cg_exo -75.16 -34.48 3.66 Favored 'Trans proline' 0 C--N 1.405 3.506 0 CA-C-N 122.518 1.935 . . . . 73.22 111.914 167.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.711 ' HG3' HG12 ' A' ' 74' ' ' VAL . 8.3 mp0 -72.43 -10.5 59.87 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.542 1.137 . . . . 74.03 111.077 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 112' ' ' GLN . 13.1 tp -68.78 -12.41 61.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.31 1.044 . . . . 73.31 111.12 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -61.9 -46.78 87.9 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.619 0.768 . . . . 42.2 110.909 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.01 -33.82 26.45 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.795 0.838 . . . . 53.54 109.677 172.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.469 ' HG2' HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER 57.57 74.22 0.68 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.983 1.313 . . . . 71.0 111.028 -179.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 79.3 Cg_endo -83.41 132.69 6.0 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 122.712 2.275 . . . . 75.3 111.656 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 51.8 Cg_exo -58.32 152.65 52.12 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.705 2.937 . . . . 63.35 114.409 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.26 -167.5 27.38 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.222 -0.899 . . . . 72.41 113.616 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.728 HG21 ' HB2' ' A' ' 91' ' ' ALA . 3.2 p -87.06 131.95 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.311 -0.625 . . . . 73.23 109.311 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.46 149.81 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.859 0.864 . . . . 60.1 109.829 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 79' ' ' VAL . 47.7 t -121.55 103.58 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.036 -1.468 . . . . 60.15 107.036 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.595 HG11 ' HB ' ' A' ' 74' ' ' VAL . 95.5 t -93.51 123.82 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.518 -0.919 . . . . 73.34 108.518 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.472 HG21 ' HB1' ' A' ' 49' ' ' ALA . 58.0 t -128.74 129.86 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.342 0.657 . . . . 54.31 109.84 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.627 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.5 t -105.8 155.86 18.88 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.332 0.653 . . . . 74.13 109.83 168.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.027 0 CA-C-O 119.174 -0.792 . . . . 37.37 111.764 179.569 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 108.727 -0.842 . . . . 74.45 108.727 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.9 m -134.47 123.49 24.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.68 0.792 . . . . 55.35 110.334 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.63 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.696 0.798 . . . . 55.1 110.23 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.69 143.16 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.072 -1.084 . . . . 74.43 108.072 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -164.24 111.92 1.11 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 74.22 110.225 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.1 t -161.71 125.81 3.3 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.305 1.042 . . . . 71.2 109.333 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.3 ptp -171.57 146.44 2.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.906 0.882 . . . . 73.03 110.241 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -173.58 141.19 0.84 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.042 0.937 . . . . 64.21 109.66 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.6 t -167.13 106.23 0.58 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.468 0.707 . . . . 74.12 110.64 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -161.1 102.92 1.27 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.251 1.421 . . . . 74.3 109.082 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.1 p -135.58 125.7 26.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.757 0.823 . . . . 74.34 109.947 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.34 132.05 7.72 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.173 0.989 . . . . 54.23 109.942 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.48 107.35 10.08 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.617 0.767 . . . . 74.52 109.983 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.41 144.75 20.57 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.953 2.435 . . . . 61.31 111.863 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.3 p -122.41 148.41 45.14 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.694 0.398 . . . . 70.15 110.685 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m -146.28 111.88 5.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.716 0.806 . . . . 53.53 109.925 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.5 p -124.74 129.45 50.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.92 0.888 . . . . 55.33 109.473 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 m -150.49 111.45 4.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.739 0.816 . . . . 75.43 108.873 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.75 131.36 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.484 0.714 . . . . 72.23 109.992 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -123.79 112.73 28.84 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.146 0.979 . . . . 73.31 108.747 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 C--N 1.376 1.978 0 C-N-CA 122.391 2.061 . . . . 74.23 111.633 177.208 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.245 0.853 0 CA-C-O 121.018 0.437 . . . . 63.52 110.17 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.81 108.13 19.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.008 0.923 . . . . 71.33 110.441 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 41.3 t -106.88 138.7 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.192 0.997 . . . . 61.41 109.613 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.53 128.95 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.433 -0.58 . . . . 73.12 109.433 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 53' ' ' ALA . 98.3 t -103.72 128.11 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.34 0.656 . . . . 75.32 109.389 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.654 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 38.3 m-85 -124.03 131.45 53.56 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.423 0.689 . . . . 74.52 110.286 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -85.7 112.08 20.7 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.988 -1.115 . . . . 72.52 107.988 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.825 HD11 ' HA ' ' A' ' 71' ' ' LEU . 9.2 tp -75.31 -47.19 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.042 0.449 . . . . 74.03 111.355 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 m -107.51 3.18 24.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.988 0.915 . . . . 72.22 110.383 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 136.83 1.48 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.52 -0.632 . . . . 51.1 111.52 -170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 t -157.28 -178.95 7.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.359 0.664 . . . . 71.52 110.032 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.72 154.11 42.22 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.222 1.009 . . . . 32.11 111.071 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.79 -2.49 16.99 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 115.022 0.769 . . . . 42.44 115.022 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.51 -28.12 69.73 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.612 0.765 . . . . 74.33 111.518 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.2 -42.75 75.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.277 0.631 . . . . 42.31 110.576 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.36 -28.46 67.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.61 -0.723 . . . . 73.54 111.667 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -65.28 -24.95 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.601 1.16 . . . . 74.33 111.752 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 98' ' ' LEU . 68.9 p -71.89 -47.59 51.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.367 0.267 . . . . 75.33 110.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -61.73 -40.1 93.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.308 0.575 . . . . 73.14 110.639 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.29 -32.96 74.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.532 -1.213 . . . . 63.4 111.422 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -72.04 -41.07 67.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.054 0.542 . . . . 73.34 109.66 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -70.91 -26.03 63.03 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.394 -0.821 . . . . 72.3 111.336 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -61.71 -51.22 69.29 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.077 -0.712 . . . . 71.44 109.077 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.3 71.36 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.152 -0.931 . . . . 74.21 111.143 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.43 1.25 16.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.536 0.734 . . . . 73.01 112.309 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.6 40.19 11.27 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 113.96 0.344 . . . . 54.53 113.96 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -89.09 155.27 19.56 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.246 0.523 . . . . 73.21 109.76 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -66.03 -60.33 2.94 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.041 0.756 . . . . 75.2 113.041 -159.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.27 103.21 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.326 -0.99 . . . . 63.5 108.326 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 16.8 p -107.96 105.51 15.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 73.43 109.86 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -115.16 156.64 24.9 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.649 1.18 . . . . 73.4 109.679 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.77 144.54 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.768 0.427 . . . . 72.41 111.023 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.57 -158.54 13.61 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.498 -0.641 . . . . 60.41 111.498 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -107.49 173.42 6.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.23 -0.656 . . . . 74.31 109.23 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 27.7 tp -144.51 138.99 27.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 111.258 0.096 . . . . 63.25 111.258 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.7 p -87.57 133.58 33.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.67 -0.863 . . . . 72.23 108.67 170.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.825 ' HA ' HD11 ' A' ' 42' ' ' ILE . 32.4 tp -44.17 101.45 0.25 Allowed Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 125.177 1.391 . . . . 72.13 113.949 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.85 -100.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.109 2.539 . . . . 32.33 109.96 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.07 -22.13 12.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.054 0.942 . . . . 45.11 111.621 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.97 128.07 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.647 -0.501 . . . . 74.4 109.647 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.57 16.43 9.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.937 0.895 . . . . 71.44 111.536 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 156.97 46.17 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.559 0.744 . . . . 45.34 109.916 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 t -62.34 100.47 0.18 Allowed 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.057 0.932 . . . . 74.31 110.316 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.2 m -148.12 143.07 26.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 72.34 109.321 -172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 118' ' ' VAL . 42.6 t -95.94 115.86 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.603 -1.258 . . . . 42.03 107.603 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.553 ' HB3' HG13 ' A' ' 117' ' ' ILE . 32.3 t80 -107.86 113.76 27.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.908 -1.145 . . . . 74.34 107.908 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.548 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 41.9 p90 -141.32 147.43 38.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.135 0.791 . . . . 74.13 113.135 -170.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -85.94 -157.82 0.36 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.96 -1.126 . . . . 70.33 107.96 167.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 82' ' ' THR . 47.2 mt-10 -124.99 7.18 7.97 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.108 -0.995 . . . . 64.31 110.907 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 98.7 t -66.61 128.41 29.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 123.82 0.848 . . . . 74.31 109.603 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 84' ' ' VAL . 35.4 mt-10 62.1 20.9 12.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.523 0.729 . . . . 74.04 111.125 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.35 35.5 52.31 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.683 -0.51 . . . . 63.32 113.387 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 29.4 mt-10 -52.57 -33.47 45.98 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.933 0.716 . . . . 74.24 112.933 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -64.57 -31.34 72.52 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.839 0.455 . . . . 74.21 112.182 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.99 -37.41 29.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.505 0.722 . . . . 75.04 111.554 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.466 HG21 ' HB3' ' A' ' 35' ' ' ALA . 69.5 p -74.41 -36.83 63.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.466 -0.788 . . . . 72.22 110.894 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -30.72 69.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.498 -1.228 . . . . 63.41 111.89 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.29 -44.33 92.52 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.333 1.021 . . . . 72.12 110.136 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.01 75.26 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.516 -0.765 . . . . 53.13 112.272 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.667 HG11 HG21 ' A' ' 118' ' ' VAL . 64.3 t -74.32 -59.3 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.498 -0.319 . . . . 74.22 110.519 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.84 -23.05 55.67 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.811 0.694 . . . . 72.11 114.011 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -67.87 -60.03 2.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.485 1.114 . . . . 73.41 109.758 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.6 m -71.63 -32.76 68.3 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 114.902 -1.045 . . . . 74.2 111.141 -172.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.57 ' HB2' HG21 ' A' ' 52' ' ' THR . 48.7 tp -81.11 -27.28 35.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.941 0.896 . . . . 72.24 110.497 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.74 43.65 83.68 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.564 0.54 . . . . 74.42 112.667 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.53 25.04 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.774 0.83 . . . . 75.11 110.173 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.77 139.98 58.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.32 0.648 . . . . 75.41 110.355 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.548 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.2 m -112.15 131.83 62.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.425 0.69 . . . . 52.11 109.24 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.53 144.2 46.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.565 0.746 . . . . 74.44 111.309 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.636 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 16.2 tp -66.36 -177.2 0.51 Allowed 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 114.198 -1.364 . . . . 73.42 110.815 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.636 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 6.7 ppt_? -56.51 -28.6 60.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.863 1.265 . . . . 65.04 113.733 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 104' ' ' LEU . 74.6 mt 62.1 168.04 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.538 1.135 . . . . 74.2 113.039 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -73.25 -12.34 25.35 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.285 1.99 . . . . 44.4 112.605 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -69.49 -18.85 63.73 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.227 1.011 . . . . 64.53 112.624 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.8 -4.26 19.27 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.666 0.617 . . . . 63.34 112.666 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -60.25 -21.72 62.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.266 0.626 . . . . 61.34 111.763 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -115.51 -32.99 5.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.84 0.856 . . . . 74.21 110.83 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -96.41 127.03 41.51 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.065 0.946 . . . . 74.22 110.846 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.96 134.11 57.94 Favored 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 122.18 1.92 . . . . 75.22 112.7 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.91 163.12 32.16 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.278 2.652 . . . . 70.42 113.415 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 130.58 146.36 5.9 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 108.647 -1.781 . . . . 43.45 108.647 -171.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 53.7 t -65.0 99.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 118.718 1.259 . . . . 55.42 108.767 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.553 HG13 ' HB3' ' A' ' 80' ' ' TYR . 29.4 pt -107.57 106.93 21.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.467 -1.308 . . . . 71.12 107.467 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.718 HG22 HG13 ' A' ' 79' ' ' VAL . 42.1 t -89.83 101.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.34 -1.356 . . . . 60.23 107.34 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.401 HG13 ' HB ' ' A' ' 42' ' ' ILE . 65.0 t -93.67 113.14 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.33 -1.359 . . . . 73.33 107.33 -174.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.53 127.36 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 110.223 -0.288 . . . . 72.21 110.223 -171.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -89.98 160.54 16.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.938 0.895 . . . . 74.43 109.743 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.958 -0.912 . . . . 61.01 111.373 178.509 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.393 -0.225 . . . . 71.23 110.393 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -160.76 145.12 13.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.03 0.532 . . . . 63.13 109.974 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.73 139.47 20.75 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.463 0.705 . . . . 71.23 109.941 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -108.87 167.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.008 0.923 . . . . 73.33 111.057 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 t -83.84 -167.29 1.67 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.324 1.049 . . . . 63.21 110.419 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.9 m -141.04 137.28 32.82 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.034 0.934 . . . . 73.32 109.246 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.495 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.5 OUTLIER -95.09 127.67 41.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.84 0.856 . . . . 74.12 110.134 -175.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 m -145.9 144.33 30.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.76 0.824 . . . . 73.11 109.776 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -145.01 166.06 26.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.88 0.872 . . . . 75.04 110.638 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -136.95 143.31 42.79 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.662 0.785 . . . . 45.1 109.83 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 t -103.11 176.45 5.14 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.321 1.048 . . . . 72.21 110.107 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.8 170.53 15.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.461 0.704 . . . . 50.21 110.482 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.36 120.06 15.7 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.344 1.057 . . . . 64.15 109.968 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.04 159.97 37.12 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.626 2.217 . . . . 43.52 112.422 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -149.42 140.02 22.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 71.4 109.322 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -145.45 139.68 27.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.227 0.611 . . . . 74.41 110.038 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -121.41 176.01 5.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.136 0.974 . . . . 72.23 109.947 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.2 p -146.65 136.76 23.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.814 0.846 . . . . 73.43 109.646 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.83 147.91 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.402 0.681 . . . . 62.24 110.251 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -103.86 157.02 34.8 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 123.81 0.844 . . . . 63.52 109.844 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo . . . . . 0 C--N 1.377 2.032 0 C-N-CA 122.477 2.118 . . . . 72.22 111.708 170.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 87' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 110.554 -0.165 . . . . 34.14 110.554 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -142.25 102.21 4.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.755 0.822 . . . . 72.44 109.96 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 64' ' ' THR . 11.4 t -114.67 151.35 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-O 121.839 0.828 . . . . 74.3 111.584 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.619 ' HB3' HG22 ' A' ' 117' ' ' ILE . 33.2 ttm105 -153.64 141.29 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.121 1.369 . . . . 72.51 108.872 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' HB1' ' A' ' 49' ' ' ALA . 39.0 t -131.48 119.83 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.7 0.8 . . . . 73.33 108.904 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' CE2' HD23 ' A' ' 71' ' ' LEU . 45.4 p90 -141.6 149.13 40.31 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.09 0.471 . . . . 73.45 111.125 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -78.81 141.28 37.88 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.09 -0.959 . . . . 74.24 109.051 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.556 HD13 HG13 ' A' ' 74' ' ' VAL . 9.2 tp -79.61 -36.97 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 122.783 0.433 . . . . 73.15 110.123 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -96.39 -39.14 9.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.647 0.779 . . . . 43.51 109.96 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.08 60.82 2.2 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.953 -0.567 . . . . 70.11 112.004 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m -119.17 -42.64 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.596 0.759 . . . . 62.0 110.812 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -122.22 148.13 45.35 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.025 0.53 . . . . 75.51 110.926 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.03 1.57 63.13 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.124 -0.82 . . . . 54.52 114.274 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.18 -35.03 10.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.742 1.217 . . . . 74.4 113.368 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB1' HG12 ' A' ' 39' ' ' VAL . . . -63.07 -52.2 63.68 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.226 0.611 . . . . 61.01 111.033 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.87 -27.48 68.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.412 -0.813 . . . . 71.4 111.402 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 18.4 ttm180 -70.46 -52.4 22.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.522 0.729 . . . . 74.11 110.644 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -72.97 -23.96 60.72 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.075 -0.511 . . . . 74.05 110.954 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.42 -20.67 54.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.974 0.909 . . . . 33.32 111.816 173.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 51' ' ' ARG . 15.4 t70 -72.45 -41.1 66.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.276 1.03 . . . . 54.13 109.11 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.51 -38.0 89.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.593 -1.185 . . . . 75.44 109.556 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 HG11 ' A' ' 37' ' ' VAL . 62.6 tp -63.12 -50.65 69.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.116 0.966 . . . . 52.2 112.331 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -67.66 -27.17 66.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.846 0.355 . . . . 70.44 110.811 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.82 -20.85 34.87 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.679 0.791 . . . . 71.21 111.202 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.6 -23.48 27.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.541 0.736 . . . . 72.14 111.623 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.74 48.89 0.32 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.718 -0.49 . . . . 63.25 112.988 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 1.5 p90 -57.32 157.46 6.44 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.403 0.681 . . . . 73.1 111.099 174.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 m -89.97 -66.34 0.93 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.133 -1.062 . . . . 62.3 108.133 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -144.28 134.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.135 -1.802 . . . . 63.54 106.135 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 91.4 m -143.25 123.59 13.85 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 122.836 0.454 . . . . 74.11 109.891 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -102.08 126.01 48.92 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.721 -0.844 . . . . 72.11 108.721 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.76 146.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.873 0.469 . . . . 71.52 110.25 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.25 -136.04 3.94 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 123.476 0.485 . . . . 75.31 113.314 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -159.39 117.53 2.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.115 0.966 . . . . 62.24 109.677 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.2 tp -150.65 140.7 22.05 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.257 0.623 . . . . 73.25 109.767 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.444 ' HA ' HD12 ' A' ' 42' ' ' ILE . 39.0 m -88.61 99.35 12.26 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.302 0.641 . . . . 73.44 110.236 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' CE2' ' A' ' 40' ' ' TYR . 4.5 mm? -85.05 125.16 71.16 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.351 -0.981 . . . . 73.25 108.351 168.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 -11.85 32.33 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.67 2.246 . . . . 64.24 113.321 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.73 -22.79 23.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.84 0.856 . . . . 71.41 112.334 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 42' ' ' ILE . 11.0 p -123.89 154.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.336 0.654 . . . . 65.34 110.131 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.36 40.61 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.209 1.004 . . . . 73.32 109.481 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.6 38.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.663 0.785 . . . . 55.11 110.57 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.747 ' HB ' HG22 ' A' ' 121' ' ' THR . 10.0 t -75.11 99.95 4.1 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.421 1.105 . . . . 42.12 108.688 172.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.7 m -149.13 131.01 15.17 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.02 -0.991 . . . . 51.21 109.492 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.755 HG22 HG13 ' A' ' 118' ' ' VAL . 86.9 t -95.62 114.13 31.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.526 -0.916 . . . . 75.43 108.526 174.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -101.51 137.43 39.84 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.084 -1.08 . . . . 71.52 108.084 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.488 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 43.9 p90 -134.46 143.08 47.31 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 74.21 112.689 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.2 m -95.28 169.63 9.95 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 113.845 -1.525 . . . . 65.15 107.376 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -116.03 13.61 15.91 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.317 0.858 . . . . 55.23 113.317 -165.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 86.0 t -64.21 115.0 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.9 0.48 . . . . 60.45 110.552 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 64.31 -77.17 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.937 1.295 . . . . 73.53 111.231 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.87 45.23 0.24 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.246 -0.342 . . . . 42.44 112.246 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . 42.4 mt-10 -61.22 -32.7 72.48 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.511 0.724 . . . . 72.42 112.31 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -56.73 -24.91 52.94 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.624 -0.716 . . . . 64.33 112.559 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.61 -43.64 75.97 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.616 0.766 . . . . 52.13 111.915 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.0 p -69.35 -39.64 77.99 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.423 -0.584 . . . . 74.42 109.423 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.97 96.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.367 1.067 . . . . 30.23 112.082 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.48 -38.38 87.15 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.377 1.048 . . . . 60.01 110.305 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.49 69.88 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.81 0.694 . . . . 73.34 110.655 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 118' ' ' VAL . 62.1 t -67.41 -35.42 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.334 0.654 . . . . 74.12 110.856 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -68.72 -34.89 79.02 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 116.029 -0.532 . . . . 73.33 112.959 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -72.21 -44.26 63.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.608 0.763 . . . . 70.51 109.877 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.5 m -67.02 -37.85 84.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.225 1.01 . . . . 74.43 111.337 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 43.9 tp -81.73 -32.13 31.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.697 0.799 . . . . 73.33 110.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.91 40.84 15.92 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.934 -0.576 . . . . 72.51 112.081 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.56 156.27 24.96 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.519 0.728 . . . . 74.4 111.16 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.37 23.34 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.009 0.923 . . . . 74.53 110.949 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.488 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 27.4 m -89.86 112.3 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-O 121.737 0.779 . . . . 74.21 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -113.54 158.3 20.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.506 1.122 . . . . 74.52 110.256 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.0 mt -66.84 -175.9 0.45 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.748 0.819 . . . . 70.22 110.743 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 5.4 ppt_? -59.19 -37.55 77.67 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 116.355 -0.384 . . . . 64.24 111.513 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.539 ' N ' ' HD2' ' A' ' 105' ' ' ARG . 83.8 mt 58.08 172.53 0.05 OUTLIER Pre-proline 0 CA--C 1.573 1.829 0 C-N-CA 123.64 0.776 . . . . 74.11 112.491 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.72 -12.31 17.55 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.55 2.166 . . . . 61.15 114.077 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.31 -46.78 82.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.712 1.205 . . . . 64.14 112.0 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.657 HD12 ' HA ' ' A' ' 114' ' ' PRO . 4.1 mm? -69.85 4.83 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.36 1.064 . . . . 65.43 113.429 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.9 t -72.1 -49.01 39.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.735 0.414 . . . . 74.41 110.368 171.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.87 -36.14 20.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.606 0.362 . . . . 50.53 111.36 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.484 ' HG3' HD13 ' A' ' 109' ' ' LEU . 4.8 pt20 -90.42 160.67 38.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 118.624 -0.703 . . . . 71.15 109.523 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.57 119.7 5.48 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.255 1.97 . . . . 74.22 112.66 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.657 ' HA ' HD12 ' A' ' 109' ' ' LEU . 56.4 Cg_endo -71.14 117.02 4.94 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.355 2.037 . . . . 65.24 113.2 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.437 ' H ' HD12 ' A' ' 109' ' ' LEU . . . 164.3 -161.08 34.16 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 110.858 -0.897 . . . . 63.42 110.858 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 70.6 t -77.07 106.24 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.231 -1.026 . . . . 75.25 108.231 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.619 HG22 ' HB3' ' A' ' 38' ' ' ARG . 2.8 pp -123.89 124.48 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.439 -0.949 . . . . 63.42 108.439 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.755 HG13 HG22 ' A' ' 79' ' ' VAL . 93.5 t -104.41 106.65 20.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.759 -1.2 . . . . 60.15 107.759 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.17 123.19 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.212 -0.662 . . . . 72.12 109.212 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.8 t -103.37 128.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.794 -0.817 . . . . 64.12 108.794 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.747 HG22 ' HB ' ' A' ' 77' ' ' THR . 10.1 t -72.94 132.32 43.31 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.467 -0.938 . . . . 43.22 108.467 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.082 0 N-CA-C 110.528 -1.029 . . . . 72.54 110.528 -166.352 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.241 0.609 0 N-CA-C 109.134 -0.691 . . . . 73.54 109.134 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.7 p -153.15 166.45 32.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.37 0.668 . . . . 60.51 109.964 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.98 154.55 51.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.509 0.724 . . . . 54.03 110.382 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 tt -144.48 138.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.786 0.834 . . . . 70.43 109.467 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 t -164.42 156.53 16.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.904 0.882 . . . . 72.11 109.743 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 t -162.95 154.77 17.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.201 0.6 . . . . 61.5 110.637 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.9 mtp -111.32 145.23 39.2 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.259 1.024 . . . . 72.4 109.932 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.7 p -141.7 138.2 32.25 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 73.21 109.875 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -115.12 171.93 7.37 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.425 0.69 . . . . 65.34 109.877 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -150.83 134.91 16.79 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.737 0.815 . . . . 74.33 109.24 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.2 m -99.26 124.73 44.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.054 0.542 . . . . 73.42 110.151 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.28 18.37 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.832 0.853 . . . . 74.33 109.109 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.71 109.9 60.59 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.092 0.557 . . . . 54.1 109.754 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.77 -171.22 1.19 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.514 2.143 . . . . 63.43 112.089 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -167.05 -179.39 4.61 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.086 0.955 . . . . 75.42 109.432 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -132.45 167.49 19.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.407 0.683 . . . . 70.44 110.607 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -113.3 136.49 52.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.406 1.082 . . . . 61.22 109.949 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -87.95 134.09 33.79 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.038 0.535 . . . . 73.11 109.972 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.61 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.71 0.804 . . . . 75.1 109.493 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.43 147.48 33.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 123.482 0.713 . . . . 52.12 110.081 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 C--N 1.379 2.15 0 C-N-CA 122.744 2.296 . . . . 64.21 111.526 173.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 112.955 0.724 . . . . 53.24 112.955 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 124.36 33.34 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 113.969 -1.469 . . . . 54.52 110.426 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.1 t -110.65 140.06 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.333 1.053 . . . . 72.3 108.937 167.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -138.4 109.17 6.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.215 0.531 . . . . 71.51 109.873 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.586 ' HA ' ' HB ' ' A' ' 118' ' ' VAL . 41.1 t -95.46 134.05 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.384 1.074 . . . . 73.34 110.014 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.519 ' HE2' HD11 ' A' ' 42' ' ' ILE . 37.5 p90 -156.24 143.89 19.39 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.648 0.379 . . . . 75.13 110.53 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -97.19 142.99 28.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.503 -0.555 . . . . 75.31 109.503 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.519 HD11 ' HE2' ' A' ' 40' ' ' TYR . 7.2 mt -120.42 20.34 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 122.306 1.051 . . . . 70.1 109.891 -177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.2 m -150.18 -137.9 0.08 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.355 1.062 . . . . 73.23 108.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.07 92.25 0.05 OUTLIER Glycine 0 C--N 1.36 1.874 0 CA-C-N 118.416 0.553 . . . . 61.13 112.344 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 t -85.0 109.04 17.9 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.802 0.841 . . . . 73.34 112.122 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -103.59 171.15 7.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.141 -0.936 . . . . 73.14 109.196 166.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 -2.01 79.65 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.432 -0.349 . . . . 53.32 113.457 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.03 -30.18 71.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.939 0.896 . . . . 65.43 112.443 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.52 97.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.27 0.628 . . . . 64.23 110.891 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.62 -25.61 67.46 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.706 0.632 . . . . 62.31 112.706 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -27.68 66.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.589 1.155 . . . . 74.24 111.673 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -69.42 -59.31 3.07 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 110.38 -0.23 . . . . 75.13 110.38 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.56 65.09 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.263 0.625 . . . . 62.04 112.022 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.37 -44.33 54.66 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.742 1.217 . . . . 74.2 111.324 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -76.63 -32.7 58.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.831 -0.622 . . . . 74.34 111.451 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.78 -33.23 75.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.513 0.325 . . . . 72.41 111.799 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -66.84 -38.58 86.69 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.898 0.38 . . . . 74.22 110.096 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.61 68.31 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.566 -0.743 . . . . 63.23 111.212 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -14.59 61.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.806 0.843 . . . . 73.0 111.255 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.09 21.58 32.53 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 119.402 -0.666 . . . . 34.1 113.226 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -74.53 157.78 34.91 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.294 0.547 . . . . 63.23 109.735 170.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -69.14 -65.03 0.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.043 -0.526 . . . . 75.13 111.378 -156.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.0 t -127.71 135.69 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.134 -1.062 . . . . 63.15 108.134 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 p -134.1 102.42 5.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.648 0.779 . . . . 54.1 109.054 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.8 150.65 22.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.186 0.594 . . . . 62.14 109.833 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 15.1 m -143.83 139.23 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.75 0.82 . . . . 75.42 110.198 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.26 -143.18 6.34 Favored Glycine 0 C--N 1.35 1.352 0 C-N-CA 121.228 -0.511 . . . . 42.34 113.829 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -158.25 128.13 5.96 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.634 0.773 . . . . 75.24 110.595 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.1 163.56 16.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.766 0.826 . . . . 63.24 110.865 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -76.85 149.38 36.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.746 1.218 . . . . 74.41 110.213 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.97 107.36 0.84 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 123.859 0.864 . . . . 73.11 111.701 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -93.67 -87.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.132 2.554 . . . . 54.32 111.173 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.82 -15.8 13.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.094 0.958 . . . . 63.51 110.935 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.14 143.09 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.744 0.818 . . . . 74.13 111.068 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.42 23.13 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.832 0.853 . . . . 71.33 111.125 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.03 143.94 37.69 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.375 0.67 . . . . 73.34 109.317 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -73.71 96.52 2.52 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.378 1.085 . . . . 65.41 108.703 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 101' ' ' ALA . 5.2 p -151.91 137.79 18.07 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.723 -1.126 . . . . 55.34 109.844 -170.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 118' ' ' VAL . 60.9 t -96.82 116.85 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.982 -0.748 . . . . 60.03 108.982 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.27 139.33 41.9 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.928 -0.767 . . . . 73.12 108.928 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.484 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 39.6 p90 -143.03 147.43 35.08 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.703 0.763 . . . . 72.33 112.436 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -78.3 166.42 22.71 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 107.396 -1.335 . . . . 72.23 107.396 160.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.49 22.56 9.92 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.357 -0.839 . . . . 73.41 112.066 -168.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.17 111.26 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 109.662 -0.496 . . . . 72.11 109.662 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 63.48 -82.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.331 1.452 . . . . 75.31 111.492 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.99 35.07 1.19 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 116.206 -0.452 . . . . 70.02 112.989 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 50.3 mt-10 -71.27 -34.29 70.56 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.429 -0.952 . . . . 72.01 108.429 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -54.56 -36.61 64.53 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.839 -1.073 . . . . 71.24 112.061 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.59 55.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.654 0.782 . . . . 64.04 111.187 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.427 HG21 ' HB3' ' A' ' 35' ' ' ALA . 81.3 p -67.97 -30.0 69.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.067 0.547 . . . . 62.31 110.831 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.86 -38.16 64.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.067 -0.969 . . . . 75.42 111.397 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.03 -38.95 90.65 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.785 0.834 . . . . 61.14 110.808 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -51.96 67.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.907 0.883 . . . . 72.22 111.275 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 118' ' ' VAL . 97.1 t -73.03 -46.1 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.053 0.541 . . . . 63.41 111.848 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.74 -24.81 57.91 Favored Glycine 0 N--CA 1.468 0.811 0 O-C-N 123.561 0.538 . . . . 71.24 112.799 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -81.48 -42.21 20.62 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.62 0.768 . . . . 74.11 109.874 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.5 m -73.76 -28.96 61.95 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.311 0.577 . . . . 44.12 111.344 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.0 tp -92.31 -29.29 16.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.785 1.234 . . . . 62.34 109.423 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 46.35 18.32 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.738 0.648 . . . . 51.1 111.958 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.31 148.49 42.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.827 0.851 . . . . 75.34 109.764 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 78' ' ' THR . . . -66.38 116.08 7.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.309 0.644 . . . . 54.13 110.459 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.484 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.9 m -85.25 140.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.256 0.622 . . . . 73.52 109.329 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -155.2 153.83 31.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.48 0.712 . . . . 53.32 109.651 -174.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.04 173.01 3.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.82 0.848 . . . . 70.13 110.811 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -83.58 26.66 0.66 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.998 1.11 . . . . 73.12 113.998 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.1 mm? -64.17 -53.65 45.81 Favored Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 118.146 -0.93 . . . . 74.23 111.41 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 22.8 Cg_exo -67.1 -38.25 16.5 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 121.663 1.575 . . . . 73.21 113.129 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.01 -21.38 61.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.253 0.345 . . . . 74.22 110.875 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.43 -14.36 56.37 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.328 1.051 . . . . 64.01 111.372 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 t -57.94 -48.02 81.16 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.268 0.627 . . . . 64.14 110.483 171.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.97 -31.87 21.84 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.851 0.86 . . . . 75.24 110.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.32 73.46 0.63 Allowed Pre-proline 0 CA--C 1.561 1.404 0 C-N-CA 125.786 1.634 . . . . 70.45 110.805 -173.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -88.4 148.48 6.4 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.338 2.692 . . . . 72.42 110.976 165.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -87.41 133.67 3.29 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.362 2.041 . . . . 71.3 112.787 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.97 -139.7 14.68 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.432 -0.803 . . . . 61.34 114.033 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.2 t -105.82 113.14 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.328 1.051 . . . . 72.41 110.258 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 117' ' ' ILE . 31.1 pt -101.04 114.38 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 122.049 0.928 . . . . 75.22 109.075 171.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.713 HG13 HG22 ' A' ' 79' ' ' VAL . 89.5 t -90.69 108.49 19.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.264 -1.013 . . . . 71.13 108.264 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.4 117.56 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.333 -0.988 . . . . 54.41 108.333 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.23 142.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.045 -1.465 . . . . 73.23 107.045 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.3 p -134.98 110.68 9.25 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.889 -0.782 . . . . 63.23 108.889 168.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.212 0 CA-C-O 118.904 -0.942 . . . . 72.32 112.97 178.596 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 p . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.982 -0.377 . . . . 71.3 109.982 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.9 p -129.76 152.36 49.34 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.64 0.776 . . . . 72.23 109.748 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.45 176.4 5.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.769 0.828 . . . . 42.25 110.825 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.77 -175.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.318 1.047 . . . . 73.53 109.887 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -150.13 161.5 42.26 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.824 0.85 . . . . 63.23 110.024 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 p -98.38 153.75 18.34 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.743 0.817 . . . . 72.23 111.655 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 92.7 mmm -113.31 152.62 29.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.543 1.137 . . . . 64.4 109.257 171.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -115.65 125.77 53.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.802 0.841 . . . . 51.12 109.014 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -118.57 142.14 47.9 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.209 0.603 . . . . 55.44 109.933 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -154.84 164.64 38.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.241 1.017 . . . . 72.35 109.447 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -149.45 168.06 24.48 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 120.909 0.385 . . . . 71.35 110.967 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.14 166.25 13.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.164 0.985 . . . . 51.0 109.846 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.34 125.19 22.47 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.262 0.625 . . . . 73.11 110.909 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.42 -170.57 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.156 2.57 . . . . 75.52 112.271 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 m -133.34 146.75 51.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.715 0.806 . . . . 74.43 109.549 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 p -77.4 167.62 21.38 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.648 0.779 . . . . 55.23 111.44 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 m -110.41 131.44 55.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.514 0.725 . . . . 74.34 109.532 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.4 t -122.23 130.86 53.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.684 0.793 . . . . 52.13 109.971 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.33 149.42 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.378 0.671 . . . . 54.33 111.195 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -82.37 139.24 44.8 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 108.574 -0.898 . . . . 74.04 108.574 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo . . . . . 0 C--N 1.377 2.042 0 C-N-CA 122.501 2.134 . . . . 75.2 112.216 173.742 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 N-CA-C 109.959 -0.385 . . . . 75.52 109.959 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.2 mt-10 -80.73 117.89 21.8 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.817 -0.629 . . . . 64.15 110.065 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.41 HG21 HD23 ' A' ' 56' ' ' LEU . 24.2 t -127.3 143.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.56 0.744 . . . . 54.02 109.422 174.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.85 132.45 15.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.769 0.428 . . . . 75.43 110.075 173.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' A' ' 118' ' ' VAL . 4.8 t -103.95 108.7 25.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 123.636 0.774 . . . . 61.32 109.148 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 23.7 m-85 -107.04 135.94 47.74 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.403 0.681 . . . . 71.22 109.781 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -101.06 127.3 47.64 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.261 -0.644 . . . . 51.01 109.261 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.752 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -71.89 -24.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.577 -0.527 . . . . 71.23 109.577 171.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 p -97.58 -67.03 0.87 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.698 1.199 . . . . 54.5 111.112 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.27 11.64 35.8 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.362 0.506 . . . . 72.12 113.096 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -80.23 -61.53 1.95 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.058 0.543 . . . . 75.01 111.186 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -78.35 123.9 27.51 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.609 -0.723 . . . . 72.35 111.12 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.9 -0.8 89.84 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 124.295 0.95 . . . . 52.43 114.303 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . . . -64.51 -21.74 66.77 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.781 0.791 . . . . 61.11 111.524 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.69 68.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.038 1.335 . . . . 40.12 111.958 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB3' HH11 ' A' ' 51' ' ' ARG . . . -62.12 -36.59 82.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.588 0.755 . . . . 63.14 111.361 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.488 HH11 ' HB3' ' A' ' 50' ' ' ALA . 9.9 mpt_? -73.0 -38.57 66.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.686 0.795 . . . . 75.24 111.167 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 p -64.71 -29.02 69.99 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.047 0.539 . . . . 62.31 111.683 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.62 7.21 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.441 0.697 . . . . 54.03 110.946 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -56.46 -43.8 79.93 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.473 1.509 . . . . 64.02 112.04 -171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.54 -0.755 . . . . 72.12 111.786 -176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.41 HD23 HG21 ' A' ' 37' ' ' VAL . 9.2 mp -73.2 -27.97 61.93 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.476 0.311 . . . . 64.12 111.406 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.77 -40.15 91.73 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.641 0.588 . . . . 54.4 109.842 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.87 -23.03 59.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.211 0.604 . . . . 22.3 111.528 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.73 -3.3 46.91 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.623 0.769 . . . . 34.13 112.557 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.44 49.26 2.22 Favored Glycine 0 C--N 1.347 1.159 0 C-N-CA 121.431 -0.414 . . . . 52.33 112.082 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.21 158.02 4.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.58 1.152 . . . . 72.25 112.654 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -91.79 -57.1 2.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 106.91 -1.515 . . . . 72.13 106.91 160.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 74.0 t -129.45 136.3 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 73.52 108.153 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.6 m -141.28 114.21 8.49 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.33 -0.989 . . . . 75.5 108.33 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -120.25 152.79 37.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.677 0.791 . . . . 73.53 110.059 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.0 139.62 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.574 -0.899 . . . . 74.25 108.574 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.45 -179.31 36.07 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.399 0.437 . . . . 71.15 112.235 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -143.96 124.21 13.78 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.405 -0.961 . . . . 71.24 108.405 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 134.46 11.33 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.746 -0.835 . . . . 74.52 108.746 -170.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.752 ' HA ' HG13 ' A' ' 42' ' ' ILE . 19.6 t -77.68 99.55 5.86 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.449 -0.945 . . . . 74.43 108.449 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 20.3 tp -103.83 120.62 50.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.464 0.706 . . . . 75.52 109.311 -172.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 31.2 Cg_exo -59.86 -28.41 87.14 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.732 2.955 . . . . 74.31 114.984 -171.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.72 9.05 25.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.476 0.711 . . . . 73.33 112.063 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.524 HG21 HG11 ' A' ' 119' ' ' VAL . 63.9 t -105.92 111.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.306 0.642 . . . . 74.24 109.54 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.43 10.37 11.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.694 0.798 . . . . 62.45 111.092 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -170.04 156.89 6.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.836 0.854 . . . . 32.43 110.791 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.656 ' HB ' ' H ' ' A' ' 121' ' ' THR . 2.1 t -69.71 102.37 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.57 0.748 . . . . 71.52 109.537 173.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.542 HG21 ' HG2' ' A' ' 103' ' ' GLU . 87.8 m -150.21 149.13 29.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.835 -0.62 . . . . 64.14 110.985 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.564 HG13 ' HB ' ' A' ' 118' ' ' VAL . 40.4 t -94.59 113.68 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.282 -1.007 . . . . 74.34 108.282 175.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.554 ' HD1' ' HB2' ' A' ' 103' ' ' GLU . 28.8 m-85 -99.27 135.44 40.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.527 -0.916 . . . . 71.31 108.527 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.93 138.16 53.24 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.144 0.497 . . . . 62.44 111.123 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -73.03 153.5 40.86 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 114.935 -1.03 . . . . 55.44 109.159 170.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.671 ' HB3' HD11 ' A' ' 104' ' ' LEU . 11.6 pt-20 -102.06 26.26 7.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.28 0.474 . . . . 74.22 112.28 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.2 t -70.8 93.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 108.499 -0.926 . . . . 55.22 108.499 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 70.52 -77.74 0.05 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.444 1.498 . . . . 60.12 111.162 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.43 50.06 0.31 Allowed Glycine 0 C--N 1.352 1.453 0 N-CA-C 112.523 -0.231 . . . . 65.15 112.523 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.24 -18.64 63.9 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 120.843 0.354 . . . . 63.42 110.675 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.64 -28.25 68.33 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.847 0.859 . . . . 72.01 111.386 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.77 -36.03 81.76 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.622 0.769 . . . . 62.22 110.754 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 m -74.7 -38.26 62.4 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.771 -1.104 . . . . 64.31 110.498 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -20.04 56.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.751 0.82 . . . . 44.33 112.351 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -58.57 -49.7 76.49 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.898 -0.778 . . . . 74.33 108.898 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.85 70.74 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 124.442 1.088 . . . . 71.03 111.45 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.82 -46.85 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.212 0.605 . . . . 70.14 111.686 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.41 -26.99 62.62 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.681 0.613 . . . . 74.51 111.913 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -85.4 -31.34 22.96 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.132 0.973 . . . . 64.02 110.777 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.0 m -76.57 -29.91 56.83 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.914 0.388 . . . . 43.03 110.435 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 tp -95.79 -32.71 12.56 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.604 0.762 . . . . 71.23 110.141 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.72 44.62 47.9 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.187 -0.461 . . . . 72.4 111.985 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.95 177.57 6.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.955 0.902 . . . . 73.42 110.116 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.81 158.55 35.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.743 -0.662 . . . . 74.53 109.918 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.56 HG12 ' HB ' ' A' ' 79' ' ' VAL . 27.3 m -127.1 144.15 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.768 0.827 . . . . 64.42 109.669 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.554 ' HB2' ' HD1' ' A' ' 80' ' ' TYR . 59.9 mm-40 -129.84 149.39 51.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.227 1.011 . . . . 73.12 109.872 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 83' ' ' GLU . 51.7 tp -69.24 175.98 3.57 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.803 -1.09 . . . . 72.32 108.837 165.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -67.62 20.31 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.37 1.619 . . . . 64.12 115.37 -175.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.84 -46.1 81.57 Favored Pre-proline 0 CA--C 1.564 1.486 0 CA-C-O 117.947 -1.025 . . . . 70.24 111.871 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.0 -42.12 32.26 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 122.188 1.925 . . . . 64.41 111.233 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 88.0 mt-10 -60.17 -26.48 66.35 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 115.998 -0.546 . . . . 73.32 111.134 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.61 -10.18 17.35 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.101 0.96 . . . . 61.1 112.319 -171.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -56.74 -49.95 73.7 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.843 0.857 . . . . 51.41 111.625 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.11 -33.44 2.19 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.579 0.752 . . . . 62.05 111.16 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 73.67 80.08 0.17 Allowed Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 126.029 1.731 . . . . 72.44 111.746 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 69.1 Cg_endo -81.26 124.34 4.78 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.574 2.183 . . . . 73.45 110.371 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.91 116.66 4.79 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.033 1.822 . . . . 73.42 111.21 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.81 156.82 12.69 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.243 0.449 . . . . 74.14 112.222 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.25 119.75 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.174 1.39 . . . . 73.54 112.774 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.517 HG13 ' HB2' ' A' ' 80' ' ' TYR . 44.4 pt -110.76 106.86 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.763 -0.828 . . . . 73.21 108.763 172.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -96.39 111.81 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.394 -0.965 . . . . 65.54 108.394 175.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.5 t -114.91 118.69 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.593 -0.276 . . . . 64.21 110.975 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -99.23 144.17 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.525 0.73 . . . . 73.24 110.019 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.656 ' H ' ' HB ' ' A' ' 77' ' ' THR . 12.0 t -118.27 165.45 13.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.788 0.835 . . . . 73.01 109.596 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 N-CA-C 110.53 -1.028 . . . . 63.22 110.53 179.253 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 110.322 -0.251 . . . . 63.45 110.322 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 p -152.12 133.66 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 72.24 110.257 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.88 119.25 3.57 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.386 -0.968 . . . . 73.44 108.386 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -116.75 133.43 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.102 0.561 . . . . 74.21 110.581 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -147.46 127.02 13.26 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.948 0.899 . . . . 64.33 108.865 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -145.72 103.12 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.706 0.803 . . . . 52.12 109.068 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -145.1 149.58 35.3 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.111 0.964 . . . . 72.34 109.725 -178.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -148.2 160.87 42.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.167 0.587 . . . . 55.34 109.812 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -147.56 150.48 34.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.58 0.752 . . . . 75.1 109.477 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -155.89 161.66 40.54 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.592 0.757 . . . . 71.42 109.957 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.7 t -153.67 178.64 9.64 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.241 1.016 . . . . 54.11 109.387 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.18 173.44 11.58 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.608 1.163 . . . . 62.12 109.262 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 121.48 6.38 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.471 0.709 . . . . 73.0 110.146 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.32 141.11 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.78 2.32 . . . . 75.2 112.325 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.6 p -136.3 142.09 43.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.664 0.786 . . . . 60.3 110.168 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.7 p -173.83 134.85 0.48 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.277 1.031 . . . . 53.41 109.913 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.0 p -102.35 -177.26 3.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.864 0.866 . . . . 72.04 111.065 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -149.12 126.83 11.73 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.487 -0.931 . . . . 72.43 108.487 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.68 157.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.692 0.797 . . . . 73.55 110.069 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -113.36 131.44 22.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 64.41 110.044 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 C--N 1.378 2.086 0 C-N-CA 122.954 2.436 . . . . 73.45 112.558 178.546 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.11 -0.33 . . . . 72.04 110.11 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.24 104.18 13.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.231 0.613 . . . . 74.5 109.387 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.9 t -96.47 127.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.538 -0.912 . . . . 63.44 108.538 174.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' ASP . 43.5 ttm105 -147.77 111.81 5.15 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.169 -0.332 . . . . 75.31 110.436 -171.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 130.99 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.169 0.588 . . . . 62.4 109.586 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 17.1 m-85 -124.95 132.46 53.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.952 0.901 . . . . 73.2 109.02 167.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 68' ' ' ASN . 41.0 m-80 -94.31 121.81 36.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 32.45 109.707 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.7 tp -78.99 -27.79 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.401 0.68 . . . . 74.42 109.332 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 122' ' ' GLY . 34.6 t -125.21 -162.04 1.07 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.596 1.158 . . . . 64.43 108.384 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.01 136.37 51.3 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 118.364 0.529 . . . . 53.55 112.791 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.3 t -78.56 122.67 26.2 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.994 0.518 . . . . 32.24 110.601 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.93 160.32 18.73 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.12 -0.696 . . . . 74.25 109.12 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.35 -41.57 87.73 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.3 0.375 . . . . 71.31 112.361 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 52' ' ' THR . . . -63.33 -31.46 72.62 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.208 1.003 . . . . 72.23 112.307 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HB2' HG11 ' A' ' 120' ' ' VAL . . . -58.43 -49.72 76.28 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.839 0.712 . . . . 71.24 111.305 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.93 -32.0 57.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.464 -0.789 . . . . 32.4 110.669 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.661 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 31.6 tpt180 -71.4 -20.19 62.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.888 0.875 . . . . 72.22 111.987 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 48' ' ' ALA . 42.1 p -58.95 -52.79 64.22 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.561 0.619 . . . . 61.42 110.208 174.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.59 -25.67 45.31 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.98 -1.009 . . . . 74.14 111.515 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 31.8 t70 -79.06 -22.71 44.95 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.116 0.966 . . . . 63.42 110.819 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -86.76 -37.96 17.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.603 0.761 . . . . 52.3 109.126 168.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 tp -71.21 -19.36 62.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.489 0.715 . . . . 72.34 112.16 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.99 -27.34 69.34 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 110.491 -0.188 . . . . 73.33 110.491 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.95 60.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.696 0.798 . . . . 74.23 111.495 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.33 12.51 6.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.739 0.816 . . . . 62.24 112.723 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.29 46.39 6.98 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 120.313 -0.159 . . . . 61.21 113.091 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -58.97 152.12 20.42 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.255 1.022 . . . . 74.52 111.316 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 35' ' ' ALA . 58.7 m -86.4 -55.03 4.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.718 -0.845 . . . . 74.15 108.718 171.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.61 147.37 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.591 -0.892 . . . . 70.33 108.591 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 54.0 m -142.84 144.9 32.7 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.523 1.129 . . . . 62.24 109.801 -172.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 29.6 t70 -143.67 143.9 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.483 1.113 . . . . 63.43 108.34 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.85 133.13 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.363 -0.977 . . . . 71.13 108.363 173.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.85 -160.8 11.23 Favored Glycine 0 C--O 1.246 0.86 0 N-CA-C 111.609 -0.597 . . . . 75.33 111.609 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.458 ' HA ' ' H ' ' A' ' 41' ' ' ASN . 26.2 p30 -130.34 140.15 50.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.366 1.066 . . . . 73.53 108.466 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -157.48 134.43 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.51 -0.552 . . . . 74.21 109.51 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.5 t -73.39 98.23 2.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.972 -1.122 . . . . 53.32 107.972 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.74 98.55 9.89 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.832 -1.173 . . . . 74.05 107.832 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.64 -1.01 10.12 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.725 2.283 . . . . 64.31 113.156 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.99 -23.55 41.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.784 0.833 . . . . 65.22 110.551 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 119' ' ' VAL . 2.7 p -134.05 140.03 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.428 1.091 . . . . 71.33 110.84 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.46 62.07 1.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.544 -0.91 . . . . 64.42 108.544 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.04 155.75 16.5 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.195 -0.911 . . . . 31.12 110.361 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.3 t -82.43 98.62 8.98 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.604 -1.258 . . . . 75.15 107.604 167.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 m -149.25 139.65 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.999 -1.001 . . . . 74.25 109.173 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 118' ' ' VAL . 97.9 t -95.74 116.27 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.205 -1.035 . . . . 74.41 108.205 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.617 ' HB2' HG13 ' A' ' 117' ' ' ILE . 90.4 m-85 -109.53 154.76 22.25 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.27 -0.641 . . . . 75.11 109.27 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -139.46 170.43 15.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.738 -0.665 . . . . 71.3 111.19 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.0 p -110.75 -159.29 0.67 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.627 -0.879 . . . . 63.13 108.627 164.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.21 21.05 12.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.192 0.997 . . . . 70.55 110.092 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.38 100.9 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.866 0.866 . . . . 75.3 110.015 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 70.06 -75.86 0.07 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.588 1.555 . . . . 71.04 111.62 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.47 40.81 0.81 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.644 -1.383 . . . . 63.14 109.644 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.54 -39.18 85.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.961 -0.619 . . . . 43.11 110.142 -172.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -67.01 -31.4 71.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.589 -0.732 . . . . 75.1 110.947 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.2 -43.11 64.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.607 0.763 . . . . 65.35 111.427 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 94' ' ' VAL . 9.8 t -76.69 -34.55 58.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.65 -0.5 . . . . 33.54 109.65 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.06 -38.74 92.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.362 0.665 . . . . 73.44 111.963 176.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.584 ' HA ' HG11 ' A' ' 102' ' ' VAL . 25.7 t70 -58.1 -36.04 72.3 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.322 1.014 . . . . 72.55 110.318 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.9 78.47 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.474 -0.785 . . . . 63.14 111.226 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 118' ' ' VAL . 22.0 t -71.26 -34.62 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.28 0.632 . . . . 63.24 112.284 -174.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -59.48 -34.86 83.03 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 121.954 0.752 . . . . 25.03 112.006 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -80.63 -30.58 36.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.836 -1.182 . . . . 71.41 110.658 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 m -74.36 -21.02 59.87 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.04 0.536 . . . . 75.33 110.942 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 38.7 tp -97.16 -32.18 12.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.178 0.591 . . . . 72.52 110.609 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.6 53.8 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.869 -0.605 . . . . 35.52 112.027 -170.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.23 -177.69 3.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.375 1.07 . . . . 72.24 111.082 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.65 154.8 17.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.522 0.729 . . . . 62.43 110.318 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.584 HG11 ' HA ' ' A' ' 92' ' ' ASP . 19.9 m -108.35 129.95 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.452 -0.573 . . . . 25.23 109.452 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.34 164.03 28.34 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.863 0.865 . . . . 75.52 111.185 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.28 -175.32 0.11 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.969 -1.014 . . . . 71.41 112.134 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.32 -27.48 62.46 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.757 -0.64 . . . . 72.51 112.048 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.64 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 124.549 1.14 . . . . 71.33 111.714 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.12 -27.16 84.23 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.487 2.124 . . . . 73.13 112.281 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -79.2 -53.57 6.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.885 1.274 . . . . 72.52 110.97 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.455 HD11 ' HB ' ' A' ' 74' ' ' VAL . 52.1 mt -82.53 16.05 2.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.84 0.856 . . . . 61.34 111.611 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.3 m -84.94 -11.13 56.21 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.82 0.448 . . . . 62.45 110.55 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.37 8.08 29.39 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.481 0.712 . . . . 73.51 110.994 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -76.66 164.98 56.12 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.925 0.89 . . . . 75.22 110.708 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.2 122.29 11.32 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.948 1.766 . . . . 74.54 111.098 163.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.29 136.77 55.49 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.926 3.084 . . . . 61.4 115.277 -164.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.75 -162.5 15.49 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.583 -0.735 . . . . 72.02 113.22 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 91' ' ' ALA . 57.9 t -66.69 115.65 4.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 124.092 0.957 . . . . 54.12 108.972 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.617 HG13 ' HB2' ' A' ' 80' ' ' TYR . 7.6 pt -106.23 106.67 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.524 -0.917 . . . . 74.45 108.524 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 79' ' ' VAL . 44.5 t -88.52 100.95 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.547 -1.649 . . . . 73.12 106.547 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 74' ' ' VAL . 49.8 t -93.5 118.46 39.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 N-CA-C 107.109 -1.441 . . . . 65.03 107.109 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 49' ' ' ALA . 48.0 t -119.24 136.6 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 122.972 0.509 . . . . 72.1 109.762 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.406 ' H ' ' HB ' ' A' ' 77' ' ' THR . 15.2 t -117.54 137.29 52.67 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.565 0.746 . . . . 63.24 109.386 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 43' ' ' SER . . . . . . . . 0 CA--C 1.534 1.265 0 N-CA-C 110.721 -0.951 . . . . 37.41 110.721 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 110.179 -0.304 . . . . 71.5 110.179 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.9 p -158.77 129.82 6.25 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.028 0.931 . . . . 64.22 109.101 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.38 133.3 8.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.515 0.726 . . . . 72.31 109.37 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.77 137.34 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.314 0.646 . . . . 71.53 109.816 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 p -156.87 129.51 7.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.512 0.725 . . . . 73.2 109.263 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -151.35 136.96 17.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.254 -0.647 . . . . 71.22 109.254 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.2 mmm -127.59 116.98 21.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.568 0.747 . . . . 74.02 109.339 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -145.05 99.92 3.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.614 0.765 . . . . 72.35 110.017 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -155.99 137.71 14.25 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.092 0.957 . . . . 74.32 109.106 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -155.84 149.49 25.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.92 . . . . 74.52 109.261 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -140.88 119.66 12.54 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.42 1.088 . . . . 75.44 109.033 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.78 147.06 25.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.597 0.759 . . . . 74.24 111.122 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.8 116.8 62.87 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.765 -0.828 . . . . 65.13 108.765 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 137.65 40.42 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.547 2.165 . . . . 74.45 112.751 -172.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -77.48 135.95 38.3 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.493 0.717 . . . . 64.44 109.572 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 p -146.26 148.76 32.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.949 0.5 . . . . 74.13 110.455 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -152.26 179.86 8.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.94 0.896 . . . . 64.51 109.31 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.7 p -158.62 156.75 30.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.817 0.847 . . . . 72.21 109.794 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.45 147.09 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.161 0.585 . . . . 62.22 109.86 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -111.91 143.95 29.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 108.729 -0.841 . . . . 71.14 108.729 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 C--N 1.371 1.751 0 C-N-CA 122.217 1.945 . . . . 74.21 111.889 171.182 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.245 0.863 0 N-CA-C 109.49 -0.559 . . . . 62.21 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.46 148.13 24.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.143 0.577 . . . . 63.14 111.565 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 64' ' ' THR . 87.3 t -137.8 125.8 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.608 1.163 . . . . 43.12 108.09 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 116' ' ' VAL . 9.6 ptp180 -127.84 111.12 13.27 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.27 -0.894 . . . . 75.34 109.706 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.68 110.36 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.477 0.711 . . . . 74.35 110.655 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.483 ' HB2' HG12 ' A' ' 119' ' ' VAL . 51.1 m-85 -100.91 106.04 17.35 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 109.179 -0.674 . . . . 70.01 109.179 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 4.5 m-20 -87.28 113.73 23.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.636 -1.246 . . . . 70.35 107.636 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.2 tt -70.13 -28.22 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.605 0.717 . . . . 72.44 110.165 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 41' ' ' ASN . 22.8 t -130.27 159.35 37.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.704 -1.134 . . . . 63.43 108.44 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.22 -45.04 44.0 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.888 0.743 . . . . 51.31 113.422 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t 47.86 -164.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.236 1.815 . . . . 62.51 112.798 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 39.6 tt0 -71.42 136.42 47.69 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 121.716 -0.615 . . . . 74.24 109.677 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.09 -26.57 65.96 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.884 0.74 . . . . 40.43 114.443 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . . . -58.27 -26.62 63.17 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.123 0.969 . . . . 75.11 112.693 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -59.62 -47.58 85.05 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.661 0.784 . . . . 55.45 111.579 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 66' ' ' VAL . . . -80.97 -29.4 35.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.269 -0.878 . . . . 61.42 111.077 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . 4.0 tmt_? -74.13 -19.25 60.63 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.577 -1.192 . . . . 63.21 111.016 -173.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 34.3 p -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 109.65 -0.5 . . . . 64.1 109.65 172.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.71 -41.52 79.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.514 0.726 . . . . 70.5 111.628 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.15 -37.69 86.16 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.44 0.696 . . . . 72.51 111.063 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -77.97 -33.01 51.65 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.113 0.565 . . . . 74.53 110.589 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' THR . 13.3 tp -63.31 -43.66 97.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.621 0.768 . . . . 64.3 112.019 -169.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -19.34 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.267 0.84 . . . . 63.3 113.267 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.21 -27.89 68.75 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.87 0.468 . . . . 45.12 112.048 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.91 -9.9 59.08 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.129 0.571 . . . . 52.11 112.266 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.48 47.11 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 113.802 0.281 . . . . 73.43 113.802 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.506 ' HE2' HG22 ' A' ' 90' ' ' THR . 6.5 m-85 -91.9 157.96 16.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.652 0.781 . . . . 75.23 109.632 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 HG23 ' A' ' 63' ' ' VAL . 20.2 m -71.59 -77.47 0.09 Allowed 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.445 0.466 . . . . 62.31 111.903 -162.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.467 HG23 HG22 ' A' ' 62' ' ' THR . 69.5 t -127.44 103.49 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 108.787 -0.82 . . . . 75.04 108.787 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 41.2 p -95.46 91.14 6.05 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.599 -0.889 . . . . 63.12 108.599 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 12.2 t70 -102.17 131.84 48.44 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.973 -1.012 . . . . 72.04 108.655 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 50' ' ' ALA . 65.7 t -125.98 133.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.93 -0.396 . . . . 43.14 109.93 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.36 146.62 17.29 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.245 -0.742 . . . . 43.11 111.245 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 24.9 p-10 -111.89 117.34 32.5 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.609 -0.515 . . . . 73.21 109.609 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.7 tp -159.15 138.54 11.46 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 122.493 -0.129 . . . . 70.13 110.831 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.614 ' HA ' HG13 ' A' ' 42' ' ' ILE . 49.3 m -68.69 103.4 1.73 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.491 -0.559 . . . . 73.03 109.491 171.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 74' ' ' VAL . 64.1 mt -112.23 132.4 22.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 123.928 0.891 . . . . 62.01 108.619 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.37 -20.57 54.89 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.608 2.205 . . . . 71.14 113.935 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.558 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 5.3 p-10 -82.04 -26.96 33.29 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.035 0.383 . . . . 72.34 112.035 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.561 HG13 HD12 ' A' ' 42' ' ' ILE . 2.4 p -97.8 117.31 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.676 0.75 . . . . 73.31 109.408 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.76 6.9 4.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.584 1.154 . . . . 75.12 108.926 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.3 151.58 15.65 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.456 1.102 . . . . 72.32 109.184 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -74.73 114.38 13.1 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.255 0.55 . . . . 61.44 110.375 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.2 m -145.73 143.62 29.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.505 1.122 . . . . 72.32 109.305 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.696 HG22 HG13 ' A' ' 118' ' ' VAL . 92.8 t -110.57 115.53 50.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 109.131 -0.692 . . . . 75.35 109.131 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.91 154.42 17.31 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.721 0.808 . . . . 74.13 109.575 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.76 152.9 42.77 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.266 -0.642 . . . . 74.22 109.266 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -106.71 135.58 48.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.163 -1.051 . . . . 63.42 108.163 172.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.5 0.31 4.19 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.378 1.251 . . . . 75.24 114.378 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.35 111.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 123.485 0.714 . . . . 71.02 110.753 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 70.74 -69.34 0.18 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.41 1.484 . . . . 63.01 112.037 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.95 51.52 0.06 OUTLIER Glycine 0 C--O 1.241 0.54 0 CA-C-O 119.976 -0.347 . . . . 54.44 112.767 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HB3' HG23 ' A' ' 116' ' ' VAL . 39.9 mm-40 -66.79 -27.12 67.32 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 111.786 0.291 . . . . 73.53 111.786 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -56.21 -34.29 66.14 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.56 0.207 . . . . 73.45 111.56 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.96 -39.19 71.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.288 0.635 . . . . 74.4 112.24 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.506 HG22 ' HE2' ' A' ' 61' ' ' PHE . 60.7 p -85.22 -44.41 12.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.862 -0.608 . . . . 72.33 110.753 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -58.87 -39.33 81.05 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.209 0.604 . . . . 75.11 112.466 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.568 ' HA ' HG11 ' A' ' 102' ' ' VAL . 23.5 t70 -72.07 -27.39 62.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.013 -0.994 . . . . 61.35 110.401 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.67 -52.08 8.42 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.206 0.602 . . . . 72.3 110.813 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 118' ' ' VAL . 69.4 t -60.44 -49.96 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.292 1.037 . . . . 44.51 111.11 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -63.88 -33.4 87.15 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.302 -0.863 . . . . 71.43 112.975 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -70.72 -37.47 73.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.151 -0.525 . . . . 61.11 110.449 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 m -68.29 -34.52 76.32 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.212 0.605 . . . . 72.25 110.927 175.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.1 tp -77.53 -33.31 54.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.704 0.802 . . . . 75.51 111.523 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.81 31.45 29.43 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.701 -0.681 . . . . 72.31 112.522 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.55 146.8 44.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.848 0.859 . . . . 64.31 109.155 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.39 149.63 33.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.131 0.572 . . . . 74.51 111.621 -172.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 92' ' ' ASP . 30.6 m -96.37 134.9 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.712 0.768 . . . . 54.04 111.319 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -134.11 165.67 24.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.438 1.495 . . . . 74.1 109.181 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.19 -174.19 0.78 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.838 0.855 . . . . 73.2 111.241 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.569 ' HB2' HD13 ' A' ' 109' ' ' LEU . 15.4 ptt180 -56.58 -40.86 75.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.804 0.842 . . . . 74.21 111.025 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.9 mt 61.2 164.39 0.1 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 125.15 1.38 . . . . 70.44 113.307 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.14 -23.56 9.77 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.329 2.686 . . . . 64.11 114.411 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 mp0 -60.67 -27.38 67.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.986 0.914 . . . . 70.41 112.825 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -66.08 -6.29 12.58 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.945 0.72 . . . . 54.12 112.945 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.0 p -66.2 -28.21 68.58 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.114 0.566 . . . . 70.23 112.066 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.61 -33.06 6.47 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.819 0.448 . . . . 51.21 111.743 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 13.4 pt20 -90.79 136.68 27.51 Favored Pre-proline 0 N--CA 1.484 1.251 0 N-CA-C 109.29 -0.633 . . . . 73.44 109.29 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.4 95.05 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.633 2.222 . . . . 61.24 112.616 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.5 161.33 35.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.898 2.399 . . . . 70.12 114.017 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 119.95 -149.0 17.89 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.661 -0.976 . . . . 74.24 110.661 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 78.7 t -84.66 121.37 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.107 0.453 . . . . 62.23 109.783 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.46 HG22 HG13 ' A' ' 119' ' ' VAL . 4.1 mp -118.97 104.95 16.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 108.27 -1.011 . . . . 74.44 108.27 174.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.696 HG13 HG22 ' A' ' 79' ' ' VAL . 58.2 t -92.48 101.37 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.369 -0.974 . . . . 64.01 108.369 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 40' ' ' TYR . 27.1 m -98.48 128.06 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.504 -0.554 . . . . 74.12 109.504 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.732 HG21 ' HB1' ' A' ' 49' ' ' ALA . 15.3 t -127.48 132.18 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.957 0.503 . . . . 71.23 110.309 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.0 t -105.08 165.9 10.76 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.562 0.745 . . . . 53.34 109.16 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 119.106 -0.83 . . . . 52.33 113.065 174.821 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 120.767 0.318 . . . . 74.3 110.411 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.2 m -88.59 -179.37 6.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.111 0.964 . . . . 74.21 111.512 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.92 141.13 30.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.406 -0.816 . . . . 73.44 109.787 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -121.73 155.65 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.712 0.805 . . . . 51.21 110.305 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.0 t -160.17 123.07 3.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.925 0.89 . . . . 23.22 108.797 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.1 m -118.65 133.11 56.1 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.934 0.494 . . . . 74.54 110.046 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtt -100.47 126.09 46.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.13 0.972 . . . . 73.11 109.52 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -134.34 109.11 8.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.789 0.836 . . . . 74.15 109.949 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -105.38 152.64 22.7 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.141 0.976 . . . . 61.04 109.968 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -153.05 116.07 4.58 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.374 0.67 . . . . 74.52 110.295 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.6 p -133.87 143.41 48.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.047 0.939 . . . . 63.31 110.497 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.23 167.48 20.61 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.806 0.842 . . . . 53.02 110.174 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.6 143.6 36.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 64.22 110.664 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.225 2.617 . . . . 73.52 113.48 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -112.99 159.38 19.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.101 0.961 . . . . 63.32 110.545 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -108.56 144.93 35.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 74.02 110.257 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -129.59 113.62 15.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.25 0.62 . . . . 70.44 110.503 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.3 m -102.89 133.94 47.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.969 0.508 . . . . 73.41 110.268 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.96 126.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 122.998 0.519 . . . . 75.03 110.331 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -114.95 106.81 51.13 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 108.354 -0.98 . . . . 71.53 108.354 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.37 1.697 0 C-N-CA 123.119 2.546 . . . . 73.21 113.294 175.844 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.429 ' HB3' HG21 ' A' ' 90' ' ' THR . . . . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.925 -0.768 . . . . 52.22 108.925 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.49 140.35 29.66 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.145 0.498 . . . . 64.21 110.446 -177.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 64' ' ' THR . 48.5 t -118.04 160.53 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.254 1.022 . . . . 73.53 109.128 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.09 127.78 11.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.725 0.41 . . . . 72.3 110.199 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 118' ' ' VAL . 94.1 t -106.36 121.3 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.639 0.776 . . . . 72.21 109.463 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -115.81 133.47 56.0 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.622 0.769 . . . . 71.51 110.793 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -82.62 116.29 21.96 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.688 -0.856 . . . . 74.04 108.688 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 74' ' ' VAL . 10.5 tp -80.12 -24.03 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.354 -0.61 . . . . 73.42 109.354 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.677 ' HB2' ' H ' ' A' ' 122' ' ' GLY . 40.4 m -139.18 169.38 17.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.272 1.029 . . . . 72.11 109.129 170.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 84.49 0.15 Allowed Glycine 0 C--N 1.347 1.183 0 O-C-N 123.551 0.532 . . . . 52.11 112.231 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 t -97.01 178.8 5.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.631 0.772 . . . . 74.23 109.89 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.77 151.19 43.72 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.133 0.573 . . . . 64.11 111.02 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.72 -4.44 46.8 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.059 -0.856 . . . . 71.2 114.823 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.5 -28.25 69.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.196 0.998 . . . . 64.05 112.271 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.49 -45.21 91.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.378 0.671 . . . . 71.12 110.842 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.29 -31.72 62.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.231 -0.895 . . . . 64.44 111.302 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -68.92 -36.32 77.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.537 1.135 . . . . 72.22 110.447 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.7 t -73.86 -35.09 64.73 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.411 -0.358 . . . . 72.22 110.109 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.88 63.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.432 0.693 . . . . 63.42 110.89 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.81 -48.18 70.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.05 0.94 . . . . 74.23 110.884 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -78.43 -29.24 46.94 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.478 -0.783 . . . . 62.23 111.274 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.75 -45.56 74.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.234 1.014 . . . . 74.05 111.359 -174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -51.63 -46.19 63.57 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.521 1.128 . . . . 62.12 111.625 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.6 -10.68 60.14 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.801 0.841 . . . . 62.35 112.556 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.83 7.3 42.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.603 0.761 . . . . 65.11 112.394 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.43 26.18 5.76 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 120.853 0.14 . . . . 24.11 113.205 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.528 ' HE2' ' HA ' ' A' ' 90' ' ' THR . 16.4 m-85 -108.09 154.04 22.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.238 1.015 . . . . 73.24 108.412 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.507 0.323 . . . . 70.41 111.681 -167.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.62 153.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.067 -1.086 . . . . 73.33 108.067 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 22.2 p -127.23 114.44 17.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.92 -0.77 . . . . 51.23 108.92 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -101.25 127.76 47.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.556 0.742 . . . . 44.15 109.256 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.65 129.68 67.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.088 -0.708 . . . . 63.45 109.088 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.91 -179.46 30.12 Favored Glycine 0 C--N 1.341 0.808 0 O-C-N 123.601 0.563 . . . . 72.21 111.91 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.65 125.92 35.26 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.143 -1.058 . . . . 71.14 108.143 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 57.1 mt -140.18 151.46 45.25 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.746 0.818 . . . . 72.41 110.15 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' HD12 ' A' ' 42' ' ' ILE . 24.2 m -126.85 98.21 5.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.782 0.833 . . . . 74.22 109.632 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HB2' HG22 ' A' ' 74' ' ' VAL . 7.4 mp -121.09 153.46 57.79 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 124.647 1.179 . . . . 61.32 109.438 -176.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.33 -27.69 6.3 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.512 2.141 . . . . 51.35 112.745 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.6 -23.05 53.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.75 0.82 . . . . 64.3 111.19 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 71' ' ' LEU . 33.0 m -120.41 117.98 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 109.088 -0.708 . . . . 73.41 109.088 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -144.46 9.46 1.4 Allowed 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.869 -0.519 . . . . 71.35 111.045 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.79 158.22 44.63 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.356 1.063 . . . . 75.4 109.345 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.573 ' HB ' HG22 ' A' ' 121' ' ' THR . 7.2 t -69.34 98.22 1.05 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.285 1.04 . . . . 73.02 108.913 174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.8 m -150.74 137.09 18.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.49 1.116 . . . . 72.34 110.217 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 118' ' ' VAL . 40.3 t -101.67 119.7 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.314 1.046 . . . . 75.41 108.861 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' CE1' HG12 ' A' ' 74' ' ' VAL . 93.4 m-85 -103.75 125.42 50.21 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.252 -0.647 . . . . 72.22 109.252 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -145.45 160.38 41.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.52 0.728 . . . . 74.32 110.37 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -109.36 -120.32 0.27 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 108.103 -1.073 . . . . 61.53 108.103 172.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -137.89 -9.34 1.58 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.251 0.932 . . . . 70.5 112.194 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.43 107.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.33 0.652 . . . . 75.04 111.735 -167.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 59.77 31.43 20.81 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 53.45 112.067 173.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.55 38.44 5.58 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.03 -0.986 . . . . 52.25 113.374 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.3 -44.44 71.99 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.189 0.495 . . . . 72.54 112.303 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -66.31 -24.62 66.57 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 111.888 0.329 . . . . 73.01 111.888 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.51 -37.2 57.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.386 0.674 . . . . 50.13 111.252 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HE2' ' A' ' 61' ' ' PHE . 81.8 p -82.01 -28.49 32.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.325 0.584 . . . . 54.33 110.277 -174.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.39 -31.47 54.21 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.636 1.174 . . . . 74.1 111.786 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.38 -55.54 32.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.832 1.253 . . . . 71.33 110.6 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.34 -32.24 71.08 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.676 -1.147 . . . . 74.54 112.727 -173.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.494 HG11 HG21 ' A' ' 118' ' ' VAL . 47.4 t -87.87 -53.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.059 0.544 . . . . 73.44 111.588 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -29.88 75.97 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.814 -0.63 . . . . 70.11 113.75 -168.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -72.97 -36.14 67.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.095 0.558 . . . . 62.51 110.552 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.7 m -62.04 -40.23 95.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.716 0.806 . . . . 62.31 111.257 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.86 -15.31 37.09 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.31 0.485 . . . . 71.2 112.31 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.12 25.04 75.74 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.891 -0.483 . . . . 71.31 111.891 -172.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.87 136.85 33.95 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.342 1.057 . . . . 63.2 109.486 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 113.32 2.6 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.953 0.783 . . . . 32.33 111.09 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -83.87 101.58 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 122.457 1.123 . . . . 64.35 109.047 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -112.9 158.36 20.29 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.519 -1.219 . . . . 74.02 111.343 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.61 177.75 1.49 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.347 -1.297 . . . . 65.3 110.397 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -59.29 -44.76 92.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.981 -0.554 . . . . 72.11 110.695 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt 60.77 173.63 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.106 0.962 . . . . 72.55 111.777 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.61 -27.33 25.35 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.419 2.079 . . . . 62.31 113.674 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.97 -47.33 83.63 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.077 0.951 . . . . 74.44 112.325 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.543 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 23.0 tp -71.67 -12.18 61.2 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 120.896 0.379 . . . . 73.43 111.215 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 t -79.06 -14.09 59.37 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.201 0.601 . . . . 72.55 110.818 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.13 -25.82 23.93 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.548 0.739 . . . . 62.35 112.362 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 1.3 pp0? -142.54 155.85 63.65 Favored Pre-proline 0 N--CA 1.495 1.802 0 CA-C-O 118.282 -0.866 . . . . 74.14 111.132 -173.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 30.9 Cg_exo -37.47 125.75 0.61 Allowed 'Trans proline' 0 C--N 1.397 3.1 0 C-N-CA 124.736 3.624 . . . . 70.15 115.867 -169.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 18.8 Cg_exo -64.61 133.3 36.28 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.089 2.526 . . . . 53.33 112.175 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.496 ' H ' HD21 ' A' ' 109' ' ' LEU . . . 157.09 177.81 30.56 Favored Glycine 0 C--O 1.245 0.812 0 N-CA-C 110.667 -0.973 . . . . 61.33 110.667 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.8 t -80.66 100.04 4.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.817 -0.438 . . . . 75.14 109.817 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 117' ' ' ILE . 41.8 pt -102.89 108.58 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.76 -0.83 . . . . 74.41 108.76 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.627 HG13 HG22 ' A' ' 79' ' ' VAL . 51.7 t -90.6 100.99 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.373 -1.343 . . . . 71.32 107.373 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.531 HG11 ' HB ' ' A' ' 74' ' ' VAL . 61.3 t -95.93 118.17 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.827 -0.805 . . . . 40.11 108.827 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.28 133.72 63.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.107 0.563 . . . . 65.33 109.619 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 77' ' ' THR . 11.8 t -98.72 156.17 16.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.505 0.722 . . . . 64.13 110.577 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.677 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.686 -1.063 . . . . 37.85 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 p . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 120.718 0.294 . . . . 73.22 110.762 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -90.7 132.78 35.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.132 0.573 . . . . 74.23 109.979 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 98.54 3.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.101 0.56 . . . . 75.22 111.128 -172.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -131.41 129.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.755 0.822 . . . . 73.54 110.335 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 p -175.47 103.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.307 1.043 . . . . 60.41 110.629 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -166.89 130.92 1.95 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.203 1.001 . . . . 63.14 109.925 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -132.35 77.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.082 -0.71 . . . . 64.03 109.082 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -85.42 104.58 15.35 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.087 -0.506 . . . . 42.05 110.14 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -146.29 145.21 30.28 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 74.03 109.562 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -149.97 168.82 22.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.769 0.428 . . . . 64.51 111.085 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.9 t -148.21 169.97 18.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.345 1.058 . . . . 64.44 109.775 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.08 167.09 22.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.314 1.045 . . . . 64.21 109.995 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.8 124.29 24.03 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.162 0.985 . . . . 64.0 109.996 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.39 123.65 11.44 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.486 2.791 . . . . 72.41 113.248 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.6 p -117.4 125.97 51.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.503 0.721 . . . . 53.24 110.98 -174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -136.98 123.19 20.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.849 0.86 . . . . 73.4 109.104 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t -155.31 127.91 7.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.47 0.708 . . . . 75.43 110.063 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.2 m -155.85 127.3 7.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.992 0.917 . . . . 44.34 109.569 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 m -90.19 156.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.503 0.721 . . . . 72.0 111.148 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.14 158.74 71.81 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 124.64 1.176 . . . . 63.35 110.201 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--N 1.382 2.308 0 C-N-CA 123.086 2.524 . . . . 73.03 112.875 172.426 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 61' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 109.497 -0.557 . . . . 73.13 109.497 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -96.94 91.51 5.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.995 0.918 . . . . 74.55 109.676 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 56' ' ' LEU . 21.1 t -95.65 139.66 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.271 1.028 . . . . 53.01 109.283 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HG3' ' HB2' ' A' ' 65' ' ' ASP . 43.7 ttm105 -148.3 131.97 16.89 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.202 -0.666 . . . . 75.11 109.202 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 66' ' ' VAL . 47.8 t -114.83 135.11 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.721 0.808 . . . . 75.34 109.819 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -137.32 107.23 6.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.923 0.889 . . . . 73.41 109.772 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.42 123.16 32.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.106 -1.072 . . . . 74.52 108.106 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.627 HG21 HG11 ' A' ' 74' ' ' VAL . 18.5 tt -85.86 -38.44 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 118.227 0.467 . . . . 55.33 110.682 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.0 m -149.63 155.89 40.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.818 0.847 . . . . 63.14 109.744 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 122' ' ' GLY . . . 93.57 -39.02 3.01 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.515 0.509 . . . . 73.23 112.718 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t 37.13 80.49 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.449 1.9 . . . . 52.22 113.131 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.67 173.11 9.23 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.963 -1.017 . . . . 72.22 111.372 -170.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.59 -45.67 94.09 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.31 -1.314 . . . . 62.42 114.036 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 -28.01 67.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.352 0.871 . . . . 74.2 113.352 -169.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -60.33 2.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.669 0.388 . . . . 72.15 111.029 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.4 69.12 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.735 -0.666 . . . . 73.22 111.849 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -34.4 77.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.258 1.423 . . . . 74.35 110.477 -174.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.448 ' O ' HD13 ' A' ' 56' ' ' LEU . 77.0 p -62.25 -57.26 12.08 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 123.468 0.48 . . . . 51.32 110.317 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 64' ' ' THR . . . -71.92 -28.37 63.44 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.08 0.152 . . . . 70.44 111.337 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.7 -31.52 71.53 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.433 0.693 . . . . 74.54 111.153 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -80.73 -45.38 17.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.32 -0.4 . . . . 71.22 110.451 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 37' ' ' VAL . 10.9 mp -66.4 -31.58 72.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.635 -0.711 . . . . 72.15 112.189 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.57 -39.65 91.89 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.885 0.374 . . . . 75.22 111.05 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.71 -29.75 61.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.456 -0.793 . . . . 51.45 110.308 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -13.08 61.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.539 0.736 . . . . 60.0 111.396 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.79 31.36 7.82 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.532 0.52 . . . . 30.01 113.687 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.403 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 7.8 m-85 -79.72 155.7 27.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.601 -0.889 . . . . 75.41 108.601 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 35' ' ' ALA . 37.0 m -73.26 -59.92 2.48 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.724 0.41 . . . . 72.12 111.468 -163.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 99.5 t -114.41 141.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.692 -0.855 . . . . 74.03 108.692 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.529 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 14.6 p -145.61 109.87 4.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.96 0.904 . . . . 72.35 108.807 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.55 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.4 m-20 -103.86 144.47 31.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.786 -0.82 . . . . 75.05 108.786 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.493 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 61.9 t -133.59 114.83 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.361 -0.977 . . . . 71.44 108.361 173.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.25 159.38 27.69 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 121.521 -0.371 . . . . 53.33 113.033 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -113.27 113.97 26.05 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.029 -1.1 . . . . 63.23 108.029 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.59 144.51 20.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.887 -0.783 . . . . 60.14 108.887 -167.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.408 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 t -83.62 108.7 16.88 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 62.42 109.251 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.59 149.31 35.58 Favored Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.631 . . . . 62.02 110.281 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.18 -20.8 18.54 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.958 2.439 . . . . 55.33 113.253 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -80.82 -19.16 45.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.252 1.021 . . . . 50.23 112.12 -174.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 42' ' ' ILE . 90.6 t -56.5 133.18 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.114 0.884 . . . . 74.15 112.375 -167.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.39 -45.13 0.08 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.954 -1.476 . . . . 53.14 108.268 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.36 158.1 43.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.379 1.072 . . . . 60.01 109.339 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.527 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.7 t -62.66 111.95 2.3 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.358 0.599 . . . . 74.34 110.201 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.0 m -149.32 138.57 21.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.561 0.745 . . . . 64.42 110.485 -172.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 118' ' ' VAL . 18.3 t -94.66 114.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.687 1.195 . . . . 71.32 108.444 173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.476 ' HB3' HD21 ' A' ' 109' ' ' LEU . 28.7 m-85 -95.53 154.52 17.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.318 -0.993 . . . . 71.52 108.318 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -153.44 -179.88 8.17 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.546 0.688 . . . . 74.13 111.784 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.498 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 24.0 m -126.83 139.48 53.07 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 105.999 -1.852 . . . . 74.23 105.999 161.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.05 -10.21 59.24 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.962 0.727 . . . . 74.33 112.962 -170.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.31 130.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 63.21 112.843 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.24 21.05 11.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.72 1.208 . . . . 74.05 112.723 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.57 62.99 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 116.308 -0.405 . . . . 63.13 112.861 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 82' ' ' THR . 11.3 tp10 -69.53 -21.92 63.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 64.35 109.95 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -57.69 -29.28 64.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.405 1.082 . . . . 72.43 112.936 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -45.11 83.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.704 0.801 . . . . 53.24 112.023 -174.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.531 HG23 HG21 ' A' ' 116' ' ' VAL . 9.9 t -74.58 -30.99 61.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.23 -0.441 . . . . 55.3 110.759 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -69.23 -34.9 75.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.885 0.474 . . . . 63.13 111.407 174.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.79 -40.58 83.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.524 1.129 . . . . 71.4 109.57 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.09 60.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.757 -1.11 . . . . 42.14 110.681 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.01 -32.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.16 0.984 . . . . 62.14 111.827 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.43 93.53 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.957 -0.457 . . . . 74.54 111.957 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 -80.31 -25.99 39.05 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.0 0.52 . . . . 73.14 111.881 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -70.81 -43.12 69.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.951 0.5 . . . . 45.14 110.231 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 tp -86.22 -30.84 22.07 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.592 -0.731 . . . . 62.14 110.598 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.03 24.95 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.771 -0.649 . . . . 21.13 112.165 -174.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.94 167.65 9.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.994 0.917 . . . . 65.14 111.279 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.34 41.92 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.923 0.889 . . . . 75.1 111.071 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.05 119.58 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.013 0.435 . . . . 44.34 110.569 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -113.46 148.26 36.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.343 0.657 . . . . 74.54 110.997 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.64 -166.89 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.905 1.282 . . . . 63.34 111.911 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -77.04 28.55 0.14 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 124.508 1.123 . . . . 75.45 113.037 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pp -47.97 157.77 0.6 Allowed Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 125.458 1.503 . . . . 60.23 113.19 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.35 -24.29 0.97 Allowed 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 124.44 3.427 . . . . 74.21 117.847 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.68 -22.29 64.38 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.361 0.664 . . . . 74.23 112.413 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 80' ' ' TYR . 4.4 mm? -64.6 -8.91 15.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.6 0.76 . . . . 42.31 111.738 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 t -63.98 -42.01 97.36 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.281 1.032 . . . . 74.54 112.003 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.477 ' HB2' ' OE1' ' A' ' 112' ' ' GLN . 4.5 m-20 -80.77 -33.57 34.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.898 0.479 . . . . 55.33 111.562 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -90.71 157.49 43.84 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.704 0.802 . . . . 71.21 108.998 178.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.7 125.07 16.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.062 1.842 . . . . 72.52 110.783 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.22 118.96 5.9 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.146 2.564 . . . . 72.2 112.719 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.51 -158.7 31.76 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.859 -0.896 . . . . 75.13 110.859 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.531 HG21 HG23 ' A' ' 90' ' ' THR . 74.1 t -79.25 105.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.196 -0.668 . . . . 73.41 109.196 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' ' 117' ' ' ILE . 31.1 pt -116.68 107.75 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.849 -0.797 . . . . 74.42 108.849 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 79' ' ' VAL . 2.1 p -87.28 105.02 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.54 -0.911 . . . . 61.02 108.54 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 74' ' ' VAL . 94.7 t -91.51 117.48 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.75 -1.204 . . . . 71.3 107.75 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.24 127.44 65.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.527 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.2 p -104.89 102.9 12.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.778 -1.564 . . . . 63.1 106.778 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 119.308 -0.718 . . . . 70.52 112.639 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.241 0.655 0 N-CA-C 110.03 -0.359 . . . . 72.44 110.03 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -170.37 106.2 0.3 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.36 1.064 . . . . 75.4 108.209 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.12 131.54 5.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.358 0.663 . . . . 63.24 110.042 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -169.07 130.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.528 1.131 . . . . 61.21 109.339 175.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 p -172.2 128.11 0.57 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.296 1.038 . . . . 62.44 108.617 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.7 t -148.29 110.48 4.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 109.52 -0.548 . . . . 71.41 109.52 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -136.46 104.72 5.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.684 0.794 . . . . 55.22 109.406 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -135.1 114.99 12.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.493 1.117 . . . . 54.24 109.816 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 p -148.06 143.05 26.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.842 1.257 . . . . 70.41 109.001 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -152.77 137.87 17.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.605 1.162 . . . . 50.41 108.851 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.7 p -143.92 106.41 4.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.954 0.902 . . . . 61.2 110.307 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.49 144.4 18.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.099 0.959 . . . . 71.14 110.08 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.73 105.78 4.27 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 123.724 0.81 . . . . 63.01 109.563 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.06 113.69 2.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.081 2.521 . . . . 75.03 112.341 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -152.03 119.12 5.86 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.233 0.539 . . . . 62.41 110.283 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -153.84 139.91 18.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.722 1.209 . . . . 72.32 109.251 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -148.44 128.35 13.5 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.028 0.531 . . . . 74.14 110.412 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.3 m -150.31 89.18 1.56 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.212 1.005 . . . . 55.44 108.992 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.34 140.74 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.814 0.846 . . . . 71.33 110.26 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.31 115.68 64.62 Favored Pre-proline 0 N--CA 1.479 1.001 0 N-CA-C 108.753 -0.832 . . . . 73.24 108.753 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--N 1.375 1.945 0 C-N-CA 122.678 2.252 . . . . 72.35 111.279 174.137 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.773 0.321 . . . . 73.42 110.424 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.448 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.3 mp0 -82.35 101.1 10.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.044 0.937 . . . . 73.33 109.086 176.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.13 140.1 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.883 -0.784 . . . . 71.25 108.883 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -152.08 129.0 10.98 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.623 0.769 . . . . 64.23 109.473 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 118' ' ' VAL . 43.7 t -114.79 126.55 72.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.131 -1.063 . . . . 70.35 108.131 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.475 ' CE1' HG22 ' A' ' 119' ' ' VAL . 7.9 p90 -127.56 139.72 52.58 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.475 0.655 . . . . 72.2 110.005 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' A' ' 46' ' ' GLU . 16.4 m120 -84.24 146.78 27.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.708 -1.133 . . . . 75.24 108.303 166.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 121' ' ' THR . 10.2 tp -76.94 -23.23 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.005 0.431 . . . . 64.3 109.993 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.9 m -118.84 -57.37 2.04 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.737 0.815 . . . . 71.13 109.758 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 76.94 1.05 Allowed Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.802 -0.519 . . . . 63.21 111.802 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.2 m -145.13 -37.6 0.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.841 0.856 . . . . 65.53 110.074 178.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HB3' HD21 ' A' ' 41' ' ' ASN . 10.9 tp10 -73.96 109.9 7.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.997 0.519 . . . . 75.32 110.346 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.53 -24.07 59.34 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.395 -0.82 . . . . 55.11 112.522 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.31 67.6 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.07 0.548 . . . . 73.54 110.855 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.65 55.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.803 0.841 . . . . 63.25 110.598 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -27.38 66.14 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.616 -0.72 . . . . 65.04 111.609 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.7 -35.93 79.71 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.441 1.097 . . . . 72.44 110.825 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -62.35 -53.2 58.5 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 122.426 0.29 . . . . 70.35 111.229 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -68.9 -30.13 68.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.379 0.272 . . . . 70.31 111.255 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.8 -39.41 94.16 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 70.42 109.95 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -74.78 -33.52 62.27 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.656 -0.702 . . . . 74.21 110.355 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.377 0.671 . . . . 75.24 111.048 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -63.04 -46.54 87.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 107.948 -1.13 . . . . 75.02 107.948 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.99 -29.23 69.02 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.263 -0.88 . . . . 60.2 111.122 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.52 -17.02 58.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.484 0.714 . . . . 40.43 111.601 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.9 37.23 7.98 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 116.492 -0.322 . . . . 44.21 113.878 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.26 159.47 28.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.063 0.545 . . . . 74.05 110.164 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.4 m -60.9 -68.91 0.26 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.811 0.694 . . . . 62.14 111.176 -167.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 89.2 t -116.48 138.16 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.806 -1.183 . . . . 71.52 107.806 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.6 p -136.4 96.28 3.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.277 -1.379 . . . . 63.22 107.277 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -102.25 145.95 28.71 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.625 -0.88 . . . . 74.35 108.625 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.09 135.1 55.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.061 0.944 . . . . 72.24 108.836 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.11 -164.27 27.37 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 121.249 -0.501 . . . . 52.33 112.3 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -146.28 118.5 8.35 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.268 -1.012 . . . . 74.44 108.268 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.53 143.03 47.19 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 108.656 -0.868 . . . . 70.44 108.656 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -86.57 97.16 10.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.117 -0.697 . . . . 45.35 109.117 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.87 110.87 62.5 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.518 1.127 . . . . 73.11 108.454 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.1 -12.96 33.23 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.247 1.965 . . . . 53.14 113.236 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -77.19 -21.43 53.97 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.661 0.385 . . . . 74.2 111.671 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.22 142.12 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.557 -0.535 . . . . 62.22 109.557 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.93 22.44 1.58 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.343 1.057 . . . . 61.23 109.983 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.25 149.25 33.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.581 0.753 . . . . 72.04 109.582 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.3 t -76.88 103.55 6.89 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.873 0.844 . . . . 73.44 109.834 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.2 m -151.47 140.11 20.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.338 -0.847 . . . . 74.21 110.113 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.677 HG22 HG13 ' A' ' 118' ' ' VAL . 41.7 t -96.46 114.25 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.848 0.859 . . . . 64.14 109.154 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.83 132.71 45.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.295 1.038 . . . . 74.01 108.493 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.605 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -137.31 165.82 25.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.991 0.516 . . . . 72.04 111.904 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.0 t -106.99 148.86 28.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.607 -1.257 . . . . 53.54 107.607 161.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.538 ' HG2' ' HD2' ' A' ' 88' ' ' ARG . 46.0 mt-10 -97.16 9.04 43.26 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.915 0.486 . . . . 65.12 111.787 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.31 143.12 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.301 -0.629 . . . . 53.42 109.301 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 62.11 -83.09 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.721 1.208 . . . . 72.03 111.969 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.31 37.72 0.21 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.991 -0.443 . . . . 63.14 111.991 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.48 -35.9 24.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.542 0.337 . . . . 62.13 111.462 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 83' ' ' GLU . 61.4 ttt180 -61.25 -26.93 68.08 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.948 -0.47 . . . . 75.5 111.294 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.47 99.85 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.628 0.771 . . . . 70.34 111.956 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -81.49 -24.26 36.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.114 0.483 . . . . 51.2 110.55 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.7 59.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.929 0.892 . . . . 71.1 111.612 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.55 -45.52 75.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.417 -1.265 . . . . 75.2 109.663 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.29 -56.9 14.73 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.648 -1.16 . . . . 53.33 111.114 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 118' ' ' VAL . 86.6 t -71.27 -37.32 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.726 -0.67 . . . . 41.52 111.823 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.81 -35.44 52.96 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.566 0.541 . . . . 62.34 112.459 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -86.17 -32.8 21.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.673 -0.763 . . . . 63.42 110.308 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.9 m -65.84 -40.98 92.28 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.353 0.597 . . . . 45.41 110.399 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.53 -28.44 28.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.656 -1.156 . . . . 72.21 109.934 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.82 75.69 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.764 -0.653 . . . . 63.43 112.606 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.91 -172.59 3.75 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.83 0.852 . . . . 53.04 110.617 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 161.34 26.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.863 0.465 . . . . 31.42 109.965 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.605 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 10.0 m -129.96 124.63 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.853 0.861 . . . . 53.14 109.016 175.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -129.08 158.57 38.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.008 0.923 . . . . 60.33 110.905 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.8 -163.64 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.027 -1.442 . . . . 74.24 111.023 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.557 ' HA ' HD12 ' A' ' 109' ' ' LEU . 14.4 ttp180 -75.4 30.77 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.136 1.374 . . . . 62.33 112.955 -172.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.2 mt -46.0 152.41 0.78 Allowed Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 125.549 1.539 . . . . 71.13 113.654 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.2 -12.72 0.5 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 124.759 3.639 . . . . 60.0 116.796 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -60.31 -33.69 72.73 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.265 0.555 . . . . 71.23 110.287 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.595 HD22 HD13 ' A' ' 117' ' ' ILE . 31.5 mt -76.71 5.6 7.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.298 1.039 . . . . 73.3 113.299 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.4 p -82.13 -41.36 20.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.735 -0.839 . . . . 73.24 108.735 170.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.7 -34.86 30.39 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.743 -1.117 . . . . 61.22 110.243 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -86.16 146.99 43.94 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.355 -0.839 . . . . 73.54 109.236 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 37.7 Cg_endo -64.32 124.04 12.76 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.338 2.025 . . . . 74.41 111.165 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 32.0 Cg_exo -60.26 133.79 51.72 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.726 2.951 . . . . 73.32 113.76 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.11 -129.14 2.17 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.204 -1.158 . . . . 42.45 110.204 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.48 105.12 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.325 -0.991 . . . . 72.45 108.325 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.595 HD13 HD22 ' A' ' 109' ' ' LEU . 2.3 mp -105.59 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 N-CA-C 108.028 -1.101 . . . . 41.2 108.028 -176.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.677 HG13 HG22 ' A' ' 79' ' ' VAL . 58.8 t -88.15 106.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.59 -1.263 . . . . 71.31 107.59 174.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 40' ' ' TYR . 19.2 t -93.13 130.56 42.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.74 -0.837 . . . . 71.12 108.74 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.58 129.21 74.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.65 0.78 . . . . 55.1 109.043 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.506 ' H ' ' HB ' ' A' ' 77' ' ' THR . 13.2 t -77.29 144.04 38.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.074 -1.084 . . . . 75.32 108.074 171.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 N-CA-C 110.488 -1.045 . . . . 65.22 110.488 -167.087 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.03 -0.73 . . . . 64.1 109.03 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 t -76.8 173.8 11.26 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.599 0.76 . . . . 64.12 111.489 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.69 157.31 44.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.704 0.802 . . . . 55.1 110.28 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 pt -102.84 -176.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.518 0.727 . . . . 72.53 110.785 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -148.68 173.67 12.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.29 0.636 . . . . 54.4 110.223 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -143.35 146.67 33.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.991 0.516 . . . . 73.11 111.373 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -121.4 135.22 55.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.841 0.856 . . . . 60.13 109.499 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.0 m -145.8 128.65 16.36 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.296 1.038 . . . . 71.35 108.789 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 p -110.24 162.89 14.17 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.65 0.78 . . . . 73.03 111.586 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -118.79 136.47 53.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.91 0.884 . . . . 72.05 109.688 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.6 m -78.29 157.68 29.12 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.778 0.831 . . . . 64.23 110.359 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.81 169.76 16.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 70.32 109.472 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.61 42.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.399 0.68 . . . . 63.22 111.095 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.32 176.87 9.43 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.402 2.068 . . . . 63.04 111.794 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 p -112.92 -175.89 2.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.331 0.652 . . . . 74.22 110.474 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.9 t -150.2 136.1 18.5 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.519 -0.919 . . . . 72.1 108.519 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -114.44 138.43 50.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.003 0.521 . . . . 72.14 109.621 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.7 m -148.15 121.7 9.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.435 0.694 . . . . 72.35 109.506 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.06 144.58 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.488 0.715 . . . . 72.44 110.149 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 10.8 mptt -105.98 157.24 35.21 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 124.084 0.954 . . . . 75.43 110.102 -176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo . . . . . 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 72.01 113.304 171.415 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 112.196 0.443 . . . . 70.04 112.196 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 27.3 mm-40 -77.07 114.49 15.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.104 0.962 . . . . 74.11 109.451 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 43.1 t -125.76 137.32 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 122.853 0.461 . . . . 73.04 110.542 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -151.27 148.99 28.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.005 0.922 . . . . 74.14 110.676 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.51 113.57 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.263 1.025 . . . . 75.21 109.505 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -103.33 107.85 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.78 0.432 . . . . 75.34 110.228 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 3.4 t-20 -94.42 119.44 33.16 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.734 -0.839 . . . . 73.14 108.734 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -102.43 -42.9 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 122.073 -0.392 . . . . 73.34 110.365 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 p -136.88 158.55 44.21 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.84 -0.8 . . . . 73.45 108.84 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.75 59.05 4.21 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.591 -1.003 . . . . 73.13 110.591 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 t -66.22 100.81 0.65 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.602 0.761 . . . . 62.01 111.491 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -147.83 155.44 41.65 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.249 0.62 . . . . 53.22 110.133 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.62 -2.53 36.36 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 118.905 -0.942 . . . . 65.13 114.001 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.98 69.46 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.095 0.958 . . . . 70.31 111.412 171.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -42.56 97.28 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 124.154 0.909 . . . . 51.43 110.988 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.22 -35.53 71.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.67 -0.696 . . . . 71.5 111.089 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.76 -31.24 71.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.901 1.28 . . . . 64.45 111.63 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.525 ' HB ' HG13 ' A' ' 94' ' ' VAL . 48.0 p -76.97 -22.18 53.59 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.7 0.4 . . . . 72.33 111.59 176.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.19 -54.73 5.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.462 0.705 . . . . 74.45 111.205 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -54.96 -31.16 60.33 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.16 0.984 . . . . 74.55 113.147 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -59.88 -39.47 85.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.321 0.648 . . . . 74.43 111.789 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.0 -38.42 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 118.917 -0.563 . . . . 75.51 111.893 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -30.93 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.825 0.738 . . . . 73.35 110.596 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.19 -27.97 66.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.479 0.712 . . . . 71.15 110.808 173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.71 -21.8 37.78 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.63 0.772 . . . . 51.12 111.989 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.06 25.99 4.85 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 113.968 0.347 . . . . 65.4 113.968 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.43 158.73 27.27 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.34 0.656 . . . . 64.12 110.443 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -65.43 -70.1 0.26 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.969 0.793 . . . . 71.34 110.854 -165.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.02 145.15 35.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.69 -0.856 . . . . 64.42 108.69 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 37' ' ' VAL . 41.4 p -137.14 100.61 4.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.527 -1.286 . . . . 71.24 107.527 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 19.0 t70 -104.9 162.5 13.27 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.897 0.879 . . . . 73.32 110.183 -172.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 141.44 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.841 0.856 . . . . 73.03 109.049 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.44 129.02 2.41 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.947 -0.461 . . . . 65.14 111.947 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 16.8 p-10 -88.66 97.39 11.09 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.447 0.699 . . . . 73.53 109.823 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.4 135.55 13.03 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.166 -0.333 . . . . 73.54 110.155 -169.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -81.16 99.41 8.53 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.433 -0.58 . . . . 70.13 109.433 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.31 151.75 89.98 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.407 -0.59 . . . . 73.33 109.407 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.04 -7.61 18.32 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.113 1.875 . . . . 54.44 112.371 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -108.93 -23.05 11.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.342 0.657 . . . . 73.4 112.43 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.06 130.13 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.36 0.6 . . . . 65.55 111.252 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.27 -7.67 4.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.431 1.092 . . . . 75.44 111.215 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.12 159.0 5.77 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.463 1.105 . . . . 55.14 109.345 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.4 t -66.75 107.24 2.09 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.694 0.759 . . . . 63.32 109.996 177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 m -144.91 153.42 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.531 -0.759 . . . . 73.5 109.293 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.685 HG21 ' HA3' ' A' ' 95' ' ' GLY . 4.3 t -112.6 114.28 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.916 -1.142 . . . . 64.13 107.916 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.582 ' HB2' HG13 ' A' ' 117' ' ' ILE . 52.4 m-85 -105.1 119.38 38.89 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.285 0.493 . . . . 73.12 110.585 -174.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HD2' ' HB3' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -112.01 140.99 46.22 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.85 0.719 . . . . 74.31 110.462 175.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.1 t -113.78 -40.05 3.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.946 0.898 . . . . 62.03 111.654 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -89.81 37.38 0.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.858 0.863 . . . . 73.21 111.856 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -45.87 163.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.518 1.927 . . . . 74.13 114.746 -174.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 86.69 -55.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.727 2.011 . . . . 75.33 108.359 -163.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.31 -50.73 1.99 Allowed Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.205 -0.452 . . . . 75.02 112.574 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.04 -19.94 50.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.653 0.263 . . . . 72.41 111.299 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -56.81 -27.97 60.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.75 -0.659 . . . . 65.53 110.972 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.8 -46.64 57.57 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.716 0.806 . . . . 72.43 112.214 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 94' ' ' VAL . 6.2 t -79.9 -33.24 40.03 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 122.672 0.389 . . . . 75.14 110.736 -171.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.59 -48.22 75.76 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 123.799 0.687 . . . . 64.31 110.353 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.534 ' HA ' HG11 ' A' ' 102' ' ' VAL . 30.5 t70 -57.52 -40.24 78.34 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.272 0.983 . . . . 73.1 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.54 -46.1 87.51 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.961 0.788 . . . . 54.2 112.149 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 52' ' ' THR . 61.4 t -65.44 -52.82 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.328 0.651 . . . . 74.31 110.605 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.685 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -64.6 -26.84 71.18 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.344 -0.844 . . . . 62.4 113.281 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 2.6 tmt_? -65.07 -39.29 93.02 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.507 0.723 . . . . 75.45 109.553 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -66.46 -52.65 43.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.922 -1.035 . . . . 73.31 111.181 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 118' ' ' VAL . 4.0 pp -82.45 -13.71 56.29 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.792 -0.64 . . . . 73.34 112.402 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.66 72.81 1.2 Allowed Glycine 0 C--N 1.349 1.255 0 O-C-N 123.574 0.546 . . . . 45.25 113.136 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.06 155.11 44.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.703 0.801 . . . . 75.34 110.001 172.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.97 142.53 33.36 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.492 -0.776 . . . . 74.3 110.289 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.534 HG11 ' HA ' ' A' ' 92' ' ' ASP . 34.0 m -95.19 148.25 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.417 0.687 . . . . 70.14 110.748 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -157.5 156.69 32.49 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 123.811 0.844 . . . . 70.21 110.81 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.63 161.51 23.12 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.402 1.081 . . . . 74.05 110.746 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.424 ' HG3' ' H ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -69.66 29.73 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.404 2.001 . . . . 71.24 116.404 -172.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.406 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.0 mm? -54.61 -53.62 58.12 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-N 119.562 1.074 . . . . 74.43 112.521 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 6.0 Cg_exo -80.26 -13.93 12.2 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 122.378 2.052 . . . . 75.34 112.953 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HG2' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -58.62 -41.61 86.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.498 0.719 . . . . 72.32 110.153 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.4 tp -64.29 -12.75 44.72 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.56 0.744 . . . . 70.03 112.566 -172.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -63.64 -47.16 82.47 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.871 0.869 . . . . 74.32 111.161 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.2 -32.49 7.48 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.353 1.061 . . . . 75.13 110.944 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.1 71.92 1.04 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 126.782 2.033 . . . . 54.52 112.708 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HD2' ' HG2' ' A' ' 108' ' ' GLU . 1.4 Cg_endo -88.71 140.74 4.34 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.1 2.533 . . . . 74.03 111.106 162.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.0 129.04 13.72 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.66 2.24 . . . . 74.11 114.468 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.23 -156.15 32.02 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.022 -0.536 . . . . 41.25 113.988 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 76.8 t -58.1 111.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 124.278 1.031 . . . . 74.2 110.138 177.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 80' ' ' TYR . 39.7 pt -117.85 104.3 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.47 -1.307 . . . . 64.52 107.47 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 79' ' ' VAL . 2.3 p -101.84 111.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.886 -0.783 . . . . 65.13 108.886 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -93.17 123.53 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.941 -1.027 . . . . 71.42 109.473 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.05 127.52 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.593 0.757 . . . . 72.54 110.108 -172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.574 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.8 p -123.4 119.61 30.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.512 -1.292 . . . . 54.11 107.512 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.594 0 CA-C-O 119.207 -0.774 . . . . 63.32 112.628 -174.613 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 109.931 -0.396 . . . . 75.45 109.931 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.3 p -153.49 124.65 7.45 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.939 0.896 . . . . 73.24 108.684 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.41 123.93 7.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.812 0.845 . . . . 64.53 109.517 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 tp -157.9 136.26 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.817 0.847 . . . . 73.4 109.345 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 p -150.77 88.78 1.5 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.86 0.864 . . . . 73.14 109.318 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.5 p -99.17 131.0 45.51 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.176 -0.675 . . . . 51.33 109.176 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -131.34 155.37 47.35 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.2 0.524 . . . . 73.41 111.251 -174.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -153.98 159.35 41.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.135 1.374 . . . . 75.53 108.352 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -139.59 42.23 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 122.043 0.925 . . . . 33.43 109.911 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 m -78.66 100.48 7.04 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.1 -0.955 . . . . 74.34 109.0 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 t -132.79 31.3 3.95 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.829 0.823 . . . . 72.43 110.128 -174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.23 134.65 37.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.212 -0.904 . . . . 70.43 110.898 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.84 111.9 4.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.509 0.724 . . . . 62.35 109.556 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.16 158.18 52.55 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.645 2.23 . . . . 74.34 111.275 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -159.5 167.26 29.06 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.16 0.584 . . . . 63.52 110.65 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -143.84 159.5 42.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.689 0.795 . . . . 74.44 110.291 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 t -127.63 140.21 52.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.555 0.742 . . . . 60.12 109.781 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 p -169.29 137.0 1.83 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.824 0.849 . . . . 43.42 109.877 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.11 125.9 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.353 0.661 . . . . 65.11 110.52 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.37 110.48 58.06 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.376 -0.972 . . . . 73.24 108.376 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 C--N 1.377 2.061 0 C-N-CA 123.256 2.637 . . . . 54.44 113.292 -174.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.845 0.355 . . . . 45.12 110.838 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.04 112.71 24.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.906 0.882 . . . . 75.11 108.944 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 64' ' ' THR . 99.4 t -116.42 138.95 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.68 0.792 . . . . 71.33 109.461 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -132.15 118.12 19.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.614 -0.513 . . . . 63.1 109.614 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.12 107.19 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.342 -0.614 . . . . 72.54 109.342 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 33.6 p90 -118.1 152.26 35.93 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 109.102 -0.703 . . . . 74.43 109.102 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.72 134.44 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.033 -0.728 . . . . 64.31 109.033 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.14 -39.71 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.812 -0.44 . . . . 74.31 109.812 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 p -141.73 -61.32 0.46 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.821 0.448 . . . . 64.41 111.208 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.65 100.69 1.72 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.703 -0.498 . . . . 44.4 112.064 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -88.17 41.45 1.0 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.155 0.982 . . . . 52.11 112.858 -168.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.16 137.34 56.2 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.961 0.505 . . . . 72.34 110.521 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -7.69 58.04 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.529 0.518 . . . . 70.51 113.643 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.32 64.68 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.267 1.027 . . . . 61.03 110.954 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.08 -56.96 14.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.922 -1.035 . . . . 51.35 110.59 171.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.99 67.65 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.518 -0.765 . . . . 74.4 112.568 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -29.92 68.08 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.039 0.935 . . . . 75.13 110.96 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 98' ' ' LEU . 64.4 p -70.13 -36.86 75.1 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 110.085 -0.339 . . . . 63.22 110.085 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB1' ' OG1' ' A' ' 64' ' ' THR . . . -67.3 -28.5 68.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.602 0.761 . . . . 72.23 111.562 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.41 -24.47 62.93 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.015 0.926 . . . . 72.2 110.711 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -70.51 -42.0 71.88 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.906 -0.405 . . . . 72.24 109.906 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.8 mp -69.39 -29.6 67.4 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.806 0.669 . . . . 73.15 112.806 -174.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.46 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.38 -27.47 67.13 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.897 0.38 . . . . 61.53 110.793 175.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.03 27.77 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.028 0.931 . . . . 62.44 111.746 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -89.39 -22.8 22.39 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.304 0.642 . . . . 72.02 112.484 -174.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.47 46.83 0.39 Allowed Glycine 0 C--N 1.352 1.439 0 CA-C-N 117.873 0.306 . . . . 54.51 113.308 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -62.41 158.22 18.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.103 0.961 . . . . 73.5 111.818 176.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.7 m -92.54 -60.72 1.76 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.214 -1.032 . . . . 73.23 108.214 161.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -134.56 140.66 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.611 -1.255 . . . . 71.2 107.611 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t -130.56 127.12 38.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.372 -0.973 . . . . 65.12 108.372 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -122.54 144.55 49.01 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.014 -1.106 . . . . 64.12 108.014 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 m -139.85 143.61 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 122.848 0.459 . . . . 63.54 110.41 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.1 -138.13 4.63 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.016 -0.538 . . . . 63.25 112.16 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -157.96 123.05 4.39 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.265 0.626 . . . . 72.31 110.546 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 10.0 mp -129.12 156.39 43.96 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.188 0.995 . . . . 45.34 108.882 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 p -106.13 100.88 10.4 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.708 0.803 . . . . 50.13 110.055 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -119.16 119.54 31.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 123.818 0.847 . . . . 34.52 109.134 167.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.16 0.33 9.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.757 2.305 . . . . 72.21 112.713 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.0 -26.77 54.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.047 0.939 . . . . 73.51 111.104 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 t -125.56 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.755 -0.832 . . . . 75.24 108.755 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.74 -54.33 2.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.962 0.905 . . . . 35.1 110.488 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.64 160.33 25.08 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.024 0.93 . . . . 62.43 110.436 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 t -64.05 104.67 0.75 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.979 0.895 . . . . 61.32 108.887 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.0 m -136.1 129.84 32.46 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.385 -0.825 . . . . 70.13 110.564 -171.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.73 HG22 HG13 ' A' ' 118' ' ' VAL . 73.5 t -95.18 113.65 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.049 -1.093 . . . . 60.4 108.049 175.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.466 ' CD2' HG12 ' A' ' 117' ' ' ILE . 10.2 t80 -96.98 136.38 37.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.057 -0.72 . . . . 73.44 109.057 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.475 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 25.1 p90 -151.73 -179.49 7.48 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.71 1.256 . . . . 73.0 108.972 172.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 4.3 m -131.7 169.22 16.49 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 106.043 -1.836 . . . . 55.32 106.043 164.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.69 21.25 2.25 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.134 -0.979 . . . . 73.12 111.826 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.45 99.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.259 1.024 . . . . 63.54 109.788 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 64.11 -75.99 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 125.56 1.544 . . . . 74.34 111.88 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.57 39.07 0.51 Allowed Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.013 0.365 . . . . 51.32 114.013 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 82' ' ' THR . 55.4 mt-10 -69.97 -36.45 75.24 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.0 0.429 . . . . 54.22 110.566 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -62.02 -37.75 86.08 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.781 -1.1 . . . . 64.15 112.54 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.77 -25.49 49.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.986 0.514 . . . . 44.33 111.492 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.5 m -78.75 -36.69 42.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.911 0.885 . . . . 74.31 109.677 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -24.38 40.45 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.928 -1.033 . . . . 65.15 111.554 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.09 -39.71 90.96 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.11 0.964 . . . . 53.21 109.977 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -23.98 66.94 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.139 -0.937 . . . . 74.13 111.996 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.675 HG11 HG21 ' A' ' 118' ' ' VAL . 58.1 t -84.34 -61.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 122.872 0.469 . . . . 74.11 111.355 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.415 ' CA ' HG21 ' A' ' 79' ' ' VAL . . . -66.73 -27.73 73.42 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.581 0.55 . . . . 53.14 114.293 -168.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -76.11 -23.46 54.9 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.002 0.521 . . . . 74.32 110.265 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 85.3 m -84.49 -38.69 19.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.621 0.769 . . . . 73.31 111.084 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.655 HD21 HG22 ' A' ' 120' ' ' VAL . 46.0 tp -81.37 -31.88 33.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.782 0.833 . . . . 63.34 111.553 -172.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.67 50.57 5.57 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 111.002 -0.839 . . . . 64.2 111.002 -170.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.59 143.74 51.12 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.53 0.732 . . . . 74.31 110.606 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.48 114.48 3.92 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.962 0.788 . . . . 62.23 110.018 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.475 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 16.1 m -88.13 101.75 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.356 0.598 . . . . 71.42 110.114 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.59 157.24 20.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.518 1.151 . . . . 73.3 111.957 -175.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 8.0 tp -93.2 -166.59 1.55 Allowed 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 112.934 -1.939 . . . . 70.33 108.367 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.503 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 48.7 ttp180 -81.43 27.69 0.42 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.588 0.755 . . . . 74.2 112.542 -175.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.8 mm? -70.87 -66.69 0.73 Allowed Pre-proline 0 CA--C 1.558 1.27 0 CA-C-O 118.045 -0.979 . . . . 71.02 111.053 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 4.5 Cg_exo -83.85 -23.57 3.12 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 121.878 1.719 . . . . 74.34 112.988 -173.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.35 -9.96 59.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.949 -0.548 . . . . 71.32 111.587 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -20.92 66.55 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.849 0.46 . . . . 71.14 110.526 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -55.66 -45.56 77.66 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.442 0.697 . . . . 63.34 110.831 171.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -86.13 -32.44 21.31 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.401 0.68 . . . . 62.14 111.221 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.62 79.15 0.36 Allowed Pre-proline 0 CA--C 1.563 1.446 0 C-N-CA 125.734 1.614 . . . . 63.44 111.033 -169.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 3.6 Cg_exo -84.56 125.64 3.38 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.061 2.508 . . . . 72.11 111.743 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 3.6 Cg_exo -79.12 118.69 4.08 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.35 2.033 . . . . 75.44 110.906 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.07 166.19 39.43 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 112.014 -0.434 . . . . 32.21 112.014 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 80' ' ' TYR . 75.9 t -66.94 126.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.023 0.929 . . . . 73.41 111.481 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.466 HG12 ' CD2' ' A' ' 80' ' ' TYR . 9.4 pt -121.85 111.95 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.162 -1.051 . . . . 62.52 108.162 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.73 HG13 HG22 ' A' ' 79' ' ' VAL . 61.3 t -94.01 108.49 20.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.845 -0.798 . . . . 75.23 108.845 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.47 120.95 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.409 -0.814 . . . . 72.24 109.789 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.655 HG22 HD21 ' A' ' 98' ' ' LEU . 44.7 t -110.28 129.59 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 122.681 0.392 . . . . 73.11 110.763 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 t -99.87 164.56 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.048 0.451 . . . . 73.4 110.745 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.806 0 CA-C-O 118.708 -1.051 . . . . 74.22 111.126 170.267 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 CA-C-O 119.508 -0.607 . . . . 74.55 112.018 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -64.4 126.35 27.54 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.998 0.919 . . . . 42.33 111.456 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -120.33 135.94 24.84 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.667 0.787 . . . . 75.14 109.188 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.25 127.18 20.36 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.007 2.471 . . . . 52.14 111.808 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -91.75 154.77 18.73 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.958 0.903 . . . . 75.05 109.49 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.9 m -56.08 132.38 50.06 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.187 0.995 . . . . 73.23 111.117 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -54.02 -79.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 O-C-N 124.194 0.934 . . . . 71.13 112.009 -170.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -134.69 -74.69 0.47 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.214 -0.662 . . . . 62.51 109.214 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -177.23 132.21 0.17 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.215 1.406 . . . . 74.34 108.196 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.0 m -87.66 134.87 33.57 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.086 0.555 . . . . 74.1 110.15 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -93.53 178.07 5.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.42 0.688 . . . . 53.12 110.108 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.31 156.5 42.97 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.749 0.82 . . . . 74.21 109.666 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 pt -128.52 170.56 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.464 0.706 . . . . 44.41 110.41 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 t -164.63 171.15 14.81 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.211 1.004 . . . . 73.14 109.438 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 p -135.78 163.54 29.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.026 0.93 . . . . 63.41 109.18 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.7 mtt -127.54 131.62 50.03 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.019 0.928 . . . . 51.44 108.698 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.5 p -111.9 141.49 45.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.411 0.684 . . . . 41.41 110.142 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.9 p -127.29 158.74 36.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.806 0.843 . . . . 71.34 110.108 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 t -143.4 162.27 36.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.628 0.771 . . . . 71.23 109.311 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.9 m -149.09 137.72 21.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.306 0.643 . . . . 74.11 109.942 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.51 165.87 12.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.55 0.74 . . . . 55.0 109.861 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.64 136.63 12.48 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.179 0.592 . . . . 73.55 109.884 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.53 139.26 37.17 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.075 2.516 . . . . 73.2 112.867 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 p -102.18 128.14 48.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.994 0.918 . . . . 62.31 109.899 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 m -87.88 121.98 30.96 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.569 0.748 . . . . 70.03 109.582 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 m -136.23 124.43 23.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.081 0.952 . . . . 55.41 109.066 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.2 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.044 0.938 . . . . 34.04 109.755 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.42 140.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.693 0.797 . . . . 55.02 109.525 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.98 136.88 19.65 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.096 0.959 . . . . 61.44 109.448 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.26 149.33 45.98 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.22 2.613 . . . . 60.25 113.841 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.93 161.55 18.98 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.995 0.918 . . . . 32.25 111.112 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.05 121.64 33.53 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 123.629 0.772 . . . . 71.31 110.312 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.14 136.14 46.55 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.209 2.606 . . . . 74.24 111.554 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -82.5 -86.19 0.1 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.103 0.561 . . . . 75.14 111.143 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.23 132.21 27.77 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.069 0.548 . . . . 71.32 109.88 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.18 149.34 26.01 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.32 0.581 . . . . 64.24 110.799 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG21 HD21 ' A' ' 56' ' ' LEU . 48.1 t -114.9 146.57 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.312 1.045 . . . . 71.23 108.84 172.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.0 ptp180 -145.18 117.02 8.21 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.225 0.536 . . . . 53.01 111.571 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.52 111.9 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.311 0.644 . . . . 62.52 109.774 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 33.7 m-85 -101.08 118.76 37.63 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.187 0.595 . . . . 73.54 109.856 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 120' ' ' VAL . 4.6 t-20 -95.9 125.36 40.4 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.345 -1.354 . . . . 71.04 107.345 169.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.769 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.6 tt -80.39 -34.06 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 111.931 0.345 . . . . 71.53 111.931 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -111.43 -20.52 12.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.689 0.396 . . . . 75.23 111.511 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.9 114.92 0.62 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.808 -0.517 . . . . 74.21 111.808 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.441 HG22 HD21 ' A' ' 41' ' ' ASN . 13.2 t -145.15 -155.67 0.63 Allowed 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.059 -0.719 . . . . 64.24 109.059 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.98 154.78 25.52 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.587 1.155 . . . . 72.31 112.477 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.33 -1.8 16.56 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 115.455 -0.793 . . . . 74.25 114.691 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.69 59.75 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.028 0.931 . . . . 74.13 111.58 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.26 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.354 -0.839 . . . . 63.1 110.863 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB2' HG21 ' A' ' 66' ' ' VAL . . . -71.3 -20.47 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.465 0.706 . . . . 75.03 111.753 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -28.97 69.07 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.603 0.761 . . . . 74.3 111.354 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.492 ' HB ' HG13 ' A' ' 94' ' ' VAL . 68.5 p -62.87 -40.99 99.19 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.486 0.492 . . . . 74.53 110.346 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 64' ' ' THR . . . -66.27 -37.41 85.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.055 0.942 . . . . 74.24 111.809 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -65.44 -51.73 58.12 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.584 -0.735 . . . . 74.41 110.946 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -67.76 -26.22 66.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.572 -1.194 . . . . 73.55 110.836 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 37' ' ' VAL . 18.3 tp -76.3 -49.85 15.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.949 -1.023 . . . . 62.21 111.198 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 34.9 ttpt -63.19 -35.82 81.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.915 0.486 . . . . 74.31 110.685 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -22.49 62.14 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 54.22 111.341 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.67 57.83 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.413 0.685 . . . . 75.44 111.36 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.37 41.17 0.98 Allowed Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.445 -0.343 . . . . 75.53 113.069 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -106.25 156.9 18.0 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.304 0.642 . . . . 74.21 109.927 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.4 m -66.95 -69.48 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.275 0.984 . . . . 53.33 111.361 -161.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.29 136.76 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.188 -1.042 . . . . 72.21 108.188 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.48 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 73.7 p -129.55 94.9 3.87 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.937 -0.764 . . . . 61.13 108.937 172.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -103.63 131.56 50.67 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.644 0.778 . . . . 72.15 109.663 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 50' ' ' ALA . 6.4 p -116.3 131.11 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 121.712 -0.617 . . . . 75.31 110.638 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -150.27 159.76 28.25 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.648 -0.705 . . . . 54.24 111.618 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -95.04 119.8 34.17 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.744 -0.836 . . . . 33.43 108.744 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.5 tt -150.64 133.93 16.25 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.004 -1.11 . . . . 74.32 108.004 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.769 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.9 m -80.85 100.07 8.64 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.361 0.665 . . . . 73.33 109.882 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.61 106.21 8.87 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.166 -0.679 . . . . 54.45 109.166 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.71 0.47 9.99 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.695 2.263 . . . . 71.23 112.465 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -95.83 -23.4 16.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.249 1.019 . . . . 74.31 110.647 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.762 HG21 HG11 ' A' ' 119' ' ' VAL . 14.3 m -97.27 155.49 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.291 0.636 . . . . 74.34 109.865 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.29 9.28 2.28 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.702 0.801 . . . . 73.11 110.586 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.46 156.51 33.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.74 1.216 . . . . 70.43 108.611 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -59.2 111.89 1.51 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.053 -0.721 . . . . 74.14 109.053 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.8 m -138.45 127.95 24.72 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 115.313 -0.858 . . . . 63.33 110.611 -168.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 118' ' ' VAL . 50.3 t -102.4 113.19 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.784 -1.191 . . . . 72.13 107.784 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 117' ' ' ILE . 1.4 t80 -98.87 142.47 30.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.969 1.308 . . . . 73.21 109.926 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 22.5 p90 -133.06 164.56 26.74 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.459 -0.792 . . . . 72.32 111.2 168.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.1 m -107.48 172.41 6.84 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 106.895 -1.521 . . . . 74.1 106.895 163.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.53 28.41 8.76 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.91 0.484 . . . . 62.22 111.176 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 84.6 t -77.17 126.25 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.416 -0.957 . . . . 74.32 108.416 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 60.92 -80.48 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.267 1.027 . . . . 73.34 110.912 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.56 35.6 0.23 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.9 -0.48 . . . . 74.44 111.9 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 48.9 mt-10 -61.8 -19.64 62.74 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.172 0.589 . . . . 73.22 112.269 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' CG ' ' A' ' 81' ' ' TYR . 41.0 ptt85 -63.08 -28.8 70.33 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.287 0.477 . . . . 65.32 112.287 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.37 82.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.723 0.809 . . . . 63.52 111.798 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.7 t -67.67 -46.52 72.13 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.422 -0.354 . . . . 74.22 111.151 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 81' ' ' TYR . . . -71.98 -27.72 62.94 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.744 0.417 . . . . 53.04 111.934 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.04 -33.8 76.91 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.529 0.732 . . . . 73.3 110.496 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.42 -47.64 19.26 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.662 -0.699 . . . . 72.21 110.509 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.492 HG13 ' HB ' ' A' ' 52' ' ' THR . 98.8 t -68.95 -33.66 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.468 0.707 . . . . 72.43 111.757 -175.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -58.54 -29.08 63.3 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.347 -0.388 . . . . 72.43 112.561 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -86.96 -30.89 20.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.282 0.633 . . . . 74.25 111.018 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.2 m -64.34 -43.24 95.23 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.644 0.735 . . . . 65.35 110.546 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.486 HD21 HG22 ' A' ' 120' ' ' VAL . 57.3 tp -85.29 -32.15 22.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.59 -1.186 . . . . 70.45 110.204 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 66.8 1.96 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.432 -1.067 . . . . 63.52 110.432 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.97 166.44 24.47 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.553 1.141 . . . . 44.52 110.359 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.32 110.99 7.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.429 0.691 . . . . 64.05 109.325 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.623 HG22 ' HA3' ' A' ' 95' ' ' GLY . 5.4 t -86.63 134.03 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.26 -1.015 . . . . 73.24 108.26 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -140.39 153.12 46.23 Favored 'General case' 0 C--O 1.248 1.021 0 CA-C-O 121.402 0.62 . . . . 62.34 111.013 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.415 ' HA ' ' CE1' ' A' ' 81' ' ' TYR . 6.2 mp -76.78 -163.62 0.36 Allowed 'General case' 0 C--N 1.348 0.512 0 CA-C-N 114.342 -1.299 . . . . 41.35 110.331 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -70.63 28.61 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 72.45 112.823 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 33.8 tp -70.88 -48.72 14.49 Favored Pre-proline 0 CA--C 1.568 1.641 0 O-C-N 121.601 -0.687 . . . . 72.1 111.265 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 106' ' ' LEU . 51.0 Cg_exo -58.39 -12.91 14.87 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 122.819 2.346 . . . . 74.44 114.006 170.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -66.37 -35.08 79.42 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.25 0.62 . . . . 52.11 109.651 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.1 tp -82.7 -34.15 27.4 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.911 0.386 . . . . 75.31 110.098 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 m -68.62 -48.78 63.21 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.454 -0.793 . . . . 52.44 111.335 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -126.86 -33.99 2.42 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.635 0.774 . . . . 64.35 111.554 -172.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.91 72.96 0.33 Allowed Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.766 1.226 . . . . 63.32 109.503 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.549 ' HB3' HD13 ' A' ' 117' ' ' ILE . 5.9 Cg_exo -81.92 148.38 15.43 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 123.407 2.738 . . . . 71.34 112.148 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.72 119.2 5.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.284 2.656 . . . . 63.44 112.938 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.17 -113.33 5.75 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.927 0.767 . . . . 54.13 112.867 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 37' ' ' VAL . 39.1 t -116.45 136.87 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.964 1.306 . . . . 71.31 108.098 173.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.584 HG22 ' HG3' ' A' ' 38' ' ' ARG . 11.8 pt -128.68 149.95 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.304 -0.628 . . . . 74.12 109.304 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 79' ' ' VAL . 59.2 t -117.54 102.18 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.114 -1.439 . . . . 72.43 107.114 175.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.762 HG11 HG21 ' A' ' 74' ' ' VAL . 23.8 t -94.18 126.04 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.108 -0.701 . . . . 53.22 109.108 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.519 ' HB ' ' ND2' ' A' ' 41' ' ' ASN . 21.5 t -115.82 128.09 73.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.558 -0.904 . . . . 62.53 108.558 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.419 HG22 HG21 ' A' ' 42' ' ' ILE . 19.7 p -95.17 137.48 34.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.214 0.605 . . . . 75.5 109.492 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 119.022 -0.877 . . . . 73.44 111.96 -177.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.585 -0.206 . . . . 73.35 112.585 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 p -87.92 14.77 8.21 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.856 0.862 . . . . 72.35 112.659 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -110.14 97.07 28.56 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.481 0.712 . . . . 70.22 109.729 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -94.1 -161.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.506 2.804 . . . . 70.43 112.062 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -148.03 144.45 27.93 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.466 0.706 . . . . 53.0 109.692 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.9 m 52.57 77.71 0.15 Allowed 'General case' 0 C--N 1.358 0.958 0 C-N-CA 125.075 1.35 . . . . 74.51 111.764 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.64 -44.57 85.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.316 1.047 . . . . 61.42 111.002 -175.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -123.82 -69.83 0.79 Allowed 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.137 -0.938 . . . . 64.1 108.77 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.6 t70 56.38 90.5 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.593 1.157 . . . . 63.12 111.985 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.6 m -143.13 122.16 12.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.217 0.607 . . . . 71.44 109.623 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 p -130.42 111.02 11.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.225 1.01 . . . . 63.24 109.066 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.15 113.35 1.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.075 0.55 . . . . 74.12 109.756 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -150.8 114.39 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.726 0.81 . . . . 71.12 109.708 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -133.59 120.37 20.64 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.081 0.952 . . . . 65.04 108.636 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -151.79 109.22 3.6 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.743 0.817 . . . . 74.33 109.395 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.42 145.38 11.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.295 1.038 . . . . 74.22 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 142.85 24.79 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.098 0.475 . . . . 75.35 111.001 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 p -139.95 131.01 26.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 74.33 109.107 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -157.41 137.4 12.51 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.048 0.939 . . . . 74.12 109.311 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.7 m -147.56 102.95 3.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.426 0.69 . . . . 74.24 109.593 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.83 107.97 19.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.464 0.706 . . . . 65.3 109.261 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.26 111.7 44.92 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.589 0.756 . . . . 73.35 109.747 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.59 169.46 15.3 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.967 2.444 . . . . 63.41 112.304 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -152.86 119.99 5.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.583 0.753 . . . . 71.44 109.545 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 m -90.41 172.3 8.83 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.994 0.517 . . . . 54.12 109.836 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 m -132.04 144.22 50.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.119 0.568 . . . . 54.42 110.655 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 161.93 27.19 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.484 1.114 . . . . 63.44 110.145 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.89 140.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.103 0.561 . . . . 73.2 109.803 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.44 113.18 64.7 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.416 -0.957 . . . . 73.44 108.416 177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.67 134.57 22.34 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.494 2.129 . . . . 74.41 111.511 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.49 114.39 21.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.487 0.715 . . . . 55.34 110.011 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.48 116.15 44.53 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.158 0.583 . . . . 73.34 110.406 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.08 150.29 33.46 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.573 2.182 . . . . 71.34 111.483 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' N ' HG21 ' A' ' 62' ' ' THR . 67.8 ttt180 -158.92 -75.49 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.149 0.28 . . . . 75.33 110.833 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.2 98.32 7.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.569 0.748 . . . . 61.33 109.99 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -98.77 107.74 20.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.038 0.535 . . . . 65.32 110.044 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 56' ' ' LEU . 22.1 t -95.64 135.89 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.194 0.598 . . . . 61.22 109.742 175.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HD3' ' HE2' ' A' ' 40' ' ' TYR . 7.9 ptp180 -150.74 134.85 16.84 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.854 0.861 . . . . 74.25 110.573 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 118' ' ' VAL . 41.0 t -100.5 133.28 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 55.31 109.545 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.53 ' HE2' ' HD3' ' A' ' 38' ' ' ARG . 69.6 m-85 -130.12 107.77 9.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.683 0.793 . . . . 73.3 109.735 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -84.39 118.03 23.99 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.988 -0.745 . . . . 72.03 108.988 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.708 HG13 ' HA ' ' A' ' 70' ' ' SER . 17.0 tt -78.86 -33.21 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 110.113 -0.329 . . . . 62.25 110.113 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -99.1 -162.48 0.96 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.18 0.992 . . . . 53.42 109.619 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.71 116.12 8.5 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 123.575 0.547 . . . . 71.24 112.312 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -69.96 101.63 1.82 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.738 0.78 . . . . 73.05 110.692 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.77 145.53 27.2 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.999 -0.546 . . . . 64.34 109.862 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -58.02 -38.41 89.12 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 124.42 1.075 . . . . 55.04 114.377 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.61 68.43 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.775 0.83 . . . . 24.33 112.398 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -32.71 71.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.715 0.806 . . . . 72.3 111.731 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.41 -23.62 37.45 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.318 0.647 . . . . 74.13 111.441 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 41.9 mmm-85 -64.75 -21.71 66.82 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.141 0.577 . . . . 63.13 112.004 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' HD13 ' A' ' 56' ' ' LEU . 80.5 p -61.54 -45.97 91.91 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.905 0.482 . . . . 60.1 110.052 173.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.9 84.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.66 0.784 . . . . 55.03 111.363 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -42.49 95.91 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 124.181 0.926 . . . . 74.53 111.968 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -63.2 -46.21 88.1 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.852 -0.613 . . . . 74.32 110.636 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 37' ' ' VAL . 10.5 mp -72.68 -26.85 61.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.506 -0.77 . . . . 51.31 111.634 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.16 -51.17 62.74 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.076 -1.083 . . . . 75.41 108.076 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.99 59.38 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.708 -1.133 . . . . 72.13 112.128 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.76 -22.45 37.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.054 0.542 . . . . 74.35 110.571 173.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.89 44.03 5.54 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.054 -0.521 . . . . 22.11 113.782 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.65 158.64 30.91 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.635 0.774 . . . . 72.14 109.448 169.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.421 HG21 ' N ' ' A' ' 34' ' ' ARG . 24.3 m -58.02 -52.29 66.11 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.165 0.916 . . . . 74.53 111.302 -159.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.72 139.55 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.328 -0.99 . . . . 63.32 108.328 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 p -134.68 113.77 12.03 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.351 1.061 . . . . 74.01 108.485 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 22.8 t70 -128.38 154.91 45.5 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.817 0.847 . . . . 55.14 109.373 -171.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.62 153.66 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.392 0.615 . . . . 73.12 110.503 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.42 169.96 42.32 Favored Glycine 0 C--O 1.245 0.806 0 CA-C-N 114.783 -1.099 . . . . 55.32 110.51 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -146.32 116.61 7.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.262 -1.014 . . . . 54.33 108.262 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 mt -148.89 136.35 20.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.693 0.797 . . . . 73.44 109.411 -170.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.708 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 m -76.52 97.94 4.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.404 -0.961 . . . . 52.35 108.404 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.8 119.8 70.0 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.861 -0.792 . . . . 71.31 108.861 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.76 -2.92 12.86 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.267 1.978 . . . . 70.41 112.712 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.09 -26.16 17.58 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.003 0.921 . . . . 73.21 111.829 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 76' ' ' ALA . 7.3 p -138.08 140.21 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.308 0.643 . . . . 73.14 110.189 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.3 33.21 3.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.336 0.654 . . . . 74.35 110.073 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' H ' HG22 ' A' ' 74' ' ' VAL . . . -135.14 149.87 50.07 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.527 0.731 . . . . 53.44 109.848 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.586 ' HB ' ' H ' ' A' ' 121' ' ' THR . 5.6 t -78.89 102.49 8.26 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-O 121.972 0.891 . . . . 74.3 108.73 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.5 m -149.8 143.35 25.31 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.169 -0.923 . . . . 61.53 108.971 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 23.2 t -93.92 114.05 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.527 -1.286 . . . . 74.35 107.527 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' HB2' HG12 ' A' ' 117' ' ' ILE . 96.8 m-85 -101.08 142.52 32.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.629 -1.249 . . . . 73.43 107.629 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -130.73 151.95 50.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.629 -0.508 . . . . 72.44 109.629 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.413 HG22 HG23 ' A' ' 84' ' ' VAL . 28.0 m -92.37 147.1 23.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.526 -1.287 . . . . 74.43 107.526 168.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.34 22.74 1.2 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.396 0.678 . . . . 74.44 112.661 -173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.413 HG23 HG22 ' A' ' 82' ' ' THR . 84.3 t -62.31 99.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.067 -0.716 . . . . 71.31 109.067 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.25 12.6 2.64 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.445 1.098 . . . . 62.34 112.182 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.32 62.65 2.05 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 120.243 -0.198 . . . . 72.24 113.401 -173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.71 -16.74 51.75 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.38 0.672 . . . . 73.31 111.524 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -26.1 6.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.047 0.939 . . . . 74.33 112.758 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.51 -53.21 60.73 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.774 0.671 . . . . 71.23 111.148 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.8 t -74.34 -32.61 62.87 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 116.293 -0.412 . . . . 62.12 110.694 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.56 75.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.393 0.677 . . . . 74.44 112.241 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.495 ' HA ' HG11 ' A' ' 102' ' ' VAL . 29.2 t70 -64.96 -43.13 93.68 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.219 1.008 . . . . 63.31 110.01 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.38 80.15 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.366 1.041 . . . . 70.32 111.846 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 90' ' ' THR . 65.3 t -64.58 -56.4 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 123.649 0.593 . . . . 74.31 110.389 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.72 67.55 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.89 0.744 . . . . 72.23 113.842 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -69.63 -47.16 64.35 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.256 1.022 . . . . 74.04 109.666 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.6 m -75.81 -35.92 59.89 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.972 -1.013 . . . . 72.44 111.03 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.01 -30.49 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.569 -0.741 . . . . 75.03 110.193 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.01 55.53 4.38 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.447 -0.661 . . . . 62.34 111.447 -175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.1 160.76 39.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.64 0.776 . . . . 74.44 110.266 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 142.18 52.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.065 0.946 . . . . 50.11 110.442 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 92' ' ' ASP . 35.9 m -103.11 131.45 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.48 -0.933 . . . . 61.44 108.48 171.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 49.5 mt-10 -140.83 159.73 41.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.478 1.111 . . . . 74.31 109.528 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.48 158.61 35.76 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.225 -0.657 . . . . 74.01 109.225 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.591 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 14.0 ptt180 -50.06 -41.74 48.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.044 1.338 . . . . 73.31 112.585 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.9 mt 67.34 158.76 0.14 Allowed Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 123.533 0.733 . . . . 72.02 110.222 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.36 -24.14 41.46 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.41 2.073 . . . . 72.43 113.701 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.2 -54.97 6.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.277 1.031 . . . . 61.53 111.54 -174.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 2.7 mm? -76.47 -20.14 57.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 116.508 -0.314 . . . . 74.1 110.258 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -69.02 -11.54 60.88 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.041 0.536 . . . . 74.53 111.856 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.34 -32.2 19.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.388 0.675 . . . . 75.13 110.713 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.485 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.5 pp0? -89.57 168.04 16.01 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 117.639 -1.172 . . . . 44.41 109.0 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 30.3 Cg_exo -29.34 122.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.406 3.568 1 C-N-CA 125.309 4.006 . . . . 63.13 116.685 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.11 161.12 47.03 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.15 2.567 . . . . 75.25 113.07 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.29 -158.95 14.04 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.253 -0.885 . . . . 64.52 111.207 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 70.7 t -83.54 108.35 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.891 0.877 . . . . 52.34 109.626 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.624 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.31 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.592 -0.892 . . . . 61.54 108.592 173.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.529 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.4 p -95.53 105.25 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.447 -0.946 . . . . 61.22 108.447 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 4.0 p -94.07 123.48 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.619 -0.882 . . . . 75.25 108.619 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.65 132.51 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.397 0.679 . . . . 73.5 109.946 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.586 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.0 t -119.89 151.61 38.63 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.058 -1.09 . . . . 62.42 108.058 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.297 0 CA-C-O 118.978 -0.901 . . . . 71.13 112.147 178.563 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.992 0 N-CA-C 112.008 -0.437 . . . . 32.21 112.008 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -86.38 80.06 8.81 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.445 0.698 . . . . 63.52 109.231 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 m -100.24 110.19 59.04 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 115.432 -0.804 . . . . 73.23 110.192 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.39 82.82 1.99 Allowed 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.179 1.919 . . . . 53.55 111.493 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -118.55 121.61 40.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.751 -0.659 . . . . 70.31 109.424 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.7 m -76.3 146.25 39.02 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.197 0.599 . . . . 53.22 110.497 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.17 -38.29 82.75 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.04 0.936 . . . . 75.51 111.055 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.29 -73.33 0.16 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.493 -0.776 . . . . 65.2 109.307 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.6 t70 61.49 151.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.08 1.352 . . . . 73.24 112.553 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.3 m -113.49 102.66 10.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.84 0.856 . . . . 65.12 109.76 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.5 t -71.43 104.75 3.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.379 -0.828 . . . . 61.52 108.941 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.63 118.36 4.99 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.372 0.669 . . . . 61.23 110.134 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.95 155.99 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.292 1.037 . . . . 61.14 109.138 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.4 m -150.89 144.15 24.81 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.919 0.887 . . . . 73.42 109.386 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -160.88 160.85 31.49 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.878 0.871 . . . . 72.21 110.272 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 53.2 ttp -171.76 113.28 0.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.78 -1.193 . . . . 74.04 107.78 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -61.45 114.11 3.04 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.253 0.621 . . . . 73.34 110.563 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -70.22 -41.75 73.2 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.401 0.68 . . . . 52.41 111.393 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.2 m 68.55 152.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.981 1.313 . . . . 74.42 110.946 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.3 t -158.67 174.69 14.66 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.093 0.557 . . . . 72.51 110.329 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.18 148.87 28.77 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.113 0.965 . . . . 43.51 109.415 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.69 107.2 34.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 108.896 -0.779 . . . . 53.01 108.896 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.99 132.22 3.26 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.761 2.307 . . . . 73.02 112.472 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.3 p -123.21 124.34 42.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.877 0.471 . . . . 72.12 110.643 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m -149.02 118.23 6.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.495 1.118 . . . . 72.35 108.027 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 p -132.82 145.69 51.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.045 0.938 . . . . 74.53 109.216 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.3 p -144.91 120.15 10.18 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.182 0.593 . . . . 73.33 110.102 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 139.67 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.54 -0.911 . . . . 63.31 108.54 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.55 157.55 41.13 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 123.344 0.658 . . . . 73.25 110.322 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.71 170.07 13.32 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.062 2.508 . . . . 72.01 113.042 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.61 168.63 19.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.924 0.89 . . . . 75.23 111.129 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.21 146.25 37.73 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.921 -0.582 . . . . 72.24 109.899 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.53 172.2 16.77 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.617 2.211 . . . . 45.42 112.363 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -97.03 158.12 15.58 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.272 1.029 . . . . 64.22 112.269 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 90' ' ' THR . . . -174.15 82.55 0.04 OUTLIER 'General case' 0 C--N 1.35 0.597 0 C-N-CA 125.12 1.368 . . . . 52.24 108.358 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.676 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -95.86 87.8 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.581 . . . . 61.12 109.616 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 94' ' ' VAL . 47.1 t -117.59 142.12 33.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.184 -0.462 . . . . 71.1 110.782 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -143.6 158.52 43.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.293 -0.412 . . . . 72.52 111.383 172.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.08 129.11 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.37 0.668 . . . . 63.42 110.244 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 19.0 m-85 -109.86 107.83 17.93 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.316 1.046 . . . . 73.34 108.323 163.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -93.31 112.73 24.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.169 -1.789 . . . . 75.34 106.169 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.671 HG13 ' HA ' ' A' ' 70' ' ' SER . 13.5 tt -73.11 -45.21 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.037 -0.414 . . . . 64.4 111.33 -172.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -29.41 28.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.505 0.722 . . . . 72.02 110.591 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.33 54.28 13.95 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 123.734 0.646 . . . . 72.42 113.016 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -139.99 -36.54 0.49 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.91 0.484 . . . . 72.23 110.584 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' A' ' 49' ' ' ALA . 10.1 tp10 -63.77 121.81 14.9 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.403 0.52 . . . . 75.03 112.403 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.75 -23.8 51.8 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.861 -0.608 . . . . 73.43 112.291 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 52' ' ' THR . . . -65.09 -27.07 68.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.157 0.583 . . . . 53.04 110.852 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' H ' ' HG3' ' A' ' 46' ' ' GLU . . . -57.17 -47.34 81.46 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 124.032 0.833 . . . . 74.54 110.931 173.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.22 77.45 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.73 -0.668 . . . . 73.25 111.368 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -69.99 -22.68 63.11 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.326 1.051 . . . . 74.12 111.139 -172.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.54 ' HB ' HG13 ' A' ' 94' ' ' VAL . 75.5 p -67.98 -49.82 59.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.262 0.225 . . . . 61.12 111.488 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -22.03 61.63 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.233 0.539 . . . . 62.14 111.209 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.94 -47.83 60.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.819 1.247 . . . . 65.4 110.512 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -70.71 -30.86 67.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.654 -0.498 . . . . 71.34 109.654 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HG22 ' A' ' 64' ' ' THR . 53.4 tp -66.16 -33.29 75.45 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.337 -0.847 . . . . 73.45 111.295 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 11.4 tmtt? -58.4 -43.13 88.46 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 108.725 -0.843 . . . . 62.52 108.725 174.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.3 -18.88 54.65 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.211 1.004 . . . . 71.34 112.319 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.34 42.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.764 0.826 . . . . 55.21 112.038 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.12 46.72 0.69 Allowed Glycine 0 C--N 1.348 1.232 0 O-C-N 123.106 0.254 . . . . 60.23 112.503 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 3.6 p90 -60.4 158.04 12.72 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.518 1.127 . . . . 71.14 112.145 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 m -109.69 -43.52 4.03 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.714 -0.847 . . . . 64.1 108.714 164.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.676 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 83.3 t -135.63 128.37 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.194 0.998 . . . . 73.55 108.597 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.482 HG22 HD23 ' A' ' 56' ' ' LEU . 3.2 p -130.31 116.79 18.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.574 1.149 . . . . 52.53 108.534 173.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 16.0 t70 -121.19 158.76 27.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.419 -0.956 . . . . 71.12 108.419 172.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.24 140.1 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.452 0.701 . . . . 73.11 109.986 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.87 146.5 11.36 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.725 -0.55 . . . . 61.1 111.725 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.11 113.1 26.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.532 0.733 . . . . 70.04 109.481 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 5.4 mp -145.22 136.05 24.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.97 -0.456 . . . . 71.01 110.303 -172.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.671 ' HA ' HG13 ' A' ' 42' ' ' ILE . 26.9 p -73.64 99.96 3.23 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 123.853 0.721 . . . . 73.23 109.722 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HB2' HG22 ' A' ' 74' ' ' VAL . 62.2 mt -93.17 123.75 59.96 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.926 -0.398 . . . . 62.41 109.926 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.71 -6.6 16.21 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.067 2.511 . . . . 75.34 113.853 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -90.06 -23.61 21.39 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.0 0.52 . . . . 63.35 110.676 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 119' ' ' VAL . 28.9 m -104.0 148.14 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.641 0.734 . . . . 73.4 110.901 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.09 13.29 1.63 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.452 -1.249 . . . . 75.41 109.024 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.02 154.74 26.25 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.984 1.314 . . . . 74.02 108.366 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -71.93 111.73 7.43 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.05 0.54 . . . . 75.22 109.993 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -144.28 134.21 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.683 0.793 . . . . 54.22 111.166 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.675 HG22 HG23 ' A' ' 118' ' ' VAL . 21.0 t -99.28 117.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.304 1.042 . . . . 71.4 109.173 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HE1' HD12 ' A' ' 106' ' ' LEU . 92.0 m-85 -94.89 120.06 34.48 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 109.155 -0.684 . . . . 74.1 109.155 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.648 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 11.4 p90 -134.53 175.54 9.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.899 0.857 . . . . 70.53 111.623 175.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 m -139.13 161.3 37.73 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.138 -1.43 . . . . 75.52 107.138 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -92.27 30.46 1.46 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.051 0.54 . . . . 61.54 111.369 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.64 100.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 123.655 0.782 . . . . 60.11 109.489 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 69.03 -75.33 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.808 1.243 . . . . 74.42 111.417 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.61 22.95 1.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.384 -0.371 . . . . 63.42 112.718 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.73 -28.6 65.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.998 0.519 . . . . 60.21 111.847 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 2.2 tmt_? -66.41 -48.24 70.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.051 -0.722 . . . . 73.43 109.051 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.87 -38.16 85.81 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.715 0.806 . . . . 72.13 111.535 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.64 HG21 ' HB1' ' A' ' 35' ' ' ALA . 28.4 m -66.64 -49.0 67.64 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 64.34 109.721 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.5 -32.3 73.56 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.744 -1.116 . . . . 42.25 112.763 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.82 -43.72 97.85 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.171 0.919 . . . . 73.42 110.031 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.58 98.65 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.146 0.904 . . . . 75.32 111.325 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.54 HG13 ' HB ' ' A' ' 52' ' ' THR . 86.3 t -64.35 -53.57 41.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 C-N-CA 124.202 1.001 . . . . 75.52 111.45 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.517 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -71.96 -21.79 78.96 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.29 -0.868 . . . . 54.41 113.463 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -73.81 -41.92 61.67 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.38 -0.6 . . . . 74.01 109.38 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -61.46 -39.82 92.26 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.409 -0.814 . . . . 70.52 110.942 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 100' ' ' ALA . 2.6 tm? -74.91 -35.77 62.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.822 0.449 . . . . 73.23 110.812 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.55 51.84 7.9 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.275 -0.73 . . . . 75.03 111.275 -166.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.765 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -109.37 168.0 9.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.425 1.09 . . . . 62.53 109.996 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.39 104.02 5.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.954 -0.758 . . . . 75.4 108.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.648 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.3 m -83.35 130.97 34.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.281 -1.007 . . . . 64.13 108.281 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -153.46 159.79 42.41 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.372 0.606 . . . . 54.04 110.875 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.29 -178.01 0.16 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.981 1.313 . . . . 74.42 111.731 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 106' ' ' LEU . 8.4 ptm180 -53.92 -43.52 69.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.84 0.856 . . . . 73.11 112.91 -174.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.436 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 77.3 mt 62.4 167.32 0.1 OUTLIER Pre-proline 0 CA--C 1.566 1.578 0 C-N-CA 124.501 1.12 . . . . 73.11 111.591 -172.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.08 -17.61 39.19 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.302 2.001 . . . . 74.34 113.0 167.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -70.16 -26.11 63.76 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.876 0.87 . . . . 73.14 111.606 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 tt -65.95 -23.54 66.63 Favored 'General case' 0 C--N 1.365 1.244 0 N-CA-C 111.78 0.289 . . . . 51.42 111.78 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.0 m -60.03 -36.62 77.65 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.181 0.592 . . . . 64.41 110.893 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -85.05 -32.31 22.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.838 0.855 . . . . 33.25 111.261 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -80.0 157.46 73.69 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.587 0.755 . . . . 72.23 109.176 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 26.1 Cg_exo -64.14 125.53 15.39 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.12 1.88 . . . . 63.1 111.389 170.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 56.5 Cg_exo -53.62 120.27 7.56 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.357 2.705 . . . . 74.53 113.706 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.74 -178.39 22.62 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.284 -1.126 . . . . 73.43 110.284 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.5 123.82 34.81 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-O 121.178 0.513 . . . . 63.4 110.849 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.53 135.52 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.105 -1.072 . . . . 74.12 108.105 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.675 HG23 HG22 ' A' ' 79' ' ' VAL . 2.4 p -105.24 106.0 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.388 -1.338 . . . . 73.34 107.388 170.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 74' ' ' VAL . 15.8 t -93.35 121.97 44.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.954 -0.758 . . . . 73.24 108.954 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 98' ' ' LEU . 41.1 t -116.99 129.47 73.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.164 0.986 . . . . 61.34 109.583 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -91.56 162.29 14.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.909 0.756 . . . . 73.22 110.273 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.592 0 CA-C-N 115.485 -0.78 . . . . 70.2 113.435 -179.271 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.973 0 N-CA-C 112.553 -0.219 . . . . 64.14 112.553 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 p -152.79 65.94 0.8 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.07 0.948 . . . . 34.21 109.892 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -63.84 133.4 95.55 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.896 0.878 . . . . 72.14 110.978 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.25 156.47 55.1 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.689 2.259 . . . . 73.14 111.962 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 147.42 28.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.054 0.542 . . . . 71.35 110.404 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.1 t -168.82 41.93 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.532 1.133 . . . . 74.52 109.004 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.64 -9.43 56.99 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.892 0.877 . . . . 30.34 111.6 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -44.25 -57.59 3.38 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.342 1.457 . . . . 72.22 112.855 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 57.72 99.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.608 1.163 . . . . 72.52 111.864 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.9 m -84.65 89.36 7.46 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.035 -0.415 . . . . 74.35 111.032 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -119.45 133.52 55.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.776 0.83 . . . . 72.44 109.546 172.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 148.62 24.71 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.87 0.868 . . . . 64.42 109.944 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -156.61 134.67 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.241 0.616 . . . . 73.34 109.952 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.5 p -146.05 166.4 26.2 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.308 0.643 . . . . 72.01 110.469 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -156.55 162.55 39.91 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.103 0.961 . . . . 74.33 109.769 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.01 146.07 32.64 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.35 0.66 . . . . 62.24 110.704 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.0 m -147.21 135.38 21.54 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 70.11 110.393 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.9 m -97.27 148.26 23.29 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.451 1.1 . . . . 72.45 110.824 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -126.17 100.64 6.41 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.266 1.027 . . . . 73.3 108.353 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 t -77.3 149.0 35.39 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.975 0.51 . . . . 74.11 110.905 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.71 167.85 16.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.551 0.74 . . . . 73.22 110.847 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . . . -91.14 146.08 32.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.659 0.783 . . . . 50.42 110.845 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 22' ' ' ALA . 11.8 Cg_exo -71.46 166.34 29.64 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.986 2.457 . . . . 75.25 112.646 177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 t -157.66 154.76 28.88 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.968 0.507 . . . . 71.43 111.04 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.8 m -146.64 130.36 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.983 0.913 . . . . 74.3 109.61 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 p -120.44 151.1 39.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.941 0.896 . . . . 63.11 110.314 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 p -158.69 146.48 18.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.666 0.786 . . . . 33.4 109.871 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.54 155.55 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.642 0.777 . . . . 70.44 109.783 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -107.64 140.75 21.87 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.652 0.781 . . . . 71.1 110.213 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -83.7 145.99 11.75 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.16 2.573 . . . . 73.21 113.054 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.49 168.67 12.41 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.71 0.804 . . . . 45.24 111.723 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.12 142.23 42.46 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 124.185 0.994 . . . . 63.24 109.969 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.42 128.93 19.14 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.504 2.136 . . . . 64.33 112.298 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.521 ' HB3' ' HG2' ' A' ' 85' ' ' GLU . 69.3 mtt85 -77.59 -71.35 0.42 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.664 0.786 . . . . 63.43 110.851 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.57 127.98 5.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.989 -0.745 . . . . 55.23 108.989 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -118.53 132.8 56.21 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.716 0.806 . . . . 73.2 109.568 -173.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HA ' HG13 ' A' ' 116' ' ' VAL . 12.1 t -95.78 142.36 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.961 0.904 . . . . 71.42 110.225 -175.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.501 ' HG3' HG22 ' A' ' 117' ' ' ILE . 7.9 ptm180 -151.23 126.4 9.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.096 0.406 . . . . 74.3 112.096 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 118' ' ' VAL . 16.6 t -101.0 111.2 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.086 0.954 . . . . 54.14 110.5 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -99.41 107.3 19.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.182 0.515 . . . . 61.5 110.236 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -98.0 110.91 23.4 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.388 -1.338 . . . . 75.41 107.388 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.644 ' HB ' HG12 ' A' ' 74' ' ' VAL . 4.8 tt -78.34 -50.7 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.953 0.406 . . . . 73.14 111.121 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -83.85 -2.68 56.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.274 -0.875 . . . . 64.21 111.504 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.32 59.6 8.69 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 111.623 -0.591 . . . . 62.01 111.623 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -78.59 -172.71 3.05 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.909 0.884 . . . . 73.45 111.063 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 43.2 tt0 -53.71 139.79 31.42 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.371 1.068 . . . . 62.3 111.384 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.92 -9.66 53.76 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.722 0.649 . . . . 71.01 114.722 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.564 ' H ' ' HG2' ' A' ' 46' ' ' GLU . . . -67.23 -22.48 65.69 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.354 0.577 . . . . 62.22 111.25 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.58 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -68.58 -39.68 80.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.291 0.636 . . . . 74.53 110.405 171.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.58 52.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.327 0.651 . . . . 72.03 111.355 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.435 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 24.0 tpp180 -70.82 -15.77 62.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.226 1.01 . . . . 74.51 111.205 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' HD13 ' A' ' 56' ' ' LEU . 78.4 p -61.63 -47.01 87.35 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 109.874 -0.417 . . . . 63.21 109.874 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.49 61.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.204 0.601 . . . . 64.2 111.2 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 25.5 t70 -60.04 -35.37 74.96 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.206 0.602 . . . . 52.43 111.465 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.479 HH21 HD11 ' A' ' 56' ' ' LEU . 52.6 ttp180 -64.41 -40.83 96.55 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.598 0.759 . . . . 65.13 110.232 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 52' ' ' THR . 9.8 mp -65.23 -34.44 78.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.451 -0.795 . . . . 65.25 110.645 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -65.62 -41.0 93.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.861 0.464 . . . . 72.41 110.722 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.42 65.85 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.599 -0.728 . . . . 73.21 111.233 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.41 -21.28 42.4 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.421 0.688 . . . . 71.21 111.011 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.55 44.46 2.5 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.463 -0.335 . . . . 60.24 113.544 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -87.67 158.44 18.83 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.643 0.777 . . . . 73.34 108.963 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -58.79 -69.5 0.19 Allowed 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.191 0.932 . . . . 62.03 112.3 -160.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.97 137.48 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.039 -1.097 . . . . 72.4 108.039 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 p -128.51 108.59 10.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.769 0.828 . . . . 55.53 109.14 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 8.3 t70 -104.27 159.03 16.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.584 1.154 . . . . 64.24 109.397 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.79 115.54 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.838 0.855 . . . . 72.13 109.128 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.24 93.45 0.69 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.626 -0.716 . . . . 73.01 111.927 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -77.46 82.88 3.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.374 0.607 . . . . 73.51 109.495 173.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.9 tp -160.15 143.97 14.15 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.199 -0.455 . . . . 73.23 111.006 -171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -82.66 100.74 10.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.009 0.924 . . . . 62.3 110.268 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -101.09 153.8 37.54 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 123.284 0.634 . . . . 53.25 109.535 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.76 -15.92 23.17 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.037 2.491 . . . . 74.53 114.566 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.37 -23.33 13.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.3 0.64 . . . . 71.32 110.914 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.745 HG13 HG13 ' A' ' 119' ' ' VAL . 79.5 t -93.52 123.06 45.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 125.133 1.373 . . . . 73.54 110.043 -177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' HA ' HD13 ' A' ' 42' ' ' ILE . . . -159.04 -74.15 0.08 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.012 0.525 . . . . 74.44 111.543 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.57 147.89 25.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.469 0.708 . . . . 71.41 110.284 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.2 t -66.15 100.24 0.59 Allowed 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.033 0.92 . . . . 73.11 109.997 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 m -152.23 135.64 15.98 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 74.24 109.096 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 118' ' ' VAL . 20.3 t -96.06 111.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.407 -0.96 . . . . 72.11 108.407 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -96.7 124.33 40.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.604 -0.887 . . . . 73.14 108.604 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -121.82 151.22 40.85 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.144 0.577 . . . . 74.14 112.156 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.712 HG23 ' HD3' ' A' ' 105' ' ' ARG . 3.3 m -103.21 166.82 10.21 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.084 -1.08 . . . . 61.33 108.084 170.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 14.63 18.25 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.974 -0.454 . . . . 73.12 111.887 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.15 110.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.779 0.832 . . . . 75.42 110.61 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.521 ' HG2' ' HB3' ' A' ' 34' ' ' ARG . 14.4 tp10 67.23 -76.48 0.05 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.831 1.252 . . . . 61.51 112.076 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.36 35.16 0.48 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.491 -1.044 . . . . 71.04 110.491 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HA ' HG22 ' A' ' 90' ' ' THR . 29.7 tt0 -75.9 -18.93 59.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 65.43 111.736 -170.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -67.57 -35.54 79.21 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 110.245 -0.28 . . . . 74.44 110.245 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.14 -26.95 56.82 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.557 0.743 . . . . 71.44 112.192 -174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 87' ' ' GLU . 12.6 t -85.0 -25.62 27.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.484 -0.562 . . . . 71.42 109.484 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.588 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -73.89 -38.71 64.3 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.916 0.886 . . . . 52.44 111.299 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.48 -56.33 17.83 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.746 -1.57 . . . . 64.04 110.52 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.6 -47.39 79.69 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.177 0.923 . . . . 61.43 111.914 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -60.25 -51.51 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.697 0.799 . . . . 61.33 111.963 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.93 -27.43 73.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 116.035 -0.53 . . . . 33.13 113.271 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -79.28 -26.44 42.32 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.407 0.683 . . . . 63.41 110.463 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.7 m -83.33 -32.69 26.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.143 0.977 . . . . 63.22 110.987 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.8 tp -85.89 -31.99 21.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.219 0.608 . . . . 71.44 110.611 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.86 27.12 35.48 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.508 -0.769 . . . . 71.21 112.464 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.36 144.2 37.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.741 0.816 . . . . 74.45 110.64 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.63 127.14 31.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.031 0.933 . . . . 71.05 111.09 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.419 HG12 ' HB ' ' A' ' 79' ' ' VAL . 18.8 m -92.43 106.68 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 124.136 0.974 . . . . 74.2 110.632 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.74 166.43 11.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.951 1.3 . . . . 55.44 109.414 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mp -67.22 175.92 2.44 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.198 0.523 . . . . 72.2 111.057 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HD3' HG23 ' A' ' 82' ' ' THR . 32.0 ptt-85 -55.95 -44.82 78.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.406 1.082 . . . . 74.22 112.412 -173.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.9 mt 60.63 170.13 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.521 1.128 . . . . 54.15 111.202 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.52 -18.13 14.39 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.079 1.853 . . . . 70.25 113.659 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.19 -55.69 26.08 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.181 1.392 . . . . 64.04 112.076 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 8.1 tt -68.04 -25.78 65.54 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 122.57 0.348 . . . . 74.04 110.381 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 t -76.35 -19.57 58.06 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.551 0.741 . . . . 62.54 111.912 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -81.08 -33.24 33.52 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.957 0.503 . . . . 65.21 111.247 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.405 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pp0? -104.89 167.31 10.04 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 124.227 1.011 . . . . 71.31 109.362 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 19.1 Cg_endo -57.16 132.48 51.53 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.037 2.491 . . . . 74.42 114.48 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 71.1 Cg_exo -50.79 160.5 1.78 Allowed 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 124.175 3.25 . . . . 61.24 116.072 -173.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.35 147.55 8.32 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 110.255 -1.138 . . . . 74.41 110.255 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 91' ' ' ALA . 2.4 p -60.58 118.82 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.466 0.706 . . . . 63.45 110.848 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.501 HG22 ' HG3' ' A' ' 38' ' ' ARG . 39.5 pt -103.8 107.43 22.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 122.033 0.92 . . . . 64.31 109.861 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.2 p -90.14 105.12 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.501 -1.296 . . . . 71.51 107.501 169.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.745 HG13 HG13 ' A' ' 74' ' ' VAL . 52.9 t -92.26 131.3 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.612 -1.176 . . . . 44.22 108.241 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.58 HG21 ' HB1' ' A' ' 49' ' ' ALA . 3.5 t -130.38 130.13 65.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.214 0.605 . . . . 72.44 109.939 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -91.37 167.37 12.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.463 0.705 . . . . 53.44 110.145 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.337 0 CA-C-O 119.515 -0.603 . . . . 72.24 112.963 178.161 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.981 0 CA-C-O 119.873 -0.404 . . . . 61.13 112.124 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 p -82.05 107.19 14.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.82 0.848 . . . . 71.22 110.546 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.2 t -147.86 126.28 6.07 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.725 0.81 . . . . 64.34 109.912 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.64 157.79 48.05 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.757 2.305 . . . . 73.23 113.551 -174.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -118.89 94.17 4.35 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.248 -1.019 . . . . 74.52 108.248 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.5 p -102.55 23.26 12.2 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.702 0.801 . . . . 74.3 111.488 -175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.26 -30.81 71.71 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.802 0.841 . . . . 73.44 111.377 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -96.21 19.71 11.43 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.168 0.987 . . . . 74.11 111.057 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.55 90.39 2.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.884 -0.784 . . . . 73.1 108.884 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.6 p -115.22 116.05 27.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.689 0.795 . . . . 75.4 109.885 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.6 t -139.95 143.42 36.55 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.44 0.696 . . . . 45.24 109.184 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.9 153.59 31.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.562 0.745 . . . . 61.11 110.693 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 tt -158.13 118.94 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.963 0.905 . . . . 71.42 110.031 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 m -144.76 109.73 5.07 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.974 0.91 . . . . 52.42 109.091 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 m -120.85 141.8 50.25 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.724 0.81 . . . . 61.34 109.678 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -125.03 146.11 49.59 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.126 0.97 . . . . 65.22 109.662 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.9 m -146.45 127.04 14.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.218 0.607 . . . . 73.34 110.002 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 p -111.81 137.46 49.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.796 0.838 . . . . 64.44 109.77 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 p -81.19 132.18 35.34 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.093 0.957 . . . . 72.44 111.492 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.5 p -113.19 160.52 18.17 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.573 1.149 . . . . 71.03 109.076 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.66 144.47 22.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.823 0.449 . . . . 63.13 111.149 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.63 124.14 43.46 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.752 0.821 . . . . 54.24 109.891 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.21 162.76 38.89 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.681 2.254 . . . . 51.1 112.819 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -83.01 146.62 28.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.211 1.005 . . . . 72.52 110.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 m -143.9 103.8 4.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.945 0.898 . . . . 74.32 109.292 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.9 p -108.81 141.12 41.3 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 64.14 109.605 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -159.01 94.32 1.21 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.034 0.933 . . . . 74.23 108.592 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.17 123.96 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 63.33 109.611 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.71 161.38 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.935 0.894 . . . . 55.11 110.633 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -56.05 164.88 4.45 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.91 2.406 . . . . 60.04 114.264 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.42 159.38 34.63 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.75 -1.114 . . . . 54.54 111.797 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.2 80.42 7.86 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.478 0.711 . . . . 40.24 109.888 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.43 128.99 8.27 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.193 1.929 . . . . 52.42 111.049 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.651 ' HB3' ' HG3' ' A' ' 85' ' ' GLU . 21.2 mmm180 -129.39 -20.53 3.31 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.476 0.71 . . . . 65.53 110.567 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.47 -172.67 3.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.869 0.867 . . . . 61.23 109.005 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.87 135.96 53.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.925 0.89 . . . . 53.23 109.234 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 64' ' ' THR . 90.7 t -132.83 123.54 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.277 -1.009 . . . . 73.45 108.277 171.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . 4.1 ptp85 -141.34 110.93 6.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.511 -0.743 . . . . 75.43 112.024 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 53' ' ' ALA . 35.8 t -92.71 120.52 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.023 . . . . 64.55 109.951 -175.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 66.3 m-85 -130.09 132.96 46.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.354 0.662 . . . . 71.14 109.794 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -88.84 141.08 28.8 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.887 -1.153 . . . . 64.11 107.887 167.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 121' ' ' THR . 6.3 tp -59.3 -46.32 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.459 0.704 . . . . 65.21 111.289 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.9 m -106.73 -9.94 16.28 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 70.5 111.858 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.91 63.29 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.223 0.327 . . . . 64.35 113.45 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.8 m -91.45 -52.73 4.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.275 0.63 . . . . 73.03 111.215 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -74.01 120.15 19.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.059 0.392 . . . . 52.12 112.059 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.96 50.97 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.303 -0.862 . . . . 72.21 112.746 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.24 73.64 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.248 0.619 . . . . 74.31 110.925 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.44 -52.07 64.81 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.18 0.925 . . . . 74.54 110.424 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.77 -37.67 88.4 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.772 -1.104 . . . . 52.41 111.631 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -64.87 -38.78 92.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.603 1.161 . . . . 63.04 111.617 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 97' ' ' THR . 68.9 p -75.76 -23.35 55.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.174 -0.466 . . . . 54.0 111.128 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -77.53 -33.7 54.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.077 0.951 . . . . 53.32 111.551 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -52.66 -32.41 42.02 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.977 0.911 . . . . 73.2 112.031 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.73 -52.26 66.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.3 1.04 . . . . 54.34 110.356 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.45 -37.63 71.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.277 0.631 . . . . 74.45 111.295 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -71.9 -36.44 70.01 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.485 0.49 . . . . 70.02 110.708 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.28 -34.45 72.78 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.357 0.41 . . . . 75.24 110.902 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.19 -21.72 58.51 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.358 -0.837 . . . . 73.32 110.862 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.44 10.53 86.13 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-N 115.639 -0.71 . . . . 53.21 113.835 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -95.41 135.62 36.81 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.856 -0.794 . . . . 73.03 108.856 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 90' ' ' THR . 70.9 p 59.24 155.29 0.02 OUTLIER 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.871 2.068 . . . . 74.4 113.653 -173.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.64 87.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.63 0 N-CA-C 108.165 -1.05 . . . . 71.11 108.165 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 26.3 m -89.0 102.45 15.09 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.367 0.667 . . . . 64.13 110.679 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 38.9 m-20 -102.48 142.63 33.35 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.76 -0.83 . . . . 65.32 108.76 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 ' HB1' ' A' ' 53' ' ' ALA . 43.4 t -132.61 143.16 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.326 0.651 . . . . 54.44 110.168 -171.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.63 -126.78 2.07 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 112.541 -0.223 . . . . 64.44 112.541 165.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -144.77 145.05 31.48 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.944 0.898 . . . . 74.25 109.912 -177.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 tp -156.26 146.45 21.42 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.746 -0.835 . . . . 72.53 108.746 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.4 p -81.11 98.73 8.15 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.107 0.563 . . . . 73.11 110.453 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.47 88.21 7.28 Favored Pre-proline 0 N--CA 1.483 1.195 0 N-CA-C 108.801 -0.814 . . . . 64.1 108.801 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.71 -6.93 14.54 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.438 2.092 . . . . 61.23 112.992 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.5 -23.44 56.75 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.742 0.417 . . . . 70.44 111.145 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.477 HG11 HG11 ' A' ' 119' ' ' VAL . 2.6 p -121.32 119.45 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.693 0.797 . . . . 72.12 109.902 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.57 20.45 17.15 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.175 0.99 . . . . 73.43 111.403 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.31 139.85 45.97 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.689 0.796 . . . . 72.24 110.098 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 t -69.18 101.88 1.56 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.548 0.69 . . . . 55.02 110.283 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -138.35 145.43 41.12 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.414 0.686 . . . . 63.33 110.905 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.714 HG13 HG22 ' A' ' 118' ' ' VAL . 48.8 t -95.97 118.44 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.599 1.16 . . . . 63.31 108.085 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -110.02 129.05 55.73 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.894 0.478 . . . . 74.05 110.166 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.435 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -126.4 154.47 43.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.151 0.981 . . . . 71.43 110.091 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 83' ' ' GLU . 11.8 m -102.0 -112.06 0.21 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.514 -0.921 . . . . 74.24 108.514 168.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' HG22 ' A' ' 82' ' ' THR . 14.7 pt-20 -143.21 -19.91 0.63 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.784 1.174 . . . . 72.34 113.738 -172.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.54 116.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 123.725 0.81 . . . . 64.23 112.072 -170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.651 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 57.3 mm-40 64.49 -77.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.054 0 C-N-CA 125.149 1.38 . . . . 73.32 111.198 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.6 52.63 0.33 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.066 -1.214 . . . . 62.5 110.066 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.18 -40.67 64.54 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.074 0.55 . . . . 61.44 112.04 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -73.57 -25.76 60.52 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.447 0.536 . . . . 72.44 112.447 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.21 -39.56 63.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.087 0.555 . . . . 73.52 111.437 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 62' ' ' THR . 6.6 t -82.89 -31.95 27.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.128 0.571 . . . . 41.31 111.404 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.53 -32.23 73.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.448 0.699 . . . . 74.32 110.927 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.02 -38.51 76.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.549 1.14 . . . . 71.42 111.58 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.65 98.08 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 123.741 0.65 . . . . 62.45 111.556 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 118' ' ' VAL . 20.7 t -73.64 -48.47 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.939 -0.393 . . . . 74.21 109.939 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.57 -21.34 49.38 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.869 0.73 . . . . 71.31 113.549 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -80.53 -58.55 3.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 74.24 109.818 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 52' ' ' THR . 24.2 m -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.554 1.109 0 O-C-N 124.41 1.069 . . . . 74.33 111.354 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.1 tp -96.18 -29.68 13.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.072 0.949 . . . . 72.54 110.461 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.57 47.43 10.22 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.32 -0.4 . . . . 61.23 112.565 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.05 152.63 38.39 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.904 0.882 . . . . 64.23 110.234 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.91 128.07 34.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.754 0.822 . . . . 54.51 111.017 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.435 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 14.4 m -94.01 98.92 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 121.982 0.896 . . . . 64.22 109.434 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -111.72 163.42 14.16 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.455 1.102 . . . . 70.25 110.606 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 tp -71.98 169.94 14.85 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.165 -0.925 . . . . 63.33 109.967 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' HD3' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -55.39 -38.06 68.38 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.327 1.051 . . . . 65.32 113.106 -176.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.512 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 97.3 mt 59.71 176.43 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 O-C-N 124.322 1.014 . . . . 52.24 112.957 172.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -53.27 -16.45 7.0 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.216 1.944 . . . . 74.44 114.193 164.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -54.71 -30.39 55.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.725 1.21 . . . . 71.15 111.403 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . 10.3 tt -62.45 -28.97 70.18 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.357 0.663 . . . . 71.1 111.192 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -62.39 -23.17 66.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.14 0.576 . . . . 74.41 111.707 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -111.29 -33.02 6.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.463 0.705 . . . . 70.23 111.862 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.799 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 9.0 pt20 -84.07 161.32 55.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.086 0.554 . . . . 64.03 110.841 -171.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HD2' HG21 ' A' ' 117' ' ' ILE . 40.8 Cg_exo -61.1 152.11 73.84 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.491 2.128 . . . . 72.33 113.402 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.73 161.54 38.51 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.171 2.581 . . . . 74.21 112.894 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.76 -166.88 52.43 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.879 -0.6 . . . . 51.12 111.712 -173.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.1 t -73.25 130.0 35.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 109.145 -0.687 . . . . 71.23 109.145 172.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 112' ' ' GLN . 17.1 pt -114.31 150.85 16.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.612 -1.255 . . . . 74.43 107.612 164.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.714 HG22 HG13 ' A' ' 79' ' ' VAL . 61.4 t -119.64 100.17 9.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 106.127 -1.805 . . . . 74.43 106.127 163.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.477 HG11 HG11 ' A' ' 74' ' ' VAL . 6.7 p -95.95 125.09 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.91 -0.774 . . . . 72.14 108.91 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.56 128.07 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 109.439 -0.578 . . . . 74.23 109.439 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.441 ' HA ' HG22 ' A' ' 42' ' ' ILE . 72.6 p -107.95 101.47 10.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.185 -1.042 . . . . 70.22 108.185 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.63 -0.713 . . . . 62.14 111.704 -174.298 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.049 0 CA-C-O 119.764 -0.464 . . . . 54.32 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 p -79.11 131.24 36.17 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.716 0.806 . . . . 74.03 111.224 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -142.27 87.26 9.62 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.557 -0.905 . . . . 75.31 108.557 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.17 157.14 46.52 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.488 2.125 . . . . 71.41 111.69 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -152.51 143.47 23.01 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.659 0.784 . . . . 74.4 110.047 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.9 p -167.26 80.5 0.2 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.373 1.069 . . . . 61.03 108.875 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.15 14.98 12.67 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.513 0.725 . . . . 64.41 110.586 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.69 -72.85 0.09 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.723 1.209 . . . . 41.21 110.649 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 t70 52.36 95.21 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.049 1.34 . . . . 72.32 112.776 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -118.93 100.75 7.57 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.356 0.598 . . . . 64.44 110.636 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.4 m -142.84 103.11 4.14 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.129 . . . . 54.31 108.618 174.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.33 144.35 33.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.066 0.546 . . . . 64.52 110.126 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 tt -164.9 138.94 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.397 1.079 . . . . 61.13 108.309 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -143.2 135.63 27.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.324 -0.621 . . . . 73.24 109.324 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -146.72 135.78 22.51 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.703 0.801 . . . . 54.2 109.374 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -161.95 141.15 9.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.749 0.82 . . . . 74.5 109.037 174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.9 t -165.86 148.4 7.39 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.588 0.755 . . . . 62.31 109.715 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 t -166.62 147.04 5.98 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.688 1.195 . . . . 64.01 107.95 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.0 t -159.13 148.1 18.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.192 0.197 . . . . 73.23 110.724 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 t -159.75 141.82 13.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.685 0.794 . . . . 65.3 109.482 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -163.78 133.91 4.24 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.48 0.712 . . . . 60.25 110.058 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.19 106.06 4.14 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.513 0.725 . . . . 44.03 109.283 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -90.76 159.99 4.16 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.679 2.253 . . . . 71.02 111.825 171.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.8 t -156.25 153.95 29.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.016 0.526 . . . . 73.53 110.474 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.5 p -153.79 166.75 31.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.703 0.801 . . . . 54.41 109.625 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -142.22 143.89 33.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.568 0.747 . . . . 70.44 109.055 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.9 p -148.48 82.96 1.47 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.837 0.855 . . . . 71.23 108.886 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.5 139.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.602 0.761 . . . . 70.21 110.915 -174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -118.21 102.94 50.21 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.047 0.939 . . . . 73.31 109.002 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.42 165.48 32.34 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.985 2.457 . . . . 71.0 112.69 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.29 153.63 23.43 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.859 0.864 . . . . 54.44 111.014 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.51 120.06 69.6 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.678 0.791 . . . . 64.14 110.434 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.95 152.23 36.24 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.747 2.298 . . . . 74.15 112.51 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.425 ' HB3' ' HG2' ' A' ' 85' ' ' GLU . 42.0 ttt180 -166.46 97.04 0.58 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.732 0.813 . . . . 64.01 109.985 -175.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.16 82.34 2.05 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.791 -0.818 . . . . 43.23 108.791 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 41.9 mt-10 -115.27 94.44 4.73 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.475 -0.784 . . . . 71.34 110.682 -169.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.694 HG11 HG21 ' A' ' 94' ' ' VAL . 22.5 t -112.86 147.16 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 123.798 0.839 . . . . 75.04 111.416 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 31.2 ttp-105 -150.78 110.04 3.96 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.486 0.714 . . . . 71.33 109.719 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.489 HG22 ' HB ' ' A' ' 118' ' ' VAL . 60.6 t -87.52 126.42 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.455 0.702 . . . . 73.05 111.129 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 10.9 m-85 -119.95 107.93 13.71 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.727 0.811 . . . . 75.44 110.561 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 47.7 t30 -97.91 138.5 35.15 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.278 -0.638 . . . . 74.01 109.278 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.436 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -97.0 -11.79 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.1 0.476 . . . . 74.41 111.414 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -156.49 119.44 4.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.259 -1.015 . . . . 73.21 108.259 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.83 -88.81 0.01 OUTLIER Glycine 0 C--N 1.362 2.002 0 O-C-N 125.154 1.534 . . . . 53.35 114.52 -169.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.7 m 51.7 -79.3 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.327 1.451 . . . . 60.34 113.525 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -86.53 117.6 25.41 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.131 0.972 . . . . 55.21 110.357 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.99 -18.37 68.74 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.531 0.519 . . . . 55.53 111.938 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 52' ' ' THR . . . -46.97 -32.37 3.83 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.748 1.619 . . . . 51.31 113.37 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.28 8.88 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.533 0.733 . . . . 45.33 111.911 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.41 -25.4 60.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.486 0.315 . . . . 51.43 111.078 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -69.69 -31.32 69.28 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.378 1.071 . . . . 63.51 111.253 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.63 ' HB ' HG13 ' A' ' 94' ' ' VAL . 29.1 p -66.35 -56.88 8.97 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 121.988 0.115 . . . . 63.52 110.817 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.39 66.1 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.905 0.383 . . . . 52.4 111.651 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.45 -45.93 87.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.402 1.081 . . . . 64.1 111.597 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -67.42 -43.74 80.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 110.431 -0.211 . . . . 73.05 110.431 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.9 -32.24 69.35 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.753 0.658 . . . . 72.51 111.821 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -60.38 -45.21 94.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.275 0.63 . . . . 61.35 110.7 176.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -19.44 45.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.427 0.691 . . . . 73.24 111.345 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 -10.47 59.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.688 0.795 . . . . 52.04 111.321 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.87 42.77 5.91 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.594 -0.275 . . . . 62.24 113.465 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -90.7 157.0 17.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.794 0.837 . . . . 55.34 109.821 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 m -72.09 -50.97 23.86 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.643 0.735 . . . . 73.53 110.71 -164.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 54.9 t -129.21 126.72 64.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-N 114.138 -1.392 . . . . 63.32 107.446 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.0 p -141.02 84.54 1.94 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.285 -1.005 . . . . 72.3 108.285 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -103.42 158.12 16.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.556 -0.747 . . . . 43.05 110.494 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.19 146.85 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.34 1.056 . . . . 75.43 109.246 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' TYR . . . -165.28 137.51 4.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.086 -0.806 . . . . 54.5 111.086 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 4.3 p-10 -105.64 108.39 19.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.554 -0.536 . . . . 64.2 109.554 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pp -156.26 161.37 40.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.123 0.569 . . . . 74.54 110.785 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.436 ' HA ' HG13 ' A' ' 42' ' ' ILE . 41.3 m -96.43 127.37 42.36 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.783 0.833 . . . . 74.0 109.636 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.647 ' HB2' HG23 ' A' ' 74' ' ' VAL . 86.4 mt -120.71 149.08 49.71 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.922 0.889 . . . . 74.54 108.679 171.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.01 -4.29 15.19 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.957 2.438 . . . . 74.23 113.184 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.47 -6.17 24.31 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.067 0.947 . . . . 74.52 112.273 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' HB2' ' A' ' 71' ' ' LEU . 90.0 t -74.86 112.22 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 122.906 0.482 . . . . 74.53 109.814 177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.86 -41.47 3.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.928 0.891 . . . . 64.21 110.281 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.7 158.94 41.78 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.952 0.901 . . . . 43.13 109.212 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.589 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.0 t -61.09 100.49 0.12 Allowed 'General case' 0 C--O 1.243 0.755 0 CA-C-O 122.71 1.243 . . . . 62.41 109.574 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.0 m -151.3 145.49 25.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.293 -1.322 . . . . 75.13 109.123 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.706 HG22 HG13 ' A' ' 118' ' ' VAL . 58.2 t -93.74 113.78 29.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.017 -1.105 . . . . 74.02 108.017 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -94.3 111.12 22.84 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.05 -1.463 . . . . 74.34 107.05 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 8.2 p90 -120.57 140.6 51.26 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.664 0.745 . . . . 75.11 112.933 -171.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 84' ' ' VAL . 29.7 m -84.97 152.93 23.11 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.738 -1.208 . . . . 75.02 107.738 162.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -109.18 19.27 19.65 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.139 0.422 . . . . 71.21 112.139 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 82' ' ' THR . 77.1 t -69.31 129.0 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.841 -0.8 . . . . 51.55 108.841 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 34' ' ' ARG . 13.7 tp10 61.04 -81.42 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.119 1.368 . . . . 71.22 111.401 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.87 33.12 0.3 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.094 -0.503 . . . . 71.52 111.875 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -69.1 -31.76 70.69 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 122.719 0.408 . . . . 75.14 111.247 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -73.4 -29.26 62.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.45 0.3 . . . . 70.52 110.717 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.6 -43.48 55.38 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.084 0.554 . . . . 74.14 110.611 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 t -74.24 -22.39 59.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.048 0.539 . . . . 74.22 109.904 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -70.85 -44.09 67.13 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.387 1.075 . . . . 75.41 111.513 172.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.74 -35.31 72.51 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.289 -1.323 . . . . 72.32 111.721 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.66 -42.53 83.69 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 123.71 0.631 . . . . 71.04 110.987 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.694 HG21 HG11 ' A' ' 37' ' ' VAL . 24.7 t -78.05 -45.9 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.068 -0.969 . . . . 64.43 111.514 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.4 -26.73 68.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.656 0.597 . . . . 73.23 112.999 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -75.59 -45.67 36.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.463 0.705 . . . . 65.53 110.123 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.2 m -61.01 -41.51 96.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.707 0.803 . . . . 73.0 111.122 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 120' ' ' VAL . 47.9 tp -75.82 -31.76 59.52 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.946 -1.025 . . . . 73.51 110.714 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 45.73 31.31 Favored Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.494 -0.642 . . . . 75.0 111.494 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.21 175.35 7.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.937 0.895 . . . . 73.22 110.282 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.24 164.62 25.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.762 0.425 . . . . 72.44 110.322 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.602 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.9 m -138.04 140.0 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.216 1.006 . . . . 72.35 108.333 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -155.63 174.25 15.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.789 0.836 . . . . 75.13 110.028 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.5 179.82 1.23 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 115.649 -0.705 . . . . 62.12 111.94 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -83.11 18.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.66 0.985 . . . . 74.0 113.66 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.13 -47.72 89.73 Favored Pre-proline 0 CA--C 1.558 1.26 0 CA-C-O 118.619 -0.705 . . . . 63.35 111.761 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.75 -37.79 11.43 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 121.577 1.518 . . . . 55.32 111.517 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -57.33 -29.82 64.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 74.21 111.572 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -17.15 64.4 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.305 1.042 . . . . 71.22 112.404 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 m -65.91 -45.09 83.21 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.27 0.557 . . . . 75.24 110.983 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -82.21 -33.06 29.53 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.477 -0.783 . . . . 74.21 109.436 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 48.39 71.49 1.58 Allowed Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.054 1.742 . . . . 61.42 111.311 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.433 ' HB2' ' NH2' ' A' ' 38' ' ' ARG . 44.0 Cg_endo -94.84 162.26 1.76 Allowed 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 123.805 3.003 . . . . 65.22 113.194 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.26 120.23 0.81 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.759 2.306 . . . . 64.21 111.265 168.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.19 162.86 20.98 Favored Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.563 -1.015 . . . . 60.45 110.563 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 91' ' ' ALA . 1.9 p -84.28 137.04 21.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 117.32 0.56 . . . . 74.33 110.529 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 38' ' ' ARG . 35.5 pt -106.43 123.1 61.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 CA-C-O 121.577 0.703 . . . . 42.42 109.809 176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 79' ' ' VAL . 98.9 t -95.94 103.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.463 -1.31 . . . . 64.12 107.463 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 69.2 t -94.06 128.77 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 109.866 -0.42 . . . . 52.35 109.866 -174.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.456 HG22 HD21 ' A' ' 98' ' ' LEU . 22.5 t -113.93 139.39 39.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 107.975 -1.12 . . . . 74.11 107.975 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.589 ' H ' ' HB ' ' A' ' 77' ' ' THR . 40.3 p -120.06 104.14 9.87 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.927 -0.768 . . . . 73.22 108.927 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.451 0 CA-C-O 119.352 -0.694 . . . . 71.2 112.445 175.137 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.907 -0.477 . . . . 63.01 111.907 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -67.37 111.25 3.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.363 0.665 . . . . 73.22 110.573 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m -128.62 139.08 34.53 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.446 0.698 . . . . 45.55 110.285 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.27 -170.39 0.96 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.834 2.356 . . . . 61.51 112.512 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -146.13 112.36 5.8 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.442 -0.577 . . . . 52.42 109.442 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.4 p -101.59 74.36 1.51 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.622 -0.881 . . . . 73.01 108.622 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -92.94 12.68 23.02 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 114.958 -1.019 . . . . 70.34 111.284 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.63 -70.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.641 0.776 . . . . 74.42 111.949 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.4 t70 62.71 113.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.804 1.242 . . . . 73.25 111.901 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.7 m -144.73 101.7 3.69 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.13 0.572 . . . . 64.14 110.637 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -159.35 120.75 3.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.625 0.77 . . . . 73.35 109.461 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.19 97.13 1.01 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.834 0.854 . . . . 73.42 109.679 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -148.6 129.1 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.727 0.811 . . . . 73.43 109.809 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.4 p -168.67 127.09 1.09 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.391 1.076 . . . . 60.52 109.226 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -149.06 161.88 41.05 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.109 0.564 . . . . 71.03 109.963 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.24 149.01 52.75 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 51.32 110.191 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -152.69 159.62 43.16 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.261 0.625 . . . . 71.25 109.815 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.7 t -149.68 159.66 44.16 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.347 0.659 . . . . 73.44 109.757 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -162.57 168.32 21.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.046 0.939 . . . . 75.11 108.841 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.0 t -162.76 142.3 9.11 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.351 0.661 . . . . 71.41 109.832 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.52 133.49 21.36 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.81 -0.811 . . . . 72.21 108.81 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.47 123.33 6.36 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 123.53 0.732 . . . . 72.45 109.676 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -79.95 -170.67 1.05 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.725 2.283 . . . . 33.34 111.415 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -137.08 161.15 36.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.104 0.562 . . . . 63.4 109.781 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.5 t -147.53 157.43 43.56 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.773 0.829 . . . . 71.43 109.228 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.9 t -145.4 163.39 34.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.112 0.565 . . . . 72.32 110.516 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -141.76 165.39 27.59 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.985 0.914 . . . . 74.21 109.864 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -130.14 152.3 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.809 0.844 . . . . 64.45 109.698 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.92 114.06 39.47 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.738 0.815 . . . . 73.33 109.238 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.45 170.54 6.62 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.272 2.648 . . . . 71.31 113.371 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.16 148.41 50.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.342 0.657 . . . . 75.32 110.565 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.65 132.05 26.98 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 123.609 0.763 . . . . 72.12 110.459 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.52 171.12 18.11 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.935 2.423 . . . . 72.02 112.122 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.622 ' HA ' HG21 ' A' ' 62' ' ' THR . 10.1 mpt_? -85.66 137.1 33.07 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.587 0.755 . . . . 73.13 110.636 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . . . -163.43 92.18 0.71 Allowed 'General case' 0 CA--C 1.545 0.771 0 O-C-N 124.079 0.862 . . . . 52.01 110.646 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.0 mt-10 -84.84 90.61 7.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.528 0.731 . . . . 71.44 109.934 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.8 t -97.67 122.01 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.08 0.467 . . . . 75.44 109.873 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HG3' HG22 ' A' ' 117' ' ' ILE . 8.9 ptm180 -142.79 131.46 22.6 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.155 -0.341 . . . . 74.22 110.99 -167.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' A' ' 118' ' ' VAL . 40.0 t -93.27 131.43 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.588 0.755 . . . . 62.1 109.875 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 70.3 m-85 -126.02 104.21 8.15 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.939 -0.764 . . . . 71.24 108.939 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.422 HD21 HG22 ' A' ' 45' ' ' THR . 44.0 t30 -97.21 130.14 44.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.623 -0.88 . . . . 64.54 108.623 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.639 HG13 ' HA ' ' A' ' 70' ' ' SER . 20.3 tt -102.35 -35.41 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.513 0.197 . . . . 64.12 111.491 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.3 m -100.07 151.29 21.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.066 0.546 . . . . 74.44 110.152 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.56 87.08 0.26 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.533 -0.627 . . . . 73.21 111.533 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.422 HG22 HD21 ' A' ' 41' ' ' ASN . 11.4 t -126.03 -173.05 2.75 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.783 0.833 . . . . 73.52 109.543 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -72.65 170.37 14.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.37 1.068 . . . . 72.05 111.622 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -1.13 50.85 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 118.976 -0.902 . . . . 73.15 113.979 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.63 -32.17 28.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 42.11 112.82 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.06 -53.94 48.46 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.296 -0.866 . . . . 44.41 111.157 174.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.21 -21.98 60.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.19 0.596 . . . . 53.1 111.672 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -63.1 -28.8 70.33 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.699 1.199 . . . . 53.51 111.444 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.568 ' HB ' HG13 ' A' ' 94' ' ' VAL . 63.0 p -63.39 -42.35 98.8 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 123.419 0.45 . . . . 72.24 110.583 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.99 78.42 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.307 0.643 . . . . 74.23 111.015 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 49.0 m-20 -57.49 -38.58 74.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.075 0.859 . . . . 64.43 111.932 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.15 -52.89 56.91 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.748 0.655 . . . . 62.23 110.591 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.5 mp -70.4 -28.39 65.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.636 -0.711 . . . . 72.51 111.351 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 38.4 ttpt -62.36 -43.76 98.06 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.581 0.752 . . . . 74.43 109.867 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.05 64.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.454 -0.794 . . . . 72.12 111.157 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -21.06 56.64 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.961 0.726 . . . . 72.4 112.961 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.79 49.15 0.29 Allowed Glycine 0 C--N 1.358 1.763 0 CA-C-N 118.007 0.367 . . . . 63.13 113.085 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -57.16 158.04 5.58 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.352 1.061 . . . . 74.54 112.173 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.622 HG21 ' HA ' ' A' ' 34' ' ' ARG . 17.3 m -91.46 -60.36 1.91 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.37 -0.974 . . . . 74.03 108.37 168.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 65.3 t -135.55 136.82 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.188 -1.412 . . . . 62.42 107.188 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 10.3 p -130.56 146.37 52.07 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.321 0.649 . . . . 75.11 110.175 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 10.8 t70 -143.51 146.58 33.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.968 -1.015 . . . . 75.45 108.396 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.02 138.48 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.064 -0.717 . . . . 65.32 109.064 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.93 143.78 9.27 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.459 -0.337 . . . . 65.15 112.427 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -109.07 110.91 22.29 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.121 -1.066 . . . . 63.42 108.121 173.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.5 tp -151.02 148.91 28.93 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.255 -0.646 . . . . 54.12 109.255 -169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.639 ' HA ' HG13 ' A' ' 42' ' ' ILE . 12.0 p -77.05 98.65 5.06 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.889 -0.596 . . . . 72.34 109.997 172.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.2 110.21 31.56 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.22 -1.03 . . . . 72.33 108.22 170.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.38 -6.4 17.08 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.456 2.104 . . . . 73.34 112.532 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 6.2 p-10 -92.55 -23.84 18.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.84 0.856 . . . . 75.11 111.269 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.2 p -80.98 149.06 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 109.954 -0.387 . . . . 65.41 109.954 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.99 -5.22 1.69 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.631 0.772 . . . . 33.42 111.643 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.94 147.42 8.21 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.255 1.022 . . . . 72.13 109.839 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 121' ' ' THR . 7.8 t -64.42 111.21 2.56 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.416 0.686 . . . . 74.22 111.296 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 m -150.2 151.88 33.75 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.835 -0.62 . . . . 60.31 109.581 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' HG12 ' A' ' 102' ' ' VAL . 28.9 t -102.22 116.49 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.591 -0.892 . . . . 53.44 108.591 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HD2' HD11 ' A' ' 117' ' ' ILE . 16.2 m-85 -102.41 148.22 25.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.937 -0.764 . . . . 65.35 108.937 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.59 169.33 17.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.863 0.84 . . . . 73.35 112.534 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.4 ' HB ' ' OE1' ' A' ' 87' ' ' GLU . 8.1 m -118.74 166.04 13.27 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 113.751 -1.568 . . . . 45.1 107.048 172.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.19 23.13 9.52 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.928 0.714 . . . . 74.42 112.928 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.61 98.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.202 0.525 . . . . 44.02 110.038 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 65.27 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.414 1.485 . . . . 71.24 111.9 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.03 25.87 2.36 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.075 -0.847 . . . . 71.12 112.963 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.746 ' HG2' ' HA ' ' A' ' 35' ' ' ALA . 31.3 mt-10 -62.98 -36.81 84.77 Favored 'General case' 0 C--N 1.362 1.127 0 CA-C-N 117.618 0.709 . . . . 75.34 111.025 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -70.8 -32.36 69.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.214 0.321 . . . . 72.24 111.754 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.33 -31.83 66.0 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.231 0.612 . . . . 72.22 110.515 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.4 m -76.6 -33.27 58.42 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.032 0.933 . . . . 74.44 109.982 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.47 -34.22 70.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.126 0.971 . . . . 50.44 111.376 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -50.91 -47.04 60.9 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.604 1.19 . . . . 71.14 110.765 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.1 83.87 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 124.534 1.146 . . . . 73.1 111.69 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 52' ' ' THR . 89.4 t -66.74 -52.27 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.12 0.968 . . . . 64.24 112.11 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -27.08 70.43 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.575 0.547 . . . . 74.3 111.754 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -78.34 -23.57 46.92 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.396 0.678 . . . . 71.24 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -78.64 -51.3 10.07 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 122.615 0.366 . . . . 72.13 110.627 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.1 tp -74.15 -26.61 60.41 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.346 0.658 . . . . 75.22 111.295 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.29 62.46 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.746 -0.661 . . . . 74.22 112.064 -172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.4 163.0 13.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.74 0.816 . . . . 63.32 110.666 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.37 134.49 38.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.128 0.571 . . . . 74.31 110.19 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 79' ' ' VAL . 34.7 m -99.22 138.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.978 -0.749 . . . . 53.35 108.978 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -154.56 168.74 25.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.7 -0.852 . . . . 61.34 108.7 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 22.5 tp -65.66 173.03 3.0 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.13 0.572 . . . . 74.12 109.851 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.5 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 2.4 ppt_? -49.33 -39.18 30.6 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.167 1.173 . . . . 73.41 114.167 -167.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 80' ' ' TYR . 41.0 mt 64.56 154.23 0.12 Allowed Pre-proline 0 CA--C 1.565 1.557 0 C-N-CA 124.307 1.043 . . . . 71.3 112.113 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.18 -29.03 35.78 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.647 2.898 . . . . 44.12 115.212 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 5.1 pm0 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.608 0.763 . . . . 75.25 112.861 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 0.5 OUTLIER -72.97 8.46 1.55 Allowed 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.188 0.518 . . . . 73.01 111.614 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 t -82.09 -10.56 59.16 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.027 0.931 . . . . 61.41 111.382 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.23 -17.05 18.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 113.419 0.896 . . . . 63.35 113.419 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 2.0 pp0? -145.98 159.57 46.07 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.465 -0.779 . . . . 73.5 110.267 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 112' ' ' GLN . 12.6 Cg_endo -52.7 125.4 17.88 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 123.795 2.997 . . . . 74.12 115.284 -167.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -57.44 153.67 39.9 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.925 3.083 . . . . 62.44 115.023 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.68 -149.41 21.55 Favored Glycine 0 N--CA 1.47 0.938 0 N-CA-C 109.861 -1.295 . . . . 51.13 109.861 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 76.1 t -94.48 105.56 17.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.377 -0.972 . . . . 74.11 108.377 167.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.562 HD11 ' HD2' ' A' ' 80' ' ' TYR . 32.0 pt -108.21 122.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.12 -1.067 . . . . 54.53 108.12 173.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 39' ' ' VAL . 1.6 p -96.15 101.21 12.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.702 -1.592 . . . . 74.22 106.702 164.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 7.1 p -100.12 120.03 49.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-N 115.561 -0.745 . . . . 72.42 109.458 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.49 128.51 65.45 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 123.729 0.812 . . . . 64.02 110.269 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.677 ' H ' ' HB ' ' A' ' 77' ' ' THR . 77.7 p -112.05 153.28 27.12 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.891 1.276 . . . . 72.13 108.002 172.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.432 0 CA-C-O 119.141 -0.81 . . . . 41.12 112.836 178.71 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.825 -0.51 . . . . 32.14 111.825 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 t -161.72 161.73 29.47 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.399 0.68 . . . . 73.32 110.136 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.5 m -78.65 124.57 85.19 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.776 0.831 . . . . 73.24 110.509 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.82 147.85 75.8 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.889 2.392 . . . . 65.21 112.892 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -100.07 122.96 43.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.265 1.026 . . . . 71.14 109.173 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.3 t -108.35 84.18 1.9 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.507 -0.923 . . . . 70.43 108.507 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -81.93 -3.99 55.58 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.453 0.701 . . . . 72.34 111.687 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -56.21 -55.06 37.77 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.007 0.923 . . . . 72.03 110.762 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.9 t70 54.96 -89.58 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.258 1.423 . . . . 74.12 112.127 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.2 p 173.94 150.45 0.08 Allowed 'General case' 0 C--N 1.368 1.38 0 C-N-CA 125.647 1.579 . . . . 71.13 109.094 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -157.24 112.08 2.75 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.279 -1.008 . . . . 73.1 108.279 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.9 140.19 20.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.924 0.489 . . . . 75.15 110.857 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 tp -149.93 129.3 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.552 0.741 . . . . 63.21 109.143 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 102.6 4.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.329 0.652 . . . . 74.13 109.623 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 p -127.04 140.94 51.93 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.077 0.951 . . . . 73.34 109.383 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -136.68 165.33 26.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.343 0.657 . . . . 72.41 109.738 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.4 p -121.43 147.0 46.32 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.141 0.977 . . . . 71.14 109.423 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -125.02 139.22 54.0 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.73 0.812 . . . . 75.05 110.377 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.4 p -123.22 175.29 6.75 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.345 1.058 . . . . 54.32 110.117 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.2 t -158.67 173.55 16.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.38 0.672 . . . . 65.34 110.402 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.72 138.4 32.36 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.699 0.8 . . . . 72.13 110.539 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.48 157.82 35.58 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.208 1.003 . . . . 74.41 110.632 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.57 172.98 11.48 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.757 2.304 . . . . 73.01 112.704 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.3 p -137.47 148.36 46.01 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.604 0.762 . . . . 75.21 109.595 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -112.12 116.23 30.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.057 0.943 . . . . 74.44 110.271 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 p -91.51 128.74 37.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.523 0.729 . . . . 73.23 109.217 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.9 p -72.86 154.53 40.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.177 0.591 . . . . 72.35 111.145 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.94 141.44 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.892 -0.781 . . . . 74.43 108.892 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -82.31 149.24 61.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.947 0.499 . . . . 74.31 110.424 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.57 169.81 16.52 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.625 2.217 . . . . 70.31 112.288 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -152.27 164.26 37.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.336 0.654 . . . . 74.44 110.852 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.06 121.8 0.96 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.085 0.954 . . . . 74.4 109.738 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -77.82 128.34 9.23 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 121.869 1.713 . . . . 74.05 111.539 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 61' ' ' PHE . 90.9 mtt-85 -117.29 103.04 9.76 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.447 1.099 . . . . 71.33 108.071 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.646 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -83.51 -179.26 7.3 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.639 0.733 . . . . 74.4 111.468 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.664 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.0 mp0 -76.69 106.45 8.36 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.545 -1.207 . . . . 75.05 108.929 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.18 136.13 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.564 -0.902 . . . . 53.31 108.564 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HG3' HG22 ' A' ' 117' ' ' ILE . 10.6 ptm180 -146.93 115.15 6.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.498 0.666 . . . . 73.5 111.035 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' A' ' 53' ' ' ALA . 58.2 t -98.71 116.17 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.101 0.96 . . . . 72.34 110.215 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 62.9 m-85 -115.69 115.06 25.71 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.705 0.802 . . . . 51.1 110.606 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.737 ' HB3' ' H ' ' A' ' 45' ' ' THR . 21.7 m-80 -90.16 114.21 26.13 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.087 0.955 . . . . 54.12 110.054 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -81.52 -53.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 122.267 -0.271 . . . . 65.53 110.295 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 m -130.15 7.8 5.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.702 0.401 . . . . 71.45 111.707 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.17 -61.5 1.91 Allowed Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.895 -0.882 . . . . 70.52 110.895 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.737 ' H ' ' HB3' ' A' ' 41' ' ' ASN . 6.9 t 43.55 31.8 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 127.231 2.212 . . . . 72.24 114.195 173.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.84 153.93 51.39 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.587 0.755 . . . . 41.34 109.448 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.26 -22.66 56.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 124.203 0.939 . . . . 43.21 114.874 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.54 75.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.131 0.572 . . . . 71.32 111.233 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 52' ' ' THR . . . -82.96 -42.94 17.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.672 0.789 . . . . 52.21 111.184 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.56 65.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.586 0.754 . . . . 51.55 112.1 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -59.42 -28.27 66.79 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.759 1.224 . . . . 63.43 112.708 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 49' ' ' ALA . 6.0 t -69.71 -28.44 65.84 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 119.902 -0.094 . . . . 73.31 110.97 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -82.55 -32.0 28.81 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.848 0.859 . . . . 73.32 111.736 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.83 -56.79 17.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.467 1.107 . . . . 64.15 110.894 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -23.26 53.98 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.786 -0.643 . . . . 73.43 110.894 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.427 HD23 HG22 ' A' ' 64' ' ' THR . 15.5 tp -63.89 -40.03 95.56 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.912 0.885 . . . . 72.01 110.636 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -61.76 -44.79 96.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.071 -0.968 . . . . 74.42 109.178 176.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.5 -11.52 60.04 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.74 -1.118 . . . . 63.2 112.252 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.99 -13.26 53.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.287 0.635 . . . . 71.01 110.905 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.36 15.24 18.06 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.793 -0.448 . . . . 63.42 114.059 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 34' ' ' ARG . 34.2 m-85 -75.49 158.1 33.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.15 0.58 . . . . 73.14 110.684 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 m -84.63 -60.62 2.01 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.655 0.382 . . . . 73.35 111.171 -162.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 46.5 t -116.75 129.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.937 -0.764 . . . . 41.0 108.937 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 HD23 ' A' ' 56' ' ' LEU . 25.3 p -138.31 83.73 1.99 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.535 1.134 . . . . 74.3 108.087 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -100.1 125.09 46.16 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.69 -0.855 . . . . 53.32 108.69 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.444 HG12 ' HB ' ' A' ' 39' ' ' VAL . 29.6 m -117.3 150.31 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.002 0.429 . . . . 74.14 110.504 -174.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.78 162.23 35.63 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-N 115.456 -0.793 . . . . 55.14 111.373 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.11 110.67 20.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.724 0.81 . . . . 55.52 109.158 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -145.28 136.84 25.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.608 0.763 . . . . 72.32 109.998 -170.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.3 p -79.7 99.64 7.51 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.937 -0.764 . . . . 52.22 108.937 171.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.53 ' HB2' HG12 ' A' ' 74' ' ' VAL . 47.8 mt -93.36 140.82 23.33 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 115.893 -0.594 . . . . 75.14 109.603 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.57 -10.1 14.6 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.575 2.183 . . . . 75.12 113.175 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.39 -24.36 25.78 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.621 0.768 . . . . 73.34 111.325 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 71' ' ' LEU . 7.1 p -91.07 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.226 0.61 . . . . 72.12 110.66 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.79 -0.83 1.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.895 -1.048 . . . . 71.43 110.325 167.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.3 155.74 18.26 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 125.292 1.437 . . . . 62.1 108.44 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -62.4 109.74 1.45 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.494 0.664 . . . . 75.14 110.623 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.9 m -143.92 143.39 31.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.464 0.705 . . . . 71.14 110.265 -171.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.791 HG22 HG13 ' A' ' 118' ' ' VAL . 92.7 t -105.94 112.81 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.137 -1.06 . . . . 73.43 108.137 174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -98.92 125.03 44.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.828 -0.804 . . . . 64.04 108.828 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 25.9 p90 -109.34 139.75 43.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.642 0.588 . . . . 72.12 110.67 175.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 83' ' ' GLU . 2.1 m -82.96 -163.36 0.71 Allowed 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 108.663 -0.866 . . . . 55.21 108.663 171.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' H ' HG22 ' A' ' 82' ' ' THR . 10.5 pt-20 -136.55 13.27 3.21 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.676 -1.265 . . . . 74.23 113.408 -160.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.75 108.24 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 N-CA-C 109.337 -0.616 . . . . 72.43 109.337 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.18 -77.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.761 1.624 . . . . 75.43 111.448 -172.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.69 57.11 0.31 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.254 -0.739 . . . . 61.52 111.254 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.59 -17.29 59.85 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.044 0.538 . . . . 74.03 112.277 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -55.16 -40.56 70.76 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.774 0.43 . . . . 73.22 110.792 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.23 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.701 0.801 . . . . 53.4 112.87 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.646 HG21 ' HB3' ' A' ' 35' ' ' ALA . 14.0 t -71.53 -33.2 68.98 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.644 0.378 . . . . 72.32 111.005 -175.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 81' ' ' TYR . . . -80.85 -30.08 35.75 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 74.55 111.872 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.617 1.167 . . . . 64.25 110.15 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.96 -27.03 68.56 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.453 -0.794 . . . . 50.52 112.056 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.715 HG11 HG21 ' A' ' 118' ' ' VAL . 24.0 t -81.4 -58.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.45 0 C-N-CA 123.129 0.571 . . . . 73.24 111.046 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -61.82 -29.23 71.69 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.714 -0.676 . . . . 62.51 113.865 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -79.27 -24.97 42.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.064 0.546 . . . . 73.31 110.897 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -77.68 -47.99 17.84 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.088 0.471 . . . . 52.15 110.015 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 120' ' ' VAL . 51.4 tp -68.56 -32.06 71.71 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.137 0.975 . . . . 50.33 111.44 -177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.93 34.44 24.3 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-N 116.186 -0.461 . . . . 62.15 112.352 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.81 140.37 49.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.09 0.956 . . . . 71.44 108.796 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.12 130.38 41.94 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.406 0.682 . . . . 73.35 110.941 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -86.33 120.79 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 123.884 0.874 . . . . 74.12 110.296 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -126.8 159.21 34.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.466 1.106 . . . . 73.41 109.874 176.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.78 168.68 12.86 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.03 111.632 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -27.59 65.66 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.929 1.291 . . . . 72.43 113.781 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt 65.03 173.13 0.08 OUTLIER Pre-proline 0 CA--C 1.568 1.654 0 N-CA-C 113.276 0.843 . . . . 72.33 113.276 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.76 -17.1 34.34 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.438 2.092 . . . . 74.51 112.67 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 112' ' ' GLN . 3.2 mp0 -65.05 -15.67 62.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.524 1.129 . . . . 73.42 112.967 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 112' ' ' GLN . 0.3 OUTLIER -61.89 -23.81 66.55 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 118.473 0.579 . . . . 74.04 109.505 -178.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.3 p -51.43 -32.5 26.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.943 0.897 . . . . 75.22 111.826 174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.52 -32.29 7.77 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.737 0.815 . . . . 53.01 111.138 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.555 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 26.0 mt-30 -64.35 133.88 95.8 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.174 0.59 . . . . 62.41 110.909 -173.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HD2' HG21 ' A' ' 117' ' ' ILE . 52.7 Cg_exo -58.17 147.44 83.7 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.357 2.705 . . . . 71.33 113.331 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 47.3 Cg_exo -57.55 131.24 43.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.583 2.855 . . . . 72.31 113.441 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.47 -178.39 31.4 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.937 -0.865 . . . . 63.53 110.937 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 m -76.4 123.9 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 109.733 -0.469 . . . . 72.54 109.733 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.568 HG21 ' HD2' ' A' ' 113' ' ' PRO . 22.7 pt -107.49 114.17 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.876 0.846 . . . . 65.52 109.843 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.791 HG13 HG22 ' A' ' 79' ' ' VAL . 58.6 t -92.62 100.83 11.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.455 -1.313 . . . . 64.33 107.455 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 10.9 p -107.41 125.57 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.552 0.691 . . . . 72.31 110.819 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.403 HG22 HD21 ' A' ' 98' ' ' LEU . 11.3 t -119.67 138.41 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.506 0.723 . . . . 64.21 111.231 -169.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 t -128.01 132.06 49.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.702 -0.851 . . . . 61.23 108.702 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.419 0 CA-C-O 118.723 -1.043 . . . . 64.32 112.757 -177.603 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.354 -0.299 . . . . 32.01 112.354 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 p -67.52 100.98 0.92 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.953 0.901 . . . . 72.3 110.483 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.8 t -143.3 67.65 16.92 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 123.816 0.846 . . . . 55.42 109.57 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.41 104.22 1.17 Allowed 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.79 2.327 . . . . 64.34 110.862 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -123.17 113.71 19.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.743 0.817 . . . . 74.54 109.152 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -116.99 68.45 0.74 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.696 0.76 . . . . 65.05 110.269 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -83.45 -18.33 38.97 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.161 -0.927 . . . . 72.4 111.321 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -72.45 -12.21 61.0 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.686 0.395 . . . . 65.01 111.765 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.36 102.03 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.464 1.106 . . . . 71.23 111.685 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.4 p -107.57 163.65 12.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.124 0.97 . . . . 60.24 110.548 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.1 t -112.63 163.38 14.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.617 0.767 . . . . 71.11 110.144 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.07 131.96 20.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.758 0.823 . . . . 74.24 109.841 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.7 pt -136.63 121.42 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.657 0.783 . . . . 72.43 109.737 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -157.17 129.75 7.5 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.259 1.024 . . . . 73.43 109.36 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.2 m -149.03 115.59 5.89 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.725 -0.842 . . . . 64.12 108.725 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -141.73 109.77 5.84 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.891 -1.151 . . . . 70.15 107.891 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -139.56 119.37 13.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.476 0.655 . . . . 65.23 110.292 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 p -142.15 150.24 40.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.844 1.258 . . . . 65.31 108.689 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.4 p -142.48 152.92 43.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.447 1.099 . . . . 53.33 108.963 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -159.85 155.34 25.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.065 0.546 . . . . 74.43 110.664 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.15 157.52 23.34 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.409 1.083 . . . . 35.23 109.051 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.92 107.15 11.57 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.43 0.692 . . . . 64.3 109.568 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.98 -172.82 1.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.98 2.453 . . . . 74.43 112.167 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.0 t -170.21 146.13 2.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.598 0.759 . . . . 54.41 110.174 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.3 p -92.64 166.8 12.3 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.289 -0.634 . . . . 73.43 109.289 171.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.4 t -133.72 137.28 45.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.253 0.621 . . . . 74.44 110.509 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.4 p -167.46 153.01 7.4 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.634 0.774 . . . . 62.41 110.235 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -167.33 109.81 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 C-N-CA 123.713 0.805 . . . . 73.53 110.403 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -126.33 120.42 23.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 C-N-CA 123.347 0.659 . . . . 64.24 110.361 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -84.37 124.19 3.17 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.464 2.11 . . . . 64.24 111.32 172.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.91 109.68 1.61 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.267 0.627 . . . . 45.33 110.189 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.46 84.97 2.81 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.834 0.854 . . . . 63.43 109.248 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -78.32 129.0 9.24 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.402 2.068 . . . . 63.2 111.478 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -93.0 -164.88 1.24 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.652 0.781 . . . . 74.4 110.168 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.75 155.87 34.81 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 109.524 -0.547 . . . . 53.03 109.524 169.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 63' ' ' VAL . 8.6 pt-20 -66.54 121.56 15.63 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.424 -0.807 . . . . 73.14 110.224 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 t -92.76 144.3 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.126 -0.943 . . . . 72.41 109.073 -175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 5.9 ptp85 -151.25 161.19 43.16 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.92 0.488 . . . . 74.42 110.885 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 50' ' ' ALA . 58.8 t -126.27 123.89 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.955 . . . . 75.32 109.081 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -112.31 108.06 17.12 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 124.286 1.035 . . . . 74.34 109.326 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.457 HD22 ' HB ' ' A' ' 120' ' ' VAL . 16.7 m120 -78.5 112.99 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.772 -1.195 . . . . 51.53 107.772 170.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 70' ' ' SER . 3.0 tp -75.85 -43.25 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.362 -0.607 . . . . 52.21 109.362 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -144.17 156.02 44.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.888 0.875 . . . . 74.31 108.843 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.89 6.94 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.146 -0.808 . . . . 74.11 113.325 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.2 t 40.79 78.46 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.949 1.7 . . . . 54.34 113.106 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -121.68 114.49 21.21 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.914 0.485 . . . . 70.04 110.468 -174.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.01 -11.9 84.92 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.42 -0.809 . . . . 71.22 113.605 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.62 91.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.237 0.615 . . . . 75.53 110.9 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -70.7 -33.39 70.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.689 -0.687 . . . . 41.23 110.727 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' HG21 ' A' ' 39' ' ' VAL . . . -77.49 -21.87 52.13 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.366 0.666 . . . . 71.34 112.135 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -66.08 -28.67 69.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.843 1.257 . . . . 63.44 111.049 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 98' ' ' LEU . 78.2 p -63.02 -46.47 87.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.136 0.574 . . . . 63.54 110.713 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -29.58 65.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.535 0.734 . . . . 63.11 111.169 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.09 -28.62 69.75 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.176 0.59 . . . . 71.51 111.415 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -69.04 -36.98 78.32 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.603 0.361 . . . . 74.33 110.659 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.6 mp -62.54 -24.29 67.43 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.17 0.588 . . . . 63.11 111.586 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -56.42 -49.02 75.74 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.262 0.625 . . . . 64.11 110.314 173.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.02 -24.12 41.03 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.515 -0.766 . . . . 75.33 111.613 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -74.5 -17.31 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.374 0.67 . . . . 65.23 111.928 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 33.73 2.53 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.055 0.382 . . . . 65.22 114.055 170.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -100.37 157.62 16.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.512 0.725 . . . . 62.2 109.815 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.8 m -62.31 -73.82 0.1 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.881 . . . . 64.41 112.291 -161.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 36' ' ' GLU . 75.6 t -123.02 144.29 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.319 -1.363 . . . . 64.1 107.319 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.4 p -138.6 101.36 4.32 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.987 -1.486 . . . . 75.51 106.987 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 9.3 t70 -107.21 149.62 27.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 64.14 109.967 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.418 HG22 ' HB1' ' A' ' 50' ' ' ALA . 88.7 t -127.32 137.14 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.942 0.897 . . . . 61.33 108.995 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.43 159.6 32.54 Favored Glycine 0 C--N 1.344 1.018 0 O-C-N 123.539 0.524 . . . . 61.0 111.862 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -123.97 104.74 9.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.461 1.105 . . . . 74.42 108.314 174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 mp -133.36 134.09 43.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.049 0.54 . . . . 54.14 110.13 -171.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.496 ' HA ' HD12 ' A' ' 42' ' ' ILE . 24.6 p -85.4 98.68 10.71 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.543 -0.753 . . . . 62.03 108.975 172.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.652 ' HB2' HG22 ' A' ' 74' ' ' VAL . 82.6 mt -107.35 141.6 23.32 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.434 -0.951 . . . . 75.25 108.434 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.86 -17.87 17.38 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.575 2.183 . . . . 72.13 113.403 -169.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -94.78 -24.61 17.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.208 1.003 . . . . 73.24 111.844 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 108' ' ' GLU . 13.1 m -91.88 147.03 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.844 0.457 . . . . 41.01 109.975 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -164.79 -41.79 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.817 0.847 . . . . 35.12 109.772 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.58 134.45 33.63 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.007 -0.997 . . . . 41.22 110.325 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.627 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.8 t -74.83 98.24 3.47 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 122.272 1.034 . . . . 73.24 109.114 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' A' ' 80' ' ' TYR . 63.2 m -153.83 155.03 35.03 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.377 -1.283 . . . . 73.01 108.808 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.694 HG13 HG22 ' A' ' 118' ' ' VAL . 23.5 t -94.57 116.22 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.516 -0.92 . . . . 64.53 108.516 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CZ ' ' HB ' ' A' ' 78' ' ' THR . 75.4 m-85 -108.53 132.75 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.4 0.68 . . . . 73.41 111.904 -171.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.588 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 38.9 p90 -144.59 -177.18 5.37 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.919 0.888 . . . . 74.2 110.662 -175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 p -141.09 -91.72 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 118.891 -0.576 . . . . 74.01 110.095 165.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.47 -22.18 0.82 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.266 1.21 . . . . 60.11 114.266 -170.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 95.9 t -58.88 117.18 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 124.161 0.984 . . . . 54.12 112.046 -169.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 52.52 25.86 3.88 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.533 1.133 . . . . 61.15 113.635 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.11 57.59 5.63 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.774 -0.53 . . . . 44.13 111.774 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.1 mt-10 -52.69 -44.95 66.61 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.768 . . . . 72.44 111.989 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -65.34 -25.38 67.57 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.819 0.847 . . . . 73.32 112.566 -176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.96 0.504 . . . . 52.51 110.615 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.426 HG23 HG11 ' A' ' 116' ' ' VAL . 10.0 t -82.33 -26.99 32.52 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.469 -0.787 . . . . 71.21 111.177 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.728 ' HB2' HG21 ' A' ' 116' ' ' VAL . . . -69.03 -36.69 78.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.832 0.853 . . . . 44.04 111.012 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.23 -49.29 78.19 Favored 'General case' 0 C--N 1.347 0.478 0 O-C-N 124.746 1.279 . . . . 73.03 109.766 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.86 78.54 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.352 1.032 . . . . 53.5 112.025 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 118' ' ' VAL . 64.8 t -63.65 -53.89 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 122.974 0.51 . . . . 61.41 110.548 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.74 -23.46 69.06 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 124.164 0.915 . . . . 61.02 113.87 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -76.1 -39.35 55.46 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.955 -0.757 . . . . 71.23 108.955 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.7 m -74.6 -34.45 62.85 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.308 -0.86 . . . . 74.52 112.119 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.573 ' HB3' HG21 ' A' ' 52' ' ' THR . 3.4 pp -93.74 -17.57 23.03 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.127 0.421 . . . . 62.45 111.932 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.48 52.75 4.08 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 113.966 0.346 . . . . 52.32 113.966 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.73 168.41 16.56 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.756 0.822 . . . . 63.44 109.718 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.46 165.5 25.02 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.599 0.759 . . . . 63.43 110.604 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.588 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 31.2 m -123.8 114.81 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 123.55 0.74 . . . . 55.12 109.586 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 80' ' ' TYR . 35.5 mm-40 -124.39 174.78 7.53 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.538 1.135 . . . . 74.24 110.156 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.16 149.48 27.93 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.676 -0.693 . . . . 74.41 109.874 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . 24.4 ptt180 -88.09 28.38 1.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.757 1.223 . . . . 72.02 111.641 -178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.596 ' HG ' ' HD3' ' A' ' 107' ' ' PRO . 4.3 pp -68.12 -32.31 3.93 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 117.597 -1.192 . . . . 55.13 112.728 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.596 ' HD3' ' HG ' ' A' ' 106' ' ' LEU . 13.1 Cg_exo -75.16 -34.48 3.66 Favored 'Trans proline' 0 C--N 1.405 3.506 0 CA-C-N 122.518 1.935 . . . . 73.22 111.914 167.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.711 ' HG3' HG12 ' A' ' 74' ' ' VAL . 8.3 mp0 -72.43 -10.5 59.87 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.542 1.137 . . . . 74.03 111.077 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 112' ' ' GLN . 13.1 tp -68.78 -12.41 61.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.31 1.044 . . . . 73.31 111.12 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -61.9 -46.78 87.9 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.619 0.768 . . . . 42.2 110.909 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.01 -33.82 26.45 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.795 0.838 . . . . 53.54 109.677 172.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.469 ' HG2' HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER 57.57 74.22 0.68 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.983 1.313 . . . . 71.0 111.028 -179.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 79.3 Cg_endo -83.41 132.69 6.0 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 C-N-CA 122.712 2.275 . . . . 75.3 111.656 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 51.8 Cg_exo -58.32 152.65 52.12 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.705 2.937 . . . . 63.35 114.409 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.26 -167.5 27.38 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.222 -0.899 . . . . 72.41 113.616 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.728 HG21 ' HB2' ' A' ' 91' ' ' ALA . 3.2 p -87.06 131.95 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.311 -0.625 . . . . 73.23 109.311 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.46 149.81 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.859 0.864 . . . . 60.1 109.829 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.694 HG22 HG13 ' A' ' 79' ' ' VAL . 47.7 t -121.55 103.58 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.036 -1.468 . . . . 60.15 107.036 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.595 HG11 ' HB ' ' A' ' 74' ' ' VAL . 95.5 t -93.51 123.82 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.518 -0.919 . . . . 73.34 108.518 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.472 HG21 ' HB1' ' A' ' 49' ' ' ALA . 58.0 t -128.74 129.86 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.342 0.657 . . . . 54.31 109.84 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.627 ' H ' ' HB ' ' A' ' 77' ' ' THR . 9.5 t -105.8 155.86 18.88 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.332 0.653 . . . . 74.13 109.83 168.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.027 0 CA-C-O 119.174 -0.792 . . . . 37.37 111.764 179.569 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.874 0 N-CA-C 112.109 -0.397 . . . . 61.14 112.109 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -169.4 163.25 10.54 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.192 0.597 . . . . 40.55 110.563 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -149.93 141.91 15.3 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.909 0.884 . . . . 71.3 109.465 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.16 139.97 47.94 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.722 2.281 . . . . 74.52 112.666 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -101.54 129.01 47.53 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.63 0.772 . . . . 73.12 109.448 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -141.75 35.39 1.6 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.652 0.781 . . . . 71.54 110.032 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -85.64 2.44 45.17 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.016 0.526 . . . . 74.12 111.884 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.0 -69.23 0.36 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.204 0.602 . . . . 70.43 110.571 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.0 t70 59.84 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.034 1.334 . . . . 54.53 111.87 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.0 t -103.61 103.74 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.727 -0.842 . . . . 74.45 108.727 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.9 m -134.47 123.49 24.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.68 0.792 . . . . 55.35 110.334 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.63 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.696 0.798 . . . . 55.1 110.23 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.69 143.16 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.072 -1.084 . . . . 74.43 108.072 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -164.24 111.92 1.11 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.327 0.651 . . . . 74.22 110.225 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.1 t -161.71 125.81 3.3 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.305 1.042 . . . . 71.2 109.333 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.3 ptp -171.57 146.44 2.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.906 0.882 . . . . 73.03 110.241 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -173.58 141.19 0.84 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.042 0.937 . . . . 64.21 109.66 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.6 t -167.13 106.23 0.58 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.468 0.707 . . . . 74.12 110.64 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -161.1 102.92 1.27 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.251 1.421 . . . . 74.3 109.082 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.1 p -135.58 125.7 26.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.757 0.823 . . . . 74.34 109.947 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.34 132.05 7.72 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.173 0.989 . . . . 54.23 109.942 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.48 107.35 10.08 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.617 0.767 . . . . 74.52 109.983 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.41 144.75 20.57 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.953 2.435 . . . . 61.31 111.863 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.3 p -122.41 148.41 45.14 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.694 0.398 . . . . 70.15 110.685 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m -146.28 111.88 5.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.716 0.806 . . . . 53.53 109.925 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.5 p -124.74 129.45 50.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.92 0.888 . . . . 55.33 109.473 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.0 m -150.49 111.45 4.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.739 0.816 . . . . 75.43 108.873 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.75 131.36 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.484 0.714 . . . . 72.23 109.992 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -123.79 112.73 28.84 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.146 0.979 . . . . 73.31 108.747 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.13 120.65 8.45 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.391 2.061 . . . . 74.23 111.633 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -177.81 122.93 0.11 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.738 0.815 . . . . 63.21 109.861 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -170.19 95.7 0.47 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 123.848 0.859 . . . . 63.22 109.086 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.66 127.56 12.52 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.998 1.799 . . . . 72.44 111.158 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -105.57 -84.53 0.5 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.79 -0.818 . . . . 64.5 108.79 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -152.7 174.71 13.67 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.293 0.637 . . . . 63.52 110.17 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.81 108.13 19.7 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.008 0.923 . . . . 71.33 110.441 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 41.3 t -106.88 138.7 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.192 0.997 . . . . 61.41 109.613 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.53 128.95 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.433 -0.58 . . . . 73.12 109.433 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 53' ' ' ALA . 98.3 t -103.72 128.11 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.34 0.656 . . . . 75.32 109.389 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.654 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 38.3 m-85 -124.03 131.45 53.56 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.423 0.689 . . . . 74.52 110.286 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -85.7 112.08 20.7 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.988 -1.115 . . . . 72.52 107.988 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.825 HD11 ' HA ' ' A' ' 71' ' ' LEU . 9.2 tp -75.31 -47.19 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.042 0.449 . . . . 74.03 111.355 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 m -107.51 3.18 24.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.988 0.915 . . . . 72.22 110.383 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.7 136.83 1.48 Allowed Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.52 -0.632 . . . . 51.1 111.52 -170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 t -157.28 -178.95 7.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.359 0.664 . . . . 71.52 110.032 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.72 154.11 42.22 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.222 1.009 . . . . 32.11 111.071 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.79 -2.49 16.99 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 115.022 0.769 . . . . 42.44 115.022 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.51 -28.12 69.73 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.612 0.765 . . . . 74.33 111.518 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.2 -42.75 75.36 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.277 0.631 . . . . 42.31 110.576 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.36 -28.46 67.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.61 -0.723 . . . . 73.54 111.667 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -65.28 -24.95 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.601 1.16 . . . . 74.33 111.752 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 98' ' ' LEU . 68.9 p -71.89 -47.59 51.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.367 0.267 . . . . 75.33 110.605 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -61.73 -40.1 93.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.308 0.575 . . . . 73.14 110.639 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.29 -32.96 74.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.532 -1.213 . . . . 63.4 111.422 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -72.04 -41.07 67.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.054 0.542 . . . . 73.34 109.66 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -70.91 -26.03 63.03 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.394 -0.821 . . . . 72.3 111.336 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -61.71 -51.22 69.29 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 109.077 -0.712 . . . . 71.44 109.077 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.3 71.36 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.152 -0.931 . . . . 74.21 111.143 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.43 1.25 16.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.536 0.734 . . . . 73.01 112.309 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.6 40.19 11.27 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 113.96 0.344 . . . . 54.53 113.96 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -89.09 155.27 19.56 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.246 0.523 . . . . 73.21 109.76 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -66.03 -60.33 2.94 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.041 0.756 . . . . 75.2 113.041 -159.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.27 103.21 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.326 -0.99 . . . . 63.5 108.326 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 16.8 p -107.96 105.51 15.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 73.43 109.86 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -115.16 156.64 24.9 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.649 1.18 . . . . 73.4 109.679 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -146.77 144.54 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.768 0.427 . . . . 72.41 111.023 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -169.57 -158.54 13.61 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.498 -0.641 . . . . 60.41 111.498 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -107.49 173.42 6.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.23 -0.656 . . . . 74.31 109.23 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 27.7 tp -144.51 138.99 27.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 111.258 0.096 . . . . 63.25 111.258 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.7 p -87.57 133.58 33.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.67 -0.863 . . . . 72.23 108.67 170.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.825 ' HA ' HD11 ' A' ' 42' ' ' ILE . 32.4 tp -44.17 101.45 0.25 Allowed Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 125.177 1.391 . . . . 72.13 113.949 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.85 -100.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.109 2.539 . . . . 32.33 109.96 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.07 -22.13 12.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.054 0.942 . . . . 45.11 111.621 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.97 128.07 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.647 -0.501 . . . . 74.4 109.647 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.57 16.43 9.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.937 0.895 . . . . 71.44 111.536 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.5 156.97 46.17 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.559 0.744 . . . . 45.34 109.916 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.3 t -62.34 100.47 0.18 Allowed 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.057 0.932 . . . . 74.31 110.316 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.2 m -148.12 143.07 26.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.194 0.998 . . . . 72.34 109.321 -172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 118' ' ' VAL . 42.6 t -95.94 115.86 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 107.603 -1.258 . . . . 42.03 107.603 173.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.553 ' HB3' HG13 ' A' ' 117' ' ' ILE . 32.3 t80 -107.86 113.76 27.21 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.908 -1.145 . . . . 74.34 107.908 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.548 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 41.9 p90 -141.32 147.43 38.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.135 0.791 . . . . 74.13 113.135 -170.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -85.94 -157.82 0.36 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 107.96 -1.126 . . . . 70.33 107.96 167.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 82' ' ' THR . 47.2 mt-10 -124.99 7.18 7.97 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.108 -0.995 . . . . 64.31 110.907 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 98.7 t -66.61 128.41 29.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 C-N-CA 123.82 0.848 . . . . 74.31 109.603 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 84' ' ' VAL . 35.4 mt-10 62.1 20.9 12.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.523 0.729 . . . . 74.04 111.125 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.35 35.5 52.31 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.683 -0.51 . . . . 63.32 113.387 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 29.4 mt-10 -52.57 -33.47 45.98 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.933 0.716 . . . . 74.24 112.933 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -64.57 -31.34 72.52 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.839 0.455 . . . . 74.21 112.182 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.99 -37.41 29.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.505 0.722 . . . . 75.04 111.554 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.466 HG21 ' HB3' ' A' ' 35' ' ' ALA . 69.5 p -74.41 -36.83 63.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.466 -0.788 . . . . 72.22 110.894 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -30.72 69.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.498 -1.228 . . . . 63.41 111.89 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.29 -44.33 92.52 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.333 1.021 . . . . 72.12 110.136 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.01 75.26 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.516 -0.765 . . . . 53.13 112.272 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.667 HG11 HG21 ' A' ' 118' ' ' VAL . 64.3 t -74.32 -59.3 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 116.498 -0.319 . . . . 74.22 110.519 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.84 -23.05 55.67 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.811 0.694 . . . . 72.11 114.011 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -67.87 -60.03 2.83 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.485 1.114 . . . . 73.41 109.758 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.6 m -71.63 -32.76 68.3 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 114.902 -1.045 . . . . 74.2 111.141 -172.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.57 ' HB2' HG21 ' A' ' 52' ' ' THR . 48.7 tp -81.11 -27.28 35.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.941 0.896 . . . . 72.24 110.497 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.74 43.65 83.68 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.564 0.54 . . . . 74.42 112.667 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.53 25.04 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.774 0.83 . . . . 75.11 110.173 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.77 139.98 58.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.32 0.648 . . . . 75.41 110.355 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.548 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 35.2 m -112.15 131.83 62.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.425 0.69 . . . . 52.11 109.24 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.53 144.2 46.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.565 0.746 . . . . 74.44 111.309 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.636 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 16.2 tp -66.36 -177.2 0.51 Allowed 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 114.198 -1.364 . . . . 73.42 110.815 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.636 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 6.7 ppt_? -56.51 -28.6 60.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.863 1.265 . . . . 65.04 113.733 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 104' ' ' LEU . 74.6 mt 62.1 168.04 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.538 1.135 . . . . 74.2 113.039 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -73.25 -12.34 25.35 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.285 1.99 . . . . 44.4 112.605 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -69.49 -18.85 63.73 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.227 1.011 . . . . 64.53 112.624 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.8 -4.26 19.27 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.666 0.617 . . . . 63.34 112.666 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -60.25 -21.72 62.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.266 0.626 . . . . 61.34 111.763 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -115.51 -32.99 5.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.84 0.856 . . . . 74.21 110.83 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -96.41 127.03 41.51 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.065 0.946 . . . . 74.22 110.846 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.96 134.11 57.94 Favored 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 122.18 1.92 . . . . 75.22 112.7 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.91 163.12 32.16 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.278 2.652 . . . . 70.42 113.415 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 130.58 146.36 5.9 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 108.647 -1.781 . . . . 43.45 108.647 -171.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 53.7 t -65.0 99.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 118.718 1.259 . . . . 55.42 108.767 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.553 HG13 ' HB3' ' A' ' 80' ' ' TYR . 29.4 pt -107.57 106.93 21.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.467 -1.308 . . . . 71.12 107.467 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG22 HG13 ' A' ' 79' ' ' VAL . 42.1 t -89.83 101.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.34 -1.356 . . . . 60.23 107.34 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.401 HG13 ' HB ' ' A' ' 42' ' ' ILE . 65.0 t -93.67 113.14 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 107.33 -1.359 . . . . 73.33 107.33 -174.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.53 127.36 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 110.223 -0.288 . . . . 72.21 110.223 -171.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.2 p -89.98 160.54 16.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.938 0.895 . . . . 74.43 109.743 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.958 -0.912 . . . . 61.01 111.373 178.509 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.113 -0.395 . . . . 55.13 112.113 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 t -136.85 144.84 43.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.166 0.586 . . . . 61.13 110.279 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -85.54 141.35 36.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.003 0.921 . . . . 74.42 110.797 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -60.13 139.65 88.46 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.967 2.445 . . . . 73.24 112.387 168.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -100.97 136.93 40.04 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.294 0.638 . . . . 73.3 110.45 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -121.41 56.28 1.05 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.677 -0.86 . . . . 72.15 108.677 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -84.46 0.6 49.02 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.19 -0.914 . . . . 72.05 112.308 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.48 -45.24 81.06 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.435 1.094 . . . . 72.0 111.555 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.3 t70 68.95 141.83 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.008 1.323 . . . . 53.14 112.929 172.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.5 m -92.93 -179.69 5.19 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.0 0.92 . . . . 71.23 110.393 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -160.76 145.12 13.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.03 0.532 . . . . 63.13 109.974 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.73 139.47 20.75 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.463 0.705 . . . . 71.23 109.941 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 pt -108.87 167.02 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.008 0.923 . . . . 73.33 111.057 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 t -83.84 -167.29 1.67 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.324 1.049 . . . . 63.21 110.419 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.9 m -141.04 137.28 32.82 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.034 0.934 . . . . 73.32 109.246 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.495 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.5 OUTLIER -95.09 127.67 41.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.84 0.856 . . . . 74.12 110.134 -175.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 m -145.9 144.33 30.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.76 0.824 . . . . 73.11 109.776 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -145.01 166.06 26.41 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.88 0.872 . . . . 75.04 110.638 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -136.95 143.31 42.79 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.662 0.785 . . . . 45.1 109.83 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.9 t -103.11 176.45 5.14 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.321 1.048 . . . . 72.21 110.107 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.8 170.53 15.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.461 0.704 . . . . 50.21 110.482 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.36 120.06 15.7 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.344 1.057 . . . . 64.15 109.968 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.04 159.97 37.12 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.626 2.217 . . . . 43.52 112.422 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -149.42 140.02 22.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 71.4 109.322 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 p -145.45 139.68 27.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.227 0.611 . . . . 74.41 110.038 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -121.41 176.01 5.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.136 0.974 . . . . 72.23 109.947 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.2 p -146.65 136.76 23.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.814 0.846 . . . . 73.43 109.646 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.83 147.91 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.402 0.681 . . . . 62.24 110.251 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -103.86 157.02 34.8 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 123.81 0.844 . . . . 63.52 109.844 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.43 163.42 23.83 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.477 2.118 . . . . 72.22 111.708 170.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.95 173.47 7.41 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.248 0.619 . . . . 72.33 111.213 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.25 147.22 33.84 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.852 0.861 . . . . 71.44 110.006 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.05 163.23 29.46 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.075 2.517 . . . . 71.13 112.795 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -140.08 147.19 39.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.188 0.44 . . . . 74.0 112.188 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.491 ' H ' HG21 ' A' ' 62' ' ' THR . . . -86.08 177.76 7.45 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.611 1.164 . . . . 34.14 110.554 173.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -142.25 102.21 4.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.755 0.822 . . . . 72.44 109.96 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 64' ' ' THR . 11.4 t -114.67 151.35 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-O 121.839 0.828 . . . . 74.3 111.584 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.619 ' HB3' HG22 ' A' ' 117' ' ' ILE . 33.2 ttm105 -153.64 141.29 19.94 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.121 1.369 . . . . 72.51 108.872 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' HB1' ' A' ' 49' ' ' ALA . 39.0 t -131.48 119.83 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.7 0.8 . . . . 73.33 108.904 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' CE2' HD23 ' A' ' 71' ' ' LEU . 45.4 p90 -141.6 149.13 40.31 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.09 0.471 . . . . 73.45 111.125 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -78.81 141.28 37.88 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.09 -0.959 . . . . 74.24 109.051 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.556 HD13 HG13 ' A' ' 74' ' ' VAL . 9.2 tp -79.61 -36.97 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 122.783 0.433 . . . . 73.15 110.123 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -96.39 -39.14 9.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.647 0.779 . . . . 43.51 109.96 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.08 60.82 2.2 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.953 -0.567 . . . . 70.11 112.004 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m -119.17 -42.64 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.596 0.759 . . . . 62.0 110.812 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -122.22 148.13 45.35 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.025 0.53 . . . . 75.51 110.926 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.03 1.57 63.13 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-O 119.124 -0.82 . . . . 54.52 114.274 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.18 -35.03 10.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.742 1.217 . . . . 74.4 113.368 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.419 ' HB1' HG12 ' A' ' 39' ' ' VAL . . . -63.07 -52.2 63.68 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 123.226 0.611 . . . . 61.01 111.033 175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.87 -27.48 68.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.412 -0.813 . . . . 71.4 111.402 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 18.4 ttm180 -70.46 -52.4 22.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.522 0.729 . . . . 74.11 110.644 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -72.97 -23.96 60.72 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.075 -0.511 . . . . 74.05 110.954 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.42 -20.67 54.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.974 0.909 . . . . 33.32 111.816 173.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 51' ' ' ARG . 15.4 t70 -72.45 -41.1 66.5 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.276 1.03 . . . . 54.13 109.11 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -63.51 -38.0 89.45 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.593 -1.185 . . . . 75.44 109.556 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 HG11 ' A' ' 37' ' ' VAL . 62.6 tp -63.12 -50.65 69.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.116 0.966 . . . . 52.2 112.331 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -67.66 -27.17 66.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.846 0.355 . . . . 70.44 110.811 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.82 -20.85 34.87 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.679 0.791 . . . . 71.21 111.202 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.6 -23.48 27.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.541 0.736 . . . . 72.14 111.623 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.74 48.89 0.32 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.718 -0.49 . . . . 63.25 112.988 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 1.5 p90 -57.32 157.46 6.44 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.403 0.681 . . . . 73.1 111.099 174.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.491 HG21 ' H ' ' A' ' 35' ' ' ALA . 28.3 m -89.97 -66.34 0.93 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.133 -1.062 . . . . 62.3 108.133 173.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.0 p -144.28 134.37 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.135 -1.802 . . . . 63.54 106.135 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 91.4 m -143.25 123.59 13.85 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 122.836 0.454 . . . . 74.11 109.891 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -102.08 126.01 48.92 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.721 -0.844 . . . . 72.11 108.721 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.76 146.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.873 0.469 . . . . 71.52 110.25 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.25 -136.04 3.94 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 123.476 0.485 . . . . 75.31 113.314 174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -159.39 117.53 2.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.115 0.966 . . . . 62.24 109.677 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.2 tp -150.65 140.7 22.05 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.257 0.623 . . . . 73.25 109.767 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.444 ' HA ' HD12 ' A' ' 42' ' ' ILE . 39.0 m -88.61 99.35 12.26 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.302 0.641 . . . . 73.44 110.236 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' CE2' ' A' ' 40' ' ' TYR . 4.5 mm? -85.05 125.16 71.16 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.351 -0.981 . . . . 73.25 108.351 168.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 -11.85 32.33 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.67 2.246 . . . . 64.24 113.321 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.73 -22.79 23.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.84 0.856 . . . . 71.41 112.334 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 42' ' ' ILE . 11.0 p -123.89 154.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.336 0.654 . . . . 65.34 110.131 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.36 40.61 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.209 1.004 . . . . 73.32 109.481 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.6 38.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.663 0.785 . . . . 55.11 110.57 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.747 ' HB ' HG22 ' A' ' 121' ' ' THR . 10.0 t -75.11 99.95 4.1 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.421 1.105 . . . . 42.12 108.688 172.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.7 m -149.13 131.01 15.17 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.02 -0.991 . . . . 51.21 109.492 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.755 HG22 HG13 ' A' ' 118' ' ' VAL . 86.9 t -95.62 114.13 31.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.526 -0.916 . . . . 75.43 108.526 174.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -101.51 137.43 39.84 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.084 -1.08 . . . . 71.52 108.084 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.488 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 43.9 p90 -134.46 143.08 47.31 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.765 0.793 . . . . 74.21 112.689 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.2 m -95.28 169.63 9.95 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 113.845 -1.525 . . . . 65.15 107.376 170.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -116.03 13.61 15.91 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.317 0.858 . . . . 55.23 113.317 -165.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 86.0 t -64.21 115.0 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.9 0.48 . . . . 60.45 110.552 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 64.31 -77.17 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.937 1.295 . . . . 73.53 111.231 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.87 45.23 0.24 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.246 -0.342 . . . . 42.44 112.246 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . 42.4 mt-10 -61.22 -32.7 72.48 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.511 0.724 . . . . 72.42 112.31 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -56.73 -24.91 52.94 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.624 -0.716 . . . . 64.33 112.559 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.61 -43.64 75.97 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.616 0.766 . . . . 52.13 111.915 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.0 p -69.35 -39.64 77.99 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.423 -0.584 . . . . 74.42 109.423 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.97 96.99 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.367 1.067 . . . . 30.23 112.082 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.48 -38.38 87.15 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.377 1.048 . . . . 60.01 110.305 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.49 69.88 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.81 0.694 . . . . 73.34 110.655 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 118' ' ' VAL . 62.1 t -67.41 -35.42 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.334 0.654 . . . . 74.12 110.856 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -68.72 -34.89 79.02 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 116.029 -0.532 . . . . 73.33 112.959 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -72.21 -44.26 63.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.608 0.763 . . . . 70.51 109.877 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.5 m -67.02 -37.85 84.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.225 1.01 . . . . 74.43 111.337 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 43.9 tp -81.73 -32.13 31.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.697 0.799 . . . . 73.33 110.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.91 40.84 15.92 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.934 -0.576 . . . . 72.51 112.081 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.56 156.27 24.96 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.519 0.728 . . . . 74.4 111.16 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.37 23.34 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.009 0.923 . . . . 74.53 110.949 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.488 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 27.4 m -89.86 112.3 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-O 121.737 0.779 . . . . 74.21 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -113.54 158.3 20.93 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.506 1.122 . . . . 74.52 110.256 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.0 mt -66.84 -175.9 0.45 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.748 0.819 . . . . 70.22 110.743 171.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 5.4 ppt_? -59.19 -37.55 77.67 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 116.355 -0.384 . . . . 64.24 111.513 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.539 ' N ' ' HD2' ' A' ' 105' ' ' ARG . 83.8 mt 58.08 172.53 0.05 OUTLIER Pre-proline 0 CA--C 1.573 1.829 0 C-N-CA 123.64 0.776 . . . . 74.11 112.491 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.72 -12.31 17.55 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.55 2.166 . . . . 61.15 114.077 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.31 -46.78 82.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.712 1.205 . . . . 64.14 112.0 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.657 HD12 ' HA ' ' A' ' 114' ' ' PRO . 4.1 mm? -69.85 4.83 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.36 1.064 . . . . 65.43 113.429 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.9 t -72.1 -49.01 39.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.735 0.414 . . . . 74.41 110.368 171.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.87 -36.14 20.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.606 0.362 . . . . 50.53 111.36 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.484 ' HG3' HD13 ' A' ' 109' ' ' LEU . 4.8 pt20 -90.42 160.67 38.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-O 118.624 -0.703 . . . . 71.15 109.523 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.57 119.7 5.48 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.255 1.97 . . . . 74.22 112.66 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.657 ' HA ' HD12 ' A' ' 109' ' ' LEU . 56.4 Cg_endo -71.14 117.02 4.94 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.355 2.037 . . . . 65.24 113.2 -175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.437 ' H ' HD12 ' A' ' 109' ' ' LEU . . . 164.3 -161.08 34.16 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 110.858 -0.897 . . . . 63.42 110.858 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 70.6 t -77.07 106.24 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.231 -1.026 . . . . 75.25 108.231 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.619 HG22 ' HB3' ' A' ' 38' ' ' ARG . 2.8 pp -123.89 124.48 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.439 -0.949 . . . . 63.42 108.439 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.755 HG13 HG22 ' A' ' 79' ' ' VAL . 93.5 t -104.41 106.65 20.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.759 -1.2 . . . . 60.15 107.759 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.17 123.19 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.212 -0.662 . . . . 72.12 109.212 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 67.8 t -103.37 128.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.794 -0.817 . . . . 64.12 108.794 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.747 HG22 ' HB ' ' A' ' 77' ' ' THR . 10.1 t -72.94 132.32 43.31 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.467 -0.938 . . . . 43.22 108.467 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.082 0 N-CA-C 110.528 -1.029 . . . . 72.54 110.528 -166.352 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.449 0 N-CA-C 111.654 -0.579 . . . . 44.21 111.654 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -158.01 169.44 24.55 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.567 0.747 . . . . 63.45 110.172 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.4 p -146.94 110.86 4.09 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.742 0.817 . . . . 71.31 109.481 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.5 156.54 41.13 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.578 2.185 . . . . 71.01 113.23 171.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -125.24 139.62 53.57 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.434 1.094 . . . . 43.31 108.748 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 m -143.4 13.14 1.77 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.583 0.753 . . . . 73.22 111.218 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.42 -6.66 57.34 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.488 1.115 . . . . 65.25 111.807 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -57.02 -33.29 67.03 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.617 1.167 . . . . 74.22 112.103 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 67.9 168.79 0.26 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.41 1.084 . . . . 75.25 111.931 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.3 t -130.96 125.48 33.5 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.134 -0.691 . . . . 73.54 109.134 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.7 p -153.15 166.45 32.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.37 0.668 . . . . 60.51 109.964 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.98 154.55 51.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.509 0.724 . . . . 54.03 110.382 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 tt -144.48 138.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.786 0.834 . . . . 70.43 109.467 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.3 t -164.42 156.53 16.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.904 0.882 . . . . 72.11 109.743 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 t -162.95 154.77 17.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.201 0.6 . . . . 61.5 110.637 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.9 mtp -111.32 145.23 39.2 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.259 1.024 . . . . 72.4 109.932 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.7 p -141.7 138.2 32.25 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.905 0.882 . . . . 73.21 109.875 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -115.12 171.93 7.37 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.425 0.69 . . . . 65.34 109.877 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.2 m -150.83 134.91 16.79 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.737 0.815 . . . . 74.33 109.24 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.2 m -99.26 124.73 44.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.054 0.542 . . . . 73.42 110.151 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.6 109.28 18.37 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.832 0.853 . . . . 74.33 109.109 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.71 109.9 60.59 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.092 0.557 . . . . 54.1 109.754 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.77 -171.22 1.19 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.514 2.143 . . . . 63.43 112.089 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -167.05 -179.39 4.61 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.086 0.955 . . . . 75.42 109.432 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -132.45 167.49 19.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.407 0.683 . . . . 70.44 110.607 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -113.3 136.49 52.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.406 1.082 . . . . 61.22 109.949 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -87.95 134.09 33.79 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.038 0.535 . . . . 73.11 109.972 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.8 p -87.61 151.9 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.71 0.804 . . . . 75.1 109.493 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.43 147.48 33.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 123.482 0.713 . . . . 52.12 110.081 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.06 149.61 58.93 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.744 2.296 . . . . 64.21 111.526 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.92 160.37 27.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.194 0.598 . . . . 51.34 110.187 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.89 156.02 80.63 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.764 . . . . 74.52 110.874 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -48.27 129.45 19.11 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.453 2.768 . . . . 74.23 113.418 171.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -98.68 -59.58 1.71 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.103 0.561 . . . . 70.45 111.506 -174.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -156.23 168.04 28.53 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.955 0.724 . . . . 53.24 112.955 -167.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.43 124.36 33.34 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 113.969 -1.469 . . . . 54.52 110.426 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.1 t -110.65 140.06 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.333 1.053 . . . . 72.3 108.937 167.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -138.4 109.17 6.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.215 0.531 . . . . 71.51 109.873 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.586 ' HA ' ' HB ' ' A' ' 118' ' ' VAL . 41.1 t -95.46 134.05 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.384 1.074 . . . . 73.34 110.014 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.519 ' HE2' HD11 ' A' ' 42' ' ' ILE . 37.5 p90 -156.24 143.89 19.39 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.648 0.379 . . . . 75.13 110.53 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -97.19 142.99 28.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.503 -0.555 . . . . 75.31 109.503 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.519 HD11 ' HE2' ' A' ' 40' ' ' TYR . 7.2 mt -120.42 20.34 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-O 122.306 1.051 . . . . 70.1 109.891 -177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.2 m -150.18 -137.9 0.08 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.355 1.062 . . . . 73.23 108.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.07 92.25 0.05 OUTLIER Glycine 0 C--N 1.36 1.874 0 CA-C-N 118.416 0.553 . . . . 61.13 112.344 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 t -85.0 109.04 17.9 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.802 0.841 . . . . 73.34 112.122 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -103.59 171.15 7.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.141 -0.936 . . . . 73.14 109.196 166.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 -2.01 79.65 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.432 -0.349 . . . . 53.32 113.457 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.03 -30.18 71.4 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.939 0.896 . . . . 65.43 112.443 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.52 97.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.27 0.628 . . . . 64.23 110.891 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.62 -25.61 67.46 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.706 0.632 . . . . 62.31 112.706 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -27.68 66.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.589 1.155 . . . . 74.24 111.673 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -69.42 -59.31 3.07 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 110.38 -0.23 . . . . 75.13 110.38 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.56 65.09 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.263 0.625 . . . . 62.04 112.022 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.37 -44.33 54.66 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.742 1.217 . . . . 74.2 111.324 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -76.63 -32.7 58.18 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.831 -0.622 . . . . 74.34 111.451 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.78 -33.23 75.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.513 0.325 . . . . 72.41 111.799 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -66.84 -38.58 86.69 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.898 0.38 . . . . 74.22 110.096 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.61 68.31 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.566 -0.743 . . . . 63.23 111.212 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -14.59 61.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.806 0.843 . . . . 73.0 111.255 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.09 21.58 32.53 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 119.402 -0.666 . . . . 34.1 113.226 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -74.53 157.78 34.91 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.294 0.547 . . . . 63.23 109.735 170.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -69.14 -65.03 0.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.043 -0.526 . . . . 75.13 111.378 -156.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.0 t -127.71 135.69 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.134 -1.062 . . . . 63.15 108.134 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 p -134.1 102.42 5.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.648 0.779 . . . . 54.1 109.054 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -101.8 150.65 22.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.186 0.594 . . . . 62.14 109.833 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 15.1 m -143.83 139.23 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.75 0.82 . . . . 75.42 110.198 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.26 -143.18 6.34 Favored Glycine 0 C--N 1.35 1.352 0 C-N-CA 121.228 -0.511 . . . . 42.34 113.829 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -158.25 128.13 5.96 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.634 0.773 . . . . 75.24 110.595 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.1 163.56 16.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.766 0.826 . . . . 63.24 110.865 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -76.85 149.38 36.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.746 1.218 . . . . 74.41 110.213 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.97 107.36 0.84 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 123.859 0.864 . . . . 73.11 111.701 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -93.67 -87.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.132 2.554 . . . . 54.32 111.173 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.82 -15.8 13.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.094 0.958 . . . . 63.51 110.935 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.1 p -129.14 143.09 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.744 0.818 . . . . 74.13 111.068 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.42 23.13 1.47 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.832 0.853 . . . . 71.33 111.125 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.03 143.94 37.69 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.375 0.67 . . . . 73.34 109.317 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -73.71 96.52 2.52 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 122.378 1.085 . . . . 65.41 108.703 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 101' ' ' ALA . 5.2 p -151.91 137.79 18.07 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.723 -1.126 . . . . 55.34 109.844 -170.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 118' ' ' VAL . 60.9 t -96.82 116.85 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.982 -0.748 . . . . 60.03 108.982 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -107.27 139.33 41.9 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.928 -0.767 . . . . 73.12 108.928 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.484 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 39.6 p90 -143.03 147.43 35.08 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.703 0.763 . . . . 72.33 112.436 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -78.3 166.42 22.71 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 107.396 -1.335 . . . . 72.23 107.396 160.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.49 22.56 9.92 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.357 -0.839 . . . . 73.41 112.066 -168.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.17 111.26 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 109.662 -0.496 . . . . 72.11 109.662 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 63.48 -82.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.331 1.452 . . . . 75.31 111.492 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.99 35.07 1.19 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 116.206 -0.452 . . . . 70.02 112.989 -171.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 50.3 mt-10 -71.27 -34.29 70.56 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.429 -0.952 . . . . 72.01 108.429 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -54.56 -36.61 64.53 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.839 -1.073 . . . . 71.24 112.061 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.59 55.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.654 0.782 . . . . 64.04 111.187 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.427 HG21 ' HB3' ' A' ' 35' ' ' ALA . 81.3 p -67.97 -30.0 69.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.067 0.547 . . . . 62.31 110.831 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.86 -38.16 64.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.067 -0.969 . . . . 75.42 111.397 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.03 -38.95 90.65 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.785 0.834 . . . . 61.14 110.808 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -51.96 67.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.907 0.883 . . . . 72.22 111.275 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 118' ' ' VAL . 97.1 t -73.03 -46.1 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.053 0.541 . . . . 63.41 111.848 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.74 -24.81 57.91 Favored Glycine 0 N--CA 1.468 0.811 0 O-C-N 123.561 0.538 . . . . 71.24 112.799 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -81.48 -42.21 20.62 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.62 0.768 . . . . 74.11 109.874 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.5 m -73.76 -28.96 61.95 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.311 0.577 . . . . 44.12 111.344 -175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.0 tp -92.31 -29.29 16.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.785 1.234 . . . . 62.34 109.423 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.76 46.35 18.32 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.738 0.648 . . . . 51.1 111.958 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.31 148.49 42.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.827 0.851 . . . . 75.34 109.764 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 78' ' ' THR . . . -66.38 116.08 7.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.309 0.644 . . . . 54.13 110.459 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.484 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 34.9 m -85.25 140.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.256 0.622 . . . . 73.52 109.329 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -155.2 153.83 31.31 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.48 0.712 . . . . 53.32 109.651 -174.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.04 173.01 3.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.82 0.848 . . . . 70.13 110.811 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -83.58 26.66 0.66 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.998 1.11 . . . . 73.12 113.998 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.1 mm? -64.17 -53.65 45.81 Favored Pre-proline 0 CA--C 1.559 1.322 0 CA-C-O 118.146 -0.93 . . . . 74.23 111.41 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 22.8 Cg_exo -67.1 -38.25 16.5 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 121.663 1.575 . . . . 73.21 113.129 -178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.01 -21.38 61.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.253 0.345 . . . . 74.22 110.875 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.43 -14.36 56.37 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.328 1.051 . . . . 64.01 111.372 -174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.6 t -57.94 -48.02 81.16 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.268 0.627 . . . . 64.14 110.483 171.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.97 -31.87 21.84 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.851 0.86 . . . . 75.24 110.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.32 73.46 0.63 Allowed Pre-proline 0 CA--C 1.561 1.404 0 C-N-CA 125.786 1.634 . . . . 70.45 110.805 -173.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -88.4 148.48 6.4 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.338 2.692 . . . . 72.42 110.976 165.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -87.41 133.67 3.29 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.362 2.041 . . . . 71.3 112.787 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.97 -139.7 14.68 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.432 -0.803 . . . . 61.34 114.033 172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.2 t -105.82 113.14 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.328 1.051 . . . . 72.41 110.258 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 117' ' ' ILE . 31.1 pt -101.04 114.38 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 122.049 0.928 . . . . 75.22 109.075 171.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.713 HG13 HG22 ' A' ' 79' ' ' VAL . 89.5 t -90.69 108.49 19.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.264 -1.013 . . . . 71.13 108.264 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.4 117.56 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.333 -0.988 . . . . 54.41 108.333 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.6 t -106.23 142.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.045 -1.465 . . . . 73.23 107.045 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.3 p -134.98 110.68 9.25 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.889 -0.782 . . . . 63.23 108.889 168.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.212 0 CA-C-O 118.904 -0.942 . . . . 72.32 112.97 178.596 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.884 0 CA-C-O 120.108 -0.274 . . . . 71.11 112.66 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.8 p -155.92 150.04 25.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.199 1.0 . . . . 72.54 109.423 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 p -94.3 133.24 27.53 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.649 0.78 . . . . 75.13 111.568 -176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.68 139.18 51.91 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 122.77 2.313 . . . . 74.25 112.842 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.93 -173.94 2.43 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.878 0.871 . . . . 71.44 109.614 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -136.78 108.17 6.88 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.96 0.504 . . . . 51.4 109.871 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -91.67 6.7 44.81 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.299 0.639 . . . . 72.32 110.289 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.47 -73.23 0.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.073 0.949 . . . . 63.21 111.39 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.0 t70 64.43 146.71 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.176 1.39 . . . . 71.24 112.901 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 p -134.69 120.61 19.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.48 0.712 . . . . 71.3 109.982 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.9 p -129.76 152.36 49.34 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.64 0.776 . . . . 72.23 109.748 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.45 176.4 5.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.769 0.828 . . . . 42.25 110.825 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.77 -175.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.318 1.047 . . . . 73.53 109.887 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -150.13 161.5 42.26 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.824 0.85 . . . . 63.23 110.024 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 p -98.38 153.75 18.34 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.743 0.817 . . . . 72.23 111.655 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 92.7 mmm -113.31 152.62 29.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.543 1.137 . . . . 64.4 109.257 171.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 m -115.65 125.77 53.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.802 0.841 . . . . 51.12 109.014 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -118.57 142.14 47.9 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.209 0.603 . . . . 55.44 109.933 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -154.84 164.64 38.53 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.241 1.017 . . . . 72.35 109.447 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -149.45 168.06 24.48 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 120.909 0.385 . . . . 71.35 110.967 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.14 166.25 13.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.164 0.985 . . . . 51.0 109.846 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.34 125.19 22.47 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.262 0.625 . . . . 73.11 110.909 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.42 -170.57 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.156 2.57 . . . . 75.52 112.271 172.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 m -133.34 146.75 51.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.715 0.806 . . . . 74.43 109.549 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 p -77.4 167.62 21.38 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.648 0.779 . . . . 55.23 111.44 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 m -110.41 131.44 55.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.514 0.725 . . . . 74.34 109.532 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.4 t -122.23 130.86 53.58 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.684 0.793 . . . . 52.13 109.971 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.33 149.42 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.378 0.671 . . . . 54.33 111.195 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -82.37 139.24 44.8 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 108.574 -0.898 . . . . 74.04 108.574 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.65 168.36 11.79 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.501 2.134 . . . . 75.2 112.216 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.37 169.48 10.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.386 0.674 . . . . 63.42 110.799 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.43 135.67 56.96 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.408 0.683 . . . . 73.14 109.857 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.12 129.18 15.77 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.436 2.09 . . . . 61.03 112.099 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -84.38 -87.23 0.12 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.45 0.7 . . . . 63.03 111.42 -176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.63 175.35 14.03 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.228 0.611 . . . . 75.52 109.959 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 42.2 mt-10 -80.73 117.89 21.8 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.817 -0.629 . . . . 64.15 110.065 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.41 HG21 HD23 ' A' ' 56' ' ' LEU . 24.2 t -127.3 143.61 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.56 0.744 . . . . 54.02 109.422 174.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.85 132.45 15.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.769 0.428 . . . . 75.43 110.075 173.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' A' ' 118' ' ' VAL . 4.8 t -103.95 108.7 25.21 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 123.636 0.774 . . . . 61.32 109.148 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 23.7 m-85 -107.04 135.94 47.74 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.403 0.681 . . . . 71.22 109.781 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -101.06 127.3 47.64 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.261 -0.644 . . . . 51.01 109.261 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.752 HG13 ' HA ' ' A' ' 70' ' ' SER . 19.4 tt -71.89 -24.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 N-CA-C 109.577 -0.527 . . . . 71.23 109.577 171.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.6 p -97.58 -67.03 0.87 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.698 1.199 . . . . 54.5 111.112 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.27 11.64 35.8 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.362 0.506 . . . . 72.12 113.096 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -80.23 -61.53 1.95 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.058 0.543 . . . . 75.01 111.186 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -78.35 123.9 27.51 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.609 -0.723 . . . . 72.35 111.12 -170.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.9 -0.8 89.84 Favored Glycine 0 C--N 1.35 1.332 0 C-N-CA 124.295 0.95 . . . . 52.43 114.303 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 51' ' ' ARG . . . -64.51 -21.74 66.77 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.781 0.791 . . . . 61.11 111.524 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.72 -29.69 68.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.038 1.335 . . . . 40.12 111.958 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB3' HH11 ' A' ' 51' ' ' ARG . . . -62.12 -36.59 82.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.588 0.755 . . . . 63.14 111.361 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.488 HH11 ' HB3' ' A' ' 50' ' ' ALA . 9.9 mpt_? -73.0 -38.57 66.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.686 0.795 . . . . 75.24 111.167 -172.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 p -64.71 -29.02 69.99 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.047 0.539 . . . . 62.31 111.683 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -52.62 7.21 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.441 0.697 . . . . 54.03 110.946 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -56.46 -43.8 79.93 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.473 1.509 . . . . 64.02 112.04 -171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.54 -0.755 . . . . 72.12 111.786 -176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.41 HD23 HG21 ' A' ' 37' ' ' VAL . 9.2 mp -73.2 -27.97 61.93 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.476 0.311 . . . . 64.12 111.406 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.77 -40.15 91.73 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.641 0.588 . . . . 54.4 109.842 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.87 -23.03 59.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.211 0.604 . . . . 22.3 111.528 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.73 -3.3 46.91 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.623 0.769 . . . . 34.13 112.557 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.44 49.26 2.22 Favored Glycine 0 C--N 1.347 1.159 0 C-N-CA 121.431 -0.414 . . . . 52.33 112.082 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.21 158.02 4.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.58 1.152 . . . . 72.25 112.654 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -91.79 -57.1 2.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 106.91 -1.515 . . . . 72.13 106.91 160.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 74.0 t -129.45 136.3 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 73.52 108.153 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.6 m -141.28 114.21 8.49 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.33 -0.989 . . . . 75.5 108.33 169.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -120.25 152.79 37.26 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.677 0.791 . . . . 73.53 110.059 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.0 139.62 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.574 -0.899 . . . . 74.25 108.574 172.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.45 -179.31 36.07 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.399 0.437 . . . . 71.15 112.235 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -143.96 124.21 13.78 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.405 -0.961 . . . . 71.24 108.405 171.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 134.46 11.33 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.746 -0.835 . . . . 74.52 108.746 -170.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.752 ' HA ' HG13 ' A' ' 42' ' ' ILE . 19.6 t -77.68 99.55 5.86 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.449 -0.945 . . . . 74.43 108.449 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 20.3 tp -103.83 120.62 50.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.464 0.706 . . . . 75.52 109.311 -172.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 31.2 Cg_exo -59.86 -28.41 87.14 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.732 2.955 . . . . 74.31 114.984 -171.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.72 9.05 25.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.476 0.711 . . . . 73.33 112.063 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.524 HG21 HG11 ' A' ' 119' ' ' VAL . 63.9 t -105.92 111.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.306 0.642 . . . . 74.24 109.54 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.43 10.37 11.86 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.694 0.798 . . . . 62.45 111.092 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -170.04 156.89 6.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.836 0.854 . . . . 32.43 110.791 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.656 ' HB ' ' H ' ' A' ' 121' ' ' THR . 2.1 t -69.71 102.37 1.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.57 0.748 . . . . 71.52 109.537 173.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.542 HG21 ' HG2' ' A' ' 103' ' ' GLU . 87.8 m -150.21 149.13 29.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.835 -0.62 . . . . 64.14 110.985 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.564 HG13 ' HB ' ' A' ' 118' ' ' VAL . 40.4 t -94.59 113.68 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.282 -1.007 . . . . 74.34 108.282 175.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.554 ' HD1' ' HB2' ' A' ' 103' ' ' GLU . 28.8 m-85 -99.27 135.44 40.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.527 -0.916 . . . . 71.31 108.527 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -126.93 138.16 53.24 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.144 0.497 . . . . 62.44 111.123 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -73.03 153.5 40.86 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 114.935 -1.03 . . . . 55.44 109.159 170.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.671 ' HB3' HD11 ' A' ' 104' ' ' LEU . 11.6 pt-20 -102.06 26.26 7.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.28 0.474 . . . . 74.22 112.28 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.2 t -70.8 93.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 108.499 -0.926 . . . . 55.22 108.499 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 70.52 -77.74 0.05 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.444 1.498 . . . . 60.12 111.162 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.43 50.06 0.31 Allowed Glycine 0 C--N 1.352 1.453 0 N-CA-C 112.523 -0.231 . . . . 65.15 112.523 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.24 -18.64 63.9 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 120.843 0.354 . . . . 63.42 110.675 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.64 -28.25 68.33 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.847 0.859 . . . . 72.01 111.386 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.77 -36.03 81.76 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.622 0.769 . . . . 62.22 110.754 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.9 m -74.7 -38.26 62.4 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.771 -1.104 . . . . 64.31 110.498 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.1 -20.04 56.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.751 0.82 . . . . 44.33 112.351 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -58.57 -49.7 76.49 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.898 -0.778 . . . . 74.33 108.898 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.85 70.74 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 124.442 1.088 . . . . 71.03 111.45 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.82 -46.85 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.212 0.605 . . . . 70.14 111.686 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.41 -26.99 62.62 Favored Glycine 0 C--N 1.348 1.195 0 O-C-N 123.681 0.613 . . . . 74.51 111.913 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -85.4 -31.34 22.96 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.132 0.973 . . . . 64.02 110.777 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.0 m -76.57 -29.91 56.83 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 120.914 0.388 . . . . 43.03 110.435 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 tp -95.79 -32.71 12.56 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.604 0.762 . . . . 71.23 110.141 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.72 44.62 47.9 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.187 -0.461 . . . . 72.4 111.985 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.95 177.57 6.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.955 0.902 . . . . 73.42 110.116 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.81 158.55 35.88 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.743 -0.662 . . . . 74.53 109.918 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.56 HG12 ' HB ' ' A' ' 79' ' ' VAL . 27.3 m -127.1 144.15 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.768 0.827 . . . . 64.42 109.669 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.554 ' HB2' ' HD1' ' A' ' 80' ' ' TYR . 59.9 mm-40 -129.84 149.39 51.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.227 1.011 . . . . 73.12 109.872 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 83' ' ' GLU . 51.7 tp -69.24 175.98 3.57 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.803 -1.09 . . . . 72.32 108.837 165.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -67.62 20.31 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.37 1.619 . . . . 64.12 115.37 -175.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.84 -46.1 81.57 Favored Pre-proline 0 CA--C 1.564 1.486 0 CA-C-O 117.947 -1.025 . . . . 70.24 111.871 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.0 -42.12 32.26 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 122.188 1.925 . . . . 64.41 111.233 168.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 88.0 mt-10 -60.17 -26.48 66.35 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-N 115.998 -0.546 . . . . 73.32 111.134 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.61 -10.18 17.35 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.101 0.96 . . . . 61.1 112.319 -171.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -56.74 -49.95 73.7 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.843 0.857 . . . . 51.41 111.625 171.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.11 -33.44 2.19 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.579 0.752 . . . . 62.05 111.16 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 73.67 80.08 0.17 Allowed Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 126.029 1.731 . . . . 72.44 111.746 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 69.1 Cg_endo -81.26 124.34 4.78 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.574 2.183 . . . . 73.45 110.371 168.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.91 116.66 4.79 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.033 1.822 . . . . 73.42 111.21 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.81 156.82 12.69 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.243 0.449 . . . . 74.14 112.222 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.25 119.75 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.174 1.39 . . . . 73.54 112.774 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.517 HG13 ' HB2' ' A' ' 80' ' ' TYR . 44.4 pt -110.76 106.86 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.763 -0.828 . . . . 73.21 108.763 172.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -96.39 111.81 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.394 -0.965 . . . . 65.54 108.394 175.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.5 t -114.91 118.69 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.593 -0.276 . . . . 64.21 110.975 -175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -99.23 144.17 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.525 0.73 . . . . 73.24 110.019 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.656 ' H ' ' HB ' ' A' ' 77' ' ' THR . 12.0 t -118.27 165.45 13.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.788 0.835 . . . . 73.01 109.596 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 N-CA-C 110.53 -1.028 . . . . 63.22 110.53 179.253 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.551 -0.22 . . . . 71.11 112.551 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -152.7 95.73 2.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.043 0.937 . . . . 74.14 108.934 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 m -88.33 131.57 41.97 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 123.074 0.549 . . . . 74.33 109.798 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.05 138.05 55.18 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.48 2.12 . . . . 73.33 112.097 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -145.91 111.19 5.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.469 0.708 . . . . 72.01 109.785 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.6 p -162.85 35.5 0.1 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.707 1.203 . . . . 73.3 108.682 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.14 14.58 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.248 1.019 . . . . 74.21 112.698 -172.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -55.93 -65.34 0.62 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.569 1.148 . . . . 72.52 110.944 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 54.93 83.07 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.278 0.986 . . . . 73.23 111.201 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.8 p -80.24 138.11 36.75 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.844 -0.616 . . . . 63.45 110.322 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 p -152.12 133.66 14.62 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.653 0.781 . . . . 72.24 110.257 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.88 119.25 3.57 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.386 -0.968 . . . . 73.44 108.386 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -116.75 133.43 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.102 0.561 . . . . 74.21 110.581 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -147.46 127.02 13.26 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.948 0.899 . . . . 64.33 108.865 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -145.72 103.12 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.706 0.803 . . . . 52.12 109.068 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -145.1 149.58 35.3 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.111 0.964 . . . . 72.34 109.725 -178.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -148.2 160.87 42.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.167 0.587 . . . . 55.34 109.812 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -147.56 150.48 34.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.58 0.752 . . . . 75.1 109.477 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -155.89 161.66 40.54 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.592 0.757 . . . . 71.42 109.957 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.7 t -153.67 178.64 9.64 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.241 1.016 . . . . 54.11 109.387 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.18 173.44 11.58 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.608 1.163 . . . . 62.12 109.262 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 121.48 6.38 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.471 0.709 . . . . 73.0 110.146 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.32 141.11 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.78 2.32 . . . . 75.2 112.325 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.6 p -136.3 142.09 43.87 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.664 0.786 . . . . 60.3 110.168 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.7 p -173.83 134.85 0.48 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.277 1.031 . . . . 53.41 109.913 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.0 p -102.35 -177.26 3.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.864 0.866 . . . . 72.04 111.065 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -149.12 126.83 11.73 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.487 -0.931 . . . . 72.43 108.487 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.68 157.88 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.692 0.797 . . . . 73.55 110.069 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -113.36 131.44 22.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 64.41 110.044 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.95 160.98 33.43 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.954 2.436 . . . . 73.45 112.558 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -124.87 177.58 5.94 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.367 1.067 . . . . 61.32 109.578 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.26 141.76 43.02 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.315 0.646 . . . . 54.11 110.413 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.75 159.35 24.8 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.89 2.393 . . . . 74.33 112.314 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.594 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 95.5 mtt180 -123.18 150.49 43.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.585 0.754 . . . . 75.33 110.216 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -171.8 134.22 0.79 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.888 0.875 . . . . 72.04 110.11 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.24 104.18 13.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.231 0.613 . . . . 74.5 109.387 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' THR . 39.9 t -96.47 127.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.538 -0.912 . . . . 63.44 108.538 174.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' ASP . 43.5 ttm105 -147.77 111.81 5.15 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.169 -0.332 . . . . 75.31 110.436 -171.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 130.99 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.169 0.588 . . . . 62.4 109.586 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 17.1 m-85 -124.95 132.46 53.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.952 0.901 . . . . 73.2 109.02 167.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 68' ' ' ASN . 41.0 m-80 -94.31 121.81 36.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 32.45 109.707 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.7 tp -78.99 -27.79 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.401 0.68 . . . . 74.42 109.332 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 122' ' ' GLY . 34.6 t -125.21 -162.04 1.07 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.596 1.158 . . . . 64.43 108.384 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.01 136.37 51.3 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 118.364 0.529 . . . . 53.55 112.791 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.3 t -78.56 122.67 26.2 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.994 0.518 . . . . 32.24 110.601 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.93 160.32 18.73 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.12 -0.696 . . . . 74.25 109.12 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.35 -41.57 87.73 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.3 0.375 . . . . 71.31 112.361 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 52' ' ' THR . . . -63.33 -31.46 72.62 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.208 1.003 . . . . 72.23 112.307 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HB2' HG11 ' A' ' 120' ' ' VAL . . . -58.43 -49.72 76.28 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.839 0.712 . . . . 71.24 111.305 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.93 -32.0 57.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.464 -0.789 . . . . 32.4 110.669 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.661 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 31.6 tpt180 -71.4 -20.19 62.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.888 0.875 . . . . 72.22 111.987 -175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 48' ' ' ALA . 42.1 p -58.95 -52.79 64.22 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.561 0.619 . . . . 61.42 110.208 174.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.59 -25.67 45.31 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.98 -1.009 . . . . 74.14 111.515 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.661 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 31.8 t70 -79.06 -22.71 44.95 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.116 0.966 . . . . 63.42 110.819 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -86.76 -37.96 17.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.603 0.761 . . . . 52.3 109.126 168.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 tp -71.21 -19.36 62.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.489 0.715 . . . . 72.34 112.16 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.99 -27.34 69.34 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 110.491 -0.188 . . . . 73.33 110.491 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.95 60.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.696 0.798 . . . . 74.23 111.495 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.33 12.51 6.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.739 0.816 . . . . 62.24 112.723 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.29 46.39 6.98 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 120.313 -0.159 . . . . 61.21 113.091 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -58.97 152.12 20.42 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.255 1.022 . . . . 74.52 111.316 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.483 HG21 ' HA ' ' A' ' 34' ' ' ARG . 58.7 m -86.4 -55.03 4.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.718 -0.845 . . . . 74.15 108.718 171.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 p -152.61 147.37 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.591 -0.892 . . . . 70.33 108.591 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 54.0 m -142.84 144.9 32.7 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.523 1.129 . . . . 62.24 109.801 -172.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 29.6 t70 -143.67 143.9 31.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.483 1.113 . . . . 63.43 108.34 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.85 133.13 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.363 -0.977 . . . . 71.13 108.363 173.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.85 -160.8 11.23 Favored Glycine 0 C--O 1.246 0.86 0 N-CA-C 111.609 -0.597 . . . . 75.33 111.609 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.458 ' HA ' ' H ' ' A' ' 41' ' ' ASN . 26.2 p30 -130.34 140.15 50.64 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.366 1.066 . . . . 73.53 108.466 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -157.48 134.43 10.12 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.51 -0.552 . . . . 74.21 109.51 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.5 t -73.39 98.23 2.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.972 -1.122 . . . . 53.32 107.972 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.74 98.55 9.89 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.832 -1.173 . . . . 74.05 107.832 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.64 -1.01 10.12 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.725 2.283 . . . . 64.31 113.156 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.99 -23.55 41.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.784 0.833 . . . . 65.22 110.551 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 119' ' ' VAL . 2.7 p -134.05 140.03 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.428 1.091 . . . . 71.33 110.84 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.46 62.07 1.46 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.544 -0.91 . . . . 64.42 108.544 175.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.04 155.75 16.5 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.195 -0.911 . . . . 31.12 110.361 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 121' ' ' THR . 6.3 t -82.43 98.62 8.98 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.604 -1.258 . . . . 75.15 107.604 167.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.6 m -149.25 139.65 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.999 -1.001 . . . . 74.25 109.173 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 118' ' ' VAL . 97.9 t -95.74 116.27 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.205 -1.035 . . . . 74.41 108.205 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.617 ' HB2' HG13 ' A' ' 117' ' ' ILE . 90.4 m-85 -109.53 154.76 22.25 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.27 -0.641 . . . . 75.11 109.27 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -139.46 170.43 15.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.738 -0.665 . . . . 71.3 111.19 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.0 p -110.75 -159.29 0.67 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.627 -0.879 . . . . 63.13 108.627 164.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.21 21.05 12.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.192 0.997 . . . . 70.55 110.092 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.38 100.9 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.866 0.866 . . . . 75.3 110.015 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.594 ' HG2' ' H ' ' A' ' 34' ' ' ARG . 14.0 tp10 70.06 -75.86 0.07 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.588 1.555 . . . . 71.04 111.62 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.47 40.81 0.81 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.644 -1.383 . . . . 63.14 109.644 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.54 -39.18 85.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.961 -0.619 . . . . 43.11 110.142 -172.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -67.01 -31.4 71.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.589 -0.732 . . . . 75.1 110.947 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.2 -43.11 64.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.607 0.763 . . . . 65.35 111.427 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 94' ' ' VAL . 9.8 t -76.69 -34.55 58.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.65 -0.5 . . . . 33.54 109.65 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.06 -38.74 92.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.362 0.665 . . . . 73.44 111.963 176.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.584 ' HA ' HG11 ' A' ' 102' ' ' VAL . 25.7 t70 -58.1 -36.04 72.3 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.322 1.014 . . . . 72.55 110.318 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.37 -42.9 78.47 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.474 -0.785 . . . . 63.14 111.226 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 118' ' ' VAL . 22.0 t -71.26 -34.62 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.28 0.632 . . . . 63.24 112.284 -174.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -59.48 -34.86 83.03 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 121.954 0.752 . . . . 25.03 112.006 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -80.63 -30.58 36.71 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.836 -1.182 . . . . 71.41 110.658 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 m -74.36 -21.02 59.87 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.04 0.536 . . . . 75.33 110.942 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 38.7 tp -97.16 -32.18 12.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.178 0.591 . . . . 72.52 110.609 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.63 19.6 53.8 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.869 -0.605 . . . . 35.52 112.027 -170.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.23 -177.69 3.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.375 1.07 . . . . 72.24 111.082 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.65 154.8 17.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.522 0.729 . . . . 62.43 110.318 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.584 HG11 ' HA ' ' A' ' 92' ' ' ASP . 19.9 m -108.35 129.95 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.452 -0.573 . . . . 25.23 109.452 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.34 164.03 28.34 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.863 0.865 . . . . 75.52 111.185 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.28 -175.32 0.11 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.969 -1.014 . . . . 71.41 112.134 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.32 -27.48 62.46 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.757 -0.64 . . . . 72.51 112.048 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 61.64 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 124.549 1.14 . . . . 71.33 111.714 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.12 -27.16 84.23 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.487 2.124 . . . . 73.13 112.281 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -79.2 -53.57 6.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.885 1.274 . . . . 72.52 110.97 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.455 HD11 ' HB ' ' A' ' 74' ' ' VAL . 52.1 mt -82.53 16.05 2.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.84 0.856 . . . . 61.34 111.611 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.3 m -84.94 -11.13 56.21 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.82 0.448 . . . . 62.45 110.55 165.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.37 8.08 29.39 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.481 0.712 . . . . 73.51 110.994 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -76.66 164.98 56.12 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.925 0.89 . . . . 75.22 110.708 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.2 122.29 11.32 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.948 1.766 . . . . 74.54 111.098 163.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.29 136.77 55.49 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.926 3.084 . . . . 61.4 115.277 -164.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.75 -162.5 15.49 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 115.583 -0.735 . . . . 72.02 113.22 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 91' ' ' ALA . 57.9 t -66.69 115.65 4.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 124.092 0.957 . . . . 54.12 108.972 171.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.617 HG13 ' HB2' ' A' ' 80' ' ' TYR . 7.6 pt -106.23 106.67 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.524 -0.917 . . . . 74.45 108.524 171.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 79' ' ' VAL . 44.5 t -88.52 100.95 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.547 -1.649 . . . . 73.12 106.547 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 74' ' ' VAL . 49.8 t -93.5 118.46 39.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 N-CA-C 107.109 -1.441 . . . . 65.03 107.109 -177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 49' ' ' ALA . 48.0 t -119.24 136.6 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 122.972 0.509 . . . . 72.1 109.762 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.406 ' H ' ' HB ' ' A' ' 77' ' ' THR . 15.2 t -117.54 137.29 52.67 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.565 0.746 . . . . 63.24 109.386 174.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 43' ' ' SER . . . . . . . . 0 CA--C 1.534 1.265 0 N-CA-C 110.721 -0.951 . . . . 37.41 110.721 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.879 -0.488 . . . . 45.03 111.879 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.0 m -141.08 103.22 4.41 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.272 0.629 . . . . 72.22 110.448 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 p -119.78 99.69 49.22 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.111 0.965 . . . . 70.32 108.969 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.62 27.27 0.54 Allowed 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 123.355 2.703 . . . . 74.34 113.386 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.19 105.39 1.38 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.954 0.902 . . . . 74.21 111.102 -172.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 t -154.86 22.61 0.45 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.335 0.654 . . . . 65.05 109.991 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -83.69 15.21 3.32 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.063 0.945 . . . . 75.41 111.773 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -96.97 17.9 15.89 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.907 1.283 . . . . 70.52 111.728 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -64.5 112.95 3.37 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.887 -0.412 . . . . 73.1 109.887 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 p -114.7 148.53 38.12 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.629 0.772 . . . . 71.5 110.179 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.9 p -158.77 129.82 6.25 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.028 0.931 . . . . 64.22 109.101 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.38 133.3 8.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.515 0.726 . . . . 72.31 109.37 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.77 137.34 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.314 0.646 . . . . 71.53 109.816 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 p -156.87 129.51 7.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.512 0.725 . . . . 73.2 109.263 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.4 t -151.35 136.96 17.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.254 -0.647 . . . . 71.22 109.254 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 94.2 mmm -127.59 116.98 21.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.568 0.747 . . . . 74.02 109.339 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -145.05 99.92 3.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.614 0.765 . . . . 72.35 110.017 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -155.99 137.71 14.25 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.092 0.957 . . . . 74.32 109.106 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -155.84 149.49 25.04 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.92 . . . . 74.52 109.261 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.2 p -140.88 119.66 12.54 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.42 1.088 . . . . 75.44 109.033 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.78 147.06 25.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.597 0.759 . . . . 74.24 111.122 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.8 116.8 62.87 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.765 -0.828 . . . . 65.13 108.765 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 137.65 40.42 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.547 2.165 . . . . 74.45 112.751 -172.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -77.48 135.95 38.3 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.493 0.717 . . . . 64.44 109.572 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 p -146.26 148.76 32.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.949 0.5 . . . . 74.13 110.455 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -152.26 179.86 8.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.94 0.896 . . . . 64.51 109.31 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.7 p -158.62 156.75 30.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.817 0.847 . . . . 72.21 109.794 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.45 147.09 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.161 0.585 . . . . 62.22 109.86 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -111.91 143.95 29.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 N-CA-C 108.729 -0.841 . . . . 71.14 108.729 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.24 138.58 61.86 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.217 1.945 . . . . 74.21 111.889 171.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.69 132.83 45.11 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.15 134.06 29.16 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 123.006 0.522 . . . . 73.12 109.676 174.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.91 146.44 42.11 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 121.973 1.782 . . . . 70.53 110.781 175.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -78.95 -79.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 110.205 -0.294 . . . . 73.12 110.205 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -164.13 171.55 14.93 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.13 0.572 . . . . 62.21 109.49 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.46 148.13 24.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.143 0.577 . . . . 63.14 111.565 -174.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 64' ' ' THR . 87.3 t -137.8 125.8 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.608 1.163 . . . . 43.12 108.09 170.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 116' ' ' VAL . 9.6 ptp180 -127.84 111.12 13.27 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.27 -0.894 . . . . 75.34 109.706 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -96.68 110.36 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.477 0.711 . . . . 74.35 110.655 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.483 ' HB2' HG12 ' A' ' 119' ' ' VAL . 51.1 m-85 -100.91 106.04 17.35 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 109.179 -0.674 . . . . 70.01 109.179 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 4.5 m-20 -87.28 113.73 23.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.636 -1.246 . . . . 70.35 107.636 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG13 ' HA ' ' A' ' 70' ' ' SER . 18.2 tt -70.13 -28.22 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.605 0.717 . . . . 72.44 110.165 176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 41' ' ' ASN . 22.8 t -130.27 159.35 37.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.704 -1.134 . . . . 63.43 108.44 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.22 -45.04 44.0 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.888 0.743 . . . . 51.31 113.422 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t 47.86 -164.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.236 1.815 . . . . 62.51 112.798 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 48' ' ' ALA . 39.6 tt0 -71.42 136.42 47.69 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 121.716 -0.615 . . . . 74.24 109.677 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.09 -26.57 65.96 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.884 0.74 . . . . 40.43 114.443 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 51' ' ' ARG . . . -58.27 -26.62 63.17 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.123 0.969 . . . . 75.11 112.693 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 120' ' ' VAL . . . -59.62 -47.58 85.05 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.661 0.784 . . . . 55.45 111.579 177.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 66' ' ' VAL . . . -80.97 -29.4 35.32 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.269 -0.878 . . . . 61.42 111.077 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . 4.0 tmt_? -74.13 -19.25 60.63 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.577 -1.192 . . . . 63.21 111.016 -173.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 34.3 p -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 109.65 -0.5 . . . . 64.1 109.65 172.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.71 -41.52 79.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.514 0.726 . . . . 70.5 111.628 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.15 -37.69 86.16 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.44 0.696 . . . . 72.51 111.063 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -77.97 -33.01 51.65 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.113 0.565 . . . . 74.53 110.589 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' THR . 13.3 tp -63.31 -43.66 97.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.621 0.768 . . . . 64.3 112.019 -169.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -19.34 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.267 0.84 . . . . 63.3 113.267 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.21 -27.89 68.75 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.87 0.468 . . . . 45.12 112.048 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.91 -9.9 59.08 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.129 0.571 . . . . 52.11 112.266 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.48 47.11 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 113.802 0.281 . . . . 73.43 113.802 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.506 ' HE2' HG22 ' A' ' 90' ' ' THR . 6.5 m-85 -91.9 157.96 16.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.652 0.781 . . . . 75.23 109.632 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 HG23 ' A' ' 63' ' ' VAL . 20.2 m -71.59 -77.47 0.09 Allowed 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.445 0.466 . . . . 62.31 111.903 -162.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.467 HG23 HG22 ' A' ' 62' ' ' THR . 69.5 t -127.44 103.49 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 108.787 -0.82 . . . . 75.04 108.787 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 41.2 p -95.46 91.14 6.05 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.599 -0.889 . . . . 63.12 108.599 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 12.2 t70 -102.17 131.84 48.44 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.973 -1.012 . . . . 72.04 108.655 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 50' ' ' ALA . 65.7 t -125.98 133.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.93 -0.396 . . . . 43.14 109.93 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.36 146.62 17.29 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.245 -0.742 . . . . 43.11 111.245 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 24.9 p-10 -111.89 117.34 32.5 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.609 -0.515 . . . . 73.21 109.609 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.7 tp -159.15 138.54 11.46 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 122.493 -0.129 . . . . 70.13 110.831 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.614 ' HA ' HG13 ' A' ' 42' ' ' ILE . 49.3 m -68.69 103.4 1.73 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.491 -0.559 . . . . 73.03 109.491 171.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 74' ' ' VAL . 64.1 mt -112.23 132.4 22.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 123.928 0.891 . . . . 62.01 108.619 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.37 -20.57 54.89 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.608 2.205 . . . . 71.14 113.935 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.558 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 5.3 p-10 -82.04 -26.96 33.29 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.035 0.383 . . . . 72.34 112.035 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.561 HG13 HD12 ' A' ' 42' ' ' ILE . 2.4 p -97.8 117.31 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.676 0.75 . . . . 73.31 109.408 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.76 6.9 4.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.584 1.154 . . . . 75.12 108.926 173.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.3 151.58 15.65 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.456 1.102 . . . . 72.32 109.184 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -74.73 114.38 13.1 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 121.255 0.55 . . . . 61.44 110.375 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.2 m -145.73 143.62 29.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.505 1.122 . . . . 72.32 109.305 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.696 HG22 HG13 ' A' ' 118' ' ' VAL . 92.8 t -110.57 115.53 50.04 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 109.131 -0.692 . . . . 75.35 109.131 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.91 154.42 17.31 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.721 0.808 . . . . 74.13 109.575 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.76 152.9 42.77 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.266 -0.642 . . . . 74.22 109.266 168.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 26.8 m -106.71 135.58 48.01 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.163 -1.051 . . . . 63.42 108.163 172.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.5 0.31 4.19 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.378 1.251 . . . . 75.24 114.378 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.35 111.56 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 123.485 0.714 . . . . 71.02 110.753 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 70.74 -69.34 0.18 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.41 1.484 . . . . 63.01 112.037 176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.95 51.52 0.06 OUTLIER Glycine 0 C--O 1.241 0.54 0 CA-C-O 119.976 -0.347 . . . . 54.44 112.767 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HB3' HG23 ' A' ' 116' ' ' VAL . 39.9 mm-40 -66.79 -27.12 67.32 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 111.786 0.291 . . . . 73.53 111.786 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -56.21 -34.29 66.14 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.56 0.207 . . . . 73.45 111.56 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.96 -39.19 71.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.288 0.635 . . . . 74.4 112.24 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.506 HG22 ' HE2' ' A' ' 61' ' ' PHE . 60.7 p -85.22 -44.41 12.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.862 -0.608 . . . . 72.33 110.753 -179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -58.87 -39.33 81.05 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.209 0.604 . . . . 75.11 112.466 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.568 ' HA ' HG11 ' A' ' 102' ' ' VAL . 23.5 t70 -72.07 -27.39 62.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.013 -0.994 . . . . 61.35 110.401 -175.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.67 -52.08 8.42 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.206 0.602 . . . . 72.3 110.813 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 118' ' ' VAL . 69.4 t -60.44 -49.96 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.292 1.037 . . . . 44.51 111.11 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 79' ' ' VAL . . . -63.88 -33.4 87.15 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.302 -0.863 . . . . 71.43 112.975 -177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -70.72 -37.47 73.53 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.151 -0.525 . . . . 61.11 110.449 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 m -68.29 -34.52 76.32 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.212 0.605 . . . . 72.25 110.927 175.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 63.1 tp -77.53 -33.31 54.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.704 0.802 . . . . 75.51 111.523 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.81 31.45 29.43 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.701 -0.681 . . . . 72.31 112.522 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.55 146.8 44.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.848 0.859 . . . . 64.31 109.155 172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.39 149.63 33.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.131 0.572 . . . . 74.51 111.621 -172.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 92' ' ' ASP . 30.6 m -96.37 134.9 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.712 0.768 . . . . 54.04 111.319 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -134.11 165.67 24.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.438 1.495 . . . . 74.1 109.181 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.19 -174.19 0.78 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.838 0.855 . . . . 73.2 111.241 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.569 ' HB2' HD13 ' A' ' 109' ' ' LEU . 15.4 ptt180 -56.58 -40.86 75.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.804 0.842 . . . . 74.21 111.025 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.9 mt 61.2 164.39 0.1 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 125.15 1.38 . . . . 70.44 113.307 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.14 -23.56 9.77 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 123.329 2.686 . . . . 64.11 114.411 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 mp0 -60.67 -27.38 67.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.986 0.914 . . . . 70.41 112.825 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -66.08 -6.29 12.58 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.945 0.72 . . . . 54.12 112.945 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.0 p -66.2 -28.21 68.58 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.114 0.566 . . . . 70.23 112.066 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -111.61 -33.06 6.47 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.819 0.448 . . . . 51.21 111.743 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 109' ' ' LEU . 13.4 pt20 -90.79 136.68 27.51 Favored Pre-proline 0 N--CA 1.484 1.251 0 N-CA-C 109.29 -0.633 . . . . 73.44 109.29 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.4 95.05 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.633 2.222 . . . . 61.24 112.616 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.5 161.33 35.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.898 2.399 . . . . 70.12 114.017 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 119.95 -149.0 17.89 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.661 -0.976 . . . . 74.24 110.661 -175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 78.7 t -84.66 121.37 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.107 0.453 . . . . 62.23 109.783 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.46 HG22 HG13 ' A' ' 119' ' ' VAL . 4.1 mp -118.97 104.95 16.7 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 108.27 -1.011 . . . . 74.44 108.27 174.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.696 HG13 HG22 ' A' ' 79' ' ' VAL . 58.2 t -92.48 101.37 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.369 -0.974 . . . . 64.01 108.369 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 40' ' ' TYR . 27.1 m -98.48 128.06 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.504 -0.554 . . . . 74.12 109.504 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.732 HG21 ' HB1' ' A' ' 49' ' ' ALA . 15.3 t -127.48 132.18 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.957 0.503 . . . . 71.23 110.309 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.0 t -105.08 165.9 10.76 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.562 0.745 . . . . 53.34 109.16 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 119.106 -0.83 . . . . 52.33 113.065 174.821 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.886 0 N-CA-C 112.316 -0.314 . . . . 41.2 112.316 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p -105.49 146.3 29.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.465 0.706 . . . . 42.42 111.217 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.8 m -105.59 103.64 44.35 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.375 0.67 . . . . 74.04 109.553 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.0 169.75 18.88 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.781 2.32 . . . . 65.42 111.755 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -158.65 151.96 22.82 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.392 0.677 . . . . 52.04 109.347 -174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -72.64 79.32 1.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.145 -0.687 . . . . 71.33 109.145 173.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -94.48 -0.52 54.64 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.564 1.146 . . . . 71.13 110.829 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.08 -73.29 0.17 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.934 0.894 . . . . 73.34 109.922 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 54.26 84.36 0.07 Allowed 'General case' 0 C--N 1.363 1.154 0 C-N-CA 124.947 1.299 . . . . 63.24 112.307 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.9 p -92.36 111.0 22.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.685 0.794 . . . . 74.3 110.411 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.2 m -88.59 -179.37 6.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.111 0.964 . . . . 74.21 111.512 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.92 141.13 30.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.406 -0.816 . . . . 73.44 109.787 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.1 pt -121.73 155.65 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.712 0.805 . . . . 51.21 110.305 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.0 t -160.17 123.07 3.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.925 0.89 . . . . 23.22 108.797 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.1 m -118.65 133.11 56.1 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.934 0.494 . . . . 74.54 110.046 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 61.9 mtt -100.47 126.09 46.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.13 0.972 . . . . 73.11 109.52 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 m -134.34 109.11 8.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.789 0.836 . . . . 74.15 109.949 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.5 p -105.38 152.64 22.7 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.141 0.976 . . . . 61.04 109.968 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -153.05 116.07 4.58 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.374 0.67 . . . . 74.52 110.295 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.6 p -133.87 143.41 48.28 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.047 0.939 . . . . 63.31 110.497 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.23 167.48 20.61 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.806 0.842 . . . . 53.02 110.174 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.6 143.6 36.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 64.22 110.664 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.24 176.32 10.1 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.225 2.617 . . . . 73.52 113.48 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -112.99 159.38 19.19 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.101 0.961 . . . . 63.32 110.545 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -108.56 144.93 35.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 74.02 110.257 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -129.59 113.62 15.04 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.25 0.62 . . . . 70.44 110.503 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.3 m -102.89 133.94 47.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.969 0.508 . . . . 73.41 110.268 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.96 126.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 122.998 0.519 . . . . 75.03 110.331 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -114.95 106.81 51.13 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 108.354 -0.98 . . . . 71.53 108.354 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.23 162.62 25.98 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.119 2.546 . . . . 73.21 113.294 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.94 102.28 6.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.405 0.682 . . . . 65.11 109.586 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.69 105.07 11.9 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.545 0.738 . . . . 74.14 110.854 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.45 160.98 17.18 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.405 2.07 . . . . 73.03 112.588 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -87.15 -69.87 0.65 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.074 0.55 . . . . 65.34 110.879 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.429 ' HB3' HG21 ' A' ' 90' ' ' THR . . . -162.0 162.79 29.04 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.364 1.065 . . . . 52.22 108.925 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.49 140.35 29.66 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.145 0.498 . . . . 64.21 110.446 -177.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 64' ' ' THR . 48.5 t -118.04 160.53 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.254 1.022 . . . . 73.53 109.128 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.09 127.78 11.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.725 0.41 . . . . 72.3 110.199 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 118' ' ' VAL . 94.1 t -106.36 121.3 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.639 0.776 . . . . 72.21 109.463 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -115.81 133.47 56.0 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.622 0.769 . . . . 71.51 110.793 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -82.62 116.29 21.96 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.688 -0.856 . . . . 74.04 108.688 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 74' ' ' VAL . 10.5 tp -80.12 -24.03 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 109.354 -0.61 . . . . 73.42 109.354 172.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.677 ' HB2' ' H ' ' A' ' 122' ' ' GLY . 40.4 m -139.18 169.38 17.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.272 1.029 . . . . 72.11 109.129 170.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 84.49 0.15 Allowed Glycine 0 C--N 1.347 1.183 0 O-C-N 123.551 0.532 . . . . 52.11 112.231 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 t -97.01 178.8 5.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.631 0.772 . . . . 74.23 109.89 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.77 151.19 43.72 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.133 0.573 . . . . 64.11 111.02 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.72 -4.44 46.8 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.059 -0.856 . . . . 71.2 114.823 -173.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.5 -28.25 69.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.196 0.998 . . . . 64.05 112.271 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.49 -45.21 91.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.378 0.671 . . . . 71.12 110.842 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.29 -31.72 62.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.231 -0.895 . . . . 64.44 111.302 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -68.92 -36.32 77.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.537 1.135 . . . . 72.22 110.447 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.7 t -73.86 -35.09 64.73 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.411 -0.358 . . . . 72.22 110.109 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.65 -40.88 63.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.432 0.693 . . . . 63.42 110.89 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -53.81 -48.18 70.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.05 0.94 . . . . 74.23 110.884 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -78.43 -29.24 46.94 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.478 -0.783 . . . . 62.23 111.274 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.75 -45.56 74.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.234 1.014 . . . . 74.05 111.359 -174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -51.63 -46.19 63.57 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.521 1.128 . . . . 62.12 111.625 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.6 -10.68 60.14 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.801 0.841 . . . . 62.35 112.556 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.83 7.3 42.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.603 0.761 . . . . 65.11 112.394 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.43 26.18 5.76 Favored Glycine 0 N--CA 1.475 1.288 0 CA-C-O 120.853 0.14 . . . . 24.11 113.205 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.528 ' HE2' ' HA ' ' A' ' 90' ' ' THR . 16.4 m-85 -108.09 154.04 22.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.238 1.015 . . . . 73.24 108.412 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.507 0.323 . . . . 70.41 111.681 -167.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.62 153.45 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.067 -1.086 . . . . 73.33 108.067 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 22.2 p -127.23 114.44 17.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.92 -0.77 . . . . 51.23 108.92 178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -101.25 127.76 47.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.556 0.742 . . . . 44.15 109.256 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.65 129.68 67.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.088 -0.708 . . . . 63.45 109.088 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.91 -179.46 30.12 Favored Glycine 0 C--N 1.341 0.808 0 O-C-N 123.601 0.563 . . . . 72.21 111.91 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -130.65 125.92 35.26 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.143 -1.058 . . . . 71.14 108.143 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . 57.1 mt -140.18 151.46 45.25 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.746 0.818 . . . . 72.41 110.15 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' HD12 ' A' ' 42' ' ' ILE . 24.2 m -126.85 98.21 5.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.782 0.833 . . . . 74.22 109.632 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HB2' HG22 ' A' ' 74' ' ' VAL . 7.4 mp -121.09 153.46 57.79 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 124.647 1.179 . . . . 61.32 109.438 -176.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.33 -27.69 6.3 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.512 2.141 . . . . 51.35 112.745 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.6 -23.05 53.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.75 0.82 . . . . 64.3 111.19 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 71' ' ' LEU . 33.0 m -120.41 117.98 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 109.088 -0.708 . . . . 73.41 109.088 174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 42' ' ' ILE . . . -144.46 9.46 1.4 Allowed 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.869 -0.519 . . . . 71.35 111.045 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.79 158.22 44.63 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.356 1.063 . . . . 75.4 109.345 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.573 ' HB ' HG22 ' A' ' 121' ' ' THR . 7.2 t -69.34 98.22 1.05 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.285 1.04 . . . . 73.02 108.913 174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.8 m -150.74 137.09 18.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.49 1.116 . . . . 72.34 110.217 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 118' ' ' VAL . 40.3 t -101.67 119.7 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.314 1.046 . . . . 75.41 108.861 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' CE1' HG12 ' A' ' 74' ' ' VAL . 93.4 m-85 -103.75 125.42 50.21 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.252 -0.647 . . . . 72.22 109.252 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -145.45 160.38 41.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.52 0.728 . . . . 74.32 110.37 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -109.36 -120.32 0.27 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 108.103 -1.073 . . . . 61.53 108.103 172.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -137.89 -9.34 1.58 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.251 0.932 . . . . 70.5 112.194 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.43 107.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.33 0.652 . . . . 75.04 111.735 -167.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 59.77 31.43 20.81 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 53.45 112.067 173.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.55 38.44 5.58 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.03 -0.986 . . . . 52.25 113.374 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.3 -44.44 71.99 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.189 0.495 . . . . 72.54 112.303 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -66.31 -24.62 66.57 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 111.888 0.329 . . . . 73.01 111.888 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.51 -37.2 57.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.386 0.674 . . . . 50.13 111.252 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HE2' ' A' ' 61' ' ' PHE . 81.8 p -82.01 -28.49 32.52 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.325 0.584 . . . . 54.33 110.277 -174.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.39 -31.47 54.21 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.636 1.174 . . . . 74.1 111.786 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.38 -55.54 32.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.832 1.253 . . . . 71.33 110.6 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.34 -32.24 71.08 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.676 -1.147 . . . . 74.54 112.727 -173.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG11 HG21 ' A' ' 118' ' ' VAL . 47.4 t -87.87 -53.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.059 0.544 . . . . 73.44 111.588 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.57 -29.88 75.97 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.814 -0.63 . . . . 70.11 113.75 -168.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -72.97 -36.14 67.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.095 0.558 . . . . 62.51 110.552 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.7 m -62.04 -40.23 95.05 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.716 0.806 . . . . 62.31 111.257 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.86 -15.31 37.09 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.31 0.485 . . . . 71.2 112.31 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.12 25.04 75.74 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.891 -0.483 . . . . 71.31 111.891 -172.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.87 136.85 33.95 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.342 1.057 . . . . 63.2 109.486 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 113.32 2.6 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.953 0.783 . . . . 32.33 111.09 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -83.87 101.58 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 122.457 1.123 . . . . 64.35 109.047 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -112.9 158.36 20.29 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.519 -1.219 . . . . 74.02 111.343 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.61 177.75 1.49 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.347 -1.297 . . . . 65.3 110.397 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -59.29 -44.76 92.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.981 -0.554 . . . . 72.11 110.695 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt 60.77 173.63 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.106 0.962 . . . . 72.55 111.777 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -51.61 -27.33 25.35 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.419 2.079 . . . . 62.31 113.674 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.97 -47.33 83.63 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.077 0.951 . . . . 74.44 112.325 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.543 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . 23.0 tp -71.67 -12.18 61.2 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 120.896 0.379 . . . . 73.43 111.215 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.4 t -79.06 -14.09 59.37 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.201 0.601 . . . . 72.55 110.818 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.13 -25.82 23.93 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.548 0.739 . . . . 62.35 112.362 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' A' ' 109' ' ' LEU . 1.3 pp0? -142.54 155.85 63.65 Favored Pre-proline 0 N--CA 1.495 1.802 0 CA-C-O 118.282 -0.866 . . . . 74.14 111.132 -173.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 30.9 Cg_exo -37.47 125.75 0.61 Allowed 'Trans proline' 0 C--N 1.397 3.1 0 C-N-CA 124.736 3.624 . . . . 70.15 115.867 -169.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 18.8 Cg_exo -64.61 133.3 36.28 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.089 2.526 . . . . 53.33 112.175 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.496 ' H ' HD21 ' A' ' 109' ' ' LEU . . . 157.09 177.81 30.56 Favored Glycine 0 C--O 1.245 0.812 0 N-CA-C 110.667 -0.973 . . . . 61.33 110.667 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.8 t -80.66 100.04 4.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.817 -0.438 . . . . 75.14 109.817 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 117' ' ' ILE . 41.8 pt -102.89 108.58 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.76 -0.83 . . . . 74.41 108.76 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.627 HG13 HG22 ' A' ' 79' ' ' VAL . 51.7 t -90.6 100.99 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.373 -1.343 . . . . 71.32 107.373 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.531 HG11 ' HB ' ' A' ' 74' ' ' VAL . 61.3 t -95.93 118.17 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.827 -0.805 . . . . 40.11 108.827 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.28 133.72 63.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.107 0.563 . . . . 65.33 109.619 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 77' ' ' THR . 11.8 t -98.72 156.17 16.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.505 0.722 . . . . 64.13 110.577 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.677 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.686 -1.063 . . . . 37.85 110.968 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 CA-C-O 120.104 -0.276 . . . . 73.43 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 m -134.36 -42.82 0.78 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.375 0.67 . . . . 71.1 110.401 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 m 68.14 81.21 0.21 Allowed Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.005 1.322 . . . . 70.14 110.542 -172.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -85.05 170.63 9.62 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.691 2.261 . . . . 71.54 112.307 171.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -148.3 153.7 39.01 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.729 0.812 . . . . 73.22 108.813 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.9 t -127.59 40.31 3.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.934 0.893 . . . . 74.34 108.716 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -83.11 -3.14 57.0 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.979 0.912 . . . . 72.41 112.183 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.59 -64.95 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.176 0.59 . . . . 55.01 109.519 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 64.45 177.85 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.171 1.389 . . . . 75.55 112.954 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.1 p -160.89 90.46 0.84 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.153 0.581 . . . . 73.22 110.762 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -90.7 132.78 35.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.132 0.573 . . . . 74.23 109.979 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.39 98.54 3.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.101 0.56 . . . . 75.22 111.128 -172.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -131.41 129.73 62.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.755 0.822 . . . . 73.54 110.335 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 p -175.47 103.83 0.08 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.307 1.043 . . . . 60.41 110.629 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -166.89 130.92 1.95 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.203 1.001 . . . . 63.14 109.925 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -132.35 77.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.082 -0.71 . . . . 64.03 109.082 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.3 p -85.42 104.58 15.35 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.087 -0.506 . . . . 42.05 110.14 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -146.29 145.21 30.28 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.203 1.001 . . . . 74.03 109.562 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -149.97 168.82 22.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.769 0.428 . . . . 64.51 111.085 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.9 t -148.21 169.97 18.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.345 1.058 . . . . 64.44 109.775 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.08 167.09 22.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.314 1.045 . . . . 64.21 109.995 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.8 124.29 24.03 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.162 0.985 . . . . 64.0 109.996 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -66.39 123.65 11.44 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.486 2.791 . . . . 72.41 113.248 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.6 p -117.4 125.97 51.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.503 0.721 . . . . 53.24 110.98 -174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 m -136.98 123.19 20.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.849 0.86 . . . . 73.4 109.104 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t -155.31 127.91 7.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.47 0.708 . . . . 75.43 110.063 -170.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.2 m -155.85 127.3 7.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.992 0.917 . . . . 44.34 109.569 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 m -90.19 156.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.503 0.721 . . . . 72.0 111.148 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.14 158.74 71.81 Favored Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 124.64 1.176 . . . . 63.35 110.201 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.89 158.87 48.86 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.086 2.524 . . . . 73.03 112.875 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.43 162.65 22.05 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.732 0.813 . . . . 74.54 111.044 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.39 143.12 79.09 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 123.507 0.723 . . . . 51.2 111.227 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.66 164.51 28.8 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.761 2.307 . . . . 74.13 114.212 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -123.63 138.47 54.54 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.341 1.057 . . . . 63.21 109.178 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 61' ' ' PHE . . . -164.22 81.73 0.41 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.497 -0.557 . . . . 73.13 109.497 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mp0 -96.94 91.51 5.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.995 0.918 . . . . 74.55 109.676 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 56' ' ' LEU . 21.1 t -95.65 139.66 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.271 1.028 . . . . 53.01 109.283 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HG3' ' HB2' ' A' ' 65' ' ' ASP . 43.7 ttm105 -148.3 131.97 16.89 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.202 -0.666 . . . . 75.11 109.202 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 66' ' ' VAL . 47.8 t -114.83 135.11 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.721 0.808 . . . . 75.34 109.819 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -137.32 107.23 6.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.923 0.889 . . . . 73.41 109.772 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.42 123.16 32.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.106 -1.072 . . . . 74.52 108.106 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.627 HG21 HG11 ' A' ' 74' ' ' VAL . 18.5 tt -85.86 -38.44 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 118.227 0.467 . . . . 55.33 110.682 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.0 m -149.63 155.89 40.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.818 0.847 . . . . 63.14 109.744 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 122' ' ' GLY . . . 93.57 -39.02 3.01 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.515 0.509 . . . . 73.23 112.718 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t 37.13 80.49 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.449 1.9 . . . . 52.22 113.131 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.67 173.11 9.23 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.963 -1.017 . . . . 72.22 111.372 -170.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.59 -45.67 94.09 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.31 -1.314 . . . . 62.42 114.036 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 -28.01 67.46 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.352 0.871 . . . . 74.2 113.352 -169.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -60.33 2.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.669 0.388 . . . . 72.15 111.029 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.4 69.12 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.735 -0.666 . . . . 73.22 111.849 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -34.4 77.97 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.258 1.423 . . . . 74.35 110.477 -174.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.448 ' O ' HD13 ' A' ' 56' ' ' LEU . 77.0 p -62.25 -57.26 12.08 Favored 'General case' 0 C--N 1.36 1.032 0 O-C-N 123.468 0.48 . . . . 51.32 110.317 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 64' ' ' THR . . . -71.92 -28.37 63.44 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.08 0.152 . . . . 70.44 111.337 -177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.7 -31.52 71.53 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.433 0.693 . . . . 74.54 111.153 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -80.73 -45.38 17.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.32 -0.4 . . . . 71.22 110.451 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 37' ' ' VAL . 10.9 mp -66.4 -31.58 72.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.635 -0.711 . . . . 72.15 112.189 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.57 -39.65 91.89 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.885 0.374 . . . . 75.22 111.05 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.71 -29.75 61.29 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.456 -0.793 . . . . 51.45 110.308 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -13.08 61.06 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.539 0.736 . . . . 60.0 111.396 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.79 31.36 7.82 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.532 0.52 . . . . 30.01 113.687 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.403 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 7.8 m-85 -79.72 155.7 27.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.601 -0.889 . . . . 75.41 108.601 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 35' ' ' ALA . 37.0 m -73.26 -59.92 2.48 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.724 0.41 . . . . 72.12 111.468 -163.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 99.5 t -114.41 141.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.692 -0.855 . . . . 74.03 108.692 178.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.529 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 14.6 p -145.61 109.87 4.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.96 0.904 . . . . 72.35 108.807 173.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.55 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.4 m-20 -103.86 144.47 31.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.786 -0.82 . . . . 75.05 108.786 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.493 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 61.9 t -133.59 114.83 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.361 -0.977 . . . . 71.44 108.361 173.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -144.25 159.38 27.69 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 121.521 -0.371 . . . . 53.33 113.033 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -113.27 113.97 26.05 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.029 -1.1 . . . . 63.23 108.029 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.59 144.51 20.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.887 -0.783 . . . . 60.14 108.887 -167.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.408 ' HA ' HG13 ' A' ' 42' ' ' ILE . 33.7 t -83.62 108.7 16.88 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 62.42 109.251 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.59 149.31 35.58 Favored Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.631 . . . . 62.02 110.281 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.18 -20.8 18.54 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.958 2.439 . . . . 55.33 113.253 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -80.82 -19.16 45.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.252 1.021 . . . . 50.23 112.12 -174.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 42' ' ' ILE . 90.6 t -56.5 133.18 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.114 0.884 . . . . 74.15 112.375 -167.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.39 -45.13 0.08 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 113.954 -1.476 . . . . 53.14 108.268 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.36 158.1 43.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.379 1.072 . . . . 60.01 109.339 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.527 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.7 t -62.66 111.95 2.3 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.358 0.599 . . . . 74.34 110.201 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.0 m -149.32 138.57 21.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.561 0.745 . . . . 64.42 110.485 -172.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 118' ' ' VAL . 18.3 t -94.66 114.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.687 1.195 . . . . 71.32 108.444 173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.476 ' HB3' HD21 ' A' ' 109' ' ' LEU . 28.7 m-85 -95.53 154.52 17.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.318 -0.993 . . . . 71.52 108.318 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -153.44 -179.88 8.17 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.546 0.688 . . . . 74.13 111.784 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.498 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 24.0 m -126.83 139.48 53.07 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 105.999 -1.852 . . . . 74.23 105.999 161.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.05 -10.21 59.24 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.962 0.727 . . . . 74.33 112.962 -170.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.31 130.97 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 63.21 112.843 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.24 21.05 11.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.72 1.208 . . . . 74.05 112.723 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.57 62.99 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 116.308 -0.405 . . . . 63.13 112.861 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 82' ' ' THR . 11.3 tp10 -69.53 -21.92 63.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.074 0.95 . . . . 64.35 109.95 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -57.69 -29.28 64.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.405 1.082 . . . . 72.43 112.936 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -45.11 83.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.704 0.801 . . . . 53.24 112.023 -174.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.531 HG23 HG21 ' A' ' 116' ' ' VAL . 9.9 t -74.58 -30.99 61.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.23 -0.441 . . . . 55.3 110.759 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -69.23 -34.9 75.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.885 0.474 . . . . 63.13 111.407 174.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.79 -40.58 83.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.524 1.129 . . . . 71.4 109.57 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.09 60.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.757 -1.11 . . . . 42.14 110.681 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.01 -32.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.16 0.984 . . . . 62.14 111.827 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.43 93.53 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.957 -0.457 . . . . 74.54 111.957 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 -80.31 -25.99 39.05 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.0 0.52 . . . . 73.14 111.881 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -70.81 -43.12 69.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.951 0.5 . . . . 45.14 110.231 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.5 tp -86.22 -30.84 22.07 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.592 -0.731 . . . . 62.14 110.598 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.03 24.95 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.771 -0.649 . . . . 21.13 112.165 -174.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.94 167.65 9.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.994 0.917 . . . . 65.14 111.279 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.85 154.34 41.92 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.923 0.889 . . . . 75.1 111.071 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 m -119.05 119.58 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-O 121.013 0.435 . . . . 44.34 110.569 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -113.46 148.26 36.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.343 0.657 . . . . 74.54 110.997 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.64 -166.89 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.905 1.282 . . . . 63.34 111.911 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -77.04 28.55 0.14 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 124.508 1.123 . . . . 75.45 113.037 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pp -47.97 157.77 0.6 Allowed Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 125.458 1.503 . . . . 60.23 113.19 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.35 -24.29 0.97 Allowed 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 124.44 3.427 . . . . 74.21 117.847 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.68 -22.29 64.38 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.361 0.664 . . . . 74.23 112.413 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 80' ' ' TYR . 4.4 mm? -64.6 -8.91 15.96 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.6 0.76 . . . . 42.31 111.738 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 t -63.98 -42.01 97.36 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.281 1.032 . . . . 74.54 112.003 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.477 ' HB2' ' OE1' ' A' ' 112' ' ' GLN . 4.5 m-20 -80.77 -33.57 34.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.898 0.479 . . . . 55.33 111.562 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 111' ' ' ASP . 1.0 OUTLIER -90.71 157.49 43.84 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.704 0.802 . . . . 71.21 108.998 178.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.7 125.07 16.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.062 1.842 . . . . 72.52 110.783 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.22 118.96 5.9 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.146 2.564 . . . . 72.2 112.719 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.51 -158.7 31.76 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.859 -0.896 . . . . 75.13 110.859 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.531 HG21 HG23 ' A' ' 90' ' ' THR . 74.1 t -79.25 105.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.196 -0.668 . . . . 73.41 109.196 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' ' 117' ' ' ILE . 31.1 pt -116.68 107.75 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 108.849 -0.797 . . . . 74.42 108.849 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 79' ' ' VAL . 2.1 p -87.28 105.02 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.54 -0.911 . . . . 61.02 108.54 173.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 74' ' ' VAL . 94.7 t -91.51 117.48 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.75 -1.204 . . . . 71.3 107.75 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.24 127.44 65.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.527 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.2 p -104.89 102.9 12.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.778 -1.564 . . . . 63.1 106.778 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 119.308 -0.718 . . . . 70.52 112.639 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.857 -0.497 . . . . 74.3 111.857 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 p -148.51 119.47 7.65 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.918 0.887 . . . . 61.34 109.639 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 t -162.08 79.47 1.96 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 123.409 0.684 . . . . 75.45 109.266 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.41 85.92 1.76 Allowed 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.327 2.684 . . . . 63.04 110.978 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -85.27 96.26 9.46 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 115.586 -0.734 . . . . 72.31 109.744 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.6 m -141.63 70.14 1.34 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.836 1.254 . . . . 73.42 108.693 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -91.9 -10.4 39.72 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 114.603 -1.18 . . . . 43.5 112.027 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -130.37 -55.09 1.1 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.277 0.631 . . . . 74.42 110.824 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 65.97 -81.53 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.007 1.323 . . . . 75.53 111.243 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 p -170.73 148.74 3.01 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.586 0.754 . . . . 72.44 110.03 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -170.37 106.2 0.3 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.36 1.064 . . . . 75.4 108.209 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.12 131.54 5.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.358 0.663 . . . . 63.24 110.042 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.2 tt -169.07 130.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.528 1.131 . . . . 61.21 109.339 175.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 p -172.2 128.11 0.57 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.296 1.038 . . . . 62.44 108.617 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.7 t -148.29 110.48 4.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 109.52 -0.548 . . . . 71.41 109.52 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.5 mtt -136.46 104.72 5.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.684 0.794 . . . . 55.22 109.406 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 m -135.1 114.99 12.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.493 1.117 . . . . 54.24 109.816 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 p -148.06 143.05 26.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.842 1.257 . . . . 70.41 109.001 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -152.77 137.87 17.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.605 1.162 . . . . 50.41 108.851 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.7 p -143.92 106.41 4.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.954 0.902 . . . . 61.2 110.307 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.49 144.4 18.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.099 0.959 . . . . 71.14 110.08 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.73 105.78 4.27 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 123.724 0.81 . . . . 63.01 109.563 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.06 113.69 2.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.081 2.521 . . . . 75.03 112.341 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -152.03 119.12 5.86 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.233 0.539 . . . . 62.41 110.283 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -153.84 139.91 18.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.722 1.209 . . . . 72.32 109.251 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -148.44 128.35 13.5 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.028 0.531 . . . . 74.14 110.412 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.3 m -150.31 89.18 1.56 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.212 1.005 . . . . 55.44 108.992 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.34 140.74 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.814 0.846 . . . . 71.33 110.26 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.31 115.68 64.62 Favored Pre-proline 0 N--CA 1.479 1.001 0 N-CA-C 108.753 -0.832 . . . . 73.24 108.753 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.12 134.84 21.91 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.678 2.252 . . . . 72.35 111.279 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.4 123.34 8.73 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.215 1.006 . . . . 72.31 108.476 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.64 147.65 5.38 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.32 0.648 . . . . 74.22 110.173 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.92 145.8 81.07 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.25 2.633 . . . . 63.3 113.341 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -134.65 -75.88 0.46 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.736 0.815 . . . . 74.11 109.969 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.48 101.5 9.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.476 0.71 . . . . 73.42 110.424 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.448 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 9.3 mp0 -82.35 101.1 10.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.044 0.937 . . . . 73.33 109.086 176.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.13 140.1 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.883 -0.784 . . . . 71.25 108.883 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -152.08 129.0 10.98 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.623 0.769 . . . . 64.23 109.473 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 118' ' ' VAL . 43.7 t -114.79 126.55 72.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.131 -1.063 . . . . 70.35 108.131 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' CE1' HG22 ' A' ' 119' ' ' VAL . 7.9 p90 -127.56 139.72 52.58 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.475 0.655 . . . . 72.2 110.005 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' A' ' 46' ' ' GLU . 16.4 m120 -84.24 146.78 27.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.708 -1.133 . . . . 75.24 108.303 166.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 121' ' ' THR . 10.2 tp -76.94 -23.23 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.005 0.431 . . . . 64.3 109.993 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.9 m -118.84 -57.37 2.04 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.737 0.815 . . . . 71.13 109.758 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 76.94 1.05 Allowed Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.802 -0.519 . . . . 63.21 111.802 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.2 m -145.13 -37.6 0.28 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.841 0.856 . . . . 65.53 110.074 178.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.549 ' HB3' HD21 ' A' ' 41' ' ' ASN . 10.9 tp10 -73.96 109.9 7.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.997 0.519 . . . . 75.32 110.346 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.53 -24.07 59.34 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.395 -0.82 . . . . 55.11 112.522 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.31 67.6 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.07 0.548 . . . . 73.54 110.855 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.65 55.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.803 0.841 . . . . 63.25 110.598 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -27.38 66.14 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.616 -0.72 . . . . 65.04 111.609 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -67.7 -35.93 79.71 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.441 1.097 . . . . 72.44 110.825 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.6 p -62.35 -53.2 58.5 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 122.426 0.29 . . . . 70.35 111.229 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -68.9 -30.13 68.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.379 0.272 . . . . 70.31 111.255 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.8 -39.41 94.16 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.5 0.72 . . . . 70.42 109.95 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -74.78 -33.52 62.27 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.656 -0.702 . . . . 74.21 110.355 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.377 0.671 . . . . 75.24 111.048 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -63.04 -46.54 87.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 107.948 -1.13 . . . . 75.02 107.948 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.99 -29.23 69.02 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.263 -0.88 . . . . 60.2 111.122 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.52 -17.02 58.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.484 0.714 . . . . 40.43 111.601 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.9 37.23 7.98 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 116.492 -0.322 . . . . 44.21 113.878 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.26 159.47 28.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.063 0.545 . . . . 74.05 110.164 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.4 m -60.9 -68.91 0.26 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.811 0.694 . . . . 62.14 111.176 -167.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 36' ' ' GLU . 89.2 t -116.48 138.16 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.806 -1.183 . . . . 71.52 107.806 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.6 p -136.4 96.28 3.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.277 -1.379 . . . . 63.22 107.277 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -102.25 145.95 28.71 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.625 -0.88 . . . . 74.35 108.625 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.09 135.1 55.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.061 0.944 . . . . 72.24 108.836 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.11 -164.27 27.37 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 121.249 -0.501 . . . . 52.33 112.3 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -146.28 118.5 8.35 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.268 -1.012 . . . . 74.44 108.268 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.53 143.03 47.19 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 108.656 -0.868 . . . . 70.44 108.656 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.9 t -86.57 97.16 10.37 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 109.117 -0.697 . . . . 45.35 109.117 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.87 110.87 62.5 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.518 1.127 . . . . 73.11 108.454 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.1 -12.96 33.23 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.247 1.965 . . . . 53.14 113.236 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -77.19 -21.43 53.97 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.661 0.385 . . . . 74.2 111.671 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.22 142.12 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.557 -0.535 . . . . 62.22 109.557 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.93 22.44 1.58 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.343 1.057 . . . . 61.23 109.983 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.25 149.25 33.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.581 0.753 . . . . 72.04 109.582 -173.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.3 t -76.88 103.55 6.89 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 121.873 0.844 . . . . 73.44 109.834 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.2 m -151.47 140.11 20.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.338 -0.847 . . . . 74.21 110.113 -175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.677 HG22 HG13 ' A' ' 118' ' ' VAL . 41.7 t -96.46 114.25 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.848 0.859 . . . . 64.14 109.154 176.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.83 132.71 45.01 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.295 1.038 . . . . 74.01 108.493 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.605 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 12.3 p90 -137.31 165.82 25.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.991 0.516 . . . . 72.04 111.904 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.0 t -106.99 148.86 28.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.607 -1.257 . . . . 53.54 107.607 161.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.538 ' HG2' ' HD2' ' A' ' 88' ' ' ARG . 46.0 mt-10 -97.16 9.04 43.26 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.915 0.486 . . . . 65.12 111.787 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.31 143.12 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.301 -0.629 . . . . 53.42 109.301 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 62.11 -83.09 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.721 1.208 . . . . 72.03 111.969 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.31 37.72 0.21 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.991 -0.443 . . . . 63.14 111.991 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.48 -35.9 24.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.542 0.337 . . . . 62.13 111.462 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HD2' ' HG2' ' A' ' 83' ' ' GLU . 61.4 ttt180 -61.25 -26.93 68.08 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.948 -0.47 . . . . 75.5 111.294 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.47 99.85 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.628 0.771 . . . . 70.34 111.956 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -81.49 -24.26 36.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.114 0.483 . . . . 51.2 110.55 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.7 59.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.929 0.892 . . . . 71.1 111.612 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.55 -45.52 75.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.417 -1.265 . . . . 75.2 109.663 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.29 -56.9 14.73 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.648 -1.16 . . . . 53.33 111.114 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 118' ' ' VAL . 86.6 t -71.27 -37.32 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.726 -0.67 . . . . 41.52 111.823 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.81 -35.44 52.96 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.566 0.541 . . . . 62.34 112.459 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -86.17 -32.8 21.05 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.673 -0.763 . . . . 63.42 110.308 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.9 m -65.84 -40.98 92.28 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.353 0.597 . . . . 45.41 110.399 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 44.4 tp -83.53 -28.44 28.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.656 -1.156 . . . . 72.21 109.934 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.82 75.69 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.764 -0.653 . . . . 63.43 112.606 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.91 -172.59 3.75 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.83 0.852 . . . . 53.04 110.617 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.09 161.34 26.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.863 0.465 . . . . 31.42 109.965 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.605 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 10.0 m -129.96 124.63 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.853 0.861 . . . . 53.14 109.016 175.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -129.08 158.57 38.57 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.008 0.923 . . . . 60.33 110.905 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.8 -163.64 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.027 -1.442 . . . . 74.24 111.023 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.557 ' HA ' HD12 ' A' ' 109' ' ' LEU . 14.4 ttp180 -75.4 30.77 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.136 1.374 . . . . 62.33 112.955 -172.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.2 mt -46.0 152.41 0.78 Allowed Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 125.549 1.539 . . . . 71.13 113.654 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.2 -12.72 0.5 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 124.759 3.639 . . . . 60.0 116.796 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -60.31 -33.69 72.73 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.265 0.555 . . . . 71.23 110.287 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.595 HD22 HD13 ' A' ' 117' ' ' ILE . 31.5 mt -76.71 5.6 7.36 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.298 1.039 . . . . 73.3 113.299 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.4 p -82.13 -41.36 20.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.735 -0.839 . . . . 73.24 108.735 170.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.7 -34.86 30.39 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.743 -1.117 . . . . 61.22 110.243 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -86.16 146.99 43.94 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.355 -0.839 . . . . 73.54 109.236 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 37.7 Cg_endo -64.32 124.04 12.76 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.338 2.025 . . . . 74.41 111.165 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 32.0 Cg_exo -60.26 133.79 51.72 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.726 2.951 . . . . 73.32 113.76 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.11 -129.14 2.17 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.204 -1.158 . . . . 42.45 110.204 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.48 105.12 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.325 -0.991 . . . . 72.45 108.325 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.595 HD13 HD22 ' A' ' 109' ' ' LEU . 2.3 mp -105.59 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 N-CA-C 108.028 -1.101 . . . . 41.2 108.028 -176.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.677 HG13 HG22 ' A' ' 79' ' ' VAL . 58.8 t -88.15 106.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.59 -1.263 . . . . 71.31 107.59 174.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' CE1' ' A' ' 40' ' ' TYR . 19.2 t -93.13 130.56 42.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.74 -0.837 . . . . 71.12 108.74 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.58 129.21 74.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.65 0.78 . . . . 55.1 109.043 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.506 ' H ' ' HB ' ' A' ' 77' ' ' THR . 13.2 t -77.29 144.04 38.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.074 -1.084 . . . . 75.32 108.074 171.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 N-CA-C 110.488 -1.045 . . . . 65.22 110.488 -167.087 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 112.65 -0.18 . . . . 72.25 112.65 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -84.95 103.3 13.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.375 0.67 . . . . 51.53 111.068 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -75.62 121.81 85.86 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.896 -0.779 . . . . 64.23 108.896 169.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.14 -174.62 1.43 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.724 2.283 . . . . 54.21 112.607 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -160.56 175.2 12.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.333 0.653 . . . . 55.11 109.749 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.0 p -60.14 161.33 7.05 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.103 0.961 . . . . 55.2 110.803 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -62.8 -73.24 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.18 0.992 . . . . 72.41 111.042 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -131.66 -76.48 0.51 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.836 0.455 . . . . 73.32 110.532 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.8 t70 175.28 144.33 0.06 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.113 1.365 . . . . 74.11 109.004 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -88.85 107.63 19.09 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.03 -0.73 . . . . 64.1 109.03 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 t -76.8 173.8 11.26 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.599 0.76 . . . . 64.12 111.489 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.69 157.31 44.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.704 0.802 . . . . 55.1 110.28 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 pt -102.84 -176.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.518 0.727 . . . . 72.53 110.785 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 t -148.68 173.67 12.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.29 0.636 . . . . 54.4 110.223 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -143.35 146.67 33.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.991 0.516 . . . . 73.11 111.373 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -121.4 135.22 55.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.841 0.856 . . . . 60.13 109.499 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.0 m -145.8 128.65 16.36 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.296 1.038 . . . . 71.35 108.789 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 p -110.24 162.89 14.17 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.65 0.78 . . . . 73.03 111.586 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -118.79 136.47 53.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.91 0.884 . . . . 72.05 109.688 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.6 m -78.29 157.68 29.12 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.778 0.831 . . . . 64.23 110.359 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.81 169.76 16.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.309 1.044 . . . . 70.32 109.472 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.61 42.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.399 0.68 . . . . 63.22 111.095 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.32 176.87 9.43 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.402 2.068 . . . . 63.04 111.794 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 p -112.92 -175.89 2.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.331 0.652 . . . . 74.22 110.474 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.9 t -150.2 136.1 18.5 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.519 -0.919 . . . . 72.1 108.519 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -114.44 138.43 50.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.003 0.521 . . . . 72.14 109.621 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.7 m -148.15 121.7 9.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.435 0.694 . . . . 72.35 109.506 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.06 144.58 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.488 0.715 . . . . 72.44 110.149 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 10.8 mptt -105.98 157.24 35.21 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 124.084 0.954 . . . . 75.43 110.102 -176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -54.19 149.99 34.11 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 72.01 113.304 171.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.4 159.8 32.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.481 0.712 . . . . 70.45 112.016 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.41 154.13 94.65 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.412 1.085 . . . . 72.41 111.98 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.34 159.35 40.22 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.98 2.454 . . . . 71.41 111.226 173.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.48 -81.9 0.64 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.439 0.533 . . . . 65.54 112.439 -173.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.12 154.96 46.2 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.219 0.463 . . . . 70.04 112.196 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 27.3 mm-40 -77.07 114.49 15.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.104 0.962 . . . . 74.11 109.451 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 43.1 t -125.76 137.32 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 122.853 0.461 . . . . 73.04 110.542 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.634 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -151.27 148.99 28.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.005 0.922 . . . . 74.14 110.676 171.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.51 113.57 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.263 1.025 . . . . 75.21 109.505 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -103.33 107.85 18.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.78 0.432 . . . . 75.34 110.228 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 68' ' ' ASN . 3.4 t-20 -94.42 119.44 33.16 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.734 -0.839 . . . . 73.14 108.734 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -102.43 -42.9 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 122.073 -0.392 . . . . 73.34 110.365 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 p -136.88 158.55 44.21 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.84 -0.8 . . . . 73.45 108.84 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.75 59.05 4.21 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.591 -1.003 . . . . 73.13 110.591 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 t -66.22 100.81 0.65 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.602 0.761 . . . . 62.01 111.491 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -147.83 155.44 41.65 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.249 0.62 . . . . 53.22 110.133 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.62 -2.53 36.36 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 118.905 -0.942 . . . . 65.13 114.001 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.98 69.46 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.095 0.958 . . . . 70.31 111.412 171.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -42.56 97.28 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 124.154 0.909 . . . . 51.43 110.988 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.22 -35.53 71.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.67 -0.696 . . . . 71.5 111.089 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.76 -31.24 71.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.901 1.28 . . . . 64.45 111.63 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.525 ' HB ' HG13 ' A' ' 94' ' ' VAL . 48.0 p -76.97 -22.18 53.59 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.7 0.4 . . . . 72.33 111.59 176.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.19 -54.73 5.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.462 0.705 . . . . 74.45 111.205 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -54.96 -31.16 60.33 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.16 0.984 . . . . 74.55 113.147 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -59.88 -39.47 85.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.321 0.648 . . . . 74.43 111.789 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.0 -38.42 36.74 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 118.917 -0.563 . . . . 75.51 111.893 -174.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -30.93 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.825 0.738 . . . . 73.35 110.596 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.19 -27.97 66.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.479 0.712 . . . . 71.15 110.808 173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.71 -21.8 37.78 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.63 0.772 . . . . 51.12 111.989 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.06 25.99 4.85 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 113.968 0.347 . . . . 65.4 113.968 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.43 158.73 27.27 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.34 0.656 . . . . 64.12 110.443 172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.0 m -65.43 -70.1 0.26 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.969 0.793 . . . . 71.34 110.854 -165.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.02 145.15 35.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.69 -0.856 . . . . 64.42 108.69 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 37' ' ' VAL . 41.4 p -137.14 100.61 4.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.527 -1.286 . . . . 71.24 107.527 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 19.0 t70 -104.9 162.5 13.27 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.897 0.879 . . . . 73.32 110.183 -172.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 141.44 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.841 0.856 . . . . 73.03 109.049 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.44 129.02 2.41 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.947 -0.461 . . . . 65.14 111.947 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 16.8 p-10 -88.66 97.39 11.09 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.447 0.699 . . . . 73.53 109.823 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.4 135.55 13.03 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.166 -0.333 . . . . 73.54 110.155 -169.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -81.16 99.41 8.53 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.433 -0.58 . . . . 70.13 109.433 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.31 151.75 89.98 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.407 -0.59 . . . . 73.33 109.407 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.04 -7.61 18.32 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.113 1.875 . . . . 54.44 112.371 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -108.93 -23.05 11.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.342 0.657 . . . . 73.4 112.43 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.06 130.13 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.36 0.6 . . . . 65.55 111.252 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.27 -7.67 4.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.431 1.092 . . . . 75.44 111.215 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.12 159.0 5.77 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.463 1.105 . . . . 55.14 109.345 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 121' ' ' THR . 9.4 t -66.75 107.24 2.09 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.694 0.759 . . . . 63.32 109.996 177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 m -144.91 153.42 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.531 -0.759 . . . . 73.5 109.293 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.685 HG21 ' HA3' ' A' ' 95' ' ' GLY . 4.3 t -112.6 114.28 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.916 -1.142 . . . . 64.13 107.916 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.582 ' HB2' HG13 ' A' ' 117' ' ' ILE . 52.4 m-85 -105.1 119.38 38.89 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.285 0.493 . . . . 73.12 110.585 -174.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HD2' ' HB3' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -112.01 140.99 46.22 Favored 'General case' 0 C--O 1.245 0.86 0 O-C-N 123.85 0.719 . . . . 74.31 110.462 175.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.1 t -113.78 -40.05 3.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.946 0.898 . . . . 62.03 111.654 -175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -89.81 37.38 0.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.858 0.863 . . . . 73.21 111.856 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 m -45.87 163.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.518 1.927 . . . . 74.13 114.746 -174.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 86.69 -55.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.727 2.011 . . . . 75.33 108.359 -163.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.31 -50.73 1.99 Allowed Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.205 -0.452 . . . . 75.02 112.574 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.04 -19.94 50.15 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.653 0.263 . . . . 72.41 111.299 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -56.81 -27.97 60.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.75 -0.659 . . . . 65.53 110.972 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.8 -46.64 57.57 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.716 0.806 . . . . 72.43 112.214 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 94' ' ' VAL . 6.2 t -79.9 -33.24 40.03 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 122.672 0.389 . . . . 75.14 110.736 -171.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 116' ' ' VAL . . . -64.59 -48.22 75.76 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 123.799 0.687 . . . . 64.31 110.353 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.534 ' HA ' HG11 ' A' ' 102' ' ' VAL . 30.5 t70 -57.52 -40.24 78.34 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.272 0.983 . . . . 73.1 110.785 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.54 -46.1 87.51 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.961 0.788 . . . . 54.2 112.149 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 52' ' ' THR . 61.4 t -65.44 -52.82 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.328 0.651 . . . . 74.31 110.605 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.685 ' HA3' HG21 ' A' ' 79' ' ' VAL . . . -64.6 -26.84 71.18 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.344 -0.844 . . . . 62.4 113.281 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 2.6 tmt_? -65.07 -39.29 93.02 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.507 0.723 . . . . 75.45 109.553 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -66.46 -52.65 43.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.922 -1.035 . . . . 73.31 111.181 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 118' ' ' VAL . 4.0 pp -82.45 -13.71 56.29 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.792 -0.64 . . . . 73.34 112.402 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.66 72.81 1.2 Allowed Glycine 0 C--N 1.349 1.255 0 O-C-N 123.574 0.546 . . . . 45.25 113.136 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.06 155.11 44.56 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.703 0.801 . . . . 75.34 110.001 172.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.97 142.53 33.36 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.492 -0.776 . . . . 74.3 110.289 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.534 HG11 ' HA ' ' A' ' 92' ' ' ASP . 34.0 m -95.19 148.25 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.417 0.687 . . . . 70.14 110.748 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -157.5 156.69 32.49 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 123.811 0.844 . . . . 70.21 110.81 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.63 161.51 23.12 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.402 1.081 . . . . 74.05 110.746 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.424 ' HG3' ' H ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -69.66 29.73 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.404 2.001 . . . . 71.24 116.404 -172.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.406 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.0 mm? -54.61 -53.62 58.12 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-N 119.562 1.074 . . . . 74.43 112.521 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 6.0 Cg_exo -80.26 -13.93 12.2 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 122.378 2.052 . . . . 75.34 112.953 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HG2' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -58.62 -41.61 86.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.498 0.719 . . . . 72.32 110.153 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.4 tp -64.29 -12.75 44.72 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.56 0.744 . . . . 70.03 112.566 -172.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -63.64 -47.16 82.47 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.871 0.869 . . . . 74.32 111.161 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.2 -32.49 7.48 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.353 1.061 . . . . 75.13 110.944 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.1 71.92 1.04 Allowed Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 126.782 2.033 . . . . 54.52 112.708 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HD2' ' HG2' ' A' ' 108' ' ' GLU . 1.4 Cg_endo -88.71 140.74 4.34 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.1 2.533 . . . . 74.03 111.106 162.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.0 129.04 13.72 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.66 2.24 . . . . 74.11 114.468 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.23 -156.15 32.02 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.022 -0.536 . . . . 41.25 113.988 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 37' ' ' VAL . 76.8 t -58.1 111.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 124.278 1.031 . . . . 74.2 110.138 177.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.582 HG13 ' HB2' ' A' ' 80' ' ' TYR . 39.7 pt -117.85 104.3 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.47 -1.307 . . . . 64.52 107.47 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.576 ' HB ' HG13 ' A' ' 79' ' ' VAL . 2.3 p -101.84 111.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 108.886 -0.783 . . . . 65.13 108.886 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -93.17 123.53 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 114.941 -1.027 . . . . 71.42 109.473 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.05 127.52 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.593 0.757 . . . . 72.54 110.108 -172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.574 ' H ' ' HB ' ' A' ' 77' ' ' THR . 63.8 p -123.4 119.61 30.55 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.512 -1.292 . . . . 54.11 107.512 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.594 0 CA-C-O 119.207 -0.774 . . . . 63.32 112.628 -174.613 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.931 0 N-CA-C 111.956 -0.457 . . . . 72.14 111.956 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.0 t -139.78 -57.96 0.57 Allowed 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.497 0.719 . . . . 71.15 109.466 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m 52.67 78.1 0.41 Allowed Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.722 1.209 . . . . 63.45 111.364 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.99 109.8 2.02 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.685 2.256 . . . . 62.12 112.4 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.95 117.47 7.66 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.612 0.765 . . . . 63.11 109.995 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 p -71.03 92.3 0.93 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.349 0.595 . . . . 63.01 109.576 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -91.44 8.64 35.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.445 1.098 . . . . 64.41 111.517 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -62.63 -68.58 0.32 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.474 0.709 . . . . 53.15 110.971 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.3 t70 65.35 113.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.011 1.324 . . . . 52.54 112.423 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.3 m -86.53 126.66 34.61 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.583 0.753 . . . . 75.45 109.931 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.3 p -153.49 124.65 7.45 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.939 0.896 . . . . 73.24 108.684 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.41 123.93 7.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.812 0.845 . . . . 64.53 109.517 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 tp -157.9 136.26 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.817 0.847 . . . . 73.4 109.345 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 p -150.77 88.78 1.5 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.86 0.864 . . . . 73.14 109.318 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.5 p -99.17 131.0 45.51 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.176 -0.675 . . . . 51.33 109.176 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -131.34 155.37 47.35 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.2 0.524 . . . . 73.41 111.251 -174.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -153.98 159.35 41.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.135 1.374 . . . . 75.53 108.352 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -139.59 42.23 2.01 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 122.043 0.925 . . . . 33.43 109.911 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 m -78.66 100.48 7.04 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.1 -0.955 . . . . 74.34 109.0 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 t -132.79 31.3 3.95 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.829 0.823 . . . . 72.43 110.128 -174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.23 134.65 37.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.212 -0.904 . . . . 70.43 110.898 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.84 111.9 4.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.509 0.724 . . . . 62.35 109.556 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.16 158.18 52.55 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.645 2.23 . . . . 74.34 111.275 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 t -159.5 167.26 29.06 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.16 0.584 . . . . 63.52 110.65 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -143.84 159.5 42.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.689 0.795 . . . . 74.44 110.291 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 t -127.63 140.21 52.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.555 0.742 . . . . 60.12 109.781 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 p -169.29 137.0 1.83 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.824 0.849 . . . . 43.42 109.877 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.11 125.9 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.353 0.661 . . . . 65.11 110.52 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.37 110.48 58.06 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 108.376 -0.972 . . . . 73.24 108.376 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.88 132.67 43.5 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.256 2.637 . . . . 54.44 113.292 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.95 179.77 6.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.734 0.814 . . . . 73.32 110.221 172.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.03 94.48 3.76 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.353 0.661 . . . . 72.52 109.744 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HB3' ' HA ' ' A' ' 62' ' ' THR . 48.3 Cg_exo -59.72 141.85 97.67 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.938 2.426 . . . . 73.31 112.6 173.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -98.92 -75.58 0.56 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.342 0.657 . . . . 74.44 111.871 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.97 168.1 26.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.036 0.534 . . . . 45.12 110.838 -171.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.04 112.71 24.57 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.906 0.882 . . . . 75.11 108.944 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 64' ' ' THR . 99.4 t -116.42 138.95 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.68 0.792 . . . . 71.33 109.461 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -132.15 118.12 19.17 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.614 -0.513 . . . . 63.1 109.614 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.12 107.19 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 109.342 -0.614 . . . . 72.54 109.342 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 33.6 p90 -118.1 152.26 35.93 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 109.102 -0.703 . . . . 74.43 109.102 175.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.72 134.44 36.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.033 -0.728 . . . . 64.31 109.033 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.14 -39.71 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.812 -0.44 . . . . 74.31 109.812 172.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 p -141.73 -61.32 0.46 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.821 0.448 . . . . 64.41 111.208 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.65 100.69 1.72 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.703 -0.498 . . . . 44.4 112.064 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -88.17 41.45 1.0 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.155 0.982 . . . . 52.11 112.858 -168.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.16 137.34 56.2 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.961 0.505 . . . . 72.34 110.521 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -7.69 58.04 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.529 0.518 . . . . 70.51 113.643 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.39 -32.32 64.68 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.267 1.027 . . . . 61.03 110.954 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.08 -56.96 14.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.922 -1.035 . . . . 51.35 110.59 171.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.99 67.65 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.518 -0.765 . . . . 74.4 112.568 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -29.92 68.08 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.039 0.935 . . . . 75.13 110.96 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 98' ' ' LEU . 64.4 p -70.13 -36.86 75.1 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 110.085 -0.339 . . . . 63.22 110.085 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB1' ' OG1' ' A' ' 64' ' ' THR . . . -67.3 -28.5 68.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.602 0.761 . . . . 72.23 111.562 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.41 -24.47 62.93 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.015 0.926 . . . . 72.2 110.711 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -70.51 -42.0 71.88 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.906 -0.405 . . . . 72.24 109.906 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.8 mp -69.39 -29.6 67.4 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.806 0.669 . . . . 73.15 112.806 -174.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.46 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.38 -27.47 67.13 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.897 0.38 . . . . 61.53 110.793 175.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.03 27.77 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.028 0.931 . . . . 62.44 111.746 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 56' ' ' LEU . . . -89.39 -22.8 22.39 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.304 0.642 . . . . 72.02 112.484 -174.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.47 46.83 0.39 Allowed Glycine 0 C--N 1.352 1.439 0 CA-C-N 117.873 0.306 . . . . 54.51 113.308 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -62.41 158.22 18.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.103 0.961 . . . . 73.5 111.818 176.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 33' ' ' PRO . 85.7 m -92.54 -60.72 1.76 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.214 -1.032 . . . . 73.23 108.214 161.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -134.56 140.66 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.611 -1.255 . . . . 71.2 107.611 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t -130.56 127.12 38.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.372 -0.973 . . . . 65.12 108.372 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -122.54 144.55 49.01 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.014 -1.106 . . . . 64.12 108.014 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 m -139.85 143.61 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 122.848 0.459 . . . . 63.54 110.41 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.1 -138.13 4.63 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.016 -0.538 . . . . 63.25 112.16 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -157.96 123.05 4.39 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.265 0.626 . . . . 72.31 110.546 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 10.0 mp -129.12 156.39 43.96 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.188 0.995 . . . . 45.34 108.882 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 p -106.13 100.88 10.4 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.708 0.803 . . . . 50.13 110.055 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -119.16 119.54 31.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 123.818 0.847 . . . . 34.52 109.134 167.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.16 0.33 9.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.757 2.305 . . . . 72.21 112.713 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.0 -26.77 54.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.047 0.939 . . . . 73.51 111.104 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 t -125.56 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.755 -0.832 . . . . 75.24 108.755 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.74 -54.33 2.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.962 0.905 . . . . 35.1 110.488 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.64 160.33 25.08 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.024 0.93 . . . . 62.43 110.436 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 t -64.05 104.67 0.75 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.979 0.895 . . . . 61.32 108.887 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.0 m -136.1 129.84 32.46 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.385 -0.825 . . . . 70.13 110.564 -171.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.73 HG22 HG13 ' A' ' 118' ' ' VAL . 73.5 t -95.18 113.65 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.049 -1.093 . . . . 60.4 108.049 175.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.466 ' CD2' HG12 ' A' ' 117' ' ' ILE . 10.2 t80 -96.98 136.38 37.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.057 -0.72 . . . . 73.44 109.057 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.475 ' HE2' ' HB ' ' A' ' 102' ' ' VAL . 25.1 p90 -151.73 -179.49 7.48 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.71 1.256 . . . . 73.0 108.972 172.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 4.3 m -131.7 169.22 16.49 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 106.043 -1.836 . . . . 55.32 106.043 164.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.69 21.25 2.25 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.134 -0.979 . . . . 73.12 111.826 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.45 99.51 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 124.259 1.024 . . . . 63.54 109.788 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 64.11 -75.99 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 125.56 1.544 . . . . 74.34 111.88 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -158.57 39.07 0.51 Allowed Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.013 0.365 . . . . 51.32 114.013 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 82' ' ' THR . 55.4 mt-10 -69.97 -36.45 75.24 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.0 0.429 . . . . 54.22 110.566 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -62.02 -37.75 86.08 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.781 -1.1 . . . . 64.15 112.54 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.77 -25.49 49.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.986 0.514 . . . . 44.33 111.492 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.5 m -78.75 -36.69 42.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.911 0.885 . . . . 74.31 109.677 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -24.38 40.45 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.928 -1.033 . . . . 65.15 111.554 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.09 -39.71 90.96 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.11 0.964 . . . . 53.21 109.977 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.2 -23.98 66.94 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.139 -0.937 . . . . 74.13 111.996 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.675 HG11 HG21 ' A' ' 118' ' ' VAL . 58.1 t -84.34 -61.96 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 122.872 0.469 . . . . 74.11 111.355 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.415 ' CA ' HG21 ' A' ' 79' ' ' VAL . . . -66.73 -27.73 73.42 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.581 0.55 . . . . 53.14 114.293 -168.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -76.11 -23.46 54.9 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.002 0.521 . . . . 74.32 110.265 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 85.3 m -84.49 -38.69 19.78 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.621 0.769 . . . . 73.31 111.084 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.655 HD21 HG22 ' A' ' 120' ' ' VAL . 46.0 tp -81.37 -31.88 33.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.782 0.833 . . . . 63.34 111.553 -172.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.67 50.57 5.57 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 111.002 -0.839 . . . . 64.2 111.002 -170.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.59 143.74 51.12 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.53 0.732 . . . . 74.31 110.606 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.48 114.48 3.92 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.962 0.788 . . . . 62.23 110.018 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.475 ' HB ' ' HE2' ' A' ' 81' ' ' TYR . 16.1 m -88.13 101.75 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.356 0.598 . . . . 71.42 110.114 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.59 157.24 20.62 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.518 1.151 . . . . 73.3 111.957 -175.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 105' ' ' ARG . 8.0 tp -93.2 -166.59 1.55 Allowed 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 112.934 -1.939 . . . . 70.33 108.367 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.503 ' H ' ' HG ' ' A' ' 104' ' ' LEU . 48.7 ttp180 -81.43 27.69 0.42 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.588 0.755 . . . . 74.2 112.542 -175.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 3.8 mm? -70.87 -66.69 0.73 Allowed Pre-proline 0 CA--C 1.558 1.27 0 CA-C-O 118.045 -0.979 . . . . 71.02 111.053 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 106' ' ' LEU . 4.5 Cg_exo -83.85 -23.57 3.12 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 121.878 1.719 . . . . 74.34 112.988 -173.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.35 -9.96 59.26 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.949 -0.548 . . . . 71.32 111.587 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.61 -20.92 66.55 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.849 0.46 . . . . 71.14 110.526 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.8 t -55.66 -45.56 77.66 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.442 0.697 . . . . 63.34 110.831 171.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -86.13 -32.44 21.31 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.401 0.68 . . . . 62.14 111.221 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.62 79.15 0.36 Allowed Pre-proline 0 CA--C 1.563 1.446 0 C-N-CA 125.734 1.614 . . . . 63.44 111.033 -169.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 3.6 Cg_exo -84.56 125.64 3.38 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.061 2.508 . . . . 72.11 111.743 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' PRO . 3.6 Cg_exo -79.12 118.69 4.08 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.35 2.033 . . . . 75.44 110.906 173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.07 166.19 39.43 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 112.014 -0.434 . . . . 32.21 112.014 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 80' ' ' TYR . 75.9 t -66.94 126.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.023 0.929 . . . . 73.41 111.481 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.466 HG12 ' CD2' ' A' ' 80' ' ' TYR . 9.4 pt -121.85 111.95 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.162 -1.051 . . . . 62.52 108.162 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.73 HG13 HG22 ' A' ' 79' ' ' VAL . 61.3 t -94.01 108.49 20.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.845 -0.798 . . . . 75.23 108.845 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.47 120.95 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.409 -0.814 . . . . 72.24 109.789 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.655 HG22 HD21 ' A' ' 98' ' ' LEU . 44.7 t -110.28 129.59 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 122.681 0.392 . . . . 73.11 110.763 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 t -99.87 164.56 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.048 0.451 . . . . 73.4 110.745 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.806 0 CA-C-O 118.708 -1.051 . . . . 74.22 111.126 170.267 . . . . . . . . 0 0 . 1 stop_ save_